MolSigDBName	PubMedID	DOINFERRED	DOIDINFERRED
1	NAKAMURA_CANCER_MICROENVIRONMENT_UP	17210693	cancer	DOID_162
2	NAKAMURA_CANCER_MICROENVIRONMENT_UP	17210693	disease of cellular proliferation	DOID_14566
3	NAKAMURA_CANCER_MICROENVIRONMENT_UP	17210693	endocrine gland cancer	DOID_170
4	NAKAMURA_CANCER_MICROENVIRONMENT_UP	17210693	organ system cancer	DOID_0050686
5	NAKAMURA_CANCER_MICROENVIRONMENT_UP	17210693	pancreatic cancer	DOID_1793
6	NAKAMURA_CANCER_MICROENVIRONMENT_DN	17210693	cancer	DOID_162
7	NAKAMURA_CANCER_MICROENVIRONMENT_DN	17210693	disease of cellular proliferation	DOID_14566
8	NAKAMURA_CANCER_MICROENVIRONMENT_DN	17210693	endocrine gland cancer	DOID_170
9	NAKAMURA_CANCER_MICROENVIRONMENT_DN	17210693	organ system cancer	DOID_0050686
10	NAKAMURA_CANCER_MICROENVIRONMENT_DN	17210693	pancreatic cancer	DOID_1793
11	WEST_ADRENOCORTICAL_TUMOR_MARKERS_UP	17234769	adenoma	DOID_657
12	WEST_ADRENOCORTICAL_TUMOR_MARKERS_UP	17234769	adrenal cortex cancer	DOID_660
13	WEST_ADRENOCORTICAL_TUMOR_MARKERS_UP	17234769	adrenal gland cancer	DOID_3953
14	WEST_ADRENOCORTICAL_TUMOR_MARKERS_UP	17234769	adrenocortical carcinoma	DOID_3948
15	WEST_ADRENOCORTICAL_TUMOR_MARKERS_UP	17234769	benign neoplasm	DOID_0060072
16	WEST_ADRENOCORTICAL_TUMOR_MARKERS_UP	17234769	cancer	DOID_162
17	WEST_ADRENOCORTICAL_TUMOR_MARKERS_UP	17234769	carcinoma	DOID_305
18	WEST_ADRENOCORTICAL_TUMOR_MARKERS_UP	17234769	cell type benign neoplasm	DOID_0060084
19	WEST_ADRENOCORTICAL_TUMOR_MARKERS_UP	17234769	cell type cancer	DOID_0050687
20	WEST_ADRENOCORTICAL_TUMOR_MARKERS_UP	17234769	disease of cellular proliferation	DOID_14566
21	WEST_ADRENOCORTICAL_TUMOR_MARKERS_UP	17234769	endocrine gland cancer	DOID_170
22	WEST_ADRENOCORTICAL_TUMOR_MARKERS_UP	17234769	organ system cancer	DOID_0050686
23	WEST_ADRENOCORTICAL_TUMOR_MARKERS_DN	17234769	adenoma	DOID_657
24	WEST_ADRENOCORTICAL_TUMOR_MARKERS_DN	17234769	adrenal cortex cancer	DOID_660
25	WEST_ADRENOCORTICAL_TUMOR_MARKERS_DN	17234769	adrenal gland cancer	DOID_3953
26	WEST_ADRENOCORTICAL_TUMOR_MARKERS_DN	17234769	adrenocortical carcinoma	DOID_3948
27	WEST_ADRENOCORTICAL_TUMOR_MARKERS_DN	17234769	benign neoplasm	DOID_0060072
28	WEST_ADRENOCORTICAL_TUMOR_MARKERS_DN	17234769	cancer	DOID_162
29	WEST_ADRENOCORTICAL_TUMOR_MARKERS_DN	17234769	carcinoma	DOID_305
30	WEST_ADRENOCORTICAL_TUMOR_MARKERS_DN	17234769	cell type benign neoplasm	DOID_0060084
31	WEST_ADRENOCORTICAL_TUMOR_MARKERS_DN	17234769	cell type cancer	DOID_0050687
32	WEST_ADRENOCORTICAL_TUMOR_MARKERS_DN	17234769	disease of cellular proliferation	DOID_14566
33	WEST_ADRENOCORTICAL_TUMOR_MARKERS_DN	17234769	endocrine gland cancer	DOID_170
34	WEST_ADRENOCORTICAL_TUMOR_MARKERS_DN	17234769	organ system cancer	DOID_0050686
35	WINTER_HYPOXIA_UP	17409455	breast cancer	DOID_1612
36	WINTER_HYPOXIA_UP	17409455	cancer	DOID_162
37	WINTER_HYPOXIA_UP	17409455	carcinoma	DOID_305
38	WINTER_HYPOXIA_UP	17409455	cell type cancer	DOID_0050687
39	WINTER_HYPOXIA_UP	17409455	disease of cellular proliferation	DOID_14566
40	WINTER_HYPOXIA_UP	17409455	head and neck cancer	DOID_11934
41	WINTER_HYPOXIA_UP	17409455	neck cancer	DOID_1112
42	WINTER_HYPOXIA_UP	17409455	organ system cancer	DOID_0050686
43	WINTER_HYPOXIA_UP	17409455	thoracic cancer	DOID_5093
44	WINTER_HYPOXIA_DN	17409455	breast cancer	DOID_1612
45	WINTER_HYPOXIA_DN	17409455	cancer	DOID_162
46	WINTER_HYPOXIA_DN	17409455	carcinoma	DOID_305
47	WINTER_HYPOXIA_DN	17409455	cell type cancer	DOID_0050687
48	WINTER_HYPOXIA_DN	17409455	disease of cellular proliferation	DOID_14566
49	WINTER_HYPOXIA_DN	17409455	head and neck cancer	DOID_11934
50	WINTER_HYPOXIA_DN	17409455	neck cancer	DOID_1112
51	WINTER_HYPOXIA_DN	17409455	organ system cancer	DOID_0050686
52	WINTER_HYPOXIA_DN	17409455	thoracic cancer	DOID_5093
53	PARENT_MTOR_SIGNALING_UP	17483347	cancer	DOID_162
54	PARENT_MTOR_SIGNALING_UP	17483347	carcinoma	DOID_305
55	PARENT_MTOR_SIGNALING_UP	17483347	cell type cancer	DOID_0050687
56	PARENT_MTOR_SIGNALING_UP	17483347	disease of cellular proliferation	DOID_14566
57	PARENT_MTOR_SIGNALING_DN	17483347	cancer	DOID_162
58	PARENT_MTOR_SIGNALING_DN	17483347	carcinoma	DOID_305
59	PARENT_MTOR_SIGNALING_DN	17483347	cell type cancer	DOID_0050687
60	PARENT_MTOR_SIGNALING_DN	17483347	disease of cellular proliferation	DOID_14566
61	PYEON_HPV_POSITIVE_TUMORS_UP	17510386	cancer	DOID_162
62	PYEON_HPV_POSITIVE_TUMORS_UP	17510386	disease of cellular proliferation	DOID_14566
63	NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_UP	17699763	cancer	DOID_162
64	NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_UP	17699763	carcinoma	DOID_305
65	NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_UP	17699763	cell type cancer	DOID_0050687
66	NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_UP	17699763	disease of cellular proliferation	DOID_14566
67	NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_UP	17699763	endocrine gland cancer	DOID_170
68	NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_UP	17699763	organ system cancer	DOID_0050686
69	NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_UP	17699763	pancreatic cancer	DOID_1793
70	NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_UP	17699763	pancreatic carcinoma	DOID_4905
71	NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN	17699763	cancer	DOID_162
72	NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN	17699763	carcinoma	DOID_305
73	NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN	17699763	cell type cancer	DOID_0050687
74	NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN	17699763	disease of cellular proliferation	DOID_14566
75	NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN	17699763	endocrine gland cancer	DOID_170
76	NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN	17699763	organ system cancer	DOID_0050686
77	NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN	17699763	pancreatic cancer	DOID_1793
78	NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN	17699763	pancreatic carcinoma	DOID_4905
79	PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP	18006812	cancer	DOID_162
80	PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP	18006812	disease of cellular proliferation	DOID_14566
81	PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP	18006812	hematologic cancer	DOID_2531
82	PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP	18006812	immune system cancer	DOID_0060083
83	PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP	18006812	lymphoma	DOID_0060058
84	PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP	18006812	mature T-cell and NK-cell neoplasm	DOID_0050743
85	PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP	18006812	organ system cancer	DOID_0050686
86	PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP	18006812	peripheral T-cell lymphoma	DOID_0050749
87	PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN	18006812	cancer	DOID_162
88	PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN	18006812	disease of cellular proliferation	DOID_14566
89	PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN	18006812	hematologic cancer	DOID_2531
90	PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN	18006812	immune system cancer	DOID_0060083
91	PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN	18006812	lymphoma	DOID_0060058
92	PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN	18006812	mature T-cell and NK-cell neoplasm	DOID_0050743
93	PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN	18006812	organ system cancer	DOID_0050686
94	PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN	18006812	peripheral T-cell lymphoma	DOID_0050749
95	LU_TUMOR_VASCULATURE_UP	17308118	cancer	DOID_162
96	LU_TUMOR_VASCULATURE_UP	17308118	carcinoma	DOID_305
97	LU_TUMOR_VASCULATURE_UP	17308118	cell type cancer	DOID_0050687
98	LU_TUMOR_VASCULATURE_UP	17308118	disease of cellular proliferation	DOID_14566
99	LU_TUMOR_VASCULATURE_UP	17308118	female reproductive organ cancer	DOID_120
100	LU_TUMOR_VASCULATURE_UP	17308118	malignant ovarian surface epithelial-stromal neoplasm	DOID_2151
101	LU_TUMOR_VASCULATURE_UP	17308118	organ system cancer	DOID_0050686
102	LU_TUMOR_VASCULATURE_UP	17308118	ovarian cancer	DOID_2394
103	LU_TUMOR_VASCULATURE_UP	17308118	ovarian carcinoma	DOID_4001
104	LU_TUMOR_VASCULATURE_UP	17308118	ovary epithelial cancer	DOID_2152
105	LU_TUMOR_VASCULATURE_UP	17308118	reproductive organ cancer	DOID_193
106	LU_TUMOR_VASCULATURE_DN	17308118	cancer	DOID_162
107	LU_TUMOR_VASCULATURE_DN	17308118	carcinoma	DOID_305
108	LU_TUMOR_VASCULATURE_DN	17308118	cell type cancer	DOID_0050687
109	LU_TUMOR_VASCULATURE_DN	17308118	disease of cellular proliferation	DOID_14566
110	LU_TUMOR_VASCULATURE_DN	17308118	female reproductive organ cancer	DOID_120
111	LU_TUMOR_VASCULATURE_DN	17308118	malignant ovarian surface epithelial-stromal neoplasm	DOID_2151
112	LU_TUMOR_VASCULATURE_DN	17308118	organ system cancer	DOID_0050686
113	LU_TUMOR_VASCULATURE_DN	17308118	ovarian cancer	DOID_2394
114	LU_TUMOR_VASCULATURE_DN	17308118	ovarian carcinoma	DOID_4001
115	LU_TUMOR_VASCULATURE_DN	17308118	ovary epithelial cancer	DOID_2152
116	LU_TUMOR_VASCULATURE_DN	17308118	reproductive organ cancer	DOID_193
117	KORKOLA_EMBRYONAL_CARCINOMA_UP	16424014	cancer	DOID_162
118	KORKOLA_EMBRYONAL_CARCINOMA_UP	16424014	carcinoma	DOID_305
119	KORKOLA_EMBRYONAL_CARCINOMA_UP	16424014	cell type cancer	DOID_0050687
120	KORKOLA_EMBRYONAL_CARCINOMA_UP	16424014	disease of cellular proliferation	DOID_14566
121	KORKOLA_EMBRYONAL_CARCINOMA_UP	16424014	embryonal cancer	DOID_688
122	KORKOLA_EMBRYONAL_CARCINOMA_UP	16424014	embryonal carcinoma	DOID_3308
123	KORKOLA_EMBRYONAL_CARCINOMA_UP	16424014	germ cell cancer	DOID_2994
124	KORKOLA_EMBRYONAL_CARCINOMA_UP	16424014	germinoma	DOID_3304
125	KORKOLA_EMBRYONAL_CARCINOMA_UP	16424014	seminoma	DOID_4440
126	KORKOLA_EMBRYONAL_CARCINOMA_DN	16424014	cancer	DOID_162
127	KORKOLA_EMBRYONAL_CARCINOMA_DN	16424014	carcinoma	DOID_305
128	KORKOLA_EMBRYONAL_CARCINOMA_DN	16424014	cell type cancer	DOID_0050687
129	KORKOLA_EMBRYONAL_CARCINOMA_DN	16424014	disease of cellular proliferation	DOID_14566
130	KORKOLA_EMBRYONAL_CARCINOMA_DN	16424014	embryonal cancer	DOID_688
131	KORKOLA_EMBRYONAL_CARCINOMA_DN	16424014	embryonal carcinoma	DOID_3308
132	KORKOLA_EMBRYONAL_CARCINOMA_DN	16424014	germ cell cancer	DOID_2994
133	KORKOLA_EMBRYONAL_CARCINOMA_DN	16424014	germinoma	DOID_3304
134	KORKOLA_EMBRYONAL_CARCINOMA_DN	16424014	seminoma	DOID_4440
135	KORKOLA_TERATOMA_UP	16424014	cancer	DOID_162
136	KORKOLA_TERATOMA_UP	16424014	carcinoma	DOID_305
137	KORKOLA_TERATOMA_UP	16424014	cell type cancer	DOID_0050687
138	KORKOLA_TERATOMA_UP	16424014	disease of cellular proliferation	DOID_14566
139	KORKOLA_TERATOMA_UP	16424014	embryonal cancer	DOID_688
140	KORKOLA_TERATOMA_UP	16424014	embryonal carcinoma	DOID_3308
141	KORKOLA_TERATOMA_UP	16424014	germ cell cancer	DOID_2994
142	KORKOLA_TERATOMA_UP	16424014	germinoma	DOID_3304
143	KORKOLA_TERATOMA_UP	16424014	seminoma	DOID_4440
144	KORKOLA_TERATOMA_DN	16424014	cancer	DOID_162
145	KORKOLA_TERATOMA_DN	16424014	carcinoma	DOID_305
146	KORKOLA_TERATOMA_DN	16424014	cell type cancer	DOID_0050687
147	KORKOLA_TERATOMA_DN	16424014	disease of cellular proliferation	DOID_14566
148	KORKOLA_TERATOMA_DN	16424014	embryonal cancer	DOID_688
149	KORKOLA_TERATOMA_DN	16424014	embryonal carcinoma	DOID_3308
150	KORKOLA_TERATOMA_DN	16424014	germ cell cancer	DOID_2994
151	KORKOLA_TERATOMA_DN	16424014	germinoma	DOID_3304
152	KORKOLA_TERATOMA_DN	16424014	seminoma	DOID_4440
153	KORKOLA_YOLK_SAC_TUMOR_UP	16424014	cancer	DOID_162
154	KORKOLA_YOLK_SAC_TUMOR_UP	16424014	carcinoma	DOID_305
155	KORKOLA_YOLK_SAC_TUMOR_UP	16424014	cell type cancer	DOID_0050687
156	KORKOLA_YOLK_SAC_TUMOR_UP	16424014	disease of cellular proliferation	DOID_14566
157	KORKOLA_YOLK_SAC_TUMOR_UP	16424014	embryonal cancer	DOID_688
158	KORKOLA_YOLK_SAC_TUMOR_UP	16424014	embryonal carcinoma	DOID_3308
159	KORKOLA_YOLK_SAC_TUMOR_UP	16424014	germ cell cancer	DOID_2994
160	KORKOLA_YOLK_SAC_TUMOR_UP	16424014	germinoma	DOID_3304
161	KORKOLA_YOLK_SAC_TUMOR_UP	16424014	seminoma	DOID_4440
162	KORKOLA_YOLK_SAC_TUMOR_DN	16424014	cancer	DOID_162
163	KORKOLA_YOLK_SAC_TUMOR_DN	16424014	carcinoma	DOID_305
164	KORKOLA_YOLK_SAC_TUMOR_DN	16424014	cell type cancer	DOID_0050687
165	KORKOLA_YOLK_SAC_TUMOR_DN	16424014	disease of cellular proliferation	DOID_14566
166	KORKOLA_YOLK_SAC_TUMOR_DN	16424014	embryonal cancer	DOID_688
167	KORKOLA_YOLK_SAC_TUMOR_DN	16424014	embryonal carcinoma	DOID_3308
168	KORKOLA_YOLK_SAC_TUMOR_DN	16424014	germ cell cancer	DOID_2994
169	KORKOLA_YOLK_SAC_TUMOR_DN	16424014	germinoma	DOID_3304
170	KORKOLA_YOLK_SAC_TUMOR_DN	16424014	seminoma	DOID_4440
171	KORKOLA_CHORIOCARCINOMA_DN	16424014	cancer	DOID_162
172	KORKOLA_CHORIOCARCINOMA_DN	16424014	carcinoma	DOID_305
173	KORKOLA_CHORIOCARCINOMA_DN	16424014	cell type cancer	DOID_0050687
174	KORKOLA_CHORIOCARCINOMA_DN	16424014	disease of cellular proliferation	DOID_14566
175	KORKOLA_CHORIOCARCINOMA_DN	16424014	embryonal cancer	DOID_688
176	KORKOLA_CHORIOCARCINOMA_DN	16424014	embryonal carcinoma	DOID_3308
177	KORKOLA_CHORIOCARCINOMA_DN	16424014	germ cell cancer	DOID_2994
178	KORKOLA_CHORIOCARCINOMA_DN	16424014	germinoma	DOID_3304
179	KORKOLA_CHORIOCARCINOMA_DN	16424014	seminoma	DOID_4440
180	KORKOLA_SEMINOMA_UP	16424014	cancer	DOID_162
181	KORKOLA_SEMINOMA_UP	16424014	carcinoma	DOID_305
182	KORKOLA_SEMINOMA_UP	16424014	cell type cancer	DOID_0050687
183	KORKOLA_SEMINOMA_UP	16424014	disease of cellular proliferation	DOID_14566
184	KORKOLA_SEMINOMA_UP	16424014	embryonal cancer	DOID_688
185	KORKOLA_SEMINOMA_UP	16424014	embryonal carcinoma	DOID_3308
186	KORKOLA_SEMINOMA_UP	16424014	germ cell cancer	DOID_2994
187	KORKOLA_SEMINOMA_UP	16424014	germinoma	DOID_3304
188	KORKOLA_SEMINOMA_UP	16424014	seminoma	DOID_4440
189	KORKOLA_SEMINOMA_DN	16424014	cancer	DOID_162
190	KORKOLA_SEMINOMA_DN	16424014	carcinoma	DOID_305
191	KORKOLA_SEMINOMA_DN	16424014	cell type cancer	DOID_0050687
192	KORKOLA_SEMINOMA_DN	16424014	disease of cellular proliferation	DOID_14566
193	KORKOLA_SEMINOMA_DN	16424014	embryonal cancer	DOID_688
194	KORKOLA_SEMINOMA_DN	16424014	embryonal carcinoma	DOID_3308
195	KORKOLA_SEMINOMA_DN	16424014	germ cell cancer	DOID_2994
196	KORKOLA_SEMINOMA_DN	16424014	germinoma	DOID_3304
197	KORKOLA_SEMINOMA_DN	16424014	seminoma	DOID_4440
198	WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_UP	16585155	cancer	DOID_162
199	WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_UP	16585155	disease of cellular proliferation	DOID_14566
200	WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN	16585155	cancer	DOID_162
201	WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN	16585155	disease of cellular proliferation	DOID_14566
202	HOLLMAN_APOPTOSIS_VIA_CD40_UP	16585179	B-cell lymphocytic neoplasm	DOID_707
203	HOLLMAN_APOPTOSIS_VIA_CD40_UP	16585179	cancer	DOID_162
204	HOLLMAN_APOPTOSIS_VIA_CD40_UP	16585179	diffuse large B-cell lymphoma	DOID_0050745
205	HOLLMAN_APOPTOSIS_VIA_CD40_UP	16585179	disease of cellular proliferation	DOID_14566
206	HOLLMAN_APOPTOSIS_VIA_CD40_UP	16585179	hematologic cancer	DOID_2531
207	HOLLMAN_APOPTOSIS_VIA_CD40_UP	16585179	immune system cancer	DOID_0060083
208	HOLLMAN_APOPTOSIS_VIA_CD40_UP	16585179	lymphoma	DOID_0060058
209	HOLLMAN_APOPTOSIS_VIA_CD40_UP	16585179	organ system cancer	DOID_0050686
210	HOLLMAN_APOPTOSIS_VIA_CD40_DN	16585179	B-cell lymphocytic neoplasm	DOID_707
211	HOLLMAN_APOPTOSIS_VIA_CD40_DN	16585179	cancer	DOID_162
212	HOLLMAN_APOPTOSIS_VIA_CD40_DN	16585179	diffuse large B-cell lymphoma	DOID_0050745
213	HOLLMAN_APOPTOSIS_VIA_CD40_DN	16585179	disease of cellular proliferation	DOID_14566
214	HOLLMAN_APOPTOSIS_VIA_CD40_DN	16585179	hematologic cancer	DOID_2531
215	HOLLMAN_APOPTOSIS_VIA_CD40_DN	16585179	immune system cancer	DOID_0060083
216	HOLLMAN_APOPTOSIS_VIA_CD40_DN	16585179	lymphoma	DOID_0060058
217	HOLLMAN_APOPTOSIS_VIA_CD40_DN	16585179	organ system cancer	DOID_0050686
218	LIU_PROSTATE_CANCER_UP	16618720	cancer	DOID_162
219	LIU_PROSTATE_CANCER_UP	16618720	disease of cellular proliferation	DOID_14566
220	LIU_PROSTATE_CANCER_UP	16618720	male reproductive organ cancer	DOID_3856
221	LIU_PROSTATE_CANCER_UP	16618720	organ system cancer	DOID_0050686
222	LIU_PROSTATE_CANCER_UP	16618720	prostate cancer	DOID_10283
223	LIU_PROSTATE_CANCER_UP	16618720	reproductive organ cancer	DOID_193
224	LIU_PROSTATE_CANCER_DN	16618720	cancer	DOID_162
225	LIU_PROSTATE_CANCER_DN	16618720	disease of cellular proliferation	DOID_14566
226	LIU_PROSTATE_CANCER_DN	16618720	male reproductive organ cancer	DOID_3856
227	LIU_PROSTATE_CANCER_DN	16618720	organ system cancer	DOID_0050686
228	LIU_PROSTATE_CANCER_DN	16618720	prostate cancer	DOID_10283
229	LIU_PROSTATE_CANCER_DN	16618720	reproductive organ cancer	DOID_193
230	LIU_SOX4_TARGETS_UP	16618720	cancer	DOID_162
231	LIU_SOX4_TARGETS_UP	16618720	disease of cellular proliferation	DOID_14566
232	LIU_SOX4_TARGETS_UP	16618720	male reproductive organ cancer	DOID_3856
233	LIU_SOX4_TARGETS_UP	16618720	organ system cancer	DOID_0050686
234	LIU_SOX4_TARGETS_UP	16618720	prostate cancer	DOID_10283
235	LIU_SOX4_TARGETS_UP	16618720	reproductive organ cancer	DOID_193
236	LIU_SOX4_TARGETS_DN	16618720	cancer	DOID_162
237	LIU_SOX4_TARGETS_DN	16618720	disease of cellular proliferation	DOID_14566
238	LIU_SOX4_TARGETS_DN	16618720	male reproductive organ cancer	DOID_3856
239	LIU_SOX4_TARGETS_DN	16618720	organ system cancer	DOID_0050686
240	LIU_SOX4_TARGETS_DN	16618720	prostate cancer	DOID_10283
241	LIU_SOX4_TARGETS_DN	16618720	reproductive organ cancer	DOID_193
242	ONKEN_UVEAL_MELANOMA_UP	16651410	cancer	DOID_162
243	ONKEN_UVEAL_MELANOMA_UP	16651410	cell type cancer	DOID_0050687
244	ONKEN_UVEAL_MELANOMA_UP	16651410	disease of cellular proliferation	DOID_14566
245	ONKEN_UVEAL_MELANOMA_UP	16651410	melanoma	DOID_1909
246	ONKEN_UVEAL_MELANOMA_DN	16651410	cancer	DOID_162
247	ONKEN_UVEAL_MELANOMA_DN	16651410	cell type cancer	DOID_0050687
248	ONKEN_UVEAL_MELANOMA_DN	16651410	disease of cellular proliferation	DOID_14566
249	ONKEN_UVEAL_MELANOMA_DN	16651410	melanoma	DOID_1909
250	BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_UP	16651414	breast cancer	DOID_1612
251	BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_UP	16651414	cancer	DOID_162
252	BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_UP	16651414	carcinoma	DOID_305
253	BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_UP	16651414	cell type cancer	DOID_0050687
254	BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_UP	16651414	disease of cellular proliferation	DOID_14566
255	BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_UP	16651414	medullary carcinoma	DOID_3974
256	BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_UP	16651414	organ system cancer	DOID_0050686
257	BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_UP	16651414	thoracic cancer	DOID_5093
258	BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_DN	16651414	breast cancer	DOID_1612
259	BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_DN	16651414	cancer	DOID_162
260	BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_DN	16651414	carcinoma	DOID_305
261	BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_DN	16651414	cell type cancer	DOID_0050687
262	BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_DN	16651414	disease of cellular proliferation	DOID_14566
263	BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_DN	16651414	medullary carcinoma	DOID_3974
264	BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_DN	16651414	organ system cancer	DOID_0050686
265	BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_DN	16651414	thoracic cancer	DOID_5093
266	SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP	16707453	breast cancer	DOID_1612
267	SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP	16707453	breast carcinoma	DOID_3459
268	SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP	16707453	breast carcinoma in situ	DOID_8791
269	SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP	16707453	cancer	DOID_162
270	SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP	16707453	carcinoma	DOID_305
271	SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP	16707453	cell type cancer	DOID_0050687
272	SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP	16707453	disease of cellular proliferation	DOID_14566
273	SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP	16707453	ductal carcinoma	DOID_3007
274	SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP	16707453	ductal carcinoma in situ	DOID_0060074
275	SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP	16707453	in situ carcinoma	DOID_8719
276	SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP	16707453	invasive ductal carcinoma	DOID_3008
277	SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP	16707453	organ system cancer	DOID_0050686
278	SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP	16707453	pre-malignant neoplasm	DOID_0060071
279	SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP	16707453	thoracic cancer	DOID_5093
280	SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_DN	16707453	breast cancer	DOID_1612
281	SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_DN	16707453	breast carcinoma	DOID_3459
282	SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_DN	16707453	breast carcinoma in situ	DOID_8791
283	SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_DN	16707453	cancer	DOID_162
284	SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_DN	16707453	carcinoma	DOID_305
285	SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_DN	16707453	cell type cancer	DOID_0050687
286	SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_DN	16707453	disease of cellular proliferation	DOID_14566
287	SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_DN	16707453	ductal carcinoma	DOID_3007
288	SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_DN	16707453	ductal carcinoma in situ	DOID_0060074
289	SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_DN	16707453	in situ carcinoma	DOID_8719
290	SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_DN	16707453	invasive ductal carcinoma	DOID_3008
291	SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_DN	16707453	organ system cancer	DOID_0050686
292	SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_DN	16707453	pre-malignant neoplasm	DOID_0060071
293	SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_DN	16707453	thoracic cancer	DOID_5093
294	DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_UP	16849537	cancer	DOID_162
295	DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_UP	16849537	disease of cellular proliferation	DOID_14566
296	DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_UP	16849537	muscle cancer	DOID_4045
297	DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_UP	16849537	musculoskeletal system cancer	DOID_0060100
298	DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_UP	16849537	organ system cancer	DOID_0050686
299	DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_UP	16849537	rhabdomyosarcoma	DOID_3247
300	DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_UP	16849537	skeletal muscle cancer	DOID_4043
301	DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_DN	16849537	cancer	DOID_162
302	DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_DN	16849537	disease of cellular proliferation	DOID_14566
303	DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_DN	16849537	muscle cancer	DOID_4045
304	DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_DN	16849537	musculoskeletal system cancer	DOID_0060100
305	DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_DN	16849537	organ system cancer	DOID_0050686
306	DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_DN	16849537	rhabdomyosarcoma	DOID_3247
307	DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_DN	16849537	skeletal muscle cancer	DOID_4043
308	FOURNIER_ACINAR_DEVELOPMENT_EARLY_UP	16849555	breast cancer	DOID_1612
309	FOURNIER_ACINAR_DEVELOPMENT_EARLY_UP	16849555	cancer	DOID_162
310	FOURNIER_ACINAR_DEVELOPMENT_EARLY_UP	16849555	disease of cellular proliferation	DOID_14566
311	FOURNIER_ACINAR_DEVELOPMENT_EARLY_UP	16849555	organ system cancer	DOID_0050686
312	FOURNIER_ACINAR_DEVELOPMENT_EARLY_UP	16849555	thoracic cancer	DOID_5093
313	FOURNIER_ACINAR_DEVELOPMENT_LATE_UP	16849555	breast cancer	DOID_1612
314	FOURNIER_ACINAR_DEVELOPMENT_LATE_UP	16849555	cancer	DOID_162
315	FOURNIER_ACINAR_DEVELOPMENT_LATE_UP	16849555	disease of cellular proliferation	DOID_14566
316	FOURNIER_ACINAR_DEVELOPMENT_LATE_UP	16849555	organ system cancer	DOID_0050686
317	FOURNIER_ACINAR_DEVELOPMENT_LATE_UP	16849555	thoracic cancer	DOID_5093
318	FOURNIER_ACINAR_DEVELOPMENT_LATE_DN	16849555	breast cancer	DOID_1612
319	FOURNIER_ACINAR_DEVELOPMENT_LATE_DN	16849555	cancer	DOID_162
320	FOURNIER_ACINAR_DEVELOPMENT_LATE_DN	16849555	disease of cellular proliferation	DOID_14566
321	FOURNIER_ACINAR_DEVELOPMENT_LATE_DN	16849555	organ system cancer	DOID_0050686
322	FOURNIER_ACINAR_DEVELOPMENT_LATE_DN	16849555	thoracic cancer	DOID_5093
323	NAM_FXYD5_TARGETS_DN	16849564	breast cancer	DOID_1612
324	NAM_FXYD5_TARGETS_DN	16849564	cancer	DOID_162
325	NAM_FXYD5_TARGETS_DN	16849564	disease of cellular proliferation	DOID_14566
326	NAM_FXYD5_TARGETS_DN	16849564	organ system cancer	DOID_0050686
327	NAM_FXYD5_TARGETS_DN	16849564	thoracic cancer	DOID_5093
328	FRASOR_TAMOXIFEN_RESPONSE_UP	16849584	breast cancer	DOID_1612
329	FRASOR_TAMOXIFEN_RESPONSE_UP	16849584	cancer	DOID_162
330	FRASOR_TAMOXIFEN_RESPONSE_UP	16849584	disease of cellular proliferation	DOID_14566
331	FRASOR_TAMOXIFEN_RESPONSE_UP	16849584	organ system cancer	DOID_0050686
332	FRASOR_TAMOXIFEN_RESPONSE_UP	16849584	thoracic cancer	DOID_5093
333	FRASOR_TAMOXIFEN_RESPONSE_DN	16849584	breast cancer	DOID_1612
334	FRASOR_TAMOXIFEN_RESPONSE_DN	16849584	cancer	DOID_162
335	FRASOR_TAMOXIFEN_RESPONSE_DN	16849584	disease of cellular proliferation	DOID_14566
336	FRASOR_TAMOXIFEN_RESPONSE_DN	16849584	organ system cancer	DOID_0050686
337	FRASOR_TAMOXIFEN_RESPONSE_DN	16849584	thoracic cancer	DOID_5093
338	KIM_RESPONSE_TO_TSA_AND_DECITABINE_UP	16885346	astrocytoma	DOID_3069
339	KIM_RESPONSE_TO_TSA_AND_DECITABINE_UP	16885346	cancer	DOID_162
340	KIM_RESPONSE_TO_TSA_AND_DECITABINE_UP	16885346	cell type cancer	DOID_0050687
341	KIM_RESPONSE_TO_TSA_AND_DECITABINE_UP	16885346	central nervous system cancer	DOID_3620
342	KIM_RESPONSE_TO_TSA_AND_DECITABINE_UP	16885346	disease of cellular proliferation	DOID_14566
343	KIM_RESPONSE_TO_TSA_AND_DECITABINE_UP	16885346	glioblastoma	DOID_3068
344	KIM_RESPONSE_TO_TSA_AND_DECITABINE_UP	16885346	malignant glioma	DOID_3070
345	KIM_RESPONSE_TO_TSA_AND_DECITABINE_UP	16885346	nervous system cancer	DOID_3093
346	KIM_RESPONSE_TO_TSA_AND_DECITABINE_UP	16885346	organ system cancer	DOID_0050686
347	KIM_RESPONSE_TO_TSA_AND_DECITABINE_DN	16885346	astrocytoma	DOID_3069
348	KIM_RESPONSE_TO_TSA_AND_DECITABINE_DN	16885346	cancer	DOID_162
349	KIM_RESPONSE_TO_TSA_AND_DECITABINE_DN	16885346	cell type cancer	DOID_0050687
350	KIM_RESPONSE_TO_TSA_AND_DECITABINE_DN	16885346	central nervous system cancer	DOID_3620
351	KIM_RESPONSE_TO_TSA_AND_DECITABINE_DN	16885346	disease of cellular proliferation	DOID_14566
352	KIM_RESPONSE_TO_TSA_AND_DECITABINE_DN	16885346	glioblastoma	DOID_3068
353	KIM_RESPONSE_TO_TSA_AND_DECITABINE_DN	16885346	malignant glioma	DOID_3070
354	KIM_RESPONSE_TO_TSA_AND_DECITABINE_DN	16885346	nervous system cancer	DOID_3093
355	KIM_RESPONSE_TO_TSA_AND_DECITABINE_DN	16885346	organ system cancer	DOID_0050686
356	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP	16912175	cancer	DOID_162
357	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP	16912175	carcinoma	DOID_305
358	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP	16912175	cell type cancer	DOID_0050687
359	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP	16912175	disease of cellular proliferation	DOID_14566
360	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP	16912175	nasopharynx carcinoma	DOID_9261
361	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP	16912175	organ system cancer	DOID_0050686
362	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP	16912175	respiratory system cancer	DOID_0050615
363	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_DN	16912175	cancer	DOID_162
364	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_DN	16912175	carcinoma	DOID_305
365	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_DN	16912175	cell type cancer	DOID_0050687
366	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_DN	16912175	disease of cellular proliferation	DOID_14566
367	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_DN	16912175	nasopharynx carcinoma	DOID_9261
368	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_DN	16912175	organ system cancer	DOID_0050686
369	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_DN	16912175	respiratory system cancer	DOID_0050615
370	WATANABE_COLON_CANCER_MSI_VS_MSS_UP	17047040	NA	NA
371	WATANABE_COLON_CANCER_MSI_VS_MSS_DN	17047040	NA	NA
372	KOBAYASHI_EGFR_SIGNALING_6HR_DN	17145885	cancer	DOID_162
373	KOBAYASHI_EGFR_SIGNALING_6HR_DN	17145885	carcinoma	DOID_305
374	KOBAYASHI_EGFR_SIGNALING_6HR_DN	17145885	cell type cancer	DOID_0050687
375	KOBAYASHI_EGFR_SIGNALING_6HR_DN	17145885	disease of cellular proliferation	DOID_14566
376	KOBAYASHI_EGFR_SIGNALING_6HR_DN	17145885	lung cancer	DOID_1324
377	KOBAYASHI_EGFR_SIGNALING_6HR_DN	17145885	lung carcinoma	DOID_3905
378	KOBAYASHI_EGFR_SIGNALING_6HR_DN	17145885	non-small cell lung carcinoma	DOID_3908
379	KOBAYASHI_EGFR_SIGNALING_6HR_DN	17145885	organ system cancer	DOID_0050686
380	KOBAYASHI_EGFR_SIGNALING_6HR_DN	17145885	respiratory system cancer	DOID_0050615
381	SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP	16478745	breast cancer	DOID_1612
382	SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP	16478745	cancer	DOID_162
383	SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP	16478745	disease of cellular proliferation	DOID_14566
384	SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP	16478745	organ system cancer	DOID_0050686
385	SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP	16478745	thoracic cancer	DOID_5093
386	SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_DN	16478745	breast cancer	DOID_1612
387	SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_DN	16478745	cancer	DOID_162
388	SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_DN	16478745	disease of cellular proliferation	DOID_14566
389	SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_DN	16478745	organ system cancer	DOID_0050686
390	SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_DN	16478745	thoracic cancer	DOID_5093
391	GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_UP	16741228	anemia	DOID_2355
392	GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_UP	16741228	aplastic anemia	DOID_12449
393	GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_UP	16741228	bone marrow disease	DOID_4961
394	GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_UP	16741228	congenital hypoplastic anemia	DOID_1342
395	GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_UP	16741228	Diamond-Blackfan anemia	DOID_1339
396	GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_UP	16741228	disease of anatomical entity	DOID_7
397	GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_UP	16741228	hematopoietic system disease	DOID_74
398	GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_UP	16741228	immune system disease	DOID_2914
399	GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN	16741228	anemia	DOID_2355
400	GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN	16741228	aplastic anemia	DOID_12449
401	GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN	16741228	bone marrow disease	DOID_4961
402	GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN	16741228	congenital hypoplastic anemia	DOID_1342
403	GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN	16741228	Diamond-Blackfan anemia	DOID_1339
404	GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN	16741228	disease of anatomical entity	DOID_7
405	GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN	16741228	hematopoietic system disease	DOID_74
406	GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN	16741228	immune system disease	DOID_2914
407	GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_UP	16741228	anemia	DOID_2355
408	GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_UP	16741228	aplastic anemia	DOID_12449
409	GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_UP	16741228	bone marrow disease	DOID_4961
410	GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_UP	16741228	congenital hypoplastic anemia	DOID_1342
411	GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_UP	16741228	Diamond-Blackfan anemia	DOID_1339
412	GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_UP	16741228	disease of anatomical entity	DOID_7
413	GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_UP	16741228	hematopoietic system disease	DOID_74
414	GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_UP	16741228	immune system disease	DOID_2914
415	GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_DN	16741228	anemia	DOID_2355
416	GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_DN	16741228	aplastic anemia	DOID_12449
417	GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_DN	16741228	bone marrow disease	DOID_4961
418	GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_DN	16741228	congenital hypoplastic anemia	DOID_1342
419	GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_DN	16741228	Diamond-Blackfan anemia	DOID_1339
420	GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_DN	16741228	disease of anatomical entity	DOID_7
421	GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_DN	16741228	hematopoietic system disease	DOID_74
422	GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_DN	16741228	immune system disease	DOID_2914
423	GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_UP	16741228	anemia	DOID_2355
424	GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_UP	16741228	aplastic anemia	DOID_12449
425	GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_UP	16741228	bone marrow disease	DOID_4961
426	GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_UP	16741228	congenital hypoplastic anemia	DOID_1342
427	GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_UP	16741228	Diamond-Blackfan anemia	DOID_1339
428	GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_UP	16741228	disease of anatomical entity	DOID_7
429	GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_UP	16741228	hematopoietic system disease	DOID_74
430	GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_UP	16741228	immune system disease	DOID_2914
431	GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_DN	16741228	anemia	DOID_2355
432	GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_DN	16741228	aplastic anemia	DOID_12449
433	GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_DN	16741228	bone marrow disease	DOID_4961
434	GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_DN	16741228	congenital hypoplastic anemia	DOID_1342
435	GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_DN	16741228	Diamond-Blackfan anemia	DOID_1339
436	GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_DN	16741228	disease of anatomical entity	DOID_7
437	GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_DN	16741228	hematopoietic system disease	DOID_74
438	GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_DN	16741228	immune system disease	DOID_2914
439	CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP	16424048	cancer	DOID_162
440	CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP	16424048	disease of cellular proliferation	DOID_14566
441	CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP	16424048	hematologic cancer	DOID_2531
442	CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP	16424048	Hodgkin's lymphoma	DOID_8567
443	CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP	16424048	immune system cancer	DOID_0060083
444	CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP	16424048	lymphoma	DOID_0060058
445	CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP	16424048	organ system cancer	DOID_0050686
446	CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_DN	16424048	cancer	DOID_162
447	CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_DN	16424048	disease of cellular proliferation	DOID_14566
448	CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_DN	16424048	hematologic cancer	DOID_2531
449	CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_DN	16424048	Hodgkin's lymphoma	DOID_8567
450	CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_DN	16424048	immune system cancer	DOID_0060083
451	CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_DN	16424048	lymphoma	DOID_0060058
452	CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_DN	16424048	organ system cancer	DOID_0050686
453	IGARASHI_ATF4_TARGETS_DN	17297441	cancer	DOID_162
454	IGARASHI_ATF4_TARGETS_DN	17297441	disease of cellular proliferation	DOID_14566
455	ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_UP	17043644	adenocarcinoma	DOID_299
456	ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_UP	17043644	cancer	DOID_162
457	ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_UP	17043644	carcinoma	DOID_305
458	ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_UP	17043644	cell type cancer	DOID_0050687
459	ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_UP	17043644	disease of cellular proliferation	DOID_14566
460	ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_UP	17043644	large cell carcinoma	DOID_4552
461	ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_UP	17043644	lung cancer	DOID_1324
462	ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_UP	17043644	lung carcinoma	DOID_3905
463	ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_UP	17043644	non-small cell lung carcinoma	DOID_3908
464	ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_UP	17043644	organ system cancer	DOID_0050686
465	ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_UP	17043644	respiratory system cancer	DOID_0050615
466	ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_DN	17043644	adenocarcinoma	DOID_299
467	ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_DN	17043644	cancer	DOID_162
468	ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_DN	17043644	carcinoma	DOID_305
469	ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_DN	17043644	cell type cancer	DOID_0050687
470	ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_DN	17043644	disease of cellular proliferation	DOID_14566
471	ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_DN	17043644	large cell carcinoma	DOID_4552
472	ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_DN	17043644	lung cancer	DOID_1324
473	ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_DN	17043644	lung carcinoma	DOID_3905
474	ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_DN	17043644	non-small cell lung carcinoma	DOID_3908
475	ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_DN	17043644	organ system cancer	DOID_0050686
476	ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_DN	17043644	respiratory system cancer	DOID_0050615
477	DAVICIONI_MOLECULAR_ARMS_VS_ERMS_UP	16849537	cancer	DOID_162
478	DAVICIONI_MOLECULAR_ARMS_VS_ERMS_UP	16849537	disease of cellular proliferation	DOID_14566
479	DAVICIONI_MOLECULAR_ARMS_VS_ERMS_UP	16849537	muscle cancer	DOID_4045
480	DAVICIONI_MOLECULAR_ARMS_VS_ERMS_UP	16849537	musculoskeletal system cancer	DOID_0060100
481	DAVICIONI_MOLECULAR_ARMS_VS_ERMS_UP	16849537	organ system cancer	DOID_0050686
482	DAVICIONI_MOLECULAR_ARMS_VS_ERMS_UP	16849537	rhabdomyosarcoma	DOID_3247
483	DAVICIONI_MOLECULAR_ARMS_VS_ERMS_UP	16849537	skeletal muscle cancer	DOID_4043
484	DAVICIONI_MOLECULAR_ARMS_VS_ERMS_DN	16849537	cancer	DOID_162
485	DAVICIONI_MOLECULAR_ARMS_VS_ERMS_DN	16849537	disease of cellular proliferation	DOID_14566
486	DAVICIONI_MOLECULAR_ARMS_VS_ERMS_DN	16849537	muscle cancer	DOID_4045
487	DAVICIONI_MOLECULAR_ARMS_VS_ERMS_DN	16849537	musculoskeletal system cancer	DOID_0060100
488	DAVICIONI_MOLECULAR_ARMS_VS_ERMS_DN	16849537	organ system cancer	DOID_0050686
489	DAVICIONI_MOLECULAR_ARMS_VS_ERMS_DN	16849537	rhabdomyosarcoma	DOID_3247
490	DAVICIONI_MOLECULAR_ARMS_VS_ERMS_DN	16849537	skeletal muscle cancer	DOID_4043
491	DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP	16849537	cancer	DOID_162
492	DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP	16849537	disease of cellular proliferation	DOID_14566
493	DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP	16849537	muscle cancer	DOID_4045
494	DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP	16849537	musculoskeletal system cancer	DOID_0060100
495	DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP	16849537	organ system cancer	DOID_0050686
496	DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP	16849537	rhabdomyosarcoma	DOID_3247
497	DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP	16849537	skeletal muscle cancer	DOID_4043
498	DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_DN	16849537	cancer	DOID_162
499	DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_DN	16849537	disease of cellular proliferation	DOID_14566
500	DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_DN	16849537	muscle cancer	DOID_4045
501	DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_DN	16849537	musculoskeletal system cancer	DOID_0060100
502	DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_DN	16849537	organ system cancer	DOID_0050686
503	DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_DN	16849537	rhabdomyosarcoma	DOID_3247
504	DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_DN	16849537	skeletal muscle cancer	DOID_4043
505	DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_UP	16849537	cancer	DOID_162
506	DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_UP	16849537	disease of cellular proliferation	DOID_14566
507	DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_UP	16849537	muscle cancer	DOID_4045
508	DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_UP	16849537	musculoskeletal system cancer	DOID_0060100
509	DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_UP	16849537	organ system cancer	DOID_0050686
510	DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_UP	16849537	rhabdomyosarcoma	DOID_3247
511	DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_UP	16849537	skeletal muscle cancer	DOID_4043
512	DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_DN	16849537	cancer	DOID_162
513	DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_DN	16849537	disease of cellular proliferation	DOID_14566
514	DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_DN	16849537	muscle cancer	DOID_4045
515	DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_DN	16849537	musculoskeletal system cancer	DOID_0060100
516	DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_DN	16849537	organ system cancer	DOID_0050686
517	DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_DN	16849537	rhabdomyosarcoma	DOID_3247
518	DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_DN	16849537	skeletal muscle cancer	DOID_4043
519	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP	16912175	cancer	DOID_162
520	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP	16912175	carcinoma	DOID_305
521	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP	16912175	cell type cancer	DOID_0050687
522	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP	16912175	disease of cellular proliferation	DOID_14566
523	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP	16912175	nasopharynx carcinoma	DOID_9261
524	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP	16912175	organ system cancer	DOID_0050686
525	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP	16912175	respiratory system cancer	DOID_0050615
526	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN	16912175	cancer	DOID_162
527	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN	16912175	carcinoma	DOID_305
528	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN	16912175	cell type cancer	DOID_0050687
529	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN	16912175	disease of cellular proliferation	DOID_14566
530	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN	16912175	nasopharynx carcinoma	DOID_9261
531	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN	16912175	organ system cancer	DOID_0050686
532	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN	16912175	respiratory system cancer	DOID_0050615
533	TURASHVILI_BREAST_NORMAL_DUCTAL_VS_LOBULAR_UP	17389037	breast cancer	DOID_1612
534	TURASHVILI_BREAST_NORMAL_DUCTAL_VS_LOBULAR_UP	17389037	breast carcinoma	DOID_3459
535	TURASHVILI_BREAST_NORMAL_DUCTAL_VS_LOBULAR_UP	17389037	cancer	DOID_162
536	TURASHVILI_BREAST_NORMAL_DUCTAL_VS_LOBULAR_UP	17389037	carcinoma	DOID_305
537	TURASHVILI_BREAST_NORMAL_DUCTAL_VS_LOBULAR_UP	17389037	cell type cancer	DOID_0050687
538	TURASHVILI_BREAST_NORMAL_DUCTAL_VS_LOBULAR_UP	17389037	disease of cellular proliferation	DOID_14566
539	TURASHVILI_BREAST_NORMAL_DUCTAL_VS_LOBULAR_UP	17389037	organ system cancer	DOID_0050686
540	TURASHVILI_BREAST_NORMAL_DUCTAL_VS_LOBULAR_UP	17389037	thoracic cancer	DOID_5093
541	TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_UP	17389037	breast cancer	DOID_1612
542	TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_UP	17389037	breast carcinoma	DOID_3459
543	TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_UP	17389037	cancer	DOID_162
544	TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_UP	17389037	carcinoma	DOID_305
545	TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_UP	17389037	cell type cancer	DOID_0050687
546	TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_UP	17389037	disease of cellular proliferation	DOID_14566
547	TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_UP	17389037	organ system cancer	DOID_0050686
548	TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_UP	17389037	thoracic cancer	DOID_5093
549	TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN	17389037	breast cancer	DOID_1612
550	TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN	17389037	breast carcinoma	DOID_3459
551	TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN	17389037	cancer	DOID_162
552	TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN	17389037	carcinoma	DOID_305
553	TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN	17389037	cell type cancer	DOID_0050687
554	TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN	17389037	disease of cellular proliferation	DOID_14566
555	TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN	17389037	organ system cancer	DOID_0050686
556	TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN	17389037	thoracic cancer	DOID_5093
557	TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_UP	17389037	breast cancer	DOID_1612
558	TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_UP	17389037	breast carcinoma	DOID_3459
559	TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_UP	17389037	cancer	DOID_162
560	TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_UP	17389037	carcinoma	DOID_305
561	TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_UP	17389037	cell type cancer	DOID_0050687
562	TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_UP	17389037	disease of cellular proliferation	DOID_14566
563	TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_UP	17389037	organ system cancer	DOID_0050686
564	TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_UP	17389037	thoracic cancer	DOID_5093
565	TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_DN	17389037	breast cancer	DOID_1612
566	TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_DN	17389037	breast carcinoma	DOID_3459
567	TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_DN	17389037	cancer	DOID_162
568	TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_DN	17389037	carcinoma	DOID_305
569	TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_DN	17389037	cell type cancer	DOID_0050687
570	TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_DN	17389037	disease of cellular proliferation	DOID_14566
571	TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_DN	17389037	organ system cancer	DOID_0050686
572	TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_DN	17389037	thoracic cancer	DOID_5093
573	TURASHVILI_BREAST_CARCINOMA_DUCTAL_VS_LOBULAR_UP	17389037	breast cancer	DOID_1612
574	TURASHVILI_BREAST_CARCINOMA_DUCTAL_VS_LOBULAR_UP	17389037	breast carcinoma	DOID_3459
575	TURASHVILI_BREAST_CARCINOMA_DUCTAL_VS_LOBULAR_UP	17389037	cancer	DOID_162
576	TURASHVILI_BREAST_CARCINOMA_DUCTAL_VS_LOBULAR_UP	17389037	carcinoma	DOID_305
577	TURASHVILI_BREAST_CARCINOMA_DUCTAL_VS_LOBULAR_UP	17389037	cell type cancer	DOID_0050687
578	TURASHVILI_BREAST_CARCINOMA_DUCTAL_VS_LOBULAR_UP	17389037	disease of cellular proliferation	DOID_14566
579	TURASHVILI_BREAST_CARCINOMA_DUCTAL_VS_LOBULAR_UP	17389037	organ system cancer	DOID_0050686
580	TURASHVILI_BREAST_CARCINOMA_DUCTAL_VS_LOBULAR_UP	17389037	thoracic cancer	DOID_5093
581	TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP	17389037	breast cancer	DOID_1612
582	TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP	17389037	breast carcinoma	DOID_3459
583	TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP	17389037	cancer	DOID_162
584	TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP	17389037	carcinoma	DOID_305
585	TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP	17389037	cell type cancer	DOID_0050687
586	TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP	17389037	disease of cellular proliferation	DOID_14566
587	TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP	17389037	organ system cancer	DOID_0050686
588	TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP	17389037	thoracic cancer	DOID_5093
589	TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_DN	17389037	breast cancer	DOID_1612
590	TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_DN	17389037	breast carcinoma	DOID_3459
591	TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_DN	17389037	cancer	DOID_162
592	TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_DN	17389037	carcinoma	DOID_305
593	TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_DN	17389037	cell type cancer	DOID_0050687
594	TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_DN	17389037	disease of cellular proliferation	DOID_14566
595	TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_DN	17389037	organ system cancer	DOID_0050686
596	TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_DN	17389037	thoracic cancer	DOID_5093
597	TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP	17389037	breast cancer	DOID_1612
598	TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP	17389037	breast carcinoma	DOID_3459
599	TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP	17389037	cancer	DOID_162
600	TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP	17389037	carcinoma	DOID_305
601	TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP	17389037	cell type cancer	DOID_0050687
602	TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP	17389037	disease of cellular proliferation	DOID_14566
603	TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP	17389037	organ system cancer	DOID_0050686
604	TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP	17389037	thoracic cancer	DOID_5093
605	TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN	17389037	breast cancer	DOID_1612
606	TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN	17389037	breast carcinoma	DOID_3459
607	TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN	17389037	cancer	DOID_162
608	TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN	17389037	carcinoma	DOID_305
609	TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN	17389037	cell type cancer	DOID_0050687
610	TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN	17389037	disease of cellular proliferation	DOID_14566
611	TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN	17389037	organ system cancer	DOID_0050686
612	TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN	17389037	thoracic cancer	DOID_5093
613	CHANDRAN_METASTASIS_TOP50_UP	17430594	cancer	DOID_162
614	CHANDRAN_METASTASIS_TOP50_UP	17430594	disease of cellular proliferation	DOID_14566
615	CHANDRAN_METASTASIS_TOP50_UP	17430594	male reproductive organ cancer	DOID_3856
616	CHANDRAN_METASTASIS_TOP50_UP	17430594	organ system cancer	DOID_0050686
617	CHANDRAN_METASTASIS_TOP50_UP	17430594	prostate cancer	DOID_10283
618	CHANDRAN_METASTASIS_TOP50_UP	17430594	reproductive organ cancer	DOID_193
619	CHANDRAN_METASTASIS_TOP50_DN	17430594	cancer	DOID_162
620	CHANDRAN_METASTASIS_TOP50_DN	17430594	disease of cellular proliferation	DOID_14566
621	CHANDRAN_METASTASIS_TOP50_DN	17430594	male reproductive organ cancer	DOID_3856
622	CHANDRAN_METASTASIS_TOP50_DN	17430594	organ system cancer	DOID_0050686
623	CHANDRAN_METASTASIS_TOP50_DN	17430594	prostate cancer	DOID_10283
624	CHANDRAN_METASTASIS_TOP50_DN	17430594	reproductive organ cancer	DOID_193
625	WILCOX_PRESPONSE_TO_ROGESTERONE_UP	18070364	cancer	DOID_162
626	WILCOX_PRESPONSE_TO_ROGESTERONE_UP	18070364	disease of cellular proliferation	DOID_14566
627	WILCOX_PRESPONSE_TO_ROGESTERONE_UP	18070364	female reproductive organ cancer	DOID_120
628	WILCOX_PRESPONSE_TO_ROGESTERONE_UP	18070364	organ system cancer	DOID_0050686
629	WILCOX_PRESPONSE_TO_ROGESTERONE_UP	18070364	ovarian cancer	DOID_2394
630	WILCOX_PRESPONSE_TO_ROGESTERONE_UP	18070364	reproductive organ cancer	DOID_193
631	WILCOX_PRESPONSE_TO_ROGESTERONE_DN	18070364	cancer	DOID_162
632	WILCOX_PRESPONSE_TO_ROGESTERONE_DN	18070364	disease of cellular proliferation	DOID_14566
633	WILCOX_PRESPONSE_TO_ROGESTERONE_DN	18070364	female reproductive organ cancer	DOID_120
634	WILCOX_PRESPONSE_TO_ROGESTERONE_DN	18070364	organ system cancer	DOID_0050686
635	WILCOX_PRESPONSE_TO_ROGESTERONE_DN	18070364	ovarian cancer	DOID_2394
636	WILCOX_PRESPONSE_TO_ROGESTERONE_DN	18070364	reproductive organ cancer	DOID_193
637	FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP	16785517	NA	NA
638	FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN	16785517	NA	NA
639	GARY_CD5_TARGETS_UP	17878328	cancer	DOID_162
640	GARY_CD5_TARGETS_UP	17878328	chronic leukemia	DOID_1036
641	GARY_CD5_TARGETS_UP	17878328	chronic lymphocytic leukemia	DOID_1040
642	GARY_CD5_TARGETS_UP	17878328	disease of cellular proliferation	DOID_14566
643	GARY_CD5_TARGETS_UP	17878328	hematologic cancer	DOID_2531
644	GARY_CD5_TARGETS_UP	17878328	immune system cancer	DOID_0060083
645	GARY_CD5_TARGETS_UP	17878328	leukemia	DOID_1240
646	GARY_CD5_TARGETS_UP	17878328	lymphoblastic leukemia	DOID_1037
647	GARY_CD5_TARGETS_UP	17878328	organ system cancer	DOID_0050686
648	GARY_CD5_TARGETS_DN	17878328	cancer	DOID_162
649	GARY_CD5_TARGETS_DN	17878328	chronic leukemia	DOID_1036
650	GARY_CD5_TARGETS_DN	17878328	chronic lymphocytic leukemia	DOID_1040
651	GARY_CD5_TARGETS_DN	17878328	disease of cellular proliferation	DOID_14566
652	GARY_CD5_TARGETS_DN	17878328	hematologic cancer	DOID_2531
653	GARY_CD5_TARGETS_DN	17878328	immune system cancer	DOID_0060083
654	GARY_CD5_TARGETS_DN	17878328	leukemia	DOID_1240
655	GARY_CD5_TARGETS_DN	17878328	lymphoblastic leukemia	DOID_1037
656	GARY_CD5_TARGETS_DN	17878328	organ system cancer	DOID_0050686
657	ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP	18025224	NA	NA
658	ZHOU_INFLAMMATORY_RESPONSE_LIVE_DN	18025224	NA	NA
659	SAMOLS_TARGETS_OF_KHSV_MIRNAS_DN	17500590	cancer	DOID_162
660	SAMOLS_TARGETS_OF_KHSV_MIRNAS_DN	17500590	cell type cancer	DOID_0050687
661	SAMOLS_TARGETS_OF_KHSV_MIRNAS_DN	17500590	disease of cellular proliferation	DOID_14566
662	SAMOLS_TARGETS_OF_KHSV_MIRNAS_DN	17500590	sarcoma	DOID_1115
663	HOOI_ST7_TARGETS_UP	16474848	breast cancer	DOID_1612
664	HOOI_ST7_TARGETS_UP	16474848	cancer	DOID_162
665	HOOI_ST7_TARGETS_UP	16474848	disease of cellular proliferation	DOID_14566
666	HOOI_ST7_TARGETS_UP	16474848	male reproductive organ cancer	DOID_3856
667	HOOI_ST7_TARGETS_UP	16474848	organ system cancer	DOID_0050686
668	HOOI_ST7_TARGETS_UP	16474848	prostate cancer	DOID_10283
669	HOOI_ST7_TARGETS_UP	16474848	reproductive organ cancer	DOID_193
670	HOOI_ST7_TARGETS_UP	16474848	thoracic cancer	DOID_5093
671	HOOI_ST7_TARGETS_DN	16474848	breast cancer	DOID_1612
672	HOOI_ST7_TARGETS_DN	16474848	cancer	DOID_162
673	HOOI_ST7_TARGETS_DN	16474848	disease of cellular proliferation	DOID_14566
674	HOOI_ST7_TARGETS_DN	16474848	male reproductive organ cancer	DOID_3856
675	HOOI_ST7_TARGETS_DN	16474848	organ system cancer	DOID_0050686
676	HOOI_ST7_TARGETS_DN	16474848	prostate cancer	DOID_10283
677	HOOI_ST7_TARGETS_DN	16474848	reproductive organ cancer	DOID_193
678	HOOI_ST7_TARGETS_DN	16474848	thoracic cancer	DOID_5093
679	PRAMOONJAGO_SOX4_TARGETS_UP	16636670	adenoid cystic carcinoma	DOID_4866
680	PRAMOONJAGO_SOX4_TARGETS_UP	16636670	cancer	DOID_162
681	PRAMOONJAGO_SOX4_TARGETS_UP	16636670	carcinoma	DOID_305
682	PRAMOONJAGO_SOX4_TARGETS_UP	16636670	cell type cancer	DOID_0050687
683	PRAMOONJAGO_SOX4_TARGETS_UP	16636670	disease of cellular proliferation	DOID_14566
684	PRAMOONJAGO_SOX4_TARGETS_DN	16636670	adenoid cystic carcinoma	DOID_4866
685	PRAMOONJAGO_SOX4_TARGETS_DN	16636670	cancer	DOID_162
686	PRAMOONJAGO_SOX4_TARGETS_DN	16636670	carcinoma	DOID_305
687	PRAMOONJAGO_SOX4_TARGETS_DN	16636670	cell type cancer	DOID_0050687
688	PRAMOONJAGO_SOX4_TARGETS_DN	16636670	disease of cellular proliferation	DOID_14566
689	PUIFFE_INVASION_INHIBITED_BY_ASCITES_UP	17971902	cancer	DOID_162
690	PUIFFE_INVASION_INHIBITED_BY_ASCITES_UP	17971902	disease of cellular proliferation	DOID_14566
691	PUIFFE_INVASION_INHIBITED_BY_ASCITES_UP	17971902	female reproductive organ cancer	DOID_120
692	PUIFFE_INVASION_INHIBITED_BY_ASCITES_UP	17971902	organ system cancer	DOID_0050686
693	PUIFFE_INVASION_INHIBITED_BY_ASCITES_UP	17971902	ovarian cancer	DOID_2394
694	PUIFFE_INVASION_INHIBITED_BY_ASCITES_UP	17971902	reproductive organ cancer	DOID_193
695	PUIFFE_INVASION_INHIBITED_BY_ASCITES_DN	17971902	cancer	DOID_162
696	PUIFFE_INVASION_INHIBITED_BY_ASCITES_DN	17971902	disease of cellular proliferation	DOID_14566
697	PUIFFE_INVASION_INHIBITED_BY_ASCITES_DN	17971902	female reproductive organ cancer	DOID_120
698	PUIFFE_INVASION_INHIBITED_BY_ASCITES_DN	17971902	organ system cancer	DOID_0050686
699	PUIFFE_INVASION_INHIBITED_BY_ASCITES_DN	17971902	ovarian cancer	DOID_2394
700	PUIFFE_INVASION_INHIBITED_BY_ASCITES_DN	17971902	reproductive organ cancer	DOID_193
701	PIEPOLI_LGI1_TARGETS_UP	16533756	astrocytoma	DOID_3069
702	PIEPOLI_LGI1_TARGETS_UP	16533756	cancer	DOID_162
703	PIEPOLI_LGI1_TARGETS_UP	16533756	cell type cancer	DOID_0050687
704	PIEPOLI_LGI1_TARGETS_UP	16533756	disease of cellular proliferation	DOID_14566
705	PIEPOLI_LGI1_TARGETS_UP	16533756	glioblastoma	DOID_3068
706	PIEPOLI_LGI1_TARGETS_UP	16533756	malignant glioma	DOID_3070
707	PIEPOLI_LGI1_TARGETS_DN	16533756	astrocytoma	DOID_3069
708	PIEPOLI_LGI1_TARGETS_DN	16533756	cancer	DOID_162
709	PIEPOLI_LGI1_TARGETS_DN	16533756	cell type cancer	DOID_0050687
710	PIEPOLI_LGI1_TARGETS_DN	16533756	disease of cellular proliferation	DOID_14566
711	PIEPOLI_LGI1_TARGETS_DN	16533756	glioblastoma	DOID_3068
712	PIEPOLI_LGI1_TARGETS_DN	16533756	malignant glioma	DOID_3070
713	THUM_SYSTOLIC_HEART_FAILURE_UP	17606841	NA	NA
714	THUM_SYSTOLIC_HEART_FAILURE_DN	17606841	NA	NA
715	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP	16990782	cancer	DOID_162
716	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP	16990782	disease of cellular proliferation	DOID_14566
717	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP	16990782	hematologic cancer	DOID_2531
718	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP	16990782	immune system cancer	DOID_0060083
719	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP	16990782	leukemia	DOID_1240
720	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP	16990782	organ system cancer	DOID_0050686
721	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN	16990782	cancer	DOID_162
722	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN	16990782	disease of cellular proliferation	DOID_14566
723	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN	16990782	hematologic cancer	DOID_2531
724	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN	16990782	immune system cancer	DOID_0060083
725	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN	16990782	leukemia	DOID_1240
726	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN	16990782	organ system cancer	DOID_0050686
727	CORRE_MULTIPLE_MYELOMA_UP	17344918	B-cell lymphocytic neoplasm	DOID_707
728	CORRE_MULTIPLE_MYELOMA_UP	17344918	bone marrow cancer	DOID_4960
729	CORRE_MULTIPLE_MYELOMA_UP	17344918	cancer	DOID_162
730	CORRE_MULTIPLE_MYELOMA_UP	17344918	disease of cellular proliferation	DOID_14566
731	CORRE_MULTIPLE_MYELOMA_UP	17344918	hematologic cancer	DOID_2531
732	CORRE_MULTIPLE_MYELOMA_UP	17344918	immune system cancer	DOID_0060083
733	CORRE_MULTIPLE_MYELOMA_UP	17344918	lymphoma	DOID_0060058
734	CORRE_MULTIPLE_MYELOMA_UP	17344918	mature B-cell neoplasm	DOID_706
735	CORRE_MULTIPLE_MYELOMA_UP	17344918	monoclonal gammopathy of uncertain significance	DOID_7442
736	CORRE_MULTIPLE_MYELOMA_UP	17344918	multiple myeloma	DOID_9538
737	CORRE_MULTIPLE_MYELOMA_UP	17344918	myeloma	DOID_0070004
738	CORRE_MULTIPLE_MYELOMA_UP	17344918	organ system cancer	DOID_0050686
739	CORRE_MULTIPLE_MYELOMA_UP	17344918	plasma cell neoplasm	DOID_6536
740	CORRE_MULTIPLE_MYELOMA_DN	17344918	B-cell lymphocytic neoplasm	DOID_707
741	CORRE_MULTIPLE_MYELOMA_DN	17344918	bone marrow cancer	DOID_4960
742	CORRE_MULTIPLE_MYELOMA_DN	17344918	cancer	DOID_162
743	CORRE_MULTIPLE_MYELOMA_DN	17344918	disease of cellular proliferation	DOID_14566
744	CORRE_MULTIPLE_MYELOMA_DN	17344918	hematologic cancer	DOID_2531
745	CORRE_MULTIPLE_MYELOMA_DN	17344918	immune system cancer	DOID_0060083
746	CORRE_MULTIPLE_MYELOMA_DN	17344918	lymphoma	DOID_0060058
747	CORRE_MULTIPLE_MYELOMA_DN	17344918	mature B-cell neoplasm	DOID_706
748	CORRE_MULTIPLE_MYELOMA_DN	17344918	monoclonal gammopathy of uncertain significance	DOID_7442
749	CORRE_MULTIPLE_MYELOMA_DN	17344918	multiple myeloma	DOID_9538
750	CORRE_MULTIPLE_MYELOMA_DN	17344918	myeloma	DOID_0070004
751	CORRE_MULTIPLE_MYELOMA_DN	17344918	organ system cancer	DOID_0050686
752	CORRE_MULTIPLE_MYELOMA_DN	17344918	plasma cell neoplasm	DOID_6536
753	HUTTMANN_B_CLL_POOR_SURVIVAL_UP	16932341	cancer	DOID_162
754	HUTTMANN_B_CLL_POOR_SURVIVAL_UP	16932341	disease of cellular proliferation	DOID_14566
755	HUTTMANN_B_CLL_POOR_SURVIVAL_UP	16932341	hematologic cancer	DOID_2531
756	HUTTMANN_B_CLL_POOR_SURVIVAL_UP	16932341	immune system cancer	DOID_0060083
757	HUTTMANN_B_CLL_POOR_SURVIVAL_UP	16932341	leukemia	DOID_1240
758	HUTTMANN_B_CLL_POOR_SURVIVAL_UP	16932341	organ system cancer	DOID_0050686
759	HUTTMANN_B_CLL_POOR_SURVIVAL_DN	16932341	cancer	DOID_162
760	HUTTMANN_B_CLL_POOR_SURVIVAL_DN	16932341	disease of cellular proliferation	DOID_14566
761	HUTTMANN_B_CLL_POOR_SURVIVAL_DN	16932341	hematologic cancer	DOID_2531
762	HUTTMANN_B_CLL_POOR_SURVIVAL_DN	16932341	immune system cancer	DOID_0060083
763	HUTTMANN_B_CLL_POOR_SURVIVAL_DN	16932341	leukemia	DOID_1240
764	HUTTMANN_B_CLL_POOR_SURVIVAL_DN	16932341	organ system cancer	DOID_0050686
765	DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN	17252012	cancer	DOID_162
766	DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN	17252012	chronic myeloid leukemia	DOID_8552
767	DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN	17252012	disease of cellular proliferation	DOID_14566
768	DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN	17252012	hematologic cancer	DOID_2531
769	DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN	17252012	immune system cancer	DOID_0060083
770	DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN	17252012	leukemia	DOID_1240
771	DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN	17252012	myeloid leukemia	DOID_8692
772	DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN	17252012	organ system cancer	DOID_0050686
773	CASORELLI_APL_SECONDARY_VS_DE_NOVO_UP	16990782	cancer	DOID_162
774	CASORELLI_APL_SECONDARY_VS_DE_NOVO_UP	16990782	disease of cellular proliferation	DOID_14566
775	CASORELLI_APL_SECONDARY_VS_DE_NOVO_UP	16990782	hematologic cancer	DOID_2531
776	CASORELLI_APL_SECONDARY_VS_DE_NOVO_UP	16990782	immune system cancer	DOID_0060083
777	CASORELLI_APL_SECONDARY_VS_DE_NOVO_UP	16990782	leukemia	DOID_1240
778	CASORELLI_APL_SECONDARY_VS_DE_NOVO_UP	16990782	organ system cancer	DOID_0050686
779	DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_UP	17713554	cancer	DOID_162
780	DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_UP	17713554	chronic leukemia	DOID_1036
781	DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_UP	17713554	chronic lymphocytic leukemia	DOID_1040
782	DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_UP	17713554	disease of cellular proliferation	DOID_14566
783	DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_UP	17713554	hematologic cancer	DOID_2531
784	DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_UP	17713554	immune system cancer	DOID_0060083
785	DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_UP	17713554	leukemia	DOID_1240
786	DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_UP	17713554	lymphoblastic leukemia	DOID_1037
787	DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_UP	17713554	lymphoma	DOID_0060058
788	DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_UP	17713554	organ system cancer	DOID_0050686
789	DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_UP	17713554	prolymphocytic leukemia	DOID_1039
790	DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN	17713554	cancer	DOID_162
791	DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN	17713554	chronic leukemia	DOID_1036
792	DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN	17713554	chronic lymphocytic leukemia	DOID_1040
793	DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN	17713554	disease of cellular proliferation	DOID_14566
794	DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN	17713554	hematologic cancer	DOID_2531
795	DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN	17713554	immune system cancer	DOID_0060083
796	DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN	17713554	leukemia	DOID_1240
797	DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN	17713554	lymphoblastic leukemia	DOID_1037
798	DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN	17713554	lymphoma	DOID_0060058
799	DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN	17713554	organ system cancer	DOID_0050686
800	DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN	17713554	prolymphocytic leukemia	DOID_1039
801	LIU_CMYB_TARGETS_UP	16205643	NA	NA
802	LIU_TARGETS_OF_VMYB_VS_CMYB_UP	16205643	NA	NA
803	LIU_TARGETS_OF_VMYB_VS_CMYB_DN	16205643	NA	NA
804	CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_UP	16288205	cancer	DOID_162
805	CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_UP	16288205	carcinoma	DOID_305
806	CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_UP	16288205	cell type cancer	DOID_0050687
807	CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_UP	16288205	disease of cellular proliferation	DOID_14566
808	CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN	16288205	cancer	DOID_162
809	CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN	16288205	carcinoma	DOID_305
810	CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN	16288205	cell type cancer	DOID_0050687
811	CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN	16288205	disease of cellular proliferation	DOID_14566
812	CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_UP	16288205	cancer	DOID_162
813	CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_UP	16288205	carcinoma	DOID_305
814	CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_UP	16288205	cell type cancer	DOID_0050687
815	CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_UP	16288205	disease of cellular proliferation	DOID_14566
816	CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN	16288205	cancer	DOID_162
817	CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN	16288205	carcinoma	DOID_305
818	CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN	16288205	cell type cancer	DOID_0050687
819	CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN	16288205	disease of cellular proliferation	DOID_14566
820	CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_UP	16288205	cancer	DOID_162
821	CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_UP	16288205	carcinoma	DOID_305
822	CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_UP	16288205	cell type cancer	DOID_0050687
823	CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_UP	16288205	disease of cellular proliferation	DOID_14566
824	CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_DN	16288205	cancer	DOID_162
825	CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_DN	16288205	carcinoma	DOID_305
826	CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_DN	16288205	cell type cancer	DOID_0050687
827	CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_DN	16288205	disease of cellular proliferation	DOID_14566
828	DOANE_BREAST_CANCER_CLASSES_UP	16491124	breast cancer	DOID_1612
829	DOANE_BREAST_CANCER_CLASSES_UP	16491124	cancer	DOID_162
830	DOANE_BREAST_CANCER_CLASSES_UP	16491124	disease of cellular proliferation	DOID_14566
831	DOANE_BREAST_CANCER_CLASSES_UP	16491124	organ system cancer	DOID_0050686
832	DOANE_BREAST_CANCER_CLASSES_UP	16491124	thoracic cancer	DOID_5093
833	DOANE_BREAST_CANCER_CLASSES_DN	16491124	breast cancer	DOID_1612
834	DOANE_BREAST_CANCER_CLASSES_DN	16491124	cancer	DOID_162
835	DOANE_BREAST_CANCER_CLASSES_DN	16491124	disease of cellular proliferation	DOID_14566
836	DOANE_BREAST_CANCER_CLASSES_DN	16491124	organ system cancer	DOID_0050686
837	DOANE_BREAST_CANCER_CLASSES_DN	16491124	thoracic cancer	DOID_5093
838	DOANE_RESPONSE_TO_ANDROGEN_UP	16491124	breast cancer	DOID_1612
839	DOANE_RESPONSE_TO_ANDROGEN_UP	16491124	cancer	DOID_162
840	DOANE_RESPONSE_TO_ANDROGEN_UP	16491124	disease of cellular proliferation	DOID_14566
841	DOANE_RESPONSE_TO_ANDROGEN_UP	16491124	organ system cancer	DOID_0050686
842	DOANE_RESPONSE_TO_ANDROGEN_UP	16491124	thoracic cancer	DOID_5093
843	DOANE_RESPONSE_TO_ANDROGEN_DN	16491124	breast cancer	DOID_1612
844	DOANE_RESPONSE_TO_ANDROGEN_DN	16491124	cancer	DOID_162
845	DOANE_RESPONSE_TO_ANDROGEN_DN	16491124	disease of cellular proliferation	DOID_14566
846	DOANE_RESPONSE_TO_ANDROGEN_DN	16491124	organ system cancer	DOID_0050686
847	DOANE_RESPONSE_TO_ANDROGEN_DN	16491124	thoracic cancer	DOID_5093
848	DOANE_BREAST_CANCER_ESR1_UP	16491124	breast cancer	DOID_1612
849	DOANE_BREAST_CANCER_ESR1_UP	16491124	cancer	DOID_162
850	DOANE_BREAST_CANCER_ESR1_UP	16491124	disease of cellular proliferation	DOID_14566
851	DOANE_BREAST_CANCER_ESR1_UP	16491124	organ system cancer	DOID_0050686
852	DOANE_BREAST_CANCER_ESR1_UP	16491124	thoracic cancer	DOID_5093
853	DOANE_BREAST_CANCER_ESR1_DN	16491124	breast cancer	DOID_1612
854	DOANE_BREAST_CANCER_ESR1_DN	16491124	cancer	DOID_162
855	DOANE_BREAST_CANCER_ESR1_DN	16491124	disease of cellular proliferation	DOID_14566
856	DOANE_BREAST_CANCER_ESR1_DN	16491124	organ system cancer	DOID_0050686
857	DOANE_BREAST_CANCER_ESR1_DN	16491124	thoracic cancer	DOID_5093
858	WANG_RESPONSE_TO_FORSKOLIN_UP	16751804	cancer	DOID_162
859	WANG_RESPONSE_TO_FORSKOLIN_UP	16751804	disease of cellular proliferation	DOID_14566
860	WANG_RESPONSE_TO_FORSKOLIN_UP	16751804	male reproductive organ cancer	DOID_3856
861	WANG_RESPONSE_TO_FORSKOLIN_UP	16751804	organ system cancer	DOID_0050686
862	WANG_RESPONSE_TO_FORSKOLIN_UP	16751804	prostate cancer	DOID_10283
863	WANG_RESPONSE_TO_FORSKOLIN_UP	16751804	reproductive organ cancer	DOID_193
864	TIMOFEEVA_GROWTH_STRESS_VIA_STAT1_DN	16799645	cancer	DOID_162
865	TIMOFEEVA_GROWTH_STRESS_VIA_STAT1_DN	16799645	disease of cellular proliferation	DOID_14566
866	TIMOFEEVA_GROWTH_STRESS_VIA_STAT1_DN	16799645	hematologic cancer	DOID_2531
867	TIMOFEEVA_GROWTH_STRESS_VIA_STAT1_DN	16799645	immune system cancer	DOID_0060083
868	TIMOFEEVA_GROWTH_STRESS_VIA_STAT1_DN	16799645	leukemia	DOID_1240
869	TIMOFEEVA_GROWTH_STRESS_VIA_STAT1_DN	16799645	organ system cancer	DOID_0050686
870	LAIHO_COLORECTAL_CANCER_SERRATED_UP	16819509	adenocarcinoma	DOID_299
871	LAIHO_COLORECTAL_CANCER_SERRATED_UP	16819509	adenoma	DOID_657
872	LAIHO_COLORECTAL_CANCER_SERRATED_UP	16819509	benign neoplasm	DOID_0060072
873	LAIHO_COLORECTAL_CANCER_SERRATED_UP	16819509	cancer	DOID_162
874	LAIHO_COLORECTAL_CANCER_SERRATED_UP	16819509	carcinoma	DOID_305
875	LAIHO_COLORECTAL_CANCER_SERRATED_UP	16819509	cell type benign neoplasm	DOID_0060084
876	LAIHO_COLORECTAL_CANCER_SERRATED_UP	16819509	cell type cancer	DOID_0050687
877	LAIHO_COLORECTAL_CANCER_SERRATED_UP	16819509	colorectal cancer	DOID_9256
878	LAIHO_COLORECTAL_CANCER_SERRATED_UP	16819509	disease of cellular proliferation	DOID_14566
879	LAIHO_COLORECTAL_CANCER_SERRATED_UP	16819509	gastrointestinal system cancer	DOID_3119
880	LAIHO_COLORECTAL_CANCER_SERRATED_UP	16819509	intestinal cancer	DOID_10155
881	LAIHO_COLORECTAL_CANCER_SERRATED_UP	16819509	large intestine cancer	DOID_5672
882	LAIHO_COLORECTAL_CANCER_SERRATED_UP	16819509	mucinous cystadenoma	DOID_2633
883	LAIHO_COLORECTAL_CANCER_SERRATED_UP	16819509	organ system cancer	DOID_0050686
884	LAIHO_COLORECTAL_CANCER_SERRATED_DN	16819509	adenocarcinoma	DOID_299
885	LAIHO_COLORECTAL_CANCER_SERRATED_DN	16819509	adenoma	DOID_657
886	LAIHO_COLORECTAL_CANCER_SERRATED_DN	16819509	benign neoplasm	DOID_0060072
887	LAIHO_COLORECTAL_CANCER_SERRATED_DN	16819509	cancer	DOID_162
888	LAIHO_COLORECTAL_CANCER_SERRATED_DN	16819509	carcinoma	DOID_305
889	LAIHO_COLORECTAL_CANCER_SERRATED_DN	16819509	cell type benign neoplasm	DOID_0060084
890	LAIHO_COLORECTAL_CANCER_SERRATED_DN	16819509	cell type cancer	DOID_0050687
891	LAIHO_COLORECTAL_CANCER_SERRATED_DN	16819509	colorectal cancer	DOID_9256
892	LAIHO_COLORECTAL_CANCER_SERRATED_DN	16819509	disease of cellular proliferation	DOID_14566
893	LAIHO_COLORECTAL_CANCER_SERRATED_DN	16819509	gastrointestinal system cancer	DOID_3119
894	LAIHO_COLORECTAL_CANCER_SERRATED_DN	16819509	intestinal cancer	DOID_10155
895	LAIHO_COLORECTAL_CANCER_SERRATED_DN	16819509	large intestine cancer	DOID_5672
896	LAIHO_COLORECTAL_CANCER_SERRATED_DN	16819509	mucinous cystadenoma	DOID_2633
897	LAIHO_COLORECTAL_CANCER_SERRATED_DN	16819509	organ system cancer	DOID_0050686
898	BORCZUK_MALIGNANT_MESOTHELIOMA_UP	16862182	benign mesothelioma	DOID_2645
899	BORCZUK_MALIGNANT_MESOTHELIOMA_UP	16862182	benign neoplasm	DOID_0060072
900	BORCZUK_MALIGNANT_MESOTHELIOMA_UP	16862182	cancer	DOID_162
901	BORCZUK_MALIGNANT_MESOTHELIOMA_UP	16862182	cell type benign neoplasm	DOID_0060084
902	BORCZUK_MALIGNANT_MESOTHELIOMA_UP	16862182	cell type cancer	DOID_0050687
903	BORCZUK_MALIGNANT_MESOTHELIOMA_UP	16862182	disease of cellular proliferation	DOID_14566
904	BORCZUK_MALIGNANT_MESOTHELIOMA_UP	16862182	malignant mesothelioma	DOID_1790
905	BORCZUK_MALIGNANT_MESOTHELIOMA_UP	16862182	malignant peritoneal mesothelioma	DOID_1788
906	BORCZUK_MALIGNANT_MESOTHELIOMA_UP	16862182	organ system cancer	DOID_0050686
907	BORCZUK_MALIGNANT_MESOTHELIOMA_UP	16862182	peritoneum cancer	DOID_1725
908	BORCZUK_MALIGNANT_MESOTHELIOMA_DN	16862182	benign mesothelioma	DOID_2645
909	BORCZUK_MALIGNANT_MESOTHELIOMA_DN	16862182	benign neoplasm	DOID_0060072
910	BORCZUK_MALIGNANT_MESOTHELIOMA_DN	16862182	cancer	DOID_162
911	BORCZUK_MALIGNANT_MESOTHELIOMA_DN	16862182	cell type benign neoplasm	DOID_0060084
912	BORCZUK_MALIGNANT_MESOTHELIOMA_DN	16862182	cell type cancer	DOID_0050687
913	BORCZUK_MALIGNANT_MESOTHELIOMA_DN	16862182	disease of cellular proliferation	DOID_14566
914	BORCZUK_MALIGNANT_MESOTHELIOMA_DN	16862182	malignant mesothelioma	DOID_1790
915	BORCZUK_MALIGNANT_MESOTHELIOMA_DN	16862182	malignant peritoneal mesothelioma	DOID_1788
916	BORCZUK_MALIGNANT_MESOTHELIOMA_DN	16862182	organ system cancer	DOID_0050686
917	BORCZUK_MALIGNANT_MESOTHELIOMA_DN	16862182	peritoneum cancer	DOID_1725
918	ROY_WOUND_BLOOD_VESSEL_UP	17728400	NA	NA
919	ROY_WOUND_BLOOD_VESSEL_DN	17728400	NA	NA
920	GRABARCZYK_BCL11B_TARGETS_UP	17173069	cancer	DOID_162
921	GRABARCZYK_BCL11B_TARGETS_UP	17173069	chronic leukemia	DOID_1036
922	GRABARCZYK_BCL11B_TARGETS_UP	17173069	chronic lymphocytic leukemia	DOID_1040
923	GRABARCZYK_BCL11B_TARGETS_UP	17173069	disease of cellular proliferation	DOID_14566
924	GRABARCZYK_BCL11B_TARGETS_UP	17173069	hematologic cancer	DOID_2531
925	GRABARCZYK_BCL11B_TARGETS_UP	17173069	immune system cancer	DOID_0060083
926	GRABARCZYK_BCL11B_TARGETS_UP	17173069	leukemia	DOID_1240
927	GRABARCZYK_BCL11B_TARGETS_UP	17173069	lymphoblastic leukemia	DOID_1037
928	GRABARCZYK_BCL11B_TARGETS_UP	17173069	lymphoid leukemia	DOID_10747
929	GRABARCZYK_BCL11B_TARGETS_UP	17173069	lymphoma	DOID_0060058
930	GRABARCZYK_BCL11B_TARGETS_UP	17173069	organ system cancer	DOID_0050686
931	GRABARCZYK_BCL11B_TARGETS_UP	17173069	T-cell leukemia	DOID_715
932	GRABARCZYK_BCL11B_TARGETS_DN	17173069	cancer	DOID_162
933	GRABARCZYK_BCL11B_TARGETS_DN	17173069	chronic leukemia	DOID_1036
934	GRABARCZYK_BCL11B_TARGETS_DN	17173069	chronic lymphocytic leukemia	DOID_1040
935	GRABARCZYK_BCL11B_TARGETS_DN	17173069	disease of cellular proliferation	DOID_14566
936	GRABARCZYK_BCL11B_TARGETS_DN	17173069	hematologic cancer	DOID_2531
937	GRABARCZYK_BCL11B_TARGETS_DN	17173069	immune system cancer	DOID_0060083
938	GRABARCZYK_BCL11B_TARGETS_DN	17173069	leukemia	DOID_1240
939	GRABARCZYK_BCL11B_TARGETS_DN	17173069	lymphoblastic leukemia	DOID_1037
940	GRABARCZYK_BCL11B_TARGETS_DN	17173069	lymphoid leukemia	DOID_10747
941	GRABARCZYK_BCL11B_TARGETS_DN	17173069	lymphoma	DOID_0060058
942	GRABARCZYK_BCL11B_TARGETS_DN	17173069	organ system cancer	DOID_0050686
943	GRABARCZYK_BCL11B_TARGETS_DN	17173069	T-cell leukemia	DOID_715
944	NEWMAN_ERCC6_TARGETS_UP	16772382	autosomal genetic disease	DOID_0050739
945	NEWMAN_ERCC6_TARGETS_UP	16772382	autosomal recessive disease	DOID_0050737
946	NEWMAN_ERCC6_TARGETS_UP	16772382	Cockayne syndrome	DOID_2962
947	NEWMAN_ERCC6_TARGETS_UP	16772382	genetic disease	DOID_630
948	NEWMAN_ERCC6_TARGETS_UP	16772382	group B streptococcal pneumonia	DOID_12017
949	NEWMAN_ERCC6_TARGETS_UP	16772382	monogenic disease	DOID_0050177
950	NEWMAN_ERCC6_TARGETS_UP	16772382	syndrome	DOID_225
951	NEWMAN_ERCC6_TARGETS_DN	16772382	autosomal genetic disease	DOID_0050739
952	NEWMAN_ERCC6_TARGETS_DN	16772382	autosomal recessive disease	DOID_0050737
953	NEWMAN_ERCC6_TARGETS_DN	16772382	Cockayne syndrome	DOID_2962
954	NEWMAN_ERCC6_TARGETS_DN	16772382	genetic disease	DOID_630
955	NEWMAN_ERCC6_TARGETS_DN	16772382	group B streptococcal pneumonia	DOID_12017
956	NEWMAN_ERCC6_TARGETS_DN	16772382	monogenic disease	DOID_0050177
957	NEWMAN_ERCC6_TARGETS_DN	16772382	syndrome	DOID_225
958	HORIUCHI_WTAP_TARGETS_UP	17088532	NA	NA
959	HORIUCHI_WTAP_TARGETS_DN	17088532	NA	NA
960	GAL_LEUKEMIC_STEM_CELL_UP	17039238	acute myeloid leukemia	DOID_9119
961	GAL_LEUKEMIC_STEM_CELL_UP	17039238	cancer	DOID_162
962	GAL_LEUKEMIC_STEM_CELL_UP	17039238	disease of cellular proliferation	DOID_14566
963	GAL_LEUKEMIC_STEM_CELL_UP	17039238	hematologic cancer	DOID_2531
964	GAL_LEUKEMIC_STEM_CELL_UP	17039238	immune system cancer	DOID_0060083
965	GAL_LEUKEMIC_STEM_CELL_UP	17039238	leukemia	DOID_1240
966	GAL_LEUKEMIC_STEM_CELL_UP	17039238	myeloid leukemia	DOID_8692
967	GAL_LEUKEMIC_STEM_CELL_UP	17039238	organ system cancer	DOID_0050686
968	GAL_LEUKEMIC_STEM_CELL_DN	17039238	acute myeloid leukemia	DOID_9119
969	GAL_LEUKEMIC_STEM_CELL_DN	17039238	cancer	DOID_162
970	GAL_LEUKEMIC_STEM_CELL_DN	17039238	disease of cellular proliferation	DOID_14566
971	GAL_LEUKEMIC_STEM_CELL_DN	17039238	hematologic cancer	DOID_2531
972	GAL_LEUKEMIC_STEM_CELL_DN	17039238	immune system cancer	DOID_0060083
973	GAL_LEUKEMIC_STEM_CELL_DN	17039238	leukemia	DOID_1240
974	GAL_LEUKEMIC_STEM_CELL_DN	17039238	myeloid leukemia	DOID_8692
975	GAL_LEUKEMIC_STEM_CELL_DN	17039238	organ system cancer	DOID_0050686
976	CHOI_ATL_CHRONIC_VS_ACUTE_DN	16909099	adult T-cell leukemia	DOID_0050523
977	CHOI_ATL_CHRONIC_VS_ACUTE_DN	16909099	cancer	DOID_162
978	CHOI_ATL_CHRONIC_VS_ACUTE_DN	16909099	disease of cellular proliferation	DOID_14566
979	CHOI_ATL_CHRONIC_VS_ACUTE_DN	16909099	hematologic cancer	DOID_2531
980	CHOI_ATL_CHRONIC_VS_ACUTE_DN	16909099	immune system cancer	DOID_0060083
981	CHOI_ATL_CHRONIC_VS_ACUTE_DN	16909099	leukemia	DOID_1240
982	CHOI_ATL_CHRONIC_VS_ACUTE_DN	16909099	lymphoblastic leukemia	DOID_1037
983	CHOI_ATL_CHRONIC_VS_ACUTE_DN	16909099	lymphoid leukemia	DOID_10747
984	CHOI_ATL_CHRONIC_VS_ACUTE_DN	16909099	organ system cancer	DOID_0050686
985	CHOI_ATL_CHRONIC_VS_ACUTE_DN	16909099	T-cell leukemia	DOID_715
986	BASAKI_YBX1_TARGETS_UP	17072343	cancer	DOID_162
987	BASAKI_YBX1_TARGETS_UP	17072343	disease of cellular proliferation	DOID_14566
988	BASAKI_YBX1_TARGETS_UP	17072343	female reproductive organ cancer	DOID_120
989	BASAKI_YBX1_TARGETS_UP	17072343	organ system cancer	DOID_0050686
990	BASAKI_YBX1_TARGETS_UP	17072343	ovarian cancer	DOID_2394
991	BASAKI_YBX1_TARGETS_UP	17072343	reproductive organ cancer	DOID_193
992	BASAKI_YBX1_TARGETS_DN	17072343	cancer	DOID_162
993	BASAKI_YBX1_TARGETS_DN	17072343	disease of cellular proliferation	DOID_14566
994	BASAKI_YBX1_TARGETS_DN	17072343	female reproductive organ cancer	DOID_120
995	BASAKI_YBX1_TARGETS_DN	17072343	organ system cancer	DOID_0050686
996	BASAKI_YBX1_TARGETS_DN	17072343	ovarian cancer	DOID_2394
997	BASAKI_YBX1_TARGETS_DN	17072343	reproductive organ cancer	DOID_193
998	NOJIMA_SFRP2_TARGETS_UP	17297461	cancer	DOID_162
999	NOJIMA_SFRP2_TARGETS_UP	17297461	carcinoma	DOID_305
1000	NOJIMA_SFRP2_TARGETS_UP	17297461	cell type cancer	DOID_0050687
1001	NOJIMA_SFRP2_TARGETS_UP	17297461	colorectal cancer	DOID_9256
1002	NOJIMA_SFRP2_TARGETS_UP	17297461	disease of cellular proliferation	DOID_14566
1003	NOJIMA_SFRP2_TARGETS_UP	17297461	gastrointestinal system cancer	DOID_3119
1004	NOJIMA_SFRP2_TARGETS_UP	17297461	intestinal cancer	DOID_10155
1005	NOJIMA_SFRP2_TARGETS_UP	17297461	large intestine cancer	DOID_5672
1006	NOJIMA_SFRP2_TARGETS_UP	17297461	organ system cancer	DOID_0050686
1007	NOJIMA_SFRP2_TARGETS_DN	17297461	cancer	DOID_162
1008	NOJIMA_SFRP2_TARGETS_DN	17297461	carcinoma	DOID_305
1009	NOJIMA_SFRP2_TARGETS_DN	17297461	cell type cancer	DOID_0050687
1010	NOJIMA_SFRP2_TARGETS_DN	17297461	colorectal cancer	DOID_9256
1011	NOJIMA_SFRP2_TARGETS_DN	17297461	disease of cellular proliferation	DOID_14566
1012	NOJIMA_SFRP2_TARGETS_DN	17297461	gastrointestinal system cancer	DOID_3119
1013	NOJIMA_SFRP2_TARGETS_DN	17297461	intestinal cancer	DOID_10155
1014	NOJIMA_SFRP2_TARGETS_DN	17297461	large intestine cancer	DOID_5672
1015	NOJIMA_SFRP2_TARGETS_DN	17297461	organ system cancer	DOID_0050686
1016	WIKMAN_ASBESTOS_LUNG_CANCER_UP	17297452	adenocarcinoma	DOID_299
1017	WIKMAN_ASBESTOS_LUNG_CANCER_UP	17297452	cancer	DOID_162
1018	WIKMAN_ASBESTOS_LUNG_CANCER_UP	17297452	carcinoma	DOID_305
1019	WIKMAN_ASBESTOS_LUNG_CANCER_UP	17297452	cell type cancer	DOID_0050687
1020	WIKMAN_ASBESTOS_LUNG_CANCER_UP	17297452	disease of cellular proliferation	DOID_14566
1021	WIKMAN_ASBESTOS_LUNG_CANCER_UP	17297452	lung cancer	DOID_1324
1022	WIKMAN_ASBESTOS_LUNG_CANCER_UP	17297452	organ system cancer	DOID_0050686
1023	WIKMAN_ASBESTOS_LUNG_CANCER_UP	17297452	respiratory system cancer	DOID_0050615
1024	WIKMAN_ASBESTOS_LUNG_CANCER_DN	17297452	adenocarcinoma	DOID_299
1025	WIKMAN_ASBESTOS_LUNG_CANCER_DN	17297452	cancer	DOID_162
1026	WIKMAN_ASBESTOS_LUNG_CANCER_DN	17297452	carcinoma	DOID_305
1027	WIKMAN_ASBESTOS_LUNG_CANCER_DN	17297452	cell type cancer	DOID_0050687
1028	WIKMAN_ASBESTOS_LUNG_CANCER_DN	17297452	disease of cellular proliferation	DOID_14566
1029	WIKMAN_ASBESTOS_LUNG_CANCER_DN	17297452	lung cancer	DOID_1324
1030	WIKMAN_ASBESTOS_LUNG_CANCER_DN	17297452	organ system cancer	DOID_0050686
1031	WIKMAN_ASBESTOS_LUNG_CANCER_DN	17297452	respiratory system cancer	DOID_0050615
1032	RODRIGUES_DCC_TARGETS_DN	17334389	cancer	DOID_162
1033	RODRIGUES_DCC_TARGETS_DN	17334389	colon cancer	DOID_219
1034	RODRIGUES_DCC_TARGETS_DN	17334389	colorectal cancer	DOID_9256
1035	RODRIGUES_DCC_TARGETS_DN	17334389	disease of cellular proliferation	DOID_14566
1036	RODRIGUES_DCC_TARGETS_DN	17334389	gastrointestinal system cancer	DOID_3119
1037	RODRIGUES_DCC_TARGETS_DN	17334389	intestinal cancer	DOID_10155
1038	RODRIGUES_DCC_TARGETS_DN	17334389	large intestine cancer	DOID_5672
1039	RODRIGUES_DCC_TARGETS_DN	17334389	organ system cancer	DOID_0050686
1040	RODRIGUES_NTN1_TARGETS_UP	17334389	cancer	DOID_162
1041	RODRIGUES_NTN1_TARGETS_UP	17334389	colon cancer	DOID_219
1042	RODRIGUES_NTN1_TARGETS_UP	17334389	colorectal cancer	DOID_9256
1043	RODRIGUES_NTN1_TARGETS_UP	17334389	disease of cellular proliferation	DOID_14566
1044	RODRIGUES_NTN1_TARGETS_UP	17334389	gastrointestinal system cancer	DOID_3119
1045	RODRIGUES_NTN1_TARGETS_UP	17334389	intestinal cancer	DOID_10155
1046	RODRIGUES_NTN1_TARGETS_UP	17334389	large intestine cancer	DOID_5672
1047	RODRIGUES_NTN1_TARGETS_UP	17334389	organ system cancer	DOID_0050686
1048	RODRIGUES_NTN1_TARGETS_DN	17334389	cancer	DOID_162
1049	RODRIGUES_NTN1_TARGETS_DN	17334389	colon cancer	DOID_219
1050	RODRIGUES_NTN1_TARGETS_DN	17334389	colorectal cancer	DOID_9256
1051	RODRIGUES_NTN1_TARGETS_DN	17334389	disease of cellular proliferation	DOID_14566
1052	RODRIGUES_NTN1_TARGETS_DN	17334389	gastrointestinal system cancer	DOID_3119
1053	RODRIGUES_NTN1_TARGETS_DN	17334389	intestinal cancer	DOID_10155
1054	RODRIGUES_NTN1_TARGETS_DN	17334389	large intestine cancer	DOID_5672
1055	RODRIGUES_NTN1_TARGETS_DN	17334389	organ system cancer	DOID_0050686
1056	WANG_LMO4_TARGETS_UP	17452977	breast cancer	DOID_1612
1057	WANG_LMO4_TARGETS_UP	17452977	cancer	DOID_162
1058	WANG_LMO4_TARGETS_UP	17452977	disease of cellular proliferation	DOID_14566
1059	WANG_LMO4_TARGETS_UP	17452977	organ system cancer	DOID_0050686
1060	WANG_LMO4_TARGETS_UP	17452977	thoracic cancer	DOID_5093
1061	WANG_LMO4_TARGETS_DN	17452977	breast cancer	DOID_1612
1062	WANG_LMO4_TARGETS_DN	17452977	cancer	DOID_162
1063	WANG_LMO4_TARGETS_DN	17452977	disease of cellular proliferation	DOID_14566
1064	WANG_LMO4_TARGETS_DN	17452977	organ system cancer	DOID_0050686
1065	WANG_LMO4_TARGETS_DN	17452977	thoracic cancer	DOID_5093
1066	WANG_CLIM2_TARGETS_UP	17452977	breast cancer	DOID_1612
1067	WANG_CLIM2_TARGETS_UP	17452977	cancer	DOID_162
1068	WANG_CLIM2_TARGETS_UP	17452977	disease of cellular proliferation	DOID_14566
1069	WANG_CLIM2_TARGETS_UP	17452977	organ system cancer	DOID_0050686
1070	WANG_CLIM2_TARGETS_UP	17452977	thoracic cancer	DOID_5093
1071	WANG_CLIM2_TARGETS_DN	17452977	breast cancer	DOID_1612
1072	WANG_CLIM2_TARGETS_DN	17452977	cancer	DOID_162
1073	WANG_CLIM2_TARGETS_DN	17452977	disease of cellular proliferation	DOID_14566
1074	WANG_CLIM2_TARGETS_DN	17452977	organ system cancer	DOID_0050686
1075	WANG_CLIM2_TARGETS_DN	17452977	thoracic cancer	DOID_5093
1076	VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP	17297478	cancer	DOID_162
1077	VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP	17297478	carcinoma	DOID_305
1078	VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP	17297478	cell type cancer	DOID_0050687
1079	VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP	17297478	disease of cellular proliferation	DOID_14566
1080	VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_DN	17297478	cancer	DOID_162
1081	VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_DN	17297478	carcinoma	DOID_305
1082	VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_DN	17297478	cell type cancer	DOID_0050687
1083	VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_DN	17297478	disease of cellular proliferation	DOID_14566
1084	VECCHI_GASTRIC_CANCER_EARLY_UP	17297478	cancer	DOID_162
1085	VECCHI_GASTRIC_CANCER_EARLY_UP	17297478	carcinoma	DOID_305
1086	VECCHI_GASTRIC_CANCER_EARLY_UP	17297478	cell type cancer	DOID_0050687
1087	VECCHI_GASTRIC_CANCER_EARLY_UP	17297478	disease of cellular proliferation	DOID_14566
1088	VECCHI_GASTRIC_CANCER_EARLY_DN	17297478	cancer	DOID_162
1089	VECCHI_GASTRIC_CANCER_EARLY_DN	17297478	carcinoma	DOID_305
1090	VECCHI_GASTRIC_CANCER_EARLY_DN	17297478	cell type cancer	DOID_0050687
1091	VECCHI_GASTRIC_CANCER_EARLY_DN	17297478	disease of cellular proliferation	DOID_14566
1092	BARRIER_COLON_CANCER_RECURRENCE_UP	17043639	adenocarcinoma	DOID_299
1093	BARRIER_COLON_CANCER_RECURRENCE_UP	17043639	cancer	DOID_162
1094	BARRIER_COLON_CANCER_RECURRENCE_UP	17043639	carcinoma	DOID_305
1095	BARRIER_COLON_CANCER_RECURRENCE_UP	17043639	cell type cancer	DOID_0050687
1096	BARRIER_COLON_CANCER_RECURRENCE_UP	17043639	colon cancer	DOID_219
1097	BARRIER_COLON_CANCER_RECURRENCE_UP	17043639	colorectal cancer	DOID_9256
1098	BARRIER_COLON_CANCER_RECURRENCE_UP	17043639	disease of cellular proliferation	DOID_14566
1099	BARRIER_COLON_CANCER_RECURRENCE_UP	17043639	gastrointestinal system cancer	DOID_3119
1100	BARRIER_COLON_CANCER_RECURRENCE_UP	17043639	intestinal cancer	DOID_10155
1101	BARRIER_COLON_CANCER_RECURRENCE_UP	17043639	large intestine cancer	DOID_5672
1102	BARRIER_COLON_CANCER_RECURRENCE_UP	17043639	organ system cancer	DOID_0050686
1103	BARRIER_COLON_CANCER_RECURRENCE_DN	17043639	adenocarcinoma	DOID_299
1104	BARRIER_COLON_CANCER_RECURRENCE_DN	17043639	cancer	DOID_162
1105	BARRIER_COLON_CANCER_RECURRENCE_DN	17043639	carcinoma	DOID_305
1106	BARRIER_COLON_CANCER_RECURRENCE_DN	17043639	cell type cancer	DOID_0050687
1107	BARRIER_COLON_CANCER_RECURRENCE_DN	17043639	colon cancer	DOID_219
1108	BARRIER_COLON_CANCER_RECURRENCE_DN	17043639	colorectal cancer	DOID_9256
1109	BARRIER_COLON_CANCER_RECURRENCE_DN	17043639	disease of cellular proliferation	DOID_14566
1110	BARRIER_COLON_CANCER_RECURRENCE_DN	17043639	gastrointestinal system cancer	DOID_3119
1111	BARRIER_COLON_CANCER_RECURRENCE_DN	17043639	intestinal cancer	DOID_10155
1112	BARRIER_COLON_CANCER_RECURRENCE_DN	17043639	large intestine cancer	DOID_5672
1113	BARRIER_COLON_CANCER_RECURRENCE_DN	17043639	organ system cancer	DOID_0050686
1114	SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP	16540638	cancer	DOID_162
1115	SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP	16540638	carcinoma	DOID_305
1116	SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP	16540638	cell type cancer	DOID_0050687
1117	SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP	16540638	disease of cellular proliferation	DOID_14566
1118	SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP	16540638	kidney cancer	DOID_263
1119	SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP	16540638	organ system cancer	DOID_0050686
1120	SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP	16540638	urinary system cancer	DOID_3996
1121	JAEGER_METASTASIS_UP	17289871	cancer	DOID_162
1122	JAEGER_METASTASIS_UP	17289871	cell type cancer	DOID_0050687
1123	JAEGER_METASTASIS_UP	17289871	disease of cellular proliferation	DOID_14566
1124	JAEGER_METASTASIS_UP	17289871	melanoma	DOID_1909
1125	JAEGER_METASTASIS_DN	17289871	cancer	DOID_162
1126	JAEGER_METASTASIS_DN	17289871	cell type cancer	DOID_0050687
1127	JAEGER_METASTASIS_DN	17289871	disease of cellular proliferation	DOID_14566
1128	JAEGER_METASTASIS_DN	17289871	melanoma	DOID_1909
1129	OSMAN_BLADDER_CANCER_UP	16740760	cancer	DOID_162
1130	OSMAN_BLADDER_CANCER_UP	16740760	carcinoma	DOID_305
1131	OSMAN_BLADDER_CANCER_UP	16740760	cell type cancer	DOID_0050687
1132	OSMAN_BLADDER_CANCER_UP	16740760	disease of cellular proliferation	DOID_14566
1133	OSMAN_BLADDER_CANCER_UP	16740760	genitourinary cancer	DOID_1265
1134	OSMAN_BLADDER_CANCER_UP	16740760	kidney cancer	DOID_263
1135	OSMAN_BLADDER_CANCER_UP	16740760	male reproductive organ cancer	DOID_3856
1136	OSMAN_BLADDER_CANCER_UP	16740760	organ system cancer	DOID_0050686
1137	OSMAN_BLADDER_CANCER_UP	16740760	renal carcinoma	DOID_4451
1138	OSMAN_BLADDER_CANCER_UP	16740760	renal cell carcinoma	DOID_4450
1139	OSMAN_BLADDER_CANCER_UP	16740760	reproductive organ cancer	DOID_193
1140	OSMAN_BLADDER_CANCER_UP	16740760	testicular cancer	DOID_2998
1141	OSMAN_BLADDER_CANCER_UP	16740760	urinary bladder cancer	DOID_11054
1142	OSMAN_BLADDER_CANCER_UP	16740760	urinary system cancer	DOID_3996
1143	OSMAN_BLADDER_CANCER_DN	16740760	cancer	DOID_162
1144	OSMAN_BLADDER_CANCER_DN	16740760	carcinoma	DOID_305
1145	OSMAN_BLADDER_CANCER_DN	16740760	cell type cancer	DOID_0050687
1146	OSMAN_BLADDER_CANCER_DN	16740760	disease of cellular proliferation	DOID_14566
1147	OSMAN_BLADDER_CANCER_DN	16740760	genitourinary cancer	DOID_1265
1148	OSMAN_BLADDER_CANCER_DN	16740760	kidney cancer	DOID_263
1149	OSMAN_BLADDER_CANCER_DN	16740760	male reproductive organ cancer	DOID_3856
1150	OSMAN_BLADDER_CANCER_DN	16740760	organ system cancer	DOID_0050686
1151	OSMAN_BLADDER_CANCER_DN	16740760	renal carcinoma	DOID_4451
1152	OSMAN_BLADDER_CANCER_DN	16740760	renal cell carcinoma	DOID_4450
1153	OSMAN_BLADDER_CANCER_DN	16740760	reproductive organ cancer	DOID_193
1154	OSMAN_BLADDER_CANCER_DN	16740760	testicular cancer	DOID_2998
1155	OSMAN_BLADDER_CANCER_DN	16740760	urinary bladder cancer	DOID_11054
1156	OSMAN_BLADDER_CANCER_DN	16740760	urinary system cancer	DOID_3996
1157	GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_UP	16899599	breast cancer	DOID_1612
1158	GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_UP	16899599	cancer	DOID_162
1159	GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_UP	16899599	carcinoma	DOID_305
1160	GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_UP	16899599	cell type cancer	DOID_0050687
1161	GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_UP	16899599	disease of cellular proliferation	DOID_14566
1162	GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_UP	16899599	organ system cancer	DOID_0050686
1163	GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_UP	16899599	thoracic cancer	DOID_5093
1164	GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN	16899599	breast cancer	DOID_1612
1165	GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN	16899599	cancer	DOID_162
1166	GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN	16899599	carcinoma	DOID_305
1167	GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN	16899599	cell type cancer	DOID_0050687
1168	GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN	16899599	disease of cellular proliferation	DOID_14566
1169	GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN	16899599	organ system cancer	DOID_0050686
1170	GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN	16899599	thoracic cancer	DOID_5093
1171	GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_UP	16899599	breast cancer	DOID_1612
1172	GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_UP	16899599	cancer	DOID_162
1173	GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_UP	16899599	carcinoma	DOID_305
1174	GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_UP	16899599	cell type cancer	DOID_0050687
1175	GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_UP	16899599	disease of cellular proliferation	DOID_14566
1176	GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_UP	16899599	organ system cancer	DOID_0050686
1177	GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_UP	16899599	thoracic cancer	DOID_5093
1178	GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN	16899599	breast cancer	DOID_1612
1179	GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN	16899599	cancer	DOID_162
1180	GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN	16899599	carcinoma	DOID_305
1181	GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN	16899599	cell type cancer	DOID_0050687
1182	GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN	16899599	disease of cellular proliferation	DOID_14566
1183	GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN	16899599	organ system cancer	DOID_0050686
1184	GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN	16899599	thoracic cancer	DOID_5093
1185	OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP	16166251	NA	NA
1186	OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN	16166251	NA	NA
1187	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_YELLOW_UP	16912112	arterial occlusive disease	DOID_2868
1188	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_YELLOW_UP	16912112	arteriosclerosis	DOID_2349
1189	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_YELLOW_UP	16912112	arteriosclerotic cardiovascular disease	DOID_2348
1190	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_YELLOW_UP	16912112	atherosclerosis	DOID_1936
1191	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_YELLOW_UP	16912112	cardiovascular system disease	DOID_1287
1192	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_YELLOW_UP	16912112	disease of anatomical entity	DOID_7
1193	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_YELLOW_UP	16912112	vascular disease	DOID_178
1194	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_YELLOW_DN	16912112	arterial occlusive disease	DOID_2868
1195	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_YELLOW_DN	16912112	arteriosclerosis	DOID_2349
1196	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_YELLOW_DN	16912112	arteriosclerotic cardiovascular disease	DOID_2348
1197	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_YELLOW_DN	16912112	atherosclerosis	DOID_1936
1198	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_YELLOW_DN	16912112	cardiovascular system disease	DOID_1287
1199	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_YELLOW_DN	16912112	disease of anatomical entity	DOID_7
1200	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_YELLOW_DN	16912112	vascular disease	DOID_178
1201	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_UP	16912112	arterial occlusive disease	DOID_2868
1202	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_UP	16912112	arteriosclerosis	DOID_2349
1203	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_UP	16912112	arteriosclerotic cardiovascular disease	DOID_2348
1204	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_UP	16912112	atherosclerosis	DOID_1936
1205	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_UP	16912112	cardiovascular system disease	DOID_1287
1206	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_UP	16912112	disease of anatomical entity	DOID_7
1207	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_UP	16912112	vascular disease	DOID_178
1208	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_DN	16912112	arterial occlusive disease	DOID_2868
1209	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_DN	16912112	arteriosclerosis	DOID_2349
1210	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_DN	16912112	arteriosclerotic cardiovascular disease	DOID_2348
1211	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_DN	16912112	atherosclerosis	DOID_1936
1212	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_DN	16912112	cardiovascular system disease	DOID_1287
1213	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_DN	16912112	disease of anatomical entity	DOID_7
1214	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_DN	16912112	vascular disease	DOID_178
1215	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_RED_UP	16912112	arterial occlusive disease	DOID_2868
1216	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_RED_UP	16912112	arteriosclerosis	DOID_2349
1217	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_RED_UP	16912112	arteriosclerotic cardiovascular disease	DOID_2348
1218	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_RED_UP	16912112	atherosclerosis	DOID_1936
1219	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_RED_UP	16912112	cardiovascular system disease	DOID_1287
1220	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_RED_UP	16912112	disease of anatomical entity	DOID_7
1221	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_RED_UP	16912112	vascular disease	DOID_178
1222	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_RED_DN	16912112	arterial occlusive disease	DOID_2868
1223	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_RED_DN	16912112	arteriosclerosis	DOID_2349
1224	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_RED_DN	16912112	arteriosclerotic cardiovascular disease	DOID_2348
1225	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_RED_DN	16912112	atherosclerosis	DOID_1936
1226	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_RED_DN	16912112	cardiovascular system disease	DOID_1287
1227	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_RED_DN	16912112	disease of anatomical entity	DOID_7
1228	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_RED_DN	16912112	vascular disease	DOID_178
1229	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_MAGENTA_UP	16912112	arterial occlusive disease	DOID_2868
1230	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_MAGENTA_UP	16912112	arteriosclerosis	DOID_2349
1231	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_MAGENTA_UP	16912112	arteriosclerotic cardiovascular disease	DOID_2348
1232	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_MAGENTA_UP	16912112	atherosclerosis	DOID_1936
1233	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_MAGENTA_UP	16912112	cardiovascular system disease	DOID_1287
1234	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_MAGENTA_UP	16912112	disease of anatomical entity	DOID_7
1235	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_MAGENTA_UP	16912112	vascular disease	DOID_178
1236	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_MAGENTA_DN	16912112	arterial occlusive disease	DOID_2868
1237	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_MAGENTA_DN	16912112	arteriosclerosis	DOID_2349
1238	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_MAGENTA_DN	16912112	arteriosclerotic cardiovascular disease	DOID_2348
1239	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_MAGENTA_DN	16912112	atherosclerosis	DOID_1936
1240	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_MAGENTA_DN	16912112	cardiovascular system disease	DOID_1287
1241	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_MAGENTA_DN	16912112	disease of anatomical entity	DOID_7
1242	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_MAGENTA_DN	16912112	vascular disease	DOID_178
1243	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_LIGHTYELLOW_UP	16912112	arterial occlusive disease	DOID_2868
1244	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_LIGHTYELLOW_UP	16912112	arteriosclerosis	DOID_2349
1245	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_LIGHTYELLOW_UP	16912112	arteriosclerotic cardiovascular disease	DOID_2348
1246	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_LIGHTYELLOW_UP	16912112	atherosclerosis	DOID_1936
1247	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_LIGHTYELLOW_UP	16912112	cardiovascular system disease	DOID_1287
1248	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_LIGHTYELLOW_UP	16912112	disease of anatomical entity	DOID_7
1249	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_LIGHTYELLOW_UP	16912112	vascular disease	DOID_178
1250	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREEN_UP	16912112	arterial occlusive disease	DOID_2868
1251	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREEN_UP	16912112	arteriosclerosis	DOID_2349
1252	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREEN_UP	16912112	arteriosclerotic cardiovascular disease	DOID_2348
1253	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREEN_UP	16912112	atherosclerosis	DOID_1936
1254	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREEN_UP	16912112	cardiovascular system disease	DOID_1287
1255	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREEN_UP	16912112	disease of anatomical entity	DOID_7
1256	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREEN_UP	16912112	vascular disease	DOID_178
1257	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREEN_DN	16912112	arterial occlusive disease	DOID_2868
1258	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREEN_DN	16912112	arteriosclerosis	DOID_2349
1259	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREEN_DN	16912112	arteriosclerotic cardiovascular disease	DOID_2348
1260	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREEN_DN	16912112	atherosclerosis	DOID_1936
1261	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREEN_DN	16912112	cardiovascular system disease	DOID_1287
1262	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREEN_DN	16912112	disease of anatomical entity	DOID_7
1263	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREEN_DN	16912112	vascular disease	DOID_178
1264	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP	16912112	arterial occlusive disease	DOID_2868
1265	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP	16912112	arteriosclerosis	DOID_2349
1266	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP	16912112	arteriosclerotic cardiovascular disease	DOID_2348
1267	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP	16912112	atherosclerosis	DOID_1936
1268	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP	16912112	cardiovascular system disease	DOID_1287
1269	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP	16912112	disease of anatomical entity	DOID_7
1270	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP	16912112	vascular disease	DOID_178
1271	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_DN	16912112	arterial occlusive disease	DOID_2868
1272	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_DN	16912112	arteriosclerosis	DOID_2349
1273	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_DN	16912112	arteriosclerotic cardiovascular disease	DOID_2348
1274	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_DN	16912112	atherosclerosis	DOID_1936
1275	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_DN	16912112	cardiovascular system disease	DOID_1287
1276	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_DN	16912112	disease of anatomical entity	DOID_7
1277	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_DN	16912112	vascular disease	DOID_178
1278	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLACK_UP	16912112	arterial occlusive disease	DOID_2868
1279	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLACK_UP	16912112	arteriosclerosis	DOID_2349
1280	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLACK_UP	16912112	arteriosclerotic cardiovascular disease	DOID_2348
1281	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLACK_UP	16912112	atherosclerosis	DOID_1936
1282	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLACK_UP	16912112	cardiovascular system disease	DOID_1287
1283	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLACK_UP	16912112	disease of anatomical entity	DOID_7
1284	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLACK_UP	16912112	vascular disease	DOID_178
1285	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLACK_DN	16912112	arterial occlusive disease	DOID_2868
1286	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLACK_DN	16912112	arteriosclerosis	DOID_2349
1287	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLACK_DN	16912112	arteriosclerotic cardiovascular disease	DOID_2348
1288	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLACK_DN	16912112	atherosclerosis	DOID_1936
1289	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLACK_DN	16912112	cardiovascular system disease	DOID_1287
1290	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLACK_DN	16912112	disease of anatomical entity	DOID_7
1291	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLACK_DN	16912112	vascular disease	DOID_178
1292	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_UP	16912112	arterial occlusive disease	DOID_2868
1293	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_UP	16912112	arteriosclerosis	DOID_2349
1294	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_UP	16912112	arteriosclerotic cardiovascular disease	DOID_2348
1295	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_UP	16912112	atherosclerosis	DOID_1936
1296	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_UP	16912112	cardiovascular system disease	DOID_1287
1297	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_UP	16912112	disease of anatomical entity	DOID_7
1298	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_UP	16912112	vascular disease	DOID_178
1299	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_DN	16912112	arterial occlusive disease	DOID_2868
1300	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_DN	16912112	arteriosclerosis	DOID_2349
1301	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_DN	16912112	arteriosclerotic cardiovascular disease	DOID_2348
1302	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_DN	16912112	atherosclerosis	DOID_1936
1303	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_DN	16912112	cardiovascular system disease	DOID_1287
1304	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_DN	16912112	disease of anatomical entity	DOID_7
1305	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_DN	16912112	vascular disease	DOID_178
1306	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_UP	16818636	acute myeloid leukemia	DOID_9119
1307	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_UP	16818636	cancer	DOID_162
1308	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_UP	16818636	disease of cellular proliferation	DOID_14566
1309	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_UP	16818636	hematologic cancer	DOID_2531
1310	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_UP	16818636	hereditary Wilms' tumor	DOID_5183
1311	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_UP	16818636	immune system cancer	DOID_0060083
1312	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_UP	16818636	kidney cancer	DOID_263
1313	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_UP	16818636	leukemia	DOID_1240
1314	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_UP	16818636	myeloid leukemia	DOID_8692
1315	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_UP	16818636	nephroblastoma	DOID_2154
1316	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_UP	16818636	organ system cancer	DOID_0050686
1317	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_UP	16818636	urinary system cancer	DOID_3996
1318	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN	16818636	acute myeloid leukemia	DOID_9119
1319	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN	16818636	cancer	DOID_162
1320	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN	16818636	disease of cellular proliferation	DOID_14566
1321	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN	16818636	hematologic cancer	DOID_2531
1322	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN	16818636	hereditary Wilms' tumor	DOID_5183
1323	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN	16818636	immune system cancer	DOID_0060083
1324	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN	16818636	kidney cancer	DOID_263
1325	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN	16818636	leukemia	DOID_1240
1326	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN	16818636	myeloid leukemia	DOID_8692
1327	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN	16818636	nephroblastoma	DOID_2154
1328	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN	16818636	organ system cancer	DOID_0050686
1329	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN	16818636	urinary system cancer	DOID_3996
1330	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP	16818636	acute myeloid leukemia	DOID_9119
1331	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP	16818636	cancer	DOID_162
1332	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP	16818636	disease of cellular proliferation	DOID_14566
1333	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP	16818636	hematologic cancer	DOID_2531
1334	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP	16818636	hereditary Wilms' tumor	DOID_5183
1335	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP	16818636	immune system cancer	DOID_0060083
1336	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP	16818636	kidney cancer	DOID_263
1337	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP	16818636	leukemia	DOID_1240
1338	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP	16818636	myeloid leukemia	DOID_8692
1339	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP	16818636	nephroblastoma	DOID_2154
1340	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP	16818636	organ system cancer	DOID_0050686
1341	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP	16818636	urinary system cancer	DOID_3996
1342	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_DN	16818636	acute myeloid leukemia	DOID_9119
1343	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_DN	16818636	cancer	DOID_162
1344	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_DN	16818636	disease of cellular proliferation	DOID_14566
1345	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_DN	16818636	hematologic cancer	DOID_2531
1346	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_DN	16818636	hereditary Wilms' tumor	DOID_5183
1347	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_DN	16818636	immune system cancer	DOID_0060083
1348	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_DN	16818636	kidney cancer	DOID_263
1349	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_DN	16818636	leukemia	DOID_1240
1350	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_DN	16818636	myeloid leukemia	DOID_8692
1351	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_DN	16818636	nephroblastoma	DOID_2154
1352	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_DN	16818636	organ system cancer	DOID_0050686
1353	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_DN	16818636	urinary system cancer	DOID_3996
1354	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_UP	16818636	acute myeloid leukemia	DOID_9119
1355	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_UP	16818636	cancer	DOID_162
1356	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_UP	16818636	disease of cellular proliferation	DOID_14566
1357	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_UP	16818636	hematologic cancer	DOID_2531
1358	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_UP	16818636	hereditary Wilms' tumor	DOID_5183
1359	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_UP	16818636	immune system cancer	DOID_0060083
1360	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_UP	16818636	kidney cancer	DOID_263
1361	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_UP	16818636	leukemia	DOID_1240
1362	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_UP	16818636	myeloid leukemia	DOID_8692
1363	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_UP	16818636	nephroblastoma	DOID_2154
1364	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_UP	16818636	organ system cancer	DOID_0050686
1365	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_UP	16818636	urinary system cancer	DOID_3996
1366	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN	16818636	acute myeloid leukemia	DOID_9119
1367	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN	16818636	cancer	DOID_162
1368	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN	16818636	disease of cellular proliferation	DOID_14566
1369	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN	16818636	hematologic cancer	DOID_2531
1370	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN	16818636	hereditary Wilms' tumor	DOID_5183
1371	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN	16818636	immune system cancer	DOID_0060083
1372	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN	16818636	kidney cancer	DOID_263
1373	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN	16818636	leukemia	DOID_1240
1374	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN	16818636	myeloid leukemia	DOID_8692
1375	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN	16818636	nephroblastoma	DOID_2154
1376	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN	16818636	organ system cancer	DOID_0050686
1377	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN	16818636	urinary system cancer	DOID_3996
1378	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP	16818636	acute myeloid leukemia	DOID_9119
1379	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP	16818636	cancer	DOID_162
1380	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP	16818636	disease of cellular proliferation	DOID_14566
1381	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP	16818636	hematologic cancer	DOID_2531
1382	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP	16818636	hereditary Wilms' tumor	DOID_5183
1383	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP	16818636	immune system cancer	DOID_0060083
1384	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP	16818636	kidney cancer	DOID_263
1385	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP	16818636	leukemia	DOID_1240
1386	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP	16818636	myeloid leukemia	DOID_8692
1387	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP	16818636	nephroblastoma	DOID_2154
1388	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP	16818636	organ system cancer	DOID_0050686
1389	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP	16818636	urinary system cancer	DOID_3996
1390	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN	16818636	acute myeloid leukemia	DOID_9119
1391	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN	16818636	cancer	DOID_162
1392	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN	16818636	disease of cellular proliferation	DOID_14566
1393	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN	16818636	hematologic cancer	DOID_2531
1394	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN	16818636	hereditary Wilms' tumor	DOID_5183
1395	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN	16818636	immune system cancer	DOID_0060083
1396	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN	16818636	kidney cancer	DOID_263
1397	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN	16818636	leukemia	DOID_1240
1398	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN	16818636	myeloid leukemia	DOID_8692
1399	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN	16818636	nephroblastoma	DOID_2154
1400	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN	16818636	organ system cancer	DOID_0050686
1401	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN	16818636	urinary system cancer	DOID_3996
1402	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP	16818636	acute myeloid leukemia	DOID_9119
1403	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP	16818636	cancer	DOID_162
1404	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP	16818636	disease of cellular proliferation	DOID_14566
1405	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP	16818636	hematologic cancer	DOID_2531
1406	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP	16818636	hereditary Wilms' tumor	DOID_5183
1407	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP	16818636	immune system cancer	DOID_0060083
1408	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP	16818636	kidney cancer	DOID_263
1409	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP	16818636	leukemia	DOID_1240
1410	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP	16818636	myeloid leukemia	DOID_8692
1411	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP	16818636	nephroblastoma	DOID_2154
1412	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP	16818636	organ system cancer	DOID_0050686
1413	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP	16818636	urinary system cancer	DOID_3996
1414	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN	16818636	acute myeloid leukemia	DOID_9119
1415	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN	16818636	cancer	DOID_162
1416	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN	16818636	disease of cellular proliferation	DOID_14566
1417	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN	16818636	hematologic cancer	DOID_2531
1418	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN	16818636	hereditary Wilms' tumor	DOID_5183
1419	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN	16818636	immune system cancer	DOID_0060083
1420	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN	16818636	kidney cancer	DOID_263
1421	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN	16818636	leukemia	DOID_1240
1422	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN	16818636	myeloid leukemia	DOID_8692
1423	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN	16818636	nephroblastoma	DOID_2154
1424	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN	16818636	organ system cancer	DOID_0050686
1425	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN	16818636	urinary system cancer	DOID_3996
1426	LOPEZ_MESOTELIOMA_SURVIVAL_TIME_UP	16540645	benign mesothelioma	DOID_2645
1427	LOPEZ_MESOTELIOMA_SURVIVAL_TIME_UP	16540645	benign neoplasm	DOID_0060072
1428	LOPEZ_MESOTELIOMA_SURVIVAL_TIME_UP	16540645	cell type benign neoplasm	DOID_0060084
1429	LOPEZ_MESOTELIOMA_SURVIVAL_TIME_UP	16540645	disease of cellular proliferation	DOID_14566
1430	BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_UP	16341039	cancer	DOID_162
1431	BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_UP	16341039	disease of cellular proliferation	DOID_14566
1432	BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_UP	16341039	hematologic cancer	DOID_2531
1433	BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_UP	16341039	immune system cancer	DOID_0060083
1434	BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_UP	16341039	leukemia	DOID_1240
1435	BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_UP	16341039	myeloid leukemia	DOID_8692
1436	BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_UP	16341039	organ system cancer	DOID_0050686
1437	BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_DN	16341039	cancer	DOID_162
1438	BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_DN	16341039	disease of cellular proliferation	DOID_14566
1439	BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_DN	16341039	hematologic cancer	DOID_2531
1440	BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_DN	16341039	immune system cancer	DOID_0060083
1441	BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_DN	16341039	leukemia	DOID_1240
1442	BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_DN	16341039	myeloid leukemia	DOID_8692
1443	BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_DN	16341039	organ system cancer	DOID_0050686
1444	BILBAN_B_CLL_LPL_UP	16617321	cancer	DOID_162
1445	BILBAN_B_CLL_LPL_UP	16617321	chronic leukemia	DOID_1036
1446	BILBAN_B_CLL_LPL_UP	16617321	chronic lymphocytic leukemia	DOID_1040
1447	BILBAN_B_CLL_LPL_UP	16617321	disease of cellular proliferation	DOID_14566
1448	BILBAN_B_CLL_LPL_UP	16617321	hematologic cancer	DOID_2531
1449	BILBAN_B_CLL_LPL_UP	16617321	immune system cancer	DOID_0060083
1450	BILBAN_B_CLL_LPL_UP	16617321	leukemia	DOID_1240
1451	BILBAN_B_CLL_LPL_UP	16617321	lymphoblastic leukemia	DOID_1037
1452	BILBAN_B_CLL_LPL_UP	16617321	organ system cancer	DOID_0050686
1453	BILBAN_B_CLL_LPL_DN	16617321	cancer	DOID_162
1454	BILBAN_B_CLL_LPL_DN	16617321	chronic leukemia	DOID_1036
1455	BILBAN_B_CLL_LPL_DN	16617321	chronic lymphocytic leukemia	DOID_1040
1456	BILBAN_B_CLL_LPL_DN	16617321	disease of cellular proliferation	DOID_14566
1457	BILBAN_B_CLL_LPL_DN	16617321	hematologic cancer	DOID_2531
1458	BILBAN_B_CLL_LPL_DN	16617321	immune system cancer	DOID_0060083
1459	BILBAN_B_CLL_LPL_DN	16617321	leukemia	DOID_1240
1460	BILBAN_B_CLL_LPL_DN	16617321	lymphoblastic leukemia	DOID_1037
1461	BILBAN_B_CLL_LPL_DN	16617321	organ system cancer	DOID_0050686
1462	HOEBEKE_LYMPHOID_STEM_CELL_UP	17170726	NA	NA
1463	HOEBEKE_LYMPHOID_STEM_CELL_DN	17170726	NA	NA
1464	PEPPER_CHRONIC_LYMPHOCYTIC_LEUKEMIA_UP	17287849	cancer	DOID_162
1465	PEPPER_CHRONIC_LYMPHOCYTIC_LEUKEMIA_UP	17287849	chronic leukemia	DOID_1036
1466	PEPPER_CHRONIC_LYMPHOCYTIC_LEUKEMIA_UP	17287849	chronic lymphocytic leukemia	DOID_1040
1467	PEPPER_CHRONIC_LYMPHOCYTIC_LEUKEMIA_UP	17287849	disease of cellular proliferation	DOID_14566
1468	PEPPER_CHRONIC_LYMPHOCYTIC_LEUKEMIA_UP	17287849	hematologic cancer	DOID_2531
1469	PEPPER_CHRONIC_LYMPHOCYTIC_LEUKEMIA_UP	17287849	immune system cancer	DOID_0060083
1470	PEPPER_CHRONIC_LYMPHOCYTIC_LEUKEMIA_UP	17287849	leukemia	DOID_1240
1471	PEPPER_CHRONIC_LYMPHOCYTIC_LEUKEMIA_UP	17287849	lymphoblastic leukemia	DOID_1037
1472	PEPPER_CHRONIC_LYMPHOCYTIC_LEUKEMIA_UP	17287849	organ system cancer	DOID_0050686
1473	PEPPER_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN	17287849	cancer	DOID_162
1474	PEPPER_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN	17287849	chronic leukemia	DOID_1036
1475	PEPPER_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN	17287849	chronic lymphocytic leukemia	DOID_1040
1476	PEPPER_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN	17287849	disease of cellular proliferation	DOID_14566
1477	PEPPER_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN	17287849	hematologic cancer	DOID_2531
1478	PEPPER_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN	17287849	immune system cancer	DOID_0060083
1479	PEPPER_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN	17287849	leukemia	DOID_1240
1480	PEPPER_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN	17287849	lymphoblastic leukemia	DOID_1037
1481	PEPPER_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN	17287849	organ system cancer	DOID_0050686
1482	AKL_HTLV1_INFECTION_UP	17287851	adult T-cell leukemia	DOID_0050523
1483	AKL_HTLV1_INFECTION_UP	17287851	cancer	DOID_162
1484	AKL_HTLV1_INFECTION_UP	17287851	disease of cellular proliferation	DOID_14566
1485	AKL_HTLV1_INFECTION_UP	17287851	hematologic cancer	DOID_2531
1486	AKL_HTLV1_INFECTION_UP	17287851	immune system cancer	DOID_0060083
1487	AKL_HTLV1_INFECTION_UP	17287851	leukemia	DOID_1240
1488	AKL_HTLV1_INFECTION_UP	17287851	lymphoblastic leukemia	DOID_1037
1489	AKL_HTLV1_INFECTION_UP	17287851	lymphoid leukemia	DOID_10747
1490	AKL_HTLV1_INFECTION_UP	17287851	lymphoma	DOID_0060058
1491	AKL_HTLV1_INFECTION_UP	17287851	organ system cancer	DOID_0050686
1492	AKL_HTLV1_INFECTION_UP	17287851	T-cell leukemia	DOID_715
1493	AKL_HTLV1_INFECTION_DN	17287851	adult T-cell leukemia	DOID_0050523
1494	AKL_HTLV1_INFECTION_DN	17287851	cancer	DOID_162
1495	AKL_HTLV1_INFECTION_DN	17287851	disease of cellular proliferation	DOID_14566
1496	AKL_HTLV1_INFECTION_DN	17287851	hematologic cancer	DOID_2531
1497	AKL_HTLV1_INFECTION_DN	17287851	immune system cancer	DOID_0060083
1498	AKL_HTLV1_INFECTION_DN	17287851	leukemia	DOID_1240
1499	AKL_HTLV1_INFECTION_DN	17287851	lymphoblastic leukemia	DOID_1037
1500	AKL_HTLV1_INFECTION_DN	17287851	lymphoid leukemia	DOID_10747
1501	AKL_HTLV1_INFECTION_DN	17287851	lymphoma	DOID_0060058
1502	AKL_HTLV1_INFECTION_DN	17287851	organ system cancer	DOID_0050686
1503	AKL_HTLV1_INFECTION_DN	17287851	T-cell leukemia	DOID_715
1504	RHEIN_ALL_GLUCOCORTICOID_THERAPY_UP	17330098	cancer	DOID_162
1505	RHEIN_ALL_GLUCOCORTICOID_THERAPY_UP	17330098	disease of cellular proliferation	DOID_14566
1506	RHEIN_ALL_GLUCOCORTICOID_THERAPY_UP	17330098	hematologic cancer	DOID_2531
1507	RHEIN_ALL_GLUCOCORTICOID_THERAPY_UP	17330098	immune system cancer	DOID_0060083
1508	RHEIN_ALL_GLUCOCORTICOID_THERAPY_UP	17330098	leukemia	DOID_1240
1509	RHEIN_ALL_GLUCOCORTICOID_THERAPY_UP	17330098	lymphoblastic leukemia	DOID_1037
1510	RHEIN_ALL_GLUCOCORTICOID_THERAPY_UP	17330098	organ system cancer	DOID_0050686
1511	RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN	17330098	cancer	DOID_162
1512	RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN	17330098	disease of cellular proliferation	DOID_14566
1513	RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN	17330098	hematologic cancer	DOID_2531
1514	RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN	17330098	immune system cancer	DOID_0060083
1515	RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN	17330098	leukemia	DOID_1240
1516	RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN	17330098	lymphoblastic leukemia	DOID_1037
1517	RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN	17330098	organ system cancer	DOID_0050686
1518	MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_UP	17597811	acute myeloid leukemia	DOID_9119
1519	MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_UP	17597811	cancer	DOID_162
1520	MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_UP	17597811	disease of cellular proliferation	DOID_14566
1521	MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_UP	17597811	hematologic cancer	DOID_2531
1522	MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_UP	17597811	immune system cancer	DOID_0060083
1523	MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_UP	17597811	leukemia	DOID_1240
1524	MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_UP	17597811	myeloid leukemia	DOID_8692
1525	MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_UP	17597811	organ system cancer	DOID_0050686
1526	MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_DN	17597811	acute myeloid leukemia	DOID_9119
1527	MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_DN	17597811	cancer	DOID_162
1528	MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_DN	17597811	disease of cellular proliferation	DOID_14566
1529	MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_DN	17597811	hematologic cancer	DOID_2531
1530	MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_DN	17597811	immune system cancer	DOID_0060083
1531	MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_DN	17597811	leukemia	DOID_1240
1532	MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_DN	17597811	myeloid leukemia	DOID_8692
1533	MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_DN	17597811	organ system cancer	DOID_0050686
1534	MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_UP	17597811	acute myeloid leukemia	DOID_9119
1535	MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_UP	17597811	cancer	DOID_162
1536	MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_UP	17597811	disease of cellular proliferation	DOID_14566
1537	MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_UP	17597811	hematologic cancer	DOID_2531
1538	MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_UP	17597811	immune system cancer	DOID_0060083
1539	MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_UP	17597811	leukemia	DOID_1240
1540	MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_UP	17597811	myeloid leukemia	DOID_8692
1541	MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_UP	17597811	organ system cancer	DOID_0050686
1542	MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_DN	17597811	acute myeloid leukemia	DOID_9119
1543	MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_DN	17597811	cancer	DOID_162
1544	MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_DN	17597811	disease of cellular proliferation	DOID_14566
1545	MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_DN	17597811	hematologic cancer	DOID_2531
1546	MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_DN	17597811	immune system cancer	DOID_0060083
1547	MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_DN	17597811	leukemia	DOID_1240
1548	MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_DN	17597811	myeloid leukemia	DOID_8692
1549	MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_DN	17597811	organ system cancer	DOID_0050686
1550	MULLIGHAN_MLL_SIGNATURE_1_UP	17597811	acute myeloid leukemia	DOID_9119
1551	MULLIGHAN_MLL_SIGNATURE_1_UP	17597811	cancer	DOID_162
1552	MULLIGHAN_MLL_SIGNATURE_1_UP	17597811	disease of cellular proliferation	DOID_14566
1553	MULLIGHAN_MLL_SIGNATURE_1_UP	17597811	hematologic cancer	DOID_2531
1554	MULLIGHAN_MLL_SIGNATURE_1_UP	17597811	immune system cancer	DOID_0060083
1555	MULLIGHAN_MLL_SIGNATURE_1_UP	17597811	leukemia	DOID_1240
1556	MULLIGHAN_MLL_SIGNATURE_1_UP	17597811	myeloid leukemia	DOID_8692
1557	MULLIGHAN_MLL_SIGNATURE_1_UP	17597811	organ system cancer	DOID_0050686
1558	MULLIGHAN_MLL_SIGNATURE_1_DN	17597811	acute myeloid leukemia	DOID_9119
1559	MULLIGHAN_MLL_SIGNATURE_1_DN	17597811	cancer	DOID_162
1560	MULLIGHAN_MLL_SIGNATURE_1_DN	17597811	disease of cellular proliferation	DOID_14566
1561	MULLIGHAN_MLL_SIGNATURE_1_DN	17597811	hematologic cancer	DOID_2531
1562	MULLIGHAN_MLL_SIGNATURE_1_DN	17597811	immune system cancer	DOID_0060083
1563	MULLIGHAN_MLL_SIGNATURE_1_DN	17597811	leukemia	DOID_1240
1564	MULLIGHAN_MLL_SIGNATURE_1_DN	17597811	myeloid leukemia	DOID_8692
1565	MULLIGHAN_MLL_SIGNATURE_1_DN	17597811	organ system cancer	DOID_0050686
1566	MULLIGHAN_MLL_SIGNATURE_2_UP	17597811	acute myeloid leukemia	DOID_9119
1567	MULLIGHAN_MLL_SIGNATURE_2_UP	17597811	cancer	DOID_162
1568	MULLIGHAN_MLL_SIGNATURE_2_UP	17597811	disease of cellular proliferation	DOID_14566
1569	MULLIGHAN_MLL_SIGNATURE_2_UP	17597811	hematologic cancer	DOID_2531
1570	MULLIGHAN_MLL_SIGNATURE_2_UP	17597811	immune system cancer	DOID_0060083
1571	MULLIGHAN_MLL_SIGNATURE_2_UP	17597811	leukemia	DOID_1240
1572	MULLIGHAN_MLL_SIGNATURE_2_UP	17597811	myeloid leukemia	DOID_8692
1573	MULLIGHAN_MLL_SIGNATURE_2_UP	17597811	organ system cancer	DOID_0050686
1574	MULLIGHAN_MLL_SIGNATURE_2_DN	17597811	acute myeloid leukemia	DOID_9119
1575	MULLIGHAN_MLL_SIGNATURE_2_DN	17597811	cancer	DOID_162
1576	MULLIGHAN_MLL_SIGNATURE_2_DN	17597811	disease of cellular proliferation	DOID_14566
1577	MULLIGHAN_MLL_SIGNATURE_2_DN	17597811	hematologic cancer	DOID_2531
1578	MULLIGHAN_MLL_SIGNATURE_2_DN	17597811	immune system cancer	DOID_0060083
1579	MULLIGHAN_MLL_SIGNATURE_2_DN	17597811	leukemia	DOID_1240
1580	MULLIGHAN_MLL_SIGNATURE_2_DN	17597811	myeloid leukemia	DOID_8692
1581	MULLIGHAN_MLL_SIGNATURE_2_DN	17597811	organ system cancer	DOID_0050686
1582	MULLIGHAN_NPM1_SIGNATURE_3_UP	17597811	acute myeloid leukemia	DOID_9119
1583	MULLIGHAN_NPM1_SIGNATURE_3_UP	17597811	cancer	DOID_162
1584	MULLIGHAN_NPM1_SIGNATURE_3_UP	17597811	disease of cellular proliferation	DOID_14566
1585	MULLIGHAN_NPM1_SIGNATURE_3_UP	17597811	hematologic cancer	DOID_2531
1586	MULLIGHAN_NPM1_SIGNATURE_3_UP	17597811	immune system cancer	DOID_0060083
1587	MULLIGHAN_NPM1_SIGNATURE_3_UP	17597811	leukemia	DOID_1240
1588	MULLIGHAN_NPM1_SIGNATURE_3_UP	17597811	myeloid leukemia	DOID_8692
1589	MULLIGHAN_NPM1_SIGNATURE_3_UP	17597811	organ system cancer	DOID_0050686
1590	MULLIGHAN_NPM1_SIGNATURE_3_DN	17597811	acute myeloid leukemia	DOID_9119
1591	MULLIGHAN_NPM1_SIGNATURE_3_DN	17597811	cancer	DOID_162
1592	MULLIGHAN_NPM1_SIGNATURE_3_DN	17597811	disease of cellular proliferation	DOID_14566
1593	MULLIGHAN_NPM1_SIGNATURE_3_DN	17597811	hematologic cancer	DOID_2531
1594	MULLIGHAN_NPM1_SIGNATURE_3_DN	17597811	immune system cancer	DOID_0060083
1595	MULLIGHAN_NPM1_SIGNATURE_3_DN	17597811	leukemia	DOID_1240
1596	MULLIGHAN_NPM1_SIGNATURE_3_DN	17597811	myeloid leukemia	DOID_8692
1597	MULLIGHAN_NPM1_SIGNATURE_3_DN	17597811	organ system cancer	DOID_0050686
1598	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_GRANULOCYTE_UP	17898786	acute myeloid leukemia	DOID_9119
1599	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_GRANULOCYTE_UP	17898786	cancer	DOID_162
1600	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_GRANULOCYTE_UP	17898786	disease of cellular proliferation	DOID_14566
1601	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_GRANULOCYTE_UP	17898786	hematologic cancer	DOID_2531
1602	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_GRANULOCYTE_UP	17898786	immune system cancer	DOID_0060083
1603	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_GRANULOCYTE_UP	17898786	leukemia	DOID_1240
1604	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_GRANULOCYTE_UP	17898786	myeloid leukemia	DOID_8692
1605	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_GRANULOCYTE_UP	17898786	organ system cancer	DOID_0050686
1606	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP	17898786	acute myeloid leukemia	DOID_9119
1607	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP	17898786	cancer	DOID_162
1608	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP	17898786	disease of cellular proliferation	DOID_14566
1609	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP	17898786	hematologic cancer	DOID_2531
1610	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP	17898786	immune system cancer	DOID_0060083
1611	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP	17898786	leukemia	DOID_1240
1612	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP	17898786	myeloid leukemia	DOID_8692
1613	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP	17898786	organ system cancer	DOID_0050686
1614	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN	17898786	acute myeloid leukemia	DOID_9119
1615	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN	17898786	cancer	DOID_162
1616	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN	17898786	disease of cellular proliferation	DOID_14566
1617	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN	17898786	hematologic cancer	DOID_2531
1618	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN	17898786	immune system cancer	DOID_0060083
1619	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN	17898786	leukemia	DOID_1240
1620	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN	17898786	myeloid leukemia	DOID_8692
1621	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN	17898786	organ system cancer	DOID_0050686
1622	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_UP	17898786	acute myeloid leukemia	DOID_9119
1623	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_UP	17898786	cancer	DOID_162
1624	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_UP	17898786	disease of cellular proliferation	DOID_14566
1625	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_UP	17898786	hematologic cancer	DOID_2531
1626	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_UP	17898786	immune system cancer	DOID_0060083
1627	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_UP	17898786	leukemia	DOID_1240
1628	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_UP	17898786	myeloid leukemia	DOID_8692
1629	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_UP	17898786	organ system cancer	DOID_0050686
1630	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_DN	17898786	acute myeloid leukemia	DOID_9119
1631	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_DN	17898786	cancer	DOID_162
1632	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_DN	17898786	disease of cellular proliferation	DOID_14566
1633	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_DN	17898786	hematologic cancer	DOID_2531
1634	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_DN	17898786	immune system cancer	DOID_0060083
1635	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_DN	17898786	leukemia	DOID_1240
1636	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_DN	17898786	myeloid leukemia	DOID_8692
1637	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_DN	17898786	organ system cancer	DOID_0050686
1638	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP	17898786	acute myeloid leukemia	DOID_9119
1639	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP	17898786	cancer	DOID_162
1640	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP	17898786	disease of cellular proliferation	DOID_14566
1641	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP	17898786	hematologic cancer	DOID_2531
1642	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP	17898786	immune system cancer	DOID_0060083
1643	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP	17898786	leukemia	DOID_1240
1644	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP	17898786	myeloid leukemia	DOID_8692
1645	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP	17898786	organ system cancer	DOID_0050686
1646	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_DN	17898786	acute myeloid leukemia	DOID_9119
1647	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_DN	17898786	cancer	DOID_162
1648	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_DN	17898786	disease of cellular proliferation	DOID_14566
1649	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_DN	17898786	hematologic cancer	DOID_2531
1650	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_DN	17898786	immune system cancer	DOID_0060083
1651	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_DN	17898786	leukemia	DOID_1240
1652	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_DN	17898786	myeloid leukemia	DOID_8692
1653	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_DN	17898786	organ system cancer	DOID_0050686
1654	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP	17898786	acute myeloid leukemia	DOID_9119
1655	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP	17898786	cancer	DOID_162
1656	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP	17898786	disease of cellular proliferation	DOID_14566
1657	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP	17898786	hematologic cancer	DOID_2531
1658	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP	17898786	immune system cancer	DOID_0060083
1659	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP	17898786	leukemia	DOID_1240
1660	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP	17898786	myeloid leukemia	DOID_8692
1661	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP	17898786	organ system cancer	DOID_0050686
1662	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_DN	17898786	acute myeloid leukemia	DOID_9119
1663	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_DN	17898786	cancer	DOID_162
1664	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_DN	17898786	disease of cellular proliferation	DOID_14566
1665	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_DN	17898786	hematologic cancer	DOID_2531
1666	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_DN	17898786	immune system cancer	DOID_0060083
1667	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_DN	17898786	leukemia	DOID_1240
1668	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_DN	17898786	myeloid leukemia	DOID_8692
1669	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_DN	17898786	organ system cancer	DOID_0050686
1670	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_MONOCYTE_UP	17898786	acute myeloid leukemia	DOID_9119
1671	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_MONOCYTE_UP	17898786	cancer	DOID_162
1672	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_MONOCYTE_UP	17898786	disease of cellular proliferation	DOID_14566
1673	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_MONOCYTE_UP	17898786	hematologic cancer	DOID_2531
1674	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_MONOCYTE_UP	17898786	immune system cancer	DOID_0060083
1675	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_MONOCYTE_UP	17898786	leukemia	DOID_1240
1676	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_MONOCYTE_UP	17898786	myeloid leukemia	DOID_8692
1677	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_MONOCYTE_UP	17898786	organ system cancer	DOID_0050686
1678	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINDED_IN_ERYTHROCYTE_UP	17898786	acute myeloid leukemia	DOID_9119
1679	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINDED_IN_ERYTHROCYTE_UP	17898786	cancer	DOID_162
1680	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINDED_IN_ERYTHROCYTE_UP	17898786	disease of cellular proliferation	DOID_14566
1681	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINDED_IN_ERYTHROCYTE_UP	17898786	hematologic cancer	DOID_2531
1682	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINDED_IN_ERYTHROCYTE_UP	17898786	immune system cancer	DOID_0060083
1683	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINDED_IN_ERYTHROCYTE_UP	17898786	leukemia	DOID_1240
1684	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINDED_IN_ERYTHROCYTE_UP	17898786	myeloid leukemia	DOID_8692
1685	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINDED_IN_ERYTHROCYTE_UP	17898786	organ system cancer	DOID_0050686
1686	LOPEZ_MESOTHELIOMA_SURVIVAL_WORST_VS_BEST_UP	16540645	benign mesothelioma	DOID_2645
1687	LOPEZ_MESOTHELIOMA_SURVIVAL_WORST_VS_BEST_UP	16540645	benign neoplasm	DOID_0060072
1688	LOPEZ_MESOTHELIOMA_SURVIVAL_WORST_VS_BEST_UP	16540645	cell type benign neoplasm	DOID_0060084
1689	LOPEZ_MESOTHELIOMA_SURVIVAL_WORST_VS_BEST_UP	16540645	disease of cellular proliferation	DOID_14566
1690	PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_UP	16741146	arterial occlusive disease	DOID_2868
1691	PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_UP	16741146	arteriosclerosis	DOID_2349
1692	PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_UP	16741146	arteriosclerotic cardiovascular disease	DOID_2348
1693	PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_UP	16741146	atherosclerosis	DOID_1936
1694	PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_UP	16741146	cardiovascular system disease	DOID_1287
1695	PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_UP	16741146	disease of anatomical entity	DOID_7
1696	PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_UP	16741146	vascular disease	DOID_178
1697	PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_DN	16741146	arterial occlusive disease	DOID_2868
1698	PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_DN	16741146	arteriosclerosis	DOID_2349
1699	PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_DN	16741146	arteriosclerotic cardiovascular disease	DOID_2348
1700	PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_DN	16741146	atherosclerosis	DOID_1936
1701	PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_DN	16741146	cardiovascular system disease	DOID_1287
1702	PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_DN	16741146	disease of anatomical entity	DOID_7
1703	PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_DN	16741146	vascular disease	DOID_178
1704	DITTMER_PTHLH_TARGETS_UP	16551631	breast cancer	DOID_1612
1705	DITTMER_PTHLH_TARGETS_UP	16551631	cancer	DOID_162
1706	DITTMER_PTHLH_TARGETS_UP	16551631	disease of cellular proliferation	DOID_14566
1707	DITTMER_PTHLH_TARGETS_UP	16551631	organ system cancer	DOID_0050686
1708	DITTMER_PTHLH_TARGETS_UP	16551631	thoracic cancer	DOID_5093
1709	DITTMER_PTHLH_TARGETS_DN	16551631	breast cancer	DOID_1612
1710	DITTMER_PTHLH_TARGETS_DN	16551631	cancer	DOID_162
1711	DITTMER_PTHLH_TARGETS_DN	16551631	disease of cellular proliferation	DOID_14566
1712	DITTMER_PTHLH_TARGETS_DN	16551631	organ system cancer	DOID_0050686
1713	DITTMER_PTHLH_TARGETS_DN	16551631	thoracic cancer	DOID_5093
1714	UDAYAKUMAR_MED1_TARGETS_UP	16574658	cancer	DOID_162
1715	UDAYAKUMAR_MED1_TARGETS_UP	16574658	disease of cellular proliferation	DOID_14566
1716	UDAYAKUMAR_MED1_TARGETS_DN	16574658	cancer	DOID_162
1717	UDAYAKUMAR_MED1_TARGETS_DN	16574658	disease of cellular proliferation	DOID_14566
1718	ODONNELL_TFRC_TARGETS_UP	16508012	cancer	DOID_162
1719	ODONNELL_TFRC_TARGETS_UP	16508012	disease of cellular proliferation	DOID_14566
1720	ODONNELL_TFRC_TARGETS_UP	16508012	hematologic cancer	DOID_2531
1721	ODONNELL_TFRC_TARGETS_UP	16508012	immune system cancer	DOID_0060083
1722	ODONNELL_TFRC_TARGETS_UP	16508012	lymphoma	DOID_0060058
1723	ODONNELL_TFRC_TARGETS_UP	16508012	organ system cancer	DOID_0050686
1724	ODONNELL_TFRC_TARGETS_DN	16508012	cancer	DOID_162
1725	ODONNELL_TFRC_TARGETS_DN	16508012	disease of cellular proliferation	DOID_14566
1726	ODONNELL_TFRC_TARGETS_DN	16508012	hematologic cancer	DOID_2531
1727	ODONNELL_TFRC_TARGETS_DN	16508012	immune system cancer	DOID_0060083
1728	ODONNELL_TFRC_TARGETS_DN	16508012	lymphoma	DOID_0060058
1729	ODONNELL_TFRC_TARGETS_DN	16508012	organ system cancer	DOID_0050686
1730	ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP	16508012	cancer	DOID_162
1731	ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP	16508012	disease of cellular proliferation	DOID_14566
1732	ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP	16508012	hematologic cancer	DOID_2531
1733	ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP	16508012	immune system cancer	DOID_0060083
1734	ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP	16508012	lymphoma	DOID_0060058
1735	ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP	16508012	organ system cancer	DOID_0050686
1736	ODONNELL_TARGETS_OF_MYC_AND_TFRC_DN	16508012	cancer	DOID_162
1737	ODONNELL_TARGETS_OF_MYC_AND_TFRC_DN	16508012	disease of cellular proliferation	DOID_14566
1738	ODONNELL_TARGETS_OF_MYC_AND_TFRC_DN	16508012	hematologic cancer	DOID_2531
1739	ODONNELL_TARGETS_OF_MYC_AND_TFRC_DN	16508012	immune system cancer	DOID_0060083
1740	ODONNELL_TARGETS_OF_MYC_AND_TFRC_DN	16508012	lymphoma	DOID_0060058
1741	ODONNELL_TARGETS_OF_MYC_AND_TFRC_DN	16508012	organ system cancer	DOID_0050686
1742	SENESE_HDAC1_TARGETS_UP	17470557	cancer	DOID_162
1743	SENESE_HDAC1_TARGETS_UP	17470557	disease of cellular proliferation	DOID_14566
1744	SENESE_HDAC1_TARGETS_DN	17470557	cancer	DOID_162
1745	SENESE_HDAC1_TARGETS_DN	17470557	disease of cellular proliferation	DOID_14566
1746	SENESE_HDAC1_AND_HDAC2_TARGETS_UP	17470557	cancer	DOID_162
1747	SENESE_HDAC1_AND_HDAC2_TARGETS_UP	17470557	disease of cellular proliferation	DOID_14566
1748	SENESE_HDAC1_AND_HDAC2_TARGETS_DN	17470557	cancer	DOID_162
1749	SENESE_HDAC1_AND_HDAC2_TARGETS_DN	17470557	disease of cellular proliferation	DOID_14566
1750	SENESE_HDAC2_TARGETS_UP	17470557	cancer	DOID_162
1751	SENESE_HDAC2_TARGETS_UP	17470557	disease of cellular proliferation	DOID_14566
1752	SENESE_HDAC2_TARGETS_DN	17470557	cancer	DOID_162
1753	SENESE_HDAC2_TARGETS_DN	17470557	disease of cellular proliferation	DOID_14566
1754	SENESE_HDAC3_TARGETS_UP	17470557	cancer	DOID_162
1755	SENESE_HDAC3_TARGETS_UP	17470557	disease of cellular proliferation	DOID_14566
1756	SENESE_HDAC3_TARGETS_DN	17470557	cancer	DOID_162
1757	SENESE_HDAC3_TARGETS_DN	17470557	disease of cellular proliferation	DOID_14566
1758	LEE_NEURAL_CREST_STEM_CELL_UP	18037878	NA	NA
1759	LEE_NEURAL_CREST_STEM_CELL_DN	18037878	NA	NA
1760	HUMMEL_BURKITTS_LYMPHOMA_UP	16760442	B-cell lymphocytic neoplasm	DOID_707
1761	HUMMEL_BURKITTS_LYMPHOMA_UP	16760442	Burkitt's lymphoma	DOID_8584
1762	HUMMEL_BURKITTS_LYMPHOMA_UP	16760442	cancer	DOID_162
1763	HUMMEL_BURKITTS_LYMPHOMA_UP	16760442	disease of cellular proliferation	DOID_14566
1764	HUMMEL_BURKITTS_LYMPHOMA_UP	16760442	hematologic cancer	DOID_2531
1765	HUMMEL_BURKITTS_LYMPHOMA_UP	16760442	immune system cancer	DOID_0060083
1766	HUMMEL_BURKITTS_LYMPHOMA_UP	16760442	lymphoma	DOID_0060058
1767	HUMMEL_BURKITTS_LYMPHOMA_UP	16760442	mature B-cell neoplasm	DOID_706
1768	HUMMEL_BURKITTS_LYMPHOMA_UP	16760442	organ system cancer	DOID_0050686
1769	HUMMEL_BURKITTS_LYMPHOMA_DN	16760442	B-cell lymphocytic neoplasm	DOID_707
1770	HUMMEL_BURKITTS_LYMPHOMA_DN	16760442	Burkitt's lymphoma	DOID_8584
1771	HUMMEL_BURKITTS_LYMPHOMA_DN	16760442	cancer	DOID_162
1772	HUMMEL_BURKITTS_LYMPHOMA_DN	16760442	disease of cellular proliferation	DOID_14566
1773	HUMMEL_BURKITTS_LYMPHOMA_DN	16760442	hematologic cancer	DOID_2531
1774	HUMMEL_BURKITTS_LYMPHOMA_DN	16760442	immune system cancer	DOID_0060083
1775	HUMMEL_BURKITTS_LYMPHOMA_DN	16760442	lymphoma	DOID_0060058
1776	HUMMEL_BURKITTS_LYMPHOMA_DN	16760442	mature B-cell neoplasm	DOID_706
1777	HUMMEL_BURKITTS_LYMPHOMA_DN	16760442	organ system cancer	DOID_0050686
1778	TIEN_INTESTINE_PROBIOTICS_2HR_UP	16394013	bacterial infectious disease	DOID_104
1779	TIEN_INTESTINE_PROBIOTICS_2HR_UP	16394013	disease by infectious agent	DOID_0050117
1780	TIEN_INTESTINE_PROBIOTICS_2HR_UP	16394013	disease of anatomical entity	DOID_7
1781	TIEN_INTESTINE_PROBIOTICS_2HR_UP	16394013	dysentery	DOID_12384
1782	TIEN_INTESTINE_PROBIOTICS_2HR_UP	16394013	gastrointestinal system disease	DOID_77
1783	TIEN_INTESTINE_PROBIOTICS_2HR_UP	16394013	intestinal disease	DOID_5295
1784	TIEN_INTESTINE_PROBIOTICS_2HR_UP	16394013	intestinal infectious disease	DOID_100
1785	TIEN_INTESTINE_PROBIOTICS_2HR_UP	16394013	primary bacterial infectious disease	DOID_0050338
1786	TIEN_INTESTINE_PROBIOTICS_2HR_UP	16394013	shigellosis	DOID_12385
1787	TIEN_INTESTINE_PROBIOTICS_2HR_DN	16394013	bacterial infectious disease	DOID_104
1788	TIEN_INTESTINE_PROBIOTICS_2HR_DN	16394013	disease by infectious agent	DOID_0050117
1789	TIEN_INTESTINE_PROBIOTICS_2HR_DN	16394013	disease of anatomical entity	DOID_7
1790	TIEN_INTESTINE_PROBIOTICS_2HR_DN	16394013	dysentery	DOID_12384
1791	TIEN_INTESTINE_PROBIOTICS_2HR_DN	16394013	gastrointestinal system disease	DOID_77
1792	TIEN_INTESTINE_PROBIOTICS_2HR_DN	16394013	intestinal disease	DOID_5295
1793	TIEN_INTESTINE_PROBIOTICS_2HR_DN	16394013	intestinal infectious disease	DOID_100
1794	TIEN_INTESTINE_PROBIOTICS_2HR_DN	16394013	primary bacterial infectious disease	DOID_0050338
1795	TIEN_INTESTINE_PROBIOTICS_2HR_DN	16394013	shigellosis	DOID_12385
1796	TIEN_INTESTINE_PROBIOTICS_6HR_UP	16394013	bacterial infectious disease	DOID_104
1797	TIEN_INTESTINE_PROBIOTICS_6HR_UP	16394013	disease by infectious agent	DOID_0050117
1798	TIEN_INTESTINE_PROBIOTICS_6HR_UP	16394013	disease of anatomical entity	DOID_7
1799	TIEN_INTESTINE_PROBIOTICS_6HR_UP	16394013	dysentery	DOID_12384
1800	TIEN_INTESTINE_PROBIOTICS_6HR_UP	16394013	gastrointestinal system disease	DOID_77
1801	TIEN_INTESTINE_PROBIOTICS_6HR_UP	16394013	intestinal disease	DOID_5295
1802	TIEN_INTESTINE_PROBIOTICS_6HR_UP	16394013	intestinal infectious disease	DOID_100
1803	TIEN_INTESTINE_PROBIOTICS_6HR_UP	16394013	primary bacterial infectious disease	DOID_0050338
1804	TIEN_INTESTINE_PROBIOTICS_6HR_UP	16394013	shigellosis	DOID_12385
1805	TIEN_INTESTINE_PROBIOTICS_6HR_DN	16394013	bacterial infectious disease	DOID_104
1806	TIEN_INTESTINE_PROBIOTICS_6HR_DN	16394013	disease by infectious agent	DOID_0050117
1807	TIEN_INTESTINE_PROBIOTICS_6HR_DN	16394013	disease of anatomical entity	DOID_7
1808	TIEN_INTESTINE_PROBIOTICS_6HR_DN	16394013	dysentery	DOID_12384
1809	TIEN_INTESTINE_PROBIOTICS_6HR_DN	16394013	gastrointestinal system disease	DOID_77
1810	TIEN_INTESTINE_PROBIOTICS_6HR_DN	16394013	intestinal disease	DOID_5295
1811	TIEN_INTESTINE_PROBIOTICS_6HR_DN	16394013	intestinal infectious disease	DOID_100
1812	TIEN_INTESTINE_PROBIOTICS_6HR_DN	16394013	primary bacterial infectious disease	DOID_0050338
1813	TIEN_INTESTINE_PROBIOTICS_6HR_DN	16394013	shigellosis	DOID_12385
1814	TIEN_INTESTINE_PROBIOTICS_24HR_UP	16394013	bacterial infectious disease	DOID_104
1815	TIEN_INTESTINE_PROBIOTICS_24HR_UP	16394013	disease by infectious agent	DOID_0050117
1816	TIEN_INTESTINE_PROBIOTICS_24HR_UP	16394013	disease of anatomical entity	DOID_7
1817	TIEN_INTESTINE_PROBIOTICS_24HR_UP	16394013	dysentery	DOID_12384
1818	TIEN_INTESTINE_PROBIOTICS_24HR_UP	16394013	gastrointestinal system disease	DOID_77
1819	TIEN_INTESTINE_PROBIOTICS_24HR_UP	16394013	intestinal disease	DOID_5295
1820	TIEN_INTESTINE_PROBIOTICS_24HR_UP	16394013	intestinal infectious disease	DOID_100
1821	TIEN_INTESTINE_PROBIOTICS_24HR_UP	16394013	primary bacterial infectious disease	DOID_0050338
1822	TIEN_INTESTINE_PROBIOTICS_24HR_UP	16394013	shigellosis	DOID_12385
1823	TIEN_INTESTINE_PROBIOTICS_24HR_DN	16394013	bacterial infectious disease	DOID_104
1824	TIEN_INTESTINE_PROBIOTICS_24HR_DN	16394013	disease by infectious agent	DOID_0050117
1825	TIEN_INTESTINE_PROBIOTICS_24HR_DN	16394013	disease of anatomical entity	DOID_7
1826	TIEN_INTESTINE_PROBIOTICS_24HR_DN	16394013	dysentery	DOID_12384
1827	TIEN_INTESTINE_PROBIOTICS_24HR_DN	16394013	gastrointestinal system disease	DOID_77
1828	TIEN_INTESTINE_PROBIOTICS_24HR_DN	16394013	intestinal disease	DOID_5295
1829	TIEN_INTESTINE_PROBIOTICS_24HR_DN	16394013	intestinal infectious disease	DOID_100
1830	TIEN_INTESTINE_PROBIOTICS_24HR_DN	16394013	primary bacterial infectious disease	DOID_0050338
1831	TIEN_INTESTINE_PROBIOTICS_24HR_DN	16394013	shigellosis	DOID_12385
1832	ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP	18025224	NA	NA
1833	ZHOU_INFLAMMATORY_RESPONSE_FIMA_DN	18025224	NA	NA
1834	ZHOU_INFLAMMATORY_RESPONSE_LPS_UP	18025224	NA	NA
1835	ZHOU_INFLAMMATORY_RESPONSE_LPS_DN	18025224	NA	NA
1836	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN	17114343	alveolar rhabdomyosarcoma	DOID_4051
1837	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN	17114343	cancer	DOID_162
1838	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN	17114343	cell type cancer	DOID_0050687
1839	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN	17114343	connective tissue cancer	DOID_201
1840	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN	17114343	disease of cellular proliferation	DOID_14566
1841	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN	17114343	lipomatous cancer	DOID_3939
1842	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN	17114343	liposarcoma	DOID_3382
1843	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN	17114343	muscle cancer	DOID_4045
1844	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN	17114343	musculoskeletal system cancer	DOID_0060100
1845	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN	17114343	myxoid liposarcoma	DOID_5363
1846	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN	17114343	organ system cancer	DOID_0050686
1847	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN	17114343	rhabdomyosarcoma	DOID_3247
1848	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN	17114343	sarcoma	DOID_1115
1849	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN	17114343	skeletal muscle cancer	DOID_4043
1850	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN	17114343	synovial sarcoma	DOID_5485
1851	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN	17114343	synovium cancer	DOID_2706
1852	SABATES_COLORECTAL_ADENOMA_SIZE_UP	18171984	adenoma	DOID_657
1853	SABATES_COLORECTAL_ADENOMA_SIZE_UP	18171984	benign neoplasm	DOID_0060072
1854	SABATES_COLORECTAL_ADENOMA_SIZE_UP	18171984	cancer	DOID_162
1855	SABATES_COLORECTAL_ADENOMA_SIZE_UP	18171984	cell type benign neoplasm	DOID_0060084
1856	SABATES_COLORECTAL_ADENOMA_SIZE_UP	18171984	colon cancer	DOID_219
1857	SABATES_COLORECTAL_ADENOMA_SIZE_UP	18171984	colorectal cancer	DOID_9256
1858	SABATES_COLORECTAL_ADENOMA_SIZE_UP	18171984	disease of cellular proliferation	DOID_14566
1859	SABATES_COLORECTAL_ADENOMA_SIZE_UP	18171984	gastrointestinal system cancer	DOID_3119
1860	SABATES_COLORECTAL_ADENOMA_SIZE_UP	18171984	intestinal cancer	DOID_10155
1861	SABATES_COLORECTAL_ADENOMA_SIZE_UP	18171984	large intestine cancer	DOID_5672
1862	SABATES_COLORECTAL_ADENOMA_SIZE_UP	18171984	organ system cancer	DOID_0050686
1863	SABATES_COLORECTAL_ADENOMA_SIZE_DN	18171984	adenoma	DOID_657
1864	SABATES_COLORECTAL_ADENOMA_SIZE_DN	18171984	benign neoplasm	DOID_0060072
1865	SABATES_COLORECTAL_ADENOMA_SIZE_DN	18171984	cancer	DOID_162
1866	SABATES_COLORECTAL_ADENOMA_SIZE_DN	18171984	cell type benign neoplasm	DOID_0060084
1867	SABATES_COLORECTAL_ADENOMA_SIZE_DN	18171984	colon cancer	DOID_219
1868	SABATES_COLORECTAL_ADENOMA_SIZE_DN	18171984	colorectal cancer	DOID_9256
1869	SABATES_COLORECTAL_ADENOMA_SIZE_DN	18171984	disease of cellular proliferation	DOID_14566
1870	SABATES_COLORECTAL_ADENOMA_SIZE_DN	18171984	gastrointestinal system cancer	DOID_3119
1871	SABATES_COLORECTAL_ADENOMA_SIZE_DN	18171984	intestinal cancer	DOID_10155
1872	SABATES_COLORECTAL_ADENOMA_SIZE_DN	18171984	large intestine cancer	DOID_5672
1873	SABATES_COLORECTAL_ADENOMA_SIZE_DN	18171984	organ system cancer	DOID_0050686
1874	SABATES_COLORECTAL_ADENOMA_UP	18171984	adenoma	DOID_657
1875	SABATES_COLORECTAL_ADENOMA_UP	18171984	benign neoplasm	DOID_0060072
1876	SABATES_COLORECTAL_ADENOMA_UP	18171984	cancer	DOID_162
1877	SABATES_COLORECTAL_ADENOMA_UP	18171984	cell type benign neoplasm	DOID_0060084
1878	SABATES_COLORECTAL_ADENOMA_UP	18171984	colon cancer	DOID_219
1879	SABATES_COLORECTAL_ADENOMA_UP	18171984	colorectal cancer	DOID_9256
1880	SABATES_COLORECTAL_ADENOMA_UP	18171984	disease of cellular proliferation	DOID_14566
1881	SABATES_COLORECTAL_ADENOMA_UP	18171984	gastrointestinal system cancer	DOID_3119
1882	SABATES_COLORECTAL_ADENOMA_UP	18171984	intestinal cancer	DOID_10155
1883	SABATES_COLORECTAL_ADENOMA_UP	18171984	large intestine cancer	DOID_5672
1884	SABATES_COLORECTAL_ADENOMA_UP	18171984	organ system cancer	DOID_0050686
1885	SABATES_COLORECTAL_ADENOMA_DN	18171984	adenoma	DOID_657
1886	SABATES_COLORECTAL_ADENOMA_DN	18171984	benign neoplasm	DOID_0060072
1887	SABATES_COLORECTAL_ADENOMA_DN	18171984	cancer	DOID_162
1888	SABATES_COLORECTAL_ADENOMA_DN	18171984	cell type benign neoplasm	DOID_0060084
1889	SABATES_COLORECTAL_ADENOMA_DN	18171984	colon cancer	DOID_219
1890	SABATES_COLORECTAL_ADENOMA_DN	18171984	colorectal cancer	DOID_9256
1891	SABATES_COLORECTAL_ADENOMA_DN	18171984	disease of cellular proliferation	DOID_14566
1892	SABATES_COLORECTAL_ADENOMA_DN	18171984	gastrointestinal system cancer	DOID_3119
1893	SABATES_COLORECTAL_ADENOMA_DN	18171984	intestinal cancer	DOID_10155
1894	SABATES_COLORECTAL_ADENOMA_DN	18171984	large intestine cancer	DOID_5672
1895	SABATES_COLORECTAL_ADENOMA_DN	18171984	organ system cancer	DOID_0050686
1896	SCIBETTA_KDM5B_TARGETS_UP	17709396	autosomal dominant disease	DOID_0050736
1897	SCIBETTA_KDM5B_TARGETS_UP	17709396	autosomal genetic disease	DOID_0050739
1898	SCIBETTA_KDM5B_TARGETS_UP	17709396	genetic disease	DOID_630
1899	SCIBETTA_KDM5B_TARGETS_UP	17709396	hereditary breast ovarian cancer	DOID_5683
1900	SCIBETTA_KDM5B_TARGETS_UP	17709396	monogenic disease	DOID_0050177
1901	SCIBETTA_KDM5B_TARGETS_DN	17709396	autosomal dominant disease	DOID_0050736
1902	SCIBETTA_KDM5B_TARGETS_DN	17709396	autosomal genetic disease	DOID_0050739
1903	SCIBETTA_KDM5B_TARGETS_DN	17709396	genetic disease	DOID_630
1904	SCIBETTA_KDM5B_TARGETS_DN	17709396	hereditary breast ovarian cancer	DOID_5683
1905	SCIBETTA_KDM5B_TARGETS_DN	17709396	monogenic disease	DOID_0050177
1906	NAGASHIMA_NRG1_SIGNALING_UP	17142811	breast cancer	DOID_1612
1907	NAGASHIMA_NRG1_SIGNALING_UP	17142811	cancer	DOID_162
1908	NAGASHIMA_NRG1_SIGNALING_UP	17142811	disease of cellular proliferation	DOID_14566
1909	NAGASHIMA_NRG1_SIGNALING_UP	17142811	organ system cancer	DOID_0050686
1910	NAGASHIMA_NRG1_SIGNALING_UP	17142811	thoracic cancer	DOID_5093
1911	NAGASHIMA_NRG1_SIGNALING_DN	17142811	breast cancer	DOID_1612
1912	NAGASHIMA_NRG1_SIGNALING_DN	17142811	cancer	DOID_162
1913	NAGASHIMA_NRG1_SIGNALING_DN	17142811	disease of cellular proliferation	DOID_14566
1914	NAGASHIMA_NRG1_SIGNALING_DN	17142811	organ system cancer	DOID_0050686
1915	NAGASHIMA_NRG1_SIGNALING_DN	17142811	thoracic cancer	DOID_5093
1916	KIM_WT1_TARGETS_UP	17430890	cancer	DOID_162
1917	KIM_WT1_TARGETS_UP	17430890	disease of cellular proliferation	DOID_14566
1918	KIM_WT1_TARGETS_UP	17430890	hereditary Wilms' tumor	DOID_5183
1919	KIM_WT1_TARGETS_UP	17430890	kidney cancer	DOID_263
1920	KIM_WT1_TARGETS_UP	17430890	nephroblastoma	DOID_2154
1921	KIM_WT1_TARGETS_UP	17430890	organ system cancer	DOID_0050686
1922	KIM_WT1_TARGETS_UP	17430890	urinary system cancer	DOID_3996
1923	KIM_WT1_TARGETS_DN	17430890	cancer	DOID_162
1924	KIM_WT1_TARGETS_DN	17430890	disease of cellular proliferation	DOID_14566
1925	KIM_WT1_TARGETS_DN	17430890	hereditary Wilms' tumor	DOID_5183
1926	KIM_WT1_TARGETS_DN	17430890	kidney cancer	DOID_263
1927	KIM_WT1_TARGETS_DN	17430890	nephroblastoma	DOID_2154
1928	KIM_WT1_TARGETS_DN	17430890	organ system cancer	DOID_0050686
1929	KIM_WT1_TARGETS_DN	17430890	urinary system cancer	DOID_3996
1930	KIM_WT1_TARGETS_8HR_UP	17430890	cancer	DOID_162
1931	KIM_WT1_TARGETS_8HR_UP	17430890	disease of cellular proliferation	DOID_14566
1932	KIM_WT1_TARGETS_8HR_UP	17430890	hereditary Wilms' tumor	DOID_5183
1933	KIM_WT1_TARGETS_8HR_UP	17430890	kidney cancer	DOID_263
1934	KIM_WT1_TARGETS_8HR_UP	17430890	nephroblastoma	DOID_2154
1935	KIM_WT1_TARGETS_8HR_UP	17430890	organ system cancer	DOID_0050686
1936	KIM_WT1_TARGETS_8HR_UP	17430890	urinary system cancer	DOID_3996
1937	KIM_WT1_TARGETS_8HR_DN	17430890	cancer	DOID_162
1938	KIM_WT1_TARGETS_8HR_DN	17430890	disease of cellular proliferation	DOID_14566
1939	KIM_WT1_TARGETS_8HR_DN	17430890	hereditary Wilms' tumor	DOID_5183
1940	KIM_WT1_TARGETS_8HR_DN	17430890	kidney cancer	DOID_263
1941	KIM_WT1_TARGETS_8HR_DN	17430890	nephroblastoma	DOID_2154
1942	KIM_WT1_TARGETS_8HR_DN	17430890	organ system cancer	DOID_0050686
1943	KIM_WT1_TARGETS_8HR_DN	17430890	urinary system cancer	DOID_3996
1944	KIM_WT1_TARGETS_12HR_UP	17430890	cancer	DOID_162
1945	KIM_WT1_TARGETS_12HR_UP	17430890	disease of cellular proliferation	DOID_14566
1946	KIM_WT1_TARGETS_12HR_UP	17430890	hereditary Wilms' tumor	DOID_5183
1947	KIM_WT1_TARGETS_12HR_UP	17430890	kidney cancer	DOID_263
1948	KIM_WT1_TARGETS_12HR_UP	17430890	nephroblastoma	DOID_2154
1949	KIM_WT1_TARGETS_12HR_UP	17430890	organ system cancer	DOID_0050686
1950	KIM_WT1_TARGETS_12HR_UP	17430890	urinary system cancer	DOID_3996
1951	KIM_WT1_TARGETS_12HR_DN	17430890	cancer	DOID_162
1952	KIM_WT1_TARGETS_12HR_DN	17430890	disease of cellular proliferation	DOID_14566
1953	KIM_WT1_TARGETS_12HR_DN	17430890	hereditary Wilms' tumor	DOID_5183
1954	KIM_WT1_TARGETS_12HR_DN	17430890	kidney cancer	DOID_263
1955	KIM_WT1_TARGETS_12HR_DN	17430890	nephroblastoma	DOID_2154
1956	KIM_WT1_TARGETS_12HR_DN	17430890	organ system cancer	DOID_0050686
1957	KIM_WT1_TARGETS_12HR_DN	17430890	urinary system cancer	DOID_3996
1958	ELVIDGE_HYPOXIA_UP	16565084	NA	NA
1959	ELVIDGE_HYPOXIA_DN	16565084	NA	NA
1960	ELVIDGE_HYPOXIA_BY_DMOG_UP	16565084	NA	NA
1961	ELVIDGE_HYPOXIA_BY_DMOG_DN	16565084	NA	NA
1962	ELVIDGE_HIF1A_TARGETS_UP	16565084	NA	NA
1963	ELVIDGE_HIF1A_TARGETS_DN	16565084	NA	NA
1964	ELVIDGE_HIF1A_AND_HIF2A_TARGETS_UP	16565084	NA	NA
1965	ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN	16565084	NA	NA
1966	JAATINEN_HEMATOPOIETIC_STEM_CELL_UP	16210406	NA	NA
1967	JAATINEN_HEMATOPOIETIC_STEM_CELL_DN	16210406	NA	NA
1968	MOROSETTI_FACIOSCAPULOHUMERAL_MUSCULAR_DISTROPHY_UP	17761758	atrophic muscular disease	DOID_913
1969	MOROSETTI_FACIOSCAPULOHUMERAL_MUSCULAR_DISTROPHY_UP	17761758	disease of anatomical entity	DOID_7
1970	MOROSETTI_FACIOSCAPULOHUMERAL_MUSCULAR_DISTROPHY_UP	17761758	facioscapulohumeral muscular dystrophy	DOID_11727
1971	MOROSETTI_FACIOSCAPULOHUMERAL_MUSCULAR_DISTROPHY_UP	17761758	muscle tissue disease	DOID_66
1972	MOROSETTI_FACIOSCAPULOHUMERAL_MUSCULAR_DISTROPHY_UP	17761758	muscular disease	DOID_0080000
1973	MOROSETTI_FACIOSCAPULOHUMERAL_MUSCULAR_DISTROPHY_UP	17761758	muscular dystrophy	DOID_9884
1974	MOROSETTI_FACIOSCAPULOHUMERAL_MUSCULAR_DISTROPHY_UP	17761758	musculoskeletal system disease	DOID_17
1975	MOROSETTI_FACIOSCAPULOHUMERAL_MUSCULAR_DISTROPHY_UP	17761758	myopathy	DOID_423
1976	MOROSETTI_FACIOSCAPULOHUMERAL_MUSCULAR_DISTROPHY_UP	17761758	nervous system disease	DOID_863
1977	MOROSETTI_FACIOSCAPULOHUMERAL_MUSCULAR_DISTROPHY_UP	17761758	neuromuscular disease	DOID_440
1978	MOROSETTI_FACIOSCAPULOHUMERAL_MUSCULAR_DISTROPHY_UP	17761758	neuropathy	DOID_870
1979	MOROSETTI_FACIOSCAPULOHUMERAL_MUSCULAR_DISTROPHY_DN	17761758	atrophic muscular disease	DOID_913
1980	MOROSETTI_FACIOSCAPULOHUMERAL_MUSCULAR_DISTROPHY_DN	17761758	disease of anatomical entity	DOID_7
1981	MOROSETTI_FACIOSCAPULOHUMERAL_MUSCULAR_DISTROPHY_DN	17761758	facioscapulohumeral muscular dystrophy	DOID_11727
1982	MOROSETTI_FACIOSCAPULOHUMERAL_MUSCULAR_DISTROPHY_DN	17761758	muscle tissue disease	DOID_66
1983	MOROSETTI_FACIOSCAPULOHUMERAL_MUSCULAR_DISTROPHY_DN	17761758	muscular disease	DOID_0080000
1984	MOROSETTI_FACIOSCAPULOHUMERAL_MUSCULAR_DISTROPHY_DN	17761758	muscular dystrophy	DOID_9884
1985	MOROSETTI_FACIOSCAPULOHUMERAL_MUSCULAR_DISTROPHY_DN	17761758	musculoskeletal system disease	DOID_17
1986	MOROSETTI_FACIOSCAPULOHUMERAL_MUSCULAR_DISTROPHY_DN	17761758	myopathy	DOID_423
1987	MOROSETTI_FACIOSCAPULOHUMERAL_MUSCULAR_DISTROPHY_DN	17761758	nervous system disease	DOID_863
1988	MOROSETTI_FACIOSCAPULOHUMERAL_MUSCULAR_DISTROPHY_DN	17761758	neuromuscular disease	DOID_440
1989	MOROSETTI_FACIOSCAPULOHUMERAL_MUSCULAR_DISTROPHY_DN	17761758	neuropathy	DOID_870
1990	GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP	17717066	cancer	DOID_162
1991	GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP	17717066	chronic myeloid leukemia	DOID_8552
1992	GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP	17717066	disease of cellular proliferation	DOID_14566
1993	GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP	17717066	hematologic cancer	DOID_2531
1994	GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP	17717066	immune system cancer	DOID_0060083
1995	GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP	17717066	leukemia	DOID_1240
1996	GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP	17717066	myeloid leukemia	DOID_8692
1997	GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP	17717066	organ system cancer	DOID_0050686
1998	GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_DN	17717066	cancer	DOID_162
1999	GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_DN	17717066	chronic myeloid leukemia	DOID_8552
2000	GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_DN	17717066	disease of cellular proliferation	DOID_14566
2001	GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_DN	17717066	hematologic cancer	DOID_2531
2002	GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_DN	17717066	immune system cancer	DOID_0060083
2003	GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_DN	17717066	leukemia	DOID_1240
2004	GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_DN	17717066	myeloid leukemia	DOID_8692
2005	GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_DN	17717066	organ system cancer	DOID_0050686
2006	GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP	17717066	cancer	DOID_162
2007	GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP	17717066	chronic myeloid leukemia	DOID_8552
2008	GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP	17717066	disease of cellular proliferation	DOID_14566
2009	GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP	17717066	hematologic cancer	DOID_2531
2010	GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP	17717066	immune system cancer	DOID_0060083
2011	GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP	17717066	leukemia	DOID_1240
2012	GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP	17717066	myeloid leukemia	DOID_8692
2013	GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP	17717066	organ system cancer	DOID_0050686
2014	GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN	17717066	cancer	DOID_162
2015	GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN	17717066	chronic myeloid leukemia	DOID_8552
2016	GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN	17717066	disease of cellular proliferation	DOID_14566
2017	GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN	17717066	hematologic cancer	DOID_2531
2018	GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN	17717066	immune system cancer	DOID_0060083
2019	GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN	17717066	leukemia	DOID_1240
2020	GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN	17717066	myeloid leukemia	DOID_8692
2021	GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN	17717066	organ system cancer	DOID_0050686
2022	GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP	17717066	cancer	DOID_162
2023	GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP	17717066	chronic myeloid leukemia	DOID_8552
2024	GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP	17717066	disease of cellular proliferation	DOID_14566
2025	GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP	17717066	hematologic cancer	DOID_2531
2026	GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP	17717066	immune system cancer	DOID_0060083
2027	GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP	17717066	leukemia	DOID_1240
2028	GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP	17717066	myeloid leukemia	DOID_8692
2029	GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP	17717066	organ system cancer	DOID_0050686
2030	GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN	17717066	cancer	DOID_162
2031	GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN	17717066	chronic myeloid leukemia	DOID_8552
2032	GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN	17717066	disease of cellular proliferation	DOID_14566
2033	GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN	17717066	hematologic cancer	DOID_2531
2034	GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN	17717066	immune system cancer	DOID_0060083
2035	GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN	17717066	leukemia	DOID_1240
2036	GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN	17717066	myeloid leukemia	DOID_8692
2037	GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN	17717066	organ system cancer	DOID_0050686
2038	GRAHAM_CML_DIVIDING_VS_NORMAL_DIVIDING_UP	17717066	cancer	DOID_162
2039	GRAHAM_CML_DIVIDING_VS_NORMAL_DIVIDING_UP	17717066	chronic myeloid leukemia	DOID_8552
2040	GRAHAM_CML_DIVIDING_VS_NORMAL_DIVIDING_UP	17717066	disease of cellular proliferation	DOID_14566
2041	GRAHAM_CML_DIVIDING_VS_NORMAL_DIVIDING_UP	17717066	hematologic cancer	DOID_2531
2042	GRAHAM_CML_DIVIDING_VS_NORMAL_DIVIDING_UP	17717066	immune system cancer	DOID_0060083
2043	GRAHAM_CML_DIVIDING_VS_NORMAL_DIVIDING_UP	17717066	leukemia	DOID_1240
2044	GRAHAM_CML_DIVIDING_VS_NORMAL_DIVIDING_UP	17717066	myeloid leukemia	DOID_8692
2045	GRAHAM_CML_DIVIDING_VS_NORMAL_DIVIDING_UP	17717066	organ system cancer	DOID_0050686
2046	GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP	17717066	cancer	DOID_162
2047	GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP	17717066	chronic myeloid leukemia	DOID_8552
2048	GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP	17717066	disease of cellular proliferation	DOID_14566
2049	GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP	17717066	hematologic cancer	DOID_2531
2050	GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP	17717066	immune system cancer	DOID_0060083
2051	GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP	17717066	leukemia	DOID_1240
2052	GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP	17717066	myeloid leukemia	DOID_8692
2053	GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP	17717066	organ system cancer	DOID_0050686
2054	GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN	17717066	cancer	DOID_162
2055	GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN	17717066	chronic myeloid leukemia	DOID_8552
2056	GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN	17717066	disease of cellular proliferation	DOID_14566
2057	GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN	17717066	hematologic cancer	DOID_2531
2058	GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN	17717066	immune system cancer	DOID_0060083
2059	GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN	17717066	leukemia	DOID_1240
2060	GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN	17717066	myeloid leukemia	DOID_8692
2061	GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN	17717066	organ system cancer	DOID_0050686
2062	GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP	17717066	cancer	DOID_162
2063	GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP	17717066	chronic myeloid leukemia	DOID_8552
2064	GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP	17717066	disease of cellular proliferation	DOID_14566
2065	GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP	17717066	hematologic cancer	DOID_2531
2066	GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP	17717066	immune system cancer	DOID_0060083
2067	GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP	17717066	leukemia	DOID_1240
2068	GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP	17717066	myeloid leukemia	DOID_8692
2069	GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP	17717066	organ system cancer	DOID_0050686
2070	GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN	17717066	cancer	DOID_162
2071	GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN	17717066	chronic myeloid leukemia	DOID_8552
2072	GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN	17717066	disease of cellular proliferation	DOID_14566
2073	GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN	17717066	hematologic cancer	DOID_2531
2074	GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN	17717066	immune system cancer	DOID_0060083
2075	GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN	17717066	leukemia	DOID_1240
2076	GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN	17717066	myeloid leukemia	DOID_8692
2077	GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN	17717066	organ system cancer	DOID_0050686
2078	BIDUS_METASTASIS_UP	16397028	cancer	DOID_162
2079	BIDUS_METASTASIS_UP	16397028	carcinoma	DOID_305
2080	BIDUS_METASTASIS_UP	16397028	cell type cancer	DOID_0050687
2081	BIDUS_METASTASIS_UP	16397028	disease of cellular proliferation	DOID_14566
2082	BIDUS_METASTASIS_UP	16397028	endometrial cancer	DOID_1380
2083	BIDUS_METASTASIS_UP	16397028	female reproductive organ cancer	DOID_120
2084	BIDUS_METASTASIS_UP	16397028	organ system cancer	DOID_0050686
2085	BIDUS_METASTASIS_UP	16397028	reproductive organ cancer	DOID_193
2086	BIDUS_METASTASIS_UP	16397028	uterine cancer	DOID_363
2087	BIDUS_METASTASIS_DN	16397028	cancer	DOID_162
2088	BIDUS_METASTASIS_DN	16397028	carcinoma	DOID_305
2089	BIDUS_METASTASIS_DN	16397028	cell type cancer	DOID_0050687
2090	BIDUS_METASTASIS_DN	16397028	disease of cellular proliferation	DOID_14566
2091	BIDUS_METASTASIS_DN	16397028	endometrial cancer	DOID_1380
2092	BIDUS_METASTASIS_DN	16397028	female reproductive organ cancer	DOID_120
2093	BIDUS_METASTASIS_DN	16397028	organ system cancer	DOID_0050686
2094	BIDUS_METASTASIS_DN	16397028	reproductive organ cancer	DOID_193
2095	BIDUS_METASTASIS_DN	16397028	uterine cancer	DOID_363
2096	WAMUNYOKOLI_OVARIAN_CANCER_LMP_UP	16467078	adenocarcinoma	DOID_299
2097	WAMUNYOKOLI_OVARIAN_CANCER_LMP_UP	16467078	cancer	DOID_162
2098	WAMUNYOKOLI_OVARIAN_CANCER_LMP_UP	16467078	carcinoma	DOID_305
2099	WAMUNYOKOLI_OVARIAN_CANCER_LMP_UP	16467078	cell type cancer	DOID_0050687
2100	WAMUNYOKOLI_OVARIAN_CANCER_LMP_UP	16467078	disease of cellular proliferation	DOID_14566
2101	WAMUNYOKOLI_OVARIAN_CANCER_LMP_UP	16467078	female reproductive organ cancer	DOID_120
2102	WAMUNYOKOLI_OVARIAN_CANCER_LMP_UP	16467078	malignant ovarian surface epithelial-stromal neoplasm	DOID_2151
2103	WAMUNYOKOLI_OVARIAN_CANCER_LMP_UP	16467078	organ system cancer	DOID_0050686
2104	WAMUNYOKOLI_OVARIAN_CANCER_LMP_UP	16467078	ovarian cancer	DOID_2394
2105	WAMUNYOKOLI_OVARIAN_CANCER_LMP_UP	16467078	ovarian carcinoma	DOID_4001
2106	WAMUNYOKOLI_OVARIAN_CANCER_LMP_UP	16467078	ovary epithelial cancer	DOID_2152
2107	WAMUNYOKOLI_OVARIAN_CANCER_LMP_UP	16467078	reproductive organ cancer	DOID_193
2108	WAMUNYOKOLI_OVARIAN_CANCER_LMP_DN	16467078	adenocarcinoma	DOID_299
2109	WAMUNYOKOLI_OVARIAN_CANCER_LMP_DN	16467078	cancer	DOID_162
2110	WAMUNYOKOLI_OVARIAN_CANCER_LMP_DN	16467078	carcinoma	DOID_305
2111	WAMUNYOKOLI_OVARIAN_CANCER_LMP_DN	16467078	cell type cancer	DOID_0050687
2112	WAMUNYOKOLI_OVARIAN_CANCER_LMP_DN	16467078	disease of cellular proliferation	DOID_14566
2113	WAMUNYOKOLI_OVARIAN_CANCER_LMP_DN	16467078	female reproductive organ cancer	DOID_120
2114	WAMUNYOKOLI_OVARIAN_CANCER_LMP_DN	16467078	malignant ovarian surface epithelial-stromal neoplasm	DOID_2151
2115	WAMUNYOKOLI_OVARIAN_CANCER_LMP_DN	16467078	organ system cancer	DOID_0050686
2116	WAMUNYOKOLI_OVARIAN_CANCER_LMP_DN	16467078	ovarian cancer	DOID_2394
2117	WAMUNYOKOLI_OVARIAN_CANCER_LMP_DN	16467078	ovarian carcinoma	DOID_4001
2118	WAMUNYOKOLI_OVARIAN_CANCER_LMP_DN	16467078	ovary epithelial cancer	DOID_2152
2119	WAMUNYOKOLI_OVARIAN_CANCER_LMP_DN	16467078	reproductive organ cancer	DOID_193
2120	WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_UP	16467078	adenocarcinoma	DOID_299
2121	WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_UP	16467078	cancer	DOID_162
2122	WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_UP	16467078	carcinoma	DOID_305
2123	WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_UP	16467078	cell type cancer	DOID_0050687
2124	WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_UP	16467078	disease of cellular proliferation	DOID_14566
2125	WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_UP	16467078	female reproductive organ cancer	DOID_120
2126	WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_UP	16467078	malignant ovarian surface epithelial-stromal neoplasm	DOID_2151
2127	WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_UP	16467078	organ system cancer	DOID_0050686
2128	WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_UP	16467078	ovarian cancer	DOID_2394
2129	WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_UP	16467078	ovarian carcinoma	DOID_4001
2130	WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_UP	16467078	ovary epithelial cancer	DOID_2152
2131	WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_UP	16467078	reproductive organ cancer	DOID_193
2132	WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_DN	16467078	adenocarcinoma	DOID_299
2133	WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_DN	16467078	cancer	DOID_162
2134	WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_DN	16467078	carcinoma	DOID_305
2135	WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_DN	16467078	cell type cancer	DOID_0050687
2136	WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_DN	16467078	disease of cellular proliferation	DOID_14566
2137	WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_DN	16467078	female reproductive organ cancer	DOID_120
2138	WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_DN	16467078	malignant ovarian surface epithelial-stromal neoplasm	DOID_2151
2139	WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_DN	16467078	organ system cancer	DOID_0050686
2140	WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_DN	16467078	ovarian cancer	DOID_2394
2141	WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_DN	16467078	ovarian carcinoma	DOID_4001
2142	WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_DN	16467078	ovary epithelial cancer	DOID_2152
2143	WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_DN	16467078	reproductive organ cancer	DOID_193
2144	MAYBURD_RESPONSE_TO_L663536_UP	16551867	cancer	DOID_162
2145	MAYBURD_RESPONSE_TO_L663536_UP	16551867	disease of cellular proliferation	DOID_14566
2146	MAYBURD_RESPONSE_TO_L663536_UP	16551867	lung cancer	DOID_1324
2147	MAYBURD_RESPONSE_TO_L663536_UP	16551867	organ system cancer	DOID_0050686
2148	MAYBURD_RESPONSE_TO_L663536_UP	16551867	respiratory system cancer	DOID_0050615
2149	MAYBURD_RESPONSE_TO_L663536_DN	16551867	cancer	DOID_162
2150	MAYBURD_RESPONSE_TO_L663536_DN	16551867	disease of cellular proliferation	DOID_14566
2151	MAYBURD_RESPONSE_TO_L663536_DN	16551867	lung cancer	DOID_1324
2152	MAYBURD_RESPONSE_TO_L663536_DN	16551867	organ system cancer	DOID_0050686
2153	MAYBURD_RESPONSE_TO_L663536_DN	16551867	respiratory system cancer	DOID_0050615
2154	WATANABE_ULCERATIVE_COLITIS_WITH_CANCER_UP	17255260	cancer	DOID_162
2155	WATANABE_ULCERATIVE_COLITIS_WITH_CANCER_UP	17255260	colorectal cancer	DOID_9256
2156	WATANABE_ULCERATIVE_COLITIS_WITH_CANCER_UP	17255260	disease of anatomical entity	DOID_7
2157	WATANABE_ULCERATIVE_COLITIS_WITH_CANCER_UP	17255260	disease of cellular proliferation	DOID_14566
2158	WATANABE_ULCERATIVE_COLITIS_WITH_CANCER_UP	17255260	gastrointestinal system cancer	DOID_3119
2159	WATANABE_ULCERATIVE_COLITIS_WITH_CANCER_UP	17255260	gastrointestinal system disease	DOID_77
2160	WATANABE_ULCERATIVE_COLITIS_WITH_CANCER_UP	17255260	inflammatory bowel disease	DOID_0050589
2161	WATANABE_ULCERATIVE_COLITIS_WITH_CANCER_UP	17255260	intestinal cancer	DOID_10155
2162	WATANABE_ULCERATIVE_COLITIS_WITH_CANCER_UP	17255260	intestinal disease	DOID_5295
2163	WATANABE_ULCERATIVE_COLITIS_WITH_CANCER_UP	17255260	large intestine cancer	DOID_5672
2164	WATANABE_ULCERATIVE_COLITIS_WITH_CANCER_UP	17255260	organ system cancer	DOID_0050686
2165	WATANABE_ULCERATIVE_COLITIS_WITH_CANCER_UP	17255260	ulcerative colitis	DOID_8577
2166	WATANABE_ULCERATIVE_COLITIS_WITH_CANCER_DN	17255260	cancer	DOID_162
2167	WATANABE_ULCERATIVE_COLITIS_WITH_CANCER_DN	17255260	colorectal cancer	DOID_9256
2168	WATANABE_ULCERATIVE_COLITIS_WITH_CANCER_DN	17255260	disease of anatomical entity	DOID_7
2169	WATANABE_ULCERATIVE_COLITIS_WITH_CANCER_DN	17255260	disease of cellular proliferation	DOID_14566
2170	WATANABE_ULCERATIVE_COLITIS_WITH_CANCER_DN	17255260	gastrointestinal system cancer	DOID_3119
2171	WATANABE_ULCERATIVE_COLITIS_WITH_CANCER_DN	17255260	gastrointestinal system disease	DOID_77
2172	WATANABE_ULCERATIVE_COLITIS_WITH_CANCER_DN	17255260	inflammatory bowel disease	DOID_0050589
2173	WATANABE_ULCERATIVE_COLITIS_WITH_CANCER_DN	17255260	intestinal cancer	DOID_10155
2174	WATANABE_ULCERATIVE_COLITIS_WITH_CANCER_DN	17255260	intestinal disease	DOID_5295
2175	WATANABE_ULCERATIVE_COLITIS_WITH_CANCER_DN	17255260	large intestine cancer	DOID_5672
2176	WATANABE_ULCERATIVE_COLITIS_WITH_CANCER_DN	17255260	organ system cancer	DOID_0050686
2177	WATANABE_ULCERATIVE_COLITIS_WITH_CANCER_DN	17255260	ulcerative colitis	DOID_8577
2178	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP	17406368	cancer	DOID_162
2179	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP	17406368	disease of cellular proliferation	DOID_14566
2180	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN	17406368	cancer	DOID_162
2181	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN	17406368	disease of cellular proliferation	DOID_14566
2182	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP	17406368	cancer	DOID_162
2183	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP	17406368	disease of cellular proliferation	DOID_14566
2184	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_DN	17406368	cancer	DOID_162
2185	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_DN	17406368	disease of cellular proliferation	DOID_14566
2186	RODRIGUES_THYROID_CARCINOMA_UP	17406368	cancer	DOID_162
2187	RODRIGUES_THYROID_CARCINOMA_UP	17406368	disease of cellular proliferation	DOID_14566
2188	RODRIGUES_THYROID_CARCINOMA_DN	17406368	cancer	DOID_162
2189	RODRIGUES_THYROID_CARCINOMA_DN	17406368	disease of cellular proliferation	DOID_14566
2190	GOZGIT_ESR1_TARGETS_UP	17726467	breast cancer	DOID_1612
2191	GOZGIT_ESR1_TARGETS_UP	17726467	cancer	DOID_162
2192	GOZGIT_ESR1_TARGETS_UP	17726467	disease of cellular proliferation	DOID_14566
2193	GOZGIT_ESR1_TARGETS_UP	17726467	organ system cancer	DOID_0050686
2194	GOZGIT_ESR1_TARGETS_UP	17726467	thoracic cancer	DOID_5093
2195	GOZGIT_ESR1_TARGETS_DN	17726467	breast cancer	DOID_1612
2196	GOZGIT_ESR1_TARGETS_DN	17726467	cancer	DOID_162
2197	GOZGIT_ESR1_TARGETS_DN	17726467	disease of cellular proliferation	DOID_14566
2198	GOZGIT_ESR1_TARGETS_DN	17726467	organ system cancer	DOID_0050686
2199	GOZGIT_ESR1_TARGETS_DN	17726467	thoracic cancer	DOID_5093
2200	HAHTOLA_SEZARY_SYNDROM_UP	16914566	cancer	DOID_162
2201	HAHTOLA_SEZARY_SYNDROM_UP	16914566	cutaneous T cell lymphoma	DOID_0060061
2202	HAHTOLA_SEZARY_SYNDROM_UP	16914566	disease by infectious agent	DOID_0050117
2203	HAHTOLA_SEZARY_SYNDROM_UP	16914566	disease of cellular proliferation	DOID_14566
2204	HAHTOLA_SEZARY_SYNDROM_UP	16914566	fungal infectious disease	DOID_1564
2205	HAHTOLA_SEZARY_SYNDROM_UP	16914566	hematologic cancer	DOID_2531
2206	HAHTOLA_SEZARY_SYNDROM_UP	16914566	immune system cancer	DOID_0060083
2207	HAHTOLA_SEZARY_SYNDROM_UP	16914566	lymphoma	DOID_0060058
2208	HAHTOLA_SEZARY_SYNDROM_UP	16914566	mature T-cell and NK-cell neoplasm	DOID_0050743
2209	HAHTOLA_SEZARY_SYNDROM_UP	16914566	mycosis fungoides	DOID_8691
2210	HAHTOLA_SEZARY_SYNDROM_UP	16914566	organ system cancer	DOID_0050686
2211	HAHTOLA_SEZARY_SYNDROM_UP	16914566	peripheral T-cell lymphoma	DOID_0050749
2212	HAHTOLA_SEZARY_SYNDROM_UP	16914566	Sezary's disease	DOID_8541
2213	HAHTOLA_SEZARY_SYNDROM_UP	16914566	syndrome	DOID_225
2214	HAHTOLA_SEZARY_SYNDROM_DN	16914566	cancer	DOID_162
2215	HAHTOLA_SEZARY_SYNDROM_DN	16914566	cutaneous T cell lymphoma	DOID_0060061
2216	HAHTOLA_SEZARY_SYNDROM_DN	16914566	disease by infectious agent	DOID_0050117
2217	HAHTOLA_SEZARY_SYNDROM_DN	16914566	disease of cellular proliferation	DOID_14566
2218	HAHTOLA_SEZARY_SYNDROM_DN	16914566	fungal infectious disease	DOID_1564
2219	HAHTOLA_SEZARY_SYNDROM_DN	16914566	hematologic cancer	DOID_2531
2220	HAHTOLA_SEZARY_SYNDROM_DN	16914566	immune system cancer	DOID_0060083
2221	HAHTOLA_SEZARY_SYNDROM_DN	16914566	lymphoma	DOID_0060058
2222	HAHTOLA_SEZARY_SYNDROM_DN	16914566	mature T-cell and NK-cell neoplasm	DOID_0050743
2223	HAHTOLA_SEZARY_SYNDROM_DN	16914566	mycosis fungoides	DOID_8691
2224	HAHTOLA_SEZARY_SYNDROM_DN	16914566	organ system cancer	DOID_0050686
2225	HAHTOLA_SEZARY_SYNDROM_DN	16914566	peripheral T-cell lymphoma	DOID_0050749
2226	HAHTOLA_SEZARY_SYNDROM_DN	16914566	Sezary's disease	DOID_8541
2227	HAHTOLA_SEZARY_SYNDROM_DN	16914566	syndrome	DOID_225
2228	HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_UP	16914566	cancer	DOID_162
2229	HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_UP	16914566	cutaneous T cell lymphoma	DOID_0060061
2230	HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_UP	16914566	disease by infectious agent	DOID_0050117
2231	HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_UP	16914566	disease of cellular proliferation	DOID_14566
2232	HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_UP	16914566	fungal infectious disease	DOID_1564
2233	HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_UP	16914566	hematologic cancer	DOID_2531
2234	HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_UP	16914566	immune system cancer	DOID_0060083
2235	HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_UP	16914566	lymphoma	DOID_0060058
2236	HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_UP	16914566	mature T-cell and NK-cell neoplasm	DOID_0050743
2237	HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_UP	16914566	mycosis fungoides	DOID_8691
2238	HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_UP	16914566	organ system cancer	DOID_0050686
2239	HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_UP	16914566	peripheral T-cell lymphoma	DOID_0050749
2240	HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_UP	16914566	Sezary's disease	DOID_8541
2241	HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_UP	16914566	syndrome	DOID_225
2242	HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_DN	16914566	cancer	DOID_162
2243	HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_DN	16914566	cutaneous T cell lymphoma	DOID_0060061
2244	HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_DN	16914566	disease by infectious agent	DOID_0050117
2245	HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_DN	16914566	disease of cellular proliferation	DOID_14566
2246	HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_DN	16914566	fungal infectious disease	DOID_1564
2247	HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_DN	16914566	hematologic cancer	DOID_2531
2248	HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_DN	16914566	immune system cancer	DOID_0060083
2249	HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_DN	16914566	lymphoma	DOID_0060058
2250	HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_DN	16914566	mature T-cell and NK-cell neoplasm	DOID_0050743
2251	HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_DN	16914566	mycosis fungoides	DOID_8691
2252	HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_DN	16914566	organ system cancer	DOID_0050686
2253	HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_DN	16914566	peripheral T-cell lymphoma	DOID_0050749
2254	HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_DN	16914566	Sezary's disease	DOID_8541
2255	HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_DN	16914566	syndrome	DOID_225
2256	HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP	16914566	cancer	DOID_162
2257	HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP	16914566	cutaneous T cell lymphoma	DOID_0060061
2258	HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP	16914566	disease by infectious agent	DOID_0050117
2259	HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP	16914566	disease of cellular proliferation	DOID_14566
2260	HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP	16914566	fungal infectious disease	DOID_1564
2261	HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP	16914566	hematologic cancer	DOID_2531
2262	HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP	16914566	immune system cancer	DOID_0060083
2263	HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP	16914566	lymphoma	DOID_0060058
2264	HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP	16914566	mature T-cell and NK-cell neoplasm	DOID_0050743
2265	HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP	16914566	mycosis fungoides	DOID_8691
2266	HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP	16914566	organ system cancer	DOID_0050686
2267	HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP	16914566	peripheral T-cell lymphoma	DOID_0050749
2268	HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP	16914566	Sezary's disease	DOID_8541
2269	HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP	16914566	syndrome	DOID_225
2270	HAHTOLA_MYCOSIS_FUNGOIDES_CD4_DN	16914566	cancer	DOID_162
2271	HAHTOLA_MYCOSIS_FUNGOIDES_CD4_DN	16914566	cutaneous T cell lymphoma	DOID_0060061
2272	HAHTOLA_MYCOSIS_FUNGOIDES_CD4_DN	16914566	disease by infectious agent	DOID_0050117
2273	HAHTOLA_MYCOSIS_FUNGOIDES_CD4_DN	16914566	disease of cellular proliferation	DOID_14566
2274	HAHTOLA_MYCOSIS_FUNGOIDES_CD4_DN	16914566	fungal infectious disease	DOID_1564
2275	HAHTOLA_MYCOSIS_FUNGOIDES_CD4_DN	16914566	hematologic cancer	DOID_2531
2276	HAHTOLA_MYCOSIS_FUNGOIDES_CD4_DN	16914566	immune system cancer	DOID_0060083
2277	HAHTOLA_MYCOSIS_FUNGOIDES_CD4_DN	16914566	lymphoma	DOID_0060058
2278	HAHTOLA_MYCOSIS_FUNGOIDES_CD4_DN	16914566	mature T-cell and NK-cell neoplasm	DOID_0050743
2279	HAHTOLA_MYCOSIS_FUNGOIDES_CD4_DN	16914566	mycosis fungoides	DOID_8691
2280	HAHTOLA_MYCOSIS_FUNGOIDES_CD4_DN	16914566	organ system cancer	DOID_0050686
2281	HAHTOLA_MYCOSIS_FUNGOIDES_CD4_DN	16914566	peripheral T-cell lymphoma	DOID_0050749
2282	HAHTOLA_MYCOSIS_FUNGOIDES_CD4_DN	16914566	Sezary's disease	DOID_8541
2283	HAHTOLA_MYCOSIS_FUNGOIDES_CD4_DN	16914566	syndrome	DOID_225
2284	HAHTOLA_MYCOSIS_FUNGOIDES_UP	16914566	cancer	DOID_162
2285	HAHTOLA_MYCOSIS_FUNGOIDES_UP	16914566	cutaneous T cell lymphoma	DOID_0060061
2286	HAHTOLA_MYCOSIS_FUNGOIDES_UP	16914566	disease by infectious agent	DOID_0050117
2287	HAHTOLA_MYCOSIS_FUNGOIDES_UP	16914566	disease of cellular proliferation	DOID_14566
2288	HAHTOLA_MYCOSIS_FUNGOIDES_UP	16914566	fungal infectious disease	DOID_1564
2289	HAHTOLA_MYCOSIS_FUNGOIDES_UP	16914566	hematologic cancer	DOID_2531
2290	HAHTOLA_MYCOSIS_FUNGOIDES_UP	16914566	immune system cancer	DOID_0060083
2291	HAHTOLA_MYCOSIS_FUNGOIDES_UP	16914566	lymphoma	DOID_0060058
2292	HAHTOLA_MYCOSIS_FUNGOIDES_UP	16914566	mature T-cell and NK-cell neoplasm	DOID_0050743
2293	HAHTOLA_MYCOSIS_FUNGOIDES_UP	16914566	mycosis fungoides	DOID_8691
2294	HAHTOLA_MYCOSIS_FUNGOIDES_UP	16914566	organ system cancer	DOID_0050686
2295	HAHTOLA_MYCOSIS_FUNGOIDES_UP	16914566	peripheral T-cell lymphoma	DOID_0050749
2296	HAHTOLA_MYCOSIS_FUNGOIDES_UP	16914566	Sezary's disease	DOID_8541
2297	HAHTOLA_MYCOSIS_FUNGOIDES_UP	16914566	syndrome	DOID_225
2298	HAHTOLA_MYCOSIS_FUNGOIDES_DN	16914566	cancer	DOID_162
2299	HAHTOLA_MYCOSIS_FUNGOIDES_DN	16914566	cutaneous T cell lymphoma	DOID_0060061
2300	HAHTOLA_MYCOSIS_FUNGOIDES_DN	16914566	disease by infectious agent	DOID_0050117
2301	HAHTOLA_MYCOSIS_FUNGOIDES_DN	16914566	disease of cellular proliferation	DOID_14566
2302	HAHTOLA_MYCOSIS_FUNGOIDES_DN	16914566	fungal infectious disease	DOID_1564
2303	HAHTOLA_MYCOSIS_FUNGOIDES_DN	16914566	hematologic cancer	DOID_2531
2304	HAHTOLA_MYCOSIS_FUNGOIDES_DN	16914566	immune system cancer	DOID_0060083
2305	HAHTOLA_MYCOSIS_FUNGOIDES_DN	16914566	lymphoma	DOID_0060058
2306	HAHTOLA_MYCOSIS_FUNGOIDES_DN	16914566	mature T-cell and NK-cell neoplasm	DOID_0050743
2307	HAHTOLA_MYCOSIS_FUNGOIDES_DN	16914566	mycosis fungoides	DOID_8691
2308	HAHTOLA_MYCOSIS_FUNGOIDES_DN	16914566	organ system cancer	DOID_0050686
2309	HAHTOLA_MYCOSIS_FUNGOIDES_DN	16914566	peripheral T-cell lymphoma	DOID_0050749
2310	HAHTOLA_MYCOSIS_FUNGOIDES_DN	16914566	Sezary's disease	DOID_8541
2311	HAHTOLA_MYCOSIS_FUNGOIDES_DN	16914566	syndrome	DOID_225
2312	PROVENZANI_METASTASIS_UP	16531451	cancer	DOID_162
2313	PROVENZANI_METASTASIS_UP	16531451	carcinoma	DOID_305
2314	PROVENZANI_METASTASIS_UP	16531451	cell type cancer	DOID_0050687
2315	PROVENZANI_METASTASIS_UP	16531451	colorectal cancer	DOID_9256
2316	PROVENZANI_METASTASIS_UP	16531451	disease of cellular proliferation	DOID_14566
2317	PROVENZANI_METASTASIS_UP	16531451	gastrointestinal system cancer	DOID_3119
2318	PROVENZANI_METASTASIS_UP	16531451	intestinal cancer	DOID_10155
2319	PROVENZANI_METASTASIS_UP	16531451	invasive carcinoma	DOID_5659
2320	PROVENZANI_METASTASIS_UP	16531451	large intestine cancer	DOID_5672
2321	PROVENZANI_METASTASIS_UP	16531451	organ system cancer	DOID_0050686
2322	PROVENZANI_METASTASIS_DN	16531451	cancer	DOID_162
2323	PROVENZANI_METASTASIS_DN	16531451	carcinoma	DOID_305
2324	PROVENZANI_METASTASIS_DN	16531451	cell type cancer	DOID_0050687
2325	PROVENZANI_METASTASIS_DN	16531451	colorectal cancer	DOID_9256
2326	PROVENZANI_METASTASIS_DN	16531451	disease of cellular proliferation	DOID_14566
2327	PROVENZANI_METASTASIS_DN	16531451	gastrointestinal system cancer	DOID_3119
2328	PROVENZANI_METASTASIS_DN	16531451	intestinal cancer	DOID_10155
2329	PROVENZANI_METASTASIS_DN	16531451	invasive carcinoma	DOID_5659
2330	PROVENZANI_METASTASIS_DN	16531451	large intestine cancer	DOID_5672
2331	PROVENZANI_METASTASIS_DN	16531451	organ system cancer	DOID_0050686
2332	LIU_CDX2_TARGETS_UP	16990345	adenocarcinoma	DOID_299
2333	LIU_CDX2_TARGETS_UP	16990345	Barrett's esophagus	DOID_9206
2334	LIU_CDX2_TARGETS_UP	16990345	cancer	DOID_162
2335	LIU_CDX2_TARGETS_UP	16990345	carcinoma	DOID_305
2336	LIU_CDX2_TARGETS_UP	16990345	cell type cancer	DOID_0050687
2337	LIU_CDX2_TARGETS_UP	16990345	disease of anatomical entity	DOID_7
2338	LIU_CDX2_TARGETS_UP	16990345	disease of cellular proliferation	DOID_14566
2339	LIU_CDX2_TARGETS_UP	16990345	esophageal disease	DOID_6050
2340	LIU_CDX2_TARGETS_UP	16990345	gastrointestinal system disease	DOID_77
2341	COLDREN_GEFITINIB_RESISTANCE_UP	16877703	cancer	DOID_162
2342	COLDREN_GEFITINIB_RESISTANCE_UP	16877703	carcinoma	DOID_305
2343	COLDREN_GEFITINIB_RESISTANCE_UP	16877703	cell type cancer	DOID_0050687
2344	COLDREN_GEFITINIB_RESISTANCE_UP	16877703	disease of cellular proliferation	DOID_14566
2345	COLDREN_GEFITINIB_RESISTANCE_UP	16877703	lung cancer	DOID_1324
2346	COLDREN_GEFITINIB_RESISTANCE_UP	16877703	lung carcinoma	DOID_3905
2347	COLDREN_GEFITINIB_RESISTANCE_UP	16877703	non-small cell lung carcinoma	DOID_3908
2348	COLDREN_GEFITINIB_RESISTANCE_UP	16877703	organ system cancer	DOID_0050686
2349	COLDREN_GEFITINIB_RESISTANCE_UP	16877703	respiratory system cancer	DOID_0050615
2350	COLDREN_GEFITINIB_RESISTANCE_DN	16877703	cancer	DOID_162
2351	COLDREN_GEFITINIB_RESISTANCE_DN	16877703	carcinoma	DOID_305
2352	COLDREN_GEFITINIB_RESISTANCE_DN	16877703	cell type cancer	DOID_0050687
2353	COLDREN_GEFITINIB_RESISTANCE_DN	16877703	disease of cellular proliferation	DOID_14566
2354	COLDREN_GEFITINIB_RESISTANCE_DN	16877703	lung cancer	DOID_1324
2355	COLDREN_GEFITINIB_RESISTANCE_DN	16877703	lung carcinoma	DOID_3905
2356	COLDREN_GEFITINIB_RESISTANCE_DN	16877703	non-small cell lung carcinoma	DOID_3908
2357	COLDREN_GEFITINIB_RESISTANCE_DN	16877703	organ system cancer	DOID_0050686
2358	COLDREN_GEFITINIB_RESISTANCE_DN	16877703	respiratory system cancer	DOID_0050615
2359	KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP	16908595	cancer	DOID_162
2360	KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP	16908595	cell type cancer	DOID_0050687
2361	KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP	16908595	disease of cellular proliferation	DOID_14566
2362	KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP	16908595	melanoma	DOID_1909
2363	KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN	16908595	cancer	DOID_162
2364	KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN	16908595	cell type cancer	DOID_0050687
2365	KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN	16908595	disease of cellular proliferation	DOID_14566
2366	KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN	16908595	melanoma	DOID_1909
2367	KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP	16908595	cancer	DOID_162
2368	KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP	16908595	cell type cancer	DOID_0050687
2369	KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP	16908595	disease of cellular proliferation	DOID_14566
2370	KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP	16908595	melanoma	DOID_1909
2371	KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN	16908595	cancer	DOID_162
2372	KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN	16908595	cell type cancer	DOID_0050687
2373	KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN	16908595	disease of cellular proliferation	DOID_14566
2374	KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN	16908595	melanoma	DOID_1909
2375	CHOW_RASSF1_TARGETS_UP	16116475	cancer	DOID_162
2376	CHOW_RASSF1_TARGETS_UP	16116475	carcinoma	DOID_305
2377	CHOW_RASSF1_TARGETS_UP	16116475	cell type cancer	DOID_0050687
2378	CHOW_RASSF1_TARGETS_UP	16116475	disease of cellular proliferation	DOID_14566
2379	CHOW_RASSF1_TARGETS_UP	16116475	nasopharynx carcinoma	DOID_9261
2380	CHOW_RASSF1_TARGETS_UP	16116475	organ system cancer	DOID_0050686
2381	CHOW_RASSF1_TARGETS_UP	16116475	respiratory system cancer	DOID_0050615
2382	CHOW_RASSF1_TARGETS_DN	16116475	cancer	DOID_162
2383	CHOW_RASSF1_TARGETS_DN	16116475	carcinoma	DOID_305
2384	CHOW_RASSF1_TARGETS_DN	16116475	cell type cancer	DOID_0050687
2385	CHOW_RASSF1_TARGETS_DN	16116475	disease of cellular proliferation	DOID_14566
2386	CHOW_RASSF1_TARGETS_DN	16116475	nasopharynx carcinoma	DOID_9261
2387	CHOW_RASSF1_TARGETS_DN	16116475	organ system cancer	DOID_0050686
2388	CHOW_RASSF1_TARGETS_DN	16116475	respiratory system cancer	DOID_0050615
2389	ENK_UV_RESPONSE_EPIDERMIS_UP	16434974	NA	NA
2390	ENK_UV_RESPONSE_EPIDERMIS_DN	16434974	NA	NA
2391	ENK_UV_RESPONSE_KERATINOCYTE_UP	16434974	NA	NA
2392	ENK_UV_RESPONSE_KERATINOCYTE_DN	16434974	NA	NA
2393	LAU_APOPTOSIS_CDKN2A_UP	17369842	cancer	DOID_162
2394	LAU_APOPTOSIS_CDKN2A_UP	17369842	cervical cancer	DOID_4362
2395	LAU_APOPTOSIS_CDKN2A_UP	17369842	disease of cellular proliferation	DOID_14566
2396	LAU_APOPTOSIS_CDKN2A_UP	17369842	female reproductive organ cancer	DOID_120
2397	LAU_APOPTOSIS_CDKN2A_UP	17369842	organ system cancer	DOID_0050686
2398	LAU_APOPTOSIS_CDKN2A_UP	17369842	reproductive organ cancer	DOID_193
2399	DELYS_THYROID_CANCER_UP	17621275	cancer	DOID_162
2400	DELYS_THYROID_CANCER_UP	17621275	carcinoma	DOID_305
2401	DELYS_THYROID_CANCER_UP	17621275	cell type cancer	DOID_0050687
2402	DELYS_THYROID_CANCER_UP	17621275	disease of cellular proliferation	DOID_14566
2403	DELYS_THYROID_CANCER_UP	17621275	endocrine gland cancer	DOID_170
2404	DELYS_THYROID_CANCER_UP	17621275	organ system cancer	DOID_0050686
2405	DELYS_THYROID_CANCER_UP	17621275	papillary thyroid carcinoma	DOID_3969
2406	DELYS_THYROID_CANCER_UP	17621275	thyroid cancer	DOID_1781
2407	DELYS_THYROID_CANCER_UP	17621275	thyroid carcinoma	DOID_3963
2408	DELYS_THYROID_CANCER_DN	17621275	cancer	DOID_162
2409	DELYS_THYROID_CANCER_DN	17621275	carcinoma	DOID_305
2410	DELYS_THYROID_CANCER_DN	17621275	cell type cancer	DOID_0050687
2411	DELYS_THYROID_CANCER_DN	17621275	disease of cellular proliferation	DOID_14566
2412	DELYS_THYROID_CANCER_DN	17621275	endocrine gland cancer	DOID_170
2413	DELYS_THYROID_CANCER_DN	17621275	organ system cancer	DOID_0050686
2414	DELYS_THYROID_CANCER_DN	17621275	papillary thyroid carcinoma	DOID_3969
2415	DELYS_THYROID_CANCER_DN	17621275	thyroid cancer	DOID_1781
2416	DELYS_THYROID_CANCER_DN	17621275	thyroid carcinoma	DOID_3963
2417	LINDGREN_BLADDER_CANCER_CLUSTER_1_UP	16532037	cancer	DOID_162
2418	LINDGREN_BLADDER_CANCER_CLUSTER_1_UP	16532037	carcinoma	DOID_305
2419	LINDGREN_BLADDER_CANCER_CLUSTER_1_UP	16532037	cell type cancer	DOID_0050687
2420	LINDGREN_BLADDER_CANCER_CLUSTER_1_UP	16532037	disease of cellular proliferation	DOID_14566
2421	LINDGREN_BLADDER_CANCER_CLUSTER_1_DN	16532037	cancer	DOID_162
2422	LINDGREN_BLADDER_CANCER_CLUSTER_1_DN	16532037	carcinoma	DOID_305
2423	LINDGREN_BLADDER_CANCER_CLUSTER_1_DN	16532037	cell type cancer	DOID_0050687
2424	LINDGREN_BLADDER_CANCER_CLUSTER_1_DN	16532037	disease of cellular proliferation	DOID_14566
2425	LINDGREN_BLADDER_CANCER_CLUSTER_2A_DN	16532037	cancer	DOID_162
2426	LINDGREN_BLADDER_CANCER_CLUSTER_2A_DN	16532037	carcinoma	DOID_305
2427	LINDGREN_BLADDER_CANCER_CLUSTER_2A_DN	16532037	cell type cancer	DOID_0050687
2428	LINDGREN_BLADDER_CANCER_CLUSTER_2A_DN	16532037	disease of cellular proliferation	DOID_14566
2429	LINDGREN_BLADDER_CANCER_CLUSTER_3_UP	16532037	cancer	DOID_162
2430	LINDGREN_BLADDER_CANCER_CLUSTER_3_UP	16532037	carcinoma	DOID_305
2431	LINDGREN_BLADDER_CANCER_CLUSTER_3_UP	16532037	cell type cancer	DOID_0050687
2432	LINDGREN_BLADDER_CANCER_CLUSTER_3_UP	16532037	disease of cellular proliferation	DOID_14566
2433	LINDGREN_BLADDER_CANCER_CLUSTER_3_DN	16532037	cancer	DOID_162
2434	LINDGREN_BLADDER_CANCER_CLUSTER_3_DN	16532037	carcinoma	DOID_305
2435	LINDGREN_BLADDER_CANCER_CLUSTER_3_DN	16532037	cell type cancer	DOID_0050687
2436	LINDGREN_BLADDER_CANCER_CLUSTER_3_DN	16532037	disease of cellular proliferation	DOID_14566
2437	KOINUMA_COLON_CANCER_MSI_DN	16247484	cancer	DOID_162
2438	KOINUMA_COLON_CANCER_MSI_DN	16247484	carcinoma	DOID_305
2439	KOINUMA_COLON_CANCER_MSI_DN	16247484	cell type cancer	DOID_0050687
2440	KOINUMA_COLON_CANCER_MSI_DN	16247484	disease of cellular proliferation	DOID_14566
2441	CREIGHTON_AKT1_SIGNALING_VIA_MTOR_UP	17213801	breast cancer	DOID_1612
2442	CREIGHTON_AKT1_SIGNALING_VIA_MTOR_UP	17213801	cancer	DOID_162
2443	CREIGHTON_AKT1_SIGNALING_VIA_MTOR_UP	17213801	disease of cellular proliferation	DOID_14566
2444	CREIGHTON_AKT1_SIGNALING_VIA_MTOR_UP	17213801	organ system cancer	DOID_0050686
2445	CREIGHTON_AKT1_SIGNALING_VIA_MTOR_UP	17213801	thoracic cancer	DOID_5093
2446	CREIGHTON_AKT1_SIGNALING_VIA_MTOR_DN	17213801	breast cancer	DOID_1612
2447	CREIGHTON_AKT1_SIGNALING_VIA_MTOR_DN	17213801	cancer	DOID_162
2448	CREIGHTON_AKT1_SIGNALING_VIA_MTOR_DN	17213801	disease of cellular proliferation	DOID_14566
2449	CREIGHTON_AKT1_SIGNALING_VIA_MTOR_DN	17213801	organ system cancer	DOID_0050686
2450	CREIGHTON_AKT1_SIGNALING_VIA_MTOR_DN	17213801	thoracic cancer	DOID_5093
2451	NADERI_BREAST_CANCER_PROGNOSIS_UP	16936776	breast cancer	DOID_1612
2452	NADERI_BREAST_CANCER_PROGNOSIS_UP	16936776	cancer	DOID_162
2453	NADERI_BREAST_CANCER_PROGNOSIS_UP	16936776	disease of cellular proliferation	DOID_14566
2454	NADERI_BREAST_CANCER_PROGNOSIS_UP	16936776	organ system cancer	DOID_0050686
2455	NADERI_BREAST_CANCER_PROGNOSIS_UP	16936776	thoracic cancer	DOID_5093
2456	NADERI_BREAST_CANCER_PROGNOSIS_DN	16936776	breast cancer	DOID_1612
2457	NADERI_BREAST_CANCER_PROGNOSIS_DN	16936776	cancer	DOID_162
2458	NADERI_BREAST_CANCER_PROGNOSIS_DN	16936776	disease of cellular proliferation	DOID_14566
2459	NADERI_BREAST_CANCER_PROGNOSIS_DN	16936776	organ system cancer	DOID_0050686
2460	NADERI_BREAST_CANCER_PROGNOSIS_DN	16936776	thoracic cancer	DOID_5093
2461	CHIN_BREAST_CANCER_COPY_NUMBER_UP	17001317	breast cancer	DOID_1612
2462	CHIN_BREAST_CANCER_COPY_NUMBER_UP	17001317	cancer	DOID_162
2463	CHIN_BREAST_CANCER_COPY_NUMBER_UP	17001317	disease of cellular proliferation	DOID_14566
2464	CHIN_BREAST_CANCER_COPY_NUMBER_UP	17001317	organ system cancer	DOID_0050686
2465	CHIN_BREAST_CANCER_COPY_NUMBER_UP	17001317	thoracic cancer	DOID_5093
2466	VANHARANTA_UTERINE_FIBROID_UP	15940248	benign neoplasm	DOID_0060072
2467	VANHARANTA_UTERINE_FIBROID_UP	15940248	cell type benign neoplasm	DOID_0060084
2468	VANHARANTA_UTERINE_FIBROID_UP	15940248	disease of cellular proliferation	DOID_14566
2469	VANHARANTA_UTERINE_FIBROID_UP	15940248	leiomyoma	DOID_127
2470	VANHARANTA_UTERINE_FIBROID_DN	15940248	benign neoplasm	DOID_0060072
2471	VANHARANTA_UTERINE_FIBROID_DN	15940248	cell type benign neoplasm	DOID_0060084
2472	VANHARANTA_UTERINE_FIBROID_DN	15940248	disease of cellular proliferation	DOID_14566
2473	VANHARANTA_UTERINE_FIBROID_DN	15940248	leiomyoma	DOID_127
2474	VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_UP	15940248	benign neoplasm	DOID_0060072
2475	VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_UP	15940248	cell type benign neoplasm	DOID_0060084
2476	VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_UP	15940248	disease of cellular proliferation	DOID_14566
2477	VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_UP	15940248	leiomyoma	DOID_127
2478	VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_DN	15940248	benign neoplasm	DOID_0060072
2479	VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_DN	15940248	cell type benign neoplasm	DOID_0060084
2480	VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_DN	15940248	disease of cellular proliferation	DOID_14566
2481	VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_DN	15940248	leiomyoma	DOID_127
2482	CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP	16983338	autonomic nervous system neoplasm	DOID_2621
2483	CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP	16983338	cancer	DOID_162
2484	CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP	16983338	colon cancer	DOID_219
2485	CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP	16983338	colorectal cancer	DOID_9256
2486	CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP	16983338	disease of cellular proliferation	DOID_14566
2487	CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP	16983338	gastrointestinal system cancer	DOID_3119
2488	CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP	16983338	intestinal cancer	DOID_10155
2489	CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP	16983338	large intestine cancer	DOID_5672
2490	CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP	16983338	nervous system cancer	DOID_3093
2491	CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP	16983338	neuroblastoma	DOID_769
2492	CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP	16983338	organ system cancer	DOID_0050686
2493	CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP	16983338	peripheral nervous system neoplasm	DOID_1192
2494	CONCANNON_APOPTOSIS_BY_EPOXOMICIN_DN	16983338	autonomic nervous system neoplasm	DOID_2621
2495	CONCANNON_APOPTOSIS_BY_EPOXOMICIN_DN	16983338	cancer	DOID_162
2496	CONCANNON_APOPTOSIS_BY_EPOXOMICIN_DN	16983338	colon cancer	DOID_219
2497	CONCANNON_APOPTOSIS_BY_EPOXOMICIN_DN	16983338	colorectal cancer	DOID_9256
2498	CONCANNON_APOPTOSIS_BY_EPOXOMICIN_DN	16983338	disease of cellular proliferation	DOID_14566
2499	CONCANNON_APOPTOSIS_BY_EPOXOMICIN_DN	16983338	gastrointestinal system cancer	DOID_3119
2500	CONCANNON_APOPTOSIS_BY_EPOXOMICIN_DN	16983338	intestinal cancer	DOID_10155
2501	CONCANNON_APOPTOSIS_BY_EPOXOMICIN_DN	16983338	large intestine cancer	DOID_5672
2502	CONCANNON_APOPTOSIS_BY_EPOXOMICIN_DN	16983338	nervous system cancer	DOID_3093
2503	CONCANNON_APOPTOSIS_BY_EPOXOMICIN_DN	16983338	neuroblastoma	DOID_769
2504	CONCANNON_APOPTOSIS_BY_EPOXOMICIN_DN	16983338	organ system cancer	DOID_0050686
2505	CONCANNON_APOPTOSIS_BY_EPOXOMICIN_DN	16983338	peripheral nervous system neoplasm	DOID_1192
2506	ODONNELL_METASTASIS_UP	15558013	cancer	DOID_162
2507	ODONNELL_METASTASIS_UP	15558013	carcinoma	DOID_305
2508	ODONNELL_METASTASIS_UP	15558013	cell type cancer	DOID_0050687
2509	ODONNELL_METASTASIS_UP	15558013	disease of cellular proliferation	DOID_14566
2510	ODONNELL_METASTASIS_UP	15558013	squamous cell carcinoma	DOID_1749
2511	ODONNELL_METASTASIS_DN	15558013	cancer	DOID_162
2512	ODONNELL_METASTASIS_DN	15558013	carcinoma	DOID_305
2513	ODONNELL_METASTASIS_DN	15558013	cell type cancer	DOID_0050687
2514	ODONNELL_METASTASIS_DN	15558013	disease of cellular proliferation	DOID_14566
2515	ODONNELL_METASTASIS_DN	15558013	squamous cell carcinoma	DOID_1749
2516	GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_UP	17130830	acute leukemia	DOID_12603
2517	GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_UP	17130830	cancer	DOID_162
2518	GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_UP	17130830	disease of cellular proliferation	DOID_14566
2519	GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_UP	17130830	hematologic cancer	DOID_2531
2520	GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_UP	17130830	immune system cancer	DOID_0060083
2521	GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_UP	17130830	leukemia	DOID_1240
2522	GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_UP	17130830	organ system cancer	DOID_0050686
2523	GAUSSMANN_MLL_AF4_FUSION_TARGETS_D_UP	17130830	acute leukemia	DOID_12603
2524	GAUSSMANN_MLL_AF4_FUSION_TARGETS_D_UP	17130830	cancer	DOID_162
2525	GAUSSMANN_MLL_AF4_FUSION_TARGETS_D_UP	17130830	disease of cellular proliferation	DOID_14566
2526	GAUSSMANN_MLL_AF4_FUSION_TARGETS_D_UP	17130830	hematologic cancer	DOID_2531
2527	GAUSSMANN_MLL_AF4_FUSION_TARGETS_D_UP	17130830	immune system cancer	DOID_0060083
2528	GAUSSMANN_MLL_AF4_FUSION_TARGETS_D_UP	17130830	leukemia	DOID_1240
2529	GAUSSMANN_MLL_AF4_FUSION_TARGETS_D_UP	17130830	organ system cancer	DOID_0050686
2530	GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_UP	17130830	acute leukemia	DOID_12603
2531	GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_UP	17130830	cancer	DOID_162
2532	GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_UP	17130830	disease of cellular proliferation	DOID_14566
2533	GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_UP	17130830	hematologic cancer	DOID_2531
2534	GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_UP	17130830	immune system cancer	DOID_0060083
2535	GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_UP	17130830	leukemia	DOID_1240
2536	GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_UP	17130830	organ system cancer	DOID_0050686
2537	GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_DN	17130830	acute leukemia	DOID_12603
2538	GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_DN	17130830	cancer	DOID_162
2539	GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_DN	17130830	disease of cellular proliferation	DOID_14566
2540	GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_DN	17130830	hematologic cancer	DOID_2531
2541	GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_DN	17130830	immune system cancer	DOID_0060083
2542	GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_DN	17130830	leukemia	DOID_1240
2543	GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_DN	17130830	organ system cancer	DOID_0050686
2544	GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP	17130830	acute leukemia	DOID_12603
2545	GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP	17130830	cancer	DOID_162
2546	GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP	17130830	disease of cellular proliferation	DOID_14566
2547	GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP	17130830	hematologic cancer	DOID_2531
2548	GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP	17130830	immune system cancer	DOID_0060083
2549	GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP	17130830	leukemia	DOID_1240
2550	GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP	17130830	organ system cancer	DOID_0050686
2551	GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_DN	17130830	acute leukemia	DOID_12603
2552	GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_DN	17130830	cancer	DOID_162
2553	GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_DN	17130830	disease of cellular proliferation	DOID_14566
2554	GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_DN	17130830	hematologic cancer	DOID_2531
2555	GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_DN	17130830	immune system cancer	DOID_0060083
2556	GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_DN	17130830	leukemia	DOID_1240
2557	GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_DN	17130830	organ system cancer	DOID_0050686
2558	GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP	17130830	acute leukemia	DOID_12603
2559	GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP	17130830	cancer	DOID_162
2560	GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP	17130830	disease of cellular proliferation	DOID_14566
2561	GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP	17130830	hematologic cancer	DOID_2531
2562	GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP	17130830	immune system cancer	DOID_0060083
2563	GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP	17130830	leukemia	DOID_1240
2564	GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP	17130830	organ system cancer	DOID_0050686
2565	GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_DN	17130830	acute leukemia	DOID_12603
2566	GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_DN	17130830	cancer	DOID_162
2567	GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_DN	17130830	disease of cellular proliferation	DOID_14566
2568	GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_DN	17130830	hematologic cancer	DOID_2531
2569	GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_DN	17130830	immune system cancer	DOID_0060083
2570	GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_DN	17130830	leukemia	DOID_1240
2571	GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_DN	17130830	organ system cancer	DOID_0050686
2572	OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_UP	15940270	NA	NA
2573	OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_DN	15940270	NA	NA
2574	BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_UP	16091735	adenocarcinoma	DOID_299
2575	BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_UP	16091735	cancer	DOID_162
2576	BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_UP	16091735	carcinoma	DOID_305
2577	BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_UP	16091735	cell type cancer	DOID_0050687
2578	BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_UP	16091735	colon cancer	DOID_219
2579	BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_UP	16091735	colorectal cancer	DOID_9256
2580	BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_UP	16091735	disease of cellular proliferation	DOID_14566
2581	BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_UP	16091735	gastrointestinal system cancer	DOID_3119
2582	BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_UP	16091735	intestinal cancer	DOID_10155
2583	BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_UP	16091735	large intestine cancer	DOID_5672
2584	BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_UP	16091735	organ system cancer	DOID_0050686
2585	BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_DN	16091735	adenocarcinoma	DOID_299
2586	BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_DN	16091735	cancer	DOID_162
2587	BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_DN	16091735	carcinoma	DOID_305
2588	BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_DN	16091735	cell type cancer	DOID_0050687
2589	BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_DN	16091735	colon cancer	DOID_219
2590	BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_DN	16091735	colorectal cancer	DOID_9256
2591	BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_DN	16091735	disease of cellular proliferation	DOID_14566
2592	BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_DN	16091735	gastrointestinal system cancer	DOID_3119
2593	BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_DN	16091735	intestinal cancer	DOID_10155
2594	BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_DN	16091735	large intestine cancer	DOID_5672
2595	BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_DN	16091735	organ system cancer	DOID_0050686
2596	BARRIER_CANCER_RELAPSE_TUMOR_SAMPLE_UP	16091735	adenocarcinoma	DOID_299
2597	BARRIER_CANCER_RELAPSE_TUMOR_SAMPLE_UP	16091735	cancer	DOID_162
2598	BARRIER_CANCER_RELAPSE_TUMOR_SAMPLE_UP	16091735	carcinoma	DOID_305
2599	BARRIER_CANCER_RELAPSE_TUMOR_SAMPLE_UP	16091735	cell type cancer	DOID_0050687
2600	BARRIER_CANCER_RELAPSE_TUMOR_SAMPLE_UP	16091735	colon cancer	DOID_219
2601	BARRIER_CANCER_RELAPSE_TUMOR_SAMPLE_UP	16091735	colorectal cancer	DOID_9256
2602	BARRIER_CANCER_RELAPSE_TUMOR_SAMPLE_UP	16091735	disease of cellular proliferation	DOID_14566
2603	BARRIER_CANCER_RELAPSE_TUMOR_SAMPLE_UP	16091735	gastrointestinal system cancer	DOID_3119
2604	BARRIER_CANCER_RELAPSE_TUMOR_SAMPLE_UP	16091735	intestinal cancer	DOID_10155
2605	BARRIER_CANCER_RELAPSE_TUMOR_SAMPLE_UP	16091735	large intestine cancer	DOID_5672
2606	BARRIER_CANCER_RELAPSE_TUMOR_SAMPLE_UP	16091735	organ system cancer	DOID_0050686
2607	BARRIER_CANCER_RELAPSE_TUMOR_SAMPLE_DN	16091735	adenocarcinoma	DOID_299
2608	BARRIER_CANCER_RELAPSE_TUMOR_SAMPLE_DN	16091735	cancer	DOID_162
2609	BARRIER_CANCER_RELAPSE_TUMOR_SAMPLE_DN	16091735	carcinoma	DOID_305
2610	BARRIER_CANCER_RELAPSE_TUMOR_SAMPLE_DN	16091735	cell type cancer	DOID_0050687
2611	BARRIER_CANCER_RELAPSE_TUMOR_SAMPLE_DN	16091735	colon cancer	DOID_219
2612	BARRIER_CANCER_RELAPSE_TUMOR_SAMPLE_DN	16091735	colorectal cancer	DOID_9256
2613	BARRIER_CANCER_RELAPSE_TUMOR_SAMPLE_DN	16091735	disease of cellular proliferation	DOID_14566
2614	BARRIER_CANCER_RELAPSE_TUMOR_SAMPLE_DN	16091735	gastrointestinal system cancer	DOID_3119
2615	BARRIER_CANCER_RELAPSE_TUMOR_SAMPLE_DN	16091735	intestinal cancer	DOID_10155
2616	BARRIER_CANCER_RELAPSE_TUMOR_SAMPLE_DN	16091735	large intestine cancer	DOID_5672
2617	BARRIER_CANCER_RELAPSE_TUMOR_SAMPLE_DN	16091735	organ system cancer	DOID_0050686
2618	BARIS_THYROID_CANCER_UP	15806164	cancer	DOID_162
2619	BARIS_THYROID_CANCER_UP	15806164	carcinoma	DOID_305
2620	BARIS_THYROID_CANCER_UP	15806164	cell type cancer	DOID_0050687
2621	BARIS_THYROID_CANCER_UP	15806164	disease of cellular proliferation	DOID_14566
2622	BARIS_THYROID_CANCER_UP	15806164	endocrine gland cancer	DOID_170
2623	BARIS_THYROID_CANCER_UP	15806164	organ system cancer	DOID_0050686
2624	BARIS_THYROID_CANCER_UP	15806164	papillary thyroid carcinoma	DOID_3969
2625	BARIS_THYROID_CANCER_UP	15806164	thyroid cancer	DOID_1781
2626	BARIS_THYROID_CANCER_UP	15806164	thyroid carcinoma	DOID_3963
2627	BARIS_THYROID_CANCER_DN	15806164	cancer	DOID_162
2628	BARIS_THYROID_CANCER_DN	15806164	carcinoma	DOID_305
2629	BARIS_THYROID_CANCER_DN	15806164	cell type cancer	DOID_0050687
2630	BARIS_THYROID_CANCER_DN	15806164	disease of cellular proliferation	DOID_14566
2631	BARIS_THYROID_CANCER_DN	15806164	endocrine gland cancer	DOID_170
2632	BARIS_THYROID_CANCER_DN	15806164	organ system cancer	DOID_0050686
2633	BARIS_THYROID_CANCER_DN	15806164	papillary thyroid carcinoma	DOID_3969
2634	BARIS_THYROID_CANCER_DN	15806164	thyroid cancer	DOID_1781
2635	BARIS_THYROID_CANCER_DN	15806164	thyroid carcinoma	DOID_3963
2636	TAKADA_GASTRIC_CANCER_COPY_NUMBER_DN	16103878	cancer	DOID_162
2637	TAKADA_GASTRIC_CANCER_COPY_NUMBER_DN	16103878	disease of cellular proliferation	DOID_14566
2638	WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_UP	16449976	adenocarcinoma	DOID_299
2639	WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_UP	16449976	Barrett's esophagus	DOID_9206
2640	WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_UP	16449976	cancer	DOID_162
2641	WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_UP	16449976	carcinoma	DOID_305
2642	WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_UP	16449976	cell type cancer	DOID_0050687
2643	WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_UP	16449976	disease of anatomical entity	DOID_7
2644	WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_UP	16449976	disease of cellular proliferation	DOID_14566
2645	WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_UP	16449976	esophageal cancer	DOID_5041
2646	WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_UP	16449976	esophageal carcinoma	DOID_1107
2647	WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_UP	16449976	esophageal disease	DOID_6050
2648	WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_UP	16449976	esophagus adenocarcinoma	DOID_4914
2649	WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_UP	16449976	gastrointestinal system cancer	DOID_3119
2650	WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_UP	16449976	gastrointestinal system disease	DOID_77
2651	WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_UP	16449976	organ system cancer	DOID_0050686
2652	WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_DN	16449976	adenocarcinoma	DOID_299
2653	WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_DN	16449976	Barrett's esophagus	DOID_9206
2654	WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_DN	16449976	cancer	DOID_162
2655	WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_DN	16449976	carcinoma	DOID_305
2656	WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_DN	16449976	cell type cancer	DOID_0050687
2657	WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_DN	16449976	disease of anatomical entity	DOID_7
2658	WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_DN	16449976	disease of cellular proliferation	DOID_14566
2659	WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_DN	16449976	esophageal cancer	DOID_5041
2660	WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_DN	16449976	esophageal carcinoma	DOID_1107
2661	WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_DN	16449976	esophageal disease	DOID_6050
2662	WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_DN	16449976	esophagus adenocarcinoma	DOID_4914
2663	WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_DN	16449976	gastrointestinal system cancer	DOID_3119
2664	WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_DN	16449976	gastrointestinal system disease	DOID_77
2665	WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_DN	16449976	organ system cancer	DOID_0050686
2666	KERLEY_RESPONSE_TO_CISPLATIN_UP	15940259	cancer	DOID_162
2667	KERLEY_RESPONSE_TO_CISPLATIN_UP	15940259	carcinoma	DOID_305
2668	KERLEY_RESPONSE_TO_CISPLATIN_UP	15940259	cell type cancer	DOID_0050687
2669	KERLEY_RESPONSE_TO_CISPLATIN_UP	15940259	disease of anatomical entity	DOID_7
2670	KERLEY_RESPONSE_TO_CISPLATIN_UP	15940259	disease of cellular proliferation	DOID_14566
2671	KERLEY_RESPONSE_TO_CISPLATIN_UP	15940259	embryonal cancer	DOID_688
2672	KERLEY_RESPONSE_TO_CISPLATIN_UP	15940259	embryonal carcinoma	DOID_3308
2673	KERLEY_RESPONSE_TO_CISPLATIN_UP	15940259	germ cell cancer	DOID_2994
2674	KERLEY_RESPONSE_TO_CISPLATIN_UP	15940259	hypersensitivity reaction disease	DOID_0060056
2675	KERLEY_RESPONSE_TO_CISPLATIN_UP	15940259	hypersensitivity reaction type I disease	DOID_1205
2676	KERLEY_RESPONSE_TO_CISPLATIN_UP	15940259	immune system disease	DOID_2914
2677	MISSIAGLIA_REGULATED_BY_METHYLATION_UP	15637593	cancer	DOID_162
2678	MISSIAGLIA_REGULATED_BY_METHYLATION_UP	15637593	disease of cellular proliferation	DOID_14566
2679	MISSIAGLIA_REGULATED_BY_METHYLATION_UP	15637593	endocrine gland cancer	DOID_170
2680	MISSIAGLIA_REGULATED_BY_METHYLATION_UP	15637593	organ system cancer	DOID_0050686
2681	MISSIAGLIA_REGULATED_BY_METHYLATION_UP	15637593	pancreatic cancer	DOID_1793
2682	MISSIAGLIA_REGULATED_BY_METHYLATION_DN	15637593	cancer	DOID_162
2683	MISSIAGLIA_REGULATED_BY_METHYLATION_DN	15637593	disease of cellular proliferation	DOID_14566
2684	MISSIAGLIA_REGULATED_BY_METHYLATION_DN	15637593	endocrine gland cancer	DOID_170
2685	MISSIAGLIA_REGULATED_BY_METHYLATION_DN	15637593	organ system cancer	DOID_0050686
2686	MISSIAGLIA_REGULATED_BY_METHYLATION_DN	15637593	pancreatic cancer	DOID_1793
2687	TANG_SENESCENCE_TP53_TARGETS_UP	17533371	autonomic nervous system neoplasm	DOID_2621
2688	TANG_SENESCENCE_TP53_TARGETS_UP	17533371	cancer	DOID_162
2689	TANG_SENESCENCE_TP53_TARGETS_UP	17533371	disease of cellular proliferation	DOID_14566
2690	TANG_SENESCENCE_TP53_TARGETS_UP	17533371	nervous system cancer	DOID_3093
2691	TANG_SENESCENCE_TP53_TARGETS_UP	17533371	neuroblastoma	DOID_769
2692	TANG_SENESCENCE_TP53_TARGETS_UP	17533371	organ system cancer	DOID_0050686
2693	TANG_SENESCENCE_TP53_TARGETS_UP	17533371	peripheral nervous system neoplasm	DOID_1192
2694	TANG_SENESCENCE_TP53_TARGETS_DN	17533371	autonomic nervous system neoplasm	DOID_2621
2695	TANG_SENESCENCE_TP53_TARGETS_DN	17533371	cancer	DOID_162
2696	TANG_SENESCENCE_TP53_TARGETS_DN	17533371	disease of cellular proliferation	DOID_14566
2697	TANG_SENESCENCE_TP53_TARGETS_DN	17533371	nervous system cancer	DOID_3093
2698	TANG_SENESCENCE_TP53_TARGETS_DN	17533371	neuroblastoma	DOID_769
2699	TANG_SENESCENCE_TP53_TARGETS_DN	17533371	organ system cancer	DOID_0050686
2700	TANG_SENESCENCE_TP53_TARGETS_DN	17533371	peripheral nervous system neoplasm	DOID_1192
2701	WANG_BARRETTS_ESOPHAGUS_UP	16449976	adenocarcinoma	DOID_299
2702	WANG_BARRETTS_ESOPHAGUS_UP	16449976	Barrett's esophagus	DOID_9206
2703	WANG_BARRETTS_ESOPHAGUS_UP	16449976	cancer	DOID_162
2704	WANG_BARRETTS_ESOPHAGUS_UP	16449976	carcinoma	DOID_305
2705	WANG_BARRETTS_ESOPHAGUS_UP	16449976	cell type cancer	DOID_0050687
2706	WANG_BARRETTS_ESOPHAGUS_UP	16449976	disease of anatomical entity	DOID_7
2707	WANG_BARRETTS_ESOPHAGUS_UP	16449976	disease of cellular proliferation	DOID_14566
2708	WANG_BARRETTS_ESOPHAGUS_UP	16449976	esophageal cancer	DOID_5041
2709	WANG_BARRETTS_ESOPHAGUS_UP	16449976	esophageal carcinoma	DOID_1107
2710	WANG_BARRETTS_ESOPHAGUS_UP	16449976	esophageal disease	DOID_6050
2711	WANG_BARRETTS_ESOPHAGUS_UP	16449976	esophagus adenocarcinoma	DOID_4914
2712	WANG_BARRETTS_ESOPHAGUS_UP	16449976	gastrointestinal system cancer	DOID_3119
2713	WANG_BARRETTS_ESOPHAGUS_UP	16449976	gastrointestinal system disease	DOID_77
2714	WANG_BARRETTS_ESOPHAGUS_UP	16449976	organ system cancer	DOID_0050686
2715	WANG_BARRETTS_ESOPHAGUS_DN	16449976	adenocarcinoma	DOID_299
2716	WANG_BARRETTS_ESOPHAGUS_DN	16449976	Barrett's esophagus	DOID_9206
2717	WANG_BARRETTS_ESOPHAGUS_DN	16449976	cancer	DOID_162
2718	WANG_BARRETTS_ESOPHAGUS_DN	16449976	carcinoma	DOID_305
2719	WANG_BARRETTS_ESOPHAGUS_DN	16449976	cell type cancer	DOID_0050687
2720	WANG_BARRETTS_ESOPHAGUS_DN	16449976	disease of anatomical entity	DOID_7
2721	WANG_BARRETTS_ESOPHAGUS_DN	16449976	disease of cellular proliferation	DOID_14566
2722	WANG_BARRETTS_ESOPHAGUS_DN	16449976	esophageal cancer	DOID_5041
2723	WANG_BARRETTS_ESOPHAGUS_DN	16449976	esophageal carcinoma	DOID_1107
2724	WANG_BARRETTS_ESOPHAGUS_DN	16449976	esophageal disease	DOID_6050
2725	WANG_BARRETTS_ESOPHAGUS_DN	16449976	esophagus adenocarcinoma	DOID_4914
2726	WANG_BARRETTS_ESOPHAGUS_DN	16449976	gastrointestinal system cancer	DOID_3119
2727	WANG_BARRETTS_ESOPHAGUS_DN	16449976	gastrointestinal system disease	DOID_77
2728	WANG_BARRETTS_ESOPHAGUS_DN	16449976	organ system cancer	DOID_0050686
2729	WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP	16449976	adenocarcinoma	DOID_299
2730	WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP	16449976	Barrett's esophagus	DOID_9206
2731	WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP	16449976	cancer	DOID_162
2732	WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP	16449976	carcinoma	DOID_305
2733	WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP	16449976	cell type cancer	DOID_0050687
2734	WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP	16449976	disease of anatomical entity	DOID_7
2735	WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP	16449976	disease of cellular proliferation	DOID_14566
2736	WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP	16449976	esophageal cancer	DOID_5041
2737	WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP	16449976	esophageal carcinoma	DOID_1107
2738	WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP	16449976	esophageal disease	DOID_6050
2739	WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP	16449976	esophagus adenocarcinoma	DOID_4914
2740	WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP	16449976	gastrointestinal system cancer	DOID_3119
2741	WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP	16449976	gastrointestinal system disease	DOID_77
2742	WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP	16449976	organ system cancer	DOID_0050686
2743	WANG_ESOPHAGUS_CANCER_VS_NORMAL_DN	16449976	adenocarcinoma	DOID_299
2744	WANG_ESOPHAGUS_CANCER_VS_NORMAL_DN	16449976	Barrett's esophagus	DOID_9206
2745	WANG_ESOPHAGUS_CANCER_VS_NORMAL_DN	16449976	cancer	DOID_162
2746	WANG_ESOPHAGUS_CANCER_VS_NORMAL_DN	16449976	carcinoma	DOID_305
2747	WANG_ESOPHAGUS_CANCER_VS_NORMAL_DN	16449976	cell type cancer	DOID_0050687
2748	WANG_ESOPHAGUS_CANCER_VS_NORMAL_DN	16449976	disease of anatomical entity	DOID_7
2749	WANG_ESOPHAGUS_CANCER_VS_NORMAL_DN	16449976	disease of cellular proliferation	DOID_14566
2750	WANG_ESOPHAGUS_CANCER_VS_NORMAL_DN	16449976	esophageal cancer	DOID_5041
2751	WANG_ESOPHAGUS_CANCER_VS_NORMAL_DN	16449976	esophageal carcinoma	DOID_1107
2752	WANG_ESOPHAGUS_CANCER_VS_NORMAL_DN	16449976	esophageal disease	DOID_6050
2753	WANG_ESOPHAGUS_CANCER_VS_NORMAL_DN	16449976	esophagus adenocarcinoma	DOID_4914
2754	WANG_ESOPHAGUS_CANCER_VS_NORMAL_DN	16449976	gastrointestinal system cancer	DOID_3119
2755	WANG_ESOPHAGUS_CANCER_VS_NORMAL_DN	16449976	gastrointestinal system disease	DOID_77
2756	WANG_ESOPHAGUS_CANCER_VS_NORMAL_DN	16449976	organ system cancer	DOID_0050686
2757	SILIGAN_TARGETS_OF_EWS_FLI1_FUSION_UP	15735734	cancer	DOID_162
2758	SILIGAN_TARGETS_OF_EWS_FLI1_FUSION_UP	15735734	cell type cancer	DOID_0050687
2759	SILIGAN_TARGETS_OF_EWS_FLI1_FUSION_UP	15735734	disease of cellular proliferation	DOID_14566
2760	SILIGAN_TARGETS_OF_EWS_FLI1_FUSION_UP	15735734	sarcoma	DOID_1115
2761	SILIGAN_TARGETS_OF_EWS_FLI1_FUSION_DN	15735734	cancer	DOID_162
2762	SILIGAN_TARGETS_OF_EWS_FLI1_FUSION_DN	15735734	cell type cancer	DOID_0050687
2763	SILIGAN_TARGETS_OF_EWS_FLI1_FUSION_DN	15735734	disease of cellular proliferation	DOID_14566
2764	SILIGAN_TARGETS_OF_EWS_FLI1_FUSION_DN	15735734	sarcoma	DOID_1115
2765	ROYLANCE_BREAST_CANCER_16Q_COPY_NUMBER_UP	16702952	breast cancer	DOID_1612
2766	ROYLANCE_BREAST_CANCER_16Q_COPY_NUMBER_UP	16702952	breast carcinoma	DOID_3459
2767	ROYLANCE_BREAST_CANCER_16Q_COPY_NUMBER_UP	16702952	cancer	DOID_162
2768	ROYLANCE_BREAST_CANCER_16Q_COPY_NUMBER_UP	16702952	carcinoma	DOID_305
2769	ROYLANCE_BREAST_CANCER_16Q_COPY_NUMBER_UP	16702952	cell type cancer	DOID_0050687
2770	ROYLANCE_BREAST_CANCER_16Q_COPY_NUMBER_UP	16702952	disease of cellular proliferation	DOID_14566
2771	ROYLANCE_BREAST_CANCER_16Q_COPY_NUMBER_UP	16702952	organ system cancer	DOID_0050686
2772	ROYLANCE_BREAST_CANCER_16Q_COPY_NUMBER_UP	16702952	thoracic cancer	DOID_5093
2773	ROYLANCE_BREAST_CANCER_16Q_COPY_NUMBER_DN	16702952	breast cancer	DOID_1612
2774	ROYLANCE_BREAST_CANCER_16Q_COPY_NUMBER_DN	16702952	breast carcinoma	DOID_3459
2775	ROYLANCE_BREAST_CANCER_16Q_COPY_NUMBER_DN	16702952	cancer	DOID_162
2776	ROYLANCE_BREAST_CANCER_16Q_COPY_NUMBER_DN	16702952	carcinoma	DOID_305
2777	ROYLANCE_BREAST_CANCER_16Q_COPY_NUMBER_DN	16702952	cell type cancer	DOID_0050687
2778	ROYLANCE_BREAST_CANCER_16Q_COPY_NUMBER_DN	16702952	disease of cellular proliferation	DOID_14566
2779	ROYLANCE_BREAST_CANCER_16Q_COPY_NUMBER_DN	16702952	organ system cancer	DOID_0050686
2780	ROYLANCE_BREAST_CANCER_16Q_COPY_NUMBER_DN	16702952	thoracic cancer	DOID_5093
2781	VETTER_TARGETS_OF_PRKCA_AND_ETS1_UP	15531915	breast cancer	DOID_1612
2782	VETTER_TARGETS_OF_PRKCA_AND_ETS1_UP	15531915	cancer	DOID_162
2783	VETTER_TARGETS_OF_PRKCA_AND_ETS1_UP	15531915	disease of cellular proliferation	DOID_14566
2784	VETTER_TARGETS_OF_PRKCA_AND_ETS1_UP	15531915	organ system cancer	DOID_0050686
2785	VETTER_TARGETS_OF_PRKCA_AND_ETS1_UP	15531915	thoracic cancer	DOID_5093
2786	VETTER_TARGETS_OF_PRKCA_AND_ETS1_DN	15531915	breast cancer	DOID_1612
2787	VETTER_TARGETS_OF_PRKCA_AND_ETS1_DN	15531915	cancer	DOID_162
2788	VETTER_TARGETS_OF_PRKCA_AND_ETS1_DN	15531915	disease of cellular proliferation	DOID_14566
2789	VETTER_TARGETS_OF_PRKCA_AND_ETS1_DN	15531915	organ system cancer	DOID_0050686
2790	VETTER_TARGETS_OF_PRKCA_AND_ETS1_DN	15531915	thoracic cancer	DOID_5093
2791	DUNNE_TARGETS_OF_AML1_MTG8_FUSION_UP	16652140	acute myeloid leukemia	DOID_9119
2792	DUNNE_TARGETS_OF_AML1_MTG8_FUSION_UP	16652140	cancer	DOID_162
2793	DUNNE_TARGETS_OF_AML1_MTG8_FUSION_UP	16652140	disease of cellular proliferation	DOID_14566
2794	DUNNE_TARGETS_OF_AML1_MTG8_FUSION_UP	16652140	hematologic cancer	DOID_2531
2795	DUNNE_TARGETS_OF_AML1_MTG8_FUSION_UP	16652140	immune system cancer	DOID_0060083
2796	DUNNE_TARGETS_OF_AML1_MTG8_FUSION_UP	16652140	leukemia	DOID_1240
2797	DUNNE_TARGETS_OF_AML1_MTG8_FUSION_UP	16652140	myeloid leukemia	DOID_8692
2798	DUNNE_TARGETS_OF_AML1_MTG8_FUSION_UP	16652140	organ system cancer	DOID_0050686
2799	DUNNE_TARGETS_OF_AML1_MTG8_FUSION_DN	16652140	acute myeloid leukemia	DOID_9119
2800	DUNNE_TARGETS_OF_AML1_MTG8_FUSION_DN	16652140	cancer	DOID_162
2801	DUNNE_TARGETS_OF_AML1_MTG8_FUSION_DN	16652140	disease of cellular proliferation	DOID_14566
2802	DUNNE_TARGETS_OF_AML1_MTG8_FUSION_DN	16652140	hematologic cancer	DOID_2531
2803	DUNNE_TARGETS_OF_AML1_MTG8_FUSION_DN	16652140	immune system cancer	DOID_0060083
2804	DUNNE_TARGETS_OF_AML1_MTG8_FUSION_DN	16652140	leukemia	DOID_1240
2805	DUNNE_TARGETS_OF_AML1_MTG8_FUSION_DN	16652140	myeloid leukemia	DOID_8692
2806	DUNNE_TARGETS_OF_AML1_MTG8_FUSION_DN	16652140	organ system cancer	DOID_0050686
2807	LUI_THYROID_CANCER_PAX8_PPARG_UP	15608688	adenocarcinoma	DOID_299
2808	LUI_THYROID_CANCER_PAX8_PPARG_UP	15608688	cancer	DOID_162
2809	LUI_THYROID_CANCER_PAX8_PPARG_UP	15608688	carcinoma	DOID_305
2810	LUI_THYROID_CANCER_PAX8_PPARG_UP	15608688	cell type cancer	DOID_0050687
2811	LUI_THYROID_CANCER_PAX8_PPARG_UP	15608688	disease of cellular proliferation	DOID_14566
2812	LUI_THYROID_CANCER_PAX8_PPARG_DN	15608688	adenocarcinoma	DOID_299
2813	LUI_THYROID_CANCER_PAX8_PPARG_DN	15608688	cancer	DOID_162
2814	LUI_THYROID_CANCER_PAX8_PPARG_DN	15608688	carcinoma	DOID_305
2815	LUI_THYROID_CANCER_PAX8_PPARG_DN	15608688	cell type cancer	DOID_0050687
2816	LUI_THYROID_CANCER_PAX8_PPARG_DN	15608688	disease of cellular proliferation	DOID_14566
2817	HAMAI_APOPTOSIS_VIA_TRAIL_UP	16983347	cancer	DOID_162
2818	HAMAI_APOPTOSIS_VIA_TRAIL_UP	16983347	cell type cancer	DOID_0050687
2819	HAMAI_APOPTOSIS_VIA_TRAIL_UP	16983347	disease of cellular proliferation	DOID_14566
2820	HAMAI_APOPTOSIS_VIA_TRAIL_UP	16983347	hematologic cancer	DOID_2531
2821	HAMAI_APOPTOSIS_VIA_TRAIL_UP	16983347	immune system cancer	DOID_0060083
2822	HAMAI_APOPTOSIS_VIA_TRAIL_UP	16983347	leukemia	DOID_1240
2823	HAMAI_APOPTOSIS_VIA_TRAIL_UP	16983347	lymphoma	DOID_0060058
2824	HAMAI_APOPTOSIS_VIA_TRAIL_UP	16983347	melanoma	DOID_1909
2825	HAMAI_APOPTOSIS_VIA_TRAIL_UP	16983347	metastatic melanoma	DOID_4358
2826	HAMAI_APOPTOSIS_VIA_TRAIL_UP	16983347	organ system cancer	DOID_0050686
2827	HAMAI_APOPTOSIS_VIA_TRAIL_DN	16983347	cancer	DOID_162
2828	HAMAI_APOPTOSIS_VIA_TRAIL_DN	16983347	cell type cancer	DOID_0050687
2829	HAMAI_APOPTOSIS_VIA_TRAIL_DN	16983347	disease of cellular proliferation	DOID_14566
2830	HAMAI_APOPTOSIS_VIA_TRAIL_DN	16983347	hematologic cancer	DOID_2531
2831	HAMAI_APOPTOSIS_VIA_TRAIL_DN	16983347	immune system cancer	DOID_0060083
2832	HAMAI_APOPTOSIS_VIA_TRAIL_DN	16983347	leukemia	DOID_1240
2833	HAMAI_APOPTOSIS_VIA_TRAIL_DN	16983347	lymphoma	DOID_0060058
2834	HAMAI_APOPTOSIS_VIA_TRAIL_DN	16983347	melanoma	DOID_1909
2835	HAMAI_APOPTOSIS_VIA_TRAIL_DN	16983347	metastatic melanoma	DOID_4358
2836	HAMAI_APOPTOSIS_VIA_TRAIL_DN	16983347	organ system cancer	DOID_0050686
2837	OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_UP	15940270	NA	NA
2838	OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN	15940270	NA	NA
2839	LUCAS_HNF4A_TARGETS_UP	16007190	cancer	DOID_162
2840	LUCAS_HNF4A_TARGETS_UP	16007190	carcinoma	DOID_305
2841	LUCAS_HNF4A_TARGETS_UP	16007190	cell type cancer	DOID_0050687
2842	LUCAS_HNF4A_TARGETS_UP	16007190	disease of cellular proliferation	DOID_14566
2843	LUCAS_HNF4A_TARGETS_UP	16007190	hereditary Wilms' tumor	DOID_5183
2844	LUCAS_HNF4A_TARGETS_UP	16007190	kidney cancer	DOID_263
2845	LUCAS_HNF4A_TARGETS_UP	16007190	nephroblastoma	DOID_2154
2846	LUCAS_HNF4A_TARGETS_UP	16007190	organ system cancer	DOID_0050686
2847	LUCAS_HNF4A_TARGETS_UP	16007190	renal carcinoma	DOID_4451
2848	LUCAS_HNF4A_TARGETS_UP	16007190	renal cell carcinoma	DOID_4450
2849	LUCAS_HNF4A_TARGETS_UP	16007190	urinary system cancer	DOID_3996
2850	ZIRN_TRETINOIN_RESPONSE_WT1_UP	15897880	NA	NA
2851	ZIRN_TRETINOIN_RESPONSE_UP	15897880	NA	NA
2852	STREICHER_LSM1_TARGETS_UP	17001308	breast cancer	DOID_1612
2853	STREICHER_LSM1_TARGETS_UP	17001308	cancer	DOID_162
2854	STREICHER_LSM1_TARGETS_UP	17001308	disease of cellular proliferation	DOID_14566
2855	STREICHER_LSM1_TARGETS_UP	17001308	organ system cancer	DOID_0050686
2856	STREICHER_LSM1_TARGETS_UP	17001308	thoracic cancer	DOID_5093
2857	STREICHER_LSM1_TARGETS_DN	17001308	breast cancer	DOID_1612
2858	STREICHER_LSM1_TARGETS_DN	17001308	cancer	DOID_162
2859	STREICHER_LSM1_TARGETS_DN	17001308	disease of cellular proliferation	DOID_14566
2860	STREICHER_LSM1_TARGETS_DN	17001308	organ system cancer	DOID_0050686
2861	STREICHER_LSM1_TARGETS_DN	17001308	thoracic cancer	DOID_5093
2862	KAN_RESPONSE_TO_ARSENIC_TRIOXIDE	15592527	cancer	DOID_162
2863	KAN_RESPONSE_TO_ARSENIC_TRIOXIDE	15592527	cell type cancer	DOID_0050687
2864	KAN_RESPONSE_TO_ARSENIC_TRIOXIDE	15592527	disease of cellular proliferation	DOID_14566
2865	KAN_RESPONSE_TO_ARSENIC_TRIOXIDE	15592527	malignant glioma	DOID_3070
2866	NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_UP	17213809	cancer	DOID_162
2867	NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_UP	17213809	chronic myeloid leukemia	DOID_8552
2868	NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_UP	17213809	disease of cellular proliferation	DOID_14566
2869	NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_UP	17213809	hematologic cancer	DOID_2531
2870	NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_UP	17213809	immune system cancer	DOID_0060083
2871	NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_UP	17213809	leukemia	DOID_1240
2872	NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_UP	17213809	myeloid leukemia	DOID_8692
2873	NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_UP	17213809	organ system cancer	DOID_0050686
2874	NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN	17213809	cancer	DOID_162
2875	NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN	17213809	chronic myeloid leukemia	DOID_8552
2876	NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN	17213809	disease of cellular proliferation	DOID_14566
2877	NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN	17213809	hematologic cancer	DOID_2531
2878	NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN	17213809	immune system cancer	DOID_0060083
2879	NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN	17213809	leukemia	DOID_1240
2880	NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN	17213809	myeloid leukemia	DOID_8692
2881	NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN	17213809	organ system cancer	DOID_0050686
2882	MAHADEVAN_IMATINIB_RESISTANCE_UP	17325667	cancer	DOID_162
2883	MAHADEVAN_IMATINIB_RESISTANCE_UP	17325667	disease of cellular proliferation	DOID_14566
2884	MAHADEVAN_IMATINIB_RESISTANCE_UP	17325667	gastrointestinal stromal tumor	DOID_9253
2885	MAHADEVAN_IMATINIB_RESISTANCE_UP	17325667	gastrointestinal system cancer	DOID_3119
2886	MAHADEVAN_IMATINIB_RESISTANCE_UP	17325667	organ system cancer	DOID_0050686
2887	MAHADEVAN_IMATINIB_RESISTANCE_UP	17325667	stromal neoplasm	DOID_2991
2888	MAHADEVAN_IMATINIB_RESISTANCE_DN	17325667	cancer	DOID_162
2889	MAHADEVAN_IMATINIB_RESISTANCE_DN	17325667	disease of cellular proliferation	DOID_14566
2890	MAHADEVAN_IMATINIB_RESISTANCE_DN	17325667	gastrointestinal stromal tumor	DOID_9253
2891	MAHADEVAN_IMATINIB_RESISTANCE_DN	17325667	gastrointestinal system cancer	DOID_3119
2892	MAHADEVAN_IMATINIB_RESISTANCE_DN	17325667	organ system cancer	DOID_0050686
2893	MAHADEVAN_IMATINIB_RESISTANCE_DN	17325667	stromal neoplasm	DOID_2991
2894	TOMIDA_METASTASIS_UP	17260014	cancer	DOID_162
2895	TOMIDA_METASTASIS_UP	17260014	combined T cell and B cell immunodeficiency	DOID_628
2896	TOMIDA_METASTASIS_UP	17260014	disease of anatomical entity	DOID_7
2897	TOMIDA_METASTASIS_UP	17260014	disease of cellular proliferation	DOID_14566
2898	TOMIDA_METASTASIS_UP	17260014	immune system disease	DOID_2914
2899	TOMIDA_METASTASIS_UP	17260014	lung cancer	DOID_1324
2900	TOMIDA_METASTASIS_UP	17260014	organ system cancer	DOID_0050686
2901	TOMIDA_METASTASIS_UP	17260014	primary immunodeficiency disease	DOID_612
2902	TOMIDA_METASTASIS_UP	17260014	respiratory system cancer	DOID_0050615
2903	TOMIDA_METASTASIS_UP	17260014	severe combined immunodeficiency	DOID_627
2904	TOMIDA_METASTASIS_DN	17260014	cancer	DOID_162
2905	TOMIDA_METASTASIS_DN	17260014	combined T cell and B cell immunodeficiency	DOID_628
2906	TOMIDA_METASTASIS_DN	17260014	disease of anatomical entity	DOID_7
2907	TOMIDA_METASTASIS_DN	17260014	disease of cellular proliferation	DOID_14566
2908	TOMIDA_METASTASIS_DN	17260014	immune system disease	DOID_2914
2909	TOMIDA_METASTASIS_DN	17260014	lung cancer	DOID_1324
2910	TOMIDA_METASTASIS_DN	17260014	organ system cancer	DOID_0050686
2911	TOMIDA_METASTASIS_DN	17260014	primary immunodeficiency disease	DOID_612
2912	TOMIDA_METASTASIS_DN	17260014	respiratory system cancer	DOID_0050615
2913	TOMIDA_METASTASIS_DN	17260014	severe combined immunodeficiency	DOID_627
2914	HWANG_PROSTATE_CANCER_MARKERS	16799640	cancer	DOID_162
2915	HWANG_PROSTATE_CANCER_MARKERS	16799640	disease of cellular proliferation	DOID_14566
2916	HWANG_PROSTATE_CANCER_MARKERS	16799640	male reproductive organ cancer	DOID_3856
2917	HWANG_PROSTATE_CANCER_MARKERS	16799640	organ system cancer	DOID_0050686
2918	HWANG_PROSTATE_CANCER_MARKERS	16799640	prostate cancer	DOID_10283
2919	HWANG_PROSTATE_CANCER_MARKERS	16799640	reproductive organ cancer	DOID_193
2920	HU_ANGIOGENESIS_UP	15592519	cancer	DOID_162
2921	HU_ANGIOGENESIS_UP	15592519	carcinoma	DOID_305
2922	HU_ANGIOGENESIS_UP	15592519	cell type cancer	DOID_0050687
2923	HU_ANGIOGENESIS_UP	15592519	disease of cellular proliferation	DOID_14566
2924	HU_ANGIOGENESIS_UP	15592519	lung cancer	DOID_1324
2925	HU_ANGIOGENESIS_UP	15592519	organ system cancer	DOID_0050686
2926	HU_ANGIOGENESIS_UP	15592519	respiratory system cancer	DOID_0050615
2927	HU_ANGIOGENESIS_DN	15592519	cancer	DOID_162
2928	HU_ANGIOGENESIS_DN	15592519	carcinoma	DOID_305
2929	HU_ANGIOGENESIS_DN	15592519	cell type cancer	DOID_0050687
2930	HU_ANGIOGENESIS_DN	15592519	disease of cellular proliferation	DOID_14566
2931	HU_ANGIOGENESIS_DN	15592519	lung cancer	DOID_1324
2932	HU_ANGIOGENESIS_DN	15592519	organ system cancer	DOID_0050686
2933	HU_ANGIOGENESIS_DN	15592519	respiratory system cancer	DOID_0050615
2934	BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_UP	15688035	cancer	DOID_162
2935	BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_UP	15688035	connective tissue cancer	DOID_201
2936	BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_UP	15688035	disease of cellular proliferation	DOID_14566
2937	BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_UP	15688035	muscle cancer	DOID_4045
2938	BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_UP	15688035	musculoskeletal system cancer	DOID_0060100
2939	BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_UP	15688035	organ system cancer	DOID_0050686
2940	BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_UP	15688035	osteosarcoma	DOID_3347
2941	BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_UP	15688035	rhabdomyosarcoma	DOID_3247
2942	BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_UP	15688035	skeletal muscle cancer	DOID_4043
2943	BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN	15688035	cancer	DOID_162
2944	BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN	15688035	connective tissue cancer	DOID_201
2945	BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN	15688035	disease of cellular proliferation	DOID_14566
2946	BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN	15688035	muscle cancer	DOID_4045
2947	BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN	15688035	musculoskeletal system cancer	DOID_0060100
2948	BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN	15688035	organ system cancer	DOID_0050686
2949	BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN	15688035	osteosarcoma	DOID_3347
2950	BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN	15688035	rhabdomyosarcoma	DOID_3247
2951	BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN	15688035	skeletal muscle cancer	DOID_4043
2952	OLSSON_E2F3_TARGETS_UP	16909110	cancer	DOID_162
2953	OLSSON_E2F3_TARGETS_UP	16909110	disease of anatomical entity	DOID_7
2954	OLSSON_E2F3_TARGETS_UP	16909110	disease of cellular proliferation	DOID_14566
2955	OLSSON_E2F3_TARGETS_UP	16909110	eye and adnexa disease	DOID_1492
2956	OLSSON_E2F3_TARGETS_UP	16909110	eye disease	DOID_5614
2957	OLSSON_E2F3_TARGETS_UP	16909110	globe disease	DOID_1242
2958	OLSSON_E2F3_TARGETS_UP	16909110	male reproductive organ cancer	DOID_3856
2959	OLSSON_E2F3_TARGETS_UP	16909110	nervous system cancer	DOID_3093
2960	OLSSON_E2F3_TARGETS_UP	16909110	nervous system disease	DOID_863
2961	OLSSON_E2F3_TARGETS_UP	16909110	ocular cancer	DOID_2174
2962	OLSSON_E2F3_TARGETS_UP	16909110	organ system cancer	DOID_0050686
2963	OLSSON_E2F3_TARGETS_UP	16909110	prostate cancer	DOID_10283
2964	OLSSON_E2F3_TARGETS_UP	16909110	reproductive organ cancer	DOID_193
2965	OLSSON_E2F3_TARGETS_UP	16909110	retinal cancer	DOID_4645
2966	OLSSON_E2F3_TARGETS_UP	16909110	retinal cell cancer	DOID_771
2967	OLSSON_E2F3_TARGETS_UP	16909110	retinal disease	DOID_5679
2968	OLSSON_E2F3_TARGETS_UP	16909110	retinoblastoma	DOID_768
2969	OLSSON_E2F3_TARGETS_UP	16909110	sensory system cancer	DOID_0060116
2970	OLSSON_E2F3_TARGETS_UP	16909110	sensory system disease	DOID_0050155
2971	OLSSON_E2F3_TARGETS_UP	16909110	urinary bladder cancer	DOID_11054
2972	OLSSON_E2F3_TARGETS_UP	16909110	urinary system cancer	DOID_3996
2973	OLSSON_E2F3_TARGETS_DN	16909110	cancer	DOID_162
2974	OLSSON_E2F3_TARGETS_DN	16909110	disease of anatomical entity	DOID_7
2975	OLSSON_E2F3_TARGETS_DN	16909110	disease of cellular proliferation	DOID_14566
2976	OLSSON_E2F3_TARGETS_DN	16909110	eye and adnexa disease	DOID_1492
2977	OLSSON_E2F3_TARGETS_DN	16909110	eye disease	DOID_5614
2978	OLSSON_E2F3_TARGETS_DN	16909110	globe disease	DOID_1242
2979	OLSSON_E2F3_TARGETS_DN	16909110	male reproductive organ cancer	DOID_3856
2980	OLSSON_E2F3_TARGETS_DN	16909110	nervous system cancer	DOID_3093
2981	OLSSON_E2F3_TARGETS_DN	16909110	nervous system disease	DOID_863
2982	OLSSON_E2F3_TARGETS_DN	16909110	ocular cancer	DOID_2174
2983	OLSSON_E2F3_TARGETS_DN	16909110	organ system cancer	DOID_0050686
2984	OLSSON_E2F3_TARGETS_DN	16909110	prostate cancer	DOID_10283
2985	OLSSON_E2F3_TARGETS_DN	16909110	reproductive organ cancer	DOID_193
2986	OLSSON_E2F3_TARGETS_DN	16909110	retinal cancer	DOID_4645
2987	OLSSON_E2F3_TARGETS_DN	16909110	retinal cell cancer	DOID_771
2988	OLSSON_E2F3_TARGETS_DN	16909110	retinal disease	DOID_5679
2989	OLSSON_E2F3_TARGETS_DN	16909110	retinoblastoma	DOID_768
2990	OLSSON_E2F3_TARGETS_DN	16909110	sensory system cancer	DOID_0060116
2991	OLSSON_E2F3_TARGETS_DN	16909110	sensory system disease	DOID_0050155
2992	OLSSON_E2F3_TARGETS_DN	16909110	urinary bladder cancer	DOID_11054
2993	OLSSON_E2F3_TARGETS_DN	16909110	urinary system cancer	DOID_3996
2994	MARKS_HDAC_TARGETS_UP	17322921	cancer	DOID_162
2995	MARKS_HDAC_TARGETS_UP	17322921	disease of cellular proliferation	DOID_14566
2996	MARKS_HDAC_TARGETS_UP	17322921	hematologic cancer	DOID_2531
2997	MARKS_HDAC_TARGETS_UP	17322921	immune system cancer	DOID_0060083
2998	MARKS_HDAC_TARGETS_UP	17322921	lymphoma	DOID_0060058
2999	MARKS_HDAC_TARGETS_UP	17322921	organ system cancer	DOID_0050686
3000	MARKS_HDAC_TARGETS_DN	17322921	cancer	DOID_162
3001	MARKS_HDAC_TARGETS_DN	17322921	disease of cellular proliferation	DOID_14566
3002	MARKS_HDAC_TARGETS_DN	17322921	hematologic cancer	DOID_2531
3003	MARKS_HDAC_TARGETS_DN	17322921	immune system cancer	DOID_0060083
3004	MARKS_HDAC_TARGETS_DN	17322921	lymphoma	DOID_0060058
3005	MARKS_HDAC_TARGETS_DN	17322921	organ system cancer	DOID_0050686
3006	CHOI_ATL_STAGE_PREDICTOR	16909099	adult T-cell leukemia	DOID_0050523
3007	CHOI_ATL_STAGE_PREDICTOR	16909099	cancer	DOID_162
3008	CHOI_ATL_STAGE_PREDICTOR	16909099	disease of cellular proliferation	DOID_14566
3009	CHOI_ATL_STAGE_PREDICTOR	16909099	hematologic cancer	DOID_2531
3010	CHOI_ATL_STAGE_PREDICTOR	16909099	immune system cancer	DOID_0060083
3011	CHOI_ATL_STAGE_PREDICTOR	16909099	leukemia	DOID_1240
3012	CHOI_ATL_STAGE_PREDICTOR	16909099	lymphoblastic leukemia	DOID_1037
3013	CHOI_ATL_STAGE_PREDICTOR	16909099	lymphoid leukemia	DOID_10747
3014	CHOI_ATL_STAGE_PREDICTOR	16909099	organ system cancer	DOID_0050686
3015	CHOI_ATL_STAGE_PREDICTOR	16909099	T-cell leukemia	DOID_715
3016	WONG_ENDMETRIUM_CANCER_UP	17043662	adenocarcinoma	DOID_299
3017	WONG_ENDMETRIUM_CANCER_UP	17043662	cancer	DOID_162
3018	WONG_ENDMETRIUM_CANCER_UP	17043662	carcinoma	DOID_305
3019	WONG_ENDMETRIUM_CANCER_UP	17043662	cell type cancer	DOID_0050687
3020	WONG_ENDMETRIUM_CANCER_UP	17043662	disease of cellular proliferation	DOID_14566
3021	WONG_ENDMETRIUM_CANCER_UP	17043662	endometrial cancer	DOID_1380
3022	WONG_ENDMETRIUM_CANCER_UP	17043662	female reproductive organ cancer	DOID_120
3023	WONG_ENDMETRIUM_CANCER_UP	17043662	organ system cancer	DOID_0050686
3024	WONG_ENDMETRIUM_CANCER_UP	17043662	reproductive organ cancer	DOID_193
3025	WONG_ENDMETRIUM_CANCER_UP	17043662	uterine cancer	DOID_363
3026	WONG_ENDMETRIUM_CANCER_DN	17043662	adenocarcinoma	DOID_299
3027	WONG_ENDMETRIUM_CANCER_DN	17043662	cancer	DOID_162
3028	WONG_ENDMETRIUM_CANCER_DN	17043662	carcinoma	DOID_305
3029	WONG_ENDMETRIUM_CANCER_DN	17043662	cell type cancer	DOID_0050687
3030	WONG_ENDMETRIUM_CANCER_DN	17043662	disease of cellular proliferation	DOID_14566
3031	WONG_ENDMETRIUM_CANCER_DN	17043662	endometrial cancer	DOID_1380
3032	WONG_ENDMETRIUM_CANCER_DN	17043662	female reproductive organ cancer	DOID_120
3033	WONG_ENDMETRIUM_CANCER_DN	17043662	organ system cancer	DOID_0050686
3034	WONG_ENDMETRIUM_CANCER_DN	17043662	reproductive organ cancer	DOID_193
3035	WONG_ENDMETRIUM_CANCER_DN	17043662	uterine cancer	DOID_363
3036	ABDULRAHMAN_KIDNEY_CANCER_VHL_DN	17001320	benign neoplasm	DOID_0060072
3037	ABDULRAHMAN_KIDNEY_CANCER_VHL_DN	17001320	cancer	DOID_162
3038	ABDULRAHMAN_KIDNEY_CANCER_VHL_DN	17001320	carcinoma	DOID_305
3039	ABDULRAHMAN_KIDNEY_CANCER_VHL_DN	17001320	cell type benign neoplasm	DOID_0060084
3040	ABDULRAHMAN_KIDNEY_CANCER_VHL_DN	17001320	cell type cancer	DOID_0050687
3041	ABDULRAHMAN_KIDNEY_CANCER_VHL_DN	17001320	disease of cellular proliferation	DOID_14566
3042	ABDULRAHMAN_KIDNEY_CANCER_VHL_DN	17001320	kidney cancer	DOID_263
3043	ABDULRAHMAN_KIDNEY_CANCER_VHL_DN	17001320	organ system cancer	DOID_0050686
3044	ABDULRAHMAN_KIDNEY_CANCER_VHL_DN	17001320	phaeochromocytoma	DOID_0050771
3045	ABDULRAHMAN_KIDNEY_CANCER_VHL_DN	17001320	renal carcinoma	DOID_4451
3046	ABDULRAHMAN_KIDNEY_CANCER_VHL_DN	17001320	renal cell carcinoma	DOID_4450
3047	ABDULRAHMAN_KIDNEY_CANCER_VHL_DN	17001320	syndrome	DOID_225
3048	ABDULRAHMAN_KIDNEY_CANCER_VHL_DN	17001320	urinary system cancer	DOID_3996
3049	TANAKA_METHYLATED_IN_ESOPHAGEAL_CARCINOMA	17438526	cancer	DOID_162
3050	TANAKA_METHYLATED_IN_ESOPHAGEAL_CARCINOMA	17438526	carcinoma	DOID_305
3051	TANAKA_METHYLATED_IN_ESOPHAGEAL_CARCINOMA	17438526	cell type cancer	DOID_0050687
3052	TANAKA_METHYLATED_IN_ESOPHAGEAL_CARCINOMA	17438526	disease of cellular proliferation	DOID_14566
3053	EGUCHI_CELL_CYCLE_RB1_TARGETS	16862181	cancer	DOID_162
3054	EGUCHI_CELL_CYCLE_RB1_TARGETS	16862181	disease of anatomical entity	DOID_7
3055	EGUCHI_CELL_CYCLE_RB1_TARGETS	16862181	disease of cellular proliferation	DOID_14566
3056	EGUCHI_CELL_CYCLE_RB1_TARGETS	16862181	eye and adnexa disease	DOID_1492
3057	EGUCHI_CELL_CYCLE_RB1_TARGETS	16862181	eye disease	DOID_5614
3058	EGUCHI_CELL_CYCLE_RB1_TARGETS	16862181	globe disease	DOID_1242
3059	EGUCHI_CELL_CYCLE_RB1_TARGETS	16862181	nervous system cancer	DOID_3093
3060	EGUCHI_CELL_CYCLE_RB1_TARGETS	16862181	nervous system disease	DOID_863
3061	EGUCHI_CELL_CYCLE_RB1_TARGETS	16862181	ocular cancer	DOID_2174
3062	EGUCHI_CELL_CYCLE_RB1_TARGETS	16862181	organ system cancer	DOID_0050686
3063	EGUCHI_CELL_CYCLE_RB1_TARGETS	16862181	retinal cancer	DOID_4645
3064	EGUCHI_CELL_CYCLE_RB1_TARGETS	16862181	retinal cell cancer	DOID_771
3065	EGUCHI_CELL_CYCLE_RB1_TARGETS	16862181	retinal disease	DOID_5679
3066	EGUCHI_CELL_CYCLE_RB1_TARGETS	16862181	retinoblastoma	DOID_768
3067	EGUCHI_CELL_CYCLE_RB1_TARGETS	16862181	sensory system cancer	DOID_0060116
3068	EGUCHI_CELL_CYCLE_RB1_TARGETS	16862181	sensory system disease	DOID_0050155
3069	CHASSOT_SKIN_WOUND	17404577	NA	NA
3070	LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_UP	17533364	autonomic nervous system neoplasm	DOID_2621
3071	LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_UP	17533364	cancer	DOID_162
3072	LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_UP	17533364	disease of cellular proliferation	DOID_14566
3073	LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_UP	17533364	nervous system cancer	DOID_3093
3074	LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_UP	17533364	neuroblastoma	DOID_769
3075	LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_UP	17533364	organ system cancer	DOID_0050686
3076	LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_UP	17533364	peripheral nervous system neoplasm	DOID_1192
3077	LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN	17533364	autonomic nervous system neoplasm	DOID_2621
3078	LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN	17533364	cancer	DOID_162
3079	LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN	17533364	disease of cellular proliferation	DOID_14566
3080	LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN	17533364	nervous system cancer	DOID_3093
3081	LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN	17533364	neuroblastoma	DOID_769
3082	LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN	17533364	organ system cancer	DOID_0050686
3083	LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN	17533364	peripheral nervous system neoplasm	DOID_1192
3084	MUELLER_METHYLATED_IN_GLIOBLASTOMA	16909125	astrocytoma	DOID_3069
3085	MUELLER_METHYLATED_IN_GLIOBLASTOMA	16909125	cancer	DOID_162
3086	MUELLER_METHYLATED_IN_GLIOBLASTOMA	16909125	cell type cancer	DOID_0050687
3087	MUELLER_METHYLATED_IN_GLIOBLASTOMA	16909125	disease of cellular proliferation	DOID_14566
3088	MUELLER_METHYLATED_IN_GLIOBLASTOMA	16909125	glioblastoma	DOID_3068
3089	MUELLER_METHYLATED_IN_GLIOBLASTOMA	16909125	malignant glioma	DOID_3070
3090	EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_UP	17525748	alveolar rhabdomyosarcoma	DOID_4051
3091	EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_UP	17525748	cancer	DOID_162
3092	EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_UP	17525748	disease of cellular proliferation	DOID_14566
3093	EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_UP	17525748	muscle cancer	DOID_4045
3094	EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_UP	17525748	musculoskeletal system cancer	DOID_0060100
3095	EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_UP	17525748	organ system cancer	DOID_0050686
3096	EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_UP	17525748	rhabdomyosarcoma	DOID_3247
3097	EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_UP	17525748	skeletal muscle cancer	DOID_4043
3098	PEREZ_TP63_TARGETS	17563751	NA	NA
3099	PEREZ_TP53_AND_TP63_TARGETS	17563751	NA	NA
3100	WAKASUGI_HAVE_ZNF143_BINDING_SITES	17297437	cancer	DOID_162
3101	WAKASUGI_HAVE_ZNF143_BINDING_SITES	17297437	disease of cellular proliferation	DOID_14566
3102	WAKASUGI_HAVE_ZNF143_BINDING_SITES	17297437	male reproductive organ cancer	DOID_3856
3103	WAKASUGI_HAVE_ZNF143_BINDING_SITES	17297437	organ system cancer	DOID_0050686
3104	WAKASUGI_HAVE_ZNF143_BINDING_SITES	17297437	prostate cancer	DOID_10283
3105	WAKASUGI_HAVE_ZNF143_BINDING_SITES	17297437	reproductive organ cancer	DOID_193
3106	RODRIGUES_NTN1_AND_DCC_TARGETS	17334389	cancer	DOID_162
3107	RODRIGUES_NTN1_AND_DCC_TARGETS	17334389	colon cancer	DOID_219
3108	RODRIGUES_NTN1_AND_DCC_TARGETS	17334389	colorectal cancer	DOID_9256
3109	RODRIGUES_NTN1_AND_DCC_TARGETS	17334389	disease of cellular proliferation	DOID_14566
3110	RODRIGUES_NTN1_AND_DCC_TARGETS	17334389	gastrointestinal system cancer	DOID_3119
3111	RODRIGUES_NTN1_AND_DCC_TARGETS	17334389	intestinal cancer	DOID_10155
3112	RODRIGUES_NTN1_AND_DCC_TARGETS	17334389	large intestine cancer	DOID_5672
3113	RODRIGUES_NTN1_AND_DCC_TARGETS	17334389	organ system cancer	DOID_0050686
3114	DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_UP	15608684	autosomal dominant disease	DOID_0050736
3115	DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_UP	15608684	autosomal genetic disease	DOID_0050739
3116	DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_UP	15608684	autosomal recessive disease	DOID_0050737
3117	DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_UP	15608684	cancer	DOID_162
3118	DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_UP	15608684	Cockayne syndrome	DOID_2962
3119	DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_UP	15608684	disease of cellular proliferation	DOID_14566
3120	DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_UP	15608684	genetic disease	DOID_630
3121	DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_UP	15608684	group B streptococcal pneumonia	DOID_12017
3122	DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_UP	15608684	integumentary system cancer	DOID_0060122
3123	DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_UP	15608684	monogenic disease	DOID_0050177
3124	DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_UP	15608684	organ system cancer	DOID_0050686
3125	DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_UP	15608684	photosensitive trichothiodystrophy	DOID_2960
3126	DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_UP	15608684	skin cancer	DOID_4159
3127	DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_UP	15608684	syndrome	DOID_225
3128	DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_UP	15608684	xeroderma pigmentosum	DOID_0050427
3129	DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN	15608684	autosomal dominant disease	DOID_0050736
3130	DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN	15608684	autosomal genetic disease	DOID_0050739
3131	DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN	15608684	autosomal recessive disease	DOID_0050737
3132	DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN	15608684	cancer	DOID_162
3133	DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN	15608684	Cockayne syndrome	DOID_2962
3134	DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN	15608684	disease of cellular proliferation	DOID_14566
3135	DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN	15608684	genetic disease	DOID_630
3136	DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN	15608684	group B streptococcal pneumonia	DOID_12017
3137	DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN	15608684	integumentary system cancer	DOID_0060122
3138	DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN	15608684	monogenic disease	DOID_0050177
3139	DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN	15608684	organ system cancer	DOID_0050686
3140	DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN	15608684	photosensitive trichothiodystrophy	DOID_2960
3141	DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN	15608684	skin cancer	DOID_4159
3142	DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN	15608684	syndrome	DOID_225
3143	DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN	15608684	xeroderma pigmentosum	DOID_0050427
3144	DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_UP	15608684	autosomal dominant disease	DOID_0050736
3145	DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_UP	15608684	autosomal genetic disease	DOID_0050739
3146	DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_UP	15608684	autosomal recessive disease	DOID_0050737
3147	DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_UP	15608684	cancer	DOID_162
3148	DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_UP	15608684	Cockayne syndrome	DOID_2962
3149	DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_UP	15608684	disease of cellular proliferation	DOID_14566
3150	DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_UP	15608684	genetic disease	DOID_630
3151	DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_UP	15608684	group B streptococcal pneumonia	DOID_12017
3152	DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_UP	15608684	integumentary system cancer	DOID_0060122
3153	DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_UP	15608684	monogenic disease	DOID_0050177
3154	DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_UP	15608684	organ system cancer	DOID_0050686
3155	DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_UP	15608684	photosensitive trichothiodystrophy	DOID_2960
3156	DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_UP	15608684	skin cancer	DOID_4159
3157	DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_UP	15608684	syndrome	DOID_225
3158	DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_UP	15608684	xeroderma pigmentosum	DOID_0050427
3159	DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_DN	15608684	autosomal dominant disease	DOID_0050736
3160	DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_DN	15608684	autosomal genetic disease	DOID_0050739
3161	DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_DN	15608684	autosomal recessive disease	DOID_0050737
3162	DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_DN	15608684	cancer	DOID_162
3163	DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_DN	15608684	Cockayne syndrome	DOID_2962
3164	DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_DN	15608684	disease of cellular proliferation	DOID_14566
3165	DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_DN	15608684	genetic disease	DOID_630
3166	DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_DN	15608684	group B streptococcal pneumonia	DOID_12017
3167	DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_DN	15608684	integumentary system cancer	DOID_0060122
3168	DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_DN	15608684	monogenic disease	DOID_0050177
3169	DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_DN	15608684	organ system cancer	DOID_0050686
3170	DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_DN	15608684	photosensitive trichothiodystrophy	DOID_2960
3171	DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_DN	15608684	skin cancer	DOID_4159
3172	DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_DN	15608684	syndrome	DOID_225
3173	DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_DN	15608684	xeroderma pigmentosum	DOID_0050427
3174	TURJANSKI_MAPK1_AND_MAPK2_TARGETS	17496919	NA	NA
3175	MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH	17325667	cancer	DOID_162
3176	MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH	17325667	disease of cellular proliferation	DOID_14566
3177	MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH	17325667	gastrointestinal stromal tumor	DOID_9253
3178	MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH	17325667	gastrointestinal system cancer	DOID_3119
3179	MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH	17325667	organ system cancer	DOID_0050686
3180	MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH	17325667	stromal neoplasm	DOID_2991
3181	MAHADEVAN_RESPONSE_TO_MP470_DN	17325667	cancer	DOID_162
3182	MAHADEVAN_RESPONSE_TO_MP470_DN	17325667	disease of cellular proliferation	DOID_14566
3183	MAHADEVAN_RESPONSE_TO_MP470_DN	17325667	gastrointestinal stromal tumor	DOID_9253
3184	MAHADEVAN_RESPONSE_TO_MP470_DN	17325667	gastrointestinal system cancer	DOID_3119
3185	MAHADEVAN_RESPONSE_TO_MP470_DN	17325667	organ system cancer	DOID_0050686
3186	MAHADEVAN_RESPONSE_TO_MP470_DN	17325667	stromal neoplasm	DOID_2991
3187	MAHADEVAN_RESPONSE_TO_MP470_UP	17325667	cancer	DOID_162
3188	MAHADEVAN_RESPONSE_TO_MP470_UP	17325667	disease of cellular proliferation	DOID_14566
3189	MAHADEVAN_RESPONSE_TO_MP470_UP	17325667	gastrointestinal stromal tumor	DOID_9253
3190	MAHADEVAN_RESPONSE_TO_MP470_UP	17325667	gastrointestinal system cancer	DOID_3119
3191	MAHADEVAN_RESPONSE_TO_MP470_UP	17325667	organ system cancer	DOID_0050686
3192	MAHADEVAN_RESPONSE_TO_MP470_UP	17325667	stromal neoplasm	DOID_2991
3193	APPIERTO_RESPONSE_TO_FENRETINIDE_UP	17213814	cancer	DOID_162
3194	APPIERTO_RESPONSE_TO_FENRETINIDE_UP	17213814	carcinoma	DOID_305
3195	APPIERTO_RESPONSE_TO_FENRETINIDE_UP	17213814	cell type cancer	DOID_0050687
3196	APPIERTO_RESPONSE_TO_FENRETINIDE_UP	17213814	disease of cellular proliferation	DOID_14566
3197	APPIERTO_RESPONSE_TO_FENRETINIDE_UP	17213814	female reproductive organ cancer	DOID_120
3198	APPIERTO_RESPONSE_TO_FENRETINIDE_UP	17213814	malignant ovarian surface epithelial-stromal neoplasm	DOID_2151
3199	APPIERTO_RESPONSE_TO_FENRETINIDE_UP	17213814	organ system cancer	DOID_0050686
3200	APPIERTO_RESPONSE_TO_FENRETINIDE_UP	17213814	ovarian cancer	DOID_2394
3201	APPIERTO_RESPONSE_TO_FENRETINIDE_UP	17213814	ovarian carcinoma	DOID_4001
3202	APPIERTO_RESPONSE_TO_FENRETINIDE_UP	17213814	ovary epithelial cancer	DOID_2152
3203	APPIERTO_RESPONSE_TO_FENRETINIDE_UP	17213814	reproductive organ cancer	DOID_193
3204	APPIERTO_RESPONSE_TO_FENRETINIDE_DN	17213814	cancer	DOID_162
3205	APPIERTO_RESPONSE_TO_FENRETINIDE_DN	17213814	carcinoma	DOID_305
3206	APPIERTO_RESPONSE_TO_FENRETINIDE_DN	17213814	cell type cancer	DOID_0050687
3207	APPIERTO_RESPONSE_TO_FENRETINIDE_DN	17213814	disease of cellular proliferation	DOID_14566
3208	APPIERTO_RESPONSE_TO_FENRETINIDE_DN	17213814	female reproductive organ cancer	DOID_120
3209	APPIERTO_RESPONSE_TO_FENRETINIDE_DN	17213814	malignant ovarian surface epithelial-stromal neoplasm	DOID_2151
3210	APPIERTO_RESPONSE_TO_FENRETINIDE_DN	17213814	organ system cancer	DOID_0050686
3211	APPIERTO_RESPONSE_TO_FENRETINIDE_DN	17213814	ovarian cancer	DOID_2394
3212	APPIERTO_RESPONSE_TO_FENRETINIDE_DN	17213814	ovarian carcinoma	DOID_4001
3213	APPIERTO_RESPONSE_TO_FENRETINIDE_DN	17213814	ovary epithelial cancer	DOID_2152
3214	APPIERTO_RESPONSE_TO_FENRETINIDE_DN	17213814	reproductive organ cancer	DOID_193
3215	NAGY_TFTC_COMPONENTS_HUMAN	17694077	NA	NA
3216	SEIDEN_MET_SIGNALING	16158056	cancer	DOID_162
3217	SEIDEN_MET_SIGNALING	16158056	colon cancer	DOID_219
3218	SEIDEN_MET_SIGNALING	16158056	colorectal cancer	DOID_9256
3219	SEIDEN_MET_SIGNALING	16158056	disease of cellular proliferation	DOID_14566
3220	SEIDEN_MET_SIGNALING	16158056	gastrointestinal system cancer	DOID_3119
3221	SEIDEN_MET_SIGNALING	16158056	intestinal cancer	DOID_10155
3222	SEIDEN_MET_SIGNALING	16158056	large intestine cancer	DOID_5672
3223	SEIDEN_MET_SIGNALING	16158056	organ system cancer	DOID_0050686
3224	AUNG_GASTRIC_CANCER	16331256	cancer	DOID_162
3225	AUNG_GASTRIC_CANCER	16331256	cell type cancer	DOID_0050687
3226	AUNG_GASTRIC_CANCER	16331256	disease of cellular proliferation	DOID_14566
3227	AUNG_GASTRIC_CANCER	16331256	melanoma	DOID_1909
3228	SANCHEZ_MDM2_TARGETS	16331255	cancer	DOID_162
3229	SANCHEZ_MDM2_TARGETS	16331255	disease of cellular proliferation	DOID_14566
3230	SANCHEZ_MDM2_TARGETS	16331255	hematologic cancer	DOID_2531
3231	SANCHEZ_MDM2_TARGETS	16331255	Hodgkin's lymphoma	DOID_8567
3232	SANCHEZ_MDM2_TARGETS	16331255	immune system cancer	DOID_0060083
3233	SANCHEZ_MDM2_TARGETS	16331255	lymphoma	DOID_0060058
3234	SANCHEZ_MDM2_TARGETS	16331255	organ system cancer	DOID_0050686
3235	BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER	16799620	cancer	DOID_162
3236	BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER	16799620	carcinoma	DOID_305
3237	BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER	16799620	cell type cancer	DOID_0050687
3238	BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER	16799620	disease of cellular proliferation	DOID_14566
3239	BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER	16799620	gastrointestinal system cancer	DOID_3119
3240	BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER	16799620	hepatocellular carcinoma	DOID_684
3241	BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER	16799620	liver cancer	DOID_3571
3242	BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER	16799620	liver carcinoma	DOID_686
3243	BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER	16799620	organ system cancer	DOID_0050686
3244	GALLUZZI_PERMEABILIZE_MITOCHONDRIA	16892093	cancer	DOID_162
3245	GALLUZZI_PERMEABILIZE_MITOCHONDRIA	16892093	disease of cellular proliferation	DOID_14566
3246	MATHEW_FANCONI_ANEMIA_GENES	16998502	acute myeloid leukemia	DOID_9119
3247	MATHEW_FANCONI_ANEMIA_GENES	16998502	anemia	DOID_2355
3248	MATHEW_FANCONI_ANEMIA_GENES	16998502	autosomal dominant disease	DOID_0050736
3249	MATHEW_FANCONI_ANEMIA_GENES	16998502	autosomal genetic disease	DOID_0050739
3250	MATHEW_FANCONI_ANEMIA_GENES	16998502	cancer	DOID_162
3251	MATHEW_FANCONI_ANEMIA_GENES	16998502	disease of anatomical entity	DOID_7
3252	MATHEW_FANCONI_ANEMIA_GENES	16998502	disease of cellular proliferation	DOID_14566
3253	MATHEW_FANCONI_ANEMIA_GENES	16998502	genetic disease	DOID_630
3254	MATHEW_FANCONI_ANEMIA_GENES	16998502	hematologic cancer	DOID_2531
3255	MATHEW_FANCONI_ANEMIA_GENES	16998502	hematopoietic system disease	DOID_74
3256	MATHEW_FANCONI_ANEMIA_GENES	16998502	hereditary breast ovarian cancer	DOID_5683
3257	MATHEW_FANCONI_ANEMIA_GENES	16998502	immune system cancer	DOID_0060083
3258	MATHEW_FANCONI_ANEMIA_GENES	16998502	immune system disease	DOID_2914
3259	MATHEW_FANCONI_ANEMIA_GENES	16998502	leukemia	DOID_1240
3260	MATHEW_FANCONI_ANEMIA_GENES	16998502	monogenic disease	DOID_0050177
3261	MATHEW_FANCONI_ANEMIA_GENES	16998502	myeloid leukemia	DOID_8692
3262	MATHEW_FANCONI_ANEMIA_GENES	16998502	organ system cancer	DOID_0050686
3263	MIDORIKAWA_AMPLIFIED_IN_LIVER_CANCER	16785998	cancer	DOID_162
3264	MIDORIKAWA_AMPLIFIED_IN_LIVER_CANCER	16785998	carcinoma	DOID_305
3265	MIDORIKAWA_AMPLIFIED_IN_LIVER_CANCER	16785998	cell type cancer	DOID_0050687
3266	MIDORIKAWA_AMPLIFIED_IN_LIVER_CANCER	16785998	disease of cellular proliferation	DOID_14566
3267	MIDORIKAWA_AMPLIFIED_IN_LIVER_CANCER	16785998	gastrointestinal system cancer	DOID_3119
3268	MIDORIKAWA_AMPLIFIED_IN_LIVER_CANCER	16785998	hepatocellular carcinoma	DOID_684
3269	MIDORIKAWA_AMPLIFIED_IN_LIVER_CANCER	16785998	liver cancer	DOID_3571
3270	MIDORIKAWA_AMPLIFIED_IN_LIVER_CANCER	16785998	liver carcinoma	DOID_686
3271	MIDORIKAWA_AMPLIFIED_IN_LIVER_CANCER	16785998	organ system cancer	DOID_0050686
3272	SCHEIDEREIT_IKK_TARGETS	17072322	NA	NA
3273	DUTTA_APOPTOSIS_VIA_NFKB	17072329	cancer	DOID_162
3274	DUTTA_APOPTOSIS_VIA_NFKB	17072329	disease of cellular proliferation	DOID_14566
3275	ROVERSI_GLIOMA_COPY_NUMBER_DN	16247447	astrocytoma	DOID_3069
3276	ROVERSI_GLIOMA_COPY_NUMBER_DN	16247447	cancer	DOID_162
3277	ROVERSI_GLIOMA_COPY_NUMBER_DN	16247447	cell type cancer	DOID_0050687
3278	ROVERSI_GLIOMA_COPY_NUMBER_DN	16247447	disease of cellular proliferation	DOID_14566
3279	ROVERSI_GLIOMA_COPY_NUMBER_DN	16247447	glioblastoma	DOID_3068
3280	ROVERSI_GLIOMA_COPY_NUMBER_DN	16247447	malignant glioma	DOID_3070
3281	SEIDEN_ONCOGENESIS_BY_MET	16158056	cancer	DOID_162
3282	SEIDEN_ONCOGENESIS_BY_MET	16158056	colon cancer	DOID_219
3283	SEIDEN_ONCOGENESIS_BY_MET	16158056	colorectal cancer	DOID_9256
3284	SEIDEN_ONCOGENESIS_BY_MET	16158056	disease of cellular proliferation	DOID_14566
3285	SEIDEN_ONCOGENESIS_BY_MET	16158056	gastrointestinal system cancer	DOID_3119
3286	SEIDEN_ONCOGENESIS_BY_MET	16158056	intestinal cancer	DOID_10155
3287	SEIDEN_ONCOGENESIS_BY_MET	16158056	large intestine cancer	DOID_5672
3288	SEIDEN_ONCOGENESIS_BY_MET	16158056	organ system cancer	DOID_0050686
3289	CAVARD_LIVER_CANCER_MALIGNANT_VS_BENIGN	16314847	adenoma	DOID_657
3290	CAVARD_LIVER_CANCER_MALIGNANT_VS_BENIGN	16314847	benign neoplasm	DOID_0060072
3291	CAVARD_LIVER_CANCER_MALIGNANT_VS_BENIGN	16314847	cancer	DOID_162
3292	CAVARD_LIVER_CANCER_MALIGNANT_VS_BENIGN	16314847	carcinoma	DOID_305
3293	CAVARD_LIVER_CANCER_MALIGNANT_VS_BENIGN	16314847	cell type benign neoplasm	DOID_0060084
3294	CAVARD_LIVER_CANCER_MALIGNANT_VS_BENIGN	16314847	cell type cancer	DOID_0050687
3295	CAVARD_LIVER_CANCER_MALIGNANT_VS_BENIGN	16314847	disease of cellular proliferation	DOID_14566
3296	CAVARD_LIVER_CANCER_MALIGNANT_VS_BENIGN	16314847	gastrointestinal system cancer	DOID_3119
3297	CAVARD_LIVER_CANCER_MALIGNANT_VS_BENIGN	16314847	hepatoblastoma	DOID_687
3298	CAVARD_LIVER_CANCER_MALIGNANT_VS_BENIGN	16314847	hepatocellular carcinoma	DOID_684
3299	CAVARD_LIVER_CANCER_MALIGNANT_VS_BENIGN	16314847	liver cancer	DOID_3571
3300	CAVARD_LIVER_CANCER_MALIGNANT_VS_BENIGN	16314847	liver carcinoma	DOID_686
3301	CAVARD_LIVER_CANCER_MALIGNANT_VS_BENIGN	16314847	organ system cancer	DOID_0050686
3302	KLEIN_TARGETS_OF_BCR_ABL1_FUSION	16205638	cancer	DOID_162
3303	KLEIN_TARGETS_OF_BCR_ABL1_FUSION	16205638	disease of cellular proliferation	DOID_14566
3304	KLEIN_TARGETS_OF_BCR_ABL1_FUSION	16205638	hematologic cancer	DOID_2531
3305	KLEIN_TARGETS_OF_BCR_ABL1_FUSION	16205638	immune system cancer	DOID_0060083
3306	KLEIN_TARGETS_OF_BCR_ABL1_FUSION	16205638	leukemia	DOID_1240
3307	KLEIN_TARGETS_OF_BCR_ABL1_FUSION	16205638	lymphoblastic leukemia	DOID_1037
3308	KLEIN_TARGETS_OF_BCR_ABL1_FUSION	16205638	organ system cancer	DOID_0050686
3309	ROVERSI_GLIOMA_LOH_REGIONS	16247447	astrocytoma	DOID_3069
3310	ROVERSI_GLIOMA_LOH_REGIONS	16247447	cancer	DOID_162
3311	ROVERSI_GLIOMA_LOH_REGIONS	16247447	cell type cancer	DOID_0050687
3312	ROVERSI_GLIOMA_LOH_REGIONS	16247447	disease of cellular proliferation	DOID_14566
3313	ROVERSI_GLIOMA_LOH_REGIONS	16247447	glioblastoma	DOID_3068
3314	ROVERSI_GLIOMA_LOH_REGIONS	16247447	malignant glioma	DOID_3070
3315	ROVERSI_GLIOMA_COPY_NUMBER_UP	16247447	astrocytoma	DOID_3069
3316	ROVERSI_GLIOMA_COPY_NUMBER_UP	16247447	cancer	DOID_162
3317	ROVERSI_GLIOMA_COPY_NUMBER_UP	16247447	cell type cancer	DOID_0050687
3318	ROVERSI_GLIOMA_COPY_NUMBER_UP	16247447	disease of cellular proliferation	DOID_14566
3319	ROVERSI_GLIOMA_COPY_NUMBER_UP	16247447	glioblastoma	DOID_3068
3320	ROVERSI_GLIOMA_COPY_NUMBER_UP	16247447	malignant glioma	DOID_3070
3321	AIGNER_ZEB1_TARGETS	17486063	breast cancer	DOID_1612
3322	AIGNER_ZEB1_TARGETS	17486063	cancer	DOID_162
3323	AIGNER_ZEB1_TARGETS	17486063	colorectal cancer	DOID_9256
3324	AIGNER_ZEB1_TARGETS	17486063	disease of cellular proliferation	DOID_14566
3325	AIGNER_ZEB1_TARGETS	17486063	gastrointestinal system cancer	DOID_3119
3326	AIGNER_ZEB1_TARGETS	17486063	intestinal cancer	DOID_10155
3327	AIGNER_ZEB1_TARGETS	17486063	large intestine cancer	DOID_5672
3328	AIGNER_ZEB1_TARGETS	17486063	organ system cancer	DOID_0050686
3329	AIGNER_ZEB1_TARGETS	17486063	thoracic cancer	DOID_5093
3330	SUZUKI_AMPLIFIED_IN_ORAL_CANCER	17599052	cancer	DOID_162
3331	SUZUKI_AMPLIFIED_IN_ORAL_CANCER	17599052	carcinoma	DOID_305
3332	SUZUKI_AMPLIFIED_IN_ORAL_CANCER	17599052	cell type cancer	DOID_0050687
3333	SUZUKI_AMPLIFIED_IN_ORAL_CANCER	17599052	disease of cellular proliferation	DOID_14566
3334	LASTOWSKA_COAMPLIFIED_WITH_MYCN	17533364	autonomic nervous system neoplasm	DOID_2621
3335	LASTOWSKA_COAMPLIFIED_WITH_MYCN	17533364	cancer	DOID_162
3336	LASTOWSKA_COAMPLIFIED_WITH_MYCN	17533364	disease of cellular proliferation	DOID_14566
3337	LASTOWSKA_COAMPLIFIED_WITH_MYCN	17533364	nervous system cancer	DOID_3093
3338	LASTOWSKA_COAMPLIFIED_WITH_MYCN	17533364	neuroblastoma	DOID_769
3339	LASTOWSKA_COAMPLIFIED_WITH_MYCN	17533364	organ system cancer	DOID_0050686
3340	LASTOWSKA_COAMPLIFIED_WITH_MYCN	17533364	peripheral nervous system neoplasm	DOID_1192
3341	LI_LUNG_CANCER	16369491	adenocarcinoma	DOID_299
3342	LI_LUNG_CANCER	16369491	cancer	DOID_162
3343	LI_LUNG_CANCER	16369491	carcinoma	DOID_305
3344	LI_LUNG_CANCER	16369491	cell type cancer	DOID_0050687
3345	LI_LUNG_CANCER	16369491	disease of cellular proliferation	DOID_14566
3346	LI_LUNG_CANCER	16369491	lung adenocarcinoma	DOID_3910
3347	LI_LUNG_CANCER	16369491	lung cancer	DOID_1324
3348	LI_LUNG_CANCER	16369491	lung carcinoma	DOID_3905
3349	LI_LUNG_CANCER	16369491	non-small cell lung carcinoma	DOID_3908
3350	LI_LUNG_CANCER	16369491	organ system cancer	DOID_0050686
3351	LI_LUNG_CANCER	16369491	respiratory system cancer	DOID_0050615
3352	LI_AMPLIFIED_IN_LUNG_CANCER	16369491	adenocarcinoma	DOID_299
3353	LI_AMPLIFIED_IN_LUNG_CANCER	16369491	cancer	DOID_162
3354	LI_AMPLIFIED_IN_LUNG_CANCER	16369491	carcinoma	DOID_305
3355	LI_AMPLIFIED_IN_LUNG_CANCER	16369491	cell type cancer	DOID_0050687
3356	LI_AMPLIFIED_IN_LUNG_CANCER	16369491	disease of cellular proliferation	DOID_14566
3357	LI_AMPLIFIED_IN_LUNG_CANCER	16369491	lung adenocarcinoma	DOID_3910
3358	LI_AMPLIFIED_IN_LUNG_CANCER	16369491	lung cancer	DOID_1324
3359	LI_AMPLIFIED_IN_LUNG_CANCER	16369491	lung carcinoma	DOID_3905
3360	LI_AMPLIFIED_IN_LUNG_CANCER	16369491	non-small cell lung carcinoma	DOID_3908
3361	LI_AMPLIFIED_IN_LUNG_CANCER	16369491	organ system cancer	DOID_0050686
3362	LI_AMPLIFIED_IN_LUNG_CANCER	16369491	respiratory system cancer	DOID_0050615
3363	LINDGREN_BLADDER_CANCER_CLUSTER_2B	16532037	cancer	DOID_162
3364	LINDGREN_BLADDER_CANCER_CLUSTER_2B	16532037	carcinoma	DOID_305
3365	LINDGREN_BLADDER_CANCER_CLUSTER_2B	16532037	cell type cancer	DOID_0050687
3366	LINDGREN_BLADDER_CANCER_CLUSTER_2B	16532037	disease of cellular proliferation	DOID_14566
3367	LINDGREN_BLADDER_CANCER_HIGH_RECURRENCE	16532037	cancer	DOID_162
3368	LINDGREN_BLADDER_CANCER_HIGH_RECURRENCE	16532037	carcinoma	DOID_305
3369	LINDGREN_BLADDER_CANCER_HIGH_RECURRENCE	16532037	cell type cancer	DOID_0050687
3370	LINDGREN_BLADDER_CANCER_HIGH_RECURRENCE	16532037	disease of cellular proliferation	DOID_14566
3371	LINDGREN_BLADDER_CANCER_WITH_LOH_IN_CHR9Q	16532037	cancer	DOID_162
3372	LINDGREN_BLADDER_CANCER_WITH_LOH_IN_CHR9Q	16532037	carcinoma	DOID_305
3373	LINDGREN_BLADDER_CANCER_WITH_LOH_IN_CHR9Q	16532037	cell type cancer	DOID_0050687
3374	LINDGREN_BLADDER_CANCER_WITH_LOH_IN_CHR9Q	16532037	disease of cellular proliferation	DOID_14566
3375	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_17	16751803	cancer	DOID_162
3376	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_17	16751803	disease of cellular proliferation	DOID_14566
3377	EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_DN	17525748	alveolar rhabdomyosarcoma	DOID_4051
3378	EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_DN	17525748	cancer	DOID_162
3379	EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_DN	17525748	disease of cellular proliferation	DOID_14566
3380	EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_DN	17525748	muscle cancer	DOID_4045
3381	EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_DN	17525748	musculoskeletal system cancer	DOID_0060100
3382	EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_DN	17525748	organ system cancer	DOID_0050686
3383	EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_DN	17525748	rhabdomyosarcoma	DOID_3247
3384	EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_DN	17525748	skeletal muscle cancer	DOID_4043
3385	EBAUER_MYOGENIC_TARGETS_OF_PAX3_FOXO1_FUSION	17525748	alveolar rhabdomyosarcoma	DOID_4051
3386	EBAUER_MYOGENIC_TARGETS_OF_PAX3_FOXO1_FUSION	17525748	cancer	DOID_162
3387	EBAUER_MYOGENIC_TARGETS_OF_PAX3_FOXO1_FUSION	17525748	disease of cellular proliferation	DOID_14566
3388	EBAUER_MYOGENIC_TARGETS_OF_PAX3_FOXO1_FUSION	17525748	muscle cancer	DOID_4045
3389	EBAUER_MYOGENIC_TARGETS_OF_PAX3_FOXO1_FUSION	17525748	musculoskeletal system cancer	DOID_0060100
3390	EBAUER_MYOGENIC_TARGETS_OF_PAX3_FOXO1_FUSION	17525748	organ system cancer	DOID_0050686
3391	EBAUER_MYOGENIC_TARGETS_OF_PAX3_FOXO1_FUSION	17525748	rhabdomyosarcoma	DOID_3247
3392	EBAUER_MYOGENIC_TARGETS_OF_PAX3_FOXO1_FUSION	17525748	skeletal muscle cancer	DOID_4043
3393	SCHAVOLT_TARGETS_OF_TP53_AND_TP63	17404570	NA	NA
3394	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_23	16751803	cancer	DOID_162
3395	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_23	16751803	disease of cellular proliferation	DOID_14566
3396	MATTIOLI_MGUS_VS_PCL	15735737	B-cell lymphocytic neoplasm	DOID_707
3397	MATTIOLI_MGUS_VS_PCL	15735737	bone marrow cancer	DOID_4960
3398	MATTIOLI_MGUS_VS_PCL	15735737	cancer	DOID_162
3399	MATTIOLI_MGUS_VS_PCL	15735737	disease of cellular proliferation	DOID_14566
3400	MATTIOLI_MGUS_VS_PCL	15735737	hematologic cancer	DOID_2531
3401	MATTIOLI_MGUS_VS_PCL	15735737	immune system cancer	DOID_0060083
3402	MATTIOLI_MGUS_VS_PCL	15735737	leukemia	DOID_1240
3403	MATTIOLI_MGUS_VS_PCL	15735737	lymphoma	DOID_0060058
3404	MATTIOLI_MGUS_VS_PCL	15735737	mature B-cell neoplasm	DOID_706
3405	MATTIOLI_MGUS_VS_PCL	15735737	monoclonal gammopathy of uncertain significance	DOID_7442
3406	MATTIOLI_MGUS_VS_PCL	15735737	multiple myeloma	DOID_9538
3407	MATTIOLI_MGUS_VS_PCL	15735737	myeloma	DOID_0070004
3408	MATTIOLI_MGUS_VS_PCL	15735737	organ system cancer	DOID_0050686
3409	MATTIOLI_MGUS_VS_PCL	15735737	plasma cell neoplasm	DOID_6536
3410	MATTIOLI_MGUS_VS_MULTIPLE_MYELOMA	15735737	B-cell lymphocytic neoplasm	DOID_707
3411	MATTIOLI_MGUS_VS_MULTIPLE_MYELOMA	15735737	bone marrow cancer	DOID_4960
3412	MATTIOLI_MGUS_VS_MULTIPLE_MYELOMA	15735737	cancer	DOID_162
3413	MATTIOLI_MGUS_VS_MULTIPLE_MYELOMA	15735737	disease of cellular proliferation	DOID_14566
3414	MATTIOLI_MGUS_VS_MULTIPLE_MYELOMA	15735737	hematologic cancer	DOID_2531
3415	MATTIOLI_MGUS_VS_MULTIPLE_MYELOMA	15735737	immune system cancer	DOID_0060083
3416	MATTIOLI_MGUS_VS_MULTIPLE_MYELOMA	15735737	leukemia	DOID_1240
3417	MATTIOLI_MGUS_VS_MULTIPLE_MYELOMA	15735737	lymphoma	DOID_0060058
3418	MATTIOLI_MGUS_VS_MULTIPLE_MYELOMA	15735737	mature B-cell neoplasm	DOID_706
3419	MATTIOLI_MGUS_VS_MULTIPLE_MYELOMA	15735737	monoclonal gammopathy of uncertain significance	DOID_7442
3420	MATTIOLI_MGUS_VS_MULTIPLE_MYELOMA	15735737	multiple myeloma	DOID_9538
3421	MATTIOLI_MGUS_VS_MULTIPLE_MYELOMA	15735737	myeloma	DOID_0070004
3422	MATTIOLI_MGUS_VS_MULTIPLE_MYELOMA	15735737	organ system cancer	DOID_0050686
3423	MATTIOLI_MGUS_VS_MULTIPLE_MYELOMA	15735737	plasma cell neoplasm	DOID_6536
3424	FARMER_BREAST_CANCER_APOCRINE_VS_BASAL	15897907	breast cancer	DOID_1612
3425	FARMER_BREAST_CANCER_APOCRINE_VS_BASAL	15897907	cancer	DOID_162
3426	FARMER_BREAST_CANCER_APOCRINE_VS_BASAL	15897907	disease of cellular proliferation	DOID_14566
3427	FARMER_BREAST_CANCER_APOCRINE_VS_BASAL	15897907	organ system cancer	DOID_0050686
3428	FARMER_BREAST_CANCER_APOCRINE_VS_BASAL	15897907	thoracic cancer	DOID_5093
3429	FARMER_BREAST_CANCER_BASAL_VS_LULMINAL	15897907	breast cancer	DOID_1612
3430	FARMER_BREAST_CANCER_BASAL_VS_LULMINAL	15897907	cancer	DOID_162
3431	FARMER_BREAST_CANCER_BASAL_VS_LULMINAL	15897907	disease of cellular proliferation	DOID_14566
3432	FARMER_BREAST_CANCER_BASAL_VS_LULMINAL	15897907	organ system cancer	DOID_0050686
3433	FARMER_BREAST_CANCER_BASAL_VS_LULMINAL	15897907	thoracic cancer	DOID_5093
3434	LUI_THYROID_CANCER_CLUSTER_1	15608688	adenocarcinoma	DOID_299
3435	LUI_THYROID_CANCER_CLUSTER_1	15608688	cancer	DOID_162
3436	LUI_THYROID_CANCER_CLUSTER_1	15608688	carcinoma	DOID_305
3437	LUI_THYROID_CANCER_CLUSTER_1	15608688	cell type cancer	DOID_0050687
3438	LUI_THYROID_CANCER_CLUSTER_1	15608688	disease of cellular proliferation	DOID_14566
3439	LUI_THYROID_CANCER_CLUSTER_2	15608688	adenocarcinoma	DOID_299
3440	LUI_THYROID_CANCER_CLUSTER_2	15608688	cancer	DOID_162
3441	LUI_THYROID_CANCER_CLUSTER_2	15608688	carcinoma	DOID_305
3442	LUI_THYROID_CANCER_CLUSTER_2	15608688	cell type cancer	DOID_0050687
3443	LUI_THYROID_CANCER_CLUSTER_2	15608688	disease of cellular proliferation	DOID_14566
3444	LUI_THYROID_CANCER_CLUSTER_3	15608688	adenocarcinoma	DOID_299
3445	LUI_THYROID_CANCER_CLUSTER_3	15608688	cancer	DOID_162
3446	LUI_THYROID_CANCER_CLUSTER_3	15608688	carcinoma	DOID_305
3447	LUI_THYROID_CANCER_CLUSTER_3	15608688	cell type cancer	DOID_0050687
3448	LUI_THYROID_CANCER_CLUSTER_3	15608688	disease of cellular proliferation	DOID_14566
3449	LUI_THYROID_CANCER_CLUSTER_4	15608688	adenocarcinoma	DOID_299
3450	LUI_THYROID_CANCER_CLUSTER_4	15608688	cancer	DOID_162
3451	LUI_THYROID_CANCER_CLUSTER_4	15608688	carcinoma	DOID_305
3452	LUI_THYROID_CANCER_CLUSTER_4	15608688	cell type cancer	DOID_0050687
3453	LUI_THYROID_CANCER_CLUSTER_4	15608688	disease of cellular proliferation	DOID_14566
3454	LUI_THYROID_CANCER_CLUSTER_5	15608688	adenocarcinoma	DOID_299
3455	LUI_THYROID_CANCER_CLUSTER_5	15608688	cancer	DOID_162
3456	LUI_THYROID_CANCER_CLUSTER_5	15608688	carcinoma	DOID_305
3457	LUI_THYROID_CANCER_CLUSTER_5	15608688	cell type cancer	DOID_0050687
3458	LUI_THYROID_CANCER_CLUSTER_5	15608688	disease of cellular proliferation	DOID_14566
3459	GRASEMANN_RETINOBLASTOMA_WITH_6P_AMPLIFICATION	16007192	cancer	DOID_162
3460	GRASEMANN_RETINOBLASTOMA_WITH_6P_AMPLIFICATION	16007192	disease of anatomical entity	DOID_7
3461	GRASEMANN_RETINOBLASTOMA_WITH_6P_AMPLIFICATION	16007192	disease of cellular proliferation	DOID_14566
3462	GRASEMANN_RETINOBLASTOMA_WITH_6P_AMPLIFICATION	16007192	eye and adnexa disease	DOID_1492
3463	GRASEMANN_RETINOBLASTOMA_WITH_6P_AMPLIFICATION	16007192	eye disease	DOID_5614
3464	GRASEMANN_RETINOBLASTOMA_WITH_6P_AMPLIFICATION	16007192	globe disease	DOID_1242
3465	GRASEMANN_RETINOBLASTOMA_WITH_6P_AMPLIFICATION	16007192	nervous system cancer	DOID_3093
3466	GRASEMANN_RETINOBLASTOMA_WITH_6P_AMPLIFICATION	16007192	nervous system disease	DOID_863
3467	GRASEMANN_RETINOBLASTOMA_WITH_6P_AMPLIFICATION	16007192	ocular cancer	DOID_2174
3468	GRASEMANN_RETINOBLASTOMA_WITH_6P_AMPLIFICATION	16007192	organ system cancer	DOID_0050686
3469	GRASEMANN_RETINOBLASTOMA_WITH_6P_AMPLIFICATION	16007192	retinal cancer	DOID_4645
3470	GRASEMANN_RETINOBLASTOMA_WITH_6P_AMPLIFICATION	16007192	retinal cell cancer	DOID_771
3471	GRASEMANN_RETINOBLASTOMA_WITH_6P_AMPLIFICATION	16007192	retinal disease	DOID_5679
3472	GRASEMANN_RETINOBLASTOMA_WITH_6P_AMPLIFICATION	16007192	retinoblastoma	DOID_768
3473	GRASEMANN_RETINOBLASTOMA_WITH_6P_AMPLIFICATION	16007192	sensory system cancer	DOID_0060116
3474	GRASEMANN_RETINOBLASTOMA_WITH_6P_AMPLIFICATION	16007192	sensory system disease	DOID_0050155
3475	LUI_TARGETS_OF_PAX8_PPARG_FUSION	15608688	adenocarcinoma	DOID_299
3476	LUI_TARGETS_OF_PAX8_PPARG_FUSION	15608688	cancer	DOID_162
3477	LUI_TARGETS_OF_PAX8_PPARG_FUSION	15608688	carcinoma	DOID_305
3478	LUI_TARGETS_OF_PAX8_PPARG_FUSION	15608688	cell type cancer	DOID_0050687
3479	LUI_TARGETS_OF_PAX8_PPARG_FUSION	15608688	disease of cellular proliferation	DOID_14566
3480	SCHLOSSER_SERUM_RESPONSE_UP	15516975	NA	NA
3481	SCHLOSSER_SERUM_RESPONSE_AUGMENTED_BY_MYC	15516975	NA	NA
3482	SCHLOSSER_MYC_AND_SERUM_RESPONSE_SYNERGY	15516975	NA	NA
3483	SCHLOSSER_MYC_TARGETS_REPRESSED_BY_SERUM	15516975	NA	NA
3484	SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_DN	15516975	NA	NA
3485	SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_UP	15516975	NA	NA
3486	SCHLOSSER_SERUM_RESPONSE_DN	15516975	NA	NA
3487	MATTIOLI_MULTIPLE_MYELOMA_SUBGROUPS	15735737	B-cell lymphocytic neoplasm	DOID_707
3488	MATTIOLI_MULTIPLE_MYELOMA_SUBGROUPS	15735737	bone marrow cancer	DOID_4960
3489	MATTIOLI_MULTIPLE_MYELOMA_SUBGROUPS	15735737	cancer	DOID_162
3490	MATTIOLI_MULTIPLE_MYELOMA_SUBGROUPS	15735737	disease of cellular proliferation	DOID_14566
3491	MATTIOLI_MULTIPLE_MYELOMA_SUBGROUPS	15735737	hematologic cancer	DOID_2531
3492	MATTIOLI_MULTIPLE_MYELOMA_SUBGROUPS	15735737	immune system cancer	DOID_0060083
3493	MATTIOLI_MULTIPLE_MYELOMA_SUBGROUPS	15735737	leukemia	DOID_1240
3494	MATTIOLI_MULTIPLE_MYELOMA_SUBGROUPS	15735737	lymphoma	DOID_0060058
3495	MATTIOLI_MULTIPLE_MYELOMA_SUBGROUPS	15735737	mature B-cell neoplasm	DOID_706
3496	MATTIOLI_MULTIPLE_MYELOMA_SUBGROUPS	15735737	monoclonal gammopathy of uncertain significance	DOID_7442
3497	MATTIOLI_MULTIPLE_MYELOMA_SUBGROUPS	15735737	multiple myeloma	DOID_9538
3498	MATTIOLI_MULTIPLE_MYELOMA_SUBGROUPS	15735737	myeloma	DOID_0070004
3499	MATTIOLI_MULTIPLE_MYELOMA_SUBGROUPS	15735737	organ system cancer	DOID_0050686
3500	MATTIOLI_MULTIPLE_MYELOMA_SUBGROUPS	15735737	plasma cell neoplasm	DOID_6536
3501	MATTIOLI_MULTIPLE_MYELOMA_WITH_14Q32_TRANSLOCATIONS	15735737	B-cell lymphocytic neoplasm	DOID_707
3502	MATTIOLI_MULTIPLE_MYELOMA_WITH_14Q32_TRANSLOCATIONS	15735737	bone marrow cancer	DOID_4960
3503	MATTIOLI_MULTIPLE_MYELOMA_WITH_14Q32_TRANSLOCATIONS	15735737	cancer	DOID_162
3504	MATTIOLI_MULTIPLE_MYELOMA_WITH_14Q32_TRANSLOCATIONS	15735737	disease of cellular proliferation	DOID_14566
3505	MATTIOLI_MULTIPLE_MYELOMA_WITH_14Q32_TRANSLOCATIONS	15735737	hematologic cancer	DOID_2531
3506	MATTIOLI_MULTIPLE_MYELOMA_WITH_14Q32_TRANSLOCATIONS	15735737	immune system cancer	DOID_0060083
3507	MATTIOLI_MULTIPLE_MYELOMA_WITH_14Q32_TRANSLOCATIONS	15735737	leukemia	DOID_1240
3508	MATTIOLI_MULTIPLE_MYELOMA_WITH_14Q32_TRANSLOCATIONS	15735737	lymphoma	DOID_0060058
3509	MATTIOLI_MULTIPLE_MYELOMA_WITH_14Q32_TRANSLOCATIONS	15735737	mature B-cell neoplasm	DOID_706
3510	MATTIOLI_MULTIPLE_MYELOMA_WITH_14Q32_TRANSLOCATIONS	15735737	monoclonal gammopathy of uncertain significance	DOID_7442
3511	MATTIOLI_MULTIPLE_MYELOMA_WITH_14Q32_TRANSLOCATIONS	15735737	multiple myeloma	DOID_9538
3512	MATTIOLI_MULTIPLE_MYELOMA_WITH_14Q32_TRANSLOCATIONS	15735737	myeloma	DOID_0070004
3513	MATTIOLI_MULTIPLE_MYELOMA_WITH_14Q32_TRANSLOCATIONS	15735737	organ system cancer	DOID_0050686
3514	MATTIOLI_MULTIPLE_MYELOMA_WITH_14Q32_TRANSLOCATIONS	15735737	plasma cell neoplasm	DOID_6536
3515	FARMER_BREAST_CANCER_CLUSTER_1	15897907	breast cancer	DOID_1612
3516	FARMER_BREAST_CANCER_CLUSTER_1	15897907	cancer	DOID_162
3517	FARMER_BREAST_CANCER_CLUSTER_1	15897907	disease of cellular proliferation	DOID_14566
3518	FARMER_BREAST_CANCER_CLUSTER_1	15897907	organ system cancer	DOID_0050686
3519	FARMER_BREAST_CANCER_CLUSTER_1	15897907	thoracic cancer	DOID_5093
3520	FARMER_BREAST_CANCER_CLUSTER_7	15897907	breast cancer	DOID_1612
3521	FARMER_BREAST_CANCER_CLUSTER_7	15897907	cancer	DOID_162
3522	FARMER_BREAST_CANCER_CLUSTER_7	15897907	disease of cellular proliferation	DOID_14566
3523	FARMER_BREAST_CANCER_CLUSTER_7	15897907	organ system cancer	DOID_0050686
3524	FARMER_BREAST_CANCER_CLUSTER_7	15897907	thoracic cancer	DOID_5093
3525	FARMER_BREAST_CANCER_CLUSTER_6	15897907	breast cancer	DOID_1612
3526	FARMER_BREAST_CANCER_CLUSTER_6	15897907	cancer	DOID_162
3527	FARMER_BREAST_CANCER_CLUSTER_6	15897907	disease of cellular proliferation	DOID_14566
3528	FARMER_BREAST_CANCER_CLUSTER_6	15897907	organ system cancer	DOID_0050686
3529	FARMER_BREAST_CANCER_CLUSTER_6	15897907	thoracic cancer	DOID_5093
3530	FARMER_BREAST_CANCER_CLUSTER_5	15897907	breast cancer	DOID_1612
3531	FARMER_BREAST_CANCER_CLUSTER_5	15897907	cancer	DOID_162
3532	FARMER_BREAST_CANCER_CLUSTER_5	15897907	disease of cellular proliferation	DOID_14566
3533	FARMER_BREAST_CANCER_CLUSTER_5	15897907	organ system cancer	DOID_0050686
3534	FARMER_BREAST_CANCER_CLUSTER_5	15897907	thoracic cancer	DOID_5093
3535	FARMER_BREAST_CANCER_CLUSTER_4	15897907	breast cancer	DOID_1612
3536	FARMER_BREAST_CANCER_CLUSTER_4	15897907	cancer	DOID_162
3537	FARMER_BREAST_CANCER_CLUSTER_4	15897907	disease of cellular proliferation	DOID_14566
3538	FARMER_BREAST_CANCER_CLUSTER_4	15897907	organ system cancer	DOID_0050686
3539	FARMER_BREAST_CANCER_CLUSTER_4	15897907	thoracic cancer	DOID_5093
3540	FARMER_BREAST_CANCER_CLUSTER_2	15897907	breast cancer	DOID_1612
3541	FARMER_BREAST_CANCER_CLUSTER_2	15897907	cancer	DOID_162
3542	FARMER_BREAST_CANCER_CLUSTER_2	15897907	disease of cellular proliferation	DOID_14566
3543	FARMER_BREAST_CANCER_CLUSTER_2	15897907	organ system cancer	DOID_0050686
3544	FARMER_BREAST_CANCER_CLUSTER_2	15897907	thoracic cancer	DOID_5093
3545	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER	16007141	cancer	DOID_162
3546	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER	16007141	carcinoma	DOID_305
3547	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER	16007141	cell type cancer	DOID_0050687
3548	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER	16007141	disease of cellular proliferation	DOID_14566
3549	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER	16007141	invasive carcinoma	DOID_5659
3550	SCHEIDEREIT_IKK_INTERACTING_PROTEINS	17072322	NA	NA
3551	JAERVINEN_AMPLIFIED_IN_LARYNGEAL_CANCER	16715129	cancer	DOID_162
3552	JAERVINEN_AMPLIFIED_IN_LARYNGEAL_CANCER	16715129	carcinoma	DOID_305
3553	JAERVINEN_AMPLIFIED_IN_LARYNGEAL_CANCER	16715129	cell type cancer	DOID_0050687
3554	JAERVINEN_AMPLIFIED_IN_LARYNGEAL_CANCER	16715129	disease of cellular proliferation	DOID_14566
3555	JAERVINEN_AMPLIFIED_IN_LARYNGEAL_CANCER	16715129	head and neck squamous cell carcinoma	DOID_5520
3556	JAERVINEN_AMPLIFIED_IN_LARYNGEAL_CANCER	16715129	laryngeal carcinoma	DOID_2600
3557	JAERVINEN_AMPLIFIED_IN_LARYNGEAL_CANCER	16715129	laryngeal squamous cell carcinoma	DOID_2876
3558	JAERVINEN_AMPLIFIED_IN_LARYNGEAL_CANCER	16715129	larynx cancer	DOID_2596
3559	JAERVINEN_AMPLIFIED_IN_LARYNGEAL_CANCER	16715129	organ system cancer	DOID_0050686
3560	JAERVINEN_AMPLIFIED_IN_LARYNGEAL_CANCER	16715129	respiratory system cancer	DOID_0050615
3561	JAERVINEN_AMPLIFIED_IN_LARYNGEAL_CANCER	16715129	squamous cell carcinoma	DOID_1749
3562	KOBAYASHI_RESPONSE_TO_ROMIDEPSIN	16186804	cancer	DOID_162
3563	KOBAYASHI_RESPONSE_TO_ROMIDEPSIN	16186804	cell type cancer	DOID_0050687
3564	KOBAYASHI_RESPONSE_TO_ROMIDEPSIN	16186804	combined T cell and B cell immunodeficiency	DOID_628
3565	KOBAYASHI_RESPONSE_TO_ROMIDEPSIN	16186804	disease of anatomical entity	DOID_7
3566	KOBAYASHI_RESPONSE_TO_ROMIDEPSIN	16186804	disease of cellular proliferation	DOID_14566
3567	KOBAYASHI_RESPONSE_TO_ROMIDEPSIN	16186804	immune system disease	DOID_2914
3568	KOBAYASHI_RESPONSE_TO_ROMIDEPSIN	16186804	melanoma	DOID_1909
3569	KOBAYASHI_RESPONSE_TO_ROMIDEPSIN	16186804	primary immunodeficiency disease	DOID_612
3570	KOBAYASHI_RESPONSE_TO_ROMIDEPSIN	16186804	severe combined immunodeficiency	DOID_627
3571	PATTERSON_DOCETAXEL_RESISTANCE	16652143	cancer	DOID_162
3572	PATTERSON_DOCETAXEL_RESISTANCE	16652143	disease of cellular proliferation	DOID_14566
3573	PATTERSON_DOCETAXEL_RESISTANCE	16652143	male reproductive organ cancer	DOID_3856
3574	PATTERSON_DOCETAXEL_RESISTANCE	16652143	organ system cancer	DOID_0050686
3575	PATTERSON_DOCETAXEL_RESISTANCE	16652143	prostate cancer	DOID_10283
3576	PATTERSON_DOCETAXEL_RESISTANCE	16652143	reproductive organ cancer	DOID_193
3577	BOWIE_RESPONSE_TO_TAMOXIFEN	17016442	NA	NA
3578	AIYAR_COBRA1_TARGETS_UP	17043641	autosomal dominant disease	DOID_0050736
3579	AIYAR_COBRA1_TARGETS_UP	17043641	autosomal genetic disease	DOID_0050739
3580	AIYAR_COBRA1_TARGETS_UP	17043641	breast cancer	DOID_1612
3581	AIYAR_COBRA1_TARGETS_UP	17043641	cancer	DOID_162
3582	AIYAR_COBRA1_TARGETS_UP	17043641	disease of cellular proliferation	DOID_14566
3583	AIYAR_COBRA1_TARGETS_UP	17043641	genetic disease	DOID_630
3584	AIYAR_COBRA1_TARGETS_UP	17043641	hereditary breast ovarian cancer	DOID_5683
3585	AIYAR_COBRA1_TARGETS_UP	17043641	monogenic disease	DOID_0050177
3586	AIYAR_COBRA1_TARGETS_UP	17043641	organ system cancer	DOID_0050686
3587	AIYAR_COBRA1_TARGETS_UP	17043641	thoracic cancer	DOID_5093
3588	AIYAR_COBRA1_TARGETS_DN	17043641	autosomal dominant disease	DOID_0050736
3589	AIYAR_COBRA1_TARGETS_DN	17043641	autosomal genetic disease	DOID_0050739
3590	AIYAR_COBRA1_TARGETS_DN	17043641	breast cancer	DOID_1612
3591	AIYAR_COBRA1_TARGETS_DN	17043641	cancer	DOID_162
3592	AIYAR_COBRA1_TARGETS_DN	17043641	disease of cellular proliferation	DOID_14566
3593	AIYAR_COBRA1_TARGETS_DN	17043641	genetic disease	DOID_630
3594	AIYAR_COBRA1_TARGETS_DN	17043641	hereditary breast ovarian cancer	DOID_5683
3595	AIYAR_COBRA1_TARGETS_DN	17043641	monogenic disease	DOID_0050177
3596	AIYAR_COBRA1_TARGETS_DN	17043641	organ system cancer	DOID_0050686
3597	AIYAR_COBRA1_TARGETS_DN	17043641	thoracic cancer	DOID_5093
3598	LI_CISPLATIN_RESISTANCE_DN	17072341	adenocarcinoma	DOID_299
3599	LI_CISPLATIN_RESISTANCE_DN	17072341	cancer	DOID_162
3600	LI_CISPLATIN_RESISTANCE_DN	17072341	carcinoma	DOID_305
3601	LI_CISPLATIN_RESISTANCE_DN	17072341	cell type cancer	DOID_0050687
3602	LI_CISPLATIN_RESISTANCE_DN	17072341	cystadenocarcinoma	DOID_3111
3603	LI_CISPLATIN_RESISTANCE_DN	17072341	disease of cellular proliferation	DOID_14566
3604	LI_CISPLATIN_RESISTANCE_DN	17072341	female reproductive organ cancer	DOID_120
3605	LI_CISPLATIN_RESISTANCE_DN	17072341	organ system cancer	DOID_0050686
3606	LI_CISPLATIN_RESISTANCE_DN	17072341	ovarian cancer	DOID_2394
3607	LI_CISPLATIN_RESISTANCE_DN	17072341	reproductive organ cancer	DOID_193
3608	LI_CISPLATIN_RESISTANCE_UP	17072341	adenocarcinoma	DOID_299
3609	LI_CISPLATIN_RESISTANCE_UP	17072341	cancer	DOID_162
3610	LI_CISPLATIN_RESISTANCE_UP	17072341	carcinoma	DOID_305
3611	LI_CISPLATIN_RESISTANCE_UP	17072341	cell type cancer	DOID_0050687
3612	LI_CISPLATIN_RESISTANCE_UP	17072341	cystadenocarcinoma	DOID_3111
3613	LI_CISPLATIN_RESISTANCE_UP	17072341	disease of cellular proliferation	DOID_14566
3614	LI_CISPLATIN_RESISTANCE_UP	17072341	female reproductive organ cancer	DOID_120
3615	LI_CISPLATIN_RESISTANCE_UP	17072341	organ system cancer	DOID_0050686
3616	LI_CISPLATIN_RESISTANCE_UP	17072341	ovarian cancer	DOID_2394
3617	LI_CISPLATIN_RESISTANCE_UP	17072341	reproductive organ cancer	DOID_193
3618	XU_HGF_SIGNALING_NOT_VIA_AKT1_6HR	17099727	cancer	DOID_162
3619	XU_HGF_SIGNALING_NOT_VIA_AKT1_6HR	17099727	disease of cellular proliferation	DOID_14566
3620	XU_HGF_SIGNALING_NOT_VIA_AKT1_6HR	17099727	male reproductive organ cancer	DOID_3856
3621	XU_HGF_SIGNALING_NOT_VIA_AKT1_6HR	17099727	organ system cancer	DOID_0050686
3622	XU_HGF_SIGNALING_NOT_VIA_AKT1_6HR	17099727	prostate cancer	DOID_10283
3623	XU_HGF_SIGNALING_NOT_VIA_AKT1_6HR	17099727	reproductive organ cancer	DOID_193
3624	XU_HGF_TARGETS_INDUCED_BY_AKT1_6HR	17099727	cancer	DOID_162
3625	XU_HGF_TARGETS_INDUCED_BY_AKT1_6HR	17099727	disease of cellular proliferation	DOID_14566
3626	XU_HGF_TARGETS_INDUCED_BY_AKT1_6HR	17099727	male reproductive organ cancer	DOID_3856
3627	XU_HGF_TARGETS_INDUCED_BY_AKT1_6HR	17099727	organ system cancer	DOID_0050686
3628	XU_HGF_TARGETS_INDUCED_BY_AKT1_6HR	17099727	prostate cancer	DOID_10283
3629	XU_HGF_TARGETS_INDUCED_BY_AKT1_6HR	17099727	reproductive organ cancer	DOID_193
3630	XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_UP	17099727	cancer	DOID_162
3631	XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_UP	17099727	disease of cellular proliferation	DOID_14566
3632	XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_UP	17099727	male reproductive organ cancer	DOID_3856
3633	XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_UP	17099727	organ system cancer	DOID_0050686
3634	XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_UP	17099727	prostate cancer	DOID_10283
3635	XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_UP	17099727	reproductive organ cancer	DOID_193
3636	XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_DN	17099727	cancer	DOID_162
3637	XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_DN	17099727	disease of cellular proliferation	DOID_14566
3638	XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_DN	17099727	male reproductive organ cancer	DOID_3856
3639	XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_DN	17099727	organ system cancer	DOID_0050686
3640	XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_DN	17099727	prostate cancer	DOID_10283
3641	XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_DN	17099727	reproductive organ cancer	DOID_193
3642	XU_HGF_TARGETS_INDUCED_BY_AKT1_48HR_UP	17099727	cancer	DOID_162
3643	XU_HGF_TARGETS_INDUCED_BY_AKT1_48HR_UP	17099727	disease of cellular proliferation	DOID_14566
3644	XU_HGF_TARGETS_INDUCED_BY_AKT1_48HR_UP	17099727	male reproductive organ cancer	DOID_3856
3645	XU_HGF_TARGETS_INDUCED_BY_AKT1_48HR_UP	17099727	organ system cancer	DOID_0050686
3646	XU_HGF_TARGETS_INDUCED_BY_AKT1_48HR_UP	17099727	prostate cancer	DOID_10283
3647	XU_HGF_TARGETS_INDUCED_BY_AKT1_48HR_UP	17099727	reproductive organ cancer	DOID_193
3648	XU_HGF_TARGETS_INDUCED_BY_AKT1_48HR_DN	17099727	cancer	DOID_162
3649	XU_HGF_TARGETS_INDUCED_BY_AKT1_48HR_DN	17099727	disease of cellular proliferation	DOID_14566
3650	XU_HGF_TARGETS_INDUCED_BY_AKT1_48HR_DN	17099727	male reproductive organ cancer	DOID_3856
3651	XU_HGF_TARGETS_INDUCED_BY_AKT1_48HR_DN	17099727	organ system cancer	DOID_0050686
3652	XU_HGF_TARGETS_INDUCED_BY_AKT1_48HR_DN	17099727	prostate cancer	DOID_10283
3653	XU_HGF_TARGETS_INDUCED_BY_AKT1_48HR_DN	17099727	reproductive organ cancer	DOID_193
3654	XU_HGF_TARGETS_REPRESSED_BY_AKT1_DN	17099727	cancer	DOID_162
3655	XU_HGF_TARGETS_REPRESSED_BY_AKT1_DN	17099727	disease of cellular proliferation	DOID_14566
3656	XU_HGF_TARGETS_REPRESSED_BY_AKT1_DN	17099727	male reproductive organ cancer	DOID_3856
3657	XU_HGF_TARGETS_REPRESSED_BY_AKT1_DN	17099727	organ system cancer	DOID_0050686
3658	XU_HGF_TARGETS_REPRESSED_BY_AKT1_DN	17099727	prostate cancer	DOID_10283
3659	XU_HGF_TARGETS_REPRESSED_BY_AKT1_DN	17099727	reproductive organ cancer	DOID_193
3660	XU_AKT1_TARGETS_6HR	17099727	cancer	DOID_162
3661	XU_AKT1_TARGETS_6HR	17099727	disease of cellular proliferation	DOID_14566
3662	XU_AKT1_TARGETS_6HR	17099727	male reproductive organ cancer	DOID_3856
3663	XU_AKT1_TARGETS_6HR	17099727	organ system cancer	DOID_0050686
3664	XU_AKT1_TARGETS_6HR	17099727	prostate cancer	DOID_10283
3665	XU_AKT1_TARGETS_6HR	17099727	reproductive organ cancer	DOID_193
3666	SHI_SPARC_TARGETS_UP	17213807	cancer	DOID_162
3667	SHI_SPARC_TARGETS_UP	17213807	cell type cancer	DOID_0050687
3668	SHI_SPARC_TARGETS_UP	17213807	disease of cellular proliferation	DOID_14566
3669	SHI_SPARC_TARGETS_UP	17213807	malignant glioma	DOID_3070
3670	SHI_SPARC_TARGETS_DN	17213807	cancer	DOID_162
3671	SHI_SPARC_TARGETS_DN	17213807	cell type cancer	DOID_0050687
3672	SHI_SPARC_TARGETS_DN	17213807	disease of cellular proliferation	DOID_14566
3673	SHI_SPARC_TARGETS_DN	17213807	malignant glioma	DOID_3070
3674	NEBEN_AML_WITH_FLT3_OR_NRAS_DN	15674343	acute myeloid leukemia	DOID_9119
3675	NEBEN_AML_WITH_FLT3_OR_NRAS_DN	15674343	cancer	DOID_162
3676	NEBEN_AML_WITH_FLT3_OR_NRAS_DN	15674343	disease of cellular proliferation	DOID_14566
3677	NEBEN_AML_WITH_FLT3_OR_NRAS_DN	15674343	hematologic cancer	DOID_2531
3678	NEBEN_AML_WITH_FLT3_OR_NRAS_DN	15674343	immune system cancer	DOID_0060083
3679	NEBEN_AML_WITH_FLT3_OR_NRAS_DN	15674343	leukemia	DOID_1240
3680	NEBEN_AML_WITH_FLT3_OR_NRAS_DN	15674343	myeloid leukemia	DOID_8692
3681	NEBEN_AML_WITH_FLT3_OR_NRAS_DN	15674343	organ system cancer	DOID_0050686
3682	DIRMEIER_LMP1_RESPONSE_EARLY	15674340	NA	NA
3683	EINAV_INTERFERON_SIGNATURE_IN_CANCER	16007187	breast cancer	DOID_1612
3684	EINAV_INTERFERON_SIGNATURE_IN_CANCER	16007187	cancer	DOID_162
3685	EINAV_INTERFERON_SIGNATURE_IN_CANCER	16007187	childhood leukemia	DOID_7757
3686	EINAV_INTERFERON_SIGNATURE_IN_CANCER	16007187	disease by infectious agent	DOID_0050117
3687	EINAV_INTERFERON_SIGNATURE_IN_CANCER	16007187	disease of cellular proliferation	DOID_14566
3688	EINAV_INTERFERON_SIGNATURE_IN_CANCER	16007187	female reproductive organ cancer	DOID_120
3689	EINAV_INTERFERON_SIGNATURE_IN_CANCER	16007187	hematologic cancer	DOID_2531
3690	EINAV_INTERFERON_SIGNATURE_IN_CANCER	16007187	immune system cancer	DOID_0060083
3691	EINAV_INTERFERON_SIGNATURE_IN_CANCER	16007187	leukemia	DOID_1240
3692	EINAV_INTERFERON_SIGNATURE_IN_CANCER	16007187	lung cancer	DOID_1324
3693	EINAV_INTERFERON_SIGNATURE_IN_CANCER	16007187	lymphoblastic leukemia	DOID_1037
3694	EINAV_INTERFERON_SIGNATURE_IN_CANCER	16007187	lymphoma	DOID_0060058
3695	EINAV_INTERFERON_SIGNATURE_IN_CANCER	16007187	male reproductive organ cancer	DOID_3856
3696	EINAV_INTERFERON_SIGNATURE_IN_CANCER	16007187	organ system cancer	DOID_0050686
3697	EINAV_INTERFERON_SIGNATURE_IN_CANCER	16007187	ovarian cancer	DOID_2394
3698	EINAV_INTERFERON_SIGNATURE_IN_CANCER	16007187	prostate cancer	DOID_10283
3699	EINAV_INTERFERON_SIGNATURE_IN_CANCER	16007187	reproductive organ cancer	DOID_193
3700	EINAV_INTERFERON_SIGNATURE_IN_CANCER	16007187	respiratory system cancer	DOID_0050615
3701	EINAV_INTERFERON_SIGNATURE_IN_CANCER	16007187	thoracic cancer	DOID_5093
3702	EINAV_INTERFERON_SIGNATURE_IN_CANCER	16007187	viral infectious disease	DOID_934
3703	AMUNDSON_DNA_DAMAGE_RESPONSE_TP53	15824734	NA	NA
3704	SNIJDERS_AMPLIFIED_IN_HEAD_AND_NECK_TUMORS	15824737	cancer	DOID_162
3705	SNIJDERS_AMPLIFIED_IN_HEAD_AND_NECK_TUMORS	15824737	carcinoma	DOID_305
3706	SNIJDERS_AMPLIFIED_IN_HEAD_AND_NECK_TUMORS	15824737	cell type cancer	DOID_0050687
3707	SNIJDERS_AMPLIFIED_IN_HEAD_AND_NECK_TUMORS	15824737	disease of cellular proliferation	DOID_14566
3708	SNIJDERS_AMPLIFIED_IN_HEAD_AND_NECK_TUMORS	15824737	squamous cell carcinoma	DOID_1749
3709	SILIGAN_BOUND_BY_EWS_FLT1_FUSION	15735734	cancer	DOID_162
3710	SILIGAN_BOUND_BY_EWS_FLT1_FUSION	15735734	cell type cancer	DOID_0050687
3711	SILIGAN_BOUND_BY_EWS_FLT1_FUSION	15735734	disease of cellular proliferation	DOID_14566
3712	SILIGAN_BOUND_BY_EWS_FLT1_FUSION	15735734	sarcoma	DOID_1115
3713	DAUER_STAT3_TARGETS_UP	15735721	cancer	DOID_162
3714	DAUER_STAT3_TARGETS_UP	15735721	disease of cellular proliferation	DOID_14566
3715	DAUER_STAT3_TARGETS_DN	15735721	cancer	DOID_162
3716	DAUER_STAT3_TARGETS_DN	15735721	disease of cellular proliferation	DOID_14566
3717	KORKOLA_TERATOMA	15870693	cancer	DOID_162
3718	KORKOLA_TERATOMA	15870693	carcinoma	DOID_305
3719	KORKOLA_TERATOMA	15870693	cell type cancer	DOID_0050687
3720	KORKOLA_TERATOMA	15870693	choriocarcinoma	DOID_3594
3721	KORKOLA_TERATOMA	15870693	disease of cellular proliferation	DOID_14566
3722	KORKOLA_TERATOMA	15870693	embryonal cancer	DOID_688
3723	KORKOLA_TERATOMA	15870693	embryonal carcinoma	DOID_3308
3724	KORKOLA_TERATOMA	15870693	female reproductive organ cancer	DOID_120
3725	KORKOLA_TERATOMA	15870693	germ cell and embryonal cancer	DOID_3095
3726	KORKOLA_TERATOMA	15870693	germ cell cancer	DOID_2994
3727	KORKOLA_TERATOMA	15870693	germinoma	DOID_3304
3728	KORKOLA_TERATOMA	15870693	organ system cancer	DOID_0050686
3729	KORKOLA_TERATOMA	15870693	placenta cancer	DOID_2021
3730	KORKOLA_TERATOMA	15870693	reproductive organ cancer	DOID_193
3731	KORKOLA_TERATOMA	15870693	seminoma	DOID_4440
3732	KORKOLA_TERATOMA	15870693	teratoma	DOID_3307
3733	KORKOLA_YOLK_SAC_TUMOR	15870693	cancer	DOID_162
3734	KORKOLA_YOLK_SAC_TUMOR	15870693	carcinoma	DOID_305
3735	KORKOLA_YOLK_SAC_TUMOR	15870693	cell type cancer	DOID_0050687
3736	KORKOLA_YOLK_SAC_TUMOR	15870693	choriocarcinoma	DOID_3594
3737	KORKOLA_YOLK_SAC_TUMOR	15870693	disease of cellular proliferation	DOID_14566
3738	KORKOLA_YOLK_SAC_TUMOR	15870693	embryonal cancer	DOID_688
3739	KORKOLA_YOLK_SAC_TUMOR	15870693	embryonal carcinoma	DOID_3308
3740	KORKOLA_YOLK_SAC_TUMOR	15870693	female reproductive organ cancer	DOID_120
3741	KORKOLA_YOLK_SAC_TUMOR	15870693	germ cell and embryonal cancer	DOID_3095
3742	KORKOLA_YOLK_SAC_TUMOR	15870693	germ cell cancer	DOID_2994
3743	KORKOLA_YOLK_SAC_TUMOR	15870693	germinoma	DOID_3304
3744	KORKOLA_YOLK_SAC_TUMOR	15870693	organ system cancer	DOID_0050686
3745	KORKOLA_YOLK_SAC_TUMOR	15870693	placenta cancer	DOID_2021
3746	KORKOLA_YOLK_SAC_TUMOR	15870693	reproductive organ cancer	DOID_193
3747	KORKOLA_YOLK_SAC_TUMOR	15870693	seminoma	DOID_4440
3748	KORKOLA_YOLK_SAC_TUMOR	15870693	teratoma	DOID_3307
3749	WANG_METHYLATED_IN_BREAST_CANCER	15735726	autosomal dominant disease	DOID_0050736
3750	WANG_METHYLATED_IN_BREAST_CANCER	15735726	autosomal genetic disease	DOID_0050739
3751	WANG_METHYLATED_IN_BREAST_CANCER	15735726	breast cancer	DOID_1612
3752	WANG_METHYLATED_IN_BREAST_CANCER	15735726	cancer	DOID_162
3753	WANG_METHYLATED_IN_BREAST_CANCER	15735726	disease of cellular proliferation	DOID_14566
3754	WANG_METHYLATED_IN_BREAST_CANCER	15735726	genetic disease	DOID_630
3755	WANG_METHYLATED_IN_BREAST_CANCER	15735726	hereditary breast ovarian cancer	DOID_5683
3756	WANG_METHYLATED_IN_BREAST_CANCER	15735726	monogenic disease	DOID_0050177
3757	WANG_METHYLATED_IN_BREAST_CANCER	15735726	organ system cancer	DOID_0050686
3758	WANG_METHYLATED_IN_BREAST_CANCER	15735726	thoracic cancer	DOID_5093
3759	HEIDENBLAD_AMPLIFIED_IN_PANCREATIC_CANCER	15688027	cancer	DOID_162
3760	HEIDENBLAD_AMPLIFIED_IN_PANCREATIC_CANCER	15688027	carcinoma	DOID_305
3761	HEIDENBLAD_AMPLIFIED_IN_PANCREATIC_CANCER	15688027	cell type cancer	DOID_0050687
3762	HEIDENBLAD_AMPLIFIED_IN_PANCREATIC_CANCER	15688027	disease of cellular proliferation	DOID_14566
3763	HEIDENBLAD_AMPLIFIED_IN_PANCREATIC_CANCER	15688027	endocrine gland cancer	DOID_170
3764	HEIDENBLAD_AMPLIFIED_IN_PANCREATIC_CANCER	15688027	organ system cancer	DOID_0050686
3765	HEIDENBLAD_AMPLIFIED_IN_PANCREATIC_CANCER	15688027	pancreatic cancer	DOID_1793
3766	HEIDENBLAD_AMPLIFIED_IN_PANCREATIC_CANCER	15688027	pancreatic carcinoma	DOID_4905
3767	SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_UP	15580292	breast cancer	DOID_1612
3768	SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_UP	15580292	cancer	DOID_162
3769	SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_UP	15580292	disease of cellular proliferation	DOID_14566
3770	SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_UP	15580292	organ system cancer	DOID_0050686
3771	SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_UP	15580292	thoracic cancer	DOID_5093
3772	SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_DN	15580292	breast cancer	DOID_1612
3773	SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_DN	15580292	cancer	DOID_162
3774	SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_DN	15580292	disease of cellular proliferation	DOID_14566
3775	SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_DN	15580292	organ system cancer	DOID_0050686
3776	SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_DN	15580292	thoracic cancer	DOID_5093
3777	MEINHOLD_OVARIAN_CANCER_LOW_GRADE_UP	15558012	adenocarcinoma	DOID_299
3778	MEINHOLD_OVARIAN_CANCER_LOW_GRADE_UP	15558012	cancer	DOID_162
3779	MEINHOLD_OVARIAN_CANCER_LOW_GRADE_UP	15558012	carcinoma	DOID_305
3780	MEINHOLD_OVARIAN_CANCER_LOW_GRADE_UP	15558012	cell type cancer	DOID_0050687
3781	MEINHOLD_OVARIAN_CANCER_LOW_GRADE_UP	15558012	disease of cellular proliferation	DOID_14566
3782	MEINHOLD_OVARIAN_CANCER_LOW_GRADE_UP	15558012	female reproductive organ cancer	DOID_120
3783	MEINHOLD_OVARIAN_CANCER_LOW_GRADE_UP	15558012	organ system cancer	DOID_0050686
3784	MEINHOLD_OVARIAN_CANCER_LOW_GRADE_UP	15558012	ovarian cancer	DOID_2394
3785	MEINHOLD_OVARIAN_CANCER_LOW_GRADE_UP	15558012	reproductive organ cancer	DOID_193
3786	MEINHOLD_OVARIAN_CANCER_LOW_GRADE_DN	15558012	adenocarcinoma	DOID_299
3787	MEINHOLD_OVARIAN_CANCER_LOW_GRADE_DN	15558012	cancer	DOID_162
3788	MEINHOLD_OVARIAN_CANCER_LOW_GRADE_DN	15558012	carcinoma	DOID_305
3789	MEINHOLD_OVARIAN_CANCER_LOW_GRADE_DN	15558012	cell type cancer	DOID_0050687
3790	MEINHOLD_OVARIAN_CANCER_LOW_GRADE_DN	15558012	disease of cellular proliferation	DOID_14566
3791	MEINHOLD_OVARIAN_CANCER_LOW_GRADE_DN	15558012	female reproductive organ cancer	DOID_120
3792	MEINHOLD_OVARIAN_CANCER_LOW_GRADE_DN	15558012	organ system cancer	DOID_0050686
3793	MEINHOLD_OVARIAN_CANCER_LOW_GRADE_DN	15558012	ovarian cancer	DOID_2394
3794	MEINHOLD_OVARIAN_CANCER_LOW_GRADE_DN	15558012	reproductive organ cancer	DOID_193
3795	DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_UP	15608684	autosomal dominant disease	DOID_0050736
3796	DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_UP	15608684	autosomal genetic disease	DOID_0050739
3797	DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_UP	15608684	autosomal recessive disease	DOID_0050737
3798	DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_UP	15608684	cancer	DOID_162
3799	DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_UP	15608684	Cockayne syndrome	DOID_2962
3800	DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_UP	15608684	disease of cellular proliferation	DOID_14566
3801	DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_UP	15608684	genetic disease	DOID_630
3802	DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_UP	15608684	group B streptococcal pneumonia	DOID_12017
3803	DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_UP	15608684	integumentary system cancer	DOID_0060122
3804	DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_UP	15608684	monogenic disease	DOID_0050177
3805	DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_UP	15608684	organ system cancer	DOID_0050686
3806	DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_UP	15608684	photosensitive trichothiodystrophy	DOID_2960
3807	DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_UP	15608684	skin cancer	DOID_4159
3808	DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_UP	15608684	syndrome	DOID_225
3809	DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_UP	15608684	xeroderma pigmentosum	DOID_0050427
3810	DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_DN	15608684	autosomal dominant disease	DOID_0050736
3811	DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_DN	15608684	autosomal genetic disease	DOID_0050739
3812	DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_DN	15608684	autosomal recessive disease	DOID_0050737
3813	DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_DN	15608684	cancer	DOID_162
3814	DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_DN	15608684	Cockayne syndrome	DOID_2962
3815	DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_DN	15608684	disease of cellular proliferation	DOID_14566
3816	DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_DN	15608684	genetic disease	DOID_630
3817	DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_DN	15608684	group B streptococcal pneumonia	DOID_12017
3818	DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_DN	15608684	integumentary system cancer	DOID_0060122
3819	DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_DN	15608684	monogenic disease	DOID_0050177
3820	DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_DN	15608684	organ system cancer	DOID_0050686
3821	DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_DN	15608684	photosensitive trichothiodystrophy	DOID_2960
3822	DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_DN	15608684	skin cancer	DOID_4159
3823	DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_DN	15608684	syndrome	DOID_225
3824	DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_DN	15608684	xeroderma pigmentosum	DOID_0050427
3825	DACOSTA_UV_RESPONSE_VIA_ERCC3_UP	15608684	autosomal dominant disease	DOID_0050736
3826	DACOSTA_UV_RESPONSE_VIA_ERCC3_UP	15608684	autosomal genetic disease	DOID_0050739
3827	DACOSTA_UV_RESPONSE_VIA_ERCC3_UP	15608684	autosomal recessive disease	DOID_0050737
3828	DACOSTA_UV_RESPONSE_VIA_ERCC3_UP	15608684	cancer	DOID_162
3829	DACOSTA_UV_RESPONSE_VIA_ERCC3_UP	15608684	Cockayne syndrome	DOID_2962
3830	DACOSTA_UV_RESPONSE_VIA_ERCC3_UP	15608684	disease of cellular proliferation	DOID_14566
3831	DACOSTA_UV_RESPONSE_VIA_ERCC3_UP	15608684	genetic disease	DOID_630
3832	DACOSTA_UV_RESPONSE_VIA_ERCC3_UP	15608684	group B streptococcal pneumonia	DOID_12017
3833	DACOSTA_UV_RESPONSE_VIA_ERCC3_UP	15608684	integumentary system cancer	DOID_0060122
3834	DACOSTA_UV_RESPONSE_VIA_ERCC3_UP	15608684	monogenic disease	DOID_0050177
3835	DACOSTA_UV_RESPONSE_VIA_ERCC3_UP	15608684	organ system cancer	DOID_0050686
3836	DACOSTA_UV_RESPONSE_VIA_ERCC3_UP	15608684	photosensitive trichothiodystrophy	DOID_2960
3837	DACOSTA_UV_RESPONSE_VIA_ERCC3_UP	15608684	skin cancer	DOID_4159
3838	DACOSTA_UV_RESPONSE_VIA_ERCC3_UP	15608684	syndrome	DOID_225
3839	DACOSTA_UV_RESPONSE_VIA_ERCC3_UP	15608684	xeroderma pigmentosum	DOID_0050427
3840	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	15608684	autosomal dominant disease	DOID_0050736
3841	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	15608684	autosomal genetic disease	DOID_0050739
3842	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	15608684	autosomal recessive disease	DOID_0050737
3843	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	15608684	cancer	DOID_162
3844	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	15608684	Cockayne syndrome	DOID_2962
3845	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	15608684	disease of cellular proliferation	DOID_14566
3846	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	15608684	genetic disease	DOID_630
3847	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	15608684	group B streptococcal pneumonia	DOID_12017
3848	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	15608684	integumentary system cancer	DOID_0060122
3849	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	15608684	monogenic disease	DOID_0050177
3850	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	15608684	organ system cancer	DOID_0050686
3851	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	15608684	photosensitive trichothiodystrophy	DOID_2960
3852	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	15608684	skin cancer	DOID_4159
3853	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	15608684	syndrome	DOID_225
3854	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	15608684	xeroderma pigmentosum	DOID_0050427
3855	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN	15608684	autosomal dominant disease	DOID_0050736
3856	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN	15608684	autosomal genetic disease	DOID_0050739
3857	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN	15608684	autosomal recessive disease	DOID_0050737
3858	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN	15608684	cancer	DOID_162
3859	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN	15608684	Cockayne syndrome	DOID_2962
3860	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN	15608684	disease of cellular proliferation	DOID_14566
3861	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN	15608684	genetic disease	DOID_630
3862	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN	15608684	group B streptococcal pneumonia	DOID_12017
3863	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN	15608684	integumentary system cancer	DOID_0060122
3864	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN	15608684	monogenic disease	DOID_0050177
3865	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN	15608684	organ system cancer	DOID_0050686
3866	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN	15608684	photosensitive trichothiodystrophy	DOID_2960
3867	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN	15608684	skin cancer	DOID_4159
3868	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN	15608684	syndrome	DOID_225
3869	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN	15608684	xeroderma pigmentosum	DOID_0050427
3870	DIRMEIER_LMP1_RESPONSE_LATE_UP	15674340	NA	NA
3871	DIRMEIER_LMP1_RESPONSE_LATE_DN	15674340	NA	NA
3872	HEIDENBLAD_AMPLICON_8Q24_UP	15688027	cancer	DOID_162
3873	HEIDENBLAD_AMPLICON_8Q24_UP	15688027	carcinoma	DOID_305
3874	HEIDENBLAD_AMPLICON_8Q24_UP	15688027	cell type cancer	DOID_0050687
3875	HEIDENBLAD_AMPLICON_8Q24_UP	15688027	disease of cellular proliferation	DOID_14566
3876	HEIDENBLAD_AMPLICON_8Q24_UP	15688027	endocrine gland cancer	DOID_170
3877	HEIDENBLAD_AMPLICON_8Q24_UP	15688027	organ system cancer	DOID_0050686
3878	HEIDENBLAD_AMPLICON_8Q24_UP	15688027	pancreatic cancer	DOID_1793
3879	HEIDENBLAD_AMPLICON_8Q24_UP	15688027	pancreatic carcinoma	DOID_4905
3880	HEIDENBLAD_AMPLICON_8Q24_DN	15688027	cancer	DOID_162
3881	HEIDENBLAD_AMPLICON_8Q24_DN	15688027	carcinoma	DOID_305
3882	HEIDENBLAD_AMPLICON_8Q24_DN	15688027	cell type cancer	DOID_0050687
3883	HEIDENBLAD_AMPLICON_8Q24_DN	15688027	disease of cellular proliferation	DOID_14566
3884	HEIDENBLAD_AMPLICON_8Q24_DN	15688027	endocrine gland cancer	DOID_170
3885	HEIDENBLAD_AMPLICON_8Q24_DN	15688027	organ system cancer	DOID_0050686
3886	HEIDENBLAD_AMPLICON_8Q24_DN	15688027	pancreatic cancer	DOID_1793
3887	HEIDENBLAD_AMPLICON_8Q24_DN	15688027	pancreatic carcinoma	DOID_4905
3888	HEIDENBLAD_AMPLICON_12P11_12_DN	15688027	cancer	DOID_162
3889	HEIDENBLAD_AMPLICON_12P11_12_DN	15688027	carcinoma	DOID_305
3890	HEIDENBLAD_AMPLICON_12P11_12_DN	15688027	cell type cancer	DOID_0050687
3891	HEIDENBLAD_AMPLICON_12P11_12_DN	15688027	disease of cellular proliferation	DOID_14566
3892	HEIDENBLAD_AMPLICON_12P11_12_DN	15688027	endocrine gland cancer	DOID_170
3893	HEIDENBLAD_AMPLICON_12P11_12_DN	15688027	organ system cancer	DOID_0050686
3894	HEIDENBLAD_AMPLICON_12P11_12_DN	15688027	pancreatic cancer	DOID_1793
3895	HEIDENBLAD_AMPLICON_12P11_12_DN	15688027	pancreatic carcinoma	DOID_4905
3896	AMUNDSON_GENOTOXIC_SIGNATURE	15824734	NA	NA
3897	AMUNDSON_RESPONSE_TO_ARSENITE	15824734	NA	NA
3898	FUNG_IL2_SIGNALING_2	15735688	cancer	DOID_162
3899	FUNG_IL2_SIGNALING_2	15735688	disease of cellular proliferation	DOID_14566
3900	FUNG_IL2_SIGNALING_2	15735688	hematologic cancer	DOID_2531
3901	FUNG_IL2_SIGNALING_2	15735688	immune system cancer	DOID_0060083
3902	FUNG_IL2_SIGNALING_2	15735688	leukemia	DOID_1240
3903	FUNG_IL2_SIGNALING_2	15735688	lymphoblastic leukemia	DOID_1037
3904	FUNG_IL2_SIGNALING_2	15735688	lymphoid leukemia	DOID_10747
3905	FUNG_IL2_SIGNALING_2	15735688	organ system cancer	DOID_0050686
3906	FUNG_IL2_SIGNALING_2	15735688	T-cell leukemia	DOID_715
3907	RUGO_RESPONSE_TO_4NQO	15856014	NA	NA
3908	RUGO_RESPONSE_TO_GAMMA_RADIATION	15856014	NA	NA
3909	RUGO_UV_RESPONSE	15856014	NA	NA
3910	RUGO_STRESS_RESPONSE_SUBSET_H	15856014	NA	NA
3911	RUGO_STRESS_RESPONSE_SUBSET_G	15856014	NA	NA
3912	YANAGIHARA_ESX1_TARGETS	15897875	cancer	DOID_162
3913	YANAGIHARA_ESX1_TARGETS	15897875	carcinoma	DOID_305
3914	YANAGIHARA_ESX1_TARGETS	15897875	cell type cancer	DOID_0050687
3915	YANAGIHARA_ESX1_TARGETS	15897875	disease of cellular proliferation	DOID_14566
3916	WEINMANN_ADAPTATION_TO_HYPOXIA_UP	15897868	NA	NA
3917	WEINMANN_ADAPTATION_TO_HYPOXIA_DN	15897868	NA	NA
3918	TSUNODA_CISPLATIN_RESISTANCE_DN	15608674	cancer	DOID_162
3919	TSUNODA_CISPLATIN_RESISTANCE_DN	15608674	disease of cellular proliferation	DOID_14566
3920	TSUNODA_CISPLATIN_RESISTANCE_DN	15608674	organ system cancer	DOID_0050686
3921	TSUNODA_CISPLATIN_RESISTANCE_DN	15608674	urinary bladder cancer	DOID_11054
3922	TSUNODA_CISPLATIN_RESISTANCE_DN	15608674	urinary system cancer	DOID_3996
3923	MANN_RESPONSE_TO_AMIFOSTINE_UP	15750621	cancer	DOID_162
3924	MANN_RESPONSE_TO_AMIFOSTINE_UP	15750621	carcinoma	DOID_305
3925	MANN_RESPONSE_TO_AMIFOSTINE_UP	15750621	cell type cancer	DOID_0050687
3926	MANN_RESPONSE_TO_AMIFOSTINE_UP	15750621	colon cancer	DOID_219
3927	MANN_RESPONSE_TO_AMIFOSTINE_UP	15750621	colon carcinoma	DOID_1520
3928	MANN_RESPONSE_TO_AMIFOSTINE_UP	15750621	colorectal cancer	DOID_9256
3929	MANN_RESPONSE_TO_AMIFOSTINE_UP	15750621	disease of cellular proliferation	DOID_14566
3930	MANN_RESPONSE_TO_AMIFOSTINE_UP	15750621	gastrointestinal system cancer	DOID_3119
3931	MANN_RESPONSE_TO_AMIFOSTINE_UP	15750621	intestinal cancer	DOID_10155
3932	MANN_RESPONSE_TO_AMIFOSTINE_UP	15750621	large intestine cancer	DOID_5672
3933	MANN_RESPONSE_TO_AMIFOSTINE_UP	15750621	organ system cancer	DOID_0050686
3934	LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP	17603561	breast cancer	DOID_1612
3935	LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP	17603561	breast carcinoma	DOID_3459
3936	LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP	17603561	breast metaplastic carcinoma	DOID_4680
3937	LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP	17603561	cancer	DOID_162
3938	LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP	17603561	carcinoma	DOID_305
3939	LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP	17603561	cell type cancer	DOID_0050687
3940	LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP	17603561	disease of cellular proliferation	DOID_14566
3941	LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP	17603561	ductal carcinoma	DOID_3007
3942	LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP	17603561	metaplastic carcinoma	DOID_5652
3943	LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP	17603561	organ system cancer	DOID_0050686
3944	LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP	17603561	sarcoma	DOID_1115
3945	LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP	17603561	thoracic cancer	DOID_5093
3946	LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_DN	17603561	breast cancer	DOID_1612
3947	LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_DN	17603561	breast carcinoma	DOID_3459
3948	LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_DN	17603561	breast metaplastic carcinoma	DOID_4680
3949	LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_DN	17603561	cancer	DOID_162
3950	LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_DN	17603561	carcinoma	DOID_305
3951	LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_DN	17603561	cell type cancer	DOID_0050687
3952	LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_DN	17603561	disease of cellular proliferation	DOID_14566
3953	LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_DN	17603561	ductal carcinoma	DOID_3007
3954	LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_DN	17603561	metaplastic carcinoma	DOID_5652
3955	LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_DN	17603561	organ system cancer	DOID_0050686
3956	LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_DN	17603561	sarcoma	DOID_1115
3957	LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_DN	17603561	thoracic cancer	DOID_5093
3958	WOOD_EBV_EBNA1_TARGETS_UP	17486072	cancer	DOID_162
3959	WOOD_EBV_EBNA1_TARGETS_UP	17486072	carcinoma	DOID_305
3960	WOOD_EBV_EBNA1_TARGETS_UP	17486072	cell type cancer	DOID_0050687
3961	WOOD_EBV_EBNA1_TARGETS_UP	17486072	disease of cellular proliferation	DOID_14566
3962	WOOD_EBV_EBNA1_TARGETS_DN	17486072	cancer	DOID_162
3963	WOOD_EBV_EBNA1_TARGETS_DN	17486072	carcinoma	DOID_305
3964	WOOD_EBV_EBNA1_TARGETS_DN	17486072	cell type cancer	DOID_0050687
3965	WOOD_EBV_EBNA1_TARGETS_DN	17486072	disease of cellular proliferation	DOID_14566
3966	MOHANKUMAR_TLX1_TARGETS_UP	17213808	breast cancer	DOID_1612
3967	MOHANKUMAR_TLX1_TARGETS_UP	17213808	breast carcinoma	DOID_3459
3968	MOHANKUMAR_TLX1_TARGETS_UP	17213808	cancer	DOID_162
3969	MOHANKUMAR_TLX1_TARGETS_UP	17213808	carcinoma	DOID_305
3970	MOHANKUMAR_TLX1_TARGETS_UP	17213808	cell type cancer	DOID_0050687
3971	MOHANKUMAR_TLX1_TARGETS_UP	17213808	disease of cellular proliferation	DOID_14566
3972	MOHANKUMAR_TLX1_TARGETS_UP	17213808	organ system cancer	DOID_0050686
3973	MOHANKUMAR_TLX1_TARGETS_UP	17213808	thoracic cancer	DOID_5093
3974	MOHANKUMAR_TLX1_TARGETS_DN	17213808	breast cancer	DOID_1612
3975	MOHANKUMAR_TLX1_TARGETS_DN	17213808	breast carcinoma	DOID_3459
3976	MOHANKUMAR_TLX1_TARGETS_DN	17213808	cancer	DOID_162
3977	MOHANKUMAR_TLX1_TARGETS_DN	17213808	carcinoma	DOID_305
3978	MOHANKUMAR_TLX1_TARGETS_DN	17213808	cell type cancer	DOID_0050687
3979	MOHANKUMAR_TLX1_TARGETS_DN	17213808	disease of cellular proliferation	DOID_14566
3980	MOHANKUMAR_TLX1_TARGETS_DN	17213808	organ system cancer	DOID_0050686
3981	MOHANKUMAR_TLX1_TARGETS_DN	17213808	thoracic cancer	DOID_5093
3982	DAIRKEE_TERT_TARGETS_UP	17471242	breast cancer	DOID_1612
3983	DAIRKEE_TERT_TARGETS_UP	17471242	cancer	DOID_162
3984	DAIRKEE_TERT_TARGETS_UP	17471242	disease of cellular proliferation	DOID_14566
3985	DAIRKEE_TERT_TARGETS_UP	17471242	organ system cancer	DOID_0050686
3986	DAIRKEE_TERT_TARGETS_UP	17471242	thoracic cancer	DOID_5093
3987	DAIRKEE_TERT_TARGETS_DN	17471242	breast cancer	DOID_1612
3988	DAIRKEE_TERT_TARGETS_DN	17471242	cancer	DOID_162
3989	DAIRKEE_TERT_TARGETS_DN	17471242	disease of cellular proliferation	DOID_14566
3990	DAIRKEE_TERT_TARGETS_DN	17471242	organ system cancer	DOID_0050686
3991	DAIRKEE_TERT_TARGETS_DN	17471242	thoracic cancer	DOID_5093
3992	MURATA_VIRULENCE_OF_H_PILORI	17237808	adenocarcinoma	DOID_299
3993	MURATA_VIRULENCE_OF_H_PILORI	17237808	cancer	DOID_162
3994	MURATA_VIRULENCE_OF_H_PILORI	17237808	carcinoma	DOID_305
3995	MURATA_VIRULENCE_OF_H_PILORI	17237808	cell type cancer	DOID_0050687
3996	MURATA_VIRULENCE_OF_H_PILORI	17237808	disease of cellular proliferation	DOID_14566
3997	MURATA_VIRULENCE_OF_H_PILORI	17237808	gastric adenocarcinoma	DOID_3717
3998	MURATA_VIRULENCE_OF_H_PILORI	17237808	gastrointestinal system cancer	DOID_3119
3999	MURATA_VIRULENCE_OF_H_PILORI	17237808	organ system cancer	DOID_0050686
4000	MURATA_VIRULENCE_OF_H_PILORI	17237808	stomach cancer	DOID_10534
4001	MURATA_VIRULENCE_OF_H_PILORI	17237808	stomach carcinoma	DOID_5517
4002	WANG_HCP_PROSTATE_CANCER	17486081	cancer	DOID_162
4003	WANG_HCP_PROSTATE_CANCER	17486081	disease of cellular proliferation	DOID_14566
4004	WANG_HCP_PROSTATE_CANCER	17486081	male reproductive organ cancer	DOID_3856
4005	WANG_HCP_PROSTATE_CANCER	17486081	organ system cancer	DOID_0050686
4006	WANG_HCP_PROSTATE_CANCER	17486081	prostate cancer	DOID_10283
4007	WANG_HCP_PROSTATE_CANCER	17486081	reproductive organ cancer	DOID_193
4008	MAINA_VHL_TARGETS_DN	15824735	cancer	DOID_162
4009	MAINA_VHL_TARGETS_DN	15824735	carcinoma	DOID_305
4010	MAINA_VHL_TARGETS_DN	15824735	cell type cancer	DOID_0050687
4011	MAINA_VHL_TARGETS_DN	15824735	disease of cellular proliferation	DOID_14566
4012	MAINA_VHL_TARGETS_DN	15824735	kidney cancer	DOID_263
4013	MAINA_VHL_TARGETS_DN	15824735	organ system cancer	DOID_0050686
4014	MAINA_VHL_TARGETS_DN	15824735	renal carcinoma	DOID_4451
4015	MAINA_VHL_TARGETS_DN	15824735	renal cell carcinoma	DOID_4450
4016	MAINA_VHL_TARGETS_DN	15824735	urinary system cancer	DOID_3996
4017	GRUETZMANN_PANCREATIC_CANCER_UP	15897887	adenocarcinoma	DOID_299
4018	GRUETZMANN_PANCREATIC_CANCER_UP	15897887	breast cancer	DOID_1612
4019	GRUETZMANN_PANCREATIC_CANCER_UP	15897887	breast carcinoma	DOID_3459
4020	GRUETZMANN_PANCREATIC_CANCER_UP	15897887	cancer	DOID_162
4021	GRUETZMANN_PANCREATIC_CANCER_UP	15897887	carcinoma	DOID_305
4022	GRUETZMANN_PANCREATIC_CANCER_UP	15897887	cell type cancer	DOID_0050687
4023	GRUETZMANN_PANCREATIC_CANCER_UP	15897887	disease of cellular proliferation	DOID_14566
4024	GRUETZMANN_PANCREATIC_CANCER_UP	15897887	endocrine gland cancer	DOID_170
4025	GRUETZMANN_PANCREATIC_CANCER_UP	15897887	invasive ductal carcinoma	DOID_3008
4026	GRUETZMANN_PANCREATIC_CANCER_UP	15897887	organ system cancer	DOID_0050686
4027	GRUETZMANN_PANCREATIC_CANCER_UP	15897887	pancreas adenocarcinoma	DOID_4074
4028	GRUETZMANN_PANCREATIC_CANCER_UP	15897887	pancreatic cancer	DOID_1793
4029	GRUETZMANN_PANCREATIC_CANCER_UP	15897887	pancreatic carcinoma	DOID_4905
4030	GRUETZMANN_PANCREATIC_CANCER_UP	15897887	pancreatic ductal adenocarcinoma	DOID_3498
4031	GRUETZMANN_PANCREATIC_CANCER_UP	15897887	thoracic cancer	DOID_5093
4032	GRUETZMANN_PANCREATIC_CANCER_DN	15897887	adenocarcinoma	DOID_299
4033	GRUETZMANN_PANCREATIC_CANCER_DN	15897887	breast cancer	DOID_1612
4034	GRUETZMANN_PANCREATIC_CANCER_DN	15897887	breast carcinoma	DOID_3459
4035	GRUETZMANN_PANCREATIC_CANCER_DN	15897887	cancer	DOID_162
4036	GRUETZMANN_PANCREATIC_CANCER_DN	15897887	carcinoma	DOID_305
4037	GRUETZMANN_PANCREATIC_CANCER_DN	15897887	cell type cancer	DOID_0050687
4038	GRUETZMANN_PANCREATIC_CANCER_DN	15897887	disease of cellular proliferation	DOID_14566
4039	GRUETZMANN_PANCREATIC_CANCER_DN	15897887	endocrine gland cancer	DOID_170
4040	GRUETZMANN_PANCREATIC_CANCER_DN	15897887	invasive ductal carcinoma	DOID_3008
4041	GRUETZMANN_PANCREATIC_CANCER_DN	15897887	organ system cancer	DOID_0050686
4042	GRUETZMANN_PANCREATIC_CANCER_DN	15897887	pancreas adenocarcinoma	DOID_4074
4043	GRUETZMANN_PANCREATIC_CANCER_DN	15897887	pancreatic cancer	DOID_1793
4044	GRUETZMANN_PANCREATIC_CANCER_DN	15897887	pancreatic carcinoma	DOID_4905
4045	GRUETZMANN_PANCREATIC_CANCER_DN	15897887	pancreatic ductal adenocarcinoma	DOID_3498
4046	GRUETZMANN_PANCREATIC_CANCER_DN	15897887	thoracic cancer	DOID_5093
4047	JAZAG_TGFB1_SIGNALING_UP	15592526	cancer	DOID_162
4048	JAZAG_TGFB1_SIGNALING_UP	15592526	disease of cellular proliferation	DOID_14566
4049	JAZAG_TGFB1_SIGNALING_UP	15592526	endocrine gland cancer	DOID_170
4050	JAZAG_TGFB1_SIGNALING_UP	15592526	organ system cancer	DOID_0050686
4051	JAZAG_TGFB1_SIGNALING_UP	15592526	pancreatic cancer	DOID_1793
4052	JAZAG_TGFB1_SIGNALING_DN	15592526	cancer	DOID_162
4053	JAZAG_TGFB1_SIGNALING_DN	15592526	disease of cellular proliferation	DOID_14566
4054	JAZAG_TGFB1_SIGNALING_DN	15592526	endocrine gland cancer	DOID_170
4055	JAZAG_TGFB1_SIGNALING_DN	15592526	organ system cancer	DOID_0050686
4056	JAZAG_TGFB1_SIGNALING_DN	15592526	pancreatic cancer	DOID_1793
4057	JAZAG_TGFB1_SIGNALING_VIA_SMAD4_UP	15592526	cancer	DOID_162
4058	JAZAG_TGFB1_SIGNALING_VIA_SMAD4_UP	15592526	disease of cellular proliferation	DOID_14566
4059	JAZAG_TGFB1_SIGNALING_VIA_SMAD4_UP	15592526	endocrine gland cancer	DOID_170
4060	JAZAG_TGFB1_SIGNALING_VIA_SMAD4_UP	15592526	organ system cancer	DOID_0050686
4061	JAZAG_TGFB1_SIGNALING_VIA_SMAD4_UP	15592526	pancreatic cancer	DOID_1793
4062	JAZAG_TGFB1_SIGNALING_VIA_SMAD4_DN	15592526	cancer	DOID_162
4063	JAZAG_TGFB1_SIGNALING_VIA_SMAD4_DN	15592526	disease of cellular proliferation	DOID_14566
4064	JAZAG_TGFB1_SIGNALING_VIA_SMAD4_DN	15592526	endocrine gland cancer	DOID_170
4065	JAZAG_TGFB1_SIGNALING_VIA_SMAD4_DN	15592526	organ system cancer	DOID_0050686
4066	JAZAG_TGFB1_SIGNALING_VIA_SMAD4_DN	15592526	pancreatic cancer	DOID_1793
4067	SIMBULAN_UV_RESPONSE_NORMAL_DN	16007217	NA	NA
4068	SIMBULAN_UV_RESPONSE_IMMORTALIZED_DN	16007217	NA	NA
4069	WATTEL_AUTONOMOUS_THYROID_ADENOMA_UP	16027733	adenoma	DOID_657
4070	WATTEL_AUTONOMOUS_THYROID_ADENOMA_UP	16027733	benign neoplasm	DOID_0060072
4071	WATTEL_AUTONOMOUS_THYROID_ADENOMA_UP	16027733	cell type benign neoplasm	DOID_0060084
4072	WATTEL_AUTONOMOUS_THYROID_ADENOMA_UP	16027733	disease of cellular proliferation	DOID_14566
4073	WATTEL_AUTONOMOUS_THYROID_ADENOMA_DN	16027733	adenoma	DOID_657
4074	WATTEL_AUTONOMOUS_THYROID_ADENOMA_DN	16027733	benign neoplasm	DOID_0060072
4075	WATTEL_AUTONOMOUS_THYROID_ADENOMA_DN	16027733	cell type benign neoplasm	DOID_0060084
4076	WATTEL_AUTONOMOUS_THYROID_ADENOMA_DN	16027733	disease of cellular proliferation	DOID_14566
4077	FARMER_BREAST_CANCER_CLUSTER_3	15897907	breast cancer	DOID_1612
4078	FARMER_BREAST_CANCER_CLUSTER_3	15897907	cancer	DOID_162
4079	FARMER_BREAST_CANCER_CLUSTER_3	15897907	disease of cellular proliferation	DOID_14566
4080	FARMER_BREAST_CANCER_CLUSTER_3	15897907	organ system cancer	DOID_0050686
4081	FARMER_BREAST_CANCER_CLUSTER_3	15897907	thoracic cancer	DOID_5093
4082	KIM_MYC_AMPLIFICATION_TARGETS_UP	16116477	cancer	DOID_162
4083	KIM_MYC_AMPLIFICATION_TARGETS_UP	16116477	carcinoma	DOID_305
4084	KIM_MYC_AMPLIFICATION_TARGETS_UP	16116477	cell type cancer	DOID_0050687
4085	KIM_MYC_AMPLIFICATION_TARGETS_UP	16116477	disease of cellular proliferation	DOID_14566
4086	KIM_MYC_AMPLIFICATION_TARGETS_UP	16116477	lung cancer	DOID_1324
4087	KIM_MYC_AMPLIFICATION_TARGETS_UP	16116477	lung carcinoma	DOID_3905
4088	KIM_MYC_AMPLIFICATION_TARGETS_UP	16116477	lung small cell carcinoma	DOID_5409
4089	KIM_MYC_AMPLIFICATION_TARGETS_UP	16116477	organ system cancer	DOID_0050686
4090	KIM_MYC_AMPLIFICATION_TARGETS_UP	16116477	respiratory system cancer	DOID_0050615
4091	KIM_MYC_AMPLIFICATION_TARGETS_DN	16116477	cancer	DOID_162
4092	KIM_MYC_AMPLIFICATION_TARGETS_DN	16116477	carcinoma	DOID_305
4093	KIM_MYC_AMPLIFICATION_TARGETS_DN	16116477	cell type cancer	DOID_0050687
4094	KIM_MYC_AMPLIFICATION_TARGETS_DN	16116477	disease of cellular proliferation	DOID_14566
4095	KIM_MYC_AMPLIFICATION_TARGETS_DN	16116477	lung cancer	DOID_1324
4096	KIM_MYC_AMPLIFICATION_TARGETS_DN	16116477	lung carcinoma	DOID_3905
4097	KIM_MYC_AMPLIFICATION_TARGETS_DN	16116477	lung small cell carcinoma	DOID_5409
4098	KIM_MYC_AMPLIFICATION_TARGETS_DN	16116477	organ system cancer	DOID_0050686
4099	KIM_MYC_AMPLIFICATION_TARGETS_DN	16116477	respiratory system cancer	DOID_0050615
4100	KIM_MYCN_AMPLIFICATION_TARGETS_UP	16116477	cancer	DOID_162
4101	KIM_MYCN_AMPLIFICATION_TARGETS_UP	16116477	carcinoma	DOID_305
4102	KIM_MYCN_AMPLIFICATION_TARGETS_UP	16116477	cell type cancer	DOID_0050687
4103	KIM_MYCN_AMPLIFICATION_TARGETS_UP	16116477	disease of cellular proliferation	DOID_14566
4104	KIM_MYCN_AMPLIFICATION_TARGETS_UP	16116477	lung cancer	DOID_1324
4105	KIM_MYCN_AMPLIFICATION_TARGETS_UP	16116477	lung carcinoma	DOID_3905
4106	KIM_MYCN_AMPLIFICATION_TARGETS_UP	16116477	lung small cell carcinoma	DOID_5409
4107	KIM_MYCN_AMPLIFICATION_TARGETS_UP	16116477	organ system cancer	DOID_0050686
4108	KIM_MYCN_AMPLIFICATION_TARGETS_UP	16116477	respiratory system cancer	DOID_0050615
4109	KIM_MYCN_AMPLIFICATION_TARGETS_DN	16116477	cancer	DOID_162
4110	KIM_MYCN_AMPLIFICATION_TARGETS_DN	16116477	carcinoma	DOID_305
4111	KIM_MYCN_AMPLIFICATION_TARGETS_DN	16116477	cell type cancer	DOID_0050687
4112	KIM_MYCN_AMPLIFICATION_TARGETS_DN	16116477	disease of cellular proliferation	DOID_14566
4113	KIM_MYCN_AMPLIFICATION_TARGETS_DN	16116477	lung cancer	DOID_1324
4114	KIM_MYCN_AMPLIFICATION_TARGETS_DN	16116477	lung carcinoma	DOID_3905
4115	KIM_MYCN_AMPLIFICATION_TARGETS_DN	16116477	lung small cell carcinoma	DOID_5409
4116	KIM_MYCN_AMPLIFICATION_TARGETS_DN	16116477	organ system cancer	DOID_0050686
4117	KIM_MYCN_AMPLIFICATION_TARGETS_DN	16116477	respiratory system cancer	DOID_0050615
4118	KIM_MYCL1_AMPLIFICATION_TARGETS_UP	16116477	cancer	DOID_162
4119	KIM_MYCL1_AMPLIFICATION_TARGETS_UP	16116477	carcinoma	DOID_305
4120	KIM_MYCL1_AMPLIFICATION_TARGETS_UP	16116477	cell type cancer	DOID_0050687
4121	KIM_MYCL1_AMPLIFICATION_TARGETS_UP	16116477	disease of cellular proliferation	DOID_14566
4122	KIM_MYCL1_AMPLIFICATION_TARGETS_UP	16116477	lung cancer	DOID_1324
4123	KIM_MYCL1_AMPLIFICATION_TARGETS_UP	16116477	lung carcinoma	DOID_3905
4124	KIM_MYCL1_AMPLIFICATION_TARGETS_UP	16116477	lung small cell carcinoma	DOID_5409
4125	KIM_MYCL1_AMPLIFICATION_TARGETS_UP	16116477	organ system cancer	DOID_0050686
4126	KIM_MYCL1_AMPLIFICATION_TARGETS_UP	16116477	respiratory system cancer	DOID_0050615
4127	KIM_MYCL1_AMPLIFICATION_TARGETS_DN	16116477	cancer	DOID_162
4128	KIM_MYCL1_AMPLIFICATION_TARGETS_DN	16116477	carcinoma	DOID_305
4129	KIM_MYCL1_AMPLIFICATION_TARGETS_DN	16116477	cell type cancer	DOID_0050687
4130	KIM_MYCL1_AMPLIFICATION_TARGETS_DN	16116477	disease of cellular proliferation	DOID_14566
4131	KIM_MYCL1_AMPLIFICATION_TARGETS_DN	16116477	lung cancer	DOID_1324
4132	KIM_MYCL1_AMPLIFICATION_TARGETS_DN	16116477	lung carcinoma	DOID_3905
4133	KIM_MYCL1_AMPLIFICATION_TARGETS_DN	16116477	lung small cell carcinoma	DOID_5409
4134	KIM_MYCL1_AMPLIFICATION_TARGETS_DN	16116477	organ system cancer	DOID_0050686
4135	KIM_MYCL1_AMPLIFICATION_TARGETS_DN	16116477	respiratory system cancer	DOID_0050615
4136	TSAI_RESPONSE_TO_IONIZING_RADIATION	16247478	NA	NA
4137	YANG_BREAST_CANCER_ESR1_UP	16261164	breast cancer	DOID_1612
4138	YANG_BREAST_CANCER_ESR1_UP	16261164	cancer	DOID_162
4139	YANG_BREAST_CANCER_ESR1_UP	16261164	disease by infectious agent	DOID_0050117
4140	YANG_BREAST_CANCER_ESR1_UP	16261164	disease of cellular proliferation	DOID_14566
4141	YANG_BREAST_CANCER_ESR1_UP	16261164	lymphocytic choriomeningitis	DOID_12155
4142	YANG_BREAST_CANCER_ESR1_UP	16261164	organ system cancer	DOID_0050686
4143	YANG_BREAST_CANCER_ESR1_UP	16261164	thoracic cancer	DOID_5093
4144	YANG_BREAST_CANCER_ESR1_UP	16261164	viral infectious disease	DOID_934
4145	YANG_BREAST_CANCER_ESR1_DN	16261164	breast cancer	DOID_1612
4146	YANG_BREAST_CANCER_ESR1_DN	16261164	cancer	DOID_162
4147	YANG_BREAST_CANCER_ESR1_DN	16261164	disease by infectious agent	DOID_0050117
4148	YANG_BREAST_CANCER_ESR1_DN	16261164	disease of cellular proliferation	DOID_14566
4149	YANG_BREAST_CANCER_ESR1_DN	16261164	lymphocytic choriomeningitis	DOID_12155
4150	YANG_BREAST_CANCER_ESR1_DN	16261164	organ system cancer	DOID_0050686
4151	YANG_BREAST_CANCER_ESR1_DN	16261164	thoracic cancer	DOID_5093
4152	YANG_BREAST_CANCER_ESR1_DN	16261164	viral infectious disease	DOID_934
4153	YANG_BREAST_CANCER_ESR1_LASER_UP	16261164	breast cancer	DOID_1612
4154	YANG_BREAST_CANCER_ESR1_LASER_UP	16261164	cancer	DOID_162
4155	YANG_BREAST_CANCER_ESR1_LASER_UP	16261164	disease by infectious agent	DOID_0050117
4156	YANG_BREAST_CANCER_ESR1_LASER_UP	16261164	disease of cellular proliferation	DOID_14566
4157	YANG_BREAST_CANCER_ESR1_LASER_UP	16261164	lymphocytic choriomeningitis	DOID_12155
4158	YANG_BREAST_CANCER_ESR1_LASER_UP	16261164	organ system cancer	DOID_0050686
4159	YANG_BREAST_CANCER_ESR1_LASER_UP	16261164	thoracic cancer	DOID_5093
4160	YANG_BREAST_CANCER_ESR1_LASER_UP	16261164	viral infectious disease	DOID_934
4161	YANG_BREAST_CANCER_ESR1_LASER_DN	16261164	breast cancer	DOID_1612
4162	YANG_BREAST_CANCER_ESR1_LASER_DN	16261164	cancer	DOID_162
4163	YANG_BREAST_CANCER_ESR1_LASER_DN	16261164	disease by infectious agent	DOID_0050117
4164	YANG_BREAST_CANCER_ESR1_LASER_DN	16261164	disease of cellular proliferation	DOID_14566
4165	YANG_BREAST_CANCER_ESR1_LASER_DN	16261164	lymphocytic choriomeningitis	DOID_12155
4166	YANG_BREAST_CANCER_ESR1_LASER_DN	16261164	organ system cancer	DOID_0050686
4167	YANG_BREAST_CANCER_ESR1_LASER_DN	16261164	thoracic cancer	DOID_5093
4168	YANG_BREAST_CANCER_ESR1_LASER_DN	16261164	viral infectious disease	DOID_934
4169	YANG_BREAST_CANCER_ESR1_BULK_UP	16261164	breast cancer	DOID_1612
4170	YANG_BREAST_CANCER_ESR1_BULK_UP	16261164	cancer	DOID_162
4171	YANG_BREAST_CANCER_ESR1_BULK_UP	16261164	disease by infectious agent	DOID_0050117
4172	YANG_BREAST_CANCER_ESR1_BULK_UP	16261164	disease of cellular proliferation	DOID_14566
4173	YANG_BREAST_CANCER_ESR1_BULK_UP	16261164	lymphocytic choriomeningitis	DOID_12155
4174	YANG_BREAST_CANCER_ESR1_BULK_UP	16261164	organ system cancer	DOID_0050686
4175	YANG_BREAST_CANCER_ESR1_BULK_UP	16261164	thoracic cancer	DOID_5093
4176	YANG_BREAST_CANCER_ESR1_BULK_UP	16261164	viral infectious disease	DOID_934
4177	YANG_BREAST_CANCER_ESR1_BULK_DN	16261164	breast cancer	DOID_1612
4178	YANG_BREAST_CANCER_ESR1_BULK_DN	16261164	cancer	DOID_162
4179	YANG_BREAST_CANCER_ESR1_BULK_DN	16261164	disease by infectious agent	DOID_0050117
4180	YANG_BREAST_CANCER_ESR1_BULK_DN	16261164	disease of cellular proliferation	DOID_14566
4181	YANG_BREAST_CANCER_ESR1_BULK_DN	16261164	lymphocytic choriomeningitis	DOID_12155
4182	YANG_BREAST_CANCER_ESR1_BULK_DN	16261164	organ system cancer	DOID_0050686
4183	YANG_BREAST_CANCER_ESR1_BULK_DN	16261164	thoracic cancer	DOID_5093
4184	YANG_BREAST_CANCER_ESR1_BULK_DN	16261164	viral infectious disease	DOID_934
4185	SEMBA_FHIT_TARGETS_UP	16407838	cancer	DOID_162
4186	SEMBA_FHIT_TARGETS_UP	16407838	disease of cellular proliferation	DOID_14566
4187	SEMBA_FHIT_TARGETS_UP	16407838	lung cancer	DOID_1324
4188	SEMBA_FHIT_TARGETS_UP	16407838	organ system cancer	DOID_0050686
4189	SEMBA_FHIT_TARGETS_UP	16407838	respiratory system cancer	DOID_0050615
4190	HASINA_NOL7_TARGETS_UP	16205646	benign neoplasm	DOID_0060072
4191	HASINA_NOL7_TARGETS_UP	16205646	cancer	DOID_162
4192	HASINA_NOL7_TARGETS_UP	16205646	carcinoma	DOID_305
4193	HASINA_NOL7_TARGETS_UP	16205646	cell type benign neoplasm	DOID_0060084
4194	HASINA_NOL7_TARGETS_UP	16205646	cell type cancer	DOID_0050687
4195	HASINA_NOL7_TARGETS_UP	16205646	cervical cancer	DOID_4362
4196	HASINA_NOL7_TARGETS_UP	16205646	disease by infectious agent	DOID_0050117
4197	HASINA_NOL7_TARGETS_UP	16205646	disease of cellular proliferation	DOID_14566
4198	HASINA_NOL7_TARGETS_UP	16205646	female reproductive organ cancer	DOID_120
4199	HASINA_NOL7_TARGETS_UP	16205646	organ system cancer	DOID_0050686
4200	HASINA_NOL7_TARGETS_UP	16205646	papilloma	DOID_2615
4201	HASINA_NOL7_TARGETS_UP	16205646	papillomavirus infectious disease	DOID_11166
4202	HASINA_NOL7_TARGETS_UP	16205646	reproductive organ cancer	DOID_193
4203	HASINA_NOL7_TARGETS_UP	16205646	viral infectious disease	DOID_934
4204	HASINA_NOL7_TARGETS_DN	16205646	benign neoplasm	DOID_0060072
4205	HASINA_NOL7_TARGETS_DN	16205646	cancer	DOID_162
4206	HASINA_NOL7_TARGETS_DN	16205646	carcinoma	DOID_305
4207	HASINA_NOL7_TARGETS_DN	16205646	cell type benign neoplasm	DOID_0060084
4208	HASINA_NOL7_TARGETS_DN	16205646	cell type cancer	DOID_0050687
4209	HASINA_NOL7_TARGETS_DN	16205646	cervical cancer	DOID_4362
4210	HASINA_NOL7_TARGETS_DN	16205646	disease by infectious agent	DOID_0050117
4211	HASINA_NOL7_TARGETS_DN	16205646	disease of cellular proliferation	DOID_14566
4212	HASINA_NOL7_TARGETS_DN	16205646	female reproductive organ cancer	DOID_120
4213	HASINA_NOL7_TARGETS_DN	16205646	organ system cancer	DOID_0050686
4214	HASINA_NOL7_TARGETS_DN	16205646	papilloma	DOID_2615
4215	HASINA_NOL7_TARGETS_DN	16205646	papillomavirus infectious disease	DOID_11166
4216	HASINA_NOL7_TARGETS_DN	16205646	reproductive organ cancer	DOID_193
4217	HASINA_NOL7_TARGETS_DN	16205646	viral infectious disease	DOID_934
4218	HATADA_METHYLATED_IN_LUNG_CANCER_UP	16407832	adenocarcinoma	DOID_299
4219	HATADA_METHYLATED_IN_LUNG_CANCER_UP	16407832	cancer	DOID_162
4220	HATADA_METHYLATED_IN_LUNG_CANCER_UP	16407832	carcinoma	DOID_305
4221	HATADA_METHYLATED_IN_LUNG_CANCER_UP	16407832	cell type cancer	DOID_0050687
4222	HATADA_METHYLATED_IN_LUNG_CANCER_UP	16407832	disease of cellular proliferation	DOID_14566
4223	HATADA_METHYLATED_IN_LUNG_CANCER_UP	16407832	small cell carcinoma	DOID_0050685
4224	HATADA_METHYLATED_IN_LUNG_CANCER_DN	16407832	adenocarcinoma	DOID_299
4225	HATADA_METHYLATED_IN_LUNG_CANCER_DN	16407832	cancer	DOID_162
4226	HATADA_METHYLATED_IN_LUNG_CANCER_DN	16407832	carcinoma	DOID_305
4227	HATADA_METHYLATED_IN_LUNG_CANCER_DN	16407832	cell type cancer	DOID_0050687
4228	HATADA_METHYLATED_IN_LUNG_CANCER_DN	16407832	disease of cellular proliferation	DOID_14566
4229	HATADA_METHYLATED_IN_LUNG_CANCER_DN	16407832	small cell carcinoma	DOID_0050685
4230	FURUKAWA_DUSP6_TARGETS_PCI35_UP	16532023	cancer	DOID_162
4231	FURUKAWA_DUSP6_TARGETS_PCI35_UP	16532023	disease of cellular proliferation	DOID_14566
4232	FURUKAWA_DUSP6_TARGETS_PCI35_UP	16532023	endocrine gland cancer	DOID_170
4233	FURUKAWA_DUSP6_TARGETS_PCI35_UP	16532023	organ system cancer	DOID_0050686
4234	FURUKAWA_DUSP6_TARGETS_PCI35_UP	16532023	pancreatic cancer	DOID_1793
4235	FURUKAWA_DUSP6_TARGETS_PCI35_DN	16532023	cancer	DOID_162
4236	FURUKAWA_DUSP6_TARGETS_PCI35_DN	16532023	disease of cellular proliferation	DOID_14566
4237	FURUKAWA_DUSP6_TARGETS_PCI35_DN	16532023	endocrine gland cancer	DOID_170
4238	FURUKAWA_DUSP6_TARGETS_PCI35_DN	16532023	organ system cancer	DOID_0050686
4239	FURUKAWA_DUSP6_TARGETS_PCI35_DN	16532023	pancreatic cancer	DOID_1793
4240	KARAKAS_TGFB1_SIGNALING	16619041	NA	NA
4241	LIEN_BREAST_CARCINOMA_METAPLASTIC	17603561	breast cancer	DOID_1612
4242	LIEN_BREAST_CARCINOMA_METAPLASTIC	17603561	breast carcinoma	DOID_3459
4243	LIEN_BREAST_CARCINOMA_METAPLASTIC	17603561	breast metaplastic carcinoma	DOID_4680
4244	LIEN_BREAST_CARCINOMA_METAPLASTIC	17603561	cancer	DOID_162
4245	LIEN_BREAST_CARCINOMA_METAPLASTIC	17603561	carcinoma	DOID_305
4246	LIEN_BREAST_CARCINOMA_METAPLASTIC	17603561	cell type cancer	DOID_0050687
4247	LIEN_BREAST_CARCINOMA_METAPLASTIC	17603561	disease of cellular proliferation	DOID_14566
4248	LIEN_BREAST_CARCINOMA_METAPLASTIC	17603561	ductal carcinoma	DOID_3007
4249	LIEN_BREAST_CARCINOMA_METAPLASTIC	17603561	metaplastic carcinoma	DOID_5652
4250	LIEN_BREAST_CARCINOMA_METAPLASTIC	17603561	organ system cancer	DOID_0050686
4251	LIEN_BREAST_CARCINOMA_METAPLASTIC	17603561	sarcoma	DOID_1115
4252	LIEN_BREAST_CARCINOMA_METAPLASTIC	17603561	thoracic cancer	DOID_5093
4253	TOMLINS_PROSTATE_CANCER_UP	17173048	cancer	DOID_162
4254	TOMLINS_PROSTATE_CANCER_UP	17173048	disease of cellular proliferation	DOID_14566
4255	TOMLINS_PROSTATE_CANCER_UP	17173048	male reproductive organ cancer	DOID_3856
4256	TOMLINS_PROSTATE_CANCER_UP	17173048	organ system cancer	DOID_0050686
4257	TOMLINS_PROSTATE_CANCER_UP	17173048	prostate cancer	DOID_10283
4258	TOMLINS_PROSTATE_CANCER_UP	17173048	reproductive organ cancer	DOID_193
4259	TOMLINS_PROSTATE_CANCER_DN	17173048	cancer	DOID_162
4260	TOMLINS_PROSTATE_CANCER_DN	17173048	disease of cellular proliferation	DOID_14566
4261	TOMLINS_PROSTATE_CANCER_DN	17173048	male reproductive organ cancer	DOID_3856
4262	TOMLINS_PROSTATE_CANCER_DN	17173048	organ system cancer	DOID_0050686
4263	TOMLINS_PROSTATE_CANCER_DN	17173048	prostate cancer	DOID_10283
4264	TOMLINS_PROSTATE_CANCER_DN	17173048	reproductive organ cancer	DOID_193
4265	TOMLINS_METASTASIS_UP	17173048	cancer	DOID_162
4266	TOMLINS_METASTASIS_UP	17173048	disease of cellular proliferation	DOID_14566
4267	TOMLINS_METASTASIS_UP	17173048	male reproductive organ cancer	DOID_3856
4268	TOMLINS_METASTASIS_UP	17173048	organ system cancer	DOID_0050686
4269	TOMLINS_METASTASIS_UP	17173048	prostate cancer	DOID_10283
4270	TOMLINS_METASTASIS_UP	17173048	reproductive organ cancer	DOID_193
4271	TOMLINS_METASTASIS_DN	17173048	cancer	DOID_162
4272	TOMLINS_METASTASIS_DN	17173048	disease of cellular proliferation	DOID_14566
4273	TOMLINS_METASTASIS_DN	17173048	male reproductive organ cancer	DOID_3856
4274	TOMLINS_METASTASIS_DN	17173048	organ system cancer	DOID_0050686
4275	TOMLINS_METASTASIS_DN	17173048	prostate cancer	DOID_10283
4276	TOMLINS_METASTASIS_DN	17173048	reproductive organ cancer	DOID_193
4277	SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_2FC_UP	17206142	acquired metabolic disease	DOID_0060158
4278	SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_2FC_UP	17206142	carbohydrate metabolism disease	DOID_0050013
4279	SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_2FC_UP	17206142	diabetes mellitus	DOID_9351
4280	SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_2FC_UP	17206142	disease of metabolism	DOID_0014667
4281	SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_2FC_UP	17206142	glucose metabolism disease	DOID_4194
4282	SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_2FC_DN	17206142	acquired metabolic disease	DOID_0060158
4283	SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_2FC_DN	17206142	carbohydrate metabolism disease	DOID_0050013
4284	SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_2FC_DN	17206142	diabetes mellitus	DOID_9351
4285	SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_2FC_DN	17206142	disease of metabolism	DOID_0014667
4286	SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_2FC_DN	17206142	glucose metabolism disease	DOID_4194
4287	SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP	17206142	acquired metabolic disease	DOID_0060158
4288	SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP	17206142	carbohydrate metabolism disease	DOID_0050013
4289	SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP	17206142	diabetes mellitus	DOID_9351
4290	SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP	17206142	disease of metabolism	DOID_0014667
4291	SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP	17206142	glucose metabolism disease	DOID_4194
4292	SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_DN	17206142	acquired metabolic disease	DOID_0060158
4293	SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_DN	17206142	carbohydrate metabolism disease	DOID_0050013
4294	SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_DN	17206142	diabetes mellitus	DOID_9351
4295	SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_DN	17206142	disease of metabolism	DOID_0014667
4296	SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_DN	17206142	glucose metabolism disease	DOID_4194
4297	BALLIF_DEVELOPMENTAL_DISABILITY_P16_P12_DELETION	17704777	syndrome	DOID_225
4298	PUJANA_BREAST_CANCER_LIT_INT_NETWORK	17922014	autosomal dominant disease	DOID_0050736
4299	PUJANA_BREAST_CANCER_LIT_INT_NETWORK	17922014	autosomal genetic disease	DOID_0050739
4300	PUJANA_BREAST_CANCER_LIT_INT_NETWORK	17922014	breast cancer	DOID_1612
4301	PUJANA_BREAST_CANCER_LIT_INT_NETWORK	17922014	cancer	DOID_162
4302	PUJANA_BREAST_CANCER_LIT_INT_NETWORK	17922014	disease of cellular proliferation	DOID_14566
4303	PUJANA_BREAST_CANCER_LIT_INT_NETWORK	17922014	genetic disease	DOID_630
4304	PUJANA_BREAST_CANCER_LIT_INT_NETWORK	17922014	hereditary breast ovarian cancer	DOID_5683
4305	PUJANA_BREAST_CANCER_LIT_INT_NETWORK	17922014	monogenic disease	DOID_0050177
4306	PUJANA_BREAST_CANCER_LIT_INT_NETWORK	17922014	organ system cancer	DOID_0050686
4307	PUJANA_BREAST_CANCER_LIT_INT_NETWORK	17922014	thoracic cancer	DOID_5093
4308	PUJANA_XPRSS_INT_NETWORK	17922014	autosomal dominant disease	DOID_0050736
4309	PUJANA_XPRSS_INT_NETWORK	17922014	autosomal genetic disease	DOID_0050739
4310	PUJANA_XPRSS_INT_NETWORK	17922014	breast cancer	DOID_1612
4311	PUJANA_XPRSS_INT_NETWORK	17922014	cancer	DOID_162
4312	PUJANA_XPRSS_INT_NETWORK	17922014	disease of cellular proliferation	DOID_14566
4313	PUJANA_XPRSS_INT_NETWORK	17922014	genetic disease	DOID_630
4314	PUJANA_XPRSS_INT_NETWORK	17922014	hereditary breast ovarian cancer	DOID_5683
4315	PUJANA_XPRSS_INT_NETWORK	17922014	monogenic disease	DOID_0050177
4316	PUJANA_XPRSS_INT_NETWORK	17922014	organ system cancer	DOID_0050686
4317	PUJANA_XPRSS_INT_NETWORK	17922014	thoracic cancer	DOID_5093
4318	PUJANA_BRCA2_PCC_NETWORK	17922014	autosomal dominant disease	DOID_0050736
4319	PUJANA_BRCA2_PCC_NETWORK	17922014	autosomal genetic disease	DOID_0050739
4320	PUJANA_BRCA2_PCC_NETWORK	17922014	breast cancer	DOID_1612
4321	PUJANA_BRCA2_PCC_NETWORK	17922014	cancer	DOID_162
4322	PUJANA_BRCA2_PCC_NETWORK	17922014	disease of cellular proliferation	DOID_14566
4323	PUJANA_BRCA2_PCC_NETWORK	17922014	genetic disease	DOID_630
4324	PUJANA_BRCA2_PCC_NETWORK	17922014	hereditary breast ovarian cancer	DOID_5683
4325	PUJANA_BRCA2_PCC_NETWORK	17922014	monogenic disease	DOID_0050177
4326	PUJANA_BRCA2_PCC_NETWORK	17922014	organ system cancer	DOID_0050686
4327	PUJANA_BRCA2_PCC_NETWORK	17922014	thoracic cancer	DOID_5093
4328	PUJANA_CHEK2_PCC_NETWORK	17922014	autosomal dominant disease	DOID_0050736
4329	PUJANA_CHEK2_PCC_NETWORK	17922014	autosomal genetic disease	DOID_0050739
4330	PUJANA_CHEK2_PCC_NETWORK	17922014	breast cancer	DOID_1612
4331	PUJANA_CHEK2_PCC_NETWORK	17922014	cancer	DOID_162
4332	PUJANA_CHEK2_PCC_NETWORK	17922014	disease of cellular proliferation	DOID_14566
4333	PUJANA_CHEK2_PCC_NETWORK	17922014	genetic disease	DOID_630
4334	PUJANA_CHEK2_PCC_NETWORK	17922014	hereditary breast ovarian cancer	DOID_5683
4335	PUJANA_CHEK2_PCC_NETWORK	17922014	monogenic disease	DOID_0050177
4336	PUJANA_CHEK2_PCC_NETWORK	17922014	organ system cancer	DOID_0050686
4337	PUJANA_CHEK2_PCC_NETWORK	17922014	thoracic cancer	DOID_5093
4338	PUJANA_BRCA_CENTERED_NETWORK	17922014	autosomal dominant disease	DOID_0050736
4339	PUJANA_BRCA_CENTERED_NETWORK	17922014	autosomal genetic disease	DOID_0050739
4340	PUJANA_BRCA_CENTERED_NETWORK	17922014	breast cancer	DOID_1612
4341	PUJANA_BRCA_CENTERED_NETWORK	17922014	cancer	DOID_162
4342	PUJANA_BRCA_CENTERED_NETWORK	17922014	disease of cellular proliferation	DOID_14566
4343	PUJANA_BRCA_CENTERED_NETWORK	17922014	genetic disease	DOID_630
4344	PUJANA_BRCA_CENTERED_NETWORK	17922014	hereditary breast ovarian cancer	DOID_5683
4345	PUJANA_BRCA_CENTERED_NETWORK	17922014	monogenic disease	DOID_0050177
4346	PUJANA_BRCA_CENTERED_NETWORK	17922014	organ system cancer	DOID_0050686
4347	PUJANA_BRCA_CENTERED_NETWORK	17922014	thoracic cancer	DOID_5093
4348	SCHLESINGER_H3K27ME3_IN_NORMAL_AND_METHYLATED_IN_CANCER	17200670	cancer	DOID_162
4349	SCHLESINGER_H3K27ME3_IN_NORMAL_AND_METHYLATED_IN_CANCER	17200670	disease of cellular proliferation	DOID_14566
4350	SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER	17200670	cancer	DOID_162
4351	SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER	17200670	disease of cellular proliferation	DOID_14566
4352	GOERING_BLOOD_HDL_CHOLESTEROL_QTL_CIS	17873875	NA	NA
4353	OHM_METHYLATED_IN_ADULT_CANCERS	17211412	cancer	DOID_162
4354	OHM_METHYLATED_IN_ADULT_CANCERS	17211412	carcinoma	DOID_305
4355	OHM_METHYLATED_IN_ADULT_CANCERS	17211412	cell type cancer	DOID_0050687
4356	OHM_METHYLATED_IN_ADULT_CANCERS	17211412	disease of cellular proliferation	DOID_14566
4357	ALCALA_APOPTOSIS	17621274	NA	NA
4358	OKAWA_NEUROBLASTOMA_1P36_31_DELETION	17667943	autonomic nervous system neoplasm	DOID_2621
4359	OKAWA_NEUROBLASTOMA_1P36_31_DELETION	17667943	cancer	DOID_162
4360	OKAWA_NEUROBLASTOMA_1P36_31_DELETION	17667943	disease of cellular proliferation	DOID_14566
4361	OKAWA_NEUROBLASTOMA_1P36_31_DELETION	17667943	nervous system cancer	DOID_3093
4362	OKAWA_NEUROBLASTOMA_1P36_31_DELETION	17667943	neuroblastoma	DOID_769
4363	OKAWA_NEUROBLASTOMA_1P36_31_DELETION	17667943	organ system cancer	DOID_0050686
4364	OKAWA_NEUROBLASTOMA_1P36_31_DELETION	17667943	peripheral nervous system neoplasm	DOID_1192
4365	COWLING_MYCN_TARGETS	17704800	NA	NA
4366	FALVELLA_SMOKERS_WITH_LUNG_CANCER	17724461	adenocarcinoma	DOID_299
4367	FALVELLA_SMOKERS_WITH_LUNG_CANCER	17724461	cancer	DOID_162
4368	FALVELLA_SMOKERS_WITH_LUNG_CANCER	17724461	carcinoma	DOID_305
4369	FALVELLA_SMOKERS_WITH_LUNG_CANCER	17724461	cell type cancer	DOID_0050687
4370	FALVELLA_SMOKERS_WITH_LUNG_CANCER	17724461	disease of cellular proliferation	DOID_14566
4371	FALVELLA_SMOKERS_WITH_LUNG_CANCER	17724461	lung adenocarcinoma	DOID_3910
4372	FALVELLA_SMOKERS_WITH_LUNG_CANCER	17724461	lung cancer	DOID_1324
4373	FALVELLA_SMOKERS_WITH_LUNG_CANCER	17724461	lung carcinoma	DOID_3905
4374	FALVELLA_SMOKERS_WITH_LUNG_CANCER	17724461	mucoepidermoid carcinoma	DOID_4531
4375	FALVELLA_SMOKERS_WITH_LUNG_CANCER	17724461	non-small cell lung carcinoma	DOID_3908
4376	FALVELLA_SMOKERS_WITH_LUNG_CANCER	17724461	organ system cancer	DOID_0050686
4377	FALVELLA_SMOKERS_WITH_LUNG_CANCER	17724461	respiratory system cancer	DOID_0050615
4378	OZEN_MIR125B1_TARGETS	17891175	cancer	DOID_162
4379	OZEN_MIR125B1_TARGETS	17891175	disease of cellular proliferation	DOID_14566
4380	OZEN_MIR125B1_TARGETS	17891175	male reproductive organ cancer	DOID_3856
4381	OZEN_MIR125B1_TARGETS	17891175	organ system cancer	DOID_0050686
4382	OZEN_MIR125B1_TARGETS	17891175	prostate cancer	DOID_10283
4383	OZEN_MIR125B1_TARGETS	17891175	reproductive organ cancer	DOID_193
4384	KAUFFMANN_MELANOMA_RELAPSE_UP	17891185	cancer	DOID_162
4385	KAUFFMANN_MELANOMA_RELAPSE_UP	17891185	cell type cancer	DOID_0050687
4386	KAUFFMANN_MELANOMA_RELAPSE_UP	17891185	disease of cellular proliferation	DOID_14566
4387	KAUFFMANN_MELANOMA_RELAPSE_UP	17891185	melanoma	DOID_1909
4388	KAUFFMANN_MELANOMA_RELAPSE_UP	17891185	metastatic melanoma	DOID_4358
4389	WILLIAMS_ESR1_TARGETS_UP	17700529	breast cancer	DOID_1612
4390	WILLIAMS_ESR1_TARGETS_UP	17700529	cancer	DOID_162
4391	WILLIAMS_ESR1_TARGETS_UP	17700529	disease of cellular proliferation	DOID_14566
4392	WILLIAMS_ESR1_TARGETS_UP	17700529	organ system cancer	DOID_0050686
4393	WILLIAMS_ESR1_TARGETS_UP	17700529	thoracic cancer	DOID_5093
4394	WILLIAMS_ESR2_TARGETS_UP	17700529	breast cancer	DOID_1612
4395	WILLIAMS_ESR2_TARGETS_UP	17700529	cancer	DOID_162
4396	WILLIAMS_ESR2_TARGETS_UP	17700529	disease of cellular proliferation	DOID_14566
4397	WILLIAMS_ESR2_TARGETS_UP	17700529	organ system cancer	DOID_0050686
4398	WILLIAMS_ESR2_TARGETS_UP	17700529	thoracic cancer	DOID_5093
4399	NUYTTEN_NIPP1_TARGETS_UP	17724462	cancer	DOID_162
4400	NUYTTEN_NIPP1_TARGETS_UP	17724462	disease of cellular proliferation	DOID_14566
4401	NUYTTEN_NIPP1_TARGETS_DN	17724462	cancer	DOID_162
4402	NUYTTEN_NIPP1_TARGETS_DN	17724462	disease of cellular proliferation	DOID_14566
4403	NUYTTEN_EZH2_TARGETS_UP	17724462	cancer	DOID_162
4404	NUYTTEN_EZH2_TARGETS_UP	17724462	disease of cellular proliferation	DOID_14566
4405	NUYTTEN_EZH2_TARGETS_DN	17724462	cancer	DOID_162
4406	NUYTTEN_EZH2_TARGETS_DN	17724462	disease of cellular proliferation	DOID_14566
4407	BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP	17952126	cancer	DOID_162
4408	BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP	17952126	disease of cellular proliferation	DOID_14566
4409	BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP	17952126	organ system cancer	DOID_0050686
4410	BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP	17952126	urinary bladder cancer	DOID_11054
4411	BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP	17952126	urinary system cancer	DOID_3996
4412	BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN	17952126	cancer	DOID_162
4413	BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN	17952126	disease of cellular proliferation	DOID_14566
4414	BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN	17952126	organ system cancer	DOID_0050686
4415	BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN	17952126	urinary bladder cancer	DOID_11054
4416	BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN	17952126	urinary system cancer	DOID_3996
4417	FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP	17952124	cancer	DOID_162
4418	FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP	17952124	cell type cancer	DOID_0050687
4419	FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP	17952124	disease of cellular proliferation	DOID_14566
4420	FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP	17952124	sarcoma	DOID_1115
4421	FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_DN	17952124	cancer	DOID_162
4422	FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_DN	17952124	cell type cancer	DOID_0050687
4423	FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_DN	17952124	disease of cellular proliferation	DOID_14566
4424	FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_DN	17952124	sarcoma	DOID_1115
4425	NAKAYAMA_FRA2_TARGETS	18071306	adult T-cell leukemia	DOID_0050523
4426	NAKAYAMA_FRA2_TARGETS	18071306	cancer	DOID_162
4427	NAKAYAMA_FRA2_TARGETS	18071306	disease of cellular proliferation	DOID_14566
4428	NAKAYAMA_FRA2_TARGETS	18071306	hematologic cancer	DOID_2531
4429	NAKAYAMA_FRA2_TARGETS	18071306	immune system cancer	DOID_0060083
4430	NAKAYAMA_FRA2_TARGETS	18071306	leukemia	DOID_1240
4431	NAKAYAMA_FRA2_TARGETS	18071306	lymphoblastic leukemia	DOID_1037
4432	NAKAYAMA_FRA2_TARGETS	18071306	lymphoid leukemia	DOID_10747
4433	NAKAYAMA_FRA2_TARGETS	18071306	organ system cancer	DOID_0050686
4434	NAKAYAMA_FRA2_TARGETS	18071306	T-cell leukemia	DOID_715
4435	LOPEZ_MBD_TARGETS	18223687	cancer	DOID_162
4436	LOPEZ_MBD_TARGETS	18223687	disease of cellular proliferation	DOID_14566
4437	LOPEZ_MBD_TARGETS_IMPRINTED_AND_X_LINKED	18223687	cancer	DOID_162
4438	LOPEZ_MBD_TARGETS_IMPRINTED_AND_X_LINKED	18223687	disease of cellular proliferation	DOID_14566
4439	ROPERO_HDAC2_TARGETS	18264134	autosomal dominant disease	DOID_0050736
4440	ROPERO_HDAC2_TARGETS	18264134	autosomal genetic disease	DOID_0050739
4441	ROPERO_HDAC2_TARGETS	18264134	cancer	DOID_162
4442	ROPERO_HDAC2_TARGETS	18264134	colorectal cancer	DOID_9256
4443	ROPERO_HDAC2_TARGETS	18264134	disease of cellular proliferation	DOID_14566
4444	ROPERO_HDAC2_TARGETS	18264134	gastrointestinal system cancer	DOID_3119
4445	ROPERO_HDAC2_TARGETS	18264134	genetic disease	DOID_630
4446	ROPERO_HDAC2_TARGETS	18264134	intestinal cancer	DOID_10155
4447	ROPERO_HDAC2_TARGETS	18264134	large intestine cancer	DOID_5672
4448	ROPERO_HDAC2_TARGETS	18264134	Lynch syndrome	DOID_3883
4449	ROPERO_HDAC2_TARGETS	18264134	monogenic disease	DOID_0050177
4450	ROPERO_HDAC2_TARGETS	18264134	organ system cancer	DOID_0050686
4451	ROPERO_HDAC2_TARGETS	18264134	syndrome	DOID_225
4452	LIU_LIVER_CANCER	18332864	breast cancer	DOID_1612
4453	LIU_LIVER_CANCER	18332864	breast carcinoma	DOID_3459
4454	LIU_LIVER_CANCER	18332864	cancer	DOID_162
4455	LIU_LIVER_CANCER	18332864	carcinoma	DOID_305
4456	LIU_LIVER_CANCER	18332864	cell type cancer	DOID_0050687
4457	LIU_LIVER_CANCER	18332864	disease of cellular proliferation	DOID_14566
4458	LIU_LIVER_CANCER	18332864	gastrointestinal system cancer	DOID_3119
4459	LIU_LIVER_CANCER	18332864	hepatocellular carcinoma	DOID_684
4460	LIU_LIVER_CANCER	18332864	liver cancer	DOID_3571
4461	LIU_LIVER_CANCER	18332864	liver carcinoma	DOID_686
4462	LIU_LIVER_CANCER	18332864	nasopharynx carcinoma	DOID_9261
4463	LIU_LIVER_CANCER	18332864	organ system cancer	DOID_0050686
4464	LIU_LIVER_CANCER	18332864	respiratory system cancer	DOID_0050615
4465	LIU_LIVER_CANCER	18332864	thoracic cancer	DOID_5093
4466	LIU_BREAST_CANCER	18332864	breast cancer	DOID_1612
4467	LIU_BREAST_CANCER	18332864	breast carcinoma	DOID_3459
4468	LIU_BREAST_CANCER	18332864	cancer	DOID_162
4469	LIU_BREAST_CANCER	18332864	carcinoma	DOID_305
4470	LIU_BREAST_CANCER	18332864	cell type cancer	DOID_0050687
4471	LIU_BREAST_CANCER	18332864	disease of cellular proliferation	DOID_14566
4472	LIU_BREAST_CANCER	18332864	gastrointestinal system cancer	DOID_3119
4473	LIU_BREAST_CANCER	18332864	hepatocellular carcinoma	DOID_684
4474	LIU_BREAST_CANCER	18332864	liver cancer	DOID_3571
4475	LIU_BREAST_CANCER	18332864	liver carcinoma	DOID_686
4476	LIU_BREAST_CANCER	18332864	nasopharynx carcinoma	DOID_9261
4477	LIU_BREAST_CANCER	18332864	organ system cancer	DOID_0050686
4478	LIU_BREAST_CANCER	18332864	respiratory system cancer	DOID_0050615
4479	LIU_BREAST_CANCER	18332864	thoracic cancer	DOID_5093
4480	LIU_NASOPHARYNGEAL_CARCINOMA	18332864	breast cancer	DOID_1612
4481	LIU_NASOPHARYNGEAL_CARCINOMA	18332864	breast carcinoma	DOID_3459
4482	LIU_NASOPHARYNGEAL_CARCINOMA	18332864	cancer	DOID_162
4483	LIU_NASOPHARYNGEAL_CARCINOMA	18332864	carcinoma	DOID_305
4484	LIU_NASOPHARYNGEAL_CARCINOMA	18332864	cell type cancer	DOID_0050687
4485	LIU_NASOPHARYNGEAL_CARCINOMA	18332864	disease of cellular proliferation	DOID_14566
4486	LIU_NASOPHARYNGEAL_CARCINOMA	18332864	gastrointestinal system cancer	DOID_3119
4487	LIU_NASOPHARYNGEAL_CARCINOMA	18332864	hepatocellular carcinoma	DOID_684
4488	LIU_NASOPHARYNGEAL_CARCINOMA	18332864	liver cancer	DOID_3571
4489	LIU_NASOPHARYNGEAL_CARCINOMA	18332864	liver carcinoma	DOID_686
4490	LIU_NASOPHARYNGEAL_CARCINOMA	18332864	nasopharynx carcinoma	DOID_9261
4491	LIU_NASOPHARYNGEAL_CARCINOMA	18332864	organ system cancer	DOID_0050686
4492	LIU_NASOPHARYNGEAL_CARCINOMA	18332864	respiratory system cancer	DOID_0050615
4493	LIU_NASOPHARYNGEAL_CARCINOMA	18332864	thoracic cancer	DOID_5093
4494	LIU_COMMON_CANCER_GENES	18332864	breast cancer	DOID_1612
4495	LIU_COMMON_CANCER_GENES	18332864	breast carcinoma	DOID_3459
4496	LIU_COMMON_CANCER_GENES	18332864	cancer	DOID_162
4497	LIU_COMMON_CANCER_GENES	18332864	carcinoma	DOID_305
4498	LIU_COMMON_CANCER_GENES	18332864	cell type cancer	DOID_0050687
4499	LIU_COMMON_CANCER_GENES	18332864	disease of cellular proliferation	DOID_14566
4500	LIU_COMMON_CANCER_GENES	18332864	gastrointestinal system cancer	DOID_3119
4501	LIU_COMMON_CANCER_GENES	18332864	hepatocellular carcinoma	DOID_684
4502	LIU_COMMON_CANCER_GENES	18332864	liver cancer	DOID_3571
4503	LIU_COMMON_CANCER_GENES	18332864	liver carcinoma	DOID_686
4504	LIU_COMMON_CANCER_GENES	18332864	nasopharynx carcinoma	DOID_9261
4505	LIU_COMMON_CANCER_GENES	18332864	organ system cancer	DOID_0050686
4506	LIU_COMMON_CANCER_GENES	18332864	respiratory system cancer	DOID_0050615
4507	LIU_COMMON_CANCER_GENES	18332864	thoracic cancer	DOID_5093
4508	LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER	18391978	cancer	DOID_162
4509	LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER	18391978	disease of cellular proliferation	DOID_14566
4510	LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER	18391978	lung cancer	DOID_1324
4511	LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER	18391978	organ system cancer	DOID_0050686
4512	LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER	18391978	respiratory system cancer	DOID_0050615
4513	WEI_MIR34A_TARGETS	18504438	autonomic nervous system neoplasm	DOID_2621
4514	WEI_MIR34A_TARGETS	18504438	cancer	DOID_162
4515	WEI_MIR34A_TARGETS	18504438	disease of cellular proliferation	DOID_14566
4516	WEI_MIR34A_TARGETS	18504438	nervous system cancer	DOID_3093
4517	WEI_MIR34A_TARGETS	18504438	neuroblastoma	DOID_769
4518	WEI_MIR34A_TARGETS	18504438	organ system cancer	DOID_0050686
4519	WEI_MIR34A_TARGETS	18504438	peripheral nervous system neoplasm	DOID_1192
4520	WEI_MYCN_TARGETS_WITH_E_BOX	18504438	autonomic nervous system neoplasm	DOID_2621
4521	WEI_MYCN_TARGETS_WITH_E_BOX	18504438	cancer	DOID_162
4522	WEI_MYCN_TARGETS_WITH_E_BOX	18504438	disease of cellular proliferation	DOID_14566
4523	WEI_MYCN_TARGETS_WITH_E_BOX	18504438	nervous system cancer	DOID_3093
4524	WEI_MYCN_TARGETS_WITH_E_BOX	18504438	neuroblastoma	DOID_769
4525	WEI_MYCN_TARGETS_WITH_E_BOX	18504438	organ system cancer	DOID_0050686
4526	WEI_MYCN_TARGETS_WITH_E_BOX	18504438	peripheral nervous system neoplasm	DOID_1192
4527	LIAO_HAVE_SOX4_BINDING_SITES	18504433	cancer	DOID_162
4528	LIAO_HAVE_SOX4_BINDING_SITES	18504433	carcinoma	DOID_305
4529	LIAO_HAVE_SOX4_BINDING_SITES	18504433	cell type cancer	DOID_0050687
4530	LIAO_HAVE_SOX4_BINDING_SITES	18504433	disease of cellular proliferation	DOID_14566
4531	LIAO_HAVE_SOX4_BINDING_SITES	18504433	gastrointestinal system cancer	DOID_3119
4532	LIAO_HAVE_SOX4_BINDING_SITES	18504433	hepatocellular carcinoma	DOID_684
4533	LIAO_HAVE_SOX4_BINDING_SITES	18504433	liver cancer	DOID_3571
4534	LIAO_HAVE_SOX4_BINDING_SITES	18504433	liver carcinoma	DOID_686
4535	LIAO_HAVE_SOX4_BINDING_SITES	18504433	organ system cancer	DOID_0050686
4536	LIAO_METASTASIS	18504433	cancer	DOID_162
4537	LIAO_METASTASIS	18504433	carcinoma	DOID_305
4538	LIAO_METASTASIS	18504433	cell type cancer	DOID_0050687
4539	LIAO_METASTASIS	18504433	disease of cellular proliferation	DOID_14566
4540	LIAO_METASTASIS	18504433	gastrointestinal system cancer	DOID_3119
4541	LIAO_METASTASIS	18504433	hepatocellular carcinoma	DOID_684
4542	LIAO_METASTASIS	18504433	liver cancer	DOID_3571
4543	LIAO_METASTASIS	18504433	liver carcinoma	DOID_686
4544	LIAO_METASTASIS	18504433	organ system cancer	DOID_0050686
4545	TONG_INTERACT_WITH_PTTG1	18663361	NA	NA
4546	SCIAN_CELL_CYCLE_TARGETS_OF_TP53_AND_TP73_DN	17982488	cancer	DOID_162
4547	SCIAN_CELL_CYCLE_TARGETS_OF_TP53_AND_TP73_DN	17982488	carcinoma	DOID_305
4548	SCIAN_CELL_CYCLE_TARGETS_OF_TP53_AND_TP73_DN	17982488	cell type cancer	DOID_0050687
4549	SCIAN_CELL_CYCLE_TARGETS_OF_TP53_AND_TP73_DN	17982488	colon cancer	DOID_219
4550	SCIAN_CELL_CYCLE_TARGETS_OF_TP53_AND_TP73_DN	17982488	colon carcinoma	DOID_1520
4551	SCIAN_CELL_CYCLE_TARGETS_OF_TP53_AND_TP73_DN	17982488	colorectal cancer	DOID_9256
4552	SCIAN_CELL_CYCLE_TARGETS_OF_TP53_AND_TP73_DN	17982488	disease of cellular proliferation	DOID_14566
4553	SCIAN_CELL_CYCLE_TARGETS_OF_TP53_AND_TP73_DN	17982488	gastrointestinal system cancer	DOID_3119
4554	SCIAN_CELL_CYCLE_TARGETS_OF_TP53_AND_TP73_DN	17982488	intestinal cancer	DOID_10155
4555	SCIAN_CELL_CYCLE_TARGETS_OF_TP53_AND_TP73_DN	17982488	large intestine cancer	DOID_5672
4556	SCIAN_CELL_CYCLE_TARGETS_OF_TP53_AND_TP73_DN	17982488	lung cancer	DOID_1324
4557	SCIAN_CELL_CYCLE_TARGETS_OF_TP53_AND_TP73_DN	17982488	lung carcinoma	DOID_3905
4558	SCIAN_CELL_CYCLE_TARGETS_OF_TP53_AND_TP73_DN	17982488	organ system cancer	DOID_0050686
4559	SCIAN_CELL_CYCLE_TARGETS_OF_TP53_AND_TP73_DN	17982488	respiratory system cancer	DOID_0050615
4560	SCIAN_INVERSED_TARGETS_OF_TP53_AND_TP73_DN	17982488	cancer	DOID_162
4561	SCIAN_INVERSED_TARGETS_OF_TP53_AND_TP73_DN	17982488	carcinoma	DOID_305
4562	SCIAN_INVERSED_TARGETS_OF_TP53_AND_TP73_DN	17982488	cell type cancer	DOID_0050687
4563	SCIAN_INVERSED_TARGETS_OF_TP53_AND_TP73_DN	17982488	colon cancer	DOID_219
4564	SCIAN_INVERSED_TARGETS_OF_TP53_AND_TP73_DN	17982488	colon carcinoma	DOID_1520
4565	SCIAN_INVERSED_TARGETS_OF_TP53_AND_TP73_DN	17982488	colorectal cancer	DOID_9256
4566	SCIAN_INVERSED_TARGETS_OF_TP53_AND_TP73_DN	17982488	disease of cellular proliferation	DOID_14566
4567	SCIAN_INVERSED_TARGETS_OF_TP53_AND_TP73_DN	17982488	gastrointestinal system cancer	DOID_3119
4568	SCIAN_INVERSED_TARGETS_OF_TP53_AND_TP73_DN	17982488	intestinal cancer	DOID_10155
4569	SCIAN_INVERSED_TARGETS_OF_TP53_AND_TP73_DN	17982488	large intestine cancer	DOID_5672
4570	SCIAN_INVERSED_TARGETS_OF_TP53_AND_TP73_DN	17982488	lung cancer	DOID_1324
4571	SCIAN_INVERSED_TARGETS_OF_TP53_AND_TP73_DN	17982488	lung carcinoma	DOID_3905
4572	SCIAN_INVERSED_TARGETS_OF_TP53_AND_TP73_DN	17982488	organ system cancer	DOID_0050686
4573	SCIAN_INVERSED_TARGETS_OF_TP53_AND_TP73_DN	17982488	respiratory system cancer	DOID_0050615
4574	GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_UP	18037961	astrocytoma	DOID_3069
4575	GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_UP	18037961	cancer	DOID_162
4576	GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_UP	18037961	cell type cancer	DOID_0050687
4577	GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_UP	18037961	disease of cellular proliferation	DOID_14566
4578	GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_UP	18037961	glioblastoma	DOID_3068
4579	GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_UP	18037961	malignant glioma	DOID_3070
4580	GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN	18037961	astrocytoma	DOID_3069
4581	GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN	18037961	cancer	DOID_162
4582	GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN	18037961	cell type cancer	DOID_0050687
4583	GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN	18037961	disease of cellular proliferation	DOID_14566
4584	GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN	18037961	glioblastoma	DOID_3068
4585	GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN	18037961	malignant glioma	DOID_3070
4586	SCHWAB_TARGETS_OF_BMYB_S427G_UP	18026132	cancer	DOID_162
4587	SCHWAB_TARGETS_OF_BMYB_S427G_UP	18026132	disease of cellular proliferation	DOID_14566
4588	SCHWAB_TARGETS_OF_BMYB_S427G_UP	18026132	neoplastic disease	DOID_0070001
4589	SCHWAB_TARGETS_OF_BMYB_S427G_DN	18026132	cancer	DOID_162
4590	SCHWAB_TARGETS_OF_BMYB_S427G_DN	18026132	disease of cellular proliferation	DOID_14566
4591	SCHWAB_TARGETS_OF_BMYB_S427G_DN	18026132	neoplastic disease	DOID_0070001
4592	SCHWAB_TARGETS_OF_BMYB_I624M_UP	18026132	cancer	DOID_162
4593	SCHWAB_TARGETS_OF_BMYB_I624M_UP	18026132	disease of cellular proliferation	DOID_14566
4594	SCHWAB_TARGETS_OF_BMYB_I624M_UP	18026132	neoplastic disease	DOID_0070001
4595	SCHWAB_TARGETS_OF_BMYB_I624M_DN	18026132	cancer	DOID_162
4596	SCHWAB_TARGETS_OF_BMYB_I624M_DN	18026132	disease of cellular proliferation	DOID_14566
4597	SCHWAB_TARGETS_OF_BMYB_I624M_DN	18026132	neoplastic disease	DOID_0070001
4598	GOUYER_TATI_TARGETS_DN	18317448	adenoma	DOID_657
4599	GOUYER_TATI_TARGETS_DN	18317448	benign neoplasm	DOID_0060072
4600	GOUYER_TATI_TARGETS_DN	18317448	cancer	DOID_162
4601	GOUYER_TATI_TARGETS_DN	18317448	carcinoma	DOID_305
4602	GOUYER_TATI_TARGETS_DN	18317448	cell type benign neoplasm	DOID_0060084
4603	GOUYER_TATI_TARGETS_DN	18317448	cell type cancer	DOID_0050687
4604	GOUYER_TATI_TARGETS_DN	18317448	colon cancer	DOID_219
4605	GOUYER_TATI_TARGETS_DN	18317448	colon carcinoma	DOID_1520
4606	GOUYER_TATI_TARGETS_DN	18317448	colorectal cancer	DOID_9256
4607	GOUYER_TATI_TARGETS_DN	18317448	combined T cell and B cell immunodeficiency	DOID_628
4608	GOUYER_TATI_TARGETS_DN	18317448	disease of anatomical entity	DOID_7
4609	GOUYER_TATI_TARGETS_DN	18317448	disease of cellular proliferation	DOID_14566
4610	GOUYER_TATI_TARGETS_DN	18317448	gastrointestinal system cancer	DOID_3119
4611	GOUYER_TATI_TARGETS_DN	18317448	immune system disease	DOID_2914
4612	GOUYER_TATI_TARGETS_DN	18317448	intestinal cancer	DOID_10155
4613	GOUYER_TATI_TARGETS_DN	18317448	large intestine cancer	DOID_5672
4614	GOUYER_TATI_TARGETS_DN	18317448	organ system cancer	DOID_0050686
4615	GOUYER_TATI_TARGETS_DN	18317448	primary immunodeficiency disease	DOID_612
4616	GOUYER_TATI_TARGETS_DN	18317448	severe combined immunodeficiency	DOID_627
4617	CAFFAREL_RESPONSE_TO_THC_UP	18454173	breast cancer	DOID_1612
4618	CAFFAREL_RESPONSE_TO_THC_UP	18454173	cancer	DOID_162
4619	CAFFAREL_RESPONSE_TO_THC_UP	18454173	disease of cellular proliferation	DOID_14566
4620	CAFFAREL_RESPONSE_TO_THC_UP	18454173	organ system cancer	DOID_0050686
4621	CAFFAREL_RESPONSE_TO_THC_UP	18454173	thoracic cancer	DOID_5093
4622	CAFFAREL_RESPONSE_TO_THC_DN	18454173	breast cancer	DOID_1612
4623	CAFFAREL_RESPONSE_TO_THC_DN	18454173	cancer	DOID_162
4624	CAFFAREL_RESPONSE_TO_THC_DN	18454173	disease of cellular proliferation	DOID_14566
4625	CAFFAREL_RESPONSE_TO_THC_DN	18454173	organ system cancer	DOID_0050686
4626	CAFFAREL_RESPONSE_TO_THC_DN	18454173	thoracic cancer	DOID_5093
4627	CAFFAREL_RESPONSE_TO_THC_8HR_5_UP	18454173	breast cancer	DOID_1612
4628	CAFFAREL_RESPONSE_TO_THC_8HR_5_UP	18454173	cancer	DOID_162
4629	CAFFAREL_RESPONSE_TO_THC_8HR_5_UP	18454173	disease of cellular proliferation	DOID_14566
4630	CAFFAREL_RESPONSE_TO_THC_8HR_5_UP	18454173	organ system cancer	DOID_0050686
4631	CAFFAREL_RESPONSE_TO_THC_8HR_5_UP	18454173	thoracic cancer	DOID_5093
4632	CAFFAREL_RESPONSE_TO_THC_8HR_5_DN	18454173	breast cancer	DOID_1612
4633	CAFFAREL_RESPONSE_TO_THC_8HR_5_DN	18454173	cancer	DOID_162
4634	CAFFAREL_RESPONSE_TO_THC_8HR_5_DN	18454173	disease of cellular proliferation	DOID_14566
4635	CAFFAREL_RESPONSE_TO_THC_8HR_5_DN	18454173	organ system cancer	DOID_0050686
4636	CAFFAREL_RESPONSE_TO_THC_8HR_5_DN	18454173	thoracic cancer	DOID_5093
4637	CAFFAREL_RESPONSE_TO_THC_24HR_3_DN	18454173	breast cancer	DOID_1612
4638	CAFFAREL_RESPONSE_TO_THC_24HR_3_DN	18454173	cancer	DOID_162
4639	CAFFAREL_RESPONSE_TO_THC_24HR_3_DN	18454173	disease of cellular proliferation	DOID_14566
4640	CAFFAREL_RESPONSE_TO_THC_24HR_3_DN	18454173	organ system cancer	DOID_0050686
4641	CAFFAREL_RESPONSE_TO_THC_24HR_3_DN	18454173	thoracic cancer	DOID_5093
4642	CAFFAREL_RESPONSE_TO_THC_24HR_5_UP	18454173	breast cancer	DOID_1612
4643	CAFFAREL_RESPONSE_TO_THC_24HR_5_UP	18454173	cancer	DOID_162
4644	CAFFAREL_RESPONSE_TO_THC_24HR_5_UP	18454173	disease of cellular proliferation	DOID_14566
4645	CAFFAREL_RESPONSE_TO_THC_24HR_5_UP	18454173	organ system cancer	DOID_0050686
4646	CAFFAREL_RESPONSE_TO_THC_24HR_5_UP	18454173	thoracic cancer	DOID_5093
4647	CAFFAREL_RESPONSE_TO_THC_24HR_5_DN	18454173	breast cancer	DOID_1612
4648	CAFFAREL_RESPONSE_TO_THC_24HR_5_DN	18454173	cancer	DOID_162
4649	CAFFAREL_RESPONSE_TO_THC_24HR_5_DN	18454173	disease of cellular proliferation	DOID_14566
4650	CAFFAREL_RESPONSE_TO_THC_24HR_5_DN	18454173	organ system cancer	DOID_0050686
4651	CAFFAREL_RESPONSE_TO_THC_24HR_5_DN	18454173	thoracic cancer	DOID_5093
4652	BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_UP	18490921	breast cancer	DOID_1612
4653	BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_UP	18490921	breast carcinoma	DOID_3459
4654	BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_UP	18490921	cancer	DOID_162
4655	BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_UP	18490921	carcinoma	DOID_305
4656	BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_UP	18490921	cell type cancer	DOID_0050687
4657	BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_UP	18490921	disease of cellular proliferation	DOID_14566
4658	BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_UP	18490921	organ system cancer	DOID_0050686
4659	BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_UP	18490921	thoracic cancer	DOID_5093
4660	BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN	18490921	breast cancer	DOID_1612
4661	BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN	18490921	breast carcinoma	DOID_3459
4662	BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN	18490921	cancer	DOID_162
4663	BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN	18490921	carcinoma	DOID_305
4664	BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN	18490921	cell type cancer	DOID_0050687
4665	BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN	18490921	disease of cellular proliferation	DOID_14566
4666	BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN	18490921	organ system cancer	DOID_0050686
4667	BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN	18490921	thoracic cancer	DOID_5093
4668	GARCIA_TARGETS_OF_FLI1_AND_DAX1_UP	18591936	cancer	DOID_162
4669	GARCIA_TARGETS_OF_FLI1_AND_DAX1_UP	18591936	cell type cancer	DOID_0050687
4670	GARCIA_TARGETS_OF_FLI1_AND_DAX1_UP	18591936	disease of cellular proliferation	DOID_14566
4671	GARCIA_TARGETS_OF_FLI1_AND_DAX1_UP	18591936	nervous system cancer	DOID_3093
4672	GARCIA_TARGETS_OF_FLI1_AND_DAX1_UP	18591936	organ system cancer	DOID_0050686
4673	GARCIA_TARGETS_OF_FLI1_AND_DAX1_UP	18591936	peripheral nervous system neoplasm	DOID_1192
4674	GARCIA_TARGETS_OF_FLI1_AND_DAX1_UP	18591936	peripheral primitive neuroectodermal tumor	DOID_3369
4675	GARCIA_TARGETS_OF_FLI1_AND_DAX1_UP	18591936	sarcoma	DOID_1115
4676	GARCIA_TARGETS_OF_FLI1_AND_DAX1_DN	18591936	cancer	DOID_162
4677	GARCIA_TARGETS_OF_FLI1_AND_DAX1_DN	18591936	cell type cancer	DOID_0050687
4678	GARCIA_TARGETS_OF_FLI1_AND_DAX1_DN	18591936	disease of cellular proliferation	DOID_14566
4679	GARCIA_TARGETS_OF_FLI1_AND_DAX1_DN	18591936	nervous system cancer	DOID_3093
4680	GARCIA_TARGETS_OF_FLI1_AND_DAX1_DN	18591936	organ system cancer	DOID_0050686
4681	GARCIA_TARGETS_OF_FLI1_AND_DAX1_DN	18591936	peripheral nervous system neoplasm	DOID_1192
4682	GARCIA_TARGETS_OF_FLI1_AND_DAX1_DN	18591936	peripheral primitive neuroectodermal tumor	DOID_3369
4683	GARCIA_TARGETS_OF_FLI1_AND_DAX1_DN	18591936	sarcoma	DOID_1115
4684	RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_UP	18679425	cancer	DOID_162
4685	RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_UP	18679425	carcinoma	DOID_305
4686	RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_UP	18679425	cell type cancer	DOID_0050687
4687	RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_UP	18679425	disease of cellular proliferation	DOID_14566
4688	RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN	18679425	cancer	DOID_162
4689	RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN	18679425	carcinoma	DOID_305
4690	RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN	18679425	cell type cancer	DOID_0050687
4691	RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN	18679425	disease of cellular proliferation	DOID_14566
4692	RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_UP	18679425	cancer	DOID_162
4693	RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_UP	18679425	carcinoma	DOID_305
4694	RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_UP	18679425	cell type cancer	DOID_0050687
4695	RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_UP	18679425	disease of cellular proliferation	DOID_14566
4696	RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN	18679425	cancer	DOID_162
4697	RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN	18679425	carcinoma	DOID_305
4698	RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN	18679425	cell type cancer	DOID_0050687
4699	RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN	18679425	disease of cellular proliferation	DOID_14566
4700	RICKMAN_TUMOR_DIFFERENTIATED_MODERATELY_VS_POORLY_UP	18679425	cancer	DOID_162
4701	RICKMAN_TUMOR_DIFFERENTIATED_MODERATELY_VS_POORLY_UP	18679425	carcinoma	DOID_305
4702	RICKMAN_TUMOR_DIFFERENTIATED_MODERATELY_VS_POORLY_UP	18679425	cell type cancer	DOID_0050687
4703	RICKMAN_TUMOR_DIFFERENTIATED_MODERATELY_VS_POORLY_UP	18679425	disease of cellular proliferation	DOID_14566
4704	RICKMAN_TUMOR_DIFFERENTIATED_MODERATELY_VS_POORLY_DN	18679425	cancer	DOID_162
4705	RICKMAN_TUMOR_DIFFERENTIATED_MODERATELY_VS_POORLY_DN	18679425	carcinoma	DOID_305
4706	RICKMAN_TUMOR_DIFFERENTIATED_MODERATELY_VS_POORLY_DN	18679425	cell type cancer	DOID_0050687
4707	RICKMAN_TUMOR_DIFFERENTIATED_MODERATELY_VS_POORLY_DN	18679425	disease of cellular proliferation	DOID_14566
4708	RICKMAN_METASTASIS_UP	18679425	cancer	DOID_162
4709	RICKMAN_METASTASIS_UP	18679425	carcinoma	DOID_305
4710	RICKMAN_METASTASIS_UP	18679425	cell type cancer	DOID_0050687
4711	RICKMAN_METASTASIS_UP	18679425	disease of cellular proliferation	DOID_14566
4712	RICKMAN_METASTASIS_DN	18679425	cancer	DOID_162
4713	RICKMAN_METASTASIS_DN	18679425	carcinoma	DOID_305
4714	RICKMAN_METASTASIS_DN	18679425	cell type cancer	DOID_0050687
4715	RICKMAN_METASTASIS_DN	18679425	disease of cellular proliferation	DOID_14566
4716	FRIDMAN_SENESCENCE_UP	18711403	cancer	DOID_162
4717	FRIDMAN_SENESCENCE_UP	18711403	disease of cellular proliferation	DOID_14566
4718	FRIDMAN_SENESCENCE_DN	18711403	cancer	DOID_162
4719	FRIDMAN_SENESCENCE_DN	18711403	disease of cellular proliferation	DOID_14566
4720	FRIDMAN_IMMORTALIZATION_DN	18711403	cancer	DOID_162
4721	FRIDMAN_IMMORTALIZATION_DN	18711403	disease of cellular proliferation	DOID_14566
4722	KOYAMA_SEMA3B_TARGETS_UP	18985860	acquired metabolic disease	DOID_0060158
4723	KOYAMA_SEMA3B_TARGETS_UP	18985860	calcinosis	DOID_182
4724	KOYAMA_SEMA3B_TARGETS_UP	18985860	calcium metabolism disease	DOID_10575
4725	KOYAMA_SEMA3B_TARGETS_UP	18985860	diffuse idiopathic skeletal hyperostosis	DOID_6652
4726	KOYAMA_SEMA3B_TARGETS_UP	18985860	disease of metabolism	DOID_0014667
4727	KOYAMA_SEMA3B_TARGETS_UP	18985860	mineral metabolism disease	DOID_0050032
4728	KOYAMA_SEMA3B_TARGETS_DN	18985860	acquired metabolic disease	DOID_0060158
4729	KOYAMA_SEMA3B_TARGETS_DN	18985860	calcinosis	DOID_182
4730	KOYAMA_SEMA3B_TARGETS_DN	18985860	calcium metabolism disease	DOID_10575
4731	KOYAMA_SEMA3B_TARGETS_DN	18985860	diffuse idiopathic skeletal hyperostosis	DOID_6652
4732	KOYAMA_SEMA3B_TARGETS_DN	18985860	disease of metabolism	DOID_0014667
4733	KOYAMA_SEMA3B_TARGETS_DN	18985860	mineral metabolism disease	DOID_0050032
4734	RICKMAN_HEAD_AND_NECK_CANCER_A	18679425	cancer	DOID_162
4735	RICKMAN_HEAD_AND_NECK_CANCER_A	18679425	carcinoma	DOID_305
4736	RICKMAN_HEAD_AND_NECK_CANCER_A	18679425	cell type cancer	DOID_0050687
4737	RICKMAN_HEAD_AND_NECK_CANCER_A	18679425	disease of cellular proliferation	DOID_14566
4738	RICKMAN_HEAD_AND_NECK_CANCER_B	18679425	cancer	DOID_162
4739	RICKMAN_HEAD_AND_NECK_CANCER_B	18679425	carcinoma	DOID_305
4740	RICKMAN_HEAD_AND_NECK_CANCER_B	18679425	cell type cancer	DOID_0050687
4741	RICKMAN_HEAD_AND_NECK_CANCER_B	18679425	disease of cellular proliferation	DOID_14566
4742	RICKMAN_HEAD_AND_NECK_CANCER_C	18679425	cancer	DOID_162
4743	RICKMAN_HEAD_AND_NECK_CANCER_C	18679425	carcinoma	DOID_305
4744	RICKMAN_HEAD_AND_NECK_CANCER_C	18679425	cell type cancer	DOID_0050687
4745	RICKMAN_HEAD_AND_NECK_CANCER_C	18679425	disease of cellular proliferation	DOID_14566
4746	RICKMAN_HEAD_AND_NECK_CANCER_D	18679425	cancer	DOID_162
4747	RICKMAN_HEAD_AND_NECK_CANCER_D	18679425	carcinoma	DOID_305
4748	RICKMAN_HEAD_AND_NECK_CANCER_D	18679425	cell type cancer	DOID_0050687
4749	RICKMAN_HEAD_AND_NECK_CANCER_D	18679425	disease of cellular proliferation	DOID_14566
4750	RICKMAN_HEAD_AND_NECK_CANCER_E	18679425	cancer	DOID_162
4751	RICKMAN_HEAD_AND_NECK_CANCER_E	18679425	carcinoma	DOID_305
4752	RICKMAN_HEAD_AND_NECK_CANCER_E	18679425	cell type cancer	DOID_0050687
4753	RICKMAN_HEAD_AND_NECK_CANCER_E	18679425	disease of cellular proliferation	DOID_14566
4754	RICKMAN_HEAD_AND_NECK_CANCER_F	18679425	cancer	DOID_162
4755	RICKMAN_HEAD_AND_NECK_CANCER_F	18679425	carcinoma	DOID_305
4756	RICKMAN_HEAD_AND_NECK_CANCER_F	18679425	cell type cancer	DOID_0050687
4757	RICKMAN_HEAD_AND_NECK_CANCER_F	18679425	disease of cellular proliferation	DOID_14566
4758	WU_CELL_MIGRATION	18724390	cancer	DOID_162
4759	WU_CELL_MIGRATION	18724390	disease of cellular proliferation	DOID_14566
4760	WU_CELL_MIGRATION	18724390	organ system cancer	DOID_0050686
4761	WU_CELL_MIGRATION	18724390	urinary bladder cancer	DOID_11054
4762	WU_CELL_MIGRATION	18724390	urinary system cancer	DOID_3996
4763	TAGHAVI_NEOPLASTIC_TRANSFORMATION	18762810	NA	NA
4764	COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_UP	16314830	astrocytoma	DOID_3069
4765	COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_UP	16314830	cancer	DOID_162
4766	COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_UP	16314830	cell type cancer	DOID_0050687
4767	COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_UP	16314830	disease of cellular proliferation	DOID_14566
4768	COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_UP	16314830	glioblastoma	DOID_3068
4769	COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_UP	16314830	malignant glioma	DOID_3070
4770	COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_UP	16314830	pilocytic astrocytoma	DOID_4851
4771	COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_DN	16314830	astrocytoma	DOID_3069
4772	COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_DN	16314830	cancer	DOID_162
4773	COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_DN	16314830	cell type cancer	DOID_0050687
4774	COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_DN	16314830	disease of cellular proliferation	DOID_14566
4775	COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_DN	16314830	glioblastoma	DOID_3068
4776	COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_DN	16314830	malignant glioma	DOID_3070
4777	COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_DN	16314830	pilocytic astrocytoma	DOID_4851
4778	AMIT_DELAYED_EARLY_GENES	17322878	NA	NA
4779	BENPORATH_ES_1	18443585	astrocytoma	DOID_3069
4780	BENPORATH_ES_1	18443585	cancer	DOID_162
4781	BENPORATH_ES_1	18443585	carcinoma	DOID_305
4782	BENPORATH_ES_1	18443585	cell type cancer	DOID_0050687
4783	BENPORATH_ES_1	18443585	disease of cellular proliferation	DOID_14566
4784	BENPORATH_ES_1	18443585	glioblastoma	DOID_3068
4785	BENPORATH_ES_1	18443585	malignant glioma	DOID_3070
4786	BENPORATH_ES_2	18443585	astrocytoma	DOID_3069
4787	BENPORATH_ES_2	18443585	cancer	DOID_162
4788	BENPORATH_ES_2	18443585	carcinoma	DOID_305
4789	BENPORATH_ES_2	18443585	cell type cancer	DOID_0050687
4790	BENPORATH_ES_2	18443585	disease of cellular proliferation	DOID_14566
4791	BENPORATH_ES_2	18443585	glioblastoma	DOID_3068
4792	BENPORATH_ES_2	18443585	malignant glioma	DOID_3070
4793	BENPORATH_NANOG_TARGETS	18443585	astrocytoma	DOID_3069
4794	BENPORATH_NANOG_TARGETS	18443585	cancer	DOID_162
4795	BENPORATH_NANOG_TARGETS	18443585	carcinoma	DOID_305
4796	BENPORATH_NANOG_TARGETS	18443585	cell type cancer	DOID_0050687
4797	BENPORATH_NANOG_TARGETS	18443585	disease of cellular proliferation	DOID_14566
4798	BENPORATH_NANOG_TARGETS	18443585	glioblastoma	DOID_3068
4799	BENPORATH_NANOG_TARGETS	18443585	malignant glioma	DOID_3070
4800	BENPORATH_OCT4_TARGETS	18443585	astrocytoma	DOID_3069
4801	BENPORATH_OCT4_TARGETS	18443585	cancer	DOID_162
4802	BENPORATH_OCT4_TARGETS	18443585	carcinoma	DOID_305
4803	BENPORATH_OCT4_TARGETS	18443585	cell type cancer	DOID_0050687
4804	BENPORATH_OCT4_TARGETS	18443585	disease of cellular proliferation	DOID_14566
4805	BENPORATH_OCT4_TARGETS	18443585	glioblastoma	DOID_3068
4806	BENPORATH_OCT4_TARGETS	18443585	malignant glioma	DOID_3070
4807	BENPORATH_SOX2_TARGETS	18443585	astrocytoma	DOID_3069
4808	BENPORATH_SOX2_TARGETS	18443585	cancer	DOID_162
4809	BENPORATH_SOX2_TARGETS	18443585	carcinoma	DOID_305
4810	BENPORATH_SOX2_TARGETS	18443585	cell type cancer	DOID_0050687
4811	BENPORATH_SOX2_TARGETS	18443585	disease of cellular proliferation	DOID_14566
4812	BENPORATH_SOX2_TARGETS	18443585	glioblastoma	DOID_3068
4813	BENPORATH_SOX2_TARGETS	18443585	malignant glioma	DOID_3070
4814	BENPORATH_NOS_TARGETS	18443585	astrocytoma	DOID_3069
4815	BENPORATH_NOS_TARGETS	18443585	cancer	DOID_162
4816	BENPORATH_NOS_TARGETS	18443585	carcinoma	DOID_305
4817	BENPORATH_NOS_TARGETS	18443585	cell type cancer	DOID_0050687
4818	BENPORATH_NOS_TARGETS	18443585	disease of cellular proliferation	DOID_14566
4819	BENPORATH_NOS_TARGETS	18443585	glioblastoma	DOID_3068
4820	BENPORATH_NOS_TARGETS	18443585	malignant glioma	DOID_3070
4821	BENPORATH_PRC2_TARGETS	18443585	astrocytoma	DOID_3069
4822	BENPORATH_PRC2_TARGETS	18443585	cancer	DOID_162
4823	BENPORATH_PRC2_TARGETS	18443585	carcinoma	DOID_305
4824	BENPORATH_PRC2_TARGETS	18443585	cell type cancer	DOID_0050687
4825	BENPORATH_PRC2_TARGETS	18443585	disease of cellular proliferation	DOID_14566
4826	BENPORATH_PRC2_TARGETS	18443585	glioblastoma	DOID_3068
4827	BENPORATH_PRC2_TARGETS	18443585	malignant glioma	DOID_3070
4828	BENPORATH_MYC_TARGETS_WITH_EBOX	18443585	astrocytoma	DOID_3069
4829	BENPORATH_MYC_TARGETS_WITH_EBOX	18443585	cancer	DOID_162
4830	BENPORATH_MYC_TARGETS_WITH_EBOX	18443585	carcinoma	DOID_305
4831	BENPORATH_MYC_TARGETS_WITH_EBOX	18443585	cell type cancer	DOID_0050687
4832	BENPORATH_MYC_TARGETS_WITH_EBOX	18443585	disease of cellular proliferation	DOID_14566
4833	BENPORATH_MYC_TARGETS_WITH_EBOX	18443585	glioblastoma	DOID_3068
4834	BENPORATH_MYC_TARGETS_WITH_EBOX	18443585	malignant glioma	DOID_3070
4835	BENPORATH_MYC_MAX_TARGETS	18443585	astrocytoma	DOID_3069
4836	BENPORATH_MYC_MAX_TARGETS	18443585	cancer	DOID_162
4837	BENPORATH_MYC_MAX_TARGETS	18443585	carcinoma	DOID_305
4838	BENPORATH_MYC_MAX_TARGETS	18443585	cell type cancer	DOID_0050687
4839	BENPORATH_MYC_MAX_TARGETS	18443585	disease of cellular proliferation	DOID_14566
4840	BENPORATH_MYC_MAX_TARGETS	18443585	glioblastoma	DOID_3068
4841	BENPORATH_MYC_MAX_TARGETS	18443585	malignant glioma	DOID_3070
4842	BENPORATH_CYCLING_GENES	18443585	astrocytoma	DOID_3069
4843	BENPORATH_CYCLING_GENES	18443585	cancer	DOID_162
4844	BENPORATH_CYCLING_GENES	18443585	carcinoma	DOID_305
4845	BENPORATH_CYCLING_GENES	18443585	cell type cancer	DOID_0050687
4846	BENPORATH_CYCLING_GENES	18443585	disease of cellular proliferation	DOID_14566
4847	BENPORATH_CYCLING_GENES	18443585	glioblastoma	DOID_3068
4848	BENPORATH_CYCLING_GENES	18443585	malignant glioma	DOID_3070
4849	BENPORATH_PROLIFERATION	18443585	astrocytoma	DOID_3069
4850	BENPORATH_PROLIFERATION	18443585	cancer	DOID_162
4851	BENPORATH_PROLIFERATION	18443585	carcinoma	DOID_305
4852	BENPORATH_PROLIFERATION	18443585	cell type cancer	DOID_0050687
4853	BENPORATH_PROLIFERATION	18443585	disease of cellular proliferation	DOID_14566
4854	BENPORATH_PROLIFERATION	18443585	glioblastoma	DOID_3068
4855	BENPORATH_PROLIFERATION	18443585	malignant glioma	DOID_3070
4856	PETRETTO_CARDIAC_HYPERTROPHY	18443592	aortic valve disease	DOID_62
4857	PETRETTO_CARDIAC_HYPERTROPHY	18443592	aortic valve stenosis	DOID_1712
4858	PETRETTO_CARDIAC_HYPERTROPHY	18443592	cardiovascular system disease	DOID_1287
4859	PETRETTO_CARDIAC_HYPERTROPHY	18443592	disease of anatomical entity	DOID_7
4860	PETRETTO_CARDIAC_HYPERTROPHY	18443592	heart disease	DOID_114
4861	PETRETTO_CARDIAC_HYPERTROPHY	18443592	heart valve disease	DOID_4079
4862	PETRETTO_CARDIAC_HYPERTROPHY	18443592	hypertension	DOID_10763
4863	PETRETTO_CARDIAC_HYPERTROPHY	18443592	vascular disease	DOID_178
4864	BENPORATH_ES_CORE_NINE_CORRELATED	18443585	astrocytoma	DOID_3069
4865	BENPORATH_ES_CORE_NINE_CORRELATED	18443585	cancer	DOID_162
4866	BENPORATH_ES_CORE_NINE_CORRELATED	18443585	carcinoma	DOID_305
4867	BENPORATH_ES_CORE_NINE_CORRELATED	18443585	cell type cancer	DOID_0050687
4868	BENPORATH_ES_CORE_NINE_CORRELATED	18443585	disease of cellular proliferation	DOID_14566
4869	BENPORATH_ES_CORE_NINE_CORRELATED	18443585	glioblastoma	DOID_3068
4870	BENPORATH_ES_CORE_NINE_CORRELATED	18443585	malignant glioma	DOID_3070
4871	AMIT_EGF_RESPONSE_20_HELA	17322878	NA	NA
4872	AMIT_EGF_RESPONSE_40_HELA	17322878	NA	NA
4873	AMIT_EGF_RESPONSE_60_HELA	17322878	NA	NA
4874	AMIT_EGF_RESPONSE_120_HELA	17322878	NA	NA
4875	AMIT_EGF_RESPONSE_240_HELA	17322878	NA	NA
4876	AMIT_EGF_RESPONSE_480_HELA	17322878	NA	NA
4877	AMIT_EGF_RESPONSE_20_MCF10A	17322878	NA	NA
4878	AMIT_EGF_RESPONSE_40_MCF10A	17322878	NA	NA
4879	AMIT_EGF_RESPONSE_60_MCF10A	17322878	NA	NA
4880	AMIT_EGF_RESPONSE_120_MCF10A	17322878	NA	NA
4881	AMIT_EGF_RESPONSE_240_MCF10A	17322878	NA	NA
4882	AMIT_EGF_RESPONSE_480_MCF10A	17322878	NA	NA
4883	AMIT_SERUM_RESPONSE_20_MCF10A	17322878	NA	NA
4884	AMIT_SERUM_RESPONSE_40_MCF10A	17322878	NA	NA
4885	AMIT_SERUM_RESPONSE_60_MCF10A	17322878	NA	NA
4886	AMIT_SERUM_RESPONSE_120_MCF10A	17322878	NA	NA
4887	AMIT_SERUM_RESPONSE_240_MCF10A	17322878	NA	NA
4888	AMIT_SERUM_RESPONSE_480_MCF10A	17322878	NA	NA
4889	GEORGES_CELL_CYCLE_MIR192_TARGETS	19074876	NA	NA
4890	GEORGES_TARGETS_OF_MIR192_AND_MIR215	19074876	NA	NA
4891	SHEN_SMARCA2_TARGETS_UP	19074882	cancer	DOID_162
4892	SHEN_SMARCA2_TARGETS_UP	19074882	disease of cellular proliferation	DOID_14566
4893	SHEN_SMARCA2_TARGETS_UP	19074882	male reproductive organ cancer	DOID_3856
4894	SHEN_SMARCA2_TARGETS_UP	19074882	organ system cancer	DOID_0050686
4895	SHEN_SMARCA2_TARGETS_UP	19074882	prostate cancer	DOID_10283
4896	SHEN_SMARCA2_TARGETS_UP	19074882	reproductive organ cancer	DOID_193
4897	SHEN_SMARCA2_TARGETS_DN	19074882	cancer	DOID_162
4898	SHEN_SMARCA2_TARGETS_DN	19074882	disease of cellular proliferation	DOID_14566
4899	SHEN_SMARCA2_TARGETS_DN	19074882	male reproductive organ cancer	DOID_3856
4900	SHEN_SMARCA2_TARGETS_DN	19074882	organ system cancer	DOID_0050686
4901	SHEN_SMARCA2_TARGETS_DN	19074882	prostate cancer	DOID_10283
4902	SHEN_SMARCA2_TARGETS_DN	19074882	reproductive organ cancer	DOID_193
4903	LIN_SILENCED_BY_TUMOR_MICROENVIRONMENT	19074894	cancer	DOID_162
4904	LIN_SILENCED_BY_TUMOR_MICROENVIRONMENT	19074894	disease of cellular proliferation	DOID_14566
4905	SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN	19074895	cancer	DOID_162
4906	SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN	19074895	carcinoma	DOID_305
4907	SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN	19074895	cell type cancer	DOID_0050687
4908	SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN	19074895	disease by infectious agent	DOID_0050117
4909	SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN	19074895	disease of anatomical entity	DOID_7
4910	SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN	19074895	disease of cellular proliferation	DOID_14566
4911	SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN	19074895	gastrointestinal system cancer	DOID_3119
4912	SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN	19074895	gastrointestinal system disease	DOID_77
4913	SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN	19074895	hepatitis C	DOID_1883
4914	SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN	19074895	hepatitis	DOID_2237
4915	SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN	19074895	hepatobiliary disease	DOID_3118
4916	SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN	19074895	hepatocellular carcinoma	DOID_684
4917	SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN	19074895	liver cancer	DOID_3571
4918	SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN	19074895	liver carcinoma	DOID_686
4919	SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN	19074895	liver cirrhosis	DOID_5082
4920	SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN	19074895	liver disease	DOID_409
4921	SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN	19074895	organ system cancer	DOID_0050686
4922	SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN	19074895	viral infectious disease	DOID_934
4923	SAKAI_TUMOR_INFILTRATING_MONOCYTES_UP	19074895	cancer	DOID_162
4924	SAKAI_TUMOR_INFILTRATING_MONOCYTES_UP	19074895	carcinoma	DOID_305
4925	SAKAI_TUMOR_INFILTRATING_MONOCYTES_UP	19074895	cell type cancer	DOID_0050687
4926	SAKAI_TUMOR_INFILTRATING_MONOCYTES_UP	19074895	disease by infectious agent	DOID_0050117
4927	SAKAI_TUMOR_INFILTRATING_MONOCYTES_UP	19074895	disease of anatomical entity	DOID_7
4928	SAKAI_TUMOR_INFILTRATING_MONOCYTES_UP	19074895	disease of cellular proliferation	DOID_14566
4929	SAKAI_TUMOR_INFILTRATING_MONOCYTES_UP	19074895	gastrointestinal system cancer	DOID_3119
4930	SAKAI_TUMOR_INFILTRATING_MONOCYTES_UP	19074895	gastrointestinal system disease	DOID_77
4931	SAKAI_TUMOR_INFILTRATING_MONOCYTES_UP	19074895	hepatitis C	DOID_1883
4932	SAKAI_TUMOR_INFILTRATING_MONOCYTES_UP	19074895	hepatitis	DOID_2237
4933	SAKAI_TUMOR_INFILTRATING_MONOCYTES_UP	19074895	hepatobiliary disease	DOID_3118
4934	SAKAI_TUMOR_INFILTRATING_MONOCYTES_UP	19074895	hepatocellular carcinoma	DOID_684
4935	SAKAI_TUMOR_INFILTRATING_MONOCYTES_UP	19074895	liver cancer	DOID_3571
4936	SAKAI_TUMOR_INFILTRATING_MONOCYTES_UP	19074895	liver carcinoma	DOID_686
4937	SAKAI_TUMOR_INFILTRATING_MONOCYTES_UP	19074895	liver cirrhosis	DOID_5082
4938	SAKAI_TUMOR_INFILTRATING_MONOCYTES_UP	19074895	liver disease	DOID_409
4939	SAKAI_TUMOR_INFILTRATING_MONOCYTES_UP	19074895	organ system cancer	DOID_0050686
4940	SAKAI_TUMOR_INFILTRATING_MONOCYTES_UP	19074895	viral infectious disease	DOID_934
4941	SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_DN	19074895	cancer	DOID_162
4942	SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_DN	19074895	carcinoma	DOID_305
4943	SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_DN	19074895	cell type cancer	DOID_0050687
4944	SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_DN	19074895	disease by infectious agent	DOID_0050117
4945	SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_DN	19074895	disease of anatomical entity	DOID_7
4946	SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_DN	19074895	disease of cellular proliferation	DOID_14566
4947	SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_DN	19074895	gastrointestinal system cancer	DOID_3119
4948	SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_DN	19074895	gastrointestinal system disease	DOID_77
4949	SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_DN	19074895	hepatitis C	DOID_1883
4950	SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_DN	19074895	hepatitis	DOID_2237
4951	SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_DN	19074895	hepatobiliary disease	DOID_3118
4952	SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_DN	19074895	hepatocellular carcinoma	DOID_684
4953	SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_DN	19074895	liver cancer	DOID_3571
4954	SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_DN	19074895	liver carcinoma	DOID_686
4955	SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_DN	19074895	liver cirrhosis	DOID_5082
4956	SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_DN	19074895	liver disease	DOID_409
4957	SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_DN	19074895	organ system cancer	DOID_0050686
4958	SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_DN	19074895	viral infectious disease	DOID_934
4959	JEON_SMAD6_TARGETS_UP	19047146	cancer	DOID_162
4960	JEON_SMAD6_TARGETS_UP	19047146	carcinoma	DOID_305
4961	JEON_SMAD6_TARGETS_UP	19047146	cell type cancer	DOID_0050687
4962	JEON_SMAD6_TARGETS_UP	19047146	disease of cellular proliferation	DOID_14566
4963	JEON_SMAD6_TARGETS_UP	19047146	lung cancer	DOID_1324
4964	JEON_SMAD6_TARGETS_UP	19047146	organ system cancer	DOID_0050686
4965	JEON_SMAD6_TARGETS_UP	19047146	respiratory system cancer	DOID_0050615
4966	JEON_SMAD6_TARGETS_DN	19047146	cancer	DOID_162
4967	JEON_SMAD6_TARGETS_DN	19047146	carcinoma	DOID_305
4968	JEON_SMAD6_TARGETS_DN	19047146	cell type cancer	DOID_0050687
4969	JEON_SMAD6_TARGETS_DN	19047146	disease of cellular proliferation	DOID_14566
4970	JEON_SMAD6_TARGETS_DN	19047146	lung cancer	DOID_1324
4971	JEON_SMAD6_TARGETS_DN	19047146	organ system cancer	DOID_0050686
4972	JEON_SMAD6_TARGETS_DN	19047146	respiratory system cancer	DOID_0050615
4973	WANG_PROSTATE_CANCER_ANDROGEN_INDEPENDENT	19047173	cancer	DOID_162
4974	WANG_PROSTATE_CANCER_ANDROGEN_INDEPENDENT	19047173	combined T cell and B cell immunodeficiency	DOID_628
4975	WANG_PROSTATE_CANCER_ANDROGEN_INDEPENDENT	19047173	disease of anatomical entity	DOID_7
4976	WANG_PROSTATE_CANCER_ANDROGEN_INDEPENDENT	19047173	disease of cellular proliferation	DOID_14566
4977	WANG_PROSTATE_CANCER_ANDROGEN_INDEPENDENT	19047173	immune system disease	DOID_2914
4978	WANG_PROSTATE_CANCER_ANDROGEN_INDEPENDENT	19047173	male reproductive organ cancer	DOID_3856
4979	WANG_PROSTATE_CANCER_ANDROGEN_INDEPENDENT	19047173	organ system cancer	DOID_0050686
4980	WANG_PROSTATE_CANCER_ANDROGEN_INDEPENDENT	19047173	primary immunodeficiency disease	DOID_612
4981	WANG_PROSTATE_CANCER_ANDROGEN_INDEPENDENT	19047173	prostate cancer	DOID_10283
4982	WANG_PROSTATE_CANCER_ANDROGEN_INDEPENDENT	19047173	reproductive organ cancer	DOID_193
4983	WANG_PROSTATE_CANCER_ANDROGEN_INDEPENDENT	19047173	severe combined immunodeficiency	DOID_627
4984	SUNG_METASTASIS_STROMA_UP	19047182	cancer	DOID_162
4985	SUNG_METASTASIS_STROMA_UP	19047182	connective tissue cancer	DOID_201
4986	SUNG_METASTASIS_STROMA_UP	19047182	disease of cellular proliferation	DOID_14566
4987	SUNG_METASTASIS_STROMA_UP	19047182	male reproductive organ cancer	DOID_3856
4988	SUNG_METASTASIS_STROMA_UP	19047182	musculoskeletal system cancer	DOID_0060100
4989	SUNG_METASTASIS_STROMA_UP	19047182	organ system cancer	DOID_0050686
4990	SUNG_METASTASIS_STROMA_UP	19047182	osteosarcoma	DOID_3347
4991	SUNG_METASTASIS_STROMA_UP	19047182	prostate cancer	DOID_10283
4992	SUNG_METASTASIS_STROMA_UP	19047182	reproductive organ cancer	DOID_193
4993	SUNG_METASTASIS_STROMA_DN	19047182	cancer	DOID_162
4994	SUNG_METASTASIS_STROMA_DN	19047182	connective tissue cancer	DOID_201
4995	SUNG_METASTASIS_STROMA_DN	19047182	disease of cellular proliferation	DOID_14566
4996	SUNG_METASTASIS_STROMA_DN	19047182	male reproductive organ cancer	DOID_3856
4997	SUNG_METASTASIS_STROMA_DN	19047182	musculoskeletal system cancer	DOID_0060100
4998	SUNG_METASTASIS_STROMA_DN	19047182	organ system cancer	DOID_0050686
4999	SUNG_METASTASIS_STROMA_DN	19047182	osteosarcoma	DOID_3347
5000	SUNG_METASTASIS_STROMA_DN	19047182	prostate cancer	DOID_10283
5001	SUNG_METASTASIS_STROMA_DN	19047182	reproductive organ cancer	DOID_193
5002	ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP	19010928	cancer	DOID_162
5003	ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP	19010928	disease of cellular proliferation	DOID_14566
5004	ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP	19010928	endocrine gland cancer	DOID_170
5005	ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP	19010928	organ system cancer	DOID_0050686
5006	ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP	19010928	pancreatic cancer	DOID_1793
5007	ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_DN	19010928	cancer	DOID_162
5008	ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_DN	19010928	disease of cellular proliferation	DOID_14566
5009	ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_DN	19010928	endocrine gland cancer	DOID_170
5010	ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_DN	19010928	organ system cancer	DOID_0050686
5011	ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_DN	19010928	pancreatic cancer	DOID_1793
5012	COLLIS_PRKDC_SUBSTRATES	15592499	disease of anatomical entity	DOID_7
5013	COLLIS_PRKDC_SUBSTRATES	15592499	hypersensitivity reaction disease	DOID_0060056
5014	COLLIS_PRKDC_SUBSTRATES	15592499	hypersensitivity reaction type I disease	DOID_1205
5015	COLLIS_PRKDC_SUBSTRATES	15592499	immune system disease	DOID_2914
5016	COLLIS_PRKDC_REGULATORS	15592499	disease of anatomical entity	DOID_7
5017	COLLIS_PRKDC_REGULATORS	15592499	hypersensitivity reaction disease	DOID_0060056
5018	COLLIS_PRKDC_REGULATORS	15592499	hypersensitivity reaction type I disease	DOID_1205
5019	COLLIS_PRKDC_REGULATORS	15592499	immune system disease	DOID_2914
5020	KAUFFMANN_DNA_REPAIR_GENES	17891185	cancer	DOID_162
5021	KAUFFMANN_DNA_REPAIR_GENES	17891185	cell type cancer	DOID_0050687
5022	KAUFFMANN_DNA_REPAIR_GENES	17891185	disease of cellular proliferation	DOID_14566
5023	KAUFFMANN_DNA_REPAIR_GENES	17891185	melanoma	DOID_1909
5024	KAUFFMANN_DNA_REPAIR_GENES	17891185	metastatic melanoma	DOID_4358
5025	KAUFFMANN_DNA_REPLICATION_GENES	17891185	cancer	DOID_162
5026	KAUFFMANN_DNA_REPLICATION_GENES	17891185	cell type cancer	DOID_0050687
5027	KAUFFMANN_DNA_REPLICATION_GENES	17891185	disease of cellular proliferation	DOID_14566
5028	KAUFFMANN_DNA_REPLICATION_GENES	17891185	melanoma	DOID_1909
5029	KAUFFMANN_DNA_REPLICATION_GENES	17891185	metastatic melanoma	DOID_4358
5030	NIKOLSKY_BREAST_CANCER_1Q21_AMPLICON	19010930	breast cancer	DOID_1612
5031	NIKOLSKY_BREAST_CANCER_1Q21_AMPLICON	19010930	cancer	DOID_162
5032	NIKOLSKY_BREAST_CANCER_1Q21_AMPLICON	19010930	disease of cellular proliferation	DOID_14566
5033	NIKOLSKY_BREAST_CANCER_1Q21_AMPLICON	19010930	organ system cancer	DOID_0050686
5034	NIKOLSKY_BREAST_CANCER_1Q21_AMPLICON	19010930	thoracic cancer	DOID_5093
5035	NIKOLSKY_BREAST_CANCER_1Q32_AMPLICON	19010930	breast cancer	DOID_1612
5036	NIKOLSKY_BREAST_CANCER_1Q32_AMPLICON	19010930	cancer	DOID_162
5037	NIKOLSKY_BREAST_CANCER_1Q32_AMPLICON	19010930	disease of cellular proliferation	DOID_14566
5038	NIKOLSKY_BREAST_CANCER_1Q32_AMPLICON	19010930	organ system cancer	DOID_0050686
5039	NIKOLSKY_BREAST_CANCER_1Q32_AMPLICON	19010930	thoracic cancer	DOID_5093
5040	NIKOLSKY_BREAST_CANCER_5P15_AMPLICON	19010930	breast cancer	DOID_1612
5041	NIKOLSKY_BREAST_CANCER_5P15_AMPLICON	19010930	cancer	DOID_162
5042	NIKOLSKY_BREAST_CANCER_5P15_AMPLICON	19010930	disease of cellular proliferation	DOID_14566
5043	NIKOLSKY_BREAST_CANCER_5P15_AMPLICON	19010930	organ system cancer	DOID_0050686
5044	NIKOLSKY_BREAST_CANCER_5P15_AMPLICON	19010930	thoracic cancer	DOID_5093
5045	NIKOLSKY_BREAST_CANCER_6P24_P22_AMPLICON	19010930	breast cancer	DOID_1612
5046	NIKOLSKY_BREAST_CANCER_6P24_P22_AMPLICON	19010930	cancer	DOID_162
5047	NIKOLSKY_BREAST_CANCER_6P24_P22_AMPLICON	19010930	disease of cellular proliferation	DOID_14566
5048	NIKOLSKY_BREAST_CANCER_6P24_P22_AMPLICON	19010930	organ system cancer	DOID_0050686
5049	NIKOLSKY_BREAST_CANCER_6P24_P22_AMPLICON	19010930	thoracic cancer	DOID_5093
5050	NIKOLSKY_BREAST_CANCER_7P22_AMPLICON	19010930	breast cancer	DOID_1612
5051	NIKOLSKY_BREAST_CANCER_7P22_AMPLICON	19010930	cancer	DOID_162
5052	NIKOLSKY_BREAST_CANCER_7P22_AMPLICON	19010930	disease of cellular proliferation	DOID_14566
5053	NIKOLSKY_BREAST_CANCER_7P22_AMPLICON	19010930	organ system cancer	DOID_0050686
5054	NIKOLSKY_BREAST_CANCER_7P22_AMPLICON	19010930	thoracic cancer	DOID_5093
5055	NIKOLSKY_BREAST_CANCER_7P15_AMPLICON	19010930	breast cancer	DOID_1612
5056	NIKOLSKY_BREAST_CANCER_7P15_AMPLICON	19010930	cancer	DOID_162
5057	NIKOLSKY_BREAST_CANCER_7P15_AMPLICON	19010930	disease of cellular proliferation	DOID_14566
5058	NIKOLSKY_BREAST_CANCER_7P15_AMPLICON	19010930	organ system cancer	DOID_0050686
5059	NIKOLSKY_BREAST_CANCER_7P15_AMPLICON	19010930	thoracic cancer	DOID_5093
5060	NIKOLSKY_BREAST_CANCER_7Q21_Q22_AMPLICON	19010930	breast cancer	DOID_1612
5061	NIKOLSKY_BREAST_CANCER_7Q21_Q22_AMPLICON	19010930	cancer	DOID_162
5062	NIKOLSKY_BREAST_CANCER_7Q21_Q22_AMPLICON	19010930	disease of cellular proliferation	DOID_14566
5063	NIKOLSKY_BREAST_CANCER_7Q21_Q22_AMPLICON	19010930	organ system cancer	DOID_0050686
5064	NIKOLSKY_BREAST_CANCER_7Q21_Q22_AMPLICON	19010930	thoracic cancer	DOID_5093
5065	NIKOLSKY_BREAST_CANCER_8P12_P11_AMPLICON	19010930	breast cancer	DOID_1612
5066	NIKOLSKY_BREAST_CANCER_8P12_P11_AMPLICON	19010930	cancer	DOID_162
5067	NIKOLSKY_BREAST_CANCER_8P12_P11_AMPLICON	19010930	disease of cellular proliferation	DOID_14566
5068	NIKOLSKY_BREAST_CANCER_8P12_P11_AMPLICON	19010930	organ system cancer	DOID_0050686
5069	NIKOLSKY_BREAST_CANCER_8P12_P11_AMPLICON	19010930	thoracic cancer	DOID_5093
5070	NIKOLSKY_BREAST_CANCER_8Q12_Q22_AMPLICON	19010930	breast cancer	DOID_1612
5071	NIKOLSKY_BREAST_CANCER_8Q12_Q22_AMPLICON	19010930	cancer	DOID_162
5072	NIKOLSKY_BREAST_CANCER_8Q12_Q22_AMPLICON	19010930	disease of cellular proliferation	DOID_14566
5073	NIKOLSKY_BREAST_CANCER_8Q12_Q22_AMPLICON	19010930	organ system cancer	DOID_0050686
5074	NIKOLSKY_BREAST_CANCER_8Q12_Q22_AMPLICON	19010930	thoracic cancer	DOID_5093
5075	NIKOLSKY_BREAST_CANCER_8Q23_Q24_AMPLICON	19010930	breast cancer	DOID_1612
5076	NIKOLSKY_BREAST_CANCER_8Q23_Q24_AMPLICON	19010930	cancer	DOID_162
5077	NIKOLSKY_BREAST_CANCER_8Q23_Q24_AMPLICON	19010930	disease of cellular proliferation	DOID_14566
5078	NIKOLSKY_BREAST_CANCER_8Q23_Q24_AMPLICON	19010930	organ system cancer	DOID_0050686
5079	NIKOLSKY_BREAST_CANCER_8Q23_Q24_AMPLICON	19010930	thoracic cancer	DOID_5093
5080	NIKOLSKY_BREAST_CANCER_11Q12_Q14_AMPLICON	19010930	breast cancer	DOID_1612
5081	NIKOLSKY_BREAST_CANCER_11Q12_Q14_AMPLICON	19010930	cancer	DOID_162
5082	NIKOLSKY_BREAST_CANCER_11Q12_Q14_AMPLICON	19010930	disease of cellular proliferation	DOID_14566
5083	NIKOLSKY_BREAST_CANCER_11Q12_Q14_AMPLICON	19010930	organ system cancer	DOID_0050686
5084	NIKOLSKY_BREAST_CANCER_11Q12_Q14_AMPLICON	19010930	thoracic cancer	DOID_5093
5085	NIKOLSKY_BREAST_CANCER_12Q13_Q21_AMPLICON	19010930	breast cancer	DOID_1612
5086	NIKOLSKY_BREAST_CANCER_12Q13_Q21_AMPLICON	19010930	cancer	DOID_162
5087	NIKOLSKY_BREAST_CANCER_12Q13_Q21_AMPLICON	19010930	disease of cellular proliferation	DOID_14566
5088	NIKOLSKY_BREAST_CANCER_12Q13_Q21_AMPLICON	19010930	organ system cancer	DOID_0050686
5089	NIKOLSKY_BREAST_CANCER_12Q13_Q21_AMPLICON	19010930	thoracic cancer	DOID_5093
5090	NIKOLSKY_BREAST_CANCER_12Q24_AMPLICON	19010930	breast cancer	DOID_1612
5091	NIKOLSKY_BREAST_CANCER_12Q24_AMPLICON	19010930	cancer	DOID_162
5092	NIKOLSKY_BREAST_CANCER_12Q24_AMPLICON	19010930	disease of cellular proliferation	DOID_14566
5093	NIKOLSKY_BREAST_CANCER_12Q24_AMPLICON	19010930	organ system cancer	DOID_0050686
5094	NIKOLSKY_BREAST_CANCER_12Q24_AMPLICON	19010930	thoracic cancer	DOID_5093
5095	NIKOLSKY_BREAST_CANCER_14Q22_AMPLICON	19010930	breast cancer	DOID_1612
5096	NIKOLSKY_BREAST_CANCER_14Q22_AMPLICON	19010930	cancer	DOID_162
5097	NIKOLSKY_BREAST_CANCER_14Q22_AMPLICON	19010930	disease of cellular proliferation	DOID_14566
5098	NIKOLSKY_BREAST_CANCER_14Q22_AMPLICON	19010930	organ system cancer	DOID_0050686
5099	NIKOLSKY_BREAST_CANCER_14Q22_AMPLICON	19010930	thoracic cancer	DOID_5093
5100	NIKOLSKY_BREAST_CANCER_15Q26_AMPLICON	19010930	breast cancer	DOID_1612
5101	NIKOLSKY_BREAST_CANCER_15Q26_AMPLICON	19010930	cancer	DOID_162
5102	NIKOLSKY_BREAST_CANCER_15Q26_AMPLICON	19010930	disease of cellular proliferation	DOID_14566
5103	NIKOLSKY_BREAST_CANCER_15Q26_AMPLICON	19010930	organ system cancer	DOID_0050686
5104	NIKOLSKY_BREAST_CANCER_15Q26_AMPLICON	19010930	thoracic cancer	DOID_5093
5105	NIKOLSKY_BREAST_CANCER_16P13_AMPLICON	19010930	breast cancer	DOID_1612
5106	NIKOLSKY_BREAST_CANCER_16P13_AMPLICON	19010930	cancer	DOID_162
5107	NIKOLSKY_BREAST_CANCER_16P13_AMPLICON	19010930	disease of cellular proliferation	DOID_14566
5108	NIKOLSKY_BREAST_CANCER_16P13_AMPLICON	19010930	organ system cancer	DOID_0050686
5109	NIKOLSKY_BREAST_CANCER_16P13_AMPLICON	19010930	thoracic cancer	DOID_5093
5110	NIKOLSKY_BREAST_CANCER_16Q24_AMPLICON	19010930	breast cancer	DOID_1612
5111	NIKOLSKY_BREAST_CANCER_16Q24_AMPLICON	19010930	cancer	DOID_162
5112	NIKOLSKY_BREAST_CANCER_16Q24_AMPLICON	19010930	disease of cellular proliferation	DOID_14566
5113	NIKOLSKY_BREAST_CANCER_16Q24_AMPLICON	19010930	organ system cancer	DOID_0050686
5114	NIKOLSKY_BREAST_CANCER_16Q24_AMPLICON	19010930	thoracic cancer	DOID_5093
5115	NIKOLSKY_BREAST_CANCER_17Q11_Q21_AMPLICON	19010930	breast cancer	DOID_1612
5116	NIKOLSKY_BREAST_CANCER_17Q11_Q21_AMPLICON	19010930	cancer	DOID_162
5117	NIKOLSKY_BREAST_CANCER_17Q11_Q21_AMPLICON	19010930	disease of cellular proliferation	DOID_14566
5118	NIKOLSKY_BREAST_CANCER_17Q11_Q21_AMPLICON	19010930	organ system cancer	DOID_0050686
5119	NIKOLSKY_BREAST_CANCER_17Q11_Q21_AMPLICON	19010930	thoracic cancer	DOID_5093
5120	NIKOLSKY_BREAST_CANCER_17Q21_Q25_AMPLICON	19010930	breast cancer	DOID_1612
5121	NIKOLSKY_BREAST_CANCER_17Q21_Q25_AMPLICON	19010930	cancer	DOID_162
5122	NIKOLSKY_BREAST_CANCER_17Q21_Q25_AMPLICON	19010930	disease of cellular proliferation	DOID_14566
5123	NIKOLSKY_BREAST_CANCER_17Q21_Q25_AMPLICON	19010930	organ system cancer	DOID_0050686
5124	NIKOLSKY_BREAST_CANCER_17Q21_Q25_AMPLICON	19010930	thoracic cancer	DOID_5093
5125	NIKOLSKY_BREAST_CANCER_20Q11_AMPLICON	19010930	breast cancer	DOID_1612
5126	NIKOLSKY_BREAST_CANCER_20Q11_AMPLICON	19010930	cancer	DOID_162
5127	NIKOLSKY_BREAST_CANCER_20Q11_AMPLICON	19010930	disease of cellular proliferation	DOID_14566
5128	NIKOLSKY_BREAST_CANCER_20Q11_AMPLICON	19010930	organ system cancer	DOID_0050686
5129	NIKOLSKY_BREAST_CANCER_20Q11_AMPLICON	19010930	thoracic cancer	DOID_5093
5130	NIKOLSKY_BREAST_CANCER_20Q12_Q13_AMPLICON	19010930	breast cancer	DOID_1612
5131	NIKOLSKY_BREAST_CANCER_20Q12_Q13_AMPLICON	19010930	cancer	DOID_162
5132	NIKOLSKY_BREAST_CANCER_20Q12_Q13_AMPLICON	19010930	disease of cellular proliferation	DOID_14566
5133	NIKOLSKY_BREAST_CANCER_20Q12_Q13_AMPLICON	19010930	organ system cancer	DOID_0050686
5134	NIKOLSKY_BREAST_CANCER_20Q12_Q13_AMPLICON	19010930	thoracic cancer	DOID_5093
5135	NIKOLSKY_BREAST_CANCER_21Q22_AMPLICON	19010930	breast cancer	DOID_1612
5136	NIKOLSKY_BREAST_CANCER_21Q22_AMPLICON	19010930	cancer	DOID_162
5137	NIKOLSKY_BREAST_CANCER_21Q22_AMPLICON	19010930	disease of cellular proliferation	DOID_14566
5138	NIKOLSKY_BREAST_CANCER_21Q22_AMPLICON	19010930	organ system cancer	DOID_0050686
5139	NIKOLSKY_BREAST_CANCER_21Q22_AMPLICON	19010930	thoracic cancer	DOID_5093
5140	NIKOLSKY_BREAST_CANCER_22Q13_AMPLICON	19010930	breast cancer	DOID_1612
5141	NIKOLSKY_BREAST_CANCER_22Q13_AMPLICON	19010930	cancer	DOID_162
5142	NIKOLSKY_BREAST_CANCER_22Q13_AMPLICON	19010930	disease of cellular proliferation	DOID_14566
5143	NIKOLSKY_BREAST_CANCER_22Q13_AMPLICON	19010930	organ system cancer	DOID_0050686
5144	NIKOLSKY_BREAST_CANCER_22Q13_AMPLICON	19010930	thoracic cancer	DOID_5093
5145	NIKOLSKY_MUTATED_AND_AMPLIFIED_IN_BREAST_CANCER	19010930	breast cancer	DOID_1612
5146	NIKOLSKY_MUTATED_AND_AMPLIFIED_IN_BREAST_CANCER	19010930	cancer	DOID_162
5147	NIKOLSKY_MUTATED_AND_AMPLIFIED_IN_BREAST_CANCER	19010930	disease of cellular proliferation	DOID_14566
5148	NIKOLSKY_MUTATED_AND_AMPLIFIED_IN_BREAST_CANCER	19010930	organ system cancer	DOID_0050686
5149	NIKOLSKY_MUTATED_AND_AMPLIFIED_IN_BREAST_CANCER	19010930	thoracic cancer	DOID_5093
5150	WHITEHURST_PACLITAXEL_SENSITIVITY	17429401	cancer	DOID_162
5151	WHITEHURST_PACLITAXEL_SENSITIVITY	17429401	carcinoma	DOID_305
5152	WHITEHURST_PACLITAXEL_SENSITIVITY	17429401	cell type cancer	DOID_0050687
5153	WHITEHURST_PACLITAXEL_SENSITIVITY	17429401	disease of cellular proliferation	DOID_14566
5154	WHITEHURST_PACLITAXEL_SENSITIVITY	17429401	lung cancer	DOID_1324
5155	WHITEHURST_PACLITAXEL_SENSITIVITY	17429401	organ system cancer	DOID_0050686
5156	WHITEHURST_PACLITAXEL_SENSITIVITY	17429401	respiratory system cancer	DOID_0050615
5157	JI_METASTASIS_REPRESSED_BY_STK11	17676035	adenocarcinoma	DOID_299
5158	JI_METASTASIS_REPRESSED_BY_STK11	17676035	cancer	DOID_162
5159	JI_METASTASIS_REPRESSED_BY_STK11	17676035	carcinoma	DOID_305
5160	JI_METASTASIS_REPRESSED_BY_STK11	17676035	cell type cancer	DOID_0050687
5161	JI_METASTASIS_REPRESSED_BY_STK11	17676035	disease of anatomical entity	DOID_7
5162	JI_METASTASIS_REPRESSED_BY_STK11	17676035	disease of cellular proliferation	DOID_14566
5163	JI_METASTASIS_REPRESSED_BY_STK11	17676035	gastrointestinal system disease	DOID_77
5164	JI_METASTASIS_REPRESSED_BY_STK11	17676035	intestinal disease	DOID_5295
5165	JI_METASTASIS_REPRESSED_BY_STK11	17676035	lung cancer	DOID_1324
5166	JI_METASTASIS_REPRESSED_BY_STK11	17676035	organ system cancer	DOID_0050686
5167	JI_METASTASIS_REPRESSED_BY_STK11	17676035	Peutz-Jeghers syndrome	DOID_3852
5168	JI_METASTASIS_REPRESSED_BY_STK11	17676035	respiratory system cancer	DOID_0050615
5169	JI_METASTASIS_REPRESSED_BY_STK11	17676035	syndrome	DOID_225
5170	GOTTWEIN_TARGETS_OF_KSHV_MIR_K12_11	18075594	anemia	DOID_2355
5171	GOTTWEIN_TARGETS_OF_KSHV_MIR_K12_11	18075594	disease of anatomical entity	DOID_7
5172	GOTTWEIN_TARGETS_OF_KSHV_MIR_K12_11	18075594	hematopoietic system disease	DOID_74
5173	GOTTWEIN_TARGETS_OF_KSHV_MIR_K12_11	18075594	immune system disease	DOID_2914
5174	CHEN_NEUROBLASTOMA_COPY_NUMBER_GAINS	18923524	adenocarcinoma	DOID_299
5175	CHEN_NEUROBLASTOMA_COPY_NUMBER_GAINS	18923524	autonomic nervous system neoplasm	DOID_2621
5176	CHEN_NEUROBLASTOMA_COPY_NUMBER_GAINS	18923524	cancer	DOID_162
5177	CHEN_NEUROBLASTOMA_COPY_NUMBER_GAINS	18923524	carcinoma	DOID_305
5178	CHEN_NEUROBLASTOMA_COPY_NUMBER_GAINS	18923524	cell type cancer	DOID_0050687
5179	CHEN_NEUROBLASTOMA_COPY_NUMBER_GAINS	18923524	disease of cellular proliferation	DOID_14566
5180	CHEN_NEUROBLASTOMA_COPY_NUMBER_GAINS	18923524	hematologic cancer	DOID_2531
5181	CHEN_NEUROBLASTOMA_COPY_NUMBER_GAINS	18923524	immune system cancer	DOID_0060083
5182	CHEN_NEUROBLASTOMA_COPY_NUMBER_GAINS	18923524	lymphoma	DOID_0060058
5183	CHEN_NEUROBLASTOMA_COPY_NUMBER_GAINS	18923524	nervous system cancer	DOID_3093
5184	CHEN_NEUROBLASTOMA_COPY_NUMBER_GAINS	18923524	neuroblastoma	DOID_769
5185	CHEN_NEUROBLASTOMA_COPY_NUMBER_GAINS	18923524	organ system cancer	DOID_0050686
5186	CHEN_NEUROBLASTOMA_COPY_NUMBER_GAINS	18923524	peripheral nervous system neoplasm	DOID_1192
5187	TCGA_GLIOBLASTOMA_COPY_NUMBER_UP	18772890	astrocytoma	DOID_3069
5188	TCGA_GLIOBLASTOMA_COPY_NUMBER_UP	18772890	cancer	DOID_162
5189	TCGA_GLIOBLASTOMA_COPY_NUMBER_UP	18772890	cell type cancer	DOID_0050687
5190	TCGA_GLIOBLASTOMA_COPY_NUMBER_UP	18772890	disease of cellular proliferation	DOID_14566
5191	TCGA_GLIOBLASTOMA_COPY_NUMBER_UP	18772890	glioblastoma	DOID_3068
5192	TCGA_GLIOBLASTOMA_COPY_NUMBER_UP	18772890	malignant glioma	DOID_3070
5193	TCGA_GLIOBLASTOMA_COPY_NUMBER_DN	18772890	astrocytoma	DOID_3069
5194	TCGA_GLIOBLASTOMA_COPY_NUMBER_DN	18772890	cancer	DOID_162
5195	TCGA_GLIOBLASTOMA_COPY_NUMBER_DN	18772890	cell type cancer	DOID_0050687
5196	TCGA_GLIOBLASTOMA_COPY_NUMBER_DN	18772890	disease of cellular proliferation	DOID_14566
5197	TCGA_GLIOBLASTOMA_COPY_NUMBER_DN	18772890	glioblastoma	DOID_3068
5198	TCGA_GLIOBLASTOMA_COPY_NUMBER_DN	18772890	malignant glioma	DOID_3070
5199	DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY	18948947	adenocarcinoma	DOID_299
5200	DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY	18948947	cancer	DOID_162
5201	DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY	18948947	carcinoma	DOID_305
5202	DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY	18948947	cell type cancer	DOID_0050687
5203	DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY	18948947	disease of cellular proliferation	DOID_14566
5204	DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY	18948947	lung adenocarcinoma	DOID_3910
5205	DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY	18948947	lung cancer	DOID_1324
5206	DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY	18948947	lung carcinoma	DOID_3905
5207	DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY	18948947	non-small cell lung carcinoma	DOID_3908
5208	DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY	18948947	organ system cancer	DOID_0050686
5209	DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY	18948947	respiratory system cancer	DOID_0050615
5210	DING_LUNG_CANCER_MUTATED_FREQUENTLY	18948947	adenocarcinoma	DOID_299
5211	DING_LUNG_CANCER_MUTATED_FREQUENTLY	18948947	cancer	DOID_162
5212	DING_LUNG_CANCER_MUTATED_FREQUENTLY	18948947	carcinoma	DOID_305
5213	DING_LUNG_CANCER_MUTATED_FREQUENTLY	18948947	cell type cancer	DOID_0050687
5214	DING_LUNG_CANCER_MUTATED_FREQUENTLY	18948947	disease of cellular proliferation	DOID_14566
5215	DING_LUNG_CANCER_MUTATED_FREQUENTLY	18948947	lung adenocarcinoma	DOID_3910
5216	DING_LUNG_CANCER_MUTATED_FREQUENTLY	18948947	lung cancer	DOID_1324
5217	DING_LUNG_CANCER_MUTATED_FREQUENTLY	18948947	lung carcinoma	DOID_3905
5218	DING_LUNG_CANCER_MUTATED_FREQUENTLY	18948947	non-small cell lung carcinoma	DOID_3908
5219	DING_LUNG_CANCER_MUTATED_FREQUENTLY	18948947	organ system cancer	DOID_0050686
5220	DING_LUNG_CANCER_MUTATED_FREQUENTLY	18948947	respiratory system cancer	DOID_0050615
5221	DING_LUNG_CANCER_EXPRESSION_BY_COPY_NUMBER	18948947	adenocarcinoma	DOID_299
5222	DING_LUNG_CANCER_EXPRESSION_BY_COPY_NUMBER	18948947	cancer	DOID_162
5223	DING_LUNG_CANCER_EXPRESSION_BY_COPY_NUMBER	18948947	carcinoma	DOID_305
5224	DING_LUNG_CANCER_EXPRESSION_BY_COPY_NUMBER	18948947	cell type cancer	DOID_0050687
5225	DING_LUNG_CANCER_EXPRESSION_BY_COPY_NUMBER	18948947	disease of cellular proliferation	DOID_14566
5226	DING_LUNG_CANCER_EXPRESSION_BY_COPY_NUMBER	18948947	lung adenocarcinoma	DOID_3910
5227	DING_LUNG_CANCER_EXPRESSION_BY_COPY_NUMBER	18948947	lung cancer	DOID_1324
5228	DING_LUNG_CANCER_EXPRESSION_BY_COPY_NUMBER	18948947	lung carcinoma	DOID_3905
5229	DING_LUNG_CANCER_EXPRESSION_BY_COPY_NUMBER	18948947	non-small cell lung carcinoma	DOID_3908
5230	DING_LUNG_CANCER_EXPRESSION_BY_COPY_NUMBER	18948947	organ system cancer	DOID_0050686
5231	DING_LUNG_CANCER_EXPRESSION_BY_COPY_NUMBER	18948947	respiratory system cancer	DOID_0050615
5232	ONDER_CDH1_TARGETS_2_UP	18483246	combined T cell and B cell immunodeficiency	DOID_628
5233	ONDER_CDH1_TARGETS_2_UP	18483246	disease of anatomical entity	DOID_7
5234	ONDER_CDH1_TARGETS_2_UP	18483246	immune system disease	DOID_2914
5235	ONDER_CDH1_TARGETS_2_UP	18483246	primary immunodeficiency disease	DOID_612
5236	ONDER_CDH1_TARGETS_2_UP	18483246	severe combined immunodeficiency	DOID_627
5237	ONDER_CDH1_TARGETS_2_DN	18483246	combined T cell and B cell immunodeficiency	DOID_628
5238	ONDER_CDH1_TARGETS_2_DN	18483246	disease of anatomical entity	DOID_7
5239	ONDER_CDH1_TARGETS_2_DN	18483246	immune system disease	DOID_2914
5240	ONDER_CDH1_TARGETS_2_DN	18483246	primary immunodeficiency disease	DOID_612
5241	ONDER_CDH1_TARGETS_2_DN	18483246	severe combined immunodeficiency	DOID_627
5242	ONDER_CDH1_TARGETS_1_UP	18483246	combined T cell and B cell immunodeficiency	DOID_628
5243	ONDER_CDH1_TARGETS_1_UP	18483246	disease of anatomical entity	DOID_7
5244	ONDER_CDH1_TARGETS_1_UP	18483246	immune system disease	DOID_2914
5245	ONDER_CDH1_TARGETS_1_UP	18483246	primary immunodeficiency disease	DOID_612
5246	ONDER_CDH1_TARGETS_1_UP	18483246	severe combined immunodeficiency	DOID_627
5247	ONDER_CDH1_TARGETS_1_DN	18483246	combined T cell and B cell immunodeficiency	DOID_628
5248	ONDER_CDH1_TARGETS_1_DN	18483246	disease of anatomical entity	DOID_7
5249	ONDER_CDH1_TARGETS_1_DN	18483246	immune system disease	DOID_2914
5250	ONDER_CDH1_TARGETS_1_DN	18483246	primary immunodeficiency disease	DOID_612
5251	ONDER_CDH1_TARGETS_1_DN	18483246	severe combined immunodeficiency	DOID_627
5252	ONDER_CDH1_TARGETS_3_UP	18483246	combined T cell and B cell immunodeficiency	DOID_628
5253	ONDER_CDH1_TARGETS_3_UP	18483246	disease of anatomical entity	DOID_7
5254	ONDER_CDH1_TARGETS_3_UP	18483246	immune system disease	DOID_2914
5255	ONDER_CDH1_TARGETS_3_UP	18483246	primary immunodeficiency disease	DOID_612
5256	ONDER_CDH1_TARGETS_3_UP	18483246	severe combined immunodeficiency	DOID_627
5257	ONDER_CDH1_TARGETS_3_DN	18483246	combined T cell and B cell immunodeficiency	DOID_628
5258	ONDER_CDH1_TARGETS_3_DN	18483246	disease of anatomical entity	DOID_7
5259	ONDER_CDH1_TARGETS_3_DN	18483246	immune system disease	DOID_2914
5260	ONDER_CDH1_TARGETS_3_DN	18483246	primary immunodeficiency disease	DOID_612
5261	ONDER_CDH1_TARGETS_3_DN	18483246	severe combined immunodeficiency	DOID_627
5262	ONDER_CDH1_SIGNALING_VIA_CTNNB1	18483246	combined T cell and B cell immunodeficiency	DOID_628
5263	ONDER_CDH1_SIGNALING_VIA_CTNNB1	18483246	disease of anatomical entity	DOID_7
5264	ONDER_CDH1_SIGNALING_VIA_CTNNB1	18483246	immune system disease	DOID_2914
5265	ONDER_CDH1_SIGNALING_VIA_CTNNB1	18483246	primary immunodeficiency disease	DOID_612
5266	ONDER_CDH1_SIGNALING_VIA_CTNNB1	18483246	severe combined immunodeficiency	DOID_627
5267	CERVERA_SDHB_TARGETS_2	18519664	NA	NA
5268	ROZANOV_MMP14_TARGETS_SUBSET	18519667	cancer	DOID_162
5269	ROZANOV_MMP14_TARGETS_SUBSET	18519667	disease of cellular proliferation	DOID_14566
5270	ROZANOV_MMP14_CORRELATED	18519667	cancer	DOID_162
5271	ROZANOV_MMP14_CORRELATED	18519667	disease of cellular proliferation	DOID_14566
5272	ROZANOV_MMP14_TARGETS_UP	18519667	cancer	DOID_162
5273	ROZANOV_MMP14_TARGETS_UP	18519667	disease of cellular proliferation	DOID_14566
5274	ROZANOV_MMP14_TARGETS_DN	18519667	cancer	DOID_162
5275	ROZANOV_MMP14_TARGETS_DN	18519667	disease of cellular proliferation	DOID_14566
5276	LANDEMAINE_LUNG_METASTASIS	18676831	breast cancer	DOID_1612
5277	LANDEMAINE_LUNG_METASTASIS	18676831	cancer	DOID_162
5278	LANDEMAINE_LUNG_METASTASIS	18676831	disease of cellular proliferation	DOID_14566
5279	LANDEMAINE_LUNG_METASTASIS	18676831	lung metastasis	DOID_2158
5280	LANDEMAINE_LUNG_METASTASIS	18676831	organ system cancer	DOID_0050686
5281	LANDEMAINE_LUNG_METASTASIS	18676831	thoracic cancer	DOID_5093
5282	CERVERA_SDHB_TARGETS_1_UP	18519664	NA	NA
5283	CERVERA_SDHB_TARGETS_1_DN	18519664	NA	NA
5284	ROSS_ACUTE_MYELOID_LEUKEMIA_CBF	15226186	acute myeloid leukemia	DOID_9119
5285	ROSS_ACUTE_MYELOID_LEUKEMIA_CBF	15226186	cancer	DOID_162
5286	ROSS_ACUTE_MYELOID_LEUKEMIA_CBF	15226186	disease of cellular proliferation	DOID_14566
5287	ROSS_ACUTE_MYELOID_LEUKEMIA_CBF	15226186	hematologic cancer	DOID_2531
5288	ROSS_ACUTE_MYELOID_LEUKEMIA_CBF	15226186	immune system cancer	DOID_0060083
5289	ROSS_ACUTE_MYELOID_LEUKEMIA_CBF	15226186	leukemia	DOID_1240
5290	ROSS_ACUTE_MYELOID_LEUKEMIA_CBF	15226186	myeloid leukemia	DOID_8692
5291	ROSS_ACUTE_MYELOID_LEUKEMIA_CBF	15226186	organ system cancer	DOID_0050686
5292	KENNY_CTNNB1_TARGETS_UP	15642117	cancer	DOID_162
5293	KENNY_CTNNB1_TARGETS_UP	15642117	carcinoma	DOID_305
5294	KENNY_CTNNB1_TARGETS_UP	15642117	cell type cancer	DOID_0050687
5295	KENNY_CTNNB1_TARGETS_UP	15642117	disease of cellular proliferation	DOID_14566
5296	CHEOK_RESPONSE_TO_MERCAPTOPURINE_DN	12704389	cancer	DOID_162
5297	CHEOK_RESPONSE_TO_MERCAPTOPURINE_DN	12704389	disease of cellular proliferation	DOID_14566
5298	CHEOK_RESPONSE_TO_MERCAPTOPURINE_DN	12704389	hematologic cancer	DOID_2531
5299	CHEOK_RESPONSE_TO_MERCAPTOPURINE_DN	12704389	immune system cancer	DOID_0060083
5300	CHEOK_RESPONSE_TO_MERCAPTOPURINE_DN	12704389	leukemia	DOID_1240
5301	CHEOK_RESPONSE_TO_MERCAPTOPURINE_DN	12704389	lymphoblastic leukemia	DOID_1037
5302	CHEOK_RESPONSE_TO_MERCAPTOPURINE_DN	12704389	lymphoid leukemia	DOID_10747
5303	CHEOK_RESPONSE_TO_MERCAPTOPURINE_DN	12704389	organ system cancer	DOID_0050686
5304	NELSON_RESPONSE_TO_ANDROGEN_DN	12185249	adenocarcinoma	DOID_299
5305	NELSON_RESPONSE_TO_ANDROGEN_DN	12185249	cancer	DOID_162
5306	NELSON_RESPONSE_TO_ANDROGEN_DN	12185249	carcinoma	DOID_305
5307	NELSON_RESPONSE_TO_ANDROGEN_DN	12185249	cell type cancer	DOID_0050687
5308	NELSON_RESPONSE_TO_ANDROGEN_DN	12185249	disease of cellular proliferation	DOID_14566
5309	TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_UP	12663452	NA	NA
5310	SWEET_KRAS_TARGETS_DN	15608639	adenocarcinoma	DOID_299
5311	SWEET_KRAS_TARGETS_DN	15608639	cancer	DOID_162
5312	SWEET_KRAS_TARGETS_DN	15608639	carcinoma	DOID_305
5313	SWEET_KRAS_TARGETS_DN	15608639	cell type cancer	DOID_0050687
5314	SWEET_KRAS_TARGETS_DN	15608639	disease of cellular proliferation	DOID_14566
5315	SWEET_KRAS_TARGETS_DN	15608639	lung adenocarcinoma	DOID_3910
5316	SWEET_KRAS_TARGETS_DN	15608639	lung cancer	DOID_1324
5317	SWEET_KRAS_TARGETS_DN	15608639	lung carcinoma	DOID_3905
5318	SWEET_KRAS_TARGETS_DN	15608639	non-small cell lung carcinoma	DOID_3908
5319	SWEET_KRAS_TARGETS_DN	15608639	organ system cancer	DOID_0050686
5320	SWEET_KRAS_TARGETS_DN	15608639	respiratory system cancer	DOID_0050615
5321	SHEPARD_CRUSH_AND_BURN_MUTANT_UP	16150706	cancer	DOID_162
5322	SHEPARD_CRUSH_AND_BURN_MUTANT_UP	16150706	disease of cellular proliferation	DOID_14566
5323	ROSS_AML_WITH_PML_RARA_FUSION	15226186	acute myeloid leukemia	DOID_9119
5324	ROSS_AML_WITH_PML_RARA_FUSION	15226186	cancer	DOID_162
5325	ROSS_AML_WITH_PML_RARA_FUSION	15226186	disease of cellular proliferation	DOID_14566
5326	ROSS_AML_WITH_PML_RARA_FUSION	15226186	hematologic cancer	DOID_2531
5327	ROSS_AML_WITH_PML_RARA_FUSION	15226186	immune system cancer	DOID_0060083
5328	ROSS_AML_WITH_PML_RARA_FUSION	15226186	leukemia	DOID_1240
5329	ROSS_AML_WITH_PML_RARA_FUSION	15226186	myeloid leukemia	DOID_8692
5330	ROSS_AML_WITH_PML_RARA_FUSION	15226186	organ system cancer	DOID_0050686
5331	LEE_LIVER_CANCER_CIPROFIBRATE_DN	15565109	cancer	DOID_162
5332	LEE_LIVER_CANCER_CIPROFIBRATE_DN	15565109	carcinoma	DOID_305
5333	LEE_LIVER_CANCER_CIPROFIBRATE_DN	15565109	cell type cancer	DOID_0050687
5334	LEE_LIVER_CANCER_CIPROFIBRATE_DN	15565109	disease of cellular proliferation	DOID_14566
5335	ASTON_MAJOR_DEPRESSIVE_DISORDER_DN	15303102	bipolar disorder	DOID_3312
5336	ASTON_MAJOR_DEPRESSIVE_DISORDER_DN	15303102	cognitive disorder	DOID_1561
5337	ASTON_MAJOR_DEPRESSIVE_DISORDER_DN	15303102	disease of mental health	DOID_150
5338	ASTON_MAJOR_DEPRESSIVE_DISORDER_DN	15303102	endogenous depression	DOID_1595
5339	ASTON_MAJOR_DEPRESSIVE_DISORDER_DN	15303102	major depressive disorder	DOID_1470
5340	ASTON_MAJOR_DEPRESSIVE_DISORDER_DN	15303102	mental depression	DOID_1596
5341	ASTON_MAJOR_DEPRESSIVE_DISORDER_DN	15303102	mood disorder	DOID_3324
5342	ASTON_MAJOR_DEPRESSIVE_DISORDER_DN	15303102	psychotic disorder	DOID_2468
5343	ASTON_MAJOR_DEPRESSIVE_DISORDER_DN	15303102	schizophrenia	DOID_5419
5344	STANELLE_E2F1_TARGETS	11937641	cancer	DOID_162
5345	STANELLE_E2F1_TARGETS	11937641	disease of cellular proliferation	DOID_14566
5346	SHIPP_DLBCL_CURED_VS_FATAL_DN	11786909	B-cell lymphocytic neoplasm	DOID_707
5347	SHIPP_DLBCL_CURED_VS_FATAL_DN	11786909	cancer	DOID_162
5348	SHIPP_DLBCL_CURED_VS_FATAL_DN	11786909	diffuse large B-cell lymphoma	DOID_0050745
5349	SHIPP_DLBCL_CURED_VS_FATAL_DN	11786909	disease of cellular proliferation	DOID_14566
5350	SHIPP_DLBCL_CURED_VS_FATAL_DN	11786909	hematologic cancer	DOID_2531
5351	SHIPP_DLBCL_CURED_VS_FATAL_DN	11786909	immune system cancer	DOID_0060083
5352	SHIPP_DLBCL_CURED_VS_FATAL_DN	11786909	lymphoma	DOID_0060058
5353	SHIPP_DLBCL_CURED_VS_FATAL_DN	11786909	organ system cancer	DOID_0050686
5354	GRANDVAUX_IFN_RESPONSE_NOT_VIA_IRF3	11991981	disease by infectious agent	DOID_0050117
5355	GRANDVAUX_IFN_RESPONSE_NOT_VIA_IRF3	11991981	viral infectious disease	DOID_934
5356	GOLUB_ALL_VS_AML_UP	10521349	acute myeloid leukemia	DOID_9119
5357	GOLUB_ALL_VS_AML_UP	10521349	cancer	DOID_162
5358	GOLUB_ALL_VS_AML_UP	10521349	disease of cellular proliferation	DOID_14566
5359	GOLUB_ALL_VS_AML_UP	10521349	hematologic cancer	DOID_2531
5360	GOLUB_ALL_VS_AML_UP	10521349	immune system cancer	DOID_0060083
5361	GOLUB_ALL_VS_AML_UP	10521349	leukemia	DOID_1240
5362	GOLUB_ALL_VS_AML_UP	10521349	lymphoblastic leukemia	DOID_1037
5363	GOLUB_ALL_VS_AML_UP	10521349	myeloid leukemia	DOID_8692
5364	GOLUB_ALL_VS_AML_UP	10521349	organ system cancer	DOID_0050686
5365	BASSO_B_LYMPHOCYTE_NETWORK	15778709	cancer	DOID_162
5366	BASSO_B_LYMPHOCYTE_NETWORK	15778709	disease of cellular proliferation	DOID_14566
5367	BASSO_B_LYMPHOCYTE_NETWORK	15778709	hematologic cancer	DOID_2531
5368	BASSO_B_LYMPHOCYTE_NETWORK	15778709	immune system cancer	DOID_0060083
5369	BASSO_B_LYMPHOCYTE_NETWORK	15778709	leukemia	DOID_1240
5370	BASSO_B_LYMPHOCYTE_NETWORK	15778709	lymphoma	DOID_0060058
5371	BASSO_B_LYMPHOCYTE_NETWORK	15778709	organ system cancer	DOID_0050686
5372	ROSS_AML_WITH_CBFB_MYH11_FUSION	15226186	acute myeloid leukemia	DOID_9119
5373	ROSS_AML_WITH_CBFB_MYH11_FUSION	15226186	cancer	DOID_162
5374	ROSS_AML_WITH_CBFB_MYH11_FUSION	15226186	disease of cellular proliferation	DOID_14566
5375	ROSS_AML_WITH_CBFB_MYH11_FUSION	15226186	hematologic cancer	DOID_2531
5376	ROSS_AML_WITH_CBFB_MYH11_FUSION	15226186	immune system cancer	DOID_0060083
5377	ROSS_AML_WITH_CBFB_MYH11_FUSION	15226186	leukemia	DOID_1240
5378	ROSS_AML_WITH_CBFB_MYH11_FUSION	15226186	myeloid leukemia	DOID_8692
5379	ROSS_AML_WITH_CBFB_MYH11_FUSION	15226186	organ system cancer	DOID_0050686
5380	IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_UP	15710396	cancer	DOID_162
5381	IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_UP	15710396	carcinoma	DOID_305
5382	IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_UP	15710396	cell type cancer	DOID_0050687
5383	IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_UP	15710396	disease by infectious agent	DOID_0050117
5384	IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_UP	15710396	disease of anatomical entity	DOID_7
5385	IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_UP	15710396	disease of cellular proliferation	DOID_14566
5386	IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_UP	15710396	gastrointestinal system cancer	DOID_3119
5387	IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_UP	15710396	gastrointestinal system disease	DOID_77
5388	IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_UP	15710396	hepatitis C	DOID_1883
5389	IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_UP	15710396	hepatitis	DOID_2237
5390	IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_UP	15710396	hepatobiliary disease	DOID_3118
5391	IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_UP	15710396	hepatocellular carcinoma	DOID_684
5392	IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_UP	15710396	liver cancer	DOID_3571
5393	IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_UP	15710396	liver carcinoma	DOID_686
5394	IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_UP	15710396	liver disease	DOID_409
5395	IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_UP	15710396	organ system cancer	DOID_0050686
5396	IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_UP	15710396	viral infectious disease	DOID_934
5397	FERRANDO_TAL1_NEIGHBORS	12086890	cancer	DOID_162
5398	FERRANDO_TAL1_NEIGHBORS	12086890	disease of cellular proliferation	DOID_14566
5399	FERRANDO_TAL1_NEIGHBORS	12086890	hematologic cancer	DOID_2531
5400	FERRANDO_TAL1_NEIGHBORS	12086890	immune system cancer	DOID_0060083
5401	FERRANDO_TAL1_NEIGHBORS	12086890	leukemia	DOID_1240
5402	FERRANDO_TAL1_NEIGHBORS	12086890	lymphoblastic leukemia	DOID_1037
5403	FERRANDO_TAL1_NEIGHBORS	12086890	organ system cancer	DOID_0050686
5404	PENG_LEUCINE_DEPRIVATION_UP	12101249	cancer	DOID_162
5405	PENG_LEUCINE_DEPRIVATION_UP	12101249	disease of cellular proliferation	DOID_14566
5406	PENG_LEUCINE_DEPRIVATION_UP	12101249	hematologic cancer	DOID_2531
5407	PENG_LEUCINE_DEPRIVATION_UP	12101249	immune system cancer	DOID_0060083
5408	PENG_LEUCINE_DEPRIVATION_UP	12101249	lymphoma	DOID_0060058
5409	PENG_LEUCINE_DEPRIVATION_UP	12101249	organ system cancer	DOID_0050686
5410	LEE_LIVER_CANCER_MYC_TGFA_DN	15565109	cancer	DOID_162
5411	LEE_LIVER_CANCER_MYC_TGFA_DN	15565109	carcinoma	DOID_305
5412	LEE_LIVER_CANCER_MYC_TGFA_DN	15565109	cell type cancer	DOID_0050687
5413	LEE_LIVER_CANCER_MYC_TGFA_DN	15565109	disease of cellular proliferation	DOID_14566
5414	IIZUKA_LIVER_CANCER_PROGRESSION_G1_G2_DN	15710396	cancer	DOID_162
5415	IIZUKA_LIVER_CANCER_PROGRESSION_G1_G2_DN	15710396	carcinoma	DOID_305
5416	IIZUKA_LIVER_CANCER_PROGRESSION_G1_G2_DN	15710396	cell type cancer	DOID_0050687
5417	IIZUKA_LIVER_CANCER_PROGRESSION_G1_G2_DN	15710396	disease by infectious agent	DOID_0050117
5418	IIZUKA_LIVER_CANCER_PROGRESSION_G1_G2_DN	15710396	disease of anatomical entity	DOID_7
5419	IIZUKA_LIVER_CANCER_PROGRESSION_G1_G2_DN	15710396	disease of cellular proliferation	DOID_14566
5420	IIZUKA_LIVER_CANCER_PROGRESSION_G1_G2_DN	15710396	gastrointestinal system cancer	DOID_3119
5421	IIZUKA_LIVER_CANCER_PROGRESSION_G1_G2_DN	15710396	gastrointestinal system disease	DOID_77
5422	IIZUKA_LIVER_CANCER_PROGRESSION_G1_G2_DN	15710396	hepatitis C	DOID_1883
5423	IIZUKA_LIVER_CANCER_PROGRESSION_G1_G2_DN	15710396	hepatitis	DOID_2237
5424	IIZUKA_LIVER_CANCER_PROGRESSION_G1_G2_DN	15710396	hepatobiliary disease	DOID_3118
5425	IIZUKA_LIVER_CANCER_PROGRESSION_G1_G2_DN	15710396	hepatocellular carcinoma	DOID_684
5426	IIZUKA_LIVER_CANCER_PROGRESSION_G1_G2_DN	15710396	liver cancer	DOID_3571
5427	IIZUKA_LIVER_CANCER_PROGRESSION_G1_G2_DN	15710396	liver carcinoma	DOID_686
5428	IIZUKA_LIVER_CANCER_PROGRESSION_G1_G2_DN	15710396	liver disease	DOID_409
5429	IIZUKA_LIVER_CANCER_PROGRESSION_G1_G2_DN	15710396	organ system cancer	DOID_0050686
5430	IIZUKA_LIVER_CANCER_PROGRESSION_G1_G2_DN	15710396	viral infectious disease	DOID_934
5431	LAMB_CCND1_TARGETS	12914697	cancer	DOID_162
5432	LAMB_CCND1_TARGETS	12914697	disease of cellular proliferation	DOID_14566
5433	GNATENKO_PLATELET_SIGNATURE	12433680	NA	NA
5434	SHEPARD_BMYB_MORPHOLINO_DN	16150706	cancer	DOID_162
5435	SHEPARD_BMYB_MORPHOLINO_DN	16150706	disease of cellular proliferation	DOID_14566
5436	LEE_LIVER_CANCER_ACOX1_DN	15565109	cancer	DOID_162
5437	LEE_LIVER_CANCER_ACOX1_DN	15565109	carcinoma	DOID_305
5438	LEE_LIVER_CANCER_ACOX1_DN	15565109	cell type cancer	DOID_0050687
5439	LEE_LIVER_CANCER_ACOX1_DN	15565109	disease of cellular proliferation	DOID_14566
5440	SMITH_TERT_TARGETS_UP	12717449	NA	NA
5441	LEE_LIVER_CANCER_MYC_UP	15565109	cancer	DOID_162
5442	LEE_LIVER_CANCER_MYC_UP	15565109	carcinoma	DOID_305
5443	LEE_LIVER_CANCER_MYC_UP	15565109	cell type cancer	DOID_0050687
5444	LEE_LIVER_CANCER_MYC_UP	15565109	disease of cellular proliferation	DOID_14566
5445	MENSSEN_MYC_TARGETS	11983916	autosomal dominant disease	DOID_0050736
5446	MENSSEN_MYC_TARGETS	11983916	autosomal genetic disease	DOID_0050739
5447	MENSSEN_MYC_TARGETS	11983916	cancer	DOID_162
5448	MENSSEN_MYC_TARGETS	11983916	disease of cellular proliferation	DOID_14566
5449	MENSSEN_MYC_TARGETS	11983916	genetic disease	DOID_630
5450	MENSSEN_MYC_TARGETS	11983916	hereditary breast ovarian cancer	DOID_5683
5451	MENSSEN_MYC_TARGETS	11983916	monogenic disease	DOID_0050177
5452	IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_DN	15710396	cancer	DOID_162
5453	IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_DN	15710396	carcinoma	DOID_305
5454	IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_DN	15710396	cell type cancer	DOID_0050687
5455	IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_DN	15710396	disease by infectious agent	DOID_0050117
5456	IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_DN	15710396	disease of anatomical entity	DOID_7
5457	IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_DN	15710396	disease of cellular proliferation	DOID_14566
5458	IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_DN	15710396	gastrointestinal system cancer	DOID_3119
5459	IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_DN	15710396	gastrointestinal system disease	DOID_77
5460	IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_DN	15710396	hepatitis C	DOID_1883
5461	IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_DN	15710396	hepatitis	DOID_2237
5462	IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_DN	15710396	hepatobiliary disease	DOID_3118
5463	IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_DN	15710396	hepatocellular carcinoma	DOID_684
5464	IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_DN	15710396	liver cancer	DOID_3571
5465	IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_DN	15710396	liver carcinoma	DOID_686
5466	IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_DN	15710396	liver disease	DOID_409
5467	IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_DN	15710396	organ system cancer	DOID_0050686
5468	IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_DN	15710396	viral infectious disease	DOID_934
5469	DER_IFN_ALPHA_RESPONSE_UP	9861020	cancer	DOID_162
5470	DER_IFN_ALPHA_RESPONSE_UP	9861020	connective tissue cancer	DOID_201
5471	DER_IFN_ALPHA_RESPONSE_UP	9861020	disease of cellular proliferation	DOID_14566
5472	DER_IFN_ALPHA_RESPONSE_UP	9861020	fibrosarcoma	DOID_3355
5473	DER_IFN_ALPHA_RESPONSE_UP	9861020	musculoskeletal system cancer	DOID_0060100
5474	DER_IFN_ALPHA_RESPONSE_UP	9861020	organ system cancer	DOID_0050686
5475	KANNAN_TP53_TARGETS_UP	11402317	cancer	DOID_162
5476	KANNAN_TP53_TARGETS_UP	11402317	disease of cellular proliferation	DOID_14566
5477	KANNAN_TP53_TARGETS_UP	11402317	lung cancer	DOID_1324
5478	KANNAN_TP53_TARGETS_UP	11402317	organ system cancer	DOID_0050686
5479	KANNAN_TP53_TARGETS_UP	11402317	respiratory system cancer	DOID_0050615
5480	FRASOR_RESPONSE_TO_ESTRADIOL_UP	14973112	breast cancer	DOID_1612
5481	FRASOR_RESPONSE_TO_ESTRADIOL_UP	14973112	cancer	DOID_162
5482	FRASOR_RESPONSE_TO_ESTRADIOL_UP	14973112	disease of cellular proliferation	DOID_14566
5483	FRASOR_RESPONSE_TO_ESTRADIOL_UP	14973112	organ system cancer	DOID_0050686
5484	FRASOR_RESPONSE_TO_ESTRADIOL_UP	14973112	thoracic cancer	DOID_5093
5485	LEE_LIVER_CANCER_MYC_TGFA_UP	15565109	cancer	DOID_162
5486	LEE_LIVER_CANCER_MYC_TGFA_UP	15565109	carcinoma	DOID_305
5487	LEE_LIVER_CANCER_MYC_TGFA_UP	15565109	cell type cancer	DOID_0050687
5488	LEE_LIVER_CANCER_MYC_TGFA_UP	15565109	disease of cellular proliferation	DOID_14566
5489	FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN	15307835	NA	NA
5490	DORSAM_HOXA9_TARGETS_UP	14604967	acute myeloid leukemia	DOID_9119
5491	DORSAM_HOXA9_TARGETS_UP	14604967	cancer	DOID_162
5492	DORSAM_HOXA9_TARGETS_UP	14604967	disease of cellular proliferation	DOID_14566
5493	DORSAM_HOXA9_TARGETS_UP	14604967	hematologic cancer	DOID_2531
5494	DORSAM_HOXA9_TARGETS_UP	14604967	immune system cancer	DOID_0060083
5495	DORSAM_HOXA9_TARGETS_UP	14604967	leukemia	DOID_1240
5496	DORSAM_HOXA9_TARGETS_UP	14604967	myeloid leukemia	DOID_8692
5497	DORSAM_HOXA9_TARGETS_UP	14604967	organ system cancer	DOID_0050686
5498	IIZUKA_LIVER_CANCER_PROGRESSION_G2_G3_UP	15710396	cancer	DOID_162
5499	IIZUKA_LIVER_CANCER_PROGRESSION_G2_G3_UP	15710396	carcinoma	DOID_305
5500	IIZUKA_LIVER_CANCER_PROGRESSION_G2_G3_UP	15710396	cell type cancer	DOID_0050687
5501	IIZUKA_LIVER_CANCER_PROGRESSION_G2_G3_UP	15710396	disease by infectious agent	DOID_0050117
5502	IIZUKA_LIVER_CANCER_PROGRESSION_G2_G3_UP	15710396	disease of anatomical entity	DOID_7
5503	IIZUKA_LIVER_CANCER_PROGRESSION_G2_G3_UP	15710396	disease of cellular proliferation	DOID_14566
5504	IIZUKA_LIVER_CANCER_PROGRESSION_G2_G3_UP	15710396	gastrointestinal system cancer	DOID_3119
5505	IIZUKA_LIVER_CANCER_PROGRESSION_G2_G3_UP	15710396	gastrointestinal system disease	DOID_77
5506	IIZUKA_LIVER_CANCER_PROGRESSION_G2_G3_UP	15710396	hepatitis C	DOID_1883
5507	IIZUKA_LIVER_CANCER_PROGRESSION_G2_G3_UP	15710396	hepatitis	DOID_2237
5508	IIZUKA_LIVER_CANCER_PROGRESSION_G2_G3_UP	15710396	hepatobiliary disease	DOID_3118
5509	IIZUKA_LIVER_CANCER_PROGRESSION_G2_G3_UP	15710396	hepatocellular carcinoma	DOID_684
5510	IIZUKA_LIVER_CANCER_PROGRESSION_G2_G3_UP	15710396	liver cancer	DOID_3571
5511	IIZUKA_LIVER_CANCER_PROGRESSION_G2_G3_UP	15710396	liver carcinoma	DOID_686
5512	IIZUKA_LIVER_CANCER_PROGRESSION_G2_G3_UP	15710396	liver disease	DOID_409
5513	IIZUKA_LIVER_CANCER_PROGRESSION_G2_G3_UP	15710396	organ system cancer	DOID_0050686
5514	IIZUKA_LIVER_CANCER_PROGRESSION_G2_G3_UP	15710396	viral infectious disease	DOID_934
5515	KLEIN_PRIMARY_EFFUSION_LYMPHOMA_DN	12531789	acquired immunodeficiency syndrome	DOID_635
5516	KLEIN_PRIMARY_EFFUSION_LYMPHOMA_DN	12531789	bone marrow cancer	DOID_4960
5517	KLEIN_PRIMARY_EFFUSION_LYMPHOMA_DN	12531789	cancer	DOID_162
5518	KLEIN_PRIMARY_EFFUSION_LYMPHOMA_DN	12531789	disease by infectious agent	DOID_0050117
5519	KLEIN_PRIMARY_EFFUSION_LYMPHOMA_DN	12531789	disease of anatomical entity	DOID_7
5520	KLEIN_PRIMARY_EFFUSION_LYMPHOMA_DN	12531789	disease of cellular proliferation	DOID_14566
5521	KLEIN_PRIMARY_EFFUSION_LYMPHOMA_DN	12531789	hematologic cancer	DOID_2531
5522	KLEIN_PRIMARY_EFFUSION_LYMPHOMA_DN	12531789	Human immunodeficiency virus infectious disease	DOID_526
5523	KLEIN_PRIMARY_EFFUSION_LYMPHOMA_DN	12531789	immune system cancer	DOID_0060083
5524	KLEIN_PRIMARY_EFFUSION_LYMPHOMA_DN	12531789	immune system disease	DOID_2914
5525	KLEIN_PRIMARY_EFFUSION_LYMPHOMA_DN	12531789	lymphoma	DOID_0060058
5526	KLEIN_PRIMARY_EFFUSION_LYMPHOMA_DN	12531789	multiple myeloma	DOID_9538
5527	KLEIN_PRIMARY_EFFUSION_LYMPHOMA_DN	12531789	myeloma	DOID_0070004
5528	KLEIN_PRIMARY_EFFUSION_LYMPHOMA_DN	12531789	non-Hodgkin lymphoma	DOID_0060060
5529	KLEIN_PRIMARY_EFFUSION_LYMPHOMA_DN	12531789	organ system cancer	DOID_0050686
5530	KLEIN_PRIMARY_EFFUSION_LYMPHOMA_DN	12531789	primary immunodeficiency disease	DOID_612
5531	KLEIN_PRIMARY_EFFUSION_LYMPHOMA_DN	12531789	syndrome	DOID_225
5532	KLEIN_PRIMARY_EFFUSION_LYMPHOMA_DN	12531789	viral infectious disease	DOID_934
5533	SHEPARD_BMYB_TARGETS	16150706	cancer	DOID_162
5534	SHEPARD_BMYB_TARGETS	16150706	disease of cellular proliferation	DOID_14566
5535	KANNAN_TP53_TARGETS_DN	11402317	cancer	DOID_162
5536	KANNAN_TP53_TARGETS_DN	11402317	disease of cellular proliferation	DOID_14566
5537	KANNAN_TP53_TARGETS_DN	11402317	lung cancer	DOID_1324
5538	KANNAN_TP53_TARGETS_DN	11402317	organ system cancer	DOID_0050686
5539	KANNAN_TP53_TARGETS_DN	11402317	respiratory system cancer	DOID_0050615
5540	CHANG_POU5F1_TARGETS_UP	18676852	bladder carcinoma	DOID_4007
5541	CHANG_POU5F1_TARGETS_UP	18676852	bladder transitional cell carcinoma	DOID_4006
5542	CHANG_POU5F1_TARGETS_UP	18676852	cancer	DOID_162
5543	CHANG_POU5F1_TARGETS_UP	18676852	carcinoma	DOID_305
5544	CHANG_POU5F1_TARGETS_UP	18676852	cell type cancer	DOID_0050687
5545	CHANG_POU5F1_TARGETS_UP	18676852	disease of cellular proliferation	DOID_14566
5546	CHANG_POU5F1_TARGETS_UP	18676852	organ system cancer	DOID_0050686
5547	CHANG_POU5F1_TARGETS_UP	18676852	transitional cell carcinoma	DOID_2671
5548	CHANG_POU5F1_TARGETS_UP	18676852	urinary bladder cancer	DOID_11054
5549	CHANG_POU5F1_TARGETS_UP	18676852	urinary system cancer	DOID_3996
5550	SANA_TNF_SIGNALING_DN	15749026	NA	NA
5551	TARTE_PLASMA_CELL_VS_PLASMABLAST_UP	12663452	NA	NA
5552	WILLERT_WNT_SIGNALING	12095419	cancer	DOID_162
5553	WILLERT_WNT_SIGNALING	12095419	carcinoma	DOID_305
5554	WILLERT_WNT_SIGNALING	12095419	cell type cancer	DOID_0050687
5555	WILLERT_WNT_SIGNALING	12095419	disease of cellular proliferation	DOID_14566
5556	WILLERT_WNT_SIGNALING	12095419	germ cell and embryonal cancer	DOID_3095
5557	WILLERT_WNT_SIGNALING	12095419	germ cell cancer	DOID_2994
5558	WILLERT_WNT_SIGNALING	12095419	mixed germ cell cancer	DOID_3306
5559	WILLERT_WNT_SIGNALING	12095419	teratocarcinoma	DOID_3305
5560	PENG_LEUCINE_DEPRIVATION_DN	12101249	cancer	DOID_162
5561	PENG_LEUCINE_DEPRIVATION_DN	12101249	disease of cellular proliferation	DOID_14566
5562	PENG_LEUCINE_DEPRIVATION_DN	12101249	hematologic cancer	DOID_2531
5563	PENG_LEUCINE_DEPRIVATION_DN	12101249	immune system cancer	DOID_0060083
5564	PENG_LEUCINE_DEPRIVATION_DN	12101249	lymphoma	DOID_0060058
5565	PENG_LEUCINE_DEPRIVATION_DN	12101249	organ system cancer	DOID_0050686
5566	KENNY_CTNNB1_TARGETS_DN	15642117	cancer	DOID_162
5567	KENNY_CTNNB1_TARGETS_DN	15642117	carcinoma	DOID_305
5568	KENNY_CTNNB1_TARGETS_DN	15642117	cell type cancer	DOID_0050687
5569	KENNY_CTNNB1_TARGETS_DN	15642117	disease of cellular proliferation	DOID_14566
5570	BECKER_TAMOXIFEN_RESISTANCE_UP	15657362	breast cancer	DOID_1612
5571	BECKER_TAMOXIFEN_RESISTANCE_UP	15657362	breast carcinoma	DOID_3459
5572	BECKER_TAMOXIFEN_RESISTANCE_UP	15657362	cancer	DOID_162
5573	BECKER_TAMOXIFEN_RESISTANCE_UP	15657362	carcinoma	DOID_305
5574	BECKER_TAMOXIFEN_RESISTANCE_UP	15657362	cell type cancer	DOID_0050687
5575	BECKER_TAMOXIFEN_RESISTANCE_UP	15657362	disease of cellular proliferation	DOID_14566
5576	BECKER_TAMOXIFEN_RESISTANCE_UP	15657362	organ system cancer	DOID_0050686
5577	BECKER_TAMOXIFEN_RESISTANCE_UP	15657362	thoracic cancer	DOID_5093
5578	SHEPARD_CRUSH_AND_BURN_MUTANT_DN	16150706	cancer	DOID_162
5579	SHEPARD_CRUSH_AND_BURN_MUTANT_DN	16150706	disease of cellular proliferation	DOID_14566
5580	RADAEVA_RESPONSE_TO_IFNA1_UP	11910354	cancer	DOID_162
5581	RADAEVA_RESPONSE_TO_IFNA1_UP	11910354	carcinoma	DOID_305
5582	RADAEVA_RESPONSE_TO_IFNA1_UP	11910354	cell type cancer	DOID_0050687
5583	RADAEVA_RESPONSE_TO_IFNA1_UP	11910354	disease of anatomical entity	DOID_7
5584	RADAEVA_RESPONSE_TO_IFNA1_UP	11910354	disease of cellular proliferation	DOID_14566
5585	RADAEVA_RESPONSE_TO_IFNA1_UP	11910354	gastrointestinal system cancer	DOID_3119
5586	RADAEVA_RESPONSE_TO_IFNA1_UP	11910354	gastrointestinal system disease	DOID_77
5587	RADAEVA_RESPONSE_TO_IFNA1_UP	11910354	hepatitis	DOID_2237
5588	RADAEVA_RESPONSE_TO_IFNA1_UP	11910354	hepatobiliary disease	DOID_3118
5589	RADAEVA_RESPONSE_TO_IFNA1_UP	11910354	hepatocellular carcinoma	DOID_684
5590	RADAEVA_RESPONSE_TO_IFNA1_UP	11910354	liver cancer	DOID_3571
5591	RADAEVA_RESPONSE_TO_IFNA1_UP	11910354	liver carcinoma	DOID_686
5592	RADAEVA_RESPONSE_TO_IFNA1_UP	11910354	liver disease	DOID_409
5593	RADAEVA_RESPONSE_TO_IFNA1_UP	11910354	organ system cancer	DOID_0050686
5594	RADAEVA_RESPONSE_TO_IFNA1_UP	11910354	viral hepatitis	DOID_1884
5595	TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_DN	12663452	NA	NA
5596	KUROKAWA_LIVER_CANCER_CHEMOTHERAPY_DN	15447987	cancer	DOID_162
5597	KUROKAWA_LIVER_CANCER_CHEMOTHERAPY_DN	15447987	carcinoma	DOID_305
5598	KUROKAWA_LIVER_CANCER_CHEMOTHERAPY_DN	15447987	cell type cancer	DOID_0050687
5599	KUROKAWA_LIVER_CANCER_CHEMOTHERAPY_DN	15447987	disease of cellular proliferation	DOID_14566
5600	KUROKAWA_LIVER_CANCER_CHEMOTHERAPY_DN	15447987	gastrointestinal system cancer	DOID_3119
5601	KUROKAWA_LIVER_CANCER_CHEMOTHERAPY_DN	15447987	hepatocellular carcinoma	DOID_684
5602	KUROKAWA_LIVER_CANCER_CHEMOTHERAPY_DN	15447987	liver cancer	DOID_3571
5603	KUROKAWA_LIVER_CANCER_CHEMOTHERAPY_DN	15447987	liver carcinoma	DOID_686
5604	KUROKAWA_LIVER_CANCER_CHEMOTHERAPY_DN	15447987	organ system cancer	DOID_0050686
5605	YAGI_AML_RELAPSE_PROGNOSIS	12738660	acute myeloid leukemia	DOID_9119
5606	YAGI_AML_RELAPSE_PROGNOSIS	12738660	cancer	DOID_162
5607	YAGI_AML_RELAPSE_PROGNOSIS	12738660	disease of cellular proliferation	DOID_14566
5608	YAGI_AML_RELAPSE_PROGNOSIS	12738660	hematologic cancer	DOID_2531
5609	YAGI_AML_RELAPSE_PROGNOSIS	12738660	immune system cancer	DOID_0060083
5610	YAGI_AML_RELAPSE_PROGNOSIS	12738660	leukemia	DOID_1240
5611	YAGI_AML_RELAPSE_PROGNOSIS	12738660	myeloid leukemia	DOID_8692
5612	YAGI_AML_RELAPSE_PROGNOSIS	12738660	organ system cancer	DOID_0050686
5613	SHIPP_DLBCL_CURED_VS_FATAL_UP	11786909	B-cell lymphocytic neoplasm	DOID_707
5614	SHIPP_DLBCL_CURED_VS_FATAL_UP	11786909	cancer	DOID_162
5615	SHIPP_DLBCL_CURED_VS_FATAL_UP	11786909	diffuse large B-cell lymphoma	DOID_0050745
5616	SHIPP_DLBCL_CURED_VS_FATAL_UP	11786909	disease of cellular proliferation	DOID_14566
5617	SHIPP_DLBCL_CURED_VS_FATAL_UP	11786909	hematologic cancer	DOID_2531
5618	SHIPP_DLBCL_CURED_VS_FATAL_UP	11786909	immune system cancer	DOID_0060083
5619	SHIPP_DLBCL_CURED_VS_FATAL_UP	11786909	lymphoma	DOID_0060058
5620	SHIPP_DLBCL_CURED_VS_FATAL_UP	11786909	organ system cancer	DOID_0050686
5621	FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP	15307835	NA	NA
5622	LEE_LIVER_CANCER_ACOX1_UP	15565109	cancer	DOID_162
5623	LEE_LIVER_CANCER_ACOX1_UP	15565109	carcinoma	DOID_305
5624	LEE_LIVER_CANCER_ACOX1_UP	15565109	cell type cancer	DOID_0050687
5625	LEE_LIVER_CANCER_ACOX1_UP	15565109	disease of cellular proliferation	DOID_14566
5626	CHEOK_RESPONSE_TO_MERCAPTOPURINE_UP	12704389	cancer	DOID_162
5627	CHEOK_RESPONSE_TO_MERCAPTOPURINE_UP	12704389	disease of cellular proliferation	DOID_14566
5628	CHEOK_RESPONSE_TO_MERCAPTOPURINE_UP	12704389	hematologic cancer	DOID_2531
5629	CHEOK_RESPONSE_TO_MERCAPTOPURINE_UP	12704389	immune system cancer	DOID_0060083
5630	CHEOK_RESPONSE_TO_MERCAPTOPURINE_UP	12704389	leukemia	DOID_1240
5631	CHEOK_RESPONSE_TO_MERCAPTOPURINE_UP	12704389	lymphoblastic leukemia	DOID_1037
5632	CHEOK_RESPONSE_TO_MERCAPTOPURINE_UP	12704389	lymphoid leukemia	DOID_10747
5633	CHEOK_RESPONSE_TO_MERCAPTOPURINE_UP	12704389	organ system cancer	DOID_0050686
5634	CHEN_LUNG_CANCER_SURVIVAL	14573703	adenocarcinoma	DOID_299
5635	CHEN_LUNG_CANCER_SURVIVAL	14573703	cancer	DOID_162
5636	CHEN_LUNG_CANCER_SURVIVAL	14573703	carcinoma	DOID_305
5637	CHEN_LUNG_CANCER_SURVIVAL	14573703	cell type cancer	DOID_0050687
5638	CHEN_LUNG_CANCER_SURVIVAL	14573703	disease of cellular proliferation	DOID_14566
5639	CHEN_LUNG_CANCER_SURVIVAL	14573703	lung adenocarcinoma	DOID_3910
5640	CHEN_LUNG_CANCER_SURVIVAL	14573703	lung cancer	DOID_1324
5641	CHEN_LUNG_CANCER_SURVIVAL	14573703	lung carcinoma	DOID_3905
5642	CHEN_LUNG_CANCER_SURVIVAL	14573703	non-small cell lung carcinoma	DOID_3908
5643	CHEN_LUNG_CANCER_SURVIVAL	14573703	organ system cancer	DOID_0050686
5644	CHEN_LUNG_CANCER_SURVIVAL	14573703	respiratory system cancer	DOID_0050615
5645	POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_UP	11807556	brain cancer	DOID_1319
5646	POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_UP	11807556	cancer	DOID_162
5647	POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_UP	11807556	cell type cancer	DOID_0050687
5648	POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_UP	11807556	central nervous system cancer	DOID_3620
5649	POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_UP	11807556	disease of cellular proliferation	DOID_14566
5650	POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_UP	11807556	germ cell and embryonal cancer	DOID_3095
5651	POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_UP	11807556	germ cell cancer	DOID_2994
5652	POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_UP	11807556	medulloblastoma	DOID_3858
5653	POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_UP	11807556	nervous system cancer	DOID_3093
5654	POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_UP	11807556	neuroectodermal tumor	DOID_171
5655	POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_UP	11807556	organ system cancer	DOID_0050686
5656	POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_UP	11807556	primitive neuroectodermal tumor	DOID_168
5657	SHEPARD_BMYB_MORPHOLINO_UP	16150706	cancer	DOID_162
5658	SHEPARD_BMYB_MORPHOLINO_UP	16150706	disease of cellular proliferation	DOID_14566
5659	GOLUB_ALL_VS_AML_DN	10521349	acute myeloid leukemia	DOID_9119
5660	GOLUB_ALL_VS_AML_DN	10521349	cancer	DOID_162
5661	GOLUB_ALL_VS_AML_DN	10521349	disease of cellular proliferation	DOID_14566
5662	GOLUB_ALL_VS_AML_DN	10521349	hematologic cancer	DOID_2531
5663	GOLUB_ALL_VS_AML_DN	10521349	immune system cancer	DOID_0060083
5664	GOLUB_ALL_VS_AML_DN	10521349	leukemia	DOID_1240
5665	GOLUB_ALL_VS_AML_DN	10521349	lymphoblastic leukemia	DOID_1037
5666	GOLUB_ALL_VS_AML_DN	10521349	myeloid leukemia	DOID_8692
5667	GOLUB_ALL_VS_AML_DN	10521349	organ system cancer	DOID_0050686
5668	DER_IFN_BETA_RESPONSE_UP	9861020	cancer	DOID_162
5669	DER_IFN_BETA_RESPONSE_UP	9861020	connective tissue cancer	DOID_201
5670	DER_IFN_BETA_RESPONSE_UP	9861020	disease of cellular proliferation	DOID_14566
5671	DER_IFN_BETA_RESPONSE_UP	9861020	fibrosarcoma	DOID_3355
5672	DER_IFN_BETA_RESPONSE_UP	9861020	musculoskeletal system cancer	DOID_0060100
5673	DER_IFN_BETA_RESPONSE_UP	9861020	organ system cancer	DOID_0050686
5674	MANALO_HYPOXIA_DN	15374877	NA	NA
5675	LEE_LIVER_CANCER_MYC_E2F1_DN	15565109	cancer	DOID_162
5676	LEE_LIVER_CANCER_MYC_E2F1_DN	15565109	carcinoma	DOID_305
5677	LEE_LIVER_CANCER_MYC_E2F1_DN	15565109	cell type cancer	DOID_0050687
5678	LEE_LIVER_CANCER_MYC_E2F1_DN	15565109	disease of cellular proliferation	DOID_14566
5679	NELSON_RESPONSE_TO_ANDROGEN_UP	12185249	adenocarcinoma	DOID_299
5680	NELSON_RESPONSE_TO_ANDROGEN_UP	12185249	cancer	DOID_162
5681	NELSON_RESPONSE_TO_ANDROGEN_UP	12185249	carcinoma	DOID_305
5682	NELSON_RESPONSE_TO_ANDROGEN_UP	12185249	cell type cancer	DOID_0050687
5683	NELSON_RESPONSE_TO_ANDROGEN_UP	12185249	disease of cellular proliferation	DOID_14566
5684	LIN_APC_TARGETS	11522623	cancer	DOID_162
5685	LIN_APC_TARGETS	11522623	colorectal cancer	DOID_9256
5686	LIN_APC_TARGETS	11522623	disease of cellular proliferation	DOID_14566
5687	LIN_APC_TARGETS	11522623	gastrointestinal system cancer	DOID_3119
5688	LIN_APC_TARGETS	11522623	intestinal cancer	DOID_10155
5689	LIN_APC_TARGETS	11522623	large intestine cancer	DOID_5672
5690	LIN_APC_TARGETS	11522623	organ system cancer	DOID_0050686
5691	VANTVEER_BREAST_CANCER_METASTASIS_DN	11823860	autosomal dominant disease	DOID_0050736
5692	VANTVEER_BREAST_CANCER_METASTASIS_DN	11823860	autosomal genetic disease	DOID_0050739
5693	VANTVEER_BREAST_CANCER_METASTASIS_DN	11823860	breast cancer	DOID_1612
5694	VANTVEER_BREAST_CANCER_METASTASIS_DN	11823860	cancer	DOID_162
5695	VANTVEER_BREAST_CANCER_METASTASIS_DN	11823860	disease of cellular proliferation	DOID_14566
5696	VANTVEER_BREAST_CANCER_METASTASIS_DN	11823860	genetic disease	DOID_630
5697	VANTVEER_BREAST_CANCER_METASTASIS_DN	11823860	hereditary breast ovarian cancer	DOID_5683
5698	VANTVEER_BREAST_CANCER_METASTASIS_DN	11823860	monogenic disease	DOID_0050177
5699	VANTVEER_BREAST_CANCER_METASTASIS_DN	11823860	organ system cancer	DOID_0050686
5700	VANTVEER_BREAST_CANCER_METASTASIS_DN	11823860	thoracic cancer	DOID_5093
5701	BROCKE_APOPTOSIS_REVERSED_BY_IL6	12969979	bone marrow cancer	DOID_4960
5702	BROCKE_APOPTOSIS_REVERSED_BY_IL6	12969979	cancer	DOID_162
5703	BROCKE_APOPTOSIS_REVERSED_BY_IL6	12969979	disease of cellular proliferation	DOID_14566
5704	BROCKE_APOPTOSIS_REVERSED_BY_IL6	12969979	hematologic cancer	DOID_2531
5705	BROCKE_APOPTOSIS_REVERSED_BY_IL6	12969979	immune system cancer	DOID_0060083
5706	BROCKE_APOPTOSIS_REVERSED_BY_IL6	12969979	multiple myeloma	DOID_9538
5707	BROCKE_APOPTOSIS_REVERSED_BY_IL6	12969979	myeloma	DOID_0070004
5708	BROCKE_APOPTOSIS_REVERSED_BY_IL6	12969979	organ system cancer	DOID_0050686
5709	POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_DN	11807556	brain cancer	DOID_1319
5710	POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_DN	11807556	cancer	DOID_162
5711	POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_DN	11807556	cell type cancer	DOID_0050687
5712	POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_DN	11807556	central nervous system cancer	DOID_3620
5713	POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_DN	11807556	disease of cellular proliferation	DOID_14566
5714	POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_DN	11807556	germ cell and embryonal cancer	DOID_3095
5715	POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_DN	11807556	germ cell cancer	DOID_2994
5716	POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_DN	11807556	medulloblastoma	DOID_3858
5717	POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_DN	11807556	nervous system cancer	DOID_3093
5718	POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_DN	11807556	neuroectodermal tumor	DOID_171
5719	POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_DN	11807556	organ system cancer	DOID_0050686
5720	POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_DN	11807556	primitive neuroectodermal tumor	DOID_168
5721	FRASOR_RESPONSE_TO_ESTRADIOL_DN	14973112	breast cancer	DOID_1612
5722	FRASOR_RESPONSE_TO_ESTRADIOL_DN	14973112	cancer	DOID_162
5723	FRASOR_RESPONSE_TO_ESTRADIOL_DN	14973112	disease of cellular proliferation	DOID_14566
5724	FRASOR_RESPONSE_TO_ESTRADIOL_DN	14973112	organ system cancer	DOID_0050686
5725	FRASOR_RESPONSE_TO_ESTRADIOL_DN	14973112	thoracic cancer	DOID_5093
5726	CHEOK_RESPONSE_TO_HD_MTX_DN	12704389	cancer	DOID_162
5727	CHEOK_RESPONSE_TO_HD_MTX_DN	12704389	disease of cellular proliferation	DOID_14566
5728	CHEOK_RESPONSE_TO_HD_MTX_DN	12704389	hematologic cancer	DOID_2531
5729	CHEOK_RESPONSE_TO_HD_MTX_DN	12704389	immune system cancer	DOID_0060083
5730	CHEOK_RESPONSE_TO_HD_MTX_DN	12704389	leukemia	DOID_1240
5731	CHEOK_RESPONSE_TO_HD_MTX_DN	12704389	lymphoblastic leukemia	DOID_1037
5732	CHEOK_RESPONSE_TO_HD_MTX_DN	12704389	lymphoid leukemia	DOID_10747
5733	CHEOK_RESPONSE_TO_HD_MTX_DN	12704389	organ system cancer	DOID_0050686
5734	TENEDINI_MEGAKARYOCYTE_MARKERS	15271793	blood coagulation disease	DOID_1247
5735	TENEDINI_MEGAKARYOCYTE_MARKERS	15271793	blood platelet disease	DOID_2218
5736	TENEDINI_MEGAKARYOCYTE_MARKERS	15271793	bone marrow cancer	DOID_4960
5737	TENEDINI_MEGAKARYOCYTE_MARKERS	15271793	cancer	DOID_162
5738	TENEDINI_MEGAKARYOCYTE_MARKERS	15271793	disease of anatomical entity	DOID_7
5739	TENEDINI_MEGAKARYOCYTE_MARKERS	15271793	disease of cellular proliferation	DOID_14566
5740	TENEDINI_MEGAKARYOCYTE_MARKERS	15271793	hematologic cancer	DOID_2531
5741	TENEDINI_MEGAKARYOCYTE_MARKERS	15271793	hematopoietic system disease	DOID_74
5742	TENEDINI_MEGAKARYOCYTE_MARKERS	15271793	hemorrhagic disease	DOID_2213
5743	TENEDINI_MEGAKARYOCYTE_MARKERS	15271793	immune system cancer	DOID_0060083
5744	TENEDINI_MEGAKARYOCYTE_MARKERS	15271793	immune system disease	DOID_2914
5745	TENEDINI_MEGAKARYOCYTE_MARKERS	15271793	myeloma	DOID_0070004
5746	TENEDINI_MEGAKARYOCYTE_MARKERS	15271793	organ system cancer	DOID_0050686
5747	TENEDINI_MEGAKARYOCYTE_MARKERS	15271793	thrombocytosis	DOID_2228
5748	TARTE_PLASMA_CELL_VS_PLASMABLAST_DN	12663452	NA	NA
5749	SMITH_LIVER_CANCER	12591738	cancer	DOID_162
5750	SMITH_LIVER_CANCER	12591738	carcinoma	DOID_305
5751	SMITH_LIVER_CANCER	12591738	cell type cancer	DOID_0050687
5752	SMITH_LIVER_CANCER	12591738	disease by infectious agent	DOID_0050117
5753	SMITH_LIVER_CANCER	12591738	disease of anatomical entity	DOID_7
5754	SMITH_LIVER_CANCER	12591738	disease of cellular proliferation	DOID_14566
5755	SMITH_LIVER_CANCER	12591738	gastrointestinal system cancer	DOID_3119
5756	SMITH_LIVER_CANCER	12591738	gastrointestinal system disease	DOID_77
5757	SMITH_LIVER_CANCER	12591738	hepatitis C	DOID_1883
5758	SMITH_LIVER_CANCER	12591738	hepatitis	DOID_2237
5759	SMITH_LIVER_CANCER	12591738	hepatobiliary disease	DOID_3118
5760	SMITH_LIVER_CANCER	12591738	hepatocellular carcinoma	DOID_684
5761	SMITH_LIVER_CANCER	12591738	liver cancer	DOID_3571
5762	SMITH_LIVER_CANCER	12591738	liver carcinoma	DOID_686
5763	SMITH_LIVER_CANCER	12591738	liver cirrhosis	DOID_5082
5764	SMITH_LIVER_CANCER	12591738	liver disease	DOID_409
5765	SMITH_LIVER_CANCER	12591738	organ system cancer	DOID_0050686
5766	SMITH_LIVER_CANCER	12591738	viral infectious disease	DOID_934
5767	ROSS_AML_WITH_MLL_FUSIONS	15226186	acute myeloid leukemia	DOID_9119
5768	ROSS_AML_WITH_MLL_FUSIONS	15226186	cancer	DOID_162
5769	ROSS_AML_WITH_MLL_FUSIONS	15226186	disease of cellular proliferation	DOID_14566
5770	ROSS_AML_WITH_MLL_FUSIONS	15226186	hematologic cancer	DOID_2531
5771	ROSS_AML_WITH_MLL_FUSIONS	15226186	immune system cancer	DOID_0060083
5772	ROSS_AML_WITH_MLL_FUSIONS	15226186	leukemia	DOID_1240
5773	ROSS_AML_WITH_MLL_FUSIONS	15226186	myeloid leukemia	DOID_8692
5774	ROSS_AML_WITH_MLL_FUSIONS	15226186	organ system cancer	DOID_0050686
5775	LEE_LIVER_CANCER_MYC_E2F1_UP	15565109	cancer	DOID_162
5776	LEE_LIVER_CANCER_MYC_E2F1_UP	15565109	carcinoma	DOID_305
5777	LEE_LIVER_CANCER_MYC_E2F1_UP	15565109	cell type cancer	DOID_0050687
5778	LEE_LIVER_CANCER_MYC_E2F1_UP	15565109	disease of cellular proliferation	DOID_14566
5779	ASTON_MAJOR_DEPRESSIVE_DISORDER_UP	15303102	bipolar disorder	DOID_3312
5780	ASTON_MAJOR_DEPRESSIVE_DISORDER_UP	15303102	cognitive disorder	DOID_1561
5781	ASTON_MAJOR_DEPRESSIVE_DISORDER_UP	15303102	disease of mental health	DOID_150
5782	ASTON_MAJOR_DEPRESSIVE_DISORDER_UP	15303102	endogenous depression	DOID_1595
5783	ASTON_MAJOR_DEPRESSIVE_DISORDER_UP	15303102	major depressive disorder	DOID_1470
5784	ASTON_MAJOR_DEPRESSIVE_DISORDER_UP	15303102	mental depression	DOID_1596
5785	ASTON_MAJOR_DEPRESSIVE_DISORDER_UP	15303102	mood disorder	DOID_3324
5786	ASTON_MAJOR_DEPRESSIVE_DISORDER_UP	15303102	psychotic disorder	DOID_2468
5787	ASTON_MAJOR_DEPRESSIVE_DISORDER_UP	15303102	schizophrenia	DOID_5419
5788	FERNANDEZ_BOUND_BY_MYC	12695333	NA	NA
5789	FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP	15307835	NA	NA
5790	ROSS_AML_OF_FAB_M7_TYPE	15226186	acute myeloid leukemia	DOID_9119
5791	ROSS_AML_OF_FAB_M7_TYPE	15226186	cancer	DOID_162
5792	ROSS_AML_OF_FAB_M7_TYPE	15226186	disease of cellular proliferation	DOID_14566
5793	ROSS_AML_OF_FAB_M7_TYPE	15226186	hematologic cancer	DOID_2531
5794	ROSS_AML_OF_FAB_M7_TYPE	15226186	immune system cancer	DOID_0060083
5795	ROSS_AML_OF_FAB_M7_TYPE	15226186	leukemia	DOID_1240
5796	ROSS_AML_OF_FAB_M7_TYPE	15226186	myeloid leukemia	DOID_8692
5797	ROSS_AML_OF_FAB_M7_TYPE	15226186	organ system cancer	DOID_0050686
5798	MOOTHA_VOXPHOS	12808457	acquired metabolic disease	DOID_0060158
5799	MOOTHA_VOXPHOS	12808457	carbohydrate metabolism disease	DOID_0050013
5800	MOOTHA_VOXPHOS	12808457	diabetes mellitus	DOID_9351
5801	MOOTHA_VOXPHOS	12808457	disease of metabolism	DOID_0014667
5802	MOOTHA_VOXPHOS	12808457	glucose metabolism disease	DOID_4194
5803	FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN	15307835	NA	NA
5804	SANA_RESPONSE_TO_IFNG_UP	15749026	NA	NA
5805	SANA_TNF_SIGNALING_UP	15749026	NA	NA
5806	POMEROY_MEDULLOBLASTOMA_PROGNOSIS_UP	11807556	brain cancer	DOID_1319
5807	POMEROY_MEDULLOBLASTOMA_PROGNOSIS_UP	11807556	cancer	DOID_162
5808	POMEROY_MEDULLOBLASTOMA_PROGNOSIS_UP	11807556	cell type cancer	DOID_0050687
5809	POMEROY_MEDULLOBLASTOMA_PROGNOSIS_UP	11807556	central nervous system cancer	DOID_3620
5810	POMEROY_MEDULLOBLASTOMA_PROGNOSIS_UP	11807556	disease of cellular proliferation	DOID_14566
5811	POMEROY_MEDULLOBLASTOMA_PROGNOSIS_UP	11807556	germ cell and embryonal cancer	DOID_3095
5812	POMEROY_MEDULLOBLASTOMA_PROGNOSIS_UP	11807556	germ cell cancer	DOID_2994
5813	POMEROY_MEDULLOBLASTOMA_PROGNOSIS_UP	11807556	medulloblastoma	DOID_3858
5814	POMEROY_MEDULLOBLASTOMA_PROGNOSIS_UP	11807556	nervous system cancer	DOID_3093
5815	POMEROY_MEDULLOBLASTOMA_PROGNOSIS_UP	11807556	neuroectodermal tumor	DOID_171
5816	POMEROY_MEDULLOBLASTOMA_PROGNOSIS_UP	11807556	organ system cancer	DOID_0050686
5817	POMEROY_MEDULLOBLASTOMA_PROGNOSIS_UP	11807556	primitive neuroectodermal tumor	DOID_168
5818	SCHUHMACHER_MYC_TARGETS_UP	11139609	B-cell lymphocytic neoplasm	DOID_707
5819	SCHUHMACHER_MYC_TARGETS_UP	11139609	Burkitt's lymphoma	DOID_8584
5820	SCHUHMACHER_MYC_TARGETS_UP	11139609	cancer	DOID_162
5821	SCHUHMACHER_MYC_TARGETS_UP	11139609	disease of cellular proliferation	DOID_14566
5822	SCHUHMACHER_MYC_TARGETS_UP	11139609	hematologic cancer	DOID_2531
5823	SCHUHMACHER_MYC_TARGETS_UP	11139609	immune system cancer	DOID_0060083
5824	SCHUHMACHER_MYC_TARGETS_UP	11139609	lymphoma	DOID_0060058
5825	SCHUHMACHER_MYC_TARGETS_UP	11139609	mature B-cell neoplasm	DOID_706
5826	SCHUHMACHER_MYC_TARGETS_UP	11139609	organ system cancer	DOID_0050686
5827	SWEET_KRAS_TARGETS_UP	15608639	adenocarcinoma	DOID_299
5828	SWEET_KRAS_TARGETS_UP	15608639	cancer	DOID_162
5829	SWEET_KRAS_TARGETS_UP	15608639	carcinoma	DOID_305
5830	SWEET_KRAS_TARGETS_UP	15608639	cell type cancer	DOID_0050687
5831	SWEET_KRAS_TARGETS_UP	15608639	disease of cellular proliferation	DOID_14566
5832	SWEET_KRAS_TARGETS_UP	15608639	lung adenocarcinoma	DOID_3910
5833	SWEET_KRAS_TARGETS_UP	15608639	lung cancer	DOID_1324
5834	SWEET_KRAS_TARGETS_UP	15608639	lung carcinoma	DOID_3905
5835	SWEET_KRAS_TARGETS_UP	15608639	non-small cell lung carcinoma	DOID_3908
5836	SWEET_KRAS_TARGETS_UP	15608639	organ system cancer	DOID_0050686
5837	SWEET_KRAS_TARGETS_UP	15608639	respiratory system cancer	DOID_0050615
5838	CHEOK_RESPONSE_TO_HD_MTX_UP	12704389	cancer	DOID_162
5839	CHEOK_RESPONSE_TO_HD_MTX_UP	12704389	disease of cellular proliferation	DOID_14566
5840	CHEOK_RESPONSE_TO_HD_MTX_UP	12704389	hematologic cancer	DOID_2531
5841	CHEOK_RESPONSE_TO_HD_MTX_UP	12704389	immune system cancer	DOID_0060083
5842	CHEOK_RESPONSE_TO_HD_MTX_UP	12704389	leukemia	DOID_1240
5843	CHEOK_RESPONSE_TO_HD_MTX_UP	12704389	lymphoblastic leukemia	DOID_1037
5844	CHEOK_RESPONSE_TO_HD_MTX_UP	12704389	lymphoid leukemia	DOID_10747
5845	CHEOK_RESPONSE_TO_HD_MTX_UP	12704389	organ system cancer	DOID_0050686
5846	OKUMURA_INFLAMMATORY_RESPONSE_LPS	12855579	NA	NA
5847	SMITH_TERT_TARGETS_DN	12717449	NA	NA
5848	SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_DN	11786909	B-cell lymphocytic neoplasm	DOID_707
5849	SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_DN	11786909	cancer	DOID_162
5850	SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_DN	11786909	diffuse large B-cell lymphoma	DOID_0050745
5851	SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_DN	11786909	disease of cellular proliferation	DOID_14566
5852	SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_DN	11786909	hematologic cancer	DOID_2531
5853	SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_DN	11786909	immune system cancer	DOID_0060083
5854	SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_DN	11786909	lymphoma	DOID_0060058
5855	SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_DN	11786909	organ system cancer	DOID_0050686
5856	LEE_LIVER_CANCER_DENA_DN	15565109	cancer	DOID_162
5857	LEE_LIVER_CANCER_DENA_DN	15565109	carcinoma	DOID_305
5858	LEE_LIVER_CANCER_DENA_DN	15565109	cell type cancer	DOID_0050687
5859	LEE_LIVER_CANCER_DENA_DN	15565109	disease of cellular proliferation	DOID_14566
5860	SANA_RESPONSE_TO_IFNG_DN	15749026	NA	NA
5861	CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_LD_MTX_DN	12704389	cancer	DOID_162
5862	CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_LD_MTX_DN	12704389	disease of cellular proliferation	DOID_14566
5863	CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_LD_MTX_DN	12704389	hematologic cancer	DOID_2531
5864	CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_LD_MTX_DN	12704389	immune system cancer	DOID_0060083
5865	CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_LD_MTX_DN	12704389	leukemia	DOID_1240
5866	CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_LD_MTX_DN	12704389	lymphoblastic leukemia	DOID_1037
5867	CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_LD_MTX_DN	12704389	lymphoid leukemia	DOID_10747
5868	CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_LD_MTX_DN	12704389	organ system cancer	DOID_0050686
5869	LEE_LIVER_CANCER_MYC_DN	15565109	cancer	DOID_162
5870	LEE_LIVER_CANCER_MYC_DN	15565109	carcinoma	DOID_305
5871	LEE_LIVER_CANCER_MYC_DN	15565109	cell type cancer	DOID_0050687
5872	LEE_LIVER_CANCER_MYC_DN	15565109	disease of cellular proliferation	DOID_14566
5873	LEE_LIVER_CANCER_CIPROFIBRATE_UP	15565109	cancer	DOID_162
5874	LEE_LIVER_CANCER_CIPROFIBRATE_UP	15565109	carcinoma	DOID_305
5875	LEE_LIVER_CANCER_CIPROFIBRATE_UP	15565109	cell type cancer	DOID_0050687
5876	LEE_LIVER_CANCER_CIPROFIBRATE_UP	15565109	disease of cellular proliferation	DOID_14566
5877	IIZUKA_LIVER_CANCER_PROGRESSION_L1_G1_UP	15710396	cancer	DOID_162
5878	IIZUKA_LIVER_CANCER_PROGRESSION_L1_G1_UP	15710396	carcinoma	DOID_305
5879	IIZUKA_LIVER_CANCER_PROGRESSION_L1_G1_UP	15710396	cell type cancer	DOID_0050687
5880	IIZUKA_LIVER_CANCER_PROGRESSION_L1_G1_UP	15710396	disease by infectious agent	DOID_0050117
5881	IIZUKA_LIVER_CANCER_PROGRESSION_L1_G1_UP	15710396	disease of anatomical entity	DOID_7
5882	IIZUKA_LIVER_CANCER_PROGRESSION_L1_G1_UP	15710396	disease of cellular proliferation	DOID_14566
5883	IIZUKA_LIVER_CANCER_PROGRESSION_L1_G1_UP	15710396	gastrointestinal system cancer	DOID_3119
5884	IIZUKA_LIVER_CANCER_PROGRESSION_L1_G1_UP	15710396	gastrointestinal system disease	DOID_77
5885	IIZUKA_LIVER_CANCER_PROGRESSION_L1_G1_UP	15710396	hepatitis C	DOID_1883
5886	IIZUKA_LIVER_CANCER_PROGRESSION_L1_G1_UP	15710396	hepatitis	DOID_2237
5887	IIZUKA_LIVER_CANCER_PROGRESSION_L1_G1_UP	15710396	hepatobiliary disease	DOID_3118
5888	IIZUKA_LIVER_CANCER_PROGRESSION_L1_G1_UP	15710396	hepatocellular carcinoma	DOID_684
5889	IIZUKA_LIVER_CANCER_PROGRESSION_L1_G1_UP	15710396	liver cancer	DOID_3571
5890	IIZUKA_LIVER_CANCER_PROGRESSION_L1_G1_UP	15710396	liver carcinoma	DOID_686
5891	IIZUKA_LIVER_CANCER_PROGRESSION_L1_G1_UP	15710396	liver disease	DOID_409
5892	IIZUKA_LIVER_CANCER_PROGRESSION_L1_G1_UP	15710396	organ system cancer	DOID_0050686
5893	IIZUKA_LIVER_CANCER_PROGRESSION_L1_G1_UP	15710396	viral infectious disease	DOID_934
5894	POMEROY_MEDULLOBLASTOMA_PROGNOSIS_DN	11807556	brain cancer	DOID_1319
5895	POMEROY_MEDULLOBLASTOMA_PROGNOSIS_DN	11807556	cancer	DOID_162
5896	POMEROY_MEDULLOBLASTOMA_PROGNOSIS_DN	11807556	cell type cancer	DOID_0050687
5897	POMEROY_MEDULLOBLASTOMA_PROGNOSIS_DN	11807556	central nervous system cancer	DOID_3620
5898	POMEROY_MEDULLOBLASTOMA_PROGNOSIS_DN	11807556	disease of cellular proliferation	DOID_14566
5899	POMEROY_MEDULLOBLASTOMA_PROGNOSIS_DN	11807556	germ cell and embryonal cancer	DOID_3095
5900	POMEROY_MEDULLOBLASTOMA_PROGNOSIS_DN	11807556	germ cell cancer	DOID_2994
5901	POMEROY_MEDULLOBLASTOMA_PROGNOSIS_DN	11807556	medulloblastoma	DOID_3858
5902	POMEROY_MEDULLOBLASTOMA_PROGNOSIS_DN	11807556	nervous system cancer	DOID_3093
5903	POMEROY_MEDULLOBLASTOMA_PROGNOSIS_DN	11807556	neuroectodermal tumor	DOID_171
5904	POMEROY_MEDULLOBLASTOMA_PROGNOSIS_DN	11807556	organ system cancer	DOID_0050686
5905	POMEROY_MEDULLOBLASTOMA_PROGNOSIS_DN	11807556	primitive neuroectodermal tumor	DOID_168
5906	LU_IL4_SIGNALING	15591113	cancer	DOID_162
5907	LU_IL4_SIGNALING	15591113	disease of cellular proliferation	DOID_14566
5908	LU_IL4_SIGNALING	15591113	hematologic cancer	DOID_2531
5909	LU_IL4_SIGNALING	15591113	immune system cancer	DOID_0060083
5910	LU_IL4_SIGNALING	15591113	lymphatic system cancer	DOID_0060073
5911	LU_IL4_SIGNALING	15591113	lymphoma	DOID_0060058
5912	LU_IL4_SIGNALING	15591113	organ system cancer	DOID_0050686
5913	LU_IL4_SIGNALING	15591113	reticulosarcoma	DOID_8538
5914	FERRANDO_LYL1_NEIGHBORS	12086890	cancer	DOID_162
5915	FERRANDO_LYL1_NEIGHBORS	12086890	disease of cellular proliferation	DOID_14566
5916	FERRANDO_LYL1_NEIGHBORS	12086890	hematologic cancer	DOID_2531
5917	FERRANDO_LYL1_NEIGHBORS	12086890	immune system cancer	DOID_0060083
5918	FERRANDO_LYL1_NEIGHBORS	12086890	leukemia	DOID_1240
5919	FERRANDO_LYL1_NEIGHBORS	12086890	lymphoblastic leukemia	DOID_1037
5920	FERRANDO_LYL1_NEIGHBORS	12086890	organ system cancer	DOID_0050686
5921	VANTVEER_BREAST_CANCER_METASTASIS_UP	11823860	autosomal dominant disease	DOID_0050736
5922	VANTVEER_BREAST_CANCER_METASTASIS_UP	11823860	autosomal genetic disease	DOID_0050739
5923	VANTVEER_BREAST_CANCER_METASTASIS_UP	11823860	breast cancer	DOID_1612
5924	VANTVEER_BREAST_CANCER_METASTASIS_UP	11823860	cancer	DOID_162
5925	VANTVEER_BREAST_CANCER_METASTASIS_UP	11823860	disease of cellular proliferation	DOID_14566
5926	VANTVEER_BREAST_CANCER_METASTASIS_UP	11823860	genetic disease	DOID_630
5927	VANTVEER_BREAST_CANCER_METASTASIS_UP	11823860	hereditary breast ovarian cancer	DOID_5683
5928	VANTVEER_BREAST_CANCER_METASTASIS_UP	11823860	monogenic disease	DOID_0050177
5929	VANTVEER_BREAST_CANCER_METASTASIS_UP	11823860	organ system cancer	DOID_0050686
5930	VANTVEER_BREAST_CANCER_METASTASIS_UP	11823860	thoracic cancer	DOID_5093
5931	COLLER_MYC_TARGETS_UP	10737792	NA	NA
5932	MANALO_HYPOXIA_UP	15374877	NA	NA
5933	REN_BOUND_BY_E2F	11799067	NA	NA
5934	WONG_IFNA2_RESISTANCE_DN	15709204	cancer	DOID_162
5935	WONG_IFNA2_RESISTANCE_DN	15709204	carcinoma	DOID_305
5936	WONG_IFNA2_RESISTANCE_DN	15709204	cell type cancer	DOID_0050687
5937	WONG_IFNA2_RESISTANCE_DN	15709204	disease by infectious agent	DOID_0050117
5938	WONG_IFNA2_RESISTANCE_DN	15709204	disease of anatomical entity	DOID_7
5939	WONG_IFNA2_RESISTANCE_DN	15709204	disease of cellular proliferation	DOID_14566
5940	WONG_IFNA2_RESISTANCE_DN	15709204	gastrointestinal system cancer	DOID_3119
5941	WONG_IFNA2_RESISTANCE_DN	15709204	gastrointestinal system disease	DOID_77
5942	WONG_IFNA2_RESISTANCE_DN	15709204	hepatitis B	DOID_2043
5943	WONG_IFNA2_RESISTANCE_DN	15709204	hepatitis C	DOID_1883
5944	WONG_IFNA2_RESISTANCE_DN	15709204	hepatitis	DOID_2237
5945	WONG_IFNA2_RESISTANCE_DN	15709204	hepatobiliary disease	DOID_3118
5946	WONG_IFNA2_RESISTANCE_DN	15709204	hepatocellular carcinoma	DOID_684
5947	WONG_IFNA2_RESISTANCE_DN	15709204	liver cancer	DOID_3571
5948	WONG_IFNA2_RESISTANCE_DN	15709204	liver carcinoma	DOID_686
5949	WONG_IFNA2_RESISTANCE_DN	15709204	liver disease	DOID_409
5950	WONG_IFNA2_RESISTANCE_DN	15709204	organ system cancer	DOID_0050686
5951	WONG_IFNA2_RESISTANCE_DN	15709204	viral infectious disease	DOID_934
5952	DORSAM_HOXA9_TARGETS_DN	14604967	acute myeloid leukemia	DOID_9119
5953	DORSAM_HOXA9_TARGETS_DN	14604967	cancer	DOID_162
5954	DORSAM_HOXA9_TARGETS_DN	14604967	disease of cellular proliferation	DOID_14566
5955	DORSAM_HOXA9_TARGETS_DN	14604967	hematologic cancer	DOID_2531
5956	DORSAM_HOXA9_TARGETS_DN	14604967	immune system cancer	DOID_0060083
5957	DORSAM_HOXA9_TARGETS_DN	14604967	leukemia	DOID_1240
5958	DORSAM_HOXA9_TARGETS_DN	14604967	myeloid leukemia	DOID_8692
5959	DORSAM_HOXA9_TARGETS_DN	14604967	organ system cancer	DOID_0050686
5960	FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN	15307835	NA	NA
5961	SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_UP	11786909	B-cell lymphocytic neoplasm	DOID_707
5962	SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_UP	11786909	cancer	DOID_162
5963	SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_UP	11786909	diffuse large B-cell lymphoma	DOID_0050745
5964	SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_UP	11786909	disease of cellular proliferation	DOID_14566
5965	SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_UP	11786909	hematologic cancer	DOID_2531
5966	SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_UP	11786909	immune system cancer	DOID_0060083
5967	SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_UP	11786909	lymphoma	DOID_0060058
5968	SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_UP	11786909	organ system cancer	DOID_0050686
5969	BECKER_TAMOXIFEN_RESISTANCE_DN	15657362	breast cancer	DOID_1612
5970	BECKER_TAMOXIFEN_RESISTANCE_DN	15657362	breast carcinoma	DOID_3459
5971	BECKER_TAMOXIFEN_RESISTANCE_DN	15657362	cancer	DOID_162
5972	BECKER_TAMOXIFEN_RESISTANCE_DN	15657362	carcinoma	DOID_305
5973	BECKER_TAMOXIFEN_RESISTANCE_DN	15657362	cell type cancer	DOID_0050687
5974	BECKER_TAMOXIFEN_RESISTANCE_DN	15657362	disease of cellular proliferation	DOID_14566
5975	BECKER_TAMOXIFEN_RESISTANCE_DN	15657362	organ system cancer	DOID_0050686
5976	BECKER_TAMOXIFEN_RESISTANCE_DN	15657362	thoracic cancer	DOID_5093
5977	KLEIN_PRIMARY_EFFUSION_LYMPHOMA_UP	12531789	acquired immunodeficiency syndrome	DOID_635
5978	KLEIN_PRIMARY_EFFUSION_LYMPHOMA_UP	12531789	bone marrow cancer	DOID_4960
5979	KLEIN_PRIMARY_EFFUSION_LYMPHOMA_UP	12531789	cancer	DOID_162
5980	KLEIN_PRIMARY_EFFUSION_LYMPHOMA_UP	12531789	disease by infectious agent	DOID_0050117
5981	KLEIN_PRIMARY_EFFUSION_LYMPHOMA_UP	12531789	disease of anatomical entity	DOID_7
5982	KLEIN_PRIMARY_EFFUSION_LYMPHOMA_UP	12531789	disease of cellular proliferation	DOID_14566
5983	KLEIN_PRIMARY_EFFUSION_LYMPHOMA_UP	12531789	hematologic cancer	DOID_2531
5984	KLEIN_PRIMARY_EFFUSION_LYMPHOMA_UP	12531789	Human immunodeficiency virus infectious disease	DOID_526
5985	KLEIN_PRIMARY_EFFUSION_LYMPHOMA_UP	12531789	immune system cancer	DOID_0060083
5986	KLEIN_PRIMARY_EFFUSION_LYMPHOMA_UP	12531789	immune system disease	DOID_2914
5987	KLEIN_PRIMARY_EFFUSION_LYMPHOMA_UP	12531789	lymphoma	DOID_0060058
5988	KLEIN_PRIMARY_EFFUSION_LYMPHOMA_UP	12531789	multiple myeloma	DOID_9538
5989	KLEIN_PRIMARY_EFFUSION_LYMPHOMA_UP	12531789	myeloma	DOID_0070004
5990	KLEIN_PRIMARY_EFFUSION_LYMPHOMA_UP	12531789	non-Hodgkin lymphoma	DOID_0060060
5991	KLEIN_PRIMARY_EFFUSION_LYMPHOMA_UP	12531789	organ system cancer	DOID_0050686
5992	KLEIN_PRIMARY_EFFUSION_LYMPHOMA_UP	12531789	primary immunodeficiency disease	DOID_612
5993	KLEIN_PRIMARY_EFFUSION_LYMPHOMA_UP	12531789	syndrome	DOID_225
5994	KLEIN_PRIMARY_EFFUSION_LYMPHOMA_UP	12531789	viral infectious disease	DOID_934
5995	SASAKI_ADULT_T_CELL_LEUKEMIA	15471956	adult T-cell leukemia	DOID_0050523
5996	SASAKI_ADULT_T_CELL_LEUKEMIA	15471956	cancer	DOID_162
5997	SASAKI_ADULT_T_CELL_LEUKEMIA	15471956	disease of cellular proliferation	DOID_14566
5998	SASAKI_ADULT_T_CELL_LEUKEMIA	15471956	hematologic cancer	DOID_2531
5999	SASAKI_ADULT_T_CELL_LEUKEMIA	15471956	immune system cancer	DOID_0060083
6000	SASAKI_ADULT_T_CELL_LEUKEMIA	15471956	leukemia	DOID_1240
6001	SASAKI_ADULT_T_CELL_LEUKEMIA	15471956	lung cancer	DOID_1324
6002	SASAKI_ADULT_T_CELL_LEUKEMIA	15471956	lymphoblastic leukemia	DOID_1037
6003	SASAKI_ADULT_T_CELL_LEUKEMIA	15471956	lymphoid leukemia	DOID_10747
6004	SASAKI_ADULT_T_CELL_LEUKEMIA	15471956	organ system cancer	DOID_0050686
6005	SASAKI_ADULT_T_CELL_LEUKEMIA	15471956	respiratory system cancer	DOID_0050615
6006	SASAKI_ADULT_T_CELL_LEUKEMIA	15471956	T-cell leukemia	DOID_715
6007	PENG_RAPAMYCIN_RESPONSE_DN	12101249	cancer	DOID_162
6008	PENG_RAPAMYCIN_RESPONSE_DN	12101249	disease of cellular proliferation	DOID_14566
6009	PENG_RAPAMYCIN_RESPONSE_DN	12101249	hematologic cancer	DOID_2531
6010	PENG_RAPAMYCIN_RESPONSE_DN	12101249	immune system cancer	DOID_0060083
6011	PENG_RAPAMYCIN_RESPONSE_DN	12101249	lymphoma	DOID_0060058
6012	PENG_RAPAMYCIN_RESPONSE_DN	12101249	organ system cancer	DOID_0050686
6013	LEE_LIVER_CANCER_E2F1_DN	15565109	cancer	DOID_162
6014	LEE_LIVER_CANCER_E2F1_DN	15565109	carcinoma	DOID_305
6015	LEE_LIVER_CANCER_E2F1_DN	15565109	cell type cancer	DOID_0050687
6016	LEE_LIVER_CANCER_E2F1_DN	15565109	disease of cellular proliferation	DOID_14566
6017	LEE_LIVER_CANCER_DENA_UP	15565109	cancer	DOID_162
6018	LEE_LIVER_CANCER_DENA_UP	15565109	carcinoma	DOID_305
6019	LEE_LIVER_CANCER_DENA_UP	15565109	cell type cancer	DOID_0050687
6020	LEE_LIVER_CANCER_DENA_UP	15565109	disease of cellular proliferation	DOID_14566
6021	FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN	15307835	NA	NA
6022	PENG_RAPAMYCIN_RESPONSE_UP	12101249	cancer	DOID_162
6023	PENG_RAPAMYCIN_RESPONSE_UP	12101249	disease of cellular proliferation	DOID_14566
6024	PENG_RAPAMYCIN_RESPONSE_UP	12101249	hematologic cancer	DOID_2531
6025	PENG_RAPAMYCIN_RESPONSE_UP	12101249	immune system cancer	DOID_0060083
6026	PENG_RAPAMYCIN_RESPONSE_UP	12101249	lymphoma	DOID_0060058
6027	PENG_RAPAMYCIN_RESPONSE_UP	12101249	organ system cancer	DOID_0050686
6028	PENG_GLUTAMINE_DEPRIVATION_DN	12101249	cancer	DOID_162
6029	PENG_GLUTAMINE_DEPRIVATION_DN	12101249	disease of cellular proliferation	DOID_14566
6030	PENG_GLUTAMINE_DEPRIVATION_DN	12101249	hematologic cancer	DOID_2531
6031	PENG_GLUTAMINE_DEPRIVATION_DN	12101249	immune system cancer	DOID_0060083
6032	PENG_GLUTAMINE_DEPRIVATION_DN	12101249	lymphoma	DOID_0060058
6033	PENG_GLUTAMINE_DEPRIVATION_DN	12101249	organ system cancer	DOID_0050686
6034	FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP	15307835	NA	NA
6035	FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP	15307835	NA	NA
6036	LEE_LIVER_CANCER_E2F1_UP	15565109	cancer	DOID_162
6037	LEE_LIVER_CANCER_E2F1_UP	15565109	carcinoma	DOID_305
6038	LEE_LIVER_CANCER_E2F1_UP	15565109	cell type cancer	DOID_0050687
6039	LEE_LIVER_CANCER_E2F1_UP	15565109	disease of cellular proliferation	DOID_14566
6040	ROSS_AML_WITH_AML1_ETO_FUSION	15226186	acute myeloid leukemia	DOID_9119
6041	ROSS_AML_WITH_AML1_ETO_FUSION	15226186	cancer	DOID_162
6042	ROSS_AML_WITH_AML1_ETO_FUSION	15226186	disease of cellular proliferation	DOID_14566
6043	ROSS_AML_WITH_AML1_ETO_FUSION	15226186	hematologic cancer	DOID_2531
6044	ROSS_AML_WITH_AML1_ETO_FUSION	15226186	immune system cancer	DOID_0060083
6045	ROSS_AML_WITH_AML1_ETO_FUSION	15226186	leukemia	DOID_1240
6046	ROSS_AML_WITH_AML1_ETO_FUSION	15226186	myeloid leukemia	DOID_8692
6047	ROSS_AML_WITH_AML1_ETO_FUSION	15226186	organ system cancer	DOID_0050686
6048	BHATTACHARYA_EMBRYONIC_STEM_CELL	15070671	NA	NA
6049	DER_IFN_GAMMA_RESPONSE_UP	9861020	cancer	DOID_162
6050	DER_IFN_GAMMA_RESPONSE_UP	9861020	connective tissue cancer	DOID_201
6051	DER_IFN_GAMMA_RESPONSE_UP	9861020	disease of cellular proliferation	DOID_14566
6052	DER_IFN_GAMMA_RESPONSE_UP	9861020	fibrosarcoma	DOID_3355
6053	DER_IFN_GAMMA_RESPONSE_UP	9861020	musculoskeletal system cancer	DOID_0060100
6054	DER_IFN_GAMMA_RESPONSE_UP	9861020	organ system cancer	DOID_0050686
6055	HASLINGER_B_CLL_WITH_17P13_DELETION	15459216	cancer	DOID_162
6056	HASLINGER_B_CLL_WITH_17P13_DELETION	15459216	chronic leukemia	DOID_1036
6057	HASLINGER_B_CLL_WITH_17P13_DELETION	15459216	chronic lymphocytic leukemia	DOID_1040
6058	HASLINGER_B_CLL_WITH_17P13_DELETION	15459216	disease of cellular proliferation	DOID_14566
6059	HASLINGER_B_CLL_WITH_17P13_DELETION	15459216	hematologic cancer	DOID_2531
6060	HASLINGER_B_CLL_WITH_17P13_DELETION	15459216	immune system cancer	DOID_0060083
6061	HASLINGER_B_CLL_WITH_17P13_DELETION	15459216	leukemia	DOID_1240
6062	HASLINGER_B_CLL_WITH_17P13_DELETION	15459216	lymphoblastic leukemia	DOID_1037
6063	HASLINGER_B_CLL_WITH_17P13_DELETION	15459216	organ system cancer	DOID_0050686
6064	NAKAJIMA_EOSINOPHIL	11493461	NA	NA
6065	ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN	15252187	NA	NA
6066	ZHAN_MULTIPLE_MYELOMA_SUBGROUPS	11861292	B-cell lymphocytic neoplasm	DOID_707
6067	ZHAN_MULTIPLE_MYELOMA_SUBGROUPS	11861292	bone marrow cancer	DOID_4960
6068	ZHAN_MULTIPLE_MYELOMA_SUBGROUPS	11861292	cancer	DOID_162
6069	ZHAN_MULTIPLE_MYELOMA_SUBGROUPS	11861292	disease of cellular proliferation	DOID_14566
6070	ZHAN_MULTIPLE_MYELOMA_SUBGROUPS	11861292	hematologic cancer	DOID_2531
6071	ZHAN_MULTIPLE_MYELOMA_SUBGROUPS	11861292	immune system cancer	DOID_0060083
6072	ZHAN_MULTIPLE_MYELOMA_SUBGROUPS	11861292	lymphoma	DOID_0060058
6073	ZHAN_MULTIPLE_MYELOMA_SUBGROUPS	11861292	mature B-cell neoplasm	DOID_706
6074	ZHAN_MULTIPLE_MYELOMA_SUBGROUPS	11861292	monoclonal gammopathy of uncertain significance	DOID_7442
6075	ZHAN_MULTIPLE_MYELOMA_SUBGROUPS	11861292	multiple myeloma	DOID_9538
6076	ZHAN_MULTIPLE_MYELOMA_SUBGROUPS	11861292	myeloma	DOID_0070004
6077	ZHAN_MULTIPLE_MYELOMA_SUBGROUPS	11861292	organ system cancer	DOID_0050686
6078	ZHAN_MULTIPLE_MYELOMA_SUBGROUPS	11861292	plasma cell neoplasm	DOID_6536
6079	HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_UP	15331438	NA	NA
6080	HASLINGER_B_CLL_WITH_MUTATED_VH_GENES	15459216	cancer	DOID_162
6081	HASLINGER_B_CLL_WITH_MUTATED_VH_GENES	15459216	chronic leukemia	DOID_1036
6082	HASLINGER_B_CLL_WITH_MUTATED_VH_GENES	15459216	chronic lymphocytic leukemia	DOID_1040
6083	HASLINGER_B_CLL_WITH_MUTATED_VH_GENES	15459216	disease of cellular proliferation	DOID_14566
6084	HASLINGER_B_CLL_WITH_MUTATED_VH_GENES	15459216	hematologic cancer	DOID_2531
6085	HASLINGER_B_CLL_WITH_MUTATED_VH_GENES	15459216	immune system cancer	DOID_0060083
6086	HASLINGER_B_CLL_WITH_MUTATED_VH_GENES	15459216	leukemia	DOID_1240
6087	HASLINGER_B_CLL_WITH_MUTATED_VH_GENES	15459216	lymphoblastic leukemia	DOID_1037
6088	HASLINGER_B_CLL_WITH_MUTATED_VH_GENES	15459216	organ system cancer	DOID_0050686
6089	CROMER_METASTASIS_UP	14676830	cancer	DOID_162
6090	CROMER_METASTASIS_UP	14676830	carcinoma	DOID_305
6091	CROMER_METASTASIS_UP	14676830	cell type cancer	DOID_0050687
6092	CROMER_METASTASIS_UP	14676830	disease of cellular proliferation	DOID_14566
6093	CROMER_METASTASIS_UP	14676830	gastrointestinal system cancer	DOID_3119
6094	CROMER_METASTASIS_UP	14676830	head and neck squamous cell carcinoma	DOID_5520
6095	CROMER_METASTASIS_UP	14676830	hypopharynx cancer	DOID_8533
6096	CROMER_METASTASIS_UP	14676830	organ system cancer	DOID_0050686
6097	CROMER_METASTASIS_UP	14676830	pharynx cancer	DOID_0060119
6098	CROMER_METASTASIS_UP	14676830	squamous cell carcinoma	DOID_1749
6099	ALCALAY_AML_BY_NPM1_LOCALIZATION_UP	15831697	acute myeloid leukemia	DOID_9119
6100	ALCALAY_AML_BY_NPM1_LOCALIZATION_UP	15831697	cancer	DOID_162
6101	ALCALAY_AML_BY_NPM1_LOCALIZATION_UP	15831697	disease of cellular proliferation	DOID_14566
6102	ALCALAY_AML_BY_NPM1_LOCALIZATION_UP	15831697	hematologic cancer	DOID_2531
6103	ALCALAY_AML_BY_NPM1_LOCALIZATION_UP	15831697	immune system cancer	DOID_0060083
6104	ALCALAY_AML_BY_NPM1_LOCALIZATION_UP	15831697	leukemia	DOID_1240
6105	ALCALAY_AML_BY_NPM1_LOCALIZATION_UP	15831697	myeloid leukemia	DOID_8692
6106	ALCALAY_AML_BY_NPM1_LOCALIZATION_UP	15831697	organ system cancer	DOID_0050686
6107	FAELT_B_CLL_WITH_VH_REARRANGEMENTS_UP	15817677	cancer	DOID_162
6108	FAELT_B_CLL_WITH_VH_REARRANGEMENTS_UP	15817677	chronic leukemia	DOID_1036
6109	FAELT_B_CLL_WITH_VH_REARRANGEMENTS_UP	15817677	chronic lymphocytic leukemia	DOID_1040
6110	FAELT_B_CLL_WITH_VH_REARRANGEMENTS_UP	15817677	disease of cellular proliferation	DOID_14566
6111	FAELT_B_CLL_WITH_VH_REARRANGEMENTS_UP	15817677	hematologic cancer	DOID_2531
6112	FAELT_B_CLL_WITH_VH_REARRANGEMENTS_UP	15817677	immune system cancer	DOID_0060083
6113	FAELT_B_CLL_WITH_VH_REARRANGEMENTS_UP	15817677	leukemia	DOID_1240
6114	FAELT_B_CLL_WITH_VH_REARRANGEMENTS_UP	15817677	lymphoblastic leukemia	DOID_1037
6115	FAELT_B_CLL_WITH_VH_REARRANGEMENTS_UP	15817677	organ system cancer	DOID_0050686
6116	XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_UP	16140955	cancer	DOID_162
6117	XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_UP	16140955	disease of cellular proliferation	DOID_14566
6118	XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_UP	16140955	hematologic cancer	DOID_2531
6119	XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_UP	16140955	immune system cancer	DOID_0060083
6120	XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_UP	16140955	leukemia	DOID_1240
6121	XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_UP	16140955	organ system cancer	DOID_0050686
6122	STOSSI_RESPONSE_TO_ESTRADIOL	15033914	cancer	DOID_162
6123	STOSSI_RESPONSE_TO_ESTRADIOL	15033914	connective tissue cancer	DOID_201
6124	STOSSI_RESPONSE_TO_ESTRADIOL	15033914	disease of cellular proliferation	DOID_14566
6125	STOSSI_RESPONSE_TO_ESTRADIOL	15033914	musculoskeletal system cancer	DOID_0060100
6126	STOSSI_RESPONSE_TO_ESTRADIOL	15033914	organ system cancer	DOID_0050686
6127	STOSSI_RESPONSE_TO_ESTRADIOL	15033914	osteosarcoma	DOID_3347
6128	MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_DN	15827134	bone marrow cancer	DOID_4960
6129	MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_DN	15827134	cancer	DOID_162
6130	MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_DN	15827134	disease of cellular proliferation	DOID_14566
6131	MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_DN	15827134	hematologic cancer	DOID_2531
6132	MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_DN	15827134	immune system cancer	DOID_0060083
6133	MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_DN	15827134	multiple myeloma	DOID_9538
6134	MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_DN	15827134	myeloma	DOID_0070004
6135	MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_DN	15827134	organ system cancer	DOID_0050686
6136	FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_UP	12637319	cancer	DOID_162
6137	FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_UP	12637319	disease of cellular proliferation	DOID_14566
6138	FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_UP	12637319	hematologic cancer	DOID_2531
6139	FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_UP	12637319	immune system cancer	DOID_0060083
6140	FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_UP	12637319	leukemia	DOID_1240
6141	FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_UP	12637319	organ system cancer	DOID_0050686
6142	HOFMANN_CELL_LYMPHOMA_DN	11468180	B-cell lymphocytic neoplasm	DOID_707
6143	HOFMANN_CELL_LYMPHOMA_DN	11468180	cancer	DOID_162
6144	HOFMANN_CELL_LYMPHOMA_DN	11468180	disease of cellular proliferation	DOID_14566
6145	HOFMANN_CELL_LYMPHOMA_DN	11468180	hematologic cancer	DOID_2531
6146	HOFMANN_CELL_LYMPHOMA_DN	11468180	immune system cancer	DOID_0060083
6147	HOFMANN_CELL_LYMPHOMA_DN	11468180	leukemia	DOID_1240
6148	HOFMANN_CELL_LYMPHOMA_DN	11468180	lymphoma	DOID_0060058
6149	HOFMANN_CELL_LYMPHOMA_DN	11468180	mantle cell lymphoma	DOID_0050746
6150	HOFMANN_CELL_LYMPHOMA_DN	11468180	organ system cancer	DOID_0050686
6151	HASLINGER_B_CLL_WITH_13Q14_DELETION	15459216	cancer	DOID_162
6152	HASLINGER_B_CLL_WITH_13Q14_DELETION	15459216	chronic leukemia	DOID_1036
6153	HASLINGER_B_CLL_WITH_13Q14_DELETION	15459216	chronic lymphocytic leukemia	DOID_1040
6154	HASLINGER_B_CLL_WITH_13Q14_DELETION	15459216	disease of cellular proliferation	DOID_14566
6155	HASLINGER_B_CLL_WITH_13Q14_DELETION	15459216	hematologic cancer	DOID_2531
6156	HASLINGER_B_CLL_WITH_13Q14_DELETION	15459216	immune system cancer	DOID_0060083
6157	HASLINGER_B_CLL_WITH_13Q14_DELETION	15459216	leukemia	DOID_1240
6158	HASLINGER_B_CLL_WITH_13Q14_DELETION	15459216	lymphoblastic leukemia	DOID_1037
6159	HASLINGER_B_CLL_WITH_13Q14_DELETION	15459216	organ system cancer	DOID_0050686
6160	HOFMANN_CELL_LYMPHOMA_UP	11468180	B-cell lymphocytic neoplasm	DOID_707
6161	HOFMANN_CELL_LYMPHOMA_UP	11468180	cancer	DOID_162
6162	HOFMANN_CELL_LYMPHOMA_UP	11468180	disease of cellular proliferation	DOID_14566
6163	HOFMANN_CELL_LYMPHOMA_UP	11468180	hematologic cancer	DOID_2531
6164	HOFMANN_CELL_LYMPHOMA_UP	11468180	immune system cancer	DOID_0060083
6165	HOFMANN_CELL_LYMPHOMA_UP	11468180	leukemia	DOID_1240
6166	HOFMANN_CELL_LYMPHOMA_UP	11468180	lymphoma	DOID_0060058
6167	HOFMANN_CELL_LYMPHOMA_UP	11468180	mantle cell lymphoma	DOID_0050746
6168	HOFMANN_CELL_LYMPHOMA_UP	11468180	organ system cancer	DOID_0050686
6169	HSIAO_LIVER_SPECIFIC_GENES	11773596	NA	NA
6170	GILDEA_METASTASIS	12438227	adenocarcinoma	DOID_299
6171	GILDEA_METASTASIS	12438227	cancer	DOID_162
6172	GILDEA_METASTASIS	12438227	carcinoma	DOID_305
6173	GILDEA_METASTASIS	12438227	cell type cancer	DOID_0050687
6174	GILDEA_METASTASIS	12438227	disease of cellular proliferation	DOID_14566
6175	GILDEA_METASTASIS	12438227	lung metastasis	DOID_2158
6176	GILDEA_METASTASIS	12438227	organ system cancer	DOID_0050686
6177	GILDEA_METASTASIS	12438227	urinary bladder cancer	DOID_11054
6178	GILDEA_METASTASIS	12438227	urinary system cancer	DOID_3996
6179	ZHAN_MULTIPLE_MYELOMA_SPIKED	11861292	B-cell lymphocytic neoplasm	DOID_707
6180	ZHAN_MULTIPLE_MYELOMA_SPIKED	11861292	bone marrow cancer	DOID_4960
6181	ZHAN_MULTIPLE_MYELOMA_SPIKED	11861292	cancer	DOID_162
6182	ZHAN_MULTIPLE_MYELOMA_SPIKED	11861292	disease of cellular proliferation	DOID_14566
6183	ZHAN_MULTIPLE_MYELOMA_SPIKED	11861292	hematologic cancer	DOID_2531
6184	ZHAN_MULTIPLE_MYELOMA_SPIKED	11861292	immune system cancer	DOID_0060083
6185	ZHAN_MULTIPLE_MYELOMA_SPIKED	11861292	lymphoma	DOID_0060058
6186	ZHAN_MULTIPLE_MYELOMA_SPIKED	11861292	mature B-cell neoplasm	DOID_706
6187	ZHAN_MULTIPLE_MYELOMA_SPIKED	11861292	monoclonal gammopathy of uncertain significance	DOID_7442
6188	ZHAN_MULTIPLE_MYELOMA_SPIKED	11861292	multiple myeloma	DOID_9538
6189	ZHAN_MULTIPLE_MYELOMA_SPIKED	11861292	myeloma	DOID_0070004
6190	ZHAN_MULTIPLE_MYELOMA_SPIKED	11861292	organ system cancer	DOID_0050686
6191	ZHAN_MULTIPLE_MYELOMA_SPIKED	11861292	plasma cell neoplasm	DOID_6536
6192	ASTIER_INTEGRIN_SIGNALING	12393420	cancer	DOID_162
6193	ASTIER_INTEGRIN_SIGNALING	12393420	disease of cellular proliferation	DOID_14566
6194	ASTIER_INTEGRIN_SIGNALING	12393420	hematologic cancer	DOID_2531
6195	ASTIER_INTEGRIN_SIGNALING	12393420	immune system cancer	DOID_0060083
6196	ASTIER_INTEGRIN_SIGNALING	12393420	leukemia	DOID_1240
6197	ASTIER_INTEGRIN_SIGNALING	12393420	organ system cancer	DOID_0050686
6198	HASLINGER_B_CLL_WITH_11Q23_DELETION	15459216	cancer	DOID_162
6199	HASLINGER_B_CLL_WITH_11Q23_DELETION	15459216	chronic leukemia	DOID_1036
6200	HASLINGER_B_CLL_WITH_11Q23_DELETION	15459216	chronic lymphocytic leukemia	DOID_1040
6201	HASLINGER_B_CLL_WITH_11Q23_DELETION	15459216	disease of cellular proliferation	DOID_14566
6202	HASLINGER_B_CLL_WITH_11Q23_DELETION	15459216	hematologic cancer	DOID_2531
6203	HASLINGER_B_CLL_WITH_11Q23_DELETION	15459216	immune system cancer	DOID_0060083
6204	HASLINGER_B_CLL_WITH_11Q23_DELETION	15459216	leukemia	DOID_1240
6205	HASLINGER_B_CLL_WITH_11Q23_DELETION	15459216	lymphoblastic leukemia	DOID_1037
6206	HASLINGER_B_CLL_WITH_11Q23_DELETION	15459216	organ system cancer	DOID_0050686
6207	LEI_MYB_TARGETS	15105423	NA	NA
6208	LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN	12057921	cancer	DOID_162
6209	LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN	12057921	disease of cellular proliferation	DOID_14566
6210	HALMOS_CEBPA_TARGETS_DN	15205324	cancer	DOID_162
6211	HALMOS_CEBPA_TARGETS_DN	15205324	disease of cellular proliferation	DOID_14566
6212	HALMOS_CEBPA_TARGETS_DN	15205324	lung cancer	DOID_1324
6213	HALMOS_CEBPA_TARGETS_DN	15205324	organ system cancer	DOID_0050686
6214	HALMOS_CEBPA_TARGETS_DN	15205324	respiratory system cancer	DOID_0050615
6215	FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_DN	12637319	cancer	DOID_162
6216	FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_DN	12637319	disease of cellular proliferation	DOID_14566
6217	FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_DN	12637319	hematologic cancer	DOID_2531
6218	FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_DN	12637319	immune system cancer	DOID_0060083
6219	FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_DN	12637319	leukemia	DOID_1240
6220	FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_DN	12637319	organ system cancer	DOID_0050686
6221	GALE_APL_WITH_FLT3_MUTATED_DN	16105978	cancer	DOID_162
6222	GALE_APL_WITH_FLT3_MUTATED_DN	16105978	disease of cellular proliferation	DOID_14566
6223	GALE_APL_WITH_FLT3_MUTATED_DN	16105978	hematologic cancer	DOID_2531
6224	GALE_APL_WITH_FLT3_MUTATED_DN	16105978	immune system cancer	DOID_0060083
6225	GALE_APL_WITH_FLT3_MUTATED_DN	16105978	leukemia	DOID_1240
6226	GALE_APL_WITH_FLT3_MUTATED_DN	16105978	organ system cancer	DOID_0050686
6227	RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_UP	14973077	autonomic nervous system neoplasm	DOID_2621
6228	RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_UP	14973077	cancer	DOID_162
6229	RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_UP	14973077	cell type cancer	DOID_0050687
6230	RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_UP	14973077	disease of cellular proliferation	DOID_14566
6231	RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_UP	14973077	germ cell and embryonal cancer	DOID_3095
6232	RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_UP	14973077	germ cell cancer	DOID_2994
6233	RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_UP	14973077	nervous system cancer	DOID_3093
6234	RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_UP	14973077	neuroblastoma	DOID_769
6235	RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_UP	14973077	neuroectodermal tumor	DOID_171
6236	RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_UP	14973077	organ system cancer	DOID_0050686
6237	RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_UP	14973077	peripheral nervous system neoplasm	DOID_1192
6238	RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_UP	14973077	peripheral primitive neuroectodermal tumor	DOID_3369
6239	RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_UP	14973077	primitive neuroectodermal tumor	DOID_168
6240	RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_UP	14973077	sarcoma	DOID_1115
6241	HALMOS_CEBPA_TARGETS_UP	15205324	cancer	DOID_162
6242	HALMOS_CEBPA_TARGETS_UP	15205324	disease of cellular proliferation	DOID_14566
6243	HALMOS_CEBPA_TARGETS_UP	15205324	lung cancer	DOID_1324
6244	HALMOS_CEBPA_TARGETS_UP	15205324	organ system cancer	DOID_0050686
6245	HALMOS_CEBPA_TARGETS_UP	15205324	respiratory system cancer	DOID_0050615
6246	ZHAN_MULTIPLE_MYELOMA_UP	11861292	B-cell lymphocytic neoplasm	DOID_707
6247	ZHAN_MULTIPLE_MYELOMA_UP	11861292	bone marrow cancer	DOID_4960
6248	ZHAN_MULTIPLE_MYELOMA_UP	11861292	cancer	DOID_162
6249	ZHAN_MULTIPLE_MYELOMA_UP	11861292	disease of cellular proliferation	DOID_14566
6250	ZHAN_MULTIPLE_MYELOMA_UP	11861292	hematologic cancer	DOID_2531
6251	ZHAN_MULTIPLE_MYELOMA_UP	11861292	immune system cancer	DOID_0060083
6252	ZHAN_MULTIPLE_MYELOMA_UP	11861292	lymphoma	DOID_0060058
6253	ZHAN_MULTIPLE_MYELOMA_UP	11861292	mature B-cell neoplasm	DOID_706
6254	ZHAN_MULTIPLE_MYELOMA_UP	11861292	monoclonal gammopathy of uncertain significance	DOID_7442
6255	ZHAN_MULTIPLE_MYELOMA_UP	11861292	multiple myeloma	DOID_9538
6256	ZHAN_MULTIPLE_MYELOMA_UP	11861292	myeloma	DOID_0070004
6257	ZHAN_MULTIPLE_MYELOMA_UP	11861292	organ system cancer	DOID_0050686
6258	ZHAN_MULTIPLE_MYELOMA_UP	11861292	plasma cell neoplasm	DOID_6536
6259	LENAOUR_DENDRITIC_CELL_MATURATION_UP	11279020	NA	NA
6260	TAVOR_CEBPA_TARGETS_DN	14517214	acute myeloid leukemia	DOID_9119
6261	TAVOR_CEBPA_TARGETS_DN	14517214	cancer	DOID_162
6262	TAVOR_CEBPA_TARGETS_DN	14517214	chronic myeloid leukemia	DOID_8552
6263	TAVOR_CEBPA_TARGETS_DN	14517214	disease of cellular proliferation	DOID_14566
6264	TAVOR_CEBPA_TARGETS_DN	14517214	hematologic cancer	DOID_2531
6265	TAVOR_CEBPA_TARGETS_DN	14517214	immune system cancer	DOID_0060083
6266	TAVOR_CEBPA_TARGETS_DN	14517214	leukemia	DOID_1240
6267	TAVOR_CEBPA_TARGETS_DN	14517214	myeloid leukemia	DOID_8692
6268	TAVOR_CEBPA_TARGETS_DN	14517214	organ system cancer	DOID_0050686
6269	LENAOUR_DENDRITIC_CELL_MATURATION_DN	11279020	NA	NA
6270	HADDAD_B_LYMPHOCYTE_PROGENITOR	15331438	NA	NA
6271	NGUYEN_NOTCH1_TARGETS_UP	16618808	NA	NA
6272	HASLINGER_B_CLL_WITH_CHROMOSOME_12_TRISOMY	15459216	cancer	DOID_162
6273	HASLINGER_B_CLL_WITH_CHROMOSOME_12_TRISOMY	15459216	chronic leukemia	DOID_1036
6274	HASLINGER_B_CLL_WITH_CHROMOSOME_12_TRISOMY	15459216	chronic lymphocytic leukemia	DOID_1040
6275	HASLINGER_B_CLL_WITH_CHROMOSOME_12_TRISOMY	15459216	disease of cellular proliferation	DOID_14566
6276	HASLINGER_B_CLL_WITH_CHROMOSOME_12_TRISOMY	15459216	hematologic cancer	DOID_2531
6277	HASLINGER_B_CLL_WITH_CHROMOSOME_12_TRISOMY	15459216	immune system cancer	DOID_0060083
6278	HASLINGER_B_CLL_WITH_CHROMOSOME_12_TRISOMY	15459216	leukemia	DOID_1240
6279	HASLINGER_B_CLL_WITH_CHROMOSOME_12_TRISOMY	15459216	lymphoblastic leukemia	DOID_1037
6280	HASLINGER_B_CLL_WITH_CHROMOSOME_12_TRISOMY	15459216	organ system cancer	DOID_0050686
6281	ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP	15388584	acquired metabolic disease	DOID_0060158
6282	ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP	15388584	amyloidosis	DOID_9120
6283	ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP	15388584	bone marrow cancer	DOID_4960
6284	ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP	15388584	cancer	DOID_162
6285	ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP	15388584	disease of anatomical entity	DOID_7
6286	ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP	15388584	disease of cellular proliferation	DOID_14566
6287	ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP	15388584	disease of metabolism	DOID_0014667
6288	ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP	15388584	eye and adnexa disease	DOID_1492
6289	ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP	15388584	eye disease	DOID_5614
6290	ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP	15388584	globe disease	DOID_1242
6291	ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP	15388584	hematologic cancer	DOID_2531
6292	ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP	15388584	immune system cancer	DOID_0060083
6293	ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP	15388584	multiple myeloma	DOID_9538
6294	ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP	15388584	myeloma	DOID_0070004
6295	ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP	15388584	nervous system cancer	DOID_3093
6296	ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP	15388584	nervous system disease	DOID_863
6297	ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP	15388584	ocular cancer	DOID_2174
6298	ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP	15388584	organ system cancer	DOID_0050686
6299	ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP	15388584	retinal cancer	DOID_4645
6300	ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP	15388584	retinal cell cancer	DOID_771
6301	ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP	15388584	retinal disease	DOID_5679
6302	ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP	15388584	retinoblastoma	DOID_768
6303	ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP	15388584	sensory system cancer	DOID_0060116
6304	ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP	15388584	sensory system disease	DOID_0050155
6305	THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP	15187151	NA	NA
6306	VERHAAK_AML_WITH_NPM1_MUTATED_UP	16109776	acute myeloid leukemia	DOID_9119
6307	VERHAAK_AML_WITH_NPM1_MUTATED_UP	16109776	cancer	DOID_162
6308	VERHAAK_AML_WITH_NPM1_MUTATED_UP	16109776	disease of cellular proliferation	DOID_14566
6309	VERHAAK_AML_WITH_NPM1_MUTATED_UP	16109776	hematologic cancer	DOID_2531
6310	VERHAAK_AML_WITH_NPM1_MUTATED_UP	16109776	immune system cancer	DOID_0060083
6311	VERHAAK_AML_WITH_NPM1_MUTATED_UP	16109776	leukemia	DOID_1240
6312	VERHAAK_AML_WITH_NPM1_MUTATED_UP	16109776	myeloid leukemia	DOID_8692
6313	VERHAAK_AML_WITH_NPM1_MUTATED_UP	16109776	organ system cancer	DOID_0050686
6314	KANG_IMMORTALIZED_BY_TERT_UP	15579653	NA	NA
6315	BASSO_CD40_SIGNALING_DN	15331443	B-cell lymphocytic neoplasm	DOID_707
6316	BASSO_CD40_SIGNALING_DN	15331443	Burkitt's lymphoma	DOID_8584
6317	BASSO_CD40_SIGNALING_DN	15331443	cancer	DOID_162
6318	BASSO_CD40_SIGNALING_DN	15331443	disease of cellular proliferation	DOID_14566
6319	BASSO_CD40_SIGNALING_DN	15331443	hematologic cancer	DOID_2531
6320	BASSO_CD40_SIGNALING_DN	15331443	immune system cancer	DOID_0060083
6321	BASSO_CD40_SIGNALING_DN	15331443	lymphoma	DOID_0060058
6322	BASSO_CD40_SIGNALING_DN	15331443	mature B-cell neoplasm	DOID_706
6323	BASSO_CD40_SIGNALING_DN	15331443	organ system cancer	DOID_0050686
6324	JAIN_NFKB_SIGNALING	15578091	CD40 ligand deficiency	DOID_0060022
6325	JAIN_NFKB_SIGNALING	15578091	combined T cell and B cell immunodeficiency	DOID_628
6326	JAIN_NFKB_SIGNALING	15578091	disease of anatomical entity	DOID_7
6327	JAIN_NFKB_SIGNALING	15578091	ectodermal dysplasia	DOID_2121
6328	JAIN_NFKB_SIGNALING	15578091	hypergammaglobulinemia	DOID_3403
6329	JAIN_NFKB_SIGNALING	15578091	immune system disease	DOID_2914
6330	JAIN_NFKB_SIGNALING	15578091	primary immunodeficiency disease	DOID_612
6331	JAIN_NFKB_SIGNALING	15578091	syndrome	DOID_225
6332	LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP	12057921	cancer	DOID_162
6333	LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP	12057921	disease of cellular proliferation	DOID_14566
6334	GALE_APL_WITH_FLT3_MUTATED_UP	16105978	cancer	DOID_162
6335	GALE_APL_WITH_FLT3_MUTATED_UP	16105978	disease of cellular proliferation	DOID_14566
6336	GALE_APL_WITH_FLT3_MUTATED_UP	16105978	hematologic cancer	DOID_2531
6337	GALE_APL_WITH_FLT3_MUTATED_UP	16105978	immune system cancer	DOID_0060083
6338	GALE_APL_WITH_FLT3_MUTATED_UP	16105978	leukemia	DOID_1240
6339	GALE_APL_WITH_FLT3_MUTATED_UP	16105978	organ system cancer	DOID_0050686
6340	THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN	15187151	NA	NA
6341	FAELT_B_CLL_WITH_VH_REARRANGEMENTS_DN	15817677	cancer	DOID_162
6342	FAELT_B_CLL_WITH_VH_REARRANGEMENTS_DN	15817677	chronic leukemia	DOID_1036
6343	FAELT_B_CLL_WITH_VH_REARRANGEMENTS_DN	15817677	chronic lymphocytic leukemia	DOID_1040
6344	FAELT_B_CLL_WITH_VH_REARRANGEMENTS_DN	15817677	disease of cellular proliferation	DOID_14566
6345	FAELT_B_CLL_WITH_VH_REARRANGEMENTS_DN	15817677	hematologic cancer	DOID_2531
6346	FAELT_B_CLL_WITH_VH_REARRANGEMENTS_DN	15817677	immune system cancer	DOID_0060083
6347	FAELT_B_CLL_WITH_VH_REARRANGEMENTS_DN	15817677	leukemia	DOID_1240
6348	FAELT_B_CLL_WITH_VH_REARRANGEMENTS_DN	15817677	lymphoblastic leukemia	DOID_1037
6349	FAELT_B_CLL_WITH_VH_REARRANGEMENTS_DN	15817677	organ system cancer	DOID_0050686
6350	VERNELL_RETINOBLASTOMA_PATHWAY_UP	12923195	cancer	DOID_162
6351	VERNELL_RETINOBLASTOMA_PATHWAY_UP	12923195	disease of anatomical entity	DOID_7
6352	VERNELL_RETINOBLASTOMA_PATHWAY_UP	12923195	disease of cellular proliferation	DOID_14566
6353	VERNELL_RETINOBLASTOMA_PATHWAY_UP	12923195	eye and adnexa disease	DOID_1492
6354	VERNELL_RETINOBLASTOMA_PATHWAY_UP	12923195	eye disease	DOID_5614
6355	VERNELL_RETINOBLASTOMA_PATHWAY_UP	12923195	globe disease	DOID_1242
6356	VERNELL_RETINOBLASTOMA_PATHWAY_UP	12923195	nervous system cancer	DOID_3093
6357	VERNELL_RETINOBLASTOMA_PATHWAY_UP	12923195	nervous system disease	DOID_863
6358	VERNELL_RETINOBLASTOMA_PATHWAY_UP	12923195	ocular cancer	DOID_2174
6359	VERNELL_RETINOBLASTOMA_PATHWAY_UP	12923195	organ system cancer	DOID_0050686
6360	VERNELL_RETINOBLASTOMA_PATHWAY_UP	12923195	retinal cancer	DOID_4645
6361	VERNELL_RETINOBLASTOMA_PATHWAY_UP	12923195	retinal cell cancer	DOID_771
6362	VERNELL_RETINOBLASTOMA_PATHWAY_UP	12923195	retinal disease	DOID_5679
6363	VERNELL_RETINOBLASTOMA_PATHWAY_UP	12923195	retinoblastoma	DOID_768
6364	VERNELL_RETINOBLASTOMA_PATHWAY_UP	12923195	sensory system cancer	DOID_0060116
6365	VERNELL_RETINOBLASTOMA_PATHWAY_UP	12923195	sensory system disease	DOID_0050155
6366	ALCALAY_AML_BY_NPM1_LOCALIZATION_DN	15831697	acute myeloid leukemia	DOID_9119
6367	ALCALAY_AML_BY_NPM1_LOCALIZATION_DN	15831697	cancer	DOID_162
6368	ALCALAY_AML_BY_NPM1_LOCALIZATION_DN	15831697	disease of cellular proliferation	DOID_14566
6369	ALCALAY_AML_BY_NPM1_LOCALIZATION_DN	15831697	hematologic cancer	DOID_2531
6370	ALCALAY_AML_BY_NPM1_LOCALIZATION_DN	15831697	immune system cancer	DOID_0060083
6371	ALCALAY_AML_BY_NPM1_LOCALIZATION_DN	15831697	leukemia	DOID_1240
6372	ALCALAY_AML_BY_NPM1_LOCALIZATION_DN	15831697	myeloid leukemia	DOID_8692
6373	ALCALAY_AML_BY_NPM1_LOCALIZATION_DN	15831697	organ system cancer	DOID_0050686
6374	KANG_IMMORTALIZED_BY_TERT_DN	15579653	NA	NA
6375	NGUYEN_NOTCH1_TARGETS_DN	16618808	NA	NA
6376	MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP	15827134	bone marrow cancer	DOID_4960
6377	MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP	15827134	cancer	DOID_162
6378	MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP	15827134	disease of cellular proliferation	DOID_14566
6379	MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP	15827134	hematologic cancer	DOID_2531
6380	MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP	15827134	immune system cancer	DOID_0060083
6381	MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP	15827134	multiple myeloma	DOID_9538
6382	MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP	15827134	myeloma	DOID_0070004
6383	MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP	15827134	organ system cancer	DOID_0050686
6384	CHIARETTI_ACUTE_LYMPHOBLASTIC_LEUKEMIA_ZAP70	16160012	cancer	DOID_162
6385	CHIARETTI_ACUTE_LYMPHOBLASTIC_LEUKEMIA_ZAP70	16160012	disease of cellular proliferation	DOID_14566
6386	CHIARETTI_ACUTE_LYMPHOBLASTIC_LEUKEMIA_ZAP70	16160012	hematologic cancer	DOID_2531
6387	CHIARETTI_ACUTE_LYMPHOBLASTIC_LEUKEMIA_ZAP70	16160012	immune system cancer	DOID_0060083
6388	CHIARETTI_ACUTE_LYMPHOBLASTIC_LEUKEMIA_ZAP70	16160012	leukemia	DOID_1240
6389	CHIARETTI_ACUTE_LYMPHOBLASTIC_LEUKEMIA_ZAP70	16160012	lymphoblastic leukemia	DOID_1037
6390	CHIARETTI_ACUTE_LYMPHOBLASTIC_LEUKEMIA_ZAP70	16160012	organ system cancer	DOID_0050686
6391	HOEGERKORP_CD44_TARGETS_DIRECT_DN	12411303	NA	NA
6392	BENNETT_SYSTEMIC_LUPUS_ERYTHEMATOSUS	12642603	connective tissue disease	DOID_65
6393	BENNETT_SYSTEMIC_LUPUS_ERYTHEMATOSUS	12642603	disease of anatomical entity	DOID_7
6394	BENNETT_SYSTEMIC_LUPUS_ERYTHEMATOSUS	12642603	hypersensitivity reaction disease	DOID_0060056
6395	BENNETT_SYSTEMIC_LUPUS_ERYTHEMATOSUS	12642603	hypersensitivity reaction type II disease	DOID_417
6396	BENNETT_SYSTEMIC_LUPUS_ERYTHEMATOSUS	12642603	immune system disease	DOID_2914
6397	BENNETT_SYSTEMIC_LUPUS_ERYTHEMATOSUS	12642603	lupus erythematosus	DOID_8857
6398	BENNETT_SYSTEMIC_LUPUS_ERYTHEMATOSUS	12642603	musculoskeletal system disease	DOID_17
6399	BENNETT_SYSTEMIC_LUPUS_ERYTHEMATOSUS	12642603	systemic lupus erythematosus	DOID_9074
6400	XU_RESPONSE_TO_TRETINOIN_UP	16140955	cancer	DOID_162
6401	XU_RESPONSE_TO_TRETINOIN_UP	16140955	disease of cellular proliferation	DOID_14566
6402	XU_RESPONSE_TO_TRETINOIN_UP	16140955	hematologic cancer	DOID_2531
6403	XU_RESPONSE_TO_TRETINOIN_UP	16140955	immune system cancer	DOID_0060083
6404	XU_RESPONSE_TO_TRETINOIN_UP	16140955	leukemia	DOID_1240
6405	XU_RESPONSE_TO_TRETINOIN_UP	16140955	organ system cancer	DOID_0050686
6406	ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN	15388584	acquired metabolic disease	DOID_0060158
6407	ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN	15388584	amyloidosis	DOID_9120
6408	ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN	15388584	bone marrow cancer	DOID_4960
6409	ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN	15388584	cancer	DOID_162
6410	ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN	15388584	disease of anatomical entity	DOID_7
6411	ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN	15388584	disease of cellular proliferation	DOID_14566
6412	ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN	15388584	disease of metabolism	DOID_0014667
6413	ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN	15388584	eye and adnexa disease	DOID_1492
6414	ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN	15388584	eye disease	DOID_5614
6415	ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN	15388584	globe disease	DOID_1242
6416	ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN	15388584	hematologic cancer	DOID_2531
6417	ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN	15388584	immune system cancer	DOID_0060083
6418	ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN	15388584	multiple myeloma	DOID_9538
6419	ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN	15388584	myeloma	DOID_0070004
6420	ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN	15388584	nervous system cancer	DOID_3093
6421	ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN	15388584	nervous system disease	DOID_863
6422	ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN	15388584	ocular cancer	DOID_2174
6423	ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN	15388584	organ system cancer	DOID_0050686
6424	ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN	15388584	retinal cancer	DOID_4645
6425	ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN	15388584	retinal cell cancer	DOID_771
6426	ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN	15388584	retinal disease	DOID_5679
6427	ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN	15388584	retinoblastoma	DOID_768
6428	ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN	15388584	sensory system cancer	DOID_0060116
6429	ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN	15388584	sensory system disease	DOID_0050155
6430	ZHAN_V2_LATE_DIFFERENTIATION_GENES	12393520	bone marrow cancer	DOID_4960
6431	ZHAN_V2_LATE_DIFFERENTIATION_GENES	12393520	cancer	DOID_162
6432	ZHAN_V2_LATE_DIFFERENTIATION_GENES	12393520	disease of cellular proliferation	DOID_14566
6433	ZHAN_V2_LATE_DIFFERENTIATION_GENES	12393520	hematologic cancer	DOID_2531
6434	ZHAN_V2_LATE_DIFFERENTIATION_GENES	12393520	immune system cancer	DOID_0060083
6435	ZHAN_V2_LATE_DIFFERENTIATION_GENES	12393520	multiple myeloma	DOID_9538
6436	ZHAN_V2_LATE_DIFFERENTIATION_GENES	12393520	myeloma	DOID_0070004
6437	ZHAN_V2_LATE_DIFFERENTIATION_GENES	12393520	organ system cancer	DOID_0050686
6438	DORSEY_GAB2_TARGETS	11830491	cancer	DOID_162
6439	DORSEY_GAB2_TARGETS	11830491	chronic myeloid leukemia	DOID_8552
6440	DORSEY_GAB2_TARGETS	11830491	disease of cellular proliferation	DOID_14566
6441	DORSEY_GAB2_TARGETS	11830491	hematologic cancer	DOID_2531
6442	DORSEY_GAB2_TARGETS	11830491	immune system cancer	DOID_0060083
6443	DORSEY_GAB2_TARGETS	11830491	leukemia	DOID_1240
6444	DORSEY_GAB2_TARGETS	11830491	myeloid leukemia	DOID_8692
6445	DORSEY_GAB2_TARGETS	11830491	organ system cancer	DOID_0050686
6446	HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_DN	15331438	NA	NA
6447	NAKAJIMA_MAST_CELL	11493461	NA	NA
6448	RADMACHER_AML_PROGNOSIS	16670265	acute myeloid leukemia	DOID_9119
6449	RADMACHER_AML_PROGNOSIS	16670265	cancer	DOID_162
6450	RADMACHER_AML_PROGNOSIS	16670265	disease of cellular proliferation	DOID_14566
6451	RADMACHER_AML_PROGNOSIS	16670265	group B streptococcal pneumonia	DOID_12017
6452	RADMACHER_AML_PROGNOSIS	16670265	hematologic cancer	DOID_2531
6453	RADMACHER_AML_PROGNOSIS	16670265	immune system cancer	DOID_0060083
6454	RADMACHER_AML_PROGNOSIS	16670265	leukemia	DOID_1240
6455	RADMACHER_AML_PROGNOSIS	16670265	myeloid leukemia	DOID_8692
6456	RADMACHER_AML_PROGNOSIS	16670265	organ system cancer	DOID_0050686
6457	CROMER_METASTASIS_DN	14676830	cancer	DOID_162
6458	CROMER_METASTASIS_DN	14676830	carcinoma	DOID_305
6459	CROMER_METASTASIS_DN	14676830	cell type cancer	DOID_0050687
6460	CROMER_METASTASIS_DN	14676830	disease of cellular proliferation	DOID_14566
6461	CROMER_METASTASIS_DN	14676830	gastrointestinal system cancer	DOID_3119
6462	CROMER_METASTASIS_DN	14676830	head and neck squamous cell carcinoma	DOID_5520
6463	CROMER_METASTASIS_DN	14676830	hypopharynx cancer	DOID_8533
6464	CROMER_METASTASIS_DN	14676830	organ system cancer	DOID_0050686
6465	CROMER_METASTASIS_DN	14676830	pharynx cancer	DOID_0060119
6466	CROMER_METASTASIS_DN	14676830	squamous cell carcinoma	DOID_1749
6467	NOUZOVA_METHYLATED_IN_APL	15302897	cancer	DOID_162
6468	NOUZOVA_METHYLATED_IN_APL	15302897	disease of cellular proliferation	DOID_14566
6469	NOUZOVA_METHYLATED_IN_APL	15302897	hematologic cancer	DOID_2531
6470	NOUZOVA_METHYLATED_IN_APL	15302897	immune system cancer	DOID_0060083
6471	NOUZOVA_METHYLATED_IN_APL	15302897	leukemia	DOID_1240
6472	NOUZOVA_METHYLATED_IN_APL	15302897	organ system cancer	DOID_0050686
6473	TAVOR_CEBPA_TARGETS_UP	14517214	acute myeloid leukemia	DOID_9119
6474	TAVOR_CEBPA_TARGETS_UP	14517214	cancer	DOID_162
6475	TAVOR_CEBPA_TARGETS_UP	14517214	chronic myeloid leukemia	DOID_8552
6476	TAVOR_CEBPA_TARGETS_UP	14517214	disease of cellular proliferation	DOID_14566
6477	TAVOR_CEBPA_TARGETS_UP	14517214	hematologic cancer	DOID_2531
6478	TAVOR_CEBPA_TARGETS_UP	14517214	immune system cancer	DOID_0060083
6479	TAVOR_CEBPA_TARGETS_UP	14517214	leukemia	DOID_1240
6480	TAVOR_CEBPA_TARGETS_UP	14517214	myeloid leukemia	DOID_8692
6481	TAVOR_CEBPA_TARGETS_UP	14517214	organ system cancer	DOID_0050686
6482	YAGI_AML_SURVIVAL	12738660	acute myeloid leukemia	DOID_9119
6483	YAGI_AML_SURVIVAL	12738660	cancer	DOID_162
6484	YAGI_AML_SURVIVAL	12738660	disease of cellular proliferation	DOID_14566
6485	YAGI_AML_SURVIVAL	12738660	hematologic cancer	DOID_2531
6486	YAGI_AML_SURVIVAL	12738660	immune system cancer	DOID_0060083
6487	YAGI_AML_SURVIVAL	12738660	leukemia	DOID_1240
6488	YAGI_AML_SURVIVAL	12738660	myeloid leukemia	DOID_8692
6489	YAGI_AML_SURVIVAL	12738660	organ system cancer	DOID_0050686
6490	VERHAAK_AML_WITH_NPM1_MUTATED_DN	16109776	acute myeloid leukemia	DOID_9119
6491	VERHAAK_AML_WITH_NPM1_MUTATED_DN	16109776	cancer	DOID_162
6492	VERHAAK_AML_WITH_NPM1_MUTATED_DN	16109776	disease of cellular proliferation	DOID_14566
6493	VERHAAK_AML_WITH_NPM1_MUTATED_DN	16109776	hematologic cancer	DOID_2531
6494	VERHAAK_AML_WITH_NPM1_MUTATED_DN	16109776	immune system cancer	DOID_0060083
6495	VERHAAK_AML_WITH_NPM1_MUTATED_DN	16109776	leukemia	DOID_1240
6496	VERHAAK_AML_WITH_NPM1_MUTATED_DN	16109776	myeloid leukemia	DOID_8692
6497	VERHAAK_AML_WITH_NPM1_MUTATED_DN	16109776	organ system cancer	DOID_0050686
6498	RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_DN	14973077	autonomic nervous system neoplasm	DOID_2621
6499	RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_DN	14973077	cancer	DOID_162
6500	RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_DN	14973077	cell type cancer	DOID_0050687
6501	RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_DN	14973077	disease of cellular proliferation	DOID_14566
6502	RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_DN	14973077	germ cell and embryonal cancer	DOID_3095
6503	RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_DN	14973077	germ cell cancer	DOID_2994
6504	RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_DN	14973077	nervous system cancer	DOID_3093
6505	RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_DN	14973077	neuroblastoma	DOID_769
6506	RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_DN	14973077	neuroectodermal tumor	DOID_171
6507	RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_DN	14973077	organ system cancer	DOID_0050686
6508	RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_DN	14973077	peripheral nervous system neoplasm	DOID_1192
6509	RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_DN	14973077	peripheral primitive neuroectodermal tumor	DOID_3369
6510	RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_DN	14973077	primitive neuroectodermal tumor	DOID_168
6511	RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_DN	14973077	sarcoma	DOID_1115
6512	APPEL_IMATINIB_RESPONSE	15756019	NA	NA
6513	YAGI_AML_FAB_MARKERS	12738660	acute myeloid leukemia	DOID_9119
6514	YAGI_AML_FAB_MARKERS	12738660	cancer	DOID_162
6515	YAGI_AML_FAB_MARKERS	12738660	disease of cellular proliferation	DOID_14566
6516	YAGI_AML_FAB_MARKERS	12738660	hematologic cancer	DOID_2531
6517	YAGI_AML_FAB_MARKERS	12738660	immune system cancer	DOID_0060083
6518	YAGI_AML_FAB_MARKERS	12738660	leukemia	DOID_1240
6519	YAGI_AML_FAB_MARKERS	12738660	myeloid leukemia	DOID_8692
6520	YAGI_AML_FAB_MARKERS	12738660	organ system cancer	DOID_0050686
6521	MOREAUX_MULTIPLE_MYELOMA_BY_TACI_DN	15827134	bone marrow cancer	DOID_4960
6522	MOREAUX_MULTIPLE_MYELOMA_BY_TACI_DN	15827134	cancer	DOID_162
6523	MOREAUX_MULTIPLE_MYELOMA_BY_TACI_DN	15827134	disease of cellular proliferation	DOID_14566
6524	MOREAUX_MULTIPLE_MYELOMA_BY_TACI_DN	15827134	hematologic cancer	DOID_2531
6525	MOREAUX_MULTIPLE_MYELOMA_BY_TACI_DN	15827134	immune system cancer	DOID_0060083
6526	MOREAUX_MULTIPLE_MYELOMA_BY_TACI_DN	15827134	multiple myeloma	DOID_9538
6527	MOREAUX_MULTIPLE_MYELOMA_BY_TACI_DN	15827134	myeloma	DOID_0070004
6528	MOREAUX_MULTIPLE_MYELOMA_BY_TACI_DN	15827134	organ system cancer	DOID_0050686
6529	HOEGERKORP_CD44_TARGETS_TEMPORAL_DN	12411303	NA	NA
6530	MUNSHI_MULTIPLE_MYELOMA_UP	12969976	bone marrow cancer	DOID_4960
6531	MUNSHI_MULTIPLE_MYELOMA_UP	12969976	cancer	DOID_162
6532	MUNSHI_MULTIPLE_MYELOMA_UP	12969976	disease of cellular proliferation	DOID_14566
6533	MUNSHI_MULTIPLE_MYELOMA_UP	12969976	hematologic cancer	DOID_2531
6534	MUNSHI_MULTIPLE_MYELOMA_UP	12969976	immune system cancer	DOID_0060083
6535	MUNSHI_MULTIPLE_MYELOMA_UP	12969976	multiple myeloma	DOID_9538
6536	MUNSHI_MULTIPLE_MYELOMA_UP	12969976	myeloma	DOID_0070004
6537	MUNSHI_MULTIPLE_MYELOMA_UP	12969976	organ system cancer	DOID_0050686
6538	ZHAN_MULTIPLE_MYELOMA_DN	11861292	B-cell lymphocytic neoplasm	DOID_707
6539	ZHAN_MULTIPLE_MYELOMA_DN	11861292	bone marrow cancer	DOID_4960
6540	ZHAN_MULTIPLE_MYELOMA_DN	11861292	cancer	DOID_162
6541	ZHAN_MULTIPLE_MYELOMA_DN	11861292	disease of cellular proliferation	DOID_14566
6542	ZHAN_MULTIPLE_MYELOMA_DN	11861292	hematologic cancer	DOID_2531
6543	ZHAN_MULTIPLE_MYELOMA_DN	11861292	immune system cancer	DOID_0060083
6544	ZHAN_MULTIPLE_MYELOMA_DN	11861292	lymphoma	DOID_0060058
6545	ZHAN_MULTIPLE_MYELOMA_DN	11861292	mature B-cell neoplasm	DOID_706
6546	ZHAN_MULTIPLE_MYELOMA_DN	11861292	monoclonal gammopathy of uncertain significance	DOID_7442
6547	ZHAN_MULTIPLE_MYELOMA_DN	11861292	multiple myeloma	DOID_9538
6548	ZHAN_MULTIPLE_MYELOMA_DN	11861292	myeloma	DOID_0070004
6549	ZHAN_MULTIPLE_MYELOMA_DN	11861292	organ system cancer	DOID_0050686
6550	ZHAN_MULTIPLE_MYELOMA_DN	11861292	plasma cell neoplasm	DOID_6536
6551	BASSO_CD40_SIGNALING_UP	15331443	B-cell lymphocytic neoplasm	DOID_707
6552	BASSO_CD40_SIGNALING_UP	15331443	Burkitt's lymphoma	DOID_8584
6553	BASSO_CD40_SIGNALING_UP	15331443	cancer	DOID_162
6554	BASSO_CD40_SIGNALING_UP	15331443	disease of cellular proliferation	DOID_14566
6555	BASSO_CD40_SIGNALING_UP	15331443	hematologic cancer	DOID_2531
6556	BASSO_CD40_SIGNALING_UP	15331443	immune system cancer	DOID_0060083
6557	BASSO_CD40_SIGNALING_UP	15331443	lymphoma	DOID_0060058
6558	BASSO_CD40_SIGNALING_UP	15331443	mature B-cell neoplasm	DOID_706
6559	BASSO_CD40_SIGNALING_UP	15331443	organ system cancer	DOID_0050686
6560	FAELT_B_CLL_WITH_VH3_21_DN	15817677	cancer	DOID_162
6561	FAELT_B_CLL_WITH_VH3_21_DN	15817677	chronic leukemia	DOID_1036
6562	FAELT_B_CLL_WITH_VH3_21_DN	15817677	chronic lymphocytic leukemia	DOID_1040
6563	FAELT_B_CLL_WITH_VH3_21_DN	15817677	disease of cellular proliferation	DOID_14566
6564	FAELT_B_CLL_WITH_VH3_21_DN	15817677	hematologic cancer	DOID_2531
6565	FAELT_B_CLL_WITH_VH3_21_DN	15817677	immune system cancer	DOID_0060083
6566	FAELT_B_CLL_WITH_VH3_21_DN	15817677	leukemia	DOID_1240
6567	FAELT_B_CLL_WITH_VH3_21_DN	15817677	lymphoblastic leukemia	DOID_1037
6568	FAELT_B_CLL_WITH_VH3_21_DN	15817677	organ system cancer	DOID_0050686
6569	XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_DN	16140955	cancer	DOID_162
6570	XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_DN	16140955	disease of cellular proliferation	DOID_14566
6571	XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_DN	16140955	hematologic cancer	DOID_2531
6572	XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_DN	16140955	immune system cancer	DOID_0060083
6573	XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_DN	16140955	leukemia	DOID_1240
6574	XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_DN	16140955	organ system cancer	DOID_0050686
6575	NOUZOVA_TRETINOIN_AND_H4_ACETYLATION	15302897	cancer	DOID_162
6576	NOUZOVA_TRETINOIN_AND_H4_ACETYLATION	15302897	disease of cellular proliferation	DOID_14566
6577	NOUZOVA_TRETINOIN_AND_H4_ACETYLATION	15302897	hematologic cancer	DOID_2531
6578	NOUZOVA_TRETINOIN_AND_H4_ACETYLATION	15302897	immune system cancer	DOID_0060083
6579	NOUZOVA_TRETINOIN_AND_H4_ACETYLATION	15302897	leukemia	DOID_1240
6580	NOUZOVA_TRETINOIN_AND_H4_ACETYLATION	15302897	organ system cancer	DOID_0050686
6581	MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_UP	15827134	bone marrow cancer	DOID_4960
6582	MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_UP	15827134	cancer	DOID_162
6583	MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_UP	15827134	disease of cellular proliferation	DOID_14566
6584	MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_UP	15827134	hematologic cancer	DOID_2531
6585	MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_UP	15827134	immune system cancer	DOID_0060083
6586	MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_UP	15827134	multiple myeloma	DOID_9538
6587	MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_UP	15827134	myeloma	DOID_0070004
6588	MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_UP	15827134	organ system cancer	DOID_0050686
6589	HOEGERKORP_CD44_TARGETS_DIRECT_UP	12411303	NA	NA
6590	FAELT_B_CLL_WITH_VH3_21_UP	15817677	cancer	DOID_162
6591	FAELT_B_CLL_WITH_VH3_21_UP	15817677	chronic leukemia	DOID_1036
6592	FAELT_B_CLL_WITH_VH3_21_UP	15817677	chronic lymphocytic leukemia	DOID_1040
6593	FAELT_B_CLL_WITH_VH3_21_UP	15817677	disease of cellular proliferation	DOID_14566
6594	FAELT_B_CLL_WITH_VH3_21_UP	15817677	hematologic cancer	DOID_2531
6595	FAELT_B_CLL_WITH_VH3_21_UP	15817677	immune system cancer	DOID_0060083
6596	FAELT_B_CLL_WITH_VH3_21_UP	15817677	leukemia	DOID_1240
6597	FAELT_B_CLL_WITH_VH3_21_UP	15817677	lymphoblastic leukemia	DOID_1037
6598	FAELT_B_CLL_WITH_VH3_21_UP	15817677	organ system cancer	DOID_0050686
6599	REN_ALVEOLAR_RHABDOMYOSARCOMA_UP	18701482	cancer	DOID_162
6600	REN_ALVEOLAR_RHABDOMYOSARCOMA_UP	18701482	disease of cellular proliferation	DOID_14566
6601	REN_ALVEOLAR_RHABDOMYOSARCOMA_UP	18701482	muscle cancer	DOID_4045
6602	REN_ALVEOLAR_RHABDOMYOSARCOMA_UP	18701482	musculoskeletal system cancer	DOID_0060100
6603	REN_ALVEOLAR_RHABDOMYOSARCOMA_UP	18701482	organ system cancer	DOID_0050686
6604	REN_ALVEOLAR_RHABDOMYOSARCOMA_UP	18701482	rhabdomyosarcoma	DOID_3247
6605	REN_ALVEOLAR_RHABDOMYOSARCOMA_UP	18701482	skeletal muscle cancer	DOID_4043
6606	REN_ALVEOLAR_RHABDOMYOSARCOMA_DN	18701482	cancer	DOID_162
6607	REN_ALVEOLAR_RHABDOMYOSARCOMA_DN	18701482	disease of cellular proliferation	DOID_14566
6608	REN_ALVEOLAR_RHABDOMYOSARCOMA_DN	18701482	muscle cancer	DOID_4045
6609	REN_ALVEOLAR_RHABDOMYOSARCOMA_DN	18701482	musculoskeletal system cancer	DOID_0060100
6610	REN_ALVEOLAR_RHABDOMYOSARCOMA_DN	18701482	organ system cancer	DOID_0050686
6611	REN_ALVEOLAR_RHABDOMYOSARCOMA_DN	18701482	rhabdomyosarcoma	DOID_3247
6612	REN_ALVEOLAR_RHABDOMYOSARCOMA_DN	18701482	skeletal muscle cancer	DOID_4043
6613	GEISS_RESPONSE_TO_DSRNA_DN	11487589	NA	NA
6614	KANG_FLUOROURACIL_RESISTANCE_DN	14734480	cancer	DOID_162
6615	KANG_FLUOROURACIL_RESISTANCE_DN	14734480	disease of cellular proliferation	DOID_14566
6616	KANG_FLUOROURACIL_RESISTANCE_UP	14734480	cancer	DOID_162
6617	KANG_FLUOROURACIL_RESISTANCE_UP	14734480	disease of cellular proliferation	DOID_14566
6618	KANG_DOXORUBICIN_RESISTANCE_UP	14734480	cancer	DOID_162
6619	KANG_DOXORUBICIN_RESISTANCE_UP	14734480	disease of cellular proliferation	DOID_14566
6620	KANG_DOXORUBICIN_RESISTANCE_DN	14734480	cancer	DOID_162
6621	KANG_DOXORUBICIN_RESISTANCE_DN	14734480	disease of cellular proliferation	DOID_14566
6622	WELCSH_BRCA1_TARGETS_1_UP	12032322	autosomal dominant disease	DOID_0050736
6623	WELCSH_BRCA1_TARGETS_1_UP	12032322	autosomal genetic disease	DOID_0050739
6624	WELCSH_BRCA1_TARGETS_1_UP	12032322	breast cancer	DOID_1612
6625	WELCSH_BRCA1_TARGETS_1_UP	12032322	cancer	DOID_162
6626	WELCSH_BRCA1_TARGETS_1_UP	12032322	disease of cellular proliferation	DOID_14566
6627	WELCSH_BRCA1_TARGETS_1_UP	12032322	female reproductive organ cancer	DOID_120
6628	WELCSH_BRCA1_TARGETS_1_UP	12032322	genetic disease	DOID_630
6629	WELCSH_BRCA1_TARGETS_1_UP	12032322	hereditary breast ovarian cancer	DOID_5683
6630	WELCSH_BRCA1_TARGETS_1_UP	12032322	monogenic disease	DOID_0050177
6631	WELCSH_BRCA1_TARGETS_1_UP	12032322	organ system cancer	DOID_0050686
6632	WELCSH_BRCA1_TARGETS_1_UP	12032322	ovarian cancer	DOID_2394
6633	WELCSH_BRCA1_TARGETS_1_UP	12032322	reproductive organ cancer	DOID_193
6634	WELCSH_BRCA1_TARGETS_1_UP	12032322	thoracic cancer	DOID_5093
6635	GEISS_RESPONSE_TO_DSRNA_UP	11487589	NA	NA
6636	KALMA_E2F1_TARGETS	11313881	NA	NA
6637	WELCSH_BRCA1_TARGETS_1_DN	12032322	autosomal dominant disease	DOID_0050736
6638	WELCSH_BRCA1_TARGETS_1_DN	12032322	autosomal genetic disease	DOID_0050739
6639	WELCSH_BRCA1_TARGETS_1_DN	12032322	breast cancer	DOID_1612
6640	WELCSH_BRCA1_TARGETS_1_DN	12032322	cancer	DOID_162
6641	WELCSH_BRCA1_TARGETS_1_DN	12032322	disease of cellular proliferation	DOID_14566
6642	WELCSH_BRCA1_TARGETS_1_DN	12032322	female reproductive organ cancer	DOID_120
6643	WELCSH_BRCA1_TARGETS_1_DN	12032322	genetic disease	DOID_630
6644	WELCSH_BRCA1_TARGETS_1_DN	12032322	hereditary breast ovarian cancer	DOID_5683
6645	WELCSH_BRCA1_TARGETS_1_DN	12032322	monogenic disease	DOID_0050177
6646	WELCSH_BRCA1_TARGETS_1_DN	12032322	organ system cancer	DOID_0050686
6647	WELCSH_BRCA1_TARGETS_1_DN	12032322	ovarian cancer	DOID_2394
6648	WELCSH_BRCA1_TARGETS_1_DN	12032322	reproductive organ cancer	DOID_193
6649	WELCSH_BRCA1_TARGETS_1_DN	12032322	thoracic cancer	DOID_5093
6650	BILD_MYC_ONCOGENIC_SIGNATURE	16273092	cancer	DOID_162
6651	BILD_MYC_ONCOGENIC_SIGNATURE	16273092	disease of cellular proliferation	DOID_14566
6652	BILD_E2F3_ONCOGENIC_SIGNATURE	16273092	cancer	DOID_162
6653	BILD_E2F3_ONCOGENIC_SIGNATURE	16273092	disease of cellular proliferation	DOID_14566
6654	BILD_HRAS_ONCOGENIC_SIGNATURE	16273092	cancer	DOID_162
6655	BILD_HRAS_ONCOGENIC_SIGNATURE	16273092	disease of cellular proliferation	DOID_14566
6656	BILD_SRC_ONCOGENIC_SIGNATURE	16273092	cancer	DOID_162
6657	BILD_SRC_ONCOGENIC_SIGNATURE	16273092	disease of cellular proliferation	DOID_14566
6658	BILD_CTNNB1_ONCOGENIC_SIGNATURE	16273092	cancer	DOID_162
6659	BILD_CTNNB1_ONCOGENIC_SIGNATURE	16273092	disease of cellular proliferation	DOID_14566
6660	DOUGLAS_BMI1_TARGETS_UP	18701473	cancer	DOID_162
6661	DOUGLAS_BMI1_TARGETS_UP	18701473	cell type cancer	DOID_0050687
6662	DOUGLAS_BMI1_TARGETS_UP	18701473	combined T cell and B cell immunodeficiency	DOID_628
6663	DOUGLAS_BMI1_TARGETS_UP	18701473	disease of anatomical entity	DOID_7
6664	DOUGLAS_BMI1_TARGETS_UP	18701473	disease of cellular proliferation	DOID_14566
6665	DOUGLAS_BMI1_TARGETS_UP	18701473	immune system disease	DOID_2914
6666	DOUGLAS_BMI1_TARGETS_UP	18701473	nervous system cancer	DOID_3093
6667	DOUGLAS_BMI1_TARGETS_UP	18701473	organ system cancer	DOID_0050686
6668	DOUGLAS_BMI1_TARGETS_UP	18701473	peripheral nervous system neoplasm	DOID_1192
6669	DOUGLAS_BMI1_TARGETS_UP	18701473	peripheral primitive neuroectodermal tumor	DOID_3369
6670	DOUGLAS_BMI1_TARGETS_UP	18701473	primary immunodeficiency disease	DOID_612
6671	DOUGLAS_BMI1_TARGETS_UP	18701473	sarcoma	DOID_1115
6672	DOUGLAS_BMI1_TARGETS_UP	18701473	severe combined immunodeficiency	DOID_627
6673	DOUGLAS_BMI1_TARGETS_DN	18701473	cancer	DOID_162
6674	DOUGLAS_BMI1_TARGETS_DN	18701473	cell type cancer	DOID_0050687
6675	DOUGLAS_BMI1_TARGETS_DN	18701473	combined T cell and B cell immunodeficiency	DOID_628
6676	DOUGLAS_BMI1_TARGETS_DN	18701473	disease of anatomical entity	DOID_7
6677	DOUGLAS_BMI1_TARGETS_DN	18701473	disease of cellular proliferation	DOID_14566
6678	DOUGLAS_BMI1_TARGETS_DN	18701473	immune system disease	DOID_2914
6679	DOUGLAS_BMI1_TARGETS_DN	18701473	nervous system cancer	DOID_3093
6680	DOUGLAS_BMI1_TARGETS_DN	18701473	organ system cancer	DOID_0050686
6681	DOUGLAS_BMI1_TARGETS_DN	18701473	peripheral nervous system neoplasm	DOID_1192
6682	DOUGLAS_BMI1_TARGETS_DN	18701473	peripheral primitive neuroectodermal tumor	DOID_3369
6683	DOUGLAS_BMI1_TARGETS_DN	18701473	primary immunodeficiency disease	DOID_612
6684	DOUGLAS_BMI1_TARGETS_DN	18701473	sarcoma	DOID_1115
6685	DOUGLAS_BMI1_TARGETS_DN	18701473	severe combined immunodeficiency	DOID_627
6686	KRIGE_AMINO_ACID_DEPRIVATION	18701491	cancer	DOID_162
6687	KRIGE_AMINO_ACID_DEPRIVATION	18701491	disease of cellular proliferation	DOID_14566
6688	KRIGE_AMINO_ACID_DEPRIVATION	18701491	hematologic cancer	DOID_2531
6689	KRIGE_AMINO_ACID_DEPRIVATION	18701491	immune system cancer	DOID_0060083
6690	KRIGE_AMINO_ACID_DEPRIVATION	18701491	leukemia	DOID_1240
6691	KRIGE_AMINO_ACID_DEPRIVATION	18701491	myeloid leukemia	DOID_8692
6692	KRIGE_AMINO_ACID_DEPRIVATION	18701491	organ system cancer	DOID_0050686
6693	KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_UP	18701491	cancer	DOID_162
6694	KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_UP	18701491	disease of cellular proliferation	DOID_14566
6695	KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_UP	18701491	hematologic cancer	DOID_2531
6696	KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_UP	18701491	immune system cancer	DOID_0060083
6697	KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_UP	18701491	leukemia	DOID_1240
6698	KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_UP	18701491	myeloid leukemia	DOID_8692
6699	KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_UP	18701491	organ system cancer	DOID_0050686
6700	KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_DN	18701491	cancer	DOID_162
6701	KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_DN	18701491	disease of cellular proliferation	DOID_14566
6702	KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_DN	18701491	hematologic cancer	DOID_2531
6703	KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_DN	18701491	immune system cancer	DOID_0060083
6704	KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_DN	18701491	leukemia	DOID_1240
6705	KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_DN	18701491	myeloid leukemia	DOID_8692
6706	KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_DN	18701491	organ system cancer	DOID_0050686
6707	KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_UP	18701491	cancer	DOID_162
6708	KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_UP	18701491	disease of cellular proliferation	DOID_14566
6709	KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_UP	18701491	hematologic cancer	DOID_2531
6710	KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_UP	18701491	immune system cancer	DOID_0060083
6711	KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_UP	18701491	leukemia	DOID_1240
6712	KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_UP	18701491	myeloid leukemia	DOID_8692
6713	KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_UP	18701491	organ system cancer	DOID_0050686
6714	KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_DN	18701491	cancer	DOID_162
6715	KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_DN	18701491	disease of cellular proliferation	DOID_14566
6716	KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_DN	18701491	hematologic cancer	DOID_2531
6717	KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_DN	18701491	immune system cancer	DOID_0060083
6718	KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_DN	18701491	leukemia	DOID_1240
6719	KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_DN	18701491	myeloid leukemia	DOID_8692
6720	KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_DN	18701491	organ system cancer	DOID_0050686
6721	GHO_ATF5_TARGETS_DN	18701499	cancer	DOID_162
6722	GHO_ATF5_TARGETS_DN	18701499	carcinoma	DOID_305
6723	GHO_ATF5_TARGETS_DN	18701499	cell type cancer	DOID_0050687
6724	GHO_ATF5_TARGETS_DN	18701499	disease of cellular proliferation	DOID_14566
6725	GHO_ATF5_TARGETS_DN	18701499	gastrointestinal system cancer	DOID_3119
6726	GHO_ATF5_TARGETS_DN	18701499	hepatocellular carcinoma	DOID_684
6727	GHO_ATF5_TARGETS_DN	18701499	liver cancer	DOID_3571
6728	GHO_ATF5_TARGETS_DN	18701499	liver carcinoma	DOID_686
6729	GHO_ATF5_TARGETS_DN	18701499	organ system cancer	DOID_0050686
6730	LI_CYTIDINE_ANALOGS_CYCTOTOXICITY	18757419	cancer	DOID_162
6731	LI_CYTIDINE_ANALOGS_CYCTOTOXICITY	18757419	disease of cellular proliferation	DOID_14566
6732	LI_CYTIDINE_ANALOG_PATHWAY	18757419	cancer	DOID_162
6733	LI_CYTIDINE_ANALOG_PATHWAY	18757419	disease of cellular proliferation	DOID_14566
6734	KIM_LRRC3B_TARGETS	18757430	cancer	DOID_162
6735	KIM_LRRC3B_TARGETS	18757430	disease of cellular proliferation	DOID_14566
6736	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_1	18794137	breast cancer	DOID_1612
6737	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_1	18794137	cancer	DOID_162
6738	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_1	18794137	disease of cellular proliferation	DOID_14566
6739	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_1	18794137	organ system cancer	DOID_0050686
6740	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_1	18794137	thoracic cancer	DOID_5093
6741	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_2	18794137	breast cancer	DOID_1612
6742	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_2	18794137	cancer	DOID_162
6743	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_2	18794137	disease of cellular proliferation	DOID_14566
6744	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_2	18794137	organ system cancer	DOID_0050686
6745	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_2	18794137	thoracic cancer	DOID_5093
6746	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_3	18794137	breast cancer	DOID_1612
6747	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_3	18794137	cancer	DOID_162
6748	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_3	18794137	disease of cellular proliferation	DOID_14566
6749	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_3	18794137	organ system cancer	DOID_0050686
6750	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_3	18794137	thoracic cancer	DOID_5093
6751	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_4	18794137	breast cancer	DOID_1612
6752	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_4	18794137	cancer	DOID_162
6753	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_4	18794137	disease of cellular proliferation	DOID_14566
6754	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_4	18794137	organ system cancer	DOID_0050686
6755	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_4	18794137	thoracic cancer	DOID_5093
6756	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5	18794137	breast cancer	DOID_1612
6757	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5	18794137	cancer	DOID_162
6758	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5	18794137	disease of cellular proliferation	DOID_14566
6759	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5	18794137	organ system cancer	DOID_0050686
6760	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5	18794137	thoracic cancer	DOID_5093
6761	SINGH_NFE2L2_TARGETS	18829555	cancer	DOID_162
6762	SINGH_NFE2L2_TARGETS	18829555	carcinoma	DOID_305
6763	SINGH_NFE2L2_TARGETS	18829555	cell type cancer	DOID_0050687
6764	SINGH_NFE2L2_TARGETS	18829555	disease of cellular proliferation	DOID_14566
6765	SINGH_NFE2L2_TARGETS	18829555	lung cancer	DOID_1324
6766	SINGH_NFE2L2_TARGETS	18829555	organ system cancer	DOID_0050686
6767	SINGH_NFE2L2_TARGETS	18829555	respiratory system cancer	DOID_0050615
6768	PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_UP	18829567	cancer	DOID_162
6769	PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_UP	18829567	disease of cellular proliferation	DOID_14566
6770	PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_DN	18829567	cancer	DOID_162
6771	PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_DN	18829567	disease of cellular proliferation	DOID_14566
6772	LOPES_METHYLATED_IN_COLON_CANCER_UP	18794111	cancer	DOID_162
6773	LOPES_METHYLATED_IN_COLON_CANCER_UP	18794111	colon cancer	DOID_219
6774	LOPES_METHYLATED_IN_COLON_CANCER_UP	18794111	colorectal cancer	DOID_9256
6775	LOPES_METHYLATED_IN_COLON_CANCER_UP	18794111	disease of cellular proliferation	DOID_14566
6776	LOPES_METHYLATED_IN_COLON_CANCER_UP	18794111	gastrointestinal system cancer	DOID_3119
6777	LOPES_METHYLATED_IN_COLON_CANCER_UP	18794111	intestinal cancer	DOID_10155
6778	LOPES_METHYLATED_IN_COLON_CANCER_UP	18794111	large intestine cancer	DOID_5672
6779	LOPES_METHYLATED_IN_COLON_CANCER_UP	18794111	organ system cancer	DOID_0050686
6780	LOPES_METHYLATED_IN_COLON_CANCER_DN	18794111	cancer	DOID_162
6781	LOPES_METHYLATED_IN_COLON_CANCER_DN	18794111	colon cancer	DOID_219
6782	LOPES_METHYLATED_IN_COLON_CANCER_DN	18794111	colorectal cancer	DOID_9256
6783	LOPES_METHYLATED_IN_COLON_CANCER_DN	18794111	disease of cellular proliferation	DOID_14566
6784	LOPES_METHYLATED_IN_COLON_CANCER_DN	18794111	gastrointestinal system cancer	DOID_3119
6785	LOPES_METHYLATED_IN_COLON_CANCER_DN	18794111	intestinal cancer	DOID_10155
6786	LOPES_METHYLATED_IN_COLON_CANCER_DN	18794111	large intestine cancer	DOID_5672
6787	LOPES_METHYLATED_IN_COLON_CANCER_DN	18794111	organ system cancer	DOID_0050686
6788	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_UP	15608684	autosomal dominant disease	DOID_0050736
6789	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_UP	15608684	autosomal genetic disease	DOID_0050739
6790	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_UP	15608684	autosomal recessive disease	DOID_0050737
6791	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_UP	15608684	cancer	DOID_162
6792	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_UP	15608684	Cockayne syndrome	DOID_2962
6793	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_UP	15608684	disease of cellular proliferation	DOID_14566
6794	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_UP	15608684	genetic disease	DOID_630
6795	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_UP	15608684	group B streptococcal pneumonia	DOID_12017
6796	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_UP	15608684	integumentary system cancer	DOID_0060122
6797	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_UP	15608684	monogenic disease	DOID_0050177
6798	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_UP	15608684	organ system cancer	DOID_0050686
6799	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_UP	15608684	photosensitive trichothiodystrophy	DOID_2960
6800	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_UP	15608684	skin cancer	DOID_4159
6801	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_UP	15608684	syndrome	DOID_225
6802	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_UP	15608684	xeroderma pigmentosum	DOID_0050427
6803	YEGNASUBRAMANIAN_PROSTATE_CANCER	18974140	cancer	DOID_162
6804	YEGNASUBRAMANIAN_PROSTATE_CANCER	18974140	disease of cellular proliferation	DOID_14566
6805	YEGNASUBRAMANIAN_PROSTATE_CANCER	18974140	male reproductive organ cancer	DOID_3856
6806	YEGNASUBRAMANIAN_PROSTATE_CANCER	18974140	organ system cancer	DOID_0050686
6807	YEGNASUBRAMANIAN_PROSTATE_CANCER	18974140	prostate cancer	DOID_10283
6808	YEGNASUBRAMANIAN_PROSTATE_CANCER	18974140	reproductive organ cancer	DOID_193
6809	RIGGINS_TAMOXIFEN_RESISTANCE_UP	18974135	breast cancer	DOID_1612
6810	RIGGINS_TAMOXIFEN_RESISTANCE_UP	18974135	breast carcinoma	DOID_3459
6811	RIGGINS_TAMOXIFEN_RESISTANCE_UP	18974135	cancer	DOID_162
6812	RIGGINS_TAMOXIFEN_RESISTANCE_UP	18974135	carcinoma	DOID_305
6813	RIGGINS_TAMOXIFEN_RESISTANCE_UP	18974135	cell type cancer	DOID_0050687
6814	RIGGINS_TAMOXIFEN_RESISTANCE_UP	18974135	disease of cellular proliferation	DOID_14566
6815	RIGGINS_TAMOXIFEN_RESISTANCE_UP	18974135	ductal carcinoma	DOID_3007
6816	RIGGINS_TAMOXIFEN_RESISTANCE_UP	18974135	invasive ductal carcinoma	DOID_3008
6817	RIGGINS_TAMOXIFEN_RESISTANCE_UP	18974135	organ system cancer	DOID_0050686
6818	RIGGINS_TAMOXIFEN_RESISTANCE_UP	18974135	thoracic cancer	DOID_5093
6819	RIGGINS_TAMOXIFEN_RESISTANCE_DN	18974135	breast cancer	DOID_1612
6820	RIGGINS_TAMOXIFEN_RESISTANCE_DN	18974135	breast carcinoma	DOID_3459
6821	RIGGINS_TAMOXIFEN_RESISTANCE_DN	18974135	cancer	DOID_162
6822	RIGGINS_TAMOXIFEN_RESISTANCE_DN	18974135	carcinoma	DOID_305
6823	RIGGINS_TAMOXIFEN_RESISTANCE_DN	18974135	cell type cancer	DOID_0050687
6824	RIGGINS_TAMOXIFEN_RESISTANCE_DN	18974135	disease of cellular proliferation	DOID_14566
6825	RIGGINS_TAMOXIFEN_RESISTANCE_DN	18974135	ductal carcinoma	DOID_3007
6826	RIGGINS_TAMOXIFEN_RESISTANCE_DN	18974135	invasive ductal carcinoma	DOID_3008
6827	RIGGINS_TAMOXIFEN_RESISTANCE_DN	18974135	organ system cancer	DOID_0050686
6828	RIGGINS_TAMOXIFEN_RESISTANCE_DN	18974135	thoracic cancer	DOID_5093
6829	NIKOLSKY_OVERCONNECTED_IN_BREAST_CANCER	19010930	breast cancer	DOID_1612
6830	NIKOLSKY_OVERCONNECTED_IN_BREAST_CANCER	19010930	cancer	DOID_162
6831	NIKOLSKY_OVERCONNECTED_IN_BREAST_CANCER	19010930	disease of cellular proliferation	DOID_14566
6832	NIKOLSKY_OVERCONNECTED_IN_BREAST_CANCER	19010930	organ system cancer	DOID_0050686
6833	NIKOLSKY_OVERCONNECTED_IN_BREAST_CANCER	19010930	thoracic cancer	DOID_5093
6834	STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_UP	18974123	breast cancer	DOID_1612
6835	STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_UP	18974123	breast carcinoma	DOID_3459
6836	STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_UP	18974123	cancer	DOID_162
6837	STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_UP	18974123	carcinoma	DOID_305
6838	STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_UP	18974123	cell type cancer	DOID_0050687
6839	STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_UP	18974123	disease of cellular proliferation	DOID_14566
6840	STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_UP	18974123	organ system cancer	DOID_0050686
6841	STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_UP	18974123	thoracic cancer	DOID_5093
6842	STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_DN	18974123	breast cancer	DOID_1612
6843	STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_DN	18974123	breast carcinoma	DOID_3459
6844	STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_DN	18974123	cancer	DOID_162
6845	STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_DN	18974123	carcinoma	DOID_305
6846	STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_DN	18974123	cell type cancer	DOID_0050687
6847	STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_DN	18974123	disease of cellular proliferation	DOID_14566
6848	STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_DN	18974123	organ system cancer	DOID_0050686
6849	STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_DN	18974123	thoracic cancer	DOID_5093
6850	STEIN_ESRRA_TARGETS_UP	18974123	breast cancer	DOID_1612
6851	STEIN_ESRRA_TARGETS_UP	18974123	breast carcinoma	DOID_3459
6852	STEIN_ESRRA_TARGETS_UP	18974123	cancer	DOID_162
6853	STEIN_ESRRA_TARGETS_UP	18974123	carcinoma	DOID_305
6854	STEIN_ESRRA_TARGETS_UP	18974123	cell type cancer	DOID_0050687
6855	STEIN_ESRRA_TARGETS_UP	18974123	disease of cellular proliferation	DOID_14566
6856	STEIN_ESRRA_TARGETS_UP	18974123	organ system cancer	DOID_0050686
6857	STEIN_ESRRA_TARGETS_UP	18974123	thoracic cancer	DOID_5093
6858	STEIN_ESRRA_TARGETS_DN	18974123	breast cancer	DOID_1612
6859	STEIN_ESRRA_TARGETS_DN	18974123	breast carcinoma	DOID_3459
6860	STEIN_ESRRA_TARGETS_DN	18974123	cancer	DOID_162
6861	STEIN_ESRRA_TARGETS_DN	18974123	carcinoma	DOID_305
6862	STEIN_ESRRA_TARGETS_DN	18974123	cell type cancer	DOID_0050687
6863	STEIN_ESRRA_TARGETS_DN	18974123	disease of cellular proliferation	DOID_14566
6864	STEIN_ESRRA_TARGETS_DN	18974123	organ system cancer	DOID_0050686
6865	STEIN_ESRRA_TARGETS_DN	18974123	thoracic cancer	DOID_5093
6866	KYNG_DNA_DAMAGE_BY_4NQO	15897889	autosomal genetic disease	DOID_0050739
6867	KYNG_DNA_DAMAGE_BY_4NQO	15897889	autosomal recessive disease	DOID_0050737
6868	KYNG_DNA_DAMAGE_BY_4NQO	15897889	cancer	DOID_162
6869	KYNG_DNA_DAMAGE_BY_4NQO	15897889	disease of cellular proliferation	DOID_14566
6870	KYNG_DNA_DAMAGE_BY_4NQO	15897889	genetic disease	DOID_630
6871	KYNG_DNA_DAMAGE_BY_4NQO	15897889	monogenic disease	DOID_0050177
6872	KYNG_DNA_DAMAGE_BY_4NQO	15897889	syndrome	DOID_225
6873	KYNG_DNA_DAMAGE_BY_4NQO	15897889	Werner syndrome	DOID_5688
6874	KYNG_DNA_DAMAGE_BY_GAMMA_RADIATION	15897889	autosomal genetic disease	DOID_0050739
6875	KYNG_DNA_DAMAGE_BY_GAMMA_RADIATION	15897889	autosomal recessive disease	DOID_0050737
6876	KYNG_DNA_DAMAGE_BY_GAMMA_RADIATION	15897889	cancer	DOID_162
6877	KYNG_DNA_DAMAGE_BY_GAMMA_RADIATION	15897889	disease of cellular proliferation	DOID_14566
6878	KYNG_DNA_DAMAGE_BY_GAMMA_RADIATION	15897889	genetic disease	DOID_630
6879	KYNG_DNA_DAMAGE_BY_GAMMA_RADIATION	15897889	monogenic disease	DOID_0050177
6880	KYNG_DNA_DAMAGE_BY_GAMMA_RADIATION	15897889	syndrome	DOID_225
6881	KYNG_DNA_DAMAGE_BY_GAMMA_RADIATION	15897889	Werner syndrome	DOID_5688
6882	KYNG_DNA_DAMAGE_BY_UV	15897889	autosomal genetic disease	DOID_0050739
6883	KYNG_DNA_DAMAGE_BY_UV	15897889	autosomal recessive disease	DOID_0050737
6884	KYNG_DNA_DAMAGE_BY_UV	15897889	cancer	DOID_162
6885	KYNG_DNA_DAMAGE_BY_UV	15897889	disease of cellular proliferation	DOID_14566
6886	KYNG_DNA_DAMAGE_BY_UV	15897889	genetic disease	DOID_630
6887	KYNG_DNA_DAMAGE_BY_UV	15897889	monogenic disease	DOID_0050177
6888	KYNG_DNA_DAMAGE_BY_UV	15897889	syndrome	DOID_225
6889	KYNG_DNA_DAMAGE_BY_UV	15897889	Werner syndrome	DOID_5688
6890	KYNG_DNA_DAMAGE_BY_4NQO_OR_UV	15897889	autosomal genetic disease	DOID_0050739
6891	KYNG_DNA_DAMAGE_BY_4NQO_OR_UV	15897889	autosomal recessive disease	DOID_0050737
6892	KYNG_DNA_DAMAGE_BY_4NQO_OR_UV	15897889	cancer	DOID_162
6893	KYNG_DNA_DAMAGE_BY_4NQO_OR_UV	15897889	disease of cellular proliferation	DOID_14566
6894	KYNG_DNA_DAMAGE_BY_4NQO_OR_UV	15897889	genetic disease	DOID_630
6895	KYNG_DNA_DAMAGE_BY_4NQO_OR_UV	15897889	monogenic disease	DOID_0050177
6896	KYNG_DNA_DAMAGE_BY_4NQO_OR_UV	15897889	syndrome	DOID_225
6897	KYNG_DNA_DAMAGE_BY_4NQO_OR_UV	15897889	Werner syndrome	DOID_5688
6898	KYNG_DNA_DAMAGE_BY_GAMMA_AND_UV_RADIATION	15897889	autosomal genetic disease	DOID_0050739
6899	KYNG_DNA_DAMAGE_BY_GAMMA_AND_UV_RADIATION	15897889	autosomal recessive disease	DOID_0050737
6900	KYNG_DNA_DAMAGE_BY_GAMMA_AND_UV_RADIATION	15897889	cancer	DOID_162
6901	KYNG_DNA_DAMAGE_BY_GAMMA_AND_UV_RADIATION	15897889	disease of cellular proliferation	DOID_14566
6902	KYNG_DNA_DAMAGE_BY_GAMMA_AND_UV_RADIATION	15897889	genetic disease	DOID_630
6903	KYNG_DNA_DAMAGE_BY_GAMMA_AND_UV_RADIATION	15897889	monogenic disease	DOID_0050177
6904	KYNG_DNA_DAMAGE_BY_GAMMA_AND_UV_RADIATION	15897889	syndrome	DOID_225
6905	KYNG_DNA_DAMAGE_BY_GAMMA_AND_UV_RADIATION	15897889	Werner syndrome	DOID_5688
6906	KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_4NQO_IN_WS	15897889	autosomal genetic disease	DOID_0050739
6907	KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_4NQO_IN_WS	15897889	autosomal recessive disease	DOID_0050737
6908	KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_4NQO_IN_WS	15897889	cancer	DOID_162
6909	KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_4NQO_IN_WS	15897889	disease of cellular proliferation	DOID_14566
6910	KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_4NQO_IN_WS	15897889	genetic disease	DOID_630
6911	KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_4NQO_IN_WS	15897889	monogenic disease	DOID_0050177
6912	KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_4NQO_IN_WS	15897889	syndrome	DOID_225
6913	KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_4NQO_IN_WS	15897889	Werner syndrome	DOID_5688
6914	KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_GAMMA_IN_OLD	15897889	autosomal genetic disease	DOID_0050739
6915	KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_GAMMA_IN_OLD	15897889	autosomal recessive disease	DOID_0050737
6916	KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_GAMMA_IN_OLD	15897889	cancer	DOID_162
6917	KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_GAMMA_IN_OLD	15897889	disease of cellular proliferation	DOID_14566
6918	KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_GAMMA_IN_OLD	15897889	genetic disease	DOID_630
6919	KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_GAMMA_IN_OLD	15897889	monogenic disease	DOID_0050177
6920	KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_GAMMA_IN_OLD	15897889	syndrome	DOID_225
6921	KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_GAMMA_IN_OLD	15897889	Werner syndrome	DOID_5688
6922	KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_GAMMA_IN_WS	15897889	autosomal genetic disease	DOID_0050739
6923	KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_GAMMA_IN_WS	15897889	autosomal recessive disease	DOID_0050737
6924	KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_GAMMA_IN_WS	15897889	cancer	DOID_162
6925	KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_GAMMA_IN_WS	15897889	disease of cellular proliferation	DOID_14566
6926	KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_GAMMA_IN_WS	15897889	genetic disease	DOID_630
6927	KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_GAMMA_IN_WS	15897889	monogenic disease	DOID_0050177
6928	KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_GAMMA_IN_WS	15897889	syndrome	DOID_225
6929	KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_GAMMA_IN_WS	15897889	Werner syndrome	DOID_5688
6930	KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_UV_IN_OLD	15897889	autosomal genetic disease	DOID_0050739
6931	KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_UV_IN_OLD	15897889	autosomal recessive disease	DOID_0050737
6932	KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_UV_IN_OLD	15897889	cancer	DOID_162
6933	KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_UV_IN_OLD	15897889	disease of cellular proliferation	DOID_14566
6934	KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_UV_IN_OLD	15897889	genetic disease	DOID_630
6935	KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_UV_IN_OLD	15897889	monogenic disease	DOID_0050177
6936	KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_UV_IN_OLD	15897889	syndrome	DOID_225
6937	KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_UV_IN_OLD	15897889	Werner syndrome	DOID_5688
6938	KYNG_DNA_DAMAGE_UP	15897889	autosomal genetic disease	DOID_0050739
6939	KYNG_DNA_DAMAGE_UP	15897889	autosomal recessive disease	DOID_0050737
6940	KYNG_DNA_DAMAGE_UP	15897889	cancer	DOID_162
6941	KYNG_DNA_DAMAGE_UP	15897889	disease of cellular proliferation	DOID_14566
6942	KYNG_DNA_DAMAGE_UP	15897889	genetic disease	DOID_630
6943	KYNG_DNA_DAMAGE_UP	15897889	monogenic disease	DOID_0050177
6944	KYNG_DNA_DAMAGE_UP	15897889	syndrome	DOID_225
6945	KYNG_DNA_DAMAGE_UP	15897889	Werner syndrome	DOID_5688
6946	KYNG_DNA_DAMAGE_DN	15897889	autosomal genetic disease	DOID_0050739
6947	KYNG_DNA_DAMAGE_DN	15897889	autosomal recessive disease	DOID_0050737
6948	KYNG_DNA_DAMAGE_DN	15897889	cancer	DOID_162
6949	KYNG_DNA_DAMAGE_DN	15897889	disease of cellular proliferation	DOID_14566
6950	KYNG_DNA_DAMAGE_DN	15897889	genetic disease	DOID_630
6951	KYNG_DNA_DAMAGE_DN	15897889	monogenic disease	DOID_0050177
6952	KYNG_DNA_DAMAGE_DN	15897889	syndrome	DOID_225
6953	KYNG_DNA_DAMAGE_DN	15897889	Werner syndrome	DOID_5688
6954	KONDO_PROSTATE_CANCER_HCP_WITH_H3K27ME3	18488029	cancer	DOID_162
6955	KONDO_PROSTATE_CANCER_HCP_WITH_H3K27ME3	18488029	disease of cellular proliferation	DOID_14566
6956	KONDO_PROSTATE_CANCER_HCP_WITH_H3K27ME3	18488029	male reproductive organ cancer	DOID_3856
6957	KONDO_PROSTATE_CANCER_HCP_WITH_H3K27ME3	18488029	organ system cancer	DOID_0050686
6958	KONDO_PROSTATE_CANCER_HCP_WITH_H3K27ME3	18488029	prostate cancer	DOID_10283
6959	KONDO_PROSTATE_CANCER_HCP_WITH_H3K27ME3	18488029	reproductive organ cancer	DOID_193
6960	KONDO_PROSTATE_CANCER_WITH_H3K27ME3	18488029	cancer	DOID_162
6961	KONDO_PROSTATE_CANCER_WITH_H3K27ME3	18488029	disease of cellular proliferation	DOID_14566
6962	KONDO_PROSTATE_CANCER_WITH_H3K27ME3	18488029	male reproductive organ cancer	DOID_3856
6963	KONDO_PROSTATE_CANCER_WITH_H3K27ME3	18488029	organ system cancer	DOID_0050686
6964	KONDO_PROSTATE_CANCER_WITH_H3K27ME3	18488029	prostate cancer	DOID_10283
6965	KONDO_PROSTATE_CANCER_WITH_H3K27ME3	18488029	reproductive organ cancer	DOID_193
6966	KONDO_COLON_CANCER_HCP_WITH_H3K27ME1	18488029	cancer	DOID_162
6967	KONDO_COLON_CANCER_HCP_WITH_H3K27ME1	18488029	disease of cellular proliferation	DOID_14566
6968	KONDO_COLON_CANCER_HCP_WITH_H3K27ME1	18488029	male reproductive organ cancer	DOID_3856
6969	KONDO_COLON_CANCER_HCP_WITH_H3K27ME1	18488029	organ system cancer	DOID_0050686
6970	KONDO_COLON_CANCER_HCP_WITH_H3K27ME1	18488029	prostate cancer	DOID_10283
6971	KONDO_COLON_CANCER_HCP_WITH_H3K27ME1	18488029	reproductive organ cancer	DOID_193
6972	KONDO_EZH2_TARGETS	18488029	cancer	DOID_162
6973	KONDO_EZH2_TARGETS	18488029	disease of cellular proliferation	DOID_14566
6974	KONDO_EZH2_TARGETS	18488029	male reproductive organ cancer	DOID_3856
6975	KONDO_EZH2_TARGETS	18488029	organ system cancer	DOID_0050686
6976	KONDO_EZH2_TARGETS	18488029	prostate cancer	DOID_10283
6977	KONDO_EZH2_TARGETS	18488029	reproductive organ cancer	DOID_193
6978	LEE_LIVER_CANCER	18519680	cancer	DOID_162
6979	LEE_LIVER_CANCER	18519680	disease of cellular proliferation	DOID_14566
6980	LEE_LIVER_CANCER	18519680	gastrointestinal system cancer	DOID_3119
6981	LEE_LIVER_CANCER	18519680	hepatocellular carcinoma	DOID_684
6982	LEE_LIVER_CANCER	18519680	liver cancer	DOID_3571
6983	LEE_LIVER_CANCER	18519680	liver carcinoma	DOID_686
6984	LEE_LIVER_CANCER	18519680	organ system cancer	DOID_0050686
6985	KANG_CISPLATIN_RESISTANCE_UP	14734480	cancer	DOID_162
6986	KANG_CISPLATIN_RESISTANCE_UP	14734480	disease of cellular proliferation	DOID_14566
6987	HELLER_SILENCED_BY_METHYLATION_UP	18172295	B-cell lymphocytic neoplasm	DOID_707
6988	HELLER_SILENCED_BY_METHYLATION_UP	18172295	bone marrow cancer	DOID_4960
6989	HELLER_SILENCED_BY_METHYLATION_UP	18172295	cancer	DOID_162
6990	HELLER_SILENCED_BY_METHYLATION_UP	18172295	disease of cellular proliferation	DOID_14566
6991	HELLER_SILENCED_BY_METHYLATION_UP	18172295	hematologic cancer	DOID_2531
6992	HELLER_SILENCED_BY_METHYLATION_UP	18172295	immune system cancer	DOID_0060083
6993	HELLER_SILENCED_BY_METHYLATION_UP	18172295	lymphoma	DOID_0060058
6994	HELLER_SILENCED_BY_METHYLATION_UP	18172295	mature B-cell neoplasm	DOID_706
6995	HELLER_SILENCED_BY_METHYLATION_UP	18172295	monoclonal gammopathy of uncertain significance	DOID_7442
6996	HELLER_SILENCED_BY_METHYLATION_UP	18172295	multiple myeloma	DOID_9538
6997	HELLER_SILENCED_BY_METHYLATION_UP	18172295	myeloma	DOID_0070004
6998	HELLER_SILENCED_BY_METHYLATION_UP	18172295	organ system cancer	DOID_0050686
6999	HELLER_SILENCED_BY_METHYLATION_UP	18172295	plasma cell neoplasm	DOID_6536
7000	HELLER_SILENCED_BY_METHYLATION_DN	18172295	B-cell lymphocytic neoplasm	DOID_707
7001	HELLER_SILENCED_BY_METHYLATION_DN	18172295	bone marrow cancer	DOID_4960
7002	HELLER_SILENCED_BY_METHYLATION_DN	18172295	cancer	DOID_162
7003	HELLER_SILENCED_BY_METHYLATION_DN	18172295	disease of cellular proliferation	DOID_14566
7004	HELLER_SILENCED_BY_METHYLATION_DN	18172295	hematologic cancer	DOID_2531
7005	HELLER_SILENCED_BY_METHYLATION_DN	18172295	immune system cancer	DOID_0060083
7006	HELLER_SILENCED_BY_METHYLATION_DN	18172295	lymphoma	DOID_0060058
7007	HELLER_SILENCED_BY_METHYLATION_DN	18172295	mature B-cell neoplasm	DOID_706
7008	HELLER_SILENCED_BY_METHYLATION_DN	18172295	monoclonal gammopathy of uncertain significance	DOID_7442
7009	HELLER_SILENCED_BY_METHYLATION_DN	18172295	multiple myeloma	DOID_9538
7010	HELLER_SILENCED_BY_METHYLATION_DN	18172295	myeloma	DOID_0070004
7011	HELLER_SILENCED_BY_METHYLATION_DN	18172295	organ system cancer	DOID_0050686
7012	HELLER_SILENCED_BY_METHYLATION_DN	18172295	plasma cell neoplasm	DOID_6536
7013	HELLER_HDAC_TARGETS_UP	18172295	B-cell lymphocytic neoplasm	DOID_707
7014	HELLER_HDAC_TARGETS_UP	18172295	bone marrow cancer	DOID_4960
7015	HELLER_HDAC_TARGETS_UP	18172295	cancer	DOID_162
7016	HELLER_HDAC_TARGETS_UP	18172295	disease of cellular proliferation	DOID_14566
7017	HELLER_HDAC_TARGETS_UP	18172295	hematologic cancer	DOID_2531
7018	HELLER_HDAC_TARGETS_UP	18172295	immune system cancer	DOID_0060083
7019	HELLER_HDAC_TARGETS_UP	18172295	lymphoma	DOID_0060058
7020	HELLER_HDAC_TARGETS_UP	18172295	mature B-cell neoplasm	DOID_706
7021	HELLER_HDAC_TARGETS_UP	18172295	monoclonal gammopathy of uncertain significance	DOID_7442
7022	HELLER_HDAC_TARGETS_UP	18172295	multiple myeloma	DOID_9538
7023	HELLER_HDAC_TARGETS_UP	18172295	myeloma	DOID_0070004
7024	HELLER_HDAC_TARGETS_UP	18172295	organ system cancer	DOID_0050686
7025	HELLER_HDAC_TARGETS_UP	18172295	plasma cell neoplasm	DOID_6536
7026	HELLER_HDAC_TARGETS_DN	18172295	B-cell lymphocytic neoplasm	DOID_707
7027	HELLER_HDAC_TARGETS_DN	18172295	bone marrow cancer	DOID_4960
7028	HELLER_HDAC_TARGETS_DN	18172295	cancer	DOID_162
7029	HELLER_HDAC_TARGETS_DN	18172295	disease of cellular proliferation	DOID_14566
7030	HELLER_HDAC_TARGETS_DN	18172295	hematologic cancer	DOID_2531
7031	HELLER_HDAC_TARGETS_DN	18172295	immune system cancer	DOID_0060083
7032	HELLER_HDAC_TARGETS_DN	18172295	lymphoma	DOID_0060058
7033	HELLER_HDAC_TARGETS_DN	18172295	mature B-cell neoplasm	DOID_706
7034	HELLER_HDAC_TARGETS_DN	18172295	monoclonal gammopathy of uncertain significance	DOID_7442
7035	HELLER_HDAC_TARGETS_DN	18172295	multiple myeloma	DOID_9538
7036	HELLER_HDAC_TARGETS_DN	18172295	myeloma	DOID_0070004
7037	HELLER_HDAC_TARGETS_DN	18172295	organ system cancer	DOID_0050686
7038	HELLER_HDAC_TARGETS_DN	18172295	plasma cell neoplasm	DOID_6536
7039	HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP	18172295	B-cell lymphocytic neoplasm	DOID_707
7040	HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP	18172295	bone marrow cancer	DOID_4960
7041	HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP	18172295	cancer	DOID_162
7042	HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP	18172295	disease of cellular proliferation	DOID_14566
7043	HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP	18172295	hematologic cancer	DOID_2531
7044	HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP	18172295	immune system cancer	DOID_0060083
7045	HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP	18172295	lymphoma	DOID_0060058
7046	HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP	18172295	mature B-cell neoplasm	DOID_706
7047	HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP	18172295	monoclonal gammopathy of uncertain significance	DOID_7442
7048	HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP	18172295	multiple myeloma	DOID_9538
7049	HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP	18172295	myeloma	DOID_0070004
7050	HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP	18172295	organ system cancer	DOID_0050686
7051	HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP	18172295	plasma cell neoplasm	DOID_6536
7052	HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN	18172295	B-cell lymphocytic neoplasm	DOID_707
7053	HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN	18172295	bone marrow cancer	DOID_4960
7054	HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN	18172295	cancer	DOID_162
7055	HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN	18172295	disease of cellular proliferation	DOID_14566
7056	HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN	18172295	hematologic cancer	DOID_2531
7057	HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN	18172295	immune system cancer	DOID_0060083
7058	HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN	18172295	lymphoma	DOID_0060058
7059	HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN	18172295	mature B-cell neoplasm	DOID_706
7060	HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN	18172295	monoclonal gammopathy of uncertain significance	DOID_7442
7061	HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN	18172295	multiple myeloma	DOID_9538
7062	HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN	18172295	myeloma	DOID_0070004
7063	HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN	18172295	organ system cancer	DOID_0050686
7064	HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN	18172295	plasma cell neoplasm	DOID_6536
7065	CLAUS_PGR_POSITIVE_MENINGIOMA_DN	18172325	autosomal dominant disease	DOID_0050736
7066	CLAUS_PGR_POSITIVE_MENINGIOMA_DN	18172325	autosomal genetic disease	DOID_0050739
7067	CLAUS_PGR_POSITIVE_MENINGIOMA_DN	18172325	cancer	DOID_162
7068	CLAUS_PGR_POSITIVE_MENINGIOMA_DN	18172325	central nervous system cancer	DOID_3620
7069	CLAUS_PGR_POSITIVE_MENINGIOMA_DN	18172325	disease of cellular proliferation	DOID_14566
7070	CLAUS_PGR_POSITIVE_MENINGIOMA_DN	18172325	genetic disease	DOID_630
7071	CLAUS_PGR_POSITIVE_MENINGIOMA_DN	18172325	meningioma	DOID_3565
7072	CLAUS_PGR_POSITIVE_MENINGIOMA_DN	18172325	monogenic disease	DOID_0050177
7073	CLAUS_PGR_POSITIVE_MENINGIOMA_DN	18172325	nervous system cancer	DOID_3093
7074	CLAUS_PGR_POSITIVE_MENINGIOMA_DN	18172325	neurofibromatosis	DOID_8712
7075	CLAUS_PGR_POSITIVE_MENINGIOMA_DN	18172325	organ system cancer	DOID_0050686
7076	WONG_MITOCHONDRIA_GENE_MODULE	18199530	bone marrow cancer	DOID_4960
7077	WONG_MITOCHONDRIA_GENE_MODULE	18199530	cancer	DOID_162
7078	WONG_MITOCHONDRIA_GENE_MODULE	18199530	disease of cellular proliferation	DOID_14566
7079	WONG_MITOCHONDRIA_GENE_MODULE	18199530	hematologic cancer	DOID_2531
7080	WONG_MITOCHONDRIA_GENE_MODULE	18199530	immune system cancer	DOID_0060083
7081	WONG_MITOCHONDRIA_GENE_MODULE	18199530	multiple myeloma	DOID_9538
7082	WONG_MITOCHONDRIA_GENE_MODULE	18199530	myeloma	DOID_0070004
7083	WONG_MITOCHONDRIA_GENE_MODULE	18199530	organ system cancer	DOID_0050686
7084	WONG_PROTEASOME_GENE_MODULE	18199530	bone marrow cancer	DOID_4960
7085	WONG_PROTEASOME_GENE_MODULE	18199530	cancer	DOID_162
7086	WONG_PROTEASOME_GENE_MODULE	18199530	disease of cellular proliferation	DOID_14566
7087	WONG_PROTEASOME_GENE_MODULE	18199530	hematologic cancer	DOID_2531
7088	WONG_PROTEASOME_GENE_MODULE	18199530	immune system cancer	DOID_0060083
7089	WONG_PROTEASOME_GENE_MODULE	18199530	multiple myeloma	DOID_9538
7090	WONG_PROTEASOME_GENE_MODULE	18199530	myeloma	DOID_0070004
7091	WONG_PROTEASOME_GENE_MODULE	18199530	organ system cancer	DOID_0050686
7092	AMUNDSON_GAMMA_RADIATION_RESISTANCE	18199535	cancer	DOID_162
7093	AMUNDSON_GAMMA_RADIATION_RESISTANCE	18199535	disease of cellular proliferation	DOID_14566
7094	AMUNDSON_GAMMA_RADIATION_RESPONSE	18199535	cancer	DOID_162
7095	AMUNDSON_GAMMA_RADIATION_RESPONSE	18199535	disease of cellular proliferation	DOID_14566
7096	AMUNDSON_POOR_SURVIVAL_AFTER_GAMMA_RADIATION_8G	18199535	cancer	DOID_162
7097	AMUNDSON_POOR_SURVIVAL_AFTER_GAMMA_RADIATION_8G	18199535	disease of cellular proliferation	DOID_14566
7098	AMUNDSON_POOR_SURVIVAL_AFTER_GAMMA_RADIATION_2G	18199535	cancer	DOID_162
7099	AMUNDSON_POOR_SURVIVAL_AFTER_GAMMA_RADIATION_2G	18199535	disease of cellular proliferation	DOID_14566
7100	LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_UP	18245461	cancer	DOID_162
7101	LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_UP	18245461	connective tissue cancer	DOID_201
7102	LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_UP	18245461	disease of cellular proliferation	DOID_14566
7103	LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_UP	18245461	musculoskeletal system cancer	DOID_0060100
7104	LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_UP	18245461	organ system cancer	DOID_0050686
7105	LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_UP	18245461	osteosarcoma	DOID_3347
7106	LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_DN	18245461	cancer	DOID_162
7107	LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_DN	18245461	connective tissue cancer	DOID_201
7108	LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_DN	18245461	disease of cellular proliferation	DOID_14566
7109	LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_DN	18245461	musculoskeletal system cancer	DOID_0060100
7110	LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_DN	18245461	organ system cancer	DOID_0050686
7111	LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_DN	18245461	osteosarcoma	DOID_3347
7112	LIN_MELANOMA_COPY_NUMBER_UP	18245465	cancer	DOID_162
7113	LIN_MELANOMA_COPY_NUMBER_UP	18245465	cell type cancer	DOID_0050687
7114	LIN_MELANOMA_COPY_NUMBER_UP	18245465	disease of cellular proliferation	DOID_14566
7115	LIN_MELANOMA_COPY_NUMBER_UP	18245465	melanoma	DOID_1909
7116	LIN_MELANOMA_COPY_NUMBER_DN	18245465	cancer	DOID_162
7117	LIN_MELANOMA_COPY_NUMBER_DN	18245465	cell type cancer	DOID_0050687
7118	LIN_MELANOMA_COPY_NUMBER_DN	18245465	disease of cellular proliferation	DOID_14566
7119	LIN_MELANOMA_COPY_NUMBER_DN	18245465	melanoma	DOID_1909
7120	FINETTI_BREAST_CANCER_KINOME_RED	18245477	adenocarcinoma	DOID_299
7121	FINETTI_BREAST_CANCER_KINOME_RED	18245477	breast cancer	DOID_1612
7122	FINETTI_BREAST_CANCER_KINOME_RED	18245477	cancer	DOID_162
7123	FINETTI_BREAST_CANCER_KINOME_RED	18245477	carcinoma	DOID_305
7124	FINETTI_BREAST_CANCER_KINOME_RED	18245477	cell type cancer	DOID_0050687
7125	FINETTI_BREAST_CANCER_KINOME_RED	18245477	disease of cellular proliferation	DOID_14566
7126	FINETTI_BREAST_CANCER_KINOME_RED	18245477	organ system cancer	DOID_0050686
7127	FINETTI_BREAST_CANCER_KINOME_RED	18245477	thoracic cancer	DOID_5093
7128	FINETTI_BREAST_CANCER_KINOME_GREEN	18245477	adenocarcinoma	DOID_299
7129	FINETTI_BREAST_CANCER_KINOME_GREEN	18245477	breast cancer	DOID_1612
7130	FINETTI_BREAST_CANCER_KINOME_GREEN	18245477	cancer	DOID_162
7131	FINETTI_BREAST_CANCER_KINOME_GREEN	18245477	carcinoma	DOID_305
7132	FINETTI_BREAST_CANCER_KINOME_GREEN	18245477	cell type cancer	DOID_0050687
7133	FINETTI_BREAST_CANCER_KINOME_GREEN	18245477	disease of cellular proliferation	DOID_14566
7134	FINETTI_BREAST_CANCER_KINOME_GREEN	18245477	organ system cancer	DOID_0050686
7135	FINETTI_BREAST_CANCER_KINOME_GREEN	18245477	thoracic cancer	DOID_5093
7136	FINETTI_BREAST_CANCERS_KINOME_BLUE	18245477	adenocarcinoma	DOID_299
7137	FINETTI_BREAST_CANCERS_KINOME_BLUE	18245477	breast cancer	DOID_1612
7138	FINETTI_BREAST_CANCERS_KINOME_BLUE	18245477	cancer	DOID_162
7139	FINETTI_BREAST_CANCERS_KINOME_BLUE	18245477	carcinoma	DOID_305
7140	FINETTI_BREAST_CANCERS_KINOME_BLUE	18245477	cell type cancer	DOID_0050687
7141	FINETTI_BREAST_CANCERS_KINOME_BLUE	18245477	disease of cellular proliferation	DOID_14566
7142	FINETTI_BREAST_CANCERS_KINOME_BLUE	18245477	organ system cancer	DOID_0050686
7143	FINETTI_BREAST_CANCERS_KINOME_BLUE	18245477	thoracic cancer	DOID_5093
7144	FINETTI_BREAST_CANCERS_KINOME_GRAY	18245477	adenocarcinoma	DOID_299
7145	FINETTI_BREAST_CANCERS_KINOME_GRAY	18245477	breast cancer	DOID_1612
7146	FINETTI_BREAST_CANCERS_KINOME_GRAY	18245477	cancer	DOID_162
7147	FINETTI_BREAST_CANCERS_KINOME_GRAY	18245477	carcinoma	DOID_305
7148	FINETTI_BREAST_CANCERS_KINOME_GRAY	18245477	cell type cancer	DOID_0050687
7149	FINETTI_BREAST_CANCERS_KINOME_GRAY	18245477	disease of cellular proliferation	DOID_14566
7150	FINETTI_BREAST_CANCERS_KINOME_GRAY	18245477	organ system cancer	DOID_0050686
7151	FINETTI_BREAST_CANCERS_KINOME_GRAY	18245477	thoracic cancer	DOID_5093
7152	FINETTI_BREAST_CANCER_BASAL_VS_LUMINAL	18245477	adenocarcinoma	DOID_299
7153	FINETTI_BREAST_CANCER_BASAL_VS_LUMINAL	18245477	breast cancer	DOID_1612
7154	FINETTI_BREAST_CANCER_BASAL_VS_LUMINAL	18245477	cancer	DOID_162
7155	FINETTI_BREAST_CANCER_BASAL_VS_LUMINAL	18245477	carcinoma	DOID_305
7156	FINETTI_BREAST_CANCER_BASAL_VS_LUMINAL	18245477	cell type cancer	DOID_0050687
7157	FINETTI_BREAST_CANCER_BASAL_VS_LUMINAL	18245477	disease of cellular proliferation	DOID_14566
7158	FINETTI_BREAST_CANCER_BASAL_VS_LUMINAL	18245477	organ system cancer	DOID_0050686
7159	FINETTI_BREAST_CANCER_BASAL_VS_LUMINAL	18245477	thoracic cancer	DOID_5093
7160	MASSARWEH_TAMOXIFEN_RESISTANCE_UP	18245484	breast cancer	DOID_1612
7161	MASSARWEH_TAMOXIFEN_RESISTANCE_UP	18245484	cancer	DOID_162
7162	MASSARWEH_TAMOXIFEN_RESISTANCE_UP	18245484	disease of cellular proliferation	DOID_14566
7163	MASSARWEH_TAMOXIFEN_RESISTANCE_UP	18245484	organ system cancer	DOID_0050686
7164	MASSARWEH_TAMOXIFEN_RESISTANCE_UP	18245484	thoracic cancer	DOID_5093
7165	MASSARWEH_TAMOXIFEN_RESISTANCE_DN	18245484	breast cancer	DOID_1612
7166	MASSARWEH_TAMOXIFEN_RESISTANCE_DN	18245484	cancer	DOID_162
7167	MASSARWEH_TAMOXIFEN_RESISTANCE_DN	18245484	disease of cellular proliferation	DOID_14566
7168	MASSARWEH_TAMOXIFEN_RESISTANCE_DN	18245484	organ system cancer	DOID_0050686
7169	MASSARWEH_TAMOXIFEN_RESISTANCE_DN	18245484	thoracic cancer	DOID_5093
7170	MASSARWEH_RESPONSE_TO_ESTRADIOL	18245484	breast cancer	DOID_1612
7171	MASSARWEH_RESPONSE_TO_ESTRADIOL	18245484	cancer	DOID_162
7172	MASSARWEH_RESPONSE_TO_ESTRADIOL	18245484	disease of cellular proliferation	DOID_14566
7173	MASSARWEH_RESPONSE_TO_ESTRADIOL	18245484	organ system cancer	DOID_0050686
7174	MASSARWEH_RESPONSE_TO_ESTRADIOL	18245484	thoracic cancer	DOID_5093
7175	WALLACE_PROSTATE_CANCER_UP	18245496	cancer	DOID_162
7176	WALLACE_PROSTATE_CANCER_UP	18245496	disease of cellular proliferation	DOID_14566
7177	WALLACE_PROSTATE_CANCER_UP	18245496	male reproductive organ cancer	DOID_3856
7178	WALLACE_PROSTATE_CANCER_UP	18245496	organ system cancer	DOID_0050686
7179	WALLACE_PROSTATE_CANCER_UP	18245496	prostate cancer	DOID_10283
7180	WALLACE_PROSTATE_CANCER_UP	18245496	reproductive organ cancer	DOID_193
7181	WALLACE_PROSTATE_CANCER_RACE_UP	18245496	cancer	DOID_162
7182	WALLACE_PROSTATE_CANCER_RACE_UP	18245496	disease of cellular proliferation	DOID_14566
7183	WALLACE_PROSTATE_CANCER_RACE_UP	18245496	male reproductive organ cancer	DOID_3856
7184	WALLACE_PROSTATE_CANCER_RACE_UP	18245496	organ system cancer	DOID_0050686
7185	WALLACE_PROSTATE_CANCER_RACE_UP	18245496	prostate cancer	DOID_10283
7186	WALLACE_PROSTATE_CANCER_RACE_UP	18245496	reproductive organ cancer	DOID_193
7187	WALLACE_PROSTATE_CANCER_RACE_DN	18245496	cancer	DOID_162
7188	WALLACE_PROSTATE_CANCER_RACE_DN	18245496	disease of cellular proliferation	DOID_14566
7189	WALLACE_PROSTATE_CANCER_RACE_DN	18245496	male reproductive organ cancer	DOID_3856
7190	WALLACE_PROSTATE_CANCER_RACE_DN	18245496	organ system cancer	DOID_0050686
7191	WALLACE_PROSTATE_CANCER_RACE_DN	18245496	prostate cancer	DOID_10283
7192	WALLACE_PROSTATE_CANCER_RACE_DN	18245496	reproductive organ cancer	DOID_193
7193	SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP	18281472	breast cancer	DOID_1612
7194	SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP	18281472	cancer	DOID_162
7195	SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP	18281472	carcinoma	DOID_305
7196	SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP	18281472	carcinosarcoma	DOID_4236
7197	SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP	18281472	cell type cancer	DOID_0050687
7198	SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP	18281472	disease of cellular proliferation	DOID_14566
7199	SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP	18281472	mixed cell type cancer	DOID_154
7200	SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP	18281472	organ system cancer	DOID_0050686
7201	SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP	18281472	thoracic cancer	DOID_5093
7202	OUILLETTE_CLL_13Q14_DELETION_UP	18281475	cancer	DOID_162
7203	OUILLETTE_CLL_13Q14_DELETION_UP	18281475	chronic leukemia	DOID_1036
7204	OUILLETTE_CLL_13Q14_DELETION_UP	18281475	chronic lymphocytic leukemia	DOID_1040
7205	OUILLETTE_CLL_13Q14_DELETION_UP	18281475	disease of cellular proliferation	DOID_14566
7206	OUILLETTE_CLL_13Q14_DELETION_UP	18281475	hematologic cancer	DOID_2531
7207	OUILLETTE_CLL_13Q14_DELETION_UP	18281475	immune system cancer	DOID_0060083
7208	OUILLETTE_CLL_13Q14_DELETION_UP	18281475	leukemia	DOID_1240
7209	OUILLETTE_CLL_13Q14_DELETION_UP	18281475	lymphoblastic leukemia	DOID_1037
7210	OUILLETTE_CLL_13Q14_DELETION_UP	18281475	organ system cancer	DOID_0050686
7211	OUILLETTE_CLL_13Q14_DELETION_DN	18281475	cancer	DOID_162
7212	OUILLETTE_CLL_13Q14_DELETION_DN	18281475	chronic leukemia	DOID_1036
7213	OUILLETTE_CLL_13Q14_DELETION_DN	18281475	chronic lymphocytic leukemia	DOID_1040
7214	OUILLETTE_CLL_13Q14_DELETION_DN	18281475	disease of cellular proliferation	DOID_14566
7215	OUILLETTE_CLL_13Q14_DELETION_DN	18281475	hematologic cancer	DOID_2531
7216	OUILLETTE_CLL_13Q14_DELETION_DN	18281475	immune system cancer	DOID_0060083
7217	OUILLETTE_CLL_13Q14_DELETION_DN	18281475	leukemia	DOID_1240
7218	OUILLETTE_CLL_13Q14_DELETION_DN	18281475	lymphoblastic leukemia	DOID_1037
7219	OUILLETTE_CLL_13Q14_DELETION_DN	18281475	organ system cancer	DOID_0050686
7220	YOKOE_CANCER_TESTIS_ANTIGENS	18281482	cancer	DOID_162
7221	YOKOE_CANCER_TESTIS_ANTIGENS	18281482	colorectal cancer	DOID_9256
7222	YOKOE_CANCER_TESTIS_ANTIGENS	18281482	disease of cellular proliferation	DOID_14566
7223	YOKOE_CANCER_TESTIS_ANTIGENS	18281482	esophageal cancer	DOID_5041
7224	YOKOE_CANCER_TESTIS_ANTIGENS	18281482	gastrointestinal system cancer	DOID_3119
7225	YOKOE_CANCER_TESTIS_ANTIGENS	18281482	intestinal cancer	DOID_10155
7226	YOKOE_CANCER_TESTIS_ANTIGENS	18281482	large intestine cancer	DOID_5672
7227	YOKOE_CANCER_TESTIS_ANTIGENS	18281482	organ system cancer	DOID_0050686
7228	MARZEC_IL2_SIGNALING_UP	18281483	cancer	DOID_162
7229	MARZEC_IL2_SIGNALING_UP	18281483	disease of cellular proliferation	DOID_14566
7230	MARZEC_IL2_SIGNALING_UP	18281483	hematologic cancer	DOID_2531
7231	MARZEC_IL2_SIGNALING_UP	18281483	immune system cancer	DOID_0060083
7232	MARZEC_IL2_SIGNALING_UP	18281483	lymphoma	DOID_0060058
7233	MARZEC_IL2_SIGNALING_UP	18281483	organ system cancer	DOID_0050686
7234	MARZEC_IL2_SIGNALING_DN	18281483	cancer	DOID_162
7235	MARZEC_IL2_SIGNALING_DN	18281483	disease of cellular proliferation	DOID_14566
7236	MARZEC_IL2_SIGNALING_DN	18281483	hematologic cancer	DOID_2531
7237	MARZEC_IL2_SIGNALING_DN	18281483	immune system cancer	DOID_0060083
7238	MARZEC_IL2_SIGNALING_DN	18281483	lymphoma	DOID_0060058
7239	MARZEC_IL2_SIGNALING_DN	18281483	organ system cancer	DOID_0050686
7240	CAMPS_COLON_CANCER_COPY_NUMBER_UP	18316590	cancer	DOID_162
7241	CAMPS_COLON_CANCER_COPY_NUMBER_UP	18316590	colon cancer	DOID_219
7242	CAMPS_COLON_CANCER_COPY_NUMBER_UP	18316590	colorectal cancer	DOID_9256
7243	CAMPS_COLON_CANCER_COPY_NUMBER_UP	18316590	disease of cellular proliferation	DOID_14566
7244	CAMPS_COLON_CANCER_COPY_NUMBER_UP	18316590	gastrointestinal system cancer	DOID_3119
7245	CAMPS_COLON_CANCER_COPY_NUMBER_UP	18316590	intestinal cancer	DOID_10155
7246	CAMPS_COLON_CANCER_COPY_NUMBER_UP	18316590	large intestine cancer	DOID_5672
7247	CAMPS_COLON_CANCER_COPY_NUMBER_UP	18316590	organ system cancer	DOID_0050686
7248	CAMPS_COLON_CANCER_COPY_NUMBER_DN	18316590	cancer	DOID_162
7249	CAMPS_COLON_CANCER_COPY_NUMBER_DN	18316590	colon cancer	DOID_219
7250	CAMPS_COLON_CANCER_COPY_NUMBER_DN	18316590	colorectal cancer	DOID_9256
7251	CAMPS_COLON_CANCER_COPY_NUMBER_DN	18316590	disease of cellular proliferation	DOID_14566
7252	CAMPS_COLON_CANCER_COPY_NUMBER_DN	18316590	gastrointestinal system cancer	DOID_3119
7253	CAMPS_COLON_CANCER_COPY_NUMBER_DN	18316590	intestinal cancer	DOID_10155
7254	CAMPS_COLON_CANCER_COPY_NUMBER_DN	18316590	large intestine cancer	DOID_5672
7255	CAMPS_COLON_CANCER_COPY_NUMBER_DN	18316590	organ system cancer	DOID_0050686
7256	RIZKI_TUMOR_INVASIVENESS_3D_UP	18316601	breast cancer	DOID_1612
7257	RIZKI_TUMOR_INVASIVENESS_3D_UP	18316601	cancer	DOID_162
7258	RIZKI_TUMOR_INVASIVENESS_3D_UP	18316601	disease of cellular proliferation	DOID_14566
7259	RIZKI_TUMOR_INVASIVENESS_3D_UP	18316601	organ system cancer	DOID_0050686
7260	RIZKI_TUMOR_INVASIVENESS_3D_UP	18316601	thoracic cancer	DOID_5093
7261	RIZKI_TUMOR_INVASIVENESS_3D_DN	18316601	breast cancer	DOID_1612
7262	RIZKI_TUMOR_INVASIVENESS_3D_DN	18316601	cancer	DOID_162
7263	RIZKI_TUMOR_INVASIVENESS_3D_DN	18316601	disease of cellular proliferation	DOID_14566
7264	RIZKI_TUMOR_INVASIVENESS_3D_DN	18316601	organ system cancer	DOID_0050686
7265	RIZKI_TUMOR_INVASIVENESS_3D_DN	18316601	thoracic cancer	DOID_5093
7266	RIZKI_TUMOR_INVASIVENESS_2D_UP	18316601	breast cancer	DOID_1612
7267	RIZKI_TUMOR_INVASIVENESS_2D_UP	18316601	cancer	DOID_162
7268	RIZKI_TUMOR_INVASIVENESS_2D_UP	18316601	disease of cellular proliferation	DOID_14566
7269	RIZKI_TUMOR_INVASIVENESS_2D_UP	18316601	organ system cancer	DOID_0050686
7270	RIZKI_TUMOR_INVASIVENESS_2D_UP	18316601	thoracic cancer	DOID_5093
7271	RIZKI_TUMOR_INVASIVENESS_2D_DN	18316601	breast cancer	DOID_1612
7272	RIZKI_TUMOR_INVASIVENESS_2D_DN	18316601	cancer	DOID_162
7273	RIZKI_TUMOR_INVASIVENESS_2D_DN	18316601	disease of cellular proliferation	DOID_14566
7274	RIZKI_TUMOR_INVASIVENESS_2D_DN	18316601	organ system cancer	DOID_0050686
7275	RIZKI_TUMOR_INVASIVENESS_2D_DN	18316601	thoracic cancer	DOID_5093
7276	FUJII_YBX1_TARGETS_UP	18316615	breast cancer	DOID_1612
7277	FUJII_YBX1_TARGETS_UP	18316615	cancer	DOID_162
7278	FUJII_YBX1_TARGETS_UP	18316615	disease of cellular proliferation	DOID_14566
7279	FUJII_YBX1_TARGETS_UP	18316615	organ system cancer	DOID_0050686
7280	FUJII_YBX1_TARGETS_UP	18316615	thoracic cancer	DOID_5093
7281	FUJII_YBX1_TARGETS_DN	18316615	breast cancer	DOID_1612
7282	FUJII_YBX1_TARGETS_DN	18316615	cancer	DOID_162
7283	FUJII_YBX1_TARGETS_DN	18316615	disease of cellular proliferation	DOID_14566
7284	FUJII_YBX1_TARGETS_DN	18316615	organ system cancer	DOID_0050686
7285	FUJII_YBX1_TARGETS_DN	18316615	thoracic cancer	DOID_5093
7286	OSADA_ASCL1_TARGETS_UP	18339843	adenocarcinoma	DOID_299
7287	OSADA_ASCL1_TARGETS_UP	18339843	cancer	DOID_162
7288	OSADA_ASCL1_TARGETS_UP	18339843	carcinoma	DOID_305
7289	OSADA_ASCL1_TARGETS_UP	18339843	cell type cancer	DOID_0050687
7290	OSADA_ASCL1_TARGETS_UP	18339843	disease of cellular proliferation	DOID_14566
7291	OSADA_ASCL1_TARGETS_UP	18339843	lung cancer	DOID_1324
7292	OSADA_ASCL1_TARGETS_UP	18339843	neuroendocrine carcinoma	DOID_1800
7293	OSADA_ASCL1_TARGETS_UP	18339843	organ system cancer	DOID_0050686
7294	OSADA_ASCL1_TARGETS_UP	18339843	respiratory system cancer	DOID_0050615
7295	OSADA_ASCL1_TARGETS_DN	18339843	adenocarcinoma	DOID_299
7296	OSADA_ASCL1_TARGETS_DN	18339843	cancer	DOID_162
7297	OSADA_ASCL1_TARGETS_DN	18339843	carcinoma	DOID_305
7298	OSADA_ASCL1_TARGETS_DN	18339843	cell type cancer	DOID_0050687
7299	OSADA_ASCL1_TARGETS_DN	18339843	disease of cellular proliferation	DOID_14566
7300	OSADA_ASCL1_TARGETS_DN	18339843	lung cancer	DOID_1324
7301	OSADA_ASCL1_TARGETS_DN	18339843	neuroendocrine carcinoma	DOID_1800
7302	OSADA_ASCL1_TARGETS_DN	18339843	organ system cancer	DOID_0050686
7303	OSADA_ASCL1_TARGETS_DN	18339843	respiratory system cancer	DOID_0050615
7304	CHENG_IMPRINTED_BY_ESTRADIOL	18339859	breast cancer	DOID_1612
7305	CHENG_IMPRINTED_BY_ESTRADIOL	18339859	cancer	DOID_162
7306	CHENG_IMPRINTED_BY_ESTRADIOL	18339859	disease of cellular proliferation	DOID_14566
7307	CHENG_IMPRINTED_BY_ESTRADIOL	18339859	organ system cancer	DOID_0050686
7308	CHENG_IMPRINTED_BY_ESTRADIOL	18339859	thoracic cancer	DOID_5093
7309	DE_YY1_TARGETS_UP	18339860	cancer	DOID_162
7310	DE_YY1_TARGETS_UP	18339860	connective tissue cancer	DOID_201
7311	DE_YY1_TARGETS_UP	18339860	disease of cellular proliferation	DOID_14566
7312	DE_YY1_TARGETS_UP	18339860	musculoskeletal system cancer	DOID_0060100
7313	DE_YY1_TARGETS_UP	18339860	organ system cancer	DOID_0050686
7314	DE_YY1_TARGETS_UP	18339860	osteosarcoma	DOID_3347
7315	DE_YY1_TARGETS_DN	18339860	cancer	DOID_162
7316	DE_YY1_TARGETS_DN	18339860	connective tissue cancer	DOID_201
7317	DE_YY1_TARGETS_DN	18339860	disease of cellular proliferation	DOID_14566
7318	DE_YY1_TARGETS_DN	18339860	musculoskeletal system cancer	DOID_0060100
7319	DE_YY1_TARGETS_DN	18339860	organ system cancer	DOID_0050686
7320	DE_YY1_TARGETS_DN	18339860	osteosarcoma	DOID_3347
7321	MCCABE_BOUND_BY_HOXC6	18339881	cancer	DOID_162
7322	MCCABE_BOUND_BY_HOXC6	18339881	disease of cellular proliferation	DOID_14566
7323	MCCABE_BOUND_BY_HOXC6	18339881	male reproductive organ cancer	DOID_3856
7324	MCCABE_BOUND_BY_HOXC6	18339881	organ system cancer	DOID_0050686
7325	MCCABE_BOUND_BY_HOXC6	18339881	prostate cancer	DOID_10283
7326	MCCABE_BOUND_BY_HOXC6	18339881	reproductive organ cancer	DOID_193
7327	DAIRKEE_CANCER_PRONE_RESPONSE_E2	18381411	breast cancer	DOID_1612
7328	DAIRKEE_CANCER_PRONE_RESPONSE_E2	18381411	cancer	DOID_162
7329	DAIRKEE_CANCER_PRONE_RESPONSE_E2	18381411	disease of cellular proliferation	DOID_14566
7330	DAIRKEE_CANCER_PRONE_RESPONSE_E2	18381411	organ system cancer	DOID_0050686
7331	DAIRKEE_CANCER_PRONE_RESPONSE_E2	18381411	thoracic cancer	DOID_5093
7332	DAIRKEE_CANCER_PRONE_RESPONSE_BPA	18381411	breast cancer	DOID_1612
7333	DAIRKEE_CANCER_PRONE_RESPONSE_BPA	18381411	cancer	DOID_162
7334	DAIRKEE_CANCER_PRONE_RESPONSE_BPA	18381411	disease of cellular proliferation	DOID_14566
7335	DAIRKEE_CANCER_PRONE_RESPONSE_BPA	18381411	organ system cancer	DOID_0050686
7336	DAIRKEE_CANCER_PRONE_RESPONSE_BPA	18381411	thoracic cancer	DOID_5093
7337	DAIRKEE_CANCER_PRONE_RESPONSE_BPA_E2	18381411	breast cancer	DOID_1612
7338	DAIRKEE_CANCER_PRONE_RESPONSE_BPA_E2	18381411	cancer	DOID_162
7339	DAIRKEE_CANCER_PRONE_RESPONSE_BPA_E2	18381411	disease of cellular proliferation	DOID_14566
7340	DAIRKEE_CANCER_PRONE_RESPONSE_BPA_E2	18381411	organ system cancer	DOID_0050686
7341	DAIRKEE_CANCER_PRONE_RESPONSE_BPA_E2	18381411	thoracic cancer	DOID_5093
7342	RIGGI_EWING_SARCOMA_PROGENITOR_UP	18381423	cancer	DOID_162
7343	RIGGI_EWING_SARCOMA_PROGENITOR_UP	18381423	cell type cancer	DOID_0050687
7344	RIGGI_EWING_SARCOMA_PROGENITOR_UP	18381423	disease of cellular proliferation	DOID_14566
7345	RIGGI_EWING_SARCOMA_PROGENITOR_UP	18381423	sarcoma	DOID_1115
7346	RIGGI_EWING_SARCOMA_PROGENITOR_DN	18381423	cancer	DOID_162
7347	RIGGI_EWING_SARCOMA_PROGENITOR_DN	18381423	cell type cancer	DOID_0050687
7348	RIGGI_EWING_SARCOMA_PROGENITOR_DN	18381423	disease of cellular proliferation	DOID_14566
7349	RIGGI_EWING_SARCOMA_PROGENITOR_DN	18381423	sarcoma	DOID_1115
7350	VICENT_METASTASIS_UP	18381434	cancer	DOID_162
7351	VICENT_METASTASIS_UP	18381434	carcinoma	DOID_305
7352	VICENT_METASTASIS_UP	18381434	cell type cancer	DOID_0050687
7353	VICENT_METASTASIS_UP	18381434	disease of cellular proliferation	DOID_14566
7354	VICENT_METASTASIS_UP	18381434	large cell carcinoma	DOID_4552
7355	VICENT_METASTASIS_UP	18381434	lung cancer	DOID_1324
7356	VICENT_METASTASIS_UP	18381434	organ system cancer	DOID_0050686
7357	VICENT_METASTASIS_UP	18381434	respiratory system cancer	DOID_0050615
7358	AMBROSINI_FLAVOPIRIDOL_TREATMENT_TP53	18381438	cancer	DOID_162
7359	AMBROSINI_FLAVOPIRIDOL_TREATMENT_TP53	18381438	colon cancer	DOID_219
7360	AMBROSINI_FLAVOPIRIDOL_TREATMENT_TP53	18381438	colorectal cancer	DOID_9256
7361	AMBROSINI_FLAVOPIRIDOL_TREATMENT_TP53	18381438	disease of cellular proliferation	DOID_14566
7362	AMBROSINI_FLAVOPIRIDOL_TREATMENT_TP53	18381438	gastrointestinal system cancer	DOID_3119
7363	AMBROSINI_FLAVOPIRIDOL_TREATMENT_TP53	18381438	intestinal cancer	DOID_10155
7364	AMBROSINI_FLAVOPIRIDOL_TREATMENT_TP53	18381438	large intestine cancer	DOID_5672
7365	AMBROSINI_FLAVOPIRIDOL_TREATMENT_TP53	18381438	organ system cancer	DOID_0050686
7366	HANN_RESISTANCE_TO_BCL2_INHIBITOR_UP	18381439	cancer	DOID_162
7367	HANN_RESISTANCE_TO_BCL2_INHIBITOR_UP	18381439	carcinoma	DOID_305
7368	HANN_RESISTANCE_TO_BCL2_INHIBITOR_UP	18381439	cell type cancer	DOID_0050687
7369	HANN_RESISTANCE_TO_BCL2_INHIBITOR_UP	18381439	disease of cellular proliferation	DOID_14566
7370	HANN_RESISTANCE_TO_BCL2_INHIBITOR_UP	18381439	lung cancer	DOID_1324
7371	HANN_RESISTANCE_TO_BCL2_INHIBITOR_UP	18381439	lung carcinoma	DOID_3905
7372	HANN_RESISTANCE_TO_BCL2_INHIBITOR_UP	18381439	lung small cell carcinoma	DOID_5409
7373	HANN_RESISTANCE_TO_BCL2_INHIBITOR_UP	18381439	organ system cancer	DOID_0050686
7374	HANN_RESISTANCE_TO_BCL2_INHIBITOR_UP	18381439	respiratory system cancer	DOID_0050615
7375	HANN_RESISTANCE_TO_BCL2_INHIBITOR_DN	18381439	cancer	DOID_162
7376	HANN_RESISTANCE_TO_BCL2_INHIBITOR_DN	18381439	carcinoma	DOID_305
7377	HANN_RESISTANCE_TO_BCL2_INHIBITOR_DN	18381439	cell type cancer	DOID_0050687
7378	HANN_RESISTANCE_TO_BCL2_INHIBITOR_DN	18381439	disease of cellular proliferation	DOID_14566
7379	HANN_RESISTANCE_TO_BCL2_INHIBITOR_DN	18381439	lung cancer	DOID_1324
7380	HANN_RESISTANCE_TO_BCL2_INHIBITOR_DN	18381439	lung carcinoma	DOID_3905
7381	HANN_RESISTANCE_TO_BCL2_INHIBITOR_DN	18381439	lung small cell carcinoma	DOID_5409
7382	HANN_RESISTANCE_TO_BCL2_INHIBITOR_DN	18381439	organ system cancer	DOID_0050686
7383	HANN_RESISTANCE_TO_BCL2_INHIBITOR_DN	18381439	respiratory system cancer	DOID_0050615
7384	ENGELMANN_CANCER_PROGENITORS_UP	18381450	breast cancer	DOID_1612
7385	ENGELMANN_CANCER_PROGENITORS_UP	18381450	cancer	DOID_162
7386	ENGELMANN_CANCER_PROGENITORS_UP	18381450	combined T cell and B cell immunodeficiency	DOID_628
7387	ENGELMANN_CANCER_PROGENITORS_UP	18381450	disease of anatomical entity	DOID_7
7388	ENGELMANN_CANCER_PROGENITORS_UP	18381450	disease of cellular proliferation	DOID_14566
7389	ENGELMANN_CANCER_PROGENITORS_UP	18381450	immune system disease	DOID_2914
7390	ENGELMANN_CANCER_PROGENITORS_UP	18381450	organ system cancer	DOID_0050686
7391	ENGELMANN_CANCER_PROGENITORS_UP	18381450	primary immunodeficiency disease	DOID_612
7392	ENGELMANN_CANCER_PROGENITORS_UP	18381450	severe combined immunodeficiency	DOID_627
7393	ENGELMANN_CANCER_PROGENITORS_UP	18381450	thoracic cancer	DOID_5093
7394	ENGELMANN_CANCER_PROGENITORS_DN	18381450	breast cancer	DOID_1612
7395	ENGELMANN_CANCER_PROGENITORS_DN	18381450	cancer	DOID_162
7396	ENGELMANN_CANCER_PROGENITORS_DN	18381450	combined T cell and B cell immunodeficiency	DOID_628
7397	ENGELMANN_CANCER_PROGENITORS_DN	18381450	disease of anatomical entity	DOID_7
7398	ENGELMANN_CANCER_PROGENITORS_DN	18381450	disease of cellular proliferation	DOID_14566
7399	ENGELMANN_CANCER_PROGENITORS_DN	18381450	immune system disease	DOID_2914
7400	ENGELMANN_CANCER_PROGENITORS_DN	18381450	organ system cancer	DOID_0050686
7401	ENGELMANN_CANCER_PROGENITORS_DN	18381450	primary immunodeficiency disease	DOID_612
7402	ENGELMANN_CANCER_PROGENITORS_DN	18381450	severe combined immunodeficiency	DOID_627
7403	ENGELMANN_CANCER_PROGENITORS_DN	18381450	thoracic cancer	DOID_5093
7404	HUANG_FOXA2_TARGETS_UP	18593902	adenocarcinoma	DOID_299
7405	HUANG_FOXA2_TARGETS_UP	18593902	cancer	DOID_162
7406	HUANG_FOXA2_TARGETS_UP	18593902	carcinoma	DOID_305
7407	HUANG_FOXA2_TARGETS_UP	18593902	cell type cancer	DOID_0050687
7408	HUANG_FOXA2_TARGETS_UP	18593902	colon cancer	DOID_219
7409	HUANG_FOXA2_TARGETS_UP	18593902	colorectal cancer	DOID_9256
7410	HUANG_FOXA2_TARGETS_UP	18593902	disease of cellular proliferation	DOID_14566
7411	HUANG_FOXA2_TARGETS_UP	18593902	gastrointestinal system cancer	DOID_3119
7412	HUANG_FOXA2_TARGETS_UP	18593902	intestinal cancer	DOID_10155
7413	HUANG_FOXA2_TARGETS_UP	18593902	large intestine cancer	DOID_5672
7414	HUANG_FOXA2_TARGETS_UP	18593902	lung cancer	DOID_1324
7415	HUANG_FOXA2_TARGETS_UP	18593902	organ system cancer	DOID_0050686
7416	HUANG_FOXA2_TARGETS_UP	18593902	respiratory system cancer	DOID_0050615
7417	HUANG_FOXA2_TARGETS_DN	18593902	adenocarcinoma	DOID_299
7418	HUANG_FOXA2_TARGETS_DN	18593902	cancer	DOID_162
7419	HUANG_FOXA2_TARGETS_DN	18593902	carcinoma	DOID_305
7420	HUANG_FOXA2_TARGETS_DN	18593902	cell type cancer	DOID_0050687
7421	HUANG_FOXA2_TARGETS_DN	18593902	colon cancer	DOID_219
7422	HUANG_FOXA2_TARGETS_DN	18593902	colorectal cancer	DOID_9256
7423	HUANG_FOXA2_TARGETS_DN	18593902	disease of cellular proliferation	DOID_14566
7424	HUANG_FOXA2_TARGETS_DN	18593902	gastrointestinal system cancer	DOID_3119
7425	HUANG_FOXA2_TARGETS_DN	18593902	intestinal cancer	DOID_10155
7426	HUANG_FOXA2_TARGETS_DN	18593902	large intestine cancer	DOID_5672
7427	HUANG_FOXA2_TARGETS_DN	18593902	lung cancer	DOID_1324
7428	HUANG_FOXA2_TARGETS_DN	18593902	organ system cancer	DOID_0050686
7429	HUANG_FOXA2_TARGETS_DN	18593902	respiratory system cancer	DOID_0050615
7430	MASRI_RESISTANCE_TO_TAMOXIFEN_AND_AROMATASE_INHIBITORS_UP	18559539	NA	NA
7431	MASRI_RESISTANCE_TO_TAMOXIFEN_AND_AROMATASE_INHIBITORS_DN	18559539	NA	NA
7432	MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP	18519693	breast cancer	DOID_1612
7433	MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP	18519693	cancer	DOID_162
7434	MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP	18519693	disease of cellular proliferation	DOID_14566
7435	MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP	18519693	organ system cancer	DOID_0050686
7436	MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP	18519693	thoracic cancer	DOID_5093
7437	MCCABE_HOXC6_TARGETS_DN	18339881	cancer	DOID_162
7438	MCCABE_HOXC6_TARGETS_DN	18339881	disease of cellular proliferation	DOID_14566
7439	MCCABE_HOXC6_TARGETS_DN	18339881	male reproductive organ cancer	DOID_3856
7440	MCCABE_HOXC6_TARGETS_DN	18339881	organ system cancer	DOID_0050686
7441	MCCABE_HOXC6_TARGETS_DN	18339881	prostate cancer	DOID_10283
7442	MCCABE_HOXC6_TARGETS_DN	18339881	reproductive organ cancer	DOID_193
7443	TING_SILENCED_BY_DICER	18413723	cancer	DOID_162
7444	TING_SILENCED_BY_DICER	18413723	colon cancer	DOID_219
7445	TING_SILENCED_BY_DICER	18413723	colorectal cancer	DOID_9256
7446	TING_SILENCED_BY_DICER	18413723	disease of cellular proliferation	DOID_14566
7447	TING_SILENCED_BY_DICER	18413723	gastrointestinal system cancer	DOID_3119
7448	TING_SILENCED_BY_DICER	18413723	intestinal cancer	DOID_10155
7449	TING_SILENCED_BY_DICER	18413723	large intestine cancer	DOID_5672
7450	TING_SILENCED_BY_DICER	18413723	organ system cancer	DOID_0050686
7451	MCCABE_HOXC6_TARGETS_CANCER_UP	18339881	cancer	DOID_162
7452	MCCABE_HOXC6_TARGETS_CANCER_UP	18339881	disease of cellular proliferation	DOID_14566
7453	MCCABE_HOXC6_TARGETS_CANCER_UP	18339881	male reproductive organ cancer	DOID_3856
7454	MCCABE_HOXC6_TARGETS_CANCER_UP	18339881	organ system cancer	DOID_0050686
7455	MCCABE_HOXC6_TARGETS_CANCER_UP	18339881	prostate cancer	DOID_10283
7456	MCCABE_HOXC6_TARGETS_CANCER_UP	18339881	reproductive organ cancer	DOID_193
7457	MCCABE_HOXC6_TARGETS_CANCER_DN	18339881	cancer	DOID_162
7458	MCCABE_HOXC6_TARGETS_CANCER_DN	18339881	disease of cellular proliferation	DOID_14566
7459	MCCABE_HOXC6_TARGETS_CANCER_DN	18339881	male reproductive organ cancer	DOID_3856
7460	MCCABE_HOXC6_TARGETS_CANCER_DN	18339881	organ system cancer	DOID_0050686
7461	MCCABE_HOXC6_TARGETS_CANCER_DN	18339881	prostate cancer	DOID_10283
7462	MCCABE_HOXC6_TARGETS_CANCER_DN	18339881	reproductive organ cancer	DOID_193
7463	MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_UP	18413728	autonomic nervous system neoplasm	DOID_2621
7464	MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_UP	18413728	cancer	DOID_162
7465	MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_UP	18413728	disease of cellular proliferation	DOID_14566
7466	MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_UP	18413728	ganglioneuroma	DOID_4817
7467	MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_UP	18413728	nervous system cancer	DOID_3093
7468	MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_UP	18413728	neuroblastoma	DOID_769
7469	MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_UP	18413728	organ system cancer	DOID_0050686
7470	MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_UP	18413728	peripheral nervous system neoplasm	DOID_1192
7471	MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_DN	18413728	autonomic nervous system neoplasm	DOID_2621
7472	MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_DN	18413728	cancer	DOID_162
7473	MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_DN	18413728	disease of cellular proliferation	DOID_14566
7474	MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_DN	18413728	ganglioneuroma	DOID_4817
7475	MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_DN	18413728	nervous system cancer	DOID_3093
7476	MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_DN	18413728	neuroblastoma	DOID_769
7477	MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_DN	18413728	organ system cancer	DOID_0050686
7478	MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_DN	18413728	peripheral nervous system neoplasm	DOID_1192
7479	ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_UP	18413731	cancer	DOID_162
7480	ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_UP	18413731	carcinoma	DOID_305
7481	ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_UP	18413731	cell type cancer	DOID_0050687
7482	ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_UP	18413731	disease of cellular proliferation	DOID_14566
7483	ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_UP	18413731	gastrointestinal system cancer	DOID_3119
7484	ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_UP	18413731	liver cancer	DOID_3571
7485	ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_UP	18413731	organ system cancer	DOID_0050686
7486	ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_DN	18413731	cancer	DOID_162
7487	ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_DN	18413731	carcinoma	DOID_305
7488	ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_DN	18413731	cell type cancer	DOID_0050687
7489	ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_DN	18413731	disease of cellular proliferation	DOID_14566
7490	ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_DN	18413731	gastrointestinal system cancer	DOID_3119
7491	ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_DN	18413731	liver cancer	DOID_3571
7492	ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_DN	18413731	organ system cancer	DOID_0050686
7493	ACEVEDO_LIVER_CANCER_UP	18413731	cancer	DOID_162
7494	ACEVEDO_LIVER_CANCER_UP	18413731	carcinoma	DOID_305
7495	ACEVEDO_LIVER_CANCER_UP	18413731	cell type cancer	DOID_0050687
7496	ACEVEDO_LIVER_CANCER_UP	18413731	disease of cellular proliferation	DOID_14566
7497	ACEVEDO_LIVER_CANCER_UP	18413731	gastrointestinal system cancer	DOID_3119
7498	ACEVEDO_LIVER_CANCER_UP	18413731	liver cancer	DOID_3571
7499	ACEVEDO_LIVER_CANCER_UP	18413731	organ system cancer	DOID_0050686
7500	ACEVEDO_LIVER_CANCER_DN	18413731	cancer	DOID_162
7501	ACEVEDO_LIVER_CANCER_DN	18413731	carcinoma	DOID_305
7502	ACEVEDO_LIVER_CANCER_DN	18413731	cell type cancer	DOID_0050687
7503	ACEVEDO_LIVER_CANCER_DN	18413731	disease of cellular proliferation	DOID_14566
7504	ACEVEDO_LIVER_CANCER_DN	18413731	gastrointestinal system cancer	DOID_3119
7505	ACEVEDO_LIVER_CANCER_DN	18413731	liver cancer	DOID_3571
7506	ACEVEDO_LIVER_CANCER_DN	18413731	organ system cancer	DOID_0050686
7507	ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_UP	18413731	cancer	DOID_162
7508	ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_UP	18413731	carcinoma	DOID_305
7509	ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_UP	18413731	cell type cancer	DOID_0050687
7510	ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_UP	18413731	disease of cellular proliferation	DOID_14566
7511	ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_UP	18413731	gastrointestinal system cancer	DOID_3119
7512	ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_UP	18413731	liver cancer	DOID_3571
7513	ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_UP	18413731	organ system cancer	DOID_0050686
7514	ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN	18413731	cancer	DOID_162
7515	ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN	18413731	carcinoma	DOID_305
7516	ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN	18413731	cell type cancer	DOID_0050687
7517	ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN	18413731	disease of cellular proliferation	DOID_14566
7518	ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN	18413731	gastrointestinal system cancer	DOID_3119
7519	ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN	18413731	liver cancer	DOID_3571
7520	ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN	18413731	organ system cancer	DOID_0050686
7521	ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_UP	18413731	cancer	DOID_162
7522	ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_UP	18413731	carcinoma	DOID_305
7523	ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_UP	18413731	cell type cancer	DOID_0050687
7524	ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_UP	18413731	disease of cellular proliferation	DOID_14566
7525	ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_UP	18413731	gastrointestinal system cancer	DOID_3119
7526	ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_UP	18413731	liver cancer	DOID_3571
7527	ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_UP	18413731	organ system cancer	DOID_0050686
7528	ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_DN	18413731	cancer	DOID_162
7529	ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_DN	18413731	carcinoma	DOID_305
7530	ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_DN	18413731	cell type cancer	DOID_0050687
7531	ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_DN	18413731	disease of cellular proliferation	DOID_14566
7532	ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_DN	18413731	gastrointestinal system cancer	DOID_3119
7533	ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_DN	18413731	liver cancer	DOID_3571
7534	ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_DN	18413731	organ system cancer	DOID_0050686
7535	ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_UP	18413731	cancer	DOID_162
7536	ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_UP	18413731	carcinoma	DOID_305
7537	ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_UP	18413731	cell type cancer	DOID_0050687
7538	ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_UP	18413731	disease of cellular proliferation	DOID_14566
7539	ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_UP	18413731	gastrointestinal system cancer	DOID_3119
7540	ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_UP	18413731	liver cancer	DOID_3571
7541	ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_UP	18413731	organ system cancer	DOID_0050686
7542	ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_DN	18413731	cancer	DOID_162
7543	ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_DN	18413731	carcinoma	DOID_305
7544	ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_DN	18413731	cell type cancer	DOID_0050687
7545	ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_DN	18413731	disease of cellular proliferation	DOID_14566
7546	ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_DN	18413731	gastrointestinal system cancer	DOID_3119
7547	ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_DN	18413731	liver cancer	DOID_3571
7548	ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_DN	18413731	organ system cancer	DOID_0050686
7549	ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN	18413731	cancer	DOID_162
7550	ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN	18413731	carcinoma	DOID_305
7551	ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN	18413731	cell type cancer	DOID_0050687
7552	ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN	18413731	disease of cellular proliferation	DOID_14566
7553	ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN	18413731	gastrointestinal system cancer	DOID_3119
7554	ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN	18413731	liver cancer	DOID_3571
7555	ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN	18413731	organ system cancer	DOID_0050686
7556	MITSIADES_RESPONSE_TO_APLIDIN_UP	18593922	bone marrow cancer	DOID_4960
7557	MITSIADES_RESPONSE_TO_APLIDIN_UP	18593922	cancer	DOID_162
7558	MITSIADES_RESPONSE_TO_APLIDIN_UP	18593922	combined T cell and B cell immunodeficiency	DOID_628
7559	MITSIADES_RESPONSE_TO_APLIDIN_UP	18593922	disease of anatomical entity	DOID_7
7560	MITSIADES_RESPONSE_TO_APLIDIN_UP	18593922	disease of cellular proliferation	DOID_14566
7561	MITSIADES_RESPONSE_TO_APLIDIN_UP	18593922	hematologic cancer	DOID_2531
7562	MITSIADES_RESPONSE_TO_APLIDIN_UP	18593922	immune system cancer	DOID_0060083
7563	MITSIADES_RESPONSE_TO_APLIDIN_UP	18593922	immune system disease	DOID_2914
7564	MITSIADES_RESPONSE_TO_APLIDIN_UP	18593922	multiple myeloma	DOID_9538
7565	MITSIADES_RESPONSE_TO_APLIDIN_UP	18593922	myeloma	DOID_0070004
7566	MITSIADES_RESPONSE_TO_APLIDIN_UP	18593922	organ system cancer	DOID_0050686
7567	MITSIADES_RESPONSE_TO_APLIDIN_UP	18593922	primary immunodeficiency disease	DOID_612
7568	MITSIADES_RESPONSE_TO_APLIDIN_UP	18593922	severe combined immunodeficiency	DOID_627
7569	MITSIADES_RESPONSE_TO_APLIDIN_DN	18593922	bone marrow cancer	DOID_4960
7570	MITSIADES_RESPONSE_TO_APLIDIN_DN	18593922	cancer	DOID_162
7571	MITSIADES_RESPONSE_TO_APLIDIN_DN	18593922	combined T cell and B cell immunodeficiency	DOID_628
7572	MITSIADES_RESPONSE_TO_APLIDIN_DN	18593922	disease of anatomical entity	DOID_7
7573	MITSIADES_RESPONSE_TO_APLIDIN_DN	18593922	disease of cellular proliferation	DOID_14566
7574	MITSIADES_RESPONSE_TO_APLIDIN_DN	18593922	hematologic cancer	DOID_2531
7575	MITSIADES_RESPONSE_TO_APLIDIN_DN	18593922	immune system cancer	DOID_0060083
7576	MITSIADES_RESPONSE_TO_APLIDIN_DN	18593922	immune system disease	DOID_2914
7577	MITSIADES_RESPONSE_TO_APLIDIN_DN	18593922	multiple myeloma	DOID_9538
7578	MITSIADES_RESPONSE_TO_APLIDIN_DN	18593922	myeloma	DOID_0070004
7579	MITSIADES_RESPONSE_TO_APLIDIN_DN	18593922	organ system cancer	DOID_0050686
7580	MITSIADES_RESPONSE_TO_APLIDIN_DN	18593922	primary immunodeficiency disease	DOID_612
7581	MITSIADES_RESPONSE_TO_APLIDIN_DN	18593922	severe combined immunodeficiency	DOID_627
7582	HOQUE_METHYLATED_IN_CANCER	18413733	cancer	DOID_162
7583	HOQUE_METHYLATED_IN_CANCER	18413733	disease of cellular proliferation	DOID_14566
7584	SAGIV_CD24_TARGETS_UP	18413748	cancer	DOID_162
7585	SAGIV_CD24_TARGETS_UP	18413748	disease of cellular proliferation	DOID_14566
7586	SAGIV_CD24_TARGETS_UP	18413748	endocrine gland cancer	DOID_170
7587	SAGIV_CD24_TARGETS_UP	18413748	organ system cancer	DOID_0050686
7588	SAGIV_CD24_TARGETS_UP	18413748	pancreatic cancer	DOID_1793
7589	SAGIV_CD24_TARGETS_DN	18413748	cancer	DOID_162
7590	SAGIV_CD24_TARGETS_DN	18413748	disease of cellular proliferation	DOID_14566
7591	SAGIV_CD24_TARGETS_DN	18413748	endocrine gland cancer	DOID_170
7592	SAGIV_CD24_TARGETS_DN	18413748	organ system cancer	DOID_0050686
7593	SAGIV_CD24_TARGETS_DN	18413748	pancreatic cancer	DOID_1793
7594	SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_UP	18451135	breast cancer	DOID_1612
7595	SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_UP	18451135	cancer	DOID_162
7596	SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_UP	18451135	disease of cellular proliferation	DOID_14566
7597	SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_UP	18451135	organ system cancer	DOID_0050686
7598	SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_UP	18451135	thoracic cancer	DOID_5093
7599	SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_DN	18451135	breast cancer	DOID_1612
7600	SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_DN	18451135	cancer	DOID_162
7601	SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_DN	18451135	disease of cellular proliferation	DOID_14566
7602	SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_DN	18451135	organ system cancer	DOID_0050686
7603	SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_DN	18451135	thoracic cancer	DOID_5093
7604	SMID_BREAST_CANCER_RELAPSE_IN_BONE_UP	18451135	breast cancer	DOID_1612
7605	SMID_BREAST_CANCER_RELAPSE_IN_BONE_UP	18451135	cancer	DOID_162
7606	SMID_BREAST_CANCER_RELAPSE_IN_BONE_UP	18451135	disease of cellular proliferation	DOID_14566
7607	SMID_BREAST_CANCER_RELAPSE_IN_BONE_UP	18451135	organ system cancer	DOID_0050686
7608	SMID_BREAST_CANCER_RELAPSE_IN_BONE_UP	18451135	thoracic cancer	DOID_5093
7609	SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN	18451135	breast cancer	DOID_1612
7610	SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN	18451135	cancer	DOID_162
7611	SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN	18451135	disease of cellular proliferation	DOID_14566
7612	SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN	18451135	organ system cancer	DOID_0050686
7613	SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN	18451135	thoracic cancer	DOID_5093
7614	SMID_BREAST_CANCER_RELAPSE_IN_LUNG_UP	18451135	breast cancer	DOID_1612
7615	SMID_BREAST_CANCER_RELAPSE_IN_LUNG_UP	18451135	cancer	DOID_162
7616	SMID_BREAST_CANCER_RELAPSE_IN_LUNG_UP	18451135	disease of cellular proliferation	DOID_14566
7617	SMID_BREAST_CANCER_RELAPSE_IN_LUNG_UP	18451135	organ system cancer	DOID_0050686
7618	SMID_BREAST_CANCER_RELAPSE_IN_LUNG_UP	18451135	thoracic cancer	DOID_5093
7619	SMID_BREAST_CANCER_RELAPSE_IN_LUNG_DN	18451135	breast cancer	DOID_1612
7620	SMID_BREAST_CANCER_RELAPSE_IN_LUNG_DN	18451135	cancer	DOID_162
7621	SMID_BREAST_CANCER_RELAPSE_IN_LUNG_DN	18451135	disease of cellular proliferation	DOID_14566
7622	SMID_BREAST_CANCER_RELAPSE_IN_LUNG_DN	18451135	organ system cancer	DOID_0050686
7623	SMID_BREAST_CANCER_RELAPSE_IN_LUNG_DN	18451135	thoracic cancer	DOID_5093
7624	SMID_BREAST_CANCER_RELAPSE_IN_PLEURA_DN	18451135	breast cancer	DOID_1612
7625	SMID_BREAST_CANCER_RELAPSE_IN_PLEURA_DN	18451135	cancer	DOID_162
7626	SMID_BREAST_CANCER_RELAPSE_IN_PLEURA_DN	18451135	disease of cellular proliferation	DOID_14566
7627	SMID_BREAST_CANCER_RELAPSE_IN_PLEURA_DN	18451135	organ system cancer	DOID_0050686
7628	SMID_BREAST_CANCER_RELAPSE_IN_PLEURA_DN	18451135	thoracic cancer	DOID_5093
7629	SMID_BREAST_CANCER_LUMINAL_B_UP	18451135	breast cancer	DOID_1612
7630	SMID_BREAST_CANCER_LUMINAL_B_UP	18451135	cancer	DOID_162
7631	SMID_BREAST_CANCER_LUMINAL_B_UP	18451135	disease of cellular proliferation	DOID_14566
7632	SMID_BREAST_CANCER_LUMINAL_B_UP	18451135	organ system cancer	DOID_0050686
7633	SMID_BREAST_CANCER_LUMINAL_B_UP	18451135	thoracic cancer	DOID_5093
7634	SMID_BREAST_CANCER_LUMINAL_B_DN	18451135	breast cancer	DOID_1612
7635	SMID_BREAST_CANCER_LUMINAL_B_DN	18451135	cancer	DOID_162
7636	SMID_BREAST_CANCER_LUMINAL_B_DN	18451135	disease of cellular proliferation	DOID_14566
7637	SMID_BREAST_CANCER_LUMINAL_B_DN	18451135	organ system cancer	DOID_0050686
7638	SMID_BREAST_CANCER_LUMINAL_B_DN	18451135	thoracic cancer	DOID_5093
7639	SMID_BREAST_CANCER_LUMINAL_A_UP	18451135	breast cancer	DOID_1612
7640	SMID_BREAST_CANCER_LUMINAL_A_UP	18451135	cancer	DOID_162
7641	SMID_BREAST_CANCER_LUMINAL_A_UP	18451135	disease of cellular proliferation	DOID_14566
7642	SMID_BREAST_CANCER_LUMINAL_A_UP	18451135	organ system cancer	DOID_0050686
7643	SMID_BREAST_CANCER_LUMINAL_A_UP	18451135	thoracic cancer	DOID_5093
7644	SMID_BREAST_CANCER_LUMINAL_A_DN	18451135	breast cancer	DOID_1612
7645	SMID_BREAST_CANCER_LUMINAL_A_DN	18451135	cancer	DOID_162
7646	SMID_BREAST_CANCER_LUMINAL_A_DN	18451135	disease of cellular proliferation	DOID_14566
7647	SMID_BREAST_CANCER_LUMINAL_A_DN	18451135	organ system cancer	DOID_0050686
7648	SMID_BREAST_CANCER_LUMINAL_A_DN	18451135	thoracic cancer	DOID_5093
7649	SMID_BREAST_CANCER_ERBB2_UP	18451135	breast cancer	DOID_1612
7650	SMID_BREAST_CANCER_ERBB2_UP	18451135	cancer	DOID_162
7651	SMID_BREAST_CANCER_ERBB2_UP	18451135	disease of cellular proliferation	DOID_14566
7652	SMID_BREAST_CANCER_ERBB2_UP	18451135	organ system cancer	DOID_0050686
7653	SMID_BREAST_CANCER_ERBB2_UP	18451135	thoracic cancer	DOID_5093
7654	SMID_BREAST_CANCER_NORMAL_LIKE_UP	18451135	breast cancer	DOID_1612
7655	SMID_BREAST_CANCER_NORMAL_LIKE_UP	18451135	cancer	DOID_162
7656	SMID_BREAST_CANCER_NORMAL_LIKE_UP	18451135	disease of cellular proliferation	DOID_14566
7657	SMID_BREAST_CANCER_NORMAL_LIKE_UP	18451135	organ system cancer	DOID_0050686
7658	SMID_BREAST_CANCER_NORMAL_LIKE_UP	18451135	thoracic cancer	DOID_5093
7659	SMID_BREAST_CANCER_BASAL_UP	18451135	breast cancer	DOID_1612
7660	SMID_BREAST_CANCER_BASAL_UP	18451135	cancer	DOID_162
7661	SMID_BREAST_CANCER_BASAL_UP	18451135	disease of cellular proliferation	DOID_14566
7662	SMID_BREAST_CANCER_BASAL_UP	18451135	organ system cancer	DOID_0050686
7663	SMID_BREAST_CANCER_BASAL_UP	18451135	thoracic cancer	DOID_5093
7664	SMID_BREAST_CANCER_BASAL_DN	18451135	breast cancer	DOID_1612
7665	SMID_BREAST_CANCER_BASAL_DN	18451135	cancer	DOID_162
7666	SMID_BREAST_CANCER_BASAL_DN	18451135	disease of cellular proliferation	DOID_14566
7667	SMID_BREAST_CANCER_BASAL_DN	18451135	organ system cancer	DOID_0050686
7668	SMID_BREAST_CANCER_BASAL_DN	18451135	thoracic cancer	DOID_5093
7669	ITO_PTTG1_TARGETS_UP	18451147	cancer	DOID_162
7670	ITO_PTTG1_TARGETS_UP	18451147	carcinoma	DOID_305
7671	ITO_PTTG1_TARGETS_UP	18451147	cell type cancer	DOID_0050687
7672	ITO_PTTG1_TARGETS_UP	18451147	disease of cellular proliferation	DOID_14566
7673	ITO_PTTG1_TARGETS_UP	18451147	squamous cell carcinoma	DOID_1749
7674	LE_SKI_TARGETS_UP	18451154	cancer	DOID_162
7675	LE_SKI_TARGETS_UP	18451154	disease of cellular proliferation	DOID_14566
7676	LE_SKI_TARGETS_UP	18451154	lung cancer	DOID_1324
7677	LE_SKI_TARGETS_UP	18451154	organ system cancer	DOID_0050686
7678	LE_SKI_TARGETS_UP	18451154	respiratory system cancer	DOID_0050615
7679	BONOME_OVARIAN_CANCER_POOR_SURVIVAL_UP	18593951	cancer	DOID_162
7680	BONOME_OVARIAN_CANCER_POOR_SURVIVAL_UP	18593951	carcinoma	DOID_305
7681	BONOME_OVARIAN_CANCER_POOR_SURVIVAL_UP	18593951	cell type cancer	DOID_0050687
7682	BONOME_OVARIAN_CANCER_POOR_SURVIVAL_UP	18593951	disease of cellular proliferation	DOID_14566
7683	BONOME_OVARIAN_CANCER_POOR_SURVIVAL_UP	18593951	female reproductive organ cancer	DOID_120
7684	BONOME_OVARIAN_CANCER_POOR_SURVIVAL_UP	18593951	organ system cancer	DOID_0050686
7685	BONOME_OVARIAN_CANCER_POOR_SURVIVAL_UP	18593951	ovarian cancer	DOID_2394
7686	BONOME_OVARIAN_CANCER_POOR_SURVIVAL_UP	18593951	reproductive organ cancer	DOID_193
7687	BONOME_OVARIAN_CANCER_POOR_SURVIVAL_DN	18593951	cancer	DOID_162
7688	BONOME_OVARIAN_CANCER_POOR_SURVIVAL_DN	18593951	carcinoma	DOID_305
7689	BONOME_OVARIAN_CANCER_POOR_SURVIVAL_DN	18593951	cell type cancer	DOID_0050687
7690	BONOME_OVARIAN_CANCER_POOR_SURVIVAL_DN	18593951	disease of cellular proliferation	DOID_14566
7691	BONOME_OVARIAN_CANCER_POOR_SURVIVAL_DN	18593951	female reproductive organ cancer	DOID_120
7692	BONOME_OVARIAN_CANCER_POOR_SURVIVAL_DN	18593951	organ system cancer	DOID_0050686
7693	BONOME_OVARIAN_CANCER_POOR_SURVIVAL_DN	18593951	ovarian cancer	DOID_2394
7694	BONOME_OVARIAN_CANCER_POOR_SURVIVAL_DN	18593951	reproductive organ cancer	DOID_193
7695	BONOME_OVARIAN_CANCER_SURVIVAL_OPTIMAL_DEBULKING	18593951	cancer	DOID_162
7696	BONOME_OVARIAN_CANCER_SURVIVAL_OPTIMAL_DEBULKING	18593951	carcinoma	DOID_305
7697	BONOME_OVARIAN_CANCER_SURVIVAL_OPTIMAL_DEBULKING	18593951	cell type cancer	DOID_0050687
7698	BONOME_OVARIAN_CANCER_SURVIVAL_OPTIMAL_DEBULKING	18593951	disease of cellular proliferation	DOID_14566
7699	BONOME_OVARIAN_CANCER_SURVIVAL_OPTIMAL_DEBULKING	18593951	female reproductive organ cancer	DOID_120
7700	BONOME_OVARIAN_CANCER_SURVIVAL_OPTIMAL_DEBULKING	18593951	organ system cancer	DOID_0050686
7701	BONOME_OVARIAN_CANCER_SURVIVAL_OPTIMAL_DEBULKING	18593951	ovarian cancer	DOID_2394
7702	BONOME_OVARIAN_CANCER_SURVIVAL_OPTIMAL_DEBULKING	18593951	reproductive organ cancer	DOID_193
7703	BONOME_OVARIAN_CANCER_SURVIVAL_SUBOPTIMAL_DEBULKING	18593951	cancer	DOID_162
7704	BONOME_OVARIAN_CANCER_SURVIVAL_SUBOPTIMAL_DEBULKING	18593951	carcinoma	DOID_305
7705	BONOME_OVARIAN_CANCER_SURVIVAL_SUBOPTIMAL_DEBULKING	18593951	cell type cancer	DOID_0050687
7706	BONOME_OVARIAN_CANCER_SURVIVAL_SUBOPTIMAL_DEBULKING	18593951	disease of cellular proliferation	DOID_14566
7707	BONOME_OVARIAN_CANCER_SURVIVAL_SUBOPTIMAL_DEBULKING	18593951	female reproductive organ cancer	DOID_120
7708	BONOME_OVARIAN_CANCER_SURVIVAL_SUBOPTIMAL_DEBULKING	18593951	organ system cancer	DOID_0050686
7709	BONOME_OVARIAN_CANCER_SURVIVAL_SUBOPTIMAL_DEBULKING	18593951	ovarian cancer	DOID_2394
7710	BONOME_OVARIAN_CANCER_SURVIVAL_SUBOPTIMAL_DEBULKING	18593951	reproductive organ cancer	DOID_193
7711	MOSERLE_IFNA_RESPONSE	18632618	cancer	DOID_162
7712	MOSERLE_IFNA_RESPONSE	18632618	combined T cell and B cell immunodeficiency	DOID_628
7713	MOSERLE_IFNA_RESPONSE	18632618	disease of anatomical entity	DOID_7
7714	MOSERLE_IFNA_RESPONSE	18632618	disease of cellular proliferation	DOID_14566
7715	MOSERLE_IFNA_RESPONSE	18632618	female reproductive organ cancer	DOID_120
7716	MOSERLE_IFNA_RESPONSE	18632618	immune system disease	DOID_2914
7717	MOSERLE_IFNA_RESPONSE	18632618	organ system cancer	DOID_0050686
7718	MOSERLE_IFNA_RESPONSE	18632618	ovarian cancer	DOID_2394
7719	MOSERLE_IFNA_RESPONSE	18632618	primary immunodeficiency disease	DOID_612
7720	MOSERLE_IFNA_RESPONSE	18632618	reproductive organ cancer	DOID_193
7721	MOSERLE_IFNA_RESPONSE	18632618	severe combined immunodeficiency	DOID_627
7722	MCGARVEY_SILENCED_BY_METHYLATION_IN_COLON_CANCER	18632628	cancer	DOID_162
7723	MCGARVEY_SILENCED_BY_METHYLATION_IN_COLON_CANCER	18632628	colon cancer	DOID_219
7724	MCGARVEY_SILENCED_BY_METHYLATION_IN_COLON_CANCER	18632628	colorectal cancer	DOID_9256
7725	MCGARVEY_SILENCED_BY_METHYLATION_IN_COLON_CANCER	18632628	disease of cellular proliferation	DOID_14566
7726	MCGARVEY_SILENCED_BY_METHYLATION_IN_COLON_CANCER	18632628	gastrointestinal system cancer	DOID_3119
7727	MCGARVEY_SILENCED_BY_METHYLATION_IN_COLON_CANCER	18632628	intestinal cancer	DOID_10155
7728	MCGARVEY_SILENCED_BY_METHYLATION_IN_COLON_CANCER	18632628	large intestine cancer	DOID_5672
7729	MCGARVEY_SILENCED_BY_METHYLATION_IN_COLON_CANCER	18632628	organ system cancer	DOID_0050686
7730	WEBER_METHYLATED_HCP_IN_FIBROBLAST_DN	17334365	NA	NA
7731	WEBER_METHYLATED_HCP_IN_SPERM_DN	17334365	NA	NA
7732	WEBER_METHYLATED_HCP_IN_SPERM_UP	17334365	NA	NA
7733	BASSO_HAIRY_CELL_LEUKEMIA_DN	14707115	cancer	DOID_162
7734	BASSO_HAIRY_CELL_LEUKEMIA_DN	14707115	chronic leukemia	DOID_1036
7735	BASSO_HAIRY_CELL_LEUKEMIA_DN	14707115	chronic lymphocytic leukemia	DOID_1040
7736	BASSO_HAIRY_CELL_LEUKEMIA_DN	14707115	disease of cellular proliferation	DOID_14566
7737	BASSO_HAIRY_CELL_LEUKEMIA_DN	14707115	hairy cell leukemia	DOID_285
7738	BASSO_HAIRY_CELL_LEUKEMIA_DN	14707115	hematologic cancer	DOID_2531
7739	BASSO_HAIRY_CELL_LEUKEMIA_DN	14707115	immune system cancer	DOID_0060083
7740	BASSO_HAIRY_CELL_LEUKEMIA_DN	14707115	leukemia	DOID_1240
7741	BASSO_HAIRY_CELL_LEUKEMIA_DN	14707115	lymphoblastic leukemia	DOID_1037
7742	BASSO_HAIRY_CELL_LEUKEMIA_DN	14707115	lymphoma	DOID_0060058
7743	BASSO_HAIRY_CELL_LEUKEMIA_DN	14707115	organ system cancer	DOID_0050686
7744	TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C	18519671	cancer	DOID_162
7745	TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C	18519671	colorectal cancer	DOID_9256
7746	TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C	18519671	disease of cellular proliferation	DOID_14566
7747	TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C	18519671	gastrointestinal system cancer	DOID_3119
7748	TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C	18519671	intestinal cancer	DOID_10155
7749	TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C	18519671	large intestine cancer	DOID_5672
7750	TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C	18519671	organ system cancer	DOID_0050686
7751	LEE_LIVER_CANCER_TOP50	18519680	cancer	DOID_162
7752	LEE_LIVER_CANCER_TOP50	18519680	disease of cellular proliferation	DOID_14566
7753	LEE_LIVER_CANCER_TOP50	18519680	gastrointestinal system cancer	DOID_3119
7754	LEE_LIVER_CANCER_TOP50	18519680	hepatocellular carcinoma	DOID_684
7755	LEE_LIVER_CANCER_TOP50	18519680	liver cancer	DOID_3571
7756	LEE_LIVER_CANCER_TOP50	18519680	liver carcinoma	DOID_686
7757	LEE_LIVER_CANCER_TOP50	18519680	organ system cancer	DOID_0050686
7758	IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_UP	18519682	NA	NA
7759	IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_DN	18519682	NA	NA
7760	MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_DN	18519693	breast cancer	DOID_1612
7761	MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_DN	18519693	cancer	DOID_162
7762	MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_DN	18519693	disease of cellular proliferation	DOID_14566
7763	MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_DN	18519693	organ system cancer	DOID_0050686
7764	MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_DN	18519693	thoracic cancer	DOID_5093
7765	BERNARD_PPAPDC1B_TARGETS_UP	18757432	breast cancer	DOID_1612
7766	BERNARD_PPAPDC1B_TARGETS_UP	18757432	breast carcinoma	DOID_3459
7767	BERNARD_PPAPDC1B_TARGETS_UP	18757432	cancer	DOID_162
7768	BERNARD_PPAPDC1B_TARGETS_UP	18757432	carcinoma	DOID_305
7769	BERNARD_PPAPDC1B_TARGETS_UP	18757432	cell type cancer	DOID_0050687
7770	BERNARD_PPAPDC1B_TARGETS_UP	18757432	disease of cellular proliferation	DOID_14566
7771	BERNARD_PPAPDC1B_TARGETS_UP	18757432	organ system cancer	DOID_0050686
7772	BERNARD_PPAPDC1B_TARGETS_UP	18757432	thoracic cancer	DOID_5093
7773	BERNARD_PPAPDC1B_TARGETS_DN	18757432	breast cancer	DOID_1612
7774	BERNARD_PPAPDC1B_TARGETS_DN	18757432	breast carcinoma	DOID_3459
7775	BERNARD_PPAPDC1B_TARGETS_DN	18757432	cancer	DOID_162
7776	BERNARD_PPAPDC1B_TARGETS_DN	18757432	carcinoma	DOID_305
7777	BERNARD_PPAPDC1B_TARGETS_DN	18757432	cell type cancer	DOID_0050687
7778	BERNARD_PPAPDC1B_TARGETS_DN	18757432	disease of cellular proliferation	DOID_14566
7779	BERNARD_PPAPDC1B_TARGETS_DN	18757432	organ system cancer	DOID_0050686
7780	BERNARD_PPAPDC1B_TARGETS_DN	18757432	thoracic cancer	DOID_5093
7781	GAURNIER_PSMD4_TARGETS	18632645	NA	NA
7782	EHLERS_ANEUPLOIDY_UP	18172260	cancer	DOID_162
7783	EHLERS_ANEUPLOIDY_UP	18172260	cell type cancer	DOID_0050687
7784	EHLERS_ANEUPLOIDY_UP	18172260	disease of cellular proliferation	DOID_14566
7785	EHLERS_ANEUPLOIDY_UP	18172260	melanoma	DOID_1909
7786	BUCKANOVICH_T_LYMPHOCYTE_HOMING_ON_TUMOR_DN	18157142	NA	NA
7787	HONMA_DOCETAXEL_RESISTANCE	18724378	breast cancer	DOID_1612
7788	HONMA_DOCETAXEL_RESISTANCE	18724378	cancer	DOID_162
7789	HONMA_DOCETAXEL_RESISTANCE	18724378	disease of cellular proliferation	DOID_14566
7790	HONMA_DOCETAXEL_RESISTANCE	18724378	organ system cancer	DOID_0050686
7791	HONMA_DOCETAXEL_RESISTANCE	18724378	thoracic cancer	DOID_5093
7792	WILENSKY_RESPONSE_TO_DARAPLADIB	18806801	arterial occlusive disease	DOID_2868
7793	WILENSKY_RESPONSE_TO_DARAPLADIB	18806801	arteriosclerosis	DOID_2349
7794	WILENSKY_RESPONSE_TO_DARAPLADIB	18806801	arteriosclerotic cardiovascular disease	DOID_2348
7795	WILENSKY_RESPONSE_TO_DARAPLADIB	18806801	atherosclerosis	DOID_1936
7796	WILENSKY_RESPONSE_TO_DARAPLADIB	18806801	cardiomyopathy	DOID_0050700
7797	WILENSKY_RESPONSE_TO_DARAPLADIB	18806801	cardiovascular system disease	DOID_1287
7798	WILENSKY_RESPONSE_TO_DARAPLADIB	18806801	disease of anatomical entity	DOID_7
7799	WILENSKY_RESPONSE_TO_DARAPLADIB	18806801	extrinsic cardiomyopathy	DOID_3978
7800	WILENSKY_RESPONSE_TO_DARAPLADIB	18806801	heart disease	DOID_114
7801	WILENSKY_RESPONSE_TO_DARAPLADIB	18806801	hypercholesterolemia	DOID_2487
7802	WILENSKY_RESPONSE_TO_DARAPLADIB	18806801	ischemic heart disease	DOID_3394
7803	WILENSKY_RESPONSE_TO_DARAPLADIB	18806801	myocardial infarction	DOID_5844
7804	WILENSKY_RESPONSE_TO_DARAPLADIB	18806801	vascular disease	DOID_178
7805	BONCI_TARGETS_OF_MIR15A_AND_MIR16_1	18931683	cancer	DOID_162
7806	BONCI_TARGETS_OF_MIR15A_AND_MIR16_1	18931683	disease of cellular proliferation	DOID_14566
7807	BONCI_TARGETS_OF_MIR15A_AND_MIR16_1	18931683	male reproductive organ cancer	DOID_3856
7808	BONCI_TARGETS_OF_MIR15A_AND_MIR16_1	18931683	organ system cancer	DOID_0050686
7809	BONCI_TARGETS_OF_MIR15A_AND_MIR16_1	18931683	prostate cancer	DOID_10283
7810	BONCI_TARGETS_OF_MIR15A_AND_MIR16_1	18931683	reproductive organ cancer	DOID_193
7811	CHUNG_BLISTER_CYTOTOXICITY_UP	19029983	disease of anatomical entity	DOID_7
7812	CHUNG_BLISTER_CYTOTOXICITY_UP	19029983	integumentary system disease	DOID_16
7813	CHUNG_BLISTER_CYTOTOXICITY_UP	19029983	skin disease	DOID_37
7814	CHUNG_BLISTER_CYTOTOXICITY_UP	19029983	Stevens-Johnson syndrome	DOID_0050426
7815	CHUNG_BLISTER_CYTOTOXICITY_UP	19029983	syndrome	DOID_225
7816	CHUNG_BLISTER_CYTOTOXICITY_DN	19029983	disease of anatomical entity	DOID_7
7817	CHUNG_BLISTER_CYTOTOXICITY_DN	19029983	integumentary system disease	DOID_16
7818	CHUNG_BLISTER_CYTOTOXICITY_DN	19029983	skin disease	DOID_37
7819	CHUNG_BLISTER_CYTOTOXICITY_DN	19029983	Stevens-Johnson syndrome	DOID_0050426
7820	CHUNG_BLISTER_CYTOTOXICITY_DN	19029983	syndrome	DOID_225
7821	WHITEFORD_PEDIATRIC_CANCER_MARKERS	17210681	NA	NA
7822	GRADE_METASTASIS_DN	17210682	adenocarcinoma	DOID_299
7823	GRADE_METASTASIS_DN	17210682	cancer	DOID_162
7824	GRADE_METASTASIS_DN	17210682	carcinoma	DOID_305
7825	GRADE_METASTASIS_DN	17210682	cell type cancer	DOID_0050687
7826	GRADE_METASTASIS_DN	17210682	disease of cellular proliferation	DOID_14566
7827	GRADE_COLON_CANCER_UP	17210682	adenocarcinoma	DOID_299
7828	GRADE_COLON_CANCER_UP	17210682	cancer	DOID_162
7829	GRADE_COLON_CANCER_UP	17210682	carcinoma	DOID_305
7830	GRADE_COLON_CANCER_UP	17210682	cell type cancer	DOID_0050687
7831	GRADE_COLON_CANCER_UP	17210682	disease of cellular proliferation	DOID_14566
7832	GRADE_COLON_CANCER_DN	17210682	adenocarcinoma	DOID_299
7833	GRADE_COLON_CANCER_DN	17210682	cancer	DOID_162
7834	GRADE_COLON_CANCER_DN	17210682	carcinoma	DOID_305
7835	GRADE_COLON_CANCER_DN	17210682	cell type cancer	DOID_0050687
7836	GRADE_COLON_CANCER_DN	17210682	disease of cellular proliferation	DOID_14566
7837	GRADE_COLON_AND_RECTAL_CANCER_UP	17210682	adenocarcinoma	DOID_299
7838	GRADE_COLON_AND_RECTAL_CANCER_UP	17210682	cancer	DOID_162
7839	GRADE_COLON_AND_RECTAL_CANCER_UP	17210682	carcinoma	DOID_305
7840	GRADE_COLON_AND_RECTAL_CANCER_UP	17210682	cell type cancer	DOID_0050687
7841	GRADE_COLON_AND_RECTAL_CANCER_UP	17210682	disease of cellular proliferation	DOID_14566
7842	GRADE_COLON_AND_RECTAL_CANCER_DN	17210682	adenocarcinoma	DOID_299
7843	GRADE_COLON_AND_RECTAL_CANCER_DN	17210682	cancer	DOID_162
7844	GRADE_COLON_AND_RECTAL_CANCER_DN	17210682	carcinoma	DOID_305
7845	GRADE_COLON_AND_RECTAL_CANCER_DN	17210682	cell type cancer	DOID_0050687
7846	GRADE_COLON_AND_RECTAL_CANCER_DN	17210682	disease of cellular proliferation	DOID_14566
7847	GRADE_COLON_VS_RECTAL_CANCER_UP	17210682	adenocarcinoma	DOID_299
7848	GRADE_COLON_VS_RECTAL_CANCER_UP	17210682	cancer	DOID_162
7849	GRADE_COLON_VS_RECTAL_CANCER_UP	17210682	carcinoma	DOID_305
7850	GRADE_COLON_VS_RECTAL_CANCER_UP	17210682	cell type cancer	DOID_0050687
7851	GRADE_COLON_VS_RECTAL_CANCER_UP	17210682	disease of cellular proliferation	DOID_14566
7852	GRADE_COLON_VS_RECTAL_CANCER_DN	17210682	adenocarcinoma	DOID_299
7853	GRADE_COLON_VS_RECTAL_CANCER_DN	17210682	cancer	DOID_162
7854	GRADE_COLON_VS_RECTAL_CANCER_DN	17210682	carcinoma	DOID_305
7855	GRADE_COLON_VS_RECTAL_CANCER_DN	17210682	cell type cancer	DOID_0050687
7856	GRADE_COLON_VS_RECTAL_CANCER_DN	17210682	disease of cellular proliferation	DOID_14566
7857	BOQUEST_STEM_CELL_CULTURED_VS_FRESH_DN	15635089	NA	NA
7858	NAKAMURA_METASTASIS	17210693	cancer	DOID_162
7859	NAKAMURA_METASTASIS	17210693	disease of cellular proliferation	DOID_14566
7860	NAKAMURA_METASTASIS	17210693	endocrine gland cancer	DOID_170
7861	NAKAMURA_METASTASIS	17210693	organ system cancer	DOID_0050686
7862	NAKAMURA_METASTASIS	17210693	pancreatic cancer	DOID_1793
7863	NAKAMURA_METASTASIS_MODEL_UP	17210693	cancer	DOID_162
7864	NAKAMURA_METASTASIS_MODEL_UP	17210693	disease of cellular proliferation	DOID_14566
7865	NAKAMURA_METASTASIS_MODEL_UP	17210693	endocrine gland cancer	DOID_170
7866	NAKAMURA_METASTASIS_MODEL_UP	17210693	organ system cancer	DOID_0050686
7867	NAKAMURA_METASTASIS_MODEL_UP	17210693	pancreatic cancer	DOID_1793
7868	NAKAMURA_METASTASIS_MODEL_DN	17210693	cancer	DOID_162
7869	NAKAMURA_METASTASIS_MODEL_DN	17210693	disease of cellular proliferation	DOID_14566
7870	NAKAMURA_METASTASIS_MODEL_DN	17210693	endocrine gland cancer	DOID_170
7871	NAKAMURA_METASTASIS_MODEL_DN	17210693	organ system cancer	DOID_0050686
7872	NAKAMURA_METASTASIS_MODEL_DN	17210693	pancreatic cancer	DOID_1793
7873	GRATIAS_RETINOBLASTOMA_16Q24	17210724	cancer	DOID_162
7874	GRATIAS_RETINOBLASTOMA_16Q24	17210724	disease of anatomical entity	DOID_7
7875	GRATIAS_RETINOBLASTOMA_16Q24	17210724	disease of cellular proliferation	DOID_14566
7876	GRATIAS_RETINOBLASTOMA_16Q24	17210724	eye and adnexa disease	DOID_1492
7877	GRATIAS_RETINOBLASTOMA_16Q24	17210724	eye disease	DOID_5614
7878	GRATIAS_RETINOBLASTOMA_16Q24	17210724	globe disease	DOID_1242
7879	GRATIAS_RETINOBLASTOMA_16Q24	17210724	nervous system cancer	DOID_3093
7880	GRATIAS_RETINOBLASTOMA_16Q24	17210724	nervous system disease	DOID_863
7881	GRATIAS_RETINOBLASTOMA_16Q24	17210724	ocular cancer	DOID_2174
7882	GRATIAS_RETINOBLASTOMA_16Q24	17210724	organ system cancer	DOID_0050686
7883	GRATIAS_RETINOBLASTOMA_16Q24	17210724	retinal cancer	DOID_4645
7884	GRATIAS_RETINOBLASTOMA_16Q24	17210724	retinal cell cancer	DOID_771
7885	GRATIAS_RETINOBLASTOMA_16Q24	17210724	retinal disease	DOID_5679
7886	GRATIAS_RETINOBLASTOMA_16Q24	17210724	retinoblastoma	DOID_768
7887	GRATIAS_RETINOBLASTOMA_16Q24	17210724	sensory system cancer	DOID_0060116
7888	GRATIAS_RETINOBLASTOMA_16Q24	17210724	sensory system disease	DOID_0050155
7889	WEST_ADRENOCORTICAL_TUMOR_UP	17234769	adenoma	DOID_657
7890	WEST_ADRENOCORTICAL_TUMOR_UP	17234769	adrenal cortex cancer	DOID_660
7891	WEST_ADRENOCORTICAL_TUMOR_UP	17234769	adrenal gland cancer	DOID_3953
7892	WEST_ADRENOCORTICAL_TUMOR_UP	17234769	adrenocortical carcinoma	DOID_3948
7893	WEST_ADRENOCORTICAL_TUMOR_UP	17234769	benign neoplasm	DOID_0060072
7894	WEST_ADRENOCORTICAL_TUMOR_UP	17234769	cancer	DOID_162
7895	WEST_ADRENOCORTICAL_TUMOR_UP	17234769	carcinoma	DOID_305
7896	WEST_ADRENOCORTICAL_TUMOR_UP	17234769	cell type benign neoplasm	DOID_0060084
7897	WEST_ADRENOCORTICAL_TUMOR_UP	17234769	cell type cancer	DOID_0050687
7898	WEST_ADRENOCORTICAL_TUMOR_UP	17234769	disease of cellular proliferation	DOID_14566
7899	WEST_ADRENOCORTICAL_TUMOR_UP	17234769	endocrine gland cancer	DOID_170
7900	WEST_ADRENOCORTICAL_TUMOR_UP	17234769	organ system cancer	DOID_0050686
7901	WEST_ADRENOCORTICAL_TUMOR_DN	17234769	adenoma	DOID_657
7902	WEST_ADRENOCORTICAL_TUMOR_DN	17234769	adrenal cortex cancer	DOID_660
7903	WEST_ADRENOCORTICAL_TUMOR_DN	17234769	adrenal gland cancer	DOID_3953
7904	WEST_ADRENOCORTICAL_TUMOR_DN	17234769	adrenocortical carcinoma	DOID_3948
7905	WEST_ADRENOCORTICAL_TUMOR_DN	17234769	benign neoplasm	DOID_0060072
7906	WEST_ADRENOCORTICAL_TUMOR_DN	17234769	cancer	DOID_162
7907	WEST_ADRENOCORTICAL_TUMOR_DN	17234769	carcinoma	DOID_305
7908	WEST_ADRENOCORTICAL_TUMOR_DN	17234769	cell type benign neoplasm	DOID_0060084
7909	WEST_ADRENOCORTICAL_TUMOR_DN	17234769	cell type cancer	DOID_0050687
7910	WEST_ADRENOCORTICAL_TUMOR_DN	17234769	disease of cellular proliferation	DOID_14566
7911	WEST_ADRENOCORTICAL_TUMOR_DN	17234769	endocrine gland cancer	DOID_170
7912	WEST_ADRENOCORTICAL_TUMOR_DN	17234769	organ system cancer	DOID_0050686
7913	WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_UP	17234769	adenoma	DOID_657
7914	WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_UP	17234769	adrenal cortex cancer	DOID_660
7915	WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_UP	17234769	adrenal gland cancer	DOID_3953
7916	WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_UP	17234769	adrenocortical carcinoma	DOID_3948
7917	WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_UP	17234769	benign neoplasm	DOID_0060072
7918	WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_UP	17234769	cancer	DOID_162
7919	WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_UP	17234769	carcinoma	DOID_305
7920	WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_UP	17234769	cell type benign neoplasm	DOID_0060084
7921	WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_UP	17234769	cell type cancer	DOID_0050687
7922	WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_UP	17234769	disease of cellular proliferation	DOID_14566
7923	WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_UP	17234769	endocrine gland cancer	DOID_170
7924	WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_UP	17234769	organ system cancer	DOID_0050686
7925	WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_DN	17234769	adenoma	DOID_657
7926	WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_DN	17234769	adrenal cortex cancer	DOID_660
7927	WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_DN	17234769	adrenal gland cancer	DOID_3953
7928	WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_DN	17234769	adrenocortical carcinoma	DOID_3948
7929	WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_DN	17234769	benign neoplasm	DOID_0060072
7930	WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_DN	17234769	cancer	DOID_162
7931	WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_DN	17234769	carcinoma	DOID_305
7932	WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_DN	17234769	cell type benign neoplasm	DOID_0060084
7933	WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_DN	17234769	cell type cancer	DOID_0050687
7934	WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_DN	17234769	disease of cellular proliferation	DOID_14566
7935	WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_DN	17234769	endocrine gland cancer	DOID_170
7936	WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_DN	17234769	organ system cancer	DOID_0050686
7937	CHO_NR4A1_TARGETS	17234778	cancer	DOID_162
7938	CHO_NR4A1_TARGETS	17234778	colon cancer	DOID_219
7939	CHO_NR4A1_TARGETS	17234778	colorectal cancer	DOID_9256
7940	CHO_NR4A1_TARGETS	17234778	disease of cellular proliferation	DOID_14566
7941	CHO_NR4A1_TARGETS	17234778	gastrointestinal system cancer	DOID_3119
7942	CHO_NR4A1_TARGETS	17234778	intestinal cancer	DOID_10155
7943	CHO_NR4A1_TARGETS	17234778	large intestine cancer	DOID_5672
7944	CHO_NR4A1_TARGETS	17234778	organ system cancer	DOID_0050686
7945	BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_UP	17234781	breast cancer	DOID_1612
7946	BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_UP	17234781	cancer	DOID_162
7947	BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_UP	17234781	disease of cellular proliferation	DOID_14566
7948	BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_UP	17234781	organ system cancer	DOID_0050686
7949	BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_UP	17234781	thoracic cancer	DOID_5093
7950	BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_DN	17234781	breast cancer	DOID_1612
7951	BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_DN	17234781	cancer	DOID_162
7952	BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_DN	17234781	disease of cellular proliferation	DOID_14566
7953	BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_DN	17234781	organ system cancer	DOID_0050686
7954	BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_DN	17234781	thoracic cancer	DOID_5093
7955	CLIMENT_BREAST_CANCER_COPY_NUMBER_UP	17234794	breast cancer	DOID_1612
7956	CLIMENT_BREAST_CANCER_COPY_NUMBER_UP	17234794	cancer	DOID_162
7957	CLIMENT_BREAST_CANCER_COPY_NUMBER_UP	17234794	disease of cellular proliferation	DOID_14566
7958	CLIMENT_BREAST_CANCER_COPY_NUMBER_UP	17234794	organ system cancer	DOID_0050686
7959	CLIMENT_BREAST_CANCER_COPY_NUMBER_UP	17234794	thoracic cancer	DOID_5093
7960	SHARMA_PILOCYTIC_ASTROCYTOMA_LOCATION_UP	17283119	astrocytoma	DOID_3069
7961	SHARMA_PILOCYTIC_ASTROCYTOMA_LOCATION_UP	17283119	autosomal dominant disease	DOID_0050736
7962	SHARMA_PILOCYTIC_ASTROCYTOMA_LOCATION_UP	17283119	autosomal genetic disease	DOID_0050739
7963	SHARMA_PILOCYTIC_ASTROCYTOMA_LOCATION_UP	17283119	cancer	DOID_162
7964	SHARMA_PILOCYTIC_ASTROCYTOMA_LOCATION_UP	17283119	cell type cancer	DOID_0050687
7965	SHARMA_PILOCYTIC_ASTROCYTOMA_LOCATION_UP	17283119	disease of cellular proliferation	DOID_14566
7966	SHARMA_PILOCYTIC_ASTROCYTOMA_LOCATION_UP	17283119	genetic disease	DOID_630
7967	SHARMA_PILOCYTIC_ASTROCYTOMA_LOCATION_UP	17283119	malignant glioma	DOID_3070
7968	SHARMA_PILOCYTIC_ASTROCYTOMA_LOCATION_UP	17283119	monogenic disease	DOID_0050177
7969	SHARMA_PILOCYTIC_ASTROCYTOMA_LOCATION_UP	17283119	neurofibromatosis	DOID_8712
7970	BRUECKNER_TARGETS_OF_MIRLET7A3_UP	17308078	adenocarcinoma	DOID_299
7971	BRUECKNER_TARGETS_OF_MIRLET7A3_UP	17308078	adenoma	DOID_657
7972	BRUECKNER_TARGETS_OF_MIRLET7A3_UP	17308078	benign neoplasm	DOID_0060072
7973	BRUECKNER_TARGETS_OF_MIRLET7A3_UP	17308078	cancer	DOID_162
7974	BRUECKNER_TARGETS_OF_MIRLET7A3_UP	17308078	carcinoma	DOID_305
7975	BRUECKNER_TARGETS_OF_MIRLET7A3_UP	17308078	cell type benign neoplasm	DOID_0060084
7976	BRUECKNER_TARGETS_OF_MIRLET7A3_UP	17308078	cell type cancer	DOID_0050687
7977	BRUECKNER_TARGETS_OF_MIRLET7A3_UP	17308078	disease of cellular proliferation	DOID_14566
7978	BRUECKNER_TARGETS_OF_MIRLET7A3_UP	17308078	lung cancer	DOID_1324
7979	BRUECKNER_TARGETS_OF_MIRLET7A3_UP	17308078	organ system cancer	DOID_0050686
7980	BRUECKNER_TARGETS_OF_MIRLET7A3_UP	17308078	respiratory system cancer	DOID_0050615
7981	BRUECKNER_TARGETS_OF_MIRLET7A3_DN	17308078	adenocarcinoma	DOID_299
7982	BRUECKNER_TARGETS_OF_MIRLET7A3_DN	17308078	adenoma	DOID_657
7983	BRUECKNER_TARGETS_OF_MIRLET7A3_DN	17308078	benign neoplasm	DOID_0060072
7984	BRUECKNER_TARGETS_OF_MIRLET7A3_DN	17308078	cancer	DOID_162
7985	BRUECKNER_TARGETS_OF_MIRLET7A3_DN	17308078	carcinoma	DOID_305
7986	BRUECKNER_TARGETS_OF_MIRLET7A3_DN	17308078	cell type benign neoplasm	DOID_0060084
7987	BRUECKNER_TARGETS_OF_MIRLET7A3_DN	17308078	cell type cancer	DOID_0050687
7988	BRUECKNER_TARGETS_OF_MIRLET7A3_DN	17308078	disease of cellular proliferation	DOID_14566
7989	BRUECKNER_TARGETS_OF_MIRLET7A3_DN	17308078	lung cancer	DOID_1324
7990	BRUECKNER_TARGETS_OF_MIRLET7A3_DN	17308078	organ system cancer	DOID_0050686
7991	BRUECKNER_TARGETS_OF_MIRLET7A3_DN	17308078	respiratory system cancer	DOID_0050615
7992	PODAR_RESPONSE_TO_ADAPHOSTIN_UP	17308109	bone marrow cancer	DOID_4960
7993	PODAR_RESPONSE_TO_ADAPHOSTIN_UP	17308109	cancer	DOID_162
7994	PODAR_RESPONSE_TO_ADAPHOSTIN_UP	17308109	disease of cellular proliferation	DOID_14566
7995	PODAR_RESPONSE_TO_ADAPHOSTIN_UP	17308109	hematologic cancer	DOID_2531
7996	PODAR_RESPONSE_TO_ADAPHOSTIN_UP	17308109	immune system cancer	DOID_0060083
7997	PODAR_RESPONSE_TO_ADAPHOSTIN_UP	17308109	leukemia	DOID_1240
7998	PODAR_RESPONSE_TO_ADAPHOSTIN_UP	17308109	multiple myeloma	DOID_9538
7999	PODAR_RESPONSE_TO_ADAPHOSTIN_UP	17308109	myeloma	DOID_0070004
8000	PODAR_RESPONSE_TO_ADAPHOSTIN_UP	17308109	organ system cancer	DOID_0050686
8001	PODAR_RESPONSE_TO_ADAPHOSTIN_DN	17308109	bone marrow cancer	DOID_4960
8002	PODAR_RESPONSE_TO_ADAPHOSTIN_DN	17308109	cancer	DOID_162
8003	PODAR_RESPONSE_TO_ADAPHOSTIN_DN	17308109	disease of cellular proliferation	DOID_14566
8004	PODAR_RESPONSE_TO_ADAPHOSTIN_DN	17308109	hematologic cancer	DOID_2531
8005	PODAR_RESPONSE_TO_ADAPHOSTIN_DN	17308109	immune system cancer	DOID_0060083
8006	PODAR_RESPONSE_TO_ADAPHOSTIN_DN	17308109	leukemia	DOID_1240
8007	PODAR_RESPONSE_TO_ADAPHOSTIN_DN	17308109	multiple myeloma	DOID_9538
8008	PODAR_RESPONSE_TO_ADAPHOSTIN_DN	17308109	myeloma	DOID_0070004
8009	PODAR_RESPONSE_TO_ADAPHOSTIN_DN	17308109	organ system cancer	DOID_0050686
8010	LU_TUMOR_ENDOTHELIAL_MARKERS_UP	17308118	cancer	DOID_162
8011	LU_TUMOR_ENDOTHELIAL_MARKERS_UP	17308118	carcinoma	DOID_305
8012	LU_TUMOR_ENDOTHELIAL_MARKERS_UP	17308118	cell type cancer	DOID_0050687
8013	LU_TUMOR_ENDOTHELIAL_MARKERS_UP	17308118	disease of cellular proliferation	DOID_14566
8014	LU_TUMOR_ENDOTHELIAL_MARKERS_UP	17308118	female reproductive organ cancer	DOID_120
8015	LU_TUMOR_ENDOTHELIAL_MARKERS_UP	17308118	malignant ovarian surface epithelial-stromal neoplasm	DOID_2151
8016	LU_TUMOR_ENDOTHELIAL_MARKERS_UP	17308118	organ system cancer	DOID_0050686
8017	LU_TUMOR_ENDOTHELIAL_MARKERS_UP	17308118	ovarian cancer	DOID_2394
8018	LU_TUMOR_ENDOTHELIAL_MARKERS_UP	17308118	ovarian carcinoma	DOID_4001
8019	LU_TUMOR_ENDOTHELIAL_MARKERS_UP	17308118	ovary epithelial cancer	DOID_2152
8020	LU_TUMOR_ENDOTHELIAL_MARKERS_UP	17308118	reproductive organ cancer	DOID_193
8021	CHEN_HOXA5_TARGETS_9HR_UP	15757903	breast cancer	DOID_1612
8022	CHEN_HOXA5_TARGETS_9HR_UP	15757903	cancer	DOID_162
8023	CHEN_HOXA5_TARGETS_9HR_UP	15757903	disease of cellular proliferation	DOID_14566
8024	CHEN_HOXA5_TARGETS_9HR_UP	15757903	organ system cancer	DOID_0050686
8025	CHEN_HOXA5_TARGETS_9HR_UP	15757903	thoracic cancer	DOID_5093
8026	CHEN_HOXA5_TARGETS_9HR_DN	15757903	breast cancer	DOID_1612
8027	CHEN_HOXA5_TARGETS_9HR_DN	15757903	cancer	DOID_162
8028	CHEN_HOXA5_TARGETS_9HR_DN	15757903	disease of cellular proliferation	DOID_14566
8029	CHEN_HOXA5_TARGETS_9HR_DN	15757903	organ system cancer	DOID_0050686
8030	CHEN_HOXA5_TARGETS_9HR_DN	15757903	thoracic cancer	DOID_5093
8031	CONRAD_STEM_CELL	18849962	cancer	DOID_162
8032	CONRAD_STEM_CELL	18849962	cell type cancer	DOID_0050687
8033	CONRAD_STEM_CELL	18849962	disease of cellular proliferation	DOID_14566
8034	CONRAD_STEM_CELL	18849962	germ cell and embryonal cancer	DOID_3095
8035	CONRAD_STEM_CELL	18849962	germ cell cancer	DOID_2994
8036	CONRAD_STEM_CELL	18849962	teratoma	DOID_3307
8037	CONRAD_GERMLINE_STEM_CELL	18849962	cancer	DOID_162
8038	CONRAD_GERMLINE_STEM_CELL	18849962	cell type cancer	DOID_0050687
8039	CONRAD_GERMLINE_STEM_CELL	18849962	disease of cellular proliferation	DOID_14566
8040	CONRAD_GERMLINE_STEM_CELL	18849962	germ cell and embryonal cancer	DOID_3095
8041	CONRAD_GERMLINE_STEM_CELL	18849962	germ cell cancer	DOID_2994
8042	CONRAD_GERMLINE_STEM_CELL	18849962	teratoma	DOID_3307
8043	KUUSELO_PANCREATIC_CANCER_19Q13_AMPLIFICATION	17332321	cancer	DOID_162
8044	KUUSELO_PANCREATIC_CANCER_19Q13_AMPLIFICATION	17332321	disease of cellular proliferation	DOID_14566
8045	KUUSELO_PANCREATIC_CANCER_19Q13_AMPLIFICATION	17332321	endocrine gland cancer	DOID_170
8046	KUUSELO_PANCREATIC_CANCER_19Q13_AMPLIFICATION	17332321	organ system cancer	DOID_0050686
8047	KUUSELO_PANCREATIC_CANCER_19Q13_AMPLIFICATION	17332321	pancreatic cancer	DOID_1793
8048	HUANG_DASATINIB_RESISTANCE_UP	17332353	breast cancer	DOID_1612
8049	HUANG_DASATINIB_RESISTANCE_UP	17332353	cancer	DOID_162
8050	HUANG_DASATINIB_RESISTANCE_UP	17332353	disease of cellular proliferation	DOID_14566
8051	HUANG_DASATINIB_RESISTANCE_UP	17332353	hematologic cancer	DOID_2531
8052	HUANG_DASATINIB_RESISTANCE_UP	17332353	immune system cancer	DOID_0060083
8053	HUANG_DASATINIB_RESISTANCE_UP	17332353	leukemia	DOID_1240
8054	HUANG_DASATINIB_RESISTANCE_UP	17332353	lung cancer	DOID_1324
8055	HUANG_DASATINIB_RESISTANCE_UP	17332353	lymphoblastic leukemia	DOID_1037
8056	HUANG_DASATINIB_RESISTANCE_UP	17332353	organ system cancer	DOID_0050686
8057	HUANG_DASATINIB_RESISTANCE_UP	17332353	respiratory system cancer	DOID_0050615
8058	HUANG_DASATINIB_RESISTANCE_UP	17332353	thoracic cancer	DOID_5093
8059	HUANG_DASATINIB_RESISTANCE_DN	17332353	breast cancer	DOID_1612
8060	HUANG_DASATINIB_RESISTANCE_DN	17332353	cancer	DOID_162
8061	HUANG_DASATINIB_RESISTANCE_DN	17332353	disease of cellular proliferation	DOID_14566
8062	HUANG_DASATINIB_RESISTANCE_DN	17332353	hematologic cancer	DOID_2531
8063	HUANG_DASATINIB_RESISTANCE_DN	17332353	immune system cancer	DOID_0060083
8064	HUANG_DASATINIB_RESISTANCE_DN	17332353	leukemia	DOID_1240
8065	HUANG_DASATINIB_RESISTANCE_DN	17332353	lung cancer	DOID_1324
8066	HUANG_DASATINIB_RESISTANCE_DN	17332353	lymphoblastic leukemia	DOID_1037
8067	HUANG_DASATINIB_RESISTANCE_DN	17332353	organ system cancer	DOID_0050686
8068	HUANG_DASATINIB_RESISTANCE_DN	17332353	respiratory system cancer	DOID_0050615
8069	HUANG_DASATINIB_RESISTANCE_DN	17332353	thoracic cancer	DOID_5093
8070	TAYLOR_METHYLATED_IN_ACUTE_LYMPHOBLASTIC_LEUKEMIA	17363581	cancer	DOID_162
8071	TAYLOR_METHYLATED_IN_ACUTE_LYMPHOBLASTIC_LEUKEMIA	17363581	disease of cellular proliferation	DOID_14566
8072	TAYLOR_METHYLATED_IN_ACUTE_LYMPHOBLASTIC_LEUKEMIA	17363581	hematologic cancer	DOID_2531
8073	TAYLOR_METHYLATED_IN_ACUTE_LYMPHOBLASTIC_LEUKEMIA	17363581	immune system cancer	DOID_0060083
8074	TAYLOR_METHYLATED_IN_ACUTE_LYMPHOBLASTIC_LEUKEMIA	17363581	leukemia	DOID_1240
8075	TAYLOR_METHYLATED_IN_ACUTE_LYMPHOBLASTIC_LEUKEMIA	17363581	lymphoblastic leukemia	DOID_1037
8076	TAYLOR_METHYLATED_IN_ACUTE_LYMPHOBLASTIC_LEUKEMIA	17363581	organ system cancer	DOID_0050686
8077	CHNG_MULTIPLE_MYELOMA_HYPERPLOID_UP	17409404	bone marrow cancer	DOID_4960
8078	CHNG_MULTIPLE_MYELOMA_HYPERPLOID_UP	17409404	cancer	DOID_162
8079	CHNG_MULTIPLE_MYELOMA_HYPERPLOID_UP	17409404	disease of cellular proliferation	DOID_14566
8080	CHNG_MULTIPLE_MYELOMA_HYPERPLOID_UP	17409404	hematologic cancer	DOID_2531
8081	CHNG_MULTIPLE_MYELOMA_HYPERPLOID_UP	17409404	immune system cancer	DOID_0060083
8082	CHNG_MULTIPLE_MYELOMA_HYPERPLOID_UP	17409404	multiple myeloma	DOID_9538
8083	CHNG_MULTIPLE_MYELOMA_HYPERPLOID_UP	17409404	myeloma	DOID_0070004
8084	CHNG_MULTIPLE_MYELOMA_HYPERPLOID_UP	17409404	organ system cancer	DOID_0050686
8085	CHNG_MULTIPLE_MYELOMA_HYPERPLOID_DN	17409404	bone marrow cancer	DOID_4960
8086	CHNG_MULTIPLE_MYELOMA_HYPERPLOID_DN	17409404	cancer	DOID_162
8087	CHNG_MULTIPLE_MYELOMA_HYPERPLOID_DN	17409404	disease of cellular proliferation	DOID_14566
8088	CHNG_MULTIPLE_MYELOMA_HYPERPLOID_DN	17409404	hematologic cancer	DOID_2531
8089	CHNG_MULTIPLE_MYELOMA_HYPERPLOID_DN	17409404	immune system cancer	DOID_0060083
8090	CHNG_MULTIPLE_MYELOMA_HYPERPLOID_DN	17409404	multiple myeloma	DOID_9538
8091	CHNG_MULTIPLE_MYELOMA_HYPERPLOID_DN	17409404	myeloma	DOID_0070004
8092	CHNG_MULTIPLE_MYELOMA_HYPERPLOID_DN	17409404	organ system cancer	DOID_0050686
8093	HUPER_BREAST_BASAL_VS_LUMINAL_UP	17409405	autosomal dominant disease	DOID_0050736
8094	HUPER_BREAST_BASAL_VS_LUMINAL_UP	17409405	autosomal genetic disease	DOID_0050739
8095	HUPER_BREAST_BASAL_VS_LUMINAL_UP	17409405	breast cancer	DOID_1612
8096	HUPER_BREAST_BASAL_VS_LUMINAL_UP	17409405	cancer	DOID_162
8097	HUPER_BREAST_BASAL_VS_LUMINAL_UP	17409405	disease of cellular proliferation	DOID_14566
8098	HUPER_BREAST_BASAL_VS_LUMINAL_UP	17409405	genetic disease	DOID_630
8099	HUPER_BREAST_BASAL_VS_LUMINAL_UP	17409405	hereditary breast ovarian cancer	DOID_5683
8100	HUPER_BREAST_BASAL_VS_LUMINAL_UP	17409405	monogenic disease	DOID_0050177
8101	HUPER_BREAST_BASAL_VS_LUMINAL_UP	17409405	organ system cancer	DOID_0050686
8102	HUPER_BREAST_BASAL_VS_LUMINAL_UP	17409405	thoracic cancer	DOID_5093
8103	HUPER_BREAST_BASAL_VS_LUMINAL_DN	17409405	autosomal dominant disease	DOID_0050736
8104	HUPER_BREAST_BASAL_VS_LUMINAL_DN	17409405	autosomal genetic disease	DOID_0050739
8105	HUPER_BREAST_BASAL_VS_LUMINAL_DN	17409405	breast cancer	DOID_1612
8106	HUPER_BREAST_BASAL_VS_LUMINAL_DN	17409405	cancer	DOID_162
8107	HUPER_BREAST_BASAL_VS_LUMINAL_DN	17409405	disease of cellular proliferation	DOID_14566
8108	HUPER_BREAST_BASAL_VS_LUMINAL_DN	17409405	genetic disease	DOID_630
8109	HUPER_BREAST_BASAL_VS_LUMINAL_DN	17409405	hereditary breast ovarian cancer	DOID_5683
8110	HUPER_BREAST_BASAL_VS_LUMINAL_DN	17409405	monogenic disease	DOID_0050177
8111	HUPER_BREAST_BASAL_VS_LUMINAL_DN	17409405	organ system cancer	DOID_0050686
8112	HUPER_BREAST_BASAL_VS_LUMINAL_DN	17409405	thoracic cancer	DOID_5093
8113	CUI_GLUCOSE_DEPRIVATION	17409444	cancer	DOID_162
8114	CUI_GLUCOSE_DEPRIVATION	17409444	disease of cellular proliferation	DOID_14566
8115	CUI_GLUCOSE_DEPRIVATION	17409444	endocrine gland cancer	DOID_170
8116	CUI_GLUCOSE_DEPRIVATION	17409444	hematologic cancer	DOID_2531
8117	CUI_GLUCOSE_DEPRIVATION	17409444	immune system cancer	DOID_0060083
8118	CUI_GLUCOSE_DEPRIVATION	17409444	leukemia	DOID_1240
8119	CUI_GLUCOSE_DEPRIVATION	17409444	organ system cancer	DOID_0050686
8120	CUI_GLUCOSE_DEPRIVATION	17409444	pancreatic cancer	DOID_1793
8121	BLUM_RESPONSE_TO_SALIRASIB_UP	17409441	cancer	DOID_162
8122	BLUM_RESPONSE_TO_SALIRASIB_UP	17409441	disease of cellular proliferation	DOID_14566
8123	BLUM_RESPONSE_TO_SALIRASIB_DN	17409441	cancer	DOID_162
8124	BLUM_RESPONSE_TO_SALIRASIB_DN	17409441	disease of cellular proliferation	DOID_14566
8125	WINTER_HYPOXIA_METAGENE	17409455	breast cancer	DOID_1612
8126	WINTER_HYPOXIA_METAGENE	17409455	cancer	DOID_162
8127	WINTER_HYPOXIA_METAGENE	17409455	carcinoma	DOID_305
8128	WINTER_HYPOXIA_METAGENE	17409455	cell type cancer	DOID_0050687
8129	WINTER_HYPOXIA_METAGENE	17409455	disease of cellular proliferation	DOID_14566
8130	WINTER_HYPOXIA_METAGENE	17409455	head and neck cancer	DOID_11934
8131	WINTER_HYPOXIA_METAGENE	17409455	neck cancer	DOID_1112
8132	WINTER_HYPOXIA_METAGENE	17409455	organ system cancer	DOID_0050686
8133	WINTER_HYPOXIA_METAGENE	17409455	thoracic cancer	DOID_5093
8134	ALONSO_METASTASIS_EMT_UP	17409456	cancer	DOID_162
8135	ALONSO_METASTASIS_EMT_UP	17409456	cell type cancer	DOID_0050687
8136	ALONSO_METASTASIS_EMT_UP	17409456	disease of cellular proliferation	DOID_14566
8137	ALONSO_METASTASIS_EMT_UP	17409456	melanoma	DOID_1909
8138	ALONSO_METASTASIS_UP	17409456	cancer	DOID_162
8139	ALONSO_METASTASIS_UP	17409456	cell type cancer	DOID_0050687
8140	ALONSO_METASTASIS_UP	17409456	disease of cellular proliferation	DOID_14566
8141	ALONSO_METASTASIS_UP	17409456	melanoma	DOID_1909
8142	ALONSO_METASTASIS_DN	17409456	cancer	DOID_162
8143	ALONSO_METASTASIS_DN	17409456	cell type cancer	DOID_0050687
8144	ALONSO_METASTASIS_DN	17409456	disease of cellular proliferation	DOID_14566
8145	ALONSO_METASTASIS_DN	17409456	melanoma	DOID_1909
8146	CROMER_TUMORIGENESIS_UP	14676830	cancer	DOID_162
8147	CROMER_TUMORIGENESIS_UP	14676830	carcinoma	DOID_305
8148	CROMER_TUMORIGENESIS_UP	14676830	cell type cancer	DOID_0050687
8149	CROMER_TUMORIGENESIS_UP	14676830	disease of cellular proliferation	DOID_14566
8150	CROMER_TUMORIGENESIS_UP	14676830	gastrointestinal system cancer	DOID_3119
8151	CROMER_TUMORIGENESIS_UP	14676830	head and neck squamous cell carcinoma	DOID_5520
8152	CROMER_TUMORIGENESIS_UP	14676830	hypopharynx cancer	DOID_8533
8153	CROMER_TUMORIGENESIS_UP	14676830	organ system cancer	DOID_0050686
8154	CROMER_TUMORIGENESIS_UP	14676830	pharynx cancer	DOID_0060119
8155	CROMER_TUMORIGENESIS_UP	14676830	squamous cell carcinoma	DOID_1749
8156	CROMER_TUMORIGENESIS_DN	14676830	cancer	DOID_162
8157	CROMER_TUMORIGENESIS_DN	14676830	carcinoma	DOID_305
8158	CROMER_TUMORIGENESIS_DN	14676830	cell type cancer	DOID_0050687
8159	CROMER_TUMORIGENESIS_DN	14676830	disease of cellular proliferation	DOID_14566
8160	CROMER_TUMORIGENESIS_DN	14676830	gastrointestinal system cancer	DOID_3119
8161	CROMER_TUMORIGENESIS_DN	14676830	head and neck squamous cell carcinoma	DOID_5520
8162	CROMER_TUMORIGENESIS_DN	14676830	hypopharynx cancer	DOID_8533
8163	CROMER_TUMORIGENESIS_DN	14676830	organ system cancer	DOID_0050686
8164	CROMER_TUMORIGENESIS_DN	14676830	pharynx cancer	DOID_0060119
8165	CROMER_TUMORIGENESIS_DN	14676830	squamous cell carcinoma	DOID_1749
8166	MUELLER_PLURINET	18724358	NA	NA
8167	FIRESTEIN_CTNNB1_PATHWAY	18794900	cancer	DOID_162
8168	FIRESTEIN_CTNNB1_PATHWAY	18794900	colon cancer	DOID_219
8169	FIRESTEIN_CTNNB1_PATHWAY	18794900	colorectal cancer	DOID_9256
8170	FIRESTEIN_CTNNB1_PATHWAY	18794900	disease of cellular proliferation	DOID_14566
8171	FIRESTEIN_CTNNB1_PATHWAY	18794900	gastrointestinal system cancer	DOID_3119
8172	FIRESTEIN_CTNNB1_PATHWAY	18794900	intestinal cancer	DOID_10155
8173	FIRESTEIN_CTNNB1_PATHWAY	18794900	large intestine cancer	DOID_5672
8174	FIRESTEIN_CTNNB1_PATHWAY	18794900	organ system cancer	DOID_0050686
8175	FIRESTEIN_PROLIFERATION	18794900	cancer	DOID_162
8176	FIRESTEIN_PROLIFERATION	18794900	colon cancer	DOID_219
8177	FIRESTEIN_PROLIFERATION	18794900	colorectal cancer	DOID_9256
8178	FIRESTEIN_PROLIFERATION	18794900	disease of cellular proliferation	DOID_14566
8179	FIRESTEIN_PROLIFERATION	18794900	gastrointestinal system cancer	DOID_3119
8180	FIRESTEIN_PROLIFERATION	18794900	intestinal cancer	DOID_10155
8181	FIRESTEIN_PROLIFERATION	18794900	large intestine cancer	DOID_5672
8182	FIRESTEIN_PROLIFERATION	18794900	organ system cancer	DOID_0050686
8183	JIANG_TIP30_TARGETS_UP	17440068	cancer	DOID_162
8184	JIANG_TIP30_TARGETS_UP	17440068	carcinoma	DOID_305
8185	JIANG_TIP30_TARGETS_UP	17440068	cell type cancer	DOID_0050687
8186	JIANG_TIP30_TARGETS_UP	17440068	disease of cellular proliferation	DOID_14566
8187	JIANG_TIP30_TARGETS_UP	17440068	gastrointestinal system cancer	DOID_3119
8188	JIANG_TIP30_TARGETS_UP	17440068	hepatocellular carcinoma	DOID_684
8189	JIANG_TIP30_TARGETS_UP	17440068	liver cancer	DOID_3571
8190	JIANG_TIP30_TARGETS_UP	17440068	liver carcinoma	DOID_686
8191	JIANG_TIP30_TARGETS_UP	17440068	organ system cancer	DOID_0050686
8192	JIANG_TIP30_TARGETS_DN	17440068	cancer	DOID_162
8193	JIANG_TIP30_TARGETS_DN	17440068	carcinoma	DOID_305
8194	JIANG_TIP30_TARGETS_DN	17440068	cell type cancer	DOID_0050687
8195	JIANG_TIP30_TARGETS_DN	17440068	disease of cellular proliferation	DOID_14566
8196	JIANG_TIP30_TARGETS_DN	17440068	gastrointestinal system cancer	DOID_3119
8197	JIANG_TIP30_TARGETS_DN	17440068	hepatocellular carcinoma	DOID_684
8198	JIANG_TIP30_TARGETS_DN	17440068	liver cancer	DOID_3571
8199	JIANG_TIP30_TARGETS_DN	17440068	liver carcinoma	DOID_686
8200	JIANG_TIP30_TARGETS_DN	17440068	organ system cancer	DOID_0050686
8201	GRESHOCK_CANCER_COPY_NUMBER_UP	17440070	cancer	DOID_162
8202	GRESHOCK_CANCER_COPY_NUMBER_UP	17440070	disease of cellular proliferation	DOID_14566
8203	GRESHOCK_CANCER_COPY_NUMBER_DN	17440070	cancer	DOID_162
8204	GRESHOCK_CANCER_COPY_NUMBER_DN	17440070	disease of cellular proliferation	DOID_14566
8205	TSAI_RESPONSE_TO_RADIATION_THERAPY	17440099	cancer	DOID_162
8206	TSAI_RESPONSE_TO_RADIATION_THERAPY	17440099	cell type cancer	DOID_0050687
8207	TSAI_RESPONSE_TO_RADIATION_THERAPY	17440099	disease of cellular proliferation	DOID_14566
8208	TSAI_RESPONSE_TO_RADIATION_THERAPY	17440099	malignant glioma	DOID_3070
8209	BEIER_GLIOMA_STEM_CELL_UP	17483311	astrocytoma	DOID_3069
8210	BEIER_GLIOMA_STEM_CELL_UP	17483311	cancer	DOID_162
8211	BEIER_GLIOMA_STEM_CELL_UP	17483311	cell type cancer	DOID_0050687
8212	BEIER_GLIOMA_STEM_CELL_UP	17483311	disease of cellular proliferation	DOID_14566
8213	BEIER_GLIOMA_STEM_CELL_UP	17483311	glioblastoma	DOID_3068
8214	BEIER_GLIOMA_STEM_CELL_UP	17483311	malignant glioma	DOID_3070
8215	BEIER_GLIOMA_STEM_CELL_DN	17483311	astrocytoma	DOID_3069
8216	BEIER_GLIOMA_STEM_CELL_DN	17483311	cancer	DOID_162
8217	BEIER_GLIOMA_STEM_CELL_DN	17483311	cell type cancer	DOID_0050687
8218	BEIER_GLIOMA_STEM_CELL_DN	17483311	disease of cellular proliferation	DOID_14566
8219	BEIER_GLIOMA_STEM_CELL_DN	17483311	glioblastoma	DOID_3068
8220	BEIER_GLIOMA_STEM_CELL_DN	17483311	malignant glioma	DOID_3070
8221	VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP	17483315	cancer	DOID_162
8222	VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP	17483315	cell type cancer	DOID_0050687
8223	VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP	17483315	connective tissue cancer	DOID_201
8224	VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP	17483315	disease of cellular proliferation	DOID_14566
8225	VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP	17483315	Kaposi's sarcoma	DOID_8632
8226	VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP	17483315	musculoskeletal system cancer	DOID_0060100
8227	VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP	17483315	organ system cancer	DOID_0050686
8228	VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP	17483315	sarcoma	DOID_1115
8229	VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN	17483315	cancer	DOID_162
8230	VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN	17483315	cell type cancer	DOID_0050687
8231	VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN	17483315	connective tissue cancer	DOID_201
8232	VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN	17483315	disease of cellular proliferation	DOID_14566
8233	VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN	17483315	Kaposi's sarcoma	DOID_8632
8234	VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN	17483315	musculoskeletal system cancer	DOID_0060100
8235	VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN	17483315	organ system cancer	DOID_0050686
8236	VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN	17483315	sarcoma	DOID_1115
8237	DAVIES_MULTIPLE_MYELOMA_VS_MGUS_DN	12947006	B-cell lymphocytic neoplasm	DOID_707
8238	DAVIES_MULTIPLE_MYELOMA_VS_MGUS_DN	12947006	bone marrow cancer	DOID_4960
8239	DAVIES_MULTIPLE_MYELOMA_VS_MGUS_DN	12947006	cancer	DOID_162
8240	DAVIES_MULTIPLE_MYELOMA_VS_MGUS_DN	12947006	disease of cellular proliferation	DOID_14566
8241	DAVIES_MULTIPLE_MYELOMA_VS_MGUS_DN	12947006	hematologic cancer	DOID_2531
8242	DAVIES_MULTIPLE_MYELOMA_VS_MGUS_DN	12947006	immune system cancer	DOID_0060083
8243	DAVIES_MULTIPLE_MYELOMA_VS_MGUS_DN	12947006	lymphoma	DOID_0060058
8244	DAVIES_MULTIPLE_MYELOMA_VS_MGUS_DN	12947006	mature B-cell neoplasm	DOID_706
8245	DAVIES_MULTIPLE_MYELOMA_VS_MGUS_DN	12947006	monoclonal gammopathy of uncertain significance	DOID_7442
8246	DAVIES_MULTIPLE_MYELOMA_VS_MGUS_DN	12947006	multiple myeloma	DOID_9538
8247	DAVIES_MULTIPLE_MYELOMA_VS_MGUS_DN	12947006	myeloma	DOID_0070004
8248	DAVIES_MULTIPLE_MYELOMA_VS_MGUS_DN	12947006	organ system cancer	DOID_0050686
8249	DAVIES_MULTIPLE_MYELOMA_VS_MGUS_DN	12947006	plasma cell neoplasm	DOID_6536
8250	WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER	17456585	cancer	DOID_162
8251	WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER	17456585	disease of cellular proliferation	DOID_14566
8252	WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER	17456585	organ system cancer	DOID_0050686
8253	WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER	17456585	urinary bladder cancer	DOID_11054
8254	WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER	17456585	urinary system cancer	DOID_3996
8255	FERRARI_RESPONSE_TO_FENRETINIDE_UP	15958647	NA	NA
8256	HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS	17483324	NA	NA
8257	GU_PDEF_TARGETS_UP	17483333	breast cancer	DOID_1612
8258	GU_PDEF_TARGETS_UP	17483333	cancer	DOID_162
8259	GU_PDEF_TARGETS_UP	17483333	disease of cellular proliferation	DOID_14566
8260	GU_PDEF_TARGETS_UP	17483333	male reproductive organ cancer	DOID_3856
8261	GU_PDEF_TARGETS_UP	17483333	organ system cancer	DOID_0050686
8262	GU_PDEF_TARGETS_UP	17483333	prostate cancer	DOID_10283
8263	GU_PDEF_TARGETS_UP	17483333	reproductive organ cancer	DOID_193
8264	GU_PDEF_TARGETS_UP	17483333	thoracic cancer	DOID_5093
8265	GU_PDEF_TARGETS_DN	17483333	breast cancer	DOID_1612
8266	GU_PDEF_TARGETS_DN	17483333	cancer	DOID_162
8267	GU_PDEF_TARGETS_DN	17483333	disease of cellular proliferation	DOID_14566
8268	GU_PDEF_TARGETS_DN	17483333	male reproductive organ cancer	DOID_3856
8269	GU_PDEF_TARGETS_DN	17483333	organ system cancer	DOID_0050686
8270	GU_PDEF_TARGETS_DN	17483333	prostate cancer	DOID_10283
8271	GU_PDEF_TARGETS_DN	17483333	reproductive organ cancer	DOID_193
8272	GU_PDEF_TARGETS_DN	17483333	thoracic cancer	DOID_5093
8273	TOOKER_GEMCITABINE_RESISTANCE_UP	17483357	cancer	DOID_162
8274	TOOKER_GEMCITABINE_RESISTANCE_UP	17483357	carcinoma	DOID_305
8275	TOOKER_GEMCITABINE_RESISTANCE_UP	17483357	cell type cancer	DOID_0050687
8276	TOOKER_GEMCITABINE_RESISTANCE_UP	17483357	disease of cellular proliferation	DOID_14566
8277	TOOKER_GEMCITABINE_RESISTANCE_UP	17483357	lung cancer	DOID_1324
8278	TOOKER_GEMCITABINE_RESISTANCE_UP	17483357	lung carcinoma	DOID_3905
8279	TOOKER_GEMCITABINE_RESISTANCE_UP	17483357	non-small cell lung carcinoma	DOID_3908
8280	TOOKER_GEMCITABINE_RESISTANCE_UP	17483357	organ system cancer	DOID_0050686
8281	TOOKER_GEMCITABINE_RESISTANCE_UP	17483357	respiratory system cancer	DOID_0050615
8282	TOOKER_GEMCITABINE_RESISTANCE_DN	17483357	cancer	DOID_162
8283	TOOKER_GEMCITABINE_RESISTANCE_DN	17483357	carcinoma	DOID_305
8284	TOOKER_GEMCITABINE_RESISTANCE_DN	17483357	cell type cancer	DOID_0050687
8285	TOOKER_GEMCITABINE_RESISTANCE_DN	17483357	disease of cellular proliferation	DOID_14566
8286	TOOKER_GEMCITABINE_RESISTANCE_DN	17483357	lung cancer	DOID_1324
8287	TOOKER_GEMCITABINE_RESISTANCE_DN	17483357	lung carcinoma	DOID_3905
8288	TOOKER_GEMCITABINE_RESISTANCE_DN	17483357	non-small cell lung carcinoma	DOID_3908
8289	TOOKER_GEMCITABINE_RESISTANCE_DN	17483357	organ system cancer	DOID_0050686
8290	TOOKER_GEMCITABINE_RESISTANCE_DN	17483357	respiratory system cancer	DOID_0050615
8291	TOOKER_RESPONSE_TO_BEXAROTENE_UP	17483357	cancer	DOID_162
8292	TOOKER_RESPONSE_TO_BEXAROTENE_UP	17483357	carcinoma	DOID_305
8293	TOOKER_RESPONSE_TO_BEXAROTENE_UP	17483357	cell type cancer	DOID_0050687
8294	TOOKER_RESPONSE_TO_BEXAROTENE_UP	17483357	disease of cellular proliferation	DOID_14566
8295	TOOKER_RESPONSE_TO_BEXAROTENE_UP	17483357	lung cancer	DOID_1324
8296	TOOKER_RESPONSE_TO_BEXAROTENE_UP	17483357	lung carcinoma	DOID_3905
8297	TOOKER_RESPONSE_TO_BEXAROTENE_UP	17483357	non-small cell lung carcinoma	DOID_3908
8298	TOOKER_RESPONSE_TO_BEXAROTENE_UP	17483357	organ system cancer	DOID_0050686
8299	TOOKER_RESPONSE_TO_BEXAROTENE_UP	17483357	respiratory system cancer	DOID_0050615
8300	TOOKER_RESPONSE_TO_BEXAROTENE_DN	17483357	cancer	DOID_162
8301	TOOKER_RESPONSE_TO_BEXAROTENE_DN	17483357	carcinoma	DOID_305
8302	TOOKER_RESPONSE_TO_BEXAROTENE_DN	17483357	cell type cancer	DOID_0050687
8303	TOOKER_RESPONSE_TO_BEXAROTENE_DN	17483357	disease of cellular proliferation	DOID_14566
8304	TOOKER_RESPONSE_TO_BEXAROTENE_DN	17483357	lung cancer	DOID_1324
8305	TOOKER_RESPONSE_TO_BEXAROTENE_DN	17483357	lung carcinoma	DOID_3905
8306	TOOKER_RESPONSE_TO_BEXAROTENE_DN	17483357	non-small cell lung carcinoma	DOID_3908
8307	TOOKER_RESPONSE_TO_BEXAROTENE_DN	17483357	organ system cancer	DOID_0050686
8308	TOOKER_RESPONSE_TO_BEXAROTENE_DN	17483357	respiratory system cancer	DOID_0050615
8309	BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_UP	17195838	disease of anatomical entity	DOID_7
8310	BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_UP	17195838	immune system disease	DOID_2914
8311	BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_UP	17195838	primary immunodeficiency disease	DOID_612
8312	BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_UP	17195838	syndrome	DOID_225
8313	BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_DN	17195838	disease of anatomical entity	DOID_7
8314	BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_DN	17195838	immune system disease	DOID_2914
8315	BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_DN	17195838	primary immunodeficiency disease	DOID_612
8316	BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_DN	17195838	syndrome	DOID_225
8317	FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_UP	16627760	cancer	DOID_162
8318	FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_UP	16627760	disease of cellular proliferation	DOID_14566
8319	FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_UP	16627760	hematologic cancer	DOID_2531
8320	FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_UP	16627760	immune system cancer	DOID_0060083
8321	FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_UP	16627760	leukemia	DOID_1240
8322	FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_UP	16627760	lymphoblastic leukemia	DOID_1037
8323	FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_UP	16627760	organ system cancer	DOID_0050686
8324	FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_DN	16627760	cancer	DOID_162
8325	FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_DN	16627760	disease of cellular proliferation	DOID_14566
8326	FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_DN	16627760	hematologic cancer	DOID_2531
8327	FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_DN	16627760	immune system cancer	DOID_0060083
8328	FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_DN	16627760	leukemia	DOID_1240
8329	FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_DN	16627760	lymphoblastic leukemia	DOID_1037
8330	FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_DN	16627760	organ system cancer	DOID_0050686
8331	SPIRA_SMOKERS_LUNG_CANCER_UP	17334370	cancer	DOID_162
8332	SPIRA_SMOKERS_LUNG_CANCER_UP	17334370	disease of cellular proliferation	DOID_14566
8333	SPIRA_SMOKERS_LUNG_CANCER_UP	17334370	lung cancer	DOID_1324
8334	SPIRA_SMOKERS_LUNG_CANCER_UP	17334370	organ system cancer	DOID_0050686
8335	SPIRA_SMOKERS_LUNG_CANCER_UP	17334370	respiratory system cancer	DOID_0050615
8336	SPIRA_SMOKERS_LUNG_CANCER_DN	17334370	cancer	DOID_162
8337	SPIRA_SMOKERS_LUNG_CANCER_DN	17334370	disease of cellular proliferation	DOID_14566
8338	SPIRA_SMOKERS_LUNG_CANCER_DN	17334370	lung cancer	DOID_1324
8339	SPIRA_SMOKERS_LUNG_CANCER_DN	17334370	organ system cancer	DOID_0050686
8340	SPIRA_SMOKERS_LUNG_CANCER_DN	17334370	respiratory system cancer	DOID_0050615
8341	WAGNER_APO2_SENSITIVITY	17767167	cancer	DOID_162
8342	WAGNER_APO2_SENSITIVITY	17767167	carcinoma	DOID_305
8343	WAGNER_APO2_SENSITIVITY	17767167	cell type cancer	DOID_0050687
8344	WAGNER_APO2_SENSITIVITY	17767167	disease of cellular proliferation	DOID_14566
8345	WAGNER_APO2_SENSITIVITY	17767167	endocrine gland cancer	DOID_170
8346	WAGNER_APO2_SENSITIVITY	17767167	lung cancer	DOID_1324
8347	WAGNER_APO2_SENSITIVITY	17767167	lung carcinoma	DOID_3905
8348	WAGNER_APO2_SENSITIVITY	17767167	melanoma	DOID_1909
8349	WAGNER_APO2_SENSITIVITY	17767167	organ system cancer	DOID_0050686
8350	WAGNER_APO2_SENSITIVITY	17767167	pancreatic cancer	DOID_1793
8351	WAGNER_APO2_SENSITIVITY	17767167	pancreatic carcinoma	DOID_4905
8352	WAGNER_APO2_SENSITIVITY	17767167	respiratory system cancer	DOID_0050615
8353	CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_UP	12480690	bone marrow cancer	DOID_4960
8354	CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_UP	12480690	cancer	DOID_162
8355	CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_UP	12480690	disease of cellular proliferation	DOID_14566
8356	CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_UP	12480690	hematologic cancer	DOID_2531
8357	CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_UP	12480690	immune system cancer	DOID_0060083
8358	CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_UP	12480690	multiple myeloma	DOID_9538
8359	CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_UP	12480690	myeloma	DOID_0070004
8360	CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_UP	12480690	organ system cancer	DOID_0050686
8361	CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_DN	12480690	bone marrow cancer	DOID_4960
8362	CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_DN	12480690	cancer	DOID_162
8363	CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_DN	12480690	disease of cellular proliferation	DOID_14566
8364	CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_DN	12480690	hematologic cancer	DOID_2531
8365	CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_DN	12480690	immune system cancer	DOID_0060083
8366	CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_DN	12480690	multiple myeloma	DOID_9538
8367	CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_DN	12480690	myeloma	DOID_0070004
8368	CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_DN	12480690	organ system cancer	DOID_0050686
8369	FRASOR_RESPONSE_TO_SERM_OR_FULVESTRANT_UP	14973112	breast cancer	DOID_1612
8370	FRASOR_RESPONSE_TO_SERM_OR_FULVESTRANT_UP	14973112	cancer	DOID_162
8371	FRASOR_RESPONSE_TO_SERM_OR_FULVESTRANT_UP	14973112	disease of cellular proliferation	DOID_14566
8372	FRASOR_RESPONSE_TO_SERM_OR_FULVESTRANT_UP	14973112	organ system cancer	DOID_0050686
8373	FRASOR_RESPONSE_TO_SERM_OR_FULVESTRANT_UP	14973112	thoracic cancer	DOID_5093
8374	FRASOR_RESPONSE_TO_SERM_OR_FULVESTRANT_DN	14973112	breast cancer	DOID_1612
8375	FRASOR_RESPONSE_TO_SERM_OR_FULVESTRANT_DN	14973112	cancer	DOID_162
8376	FRASOR_RESPONSE_TO_SERM_OR_FULVESTRANT_DN	14973112	disease of cellular proliferation	DOID_14566
8377	FRASOR_RESPONSE_TO_SERM_OR_FULVESTRANT_DN	14973112	organ system cancer	DOID_0050686
8378	FRASOR_RESPONSE_TO_SERM_OR_FULVESTRANT_DN	14973112	thoracic cancer	DOID_5093
8379	LINDSTEDT_DENDRITIC_CELL_MATURATION_A	12356685	NA	NA
8380	LINDSTEDT_DENDRITIC_CELL_MATURATION_B	12356685	NA	NA
8381	LINDSTEDT_DENDRITIC_CELL_MATURATION_C	12356685	NA	NA
8382	LINDSTEDT_DENDRITIC_CELL_MATURATION_D	12356685	NA	NA
8383	NICK_RESPONSE_TO_PROC_TREATMENT_DN	15339848	NA	NA
8384	NUTT_GBM_VS_AO_GLIOMA_UP	12670911	anaplastic oligodendroglioma	DOID_7154
8385	NUTT_GBM_VS_AO_GLIOMA_UP	12670911	astrocytoma	DOID_3069
8386	NUTT_GBM_VS_AO_GLIOMA_UP	12670911	cancer	DOID_162
8387	NUTT_GBM_VS_AO_GLIOMA_UP	12670911	cell type cancer	DOID_0050687
8388	NUTT_GBM_VS_AO_GLIOMA_UP	12670911	disease of cellular proliferation	DOID_14566
8389	NUTT_GBM_VS_AO_GLIOMA_UP	12670911	glioblastoma	DOID_3068
8390	NUTT_GBM_VS_AO_GLIOMA_UP	12670911	malignant glioma	DOID_3070
8391	NUTT_GBM_VS_AO_GLIOMA_UP	12670911	oligodendroglioma	DOID_3181
8392	NUTT_GBM_VS_AO_GLIOMA_DN	12670911	anaplastic oligodendroglioma	DOID_7154
8393	NUTT_GBM_VS_AO_GLIOMA_DN	12670911	astrocytoma	DOID_3069
8394	NUTT_GBM_VS_AO_GLIOMA_DN	12670911	cancer	DOID_162
8395	NUTT_GBM_VS_AO_GLIOMA_DN	12670911	cell type cancer	DOID_0050687
8396	NUTT_GBM_VS_AO_GLIOMA_DN	12670911	disease of cellular proliferation	DOID_14566
8397	NUTT_GBM_VS_AO_GLIOMA_DN	12670911	glioblastoma	DOID_3068
8398	NUTT_GBM_VS_AO_GLIOMA_DN	12670911	malignant glioma	DOID_3070
8399	NUTT_GBM_VS_AO_GLIOMA_DN	12670911	oligodendroglioma	DOID_3181
8400	PARK_APL_PATHOGENESIS_UP	12893766	acute myeloid leukemia	DOID_9119
8401	PARK_APL_PATHOGENESIS_UP	12893766	cancer	DOID_162
8402	PARK_APL_PATHOGENESIS_UP	12893766	disease of cellular proliferation	DOID_14566
8403	PARK_APL_PATHOGENESIS_UP	12893766	hematologic cancer	DOID_2531
8404	PARK_APL_PATHOGENESIS_UP	12893766	immune system cancer	DOID_0060083
8405	PARK_APL_PATHOGENESIS_UP	12893766	leukemia	DOID_1240
8406	PARK_APL_PATHOGENESIS_UP	12893766	myeloid leukemia	DOID_8692
8407	PARK_APL_PATHOGENESIS_UP	12893766	organ system cancer	DOID_0050686
8408	PARK_APL_PATHOGENESIS_DN	12893766	acute myeloid leukemia	DOID_9119
8409	PARK_APL_PATHOGENESIS_DN	12893766	cancer	DOID_162
8410	PARK_APL_PATHOGENESIS_DN	12893766	disease of cellular proliferation	DOID_14566
8411	PARK_APL_PATHOGENESIS_DN	12893766	hematologic cancer	DOID_2531
8412	PARK_APL_PATHOGENESIS_DN	12893766	immune system cancer	DOID_0060083
8413	PARK_APL_PATHOGENESIS_DN	12893766	leukemia	DOID_1240
8414	PARK_APL_PATHOGENESIS_DN	12893766	myeloid leukemia	DOID_8692
8415	PARK_APL_PATHOGENESIS_DN	12893766	organ system cancer	DOID_0050686
8416	PARK_TRETINOIN_RESPONSE_AND_PML_RARA_FUSION	12893766	acute myeloid leukemia	DOID_9119
8417	PARK_TRETINOIN_RESPONSE_AND_PML_RARA_FUSION	12893766	cancer	DOID_162
8418	PARK_TRETINOIN_RESPONSE_AND_PML_RARA_FUSION	12893766	disease of cellular proliferation	DOID_14566
8419	PARK_TRETINOIN_RESPONSE_AND_PML_RARA_FUSION	12893766	hematologic cancer	DOID_2531
8420	PARK_TRETINOIN_RESPONSE_AND_PML_RARA_FUSION	12893766	immune system cancer	DOID_0060083
8421	PARK_TRETINOIN_RESPONSE_AND_PML_RARA_FUSION	12893766	leukemia	DOID_1240
8422	PARK_TRETINOIN_RESPONSE_AND_PML_RARA_FUSION	12893766	myeloid leukemia	DOID_8692
8423	PARK_TRETINOIN_RESPONSE_AND_PML_RARA_FUSION	12893766	organ system cancer	DOID_0050686
8424	PARK_TRETINOIN_RESPONSE_AND_RARA_PLZF_FUSION	12893766	acute myeloid leukemia	DOID_9119
8425	PARK_TRETINOIN_RESPONSE_AND_RARA_PLZF_FUSION	12893766	cancer	DOID_162
8426	PARK_TRETINOIN_RESPONSE_AND_RARA_PLZF_FUSION	12893766	disease of cellular proliferation	DOID_14566
8427	PARK_TRETINOIN_RESPONSE_AND_RARA_PLZF_FUSION	12893766	hematologic cancer	DOID_2531
8428	PARK_TRETINOIN_RESPONSE_AND_RARA_PLZF_FUSION	12893766	immune system cancer	DOID_0060083
8429	PARK_TRETINOIN_RESPONSE_AND_RARA_PLZF_FUSION	12893766	leukemia	DOID_1240
8430	PARK_TRETINOIN_RESPONSE_AND_RARA_PLZF_FUSION	12893766	myeloid leukemia	DOID_8692
8431	PARK_TRETINOIN_RESPONSE_AND_RARA_PLZF_FUSION	12893766	organ system cancer	DOID_0050686
8432	ZHANG_INTERFERON_RESPONSE	15619625	disease by infectious agent	DOID_0050117
8433	ZHANG_INTERFERON_RESPONSE	15619625	viral infectious disease	DOID_934
8434	WU_ALZHEIMER_DISEASE_DN	16116430	NA	NA
8435	MIZUKAMI_HYPOXIA_UP	16127434	cancer	DOID_162
8436	MIZUKAMI_HYPOXIA_UP	16127434	colon cancer	DOID_219
8437	MIZUKAMI_HYPOXIA_UP	16127434	colorectal cancer	DOID_9256
8438	MIZUKAMI_HYPOXIA_UP	16127434	disease of cellular proliferation	DOID_14566
8439	MIZUKAMI_HYPOXIA_UP	16127434	gastrointestinal system cancer	DOID_3119
8440	MIZUKAMI_HYPOXIA_UP	16127434	intestinal cancer	DOID_10155
8441	MIZUKAMI_HYPOXIA_UP	16127434	large intestine cancer	DOID_5672
8442	MIZUKAMI_HYPOXIA_UP	16127434	organ system cancer	DOID_0050686
8443	POTTI_CYTOXAN_SENSITIVITY	17057710	NA	NA
8444	RAY_TARGETS_OF_P210_BCR_ABL_FUSION_UP	15155749	cancer	DOID_162
8445	RAY_TARGETS_OF_P210_BCR_ABL_FUSION_UP	15155749	chronic myeloid leukemia	DOID_8552
8446	RAY_TARGETS_OF_P210_BCR_ABL_FUSION_UP	15155749	disease of cellular proliferation	DOID_14566
8447	RAY_TARGETS_OF_P210_BCR_ABL_FUSION_UP	15155749	hematologic cancer	DOID_2531
8448	RAY_TARGETS_OF_P210_BCR_ABL_FUSION_UP	15155749	immune system cancer	DOID_0060083
8449	RAY_TARGETS_OF_P210_BCR_ABL_FUSION_UP	15155749	leukemia	DOID_1240
8450	RAY_TARGETS_OF_P210_BCR_ABL_FUSION_UP	15155749	myeloid leukemia	DOID_8692
8451	RAY_TARGETS_OF_P210_BCR_ABL_FUSION_UP	15155749	organ system cancer	DOID_0050686
8452	RAY_TARGETS_OF_P210_BCR_ABL_FUSION_DN	15155749	cancer	DOID_162
8453	RAY_TARGETS_OF_P210_BCR_ABL_FUSION_DN	15155749	chronic myeloid leukemia	DOID_8552
8454	RAY_TARGETS_OF_P210_BCR_ABL_FUSION_DN	15155749	disease of cellular proliferation	DOID_14566
8455	RAY_TARGETS_OF_P210_BCR_ABL_FUSION_DN	15155749	hematologic cancer	DOID_2531
8456	RAY_TARGETS_OF_P210_BCR_ABL_FUSION_DN	15155749	immune system cancer	DOID_0060083
8457	RAY_TARGETS_OF_P210_BCR_ABL_FUSION_DN	15155749	leukemia	DOID_1240
8458	RAY_TARGETS_OF_P210_BCR_ABL_FUSION_DN	15155749	myeloid leukemia	DOID_8692
8459	RAY_TARGETS_OF_P210_BCR_ABL_FUSION_DN	15155749	organ system cancer	DOID_0050686
8460	RUIZ_TNC_TARGETS_UP	15492259	astrocytoma	DOID_3069
8461	RUIZ_TNC_TARGETS_UP	15492259	cancer	DOID_162
8462	RUIZ_TNC_TARGETS_UP	15492259	cell type cancer	DOID_0050687
8463	RUIZ_TNC_TARGETS_UP	15492259	disease of cellular proliferation	DOID_14566
8464	RUIZ_TNC_TARGETS_UP	15492259	glioblastoma	DOID_3068
8465	RUIZ_TNC_TARGETS_UP	15492259	malignant glioma	DOID_3070
8466	RUIZ_TNC_TARGETS_DN	15492259	astrocytoma	DOID_3069
8467	RUIZ_TNC_TARGETS_DN	15492259	cancer	DOID_162
8468	RUIZ_TNC_TARGETS_DN	15492259	cell type cancer	DOID_0050687
8469	RUIZ_TNC_TARGETS_DN	15492259	disease of cellular proliferation	DOID_14566
8470	RUIZ_TNC_TARGETS_DN	15492259	glioblastoma	DOID_3068
8471	RUIZ_TNC_TARGETS_DN	15492259	malignant glioma	DOID_3070
8472	RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP	16527888	NA	NA
8473	RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN	16527888	NA	NA
8474	RUTELLA_RESPONSE_TO_HGF_UP	16527888	NA	NA
8475	RUTELLA_RESPONSE_TO_HGF_DN	16527888	NA	NA
8476	RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP	16527888	NA	NA
8477	RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN	16527888	NA	NA
8478	CHANG_CORE_SERUM_RESPONSE_UP	14737219	cancer	DOID_162
8479	CHANG_CORE_SERUM_RESPONSE_UP	14737219	disease of cellular proliferation	DOID_14566
8480	CHANG_CORE_SERUM_RESPONSE_DN	14737219	cancer	DOID_162
8481	CHANG_CORE_SERUM_RESPONSE_DN	14737219	disease of cellular proliferation	DOID_14566
8482	CHANG_CYCLING_GENES	14737219	cancer	DOID_162
8483	CHANG_CYCLING_GENES	14737219	disease of cellular proliferation	DOID_14566
8484	MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_UP	15024077	acute myeloid leukemia	DOID_9119
8485	MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_UP	15024077	cancer	DOID_162
8486	MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_UP	15024077	disease of cellular proliferation	DOID_14566
8487	MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_UP	15024077	hematologic cancer	DOID_2531
8488	MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_UP	15024077	immune system cancer	DOID_0060083
8489	MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_UP	15024077	leukemia	DOID_1240
8490	MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_UP	15024077	myeloid leukemia	DOID_8692
8491	MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_UP	15024077	organ system cancer	DOID_0050686
8492	MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_DN	15024077	acute myeloid leukemia	DOID_9119
8493	MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_DN	15024077	cancer	DOID_162
8494	MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_DN	15024077	disease of cellular proliferation	DOID_14566
8495	MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_DN	15024077	hematologic cancer	DOID_2531
8496	MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_DN	15024077	immune system cancer	DOID_0060083
8497	MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_DN	15024077	leukemia	DOID_1240
8498	MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_DN	15024077	myeloid leukemia	DOID_8692
8499	MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_DN	15024077	organ system cancer	DOID_0050686
8500	ROSS_LEUKEMIA_WITH_MLL_FUSIONS	15226186	acute myeloid leukemia	DOID_9119
8501	ROSS_LEUKEMIA_WITH_MLL_FUSIONS	15226186	cancer	DOID_162
8502	ROSS_LEUKEMIA_WITH_MLL_FUSIONS	15226186	disease of cellular proliferation	DOID_14566
8503	ROSS_LEUKEMIA_WITH_MLL_FUSIONS	15226186	hematologic cancer	DOID_2531
8504	ROSS_LEUKEMIA_WITH_MLL_FUSIONS	15226186	immune system cancer	DOID_0060083
8505	ROSS_LEUKEMIA_WITH_MLL_FUSIONS	15226186	leukemia	DOID_1240
8506	ROSS_LEUKEMIA_WITH_MLL_FUSIONS	15226186	myeloid leukemia	DOID_8692
8507	ROSS_LEUKEMIA_WITH_MLL_FUSIONS	15226186	organ system cancer	DOID_0050686
8508	VANTVEER_BREAST_CANCER_ESR1_UP	11823860	autosomal dominant disease	DOID_0050736
8509	VANTVEER_BREAST_CANCER_ESR1_UP	11823860	autosomal genetic disease	DOID_0050739
8510	VANTVEER_BREAST_CANCER_ESR1_UP	11823860	breast cancer	DOID_1612
8511	VANTVEER_BREAST_CANCER_ESR1_UP	11823860	cancer	DOID_162
8512	VANTVEER_BREAST_CANCER_ESR1_UP	11823860	disease of cellular proliferation	DOID_14566
8513	VANTVEER_BREAST_CANCER_ESR1_UP	11823860	genetic disease	DOID_630
8514	VANTVEER_BREAST_CANCER_ESR1_UP	11823860	hereditary breast ovarian cancer	DOID_5683
8515	VANTVEER_BREAST_CANCER_ESR1_UP	11823860	monogenic disease	DOID_0050177
8516	VANTVEER_BREAST_CANCER_ESR1_UP	11823860	organ system cancer	DOID_0050686
8517	VANTVEER_BREAST_CANCER_ESR1_UP	11823860	thoracic cancer	DOID_5093
8518	VANTVEER_BREAST_CANCER_ESR1_DN	11823860	autosomal dominant disease	DOID_0050736
8519	VANTVEER_BREAST_CANCER_ESR1_DN	11823860	autosomal genetic disease	DOID_0050739
8520	VANTVEER_BREAST_CANCER_ESR1_DN	11823860	breast cancer	DOID_1612
8521	VANTVEER_BREAST_CANCER_ESR1_DN	11823860	cancer	DOID_162
8522	VANTVEER_BREAST_CANCER_ESR1_DN	11823860	disease of cellular proliferation	DOID_14566
8523	VANTVEER_BREAST_CANCER_ESR1_DN	11823860	genetic disease	DOID_630
8524	VANTVEER_BREAST_CANCER_ESR1_DN	11823860	hereditary breast ovarian cancer	DOID_5683
8525	VANTVEER_BREAST_CANCER_ESR1_DN	11823860	monogenic disease	DOID_0050177
8526	VANTVEER_BREAST_CANCER_ESR1_DN	11823860	organ system cancer	DOID_0050686
8527	VANTVEER_BREAST_CANCER_ESR1_DN	11823860	thoracic cancer	DOID_5093
8528	VANTVEER_BREAST_CANCER_BRCA1_UP	11823860	autosomal dominant disease	DOID_0050736
8529	VANTVEER_BREAST_CANCER_BRCA1_UP	11823860	autosomal genetic disease	DOID_0050739
8530	VANTVEER_BREAST_CANCER_BRCA1_UP	11823860	breast cancer	DOID_1612
8531	VANTVEER_BREAST_CANCER_BRCA1_UP	11823860	cancer	DOID_162
8532	VANTVEER_BREAST_CANCER_BRCA1_UP	11823860	disease of cellular proliferation	DOID_14566
8533	VANTVEER_BREAST_CANCER_BRCA1_UP	11823860	genetic disease	DOID_630
8534	VANTVEER_BREAST_CANCER_BRCA1_UP	11823860	hereditary breast ovarian cancer	DOID_5683
8535	VANTVEER_BREAST_CANCER_BRCA1_UP	11823860	monogenic disease	DOID_0050177
8536	VANTVEER_BREAST_CANCER_BRCA1_UP	11823860	organ system cancer	DOID_0050686
8537	VANTVEER_BREAST_CANCER_BRCA1_UP	11823860	thoracic cancer	DOID_5093
8538	VANTVEER_BREAST_CANCER_BRCA1_DN	11823860	autosomal dominant disease	DOID_0050736
8539	VANTVEER_BREAST_CANCER_BRCA1_DN	11823860	autosomal genetic disease	DOID_0050739
8540	VANTVEER_BREAST_CANCER_BRCA1_DN	11823860	breast cancer	DOID_1612
8541	VANTVEER_BREAST_CANCER_BRCA1_DN	11823860	cancer	DOID_162
8542	VANTVEER_BREAST_CANCER_BRCA1_DN	11823860	disease of cellular proliferation	DOID_14566
8543	VANTVEER_BREAST_CANCER_BRCA1_DN	11823860	genetic disease	DOID_630
8544	VANTVEER_BREAST_CANCER_BRCA1_DN	11823860	hereditary breast ovarian cancer	DOID_5683
8545	VANTVEER_BREAST_CANCER_BRCA1_DN	11823860	monogenic disease	DOID_0050177
8546	VANTVEER_BREAST_CANCER_BRCA1_DN	11823860	organ system cancer	DOID_0050686
8547	VANTVEER_BREAST_CANCER_BRCA1_DN	11823860	thoracic cancer	DOID_5093
8548	AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_UP	15199222	adenocarcinoma	DOID_299
8549	AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_UP	15199222	cancer	DOID_162
8550	AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_UP	15199222	carcinoma	DOID_305
8551	AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_UP	15199222	cell type cancer	DOID_0050687
8552	AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_UP	15199222	disease of cellular proliferation	DOID_14566
8553	AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_UP	15199222	endocrine gland cancer	DOID_170
8554	AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_UP	15199222	organ system cancer	DOID_0050686
8555	AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_UP	15199222	pancreas adenocarcinoma	DOID_4074
8556	AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_UP	15199222	pancreatic cancer	DOID_1793
8557	AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_UP	15199222	pancreatic carcinoma	DOID_4905
8558	AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_DN	15199222	adenocarcinoma	DOID_299
8559	AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_DN	15199222	cancer	DOID_162
8560	AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_DN	15199222	carcinoma	DOID_305
8561	AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_DN	15199222	cell type cancer	DOID_0050687
8562	AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_DN	15199222	disease of cellular proliferation	DOID_14566
8563	AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_DN	15199222	endocrine gland cancer	DOID_170
8564	AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_DN	15199222	organ system cancer	DOID_0050686
8565	AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_DN	15199222	pancreas adenocarcinoma	DOID_4074
8566	AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_DN	15199222	pancreatic cancer	DOID_1793
8567	AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_DN	15199222	pancreatic carcinoma	DOID_4905
8568	SWEET_KRAS_ONCOGENIC_SIGNATURE	15608639	adenocarcinoma	DOID_299
8569	SWEET_KRAS_ONCOGENIC_SIGNATURE	15608639	cancer	DOID_162
8570	SWEET_KRAS_ONCOGENIC_SIGNATURE	15608639	carcinoma	DOID_305
8571	SWEET_KRAS_ONCOGENIC_SIGNATURE	15608639	cell type cancer	DOID_0050687
8572	SWEET_KRAS_ONCOGENIC_SIGNATURE	15608639	disease of cellular proliferation	DOID_14566
8573	SWEET_KRAS_ONCOGENIC_SIGNATURE	15608639	lung adenocarcinoma	DOID_3910
8574	SWEET_KRAS_ONCOGENIC_SIGNATURE	15608639	lung cancer	DOID_1324
8575	SWEET_KRAS_ONCOGENIC_SIGNATURE	15608639	lung carcinoma	DOID_3905
8576	SWEET_KRAS_ONCOGENIC_SIGNATURE	15608639	non-small cell lung carcinoma	DOID_3908
8577	SWEET_KRAS_ONCOGENIC_SIGNATURE	15608639	organ system cancer	DOID_0050686
8578	SWEET_KRAS_ONCOGENIC_SIGNATURE	15608639	respiratory system cancer	DOID_0050615
8579	HINATA_NFKB_TARGETS_KERATINOCYTE_UP	12673201	cancer	DOID_162
8580	HINATA_NFKB_TARGETS_KERATINOCYTE_UP	12673201	carcinoma	DOID_305
8581	HINATA_NFKB_TARGETS_KERATINOCYTE_UP	12673201	cell type cancer	DOID_0050687
8582	HINATA_NFKB_TARGETS_KERATINOCYTE_UP	12673201	disease of cellular proliferation	DOID_14566
8583	HINATA_NFKB_TARGETS_KERATINOCYTE_UP	12673201	squamous cell carcinoma	DOID_1749
8584	HINATA_NFKB_TARGETS_KERATINOCYTE_DN	12673201	cancer	DOID_162
8585	HINATA_NFKB_TARGETS_KERATINOCYTE_DN	12673201	carcinoma	DOID_305
8586	HINATA_NFKB_TARGETS_KERATINOCYTE_DN	12673201	cell type cancer	DOID_0050687
8587	HINATA_NFKB_TARGETS_KERATINOCYTE_DN	12673201	disease of cellular proliferation	DOID_14566
8588	HINATA_NFKB_TARGETS_KERATINOCYTE_DN	12673201	squamous cell carcinoma	DOID_1749
8589	HOFMANN_MYELODYSPLASTIC_SYNDROM_LOW_RISK_UP	12411319	syndrome	DOID_225
8590	HOFMANN_MYELODYSPLASTIC_SYNDROM_LOW_RISK_DN	12411319	syndrome	DOID_225
8591	HOFMANN_MYELODYSPLASTIC_SYNDROM_HIGH_RISK_DN	12411319	syndrome	DOID_225
8592	HOFMANN_MYELODYSPLASTIC_SYNDROM_RISK_UP	12411319	syndrome	DOID_225
8593	HOFMANN_MYELODYSPLASTIC_SYNDROM_RISK_DN	12411319	syndrome	DOID_225
8594	LEE_EARLY_T_LYMPHOCYTE_UP	15210650	NA	NA
8595	LEE_EARLY_T_LYMPHOCYTE_DN	15210650	NA	NA
8596	LEE_INTRATHYMIC_T_PROGENITOR	15210650	NA	NA
8597	LEE_DOUBLE_POLAR_THYMOCYTE	15210650	NA	NA
8598	LEE_RECENT_THYMIC_EMIGRANT	15210650	NA	NA
8599	LEE_DIFFERENTIATING_T_LYMPHOCYTE	15210650	NA	NA
8600	LI_WILMS_TUMOR	12057921	cancer	DOID_162
8601	LI_WILMS_TUMOR	12057921	disease of cellular proliferation	DOID_14566
8602	FINAK_BREAST_CANCER_SDPP_SIGNATURE	18438415	breast cancer	DOID_1612
8603	FINAK_BREAST_CANCER_SDPP_SIGNATURE	18438415	cancer	DOID_162
8604	FINAK_BREAST_CANCER_SDPP_SIGNATURE	18438415	disease of cellular proliferation	DOID_14566
8605	FINAK_BREAST_CANCER_SDPP_SIGNATURE	18438415	organ system cancer	DOID_0050686
8606	FINAK_BREAST_CANCER_SDPP_SIGNATURE	18438415	thoracic cancer	DOID_5093
8607	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	18641660	adenocarcinoma	DOID_299
8608	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	18641660	cancer	DOID_162
8609	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	18641660	carcinoma	DOID_305
8610	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	18641660	cell type cancer	DOID_0050687
8611	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	18641660	disease of cellular proliferation	DOID_14566
8612	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	18641660	lung adenocarcinoma	DOID_3910
8613	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	18641660	lung cancer	DOID_1324
8614	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	18641660	lung carcinoma	DOID_3905
8615	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	18641660	non-small cell lung carcinoma	DOID_3908
8616	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	18641660	organ system cancer	DOID_0050686
8617	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	18641660	respiratory system cancer	DOID_0050615
8618	SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4	18641660	adenocarcinoma	DOID_299
8619	SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4	18641660	cancer	DOID_162
8620	SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4	18641660	carcinoma	DOID_305
8621	SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4	18641660	cell type cancer	DOID_0050687
8622	SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4	18641660	disease of cellular proliferation	DOID_14566
8623	SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4	18641660	lung adenocarcinoma	DOID_3910
8624	SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4	18641660	lung cancer	DOID_1324
8625	SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4	18641660	lung carcinoma	DOID_3905
8626	SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4	18641660	non-small cell lung carcinoma	DOID_3908
8627	SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4	18641660	organ system cancer	DOID_0050686
8628	SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4	18641660	respiratory system cancer	DOID_0050615
8629	SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A5	18641660	adenocarcinoma	DOID_299
8630	SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A5	18641660	cancer	DOID_162
8631	SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A5	18641660	carcinoma	DOID_305
8632	SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A5	18641660	cell type cancer	DOID_0050687
8633	SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A5	18641660	disease of cellular proliferation	DOID_14566
8634	SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A5	18641660	lung adenocarcinoma	DOID_3910
8635	SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A5	18641660	lung cancer	DOID_1324
8636	SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A5	18641660	lung carcinoma	DOID_3905
8637	SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A5	18641660	non-small cell lung carcinoma	DOID_3908
8638	SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A5	18641660	organ system cancer	DOID_0050686
8639	SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A5	18641660	respiratory system cancer	DOID_0050615
8640	MELLMAN_TUT1_TARGETS_UP	18288197	NA	NA
8641	MELLMAN_TUT1_TARGETS_DN	18288197	NA	NA
8642	HAN_SATB1_TARGETS_UP	18337816	breast cancer	DOID_1612
8643	HAN_SATB1_TARGETS_UP	18337816	cancer	DOID_162
8644	HAN_SATB1_TARGETS_UP	18337816	disease of cellular proliferation	DOID_14566
8645	HAN_SATB1_TARGETS_UP	18337816	organ system cancer	DOID_0050686
8646	HAN_SATB1_TARGETS_UP	18337816	thoracic cancer	DOID_5093
8647	HAN_SATB1_TARGETS_DN	18337816	breast cancer	DOID_1612
8648	HAN_SATB1_TARGETS_DN	18337816	cancer	DOID_162
8649	HAN_SATB1_TARGETS_DN	18337816	disease of cellular proliferation	DOID_14566
8650	HAN_SATB1_TARGETS_DN	18337816	organ system cancer	DOID_0050686
8651	HAN_SATB1_TARGETS_DN	18337816	thoracic cancer	DOID_5093
8652	SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12	18641660	adenocarcinoma	DOID_299
8653	SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12	18641660	cancer	DOID_162
8654	SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12	18641660	carcinoma	DOID_305
8655	SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12	18641660	cell type cancer	DOID_0050687
8656	SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12	18641660	disease of cellular proliferation	DOID_14566
8657	SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12	18641660	lung adenocarcinoma	DOID_3910
8658	SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12	18641660	lung cancer	DOID_1324
8659	SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12	18641660	lung carcinoma	DOID_3905
8660	SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12	18641660	non-small cell lung carcinoma	DOID_3908
8661	SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12	18641660	organ system cancer	DOID_0050686
8662	SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12	18641660	respiratory system cancer	DOID_0050615
8663	SHAFFER_IRF4_MULTIPLE_MYELOMA_PROGRAM	18568025	bone marrow cancer	DOID_4960
8664	SHAFFER_IRF4_MULTIPLE_MYELOMA_PROGRAM	18568025	cancer	DOID_162
8665	SHAFFER_IRF4_MULTIPLE_MYELOMA_PROGRAM	18568025	disease of cellular proliferation	DOID_14566
8666	SHAFFER_IRF4_MULTIPLE_MYELOMA_PROGRAM	18568025	hematologic cancer	DOID_2531
8667	SHAFFER_IRF4_MULTIPLE_MYELOMA_PROGRAM	18568025	immune system cancer	DOID_0060083
8668	SHAFFER_IRF4_MULTIPLE_MYELOMA_PROGRAM	18568025	multiple myeloma	DOID_9538
8669	SHAFFER_IRF4_MULTIPLE_MYELOMA_PROGRAM	18568025	myeloma	DOID_0070004
8670	SHAFFER_IRF4_MULTIPLE_MYELOMA_PROGRAM	18568025	organ system cancer	DOID_0050686
8671	SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE	18568025	bone marrow cancer	DOID_4960
8672	SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE	18568025	cancer	DOID_162
8673	SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE	18568025	disease of cellular proliferation	DOID_14566
8674	SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE	18568025	hematologic cancer	DOID_2531
8675	SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE	18568025	immune system cancer	DOID_0060083
8676	SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE	18568025	multiple myeloma	DOID_9538
8677	SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE	18568025	myeloma	DOID_0070004
8678	SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE	18568025	organ system cancer	DOID_0050686
8679	SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE	18568025	bone marrow cancer	DOID_4960
8680	SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE	18568025	cancer	DOID_162
8681	SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE	18568025	disease of cellular proliferation	DOID_14566
8682	SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE	18568025	hematologic cancer	DOID_2531
8683	SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE	18568025	immune system cancer	DOID_0060083
8684	SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE	18568025	multiple myeloma	DOID_9538
8685	SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE	18568025	myeloma	DOID_0070004
8686	SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE	18568025	organ system cancer	DOID_0050686
8687	SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE	18568025	bone marrow cancer	DOID_4960
8688	SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE	18568025	cancer	DOID_162
8689	SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE	18568025	disease of cellular proliferation	DOID_14566
8690	SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE	18568025	hematologic cancer	DOID_2531
8691	SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE	18568025	immune system cancer	DOID_0060083
8692	SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE	18568025	multiple myeloma	DOID_9538
8693	SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE	18568025	myeloma	DOID_0070004
8694	SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE	18568025	organ system cancer	DOID_0050686
8695	SHAFFER_IRF4_TARGETS_IN_ACTIVATED_DENDRITIC_CELL	18568025	bone marrow cancer	DOID_4960
8696	SHAFFER_IRF4_TARGETS_IN_ACTIVATED_DENDRITIC_CELL	18568025	cancer	DOID_162
8697	SHAFFER_IRF4_TARGETS_IN_ACTIVATED_DENDRITIC_CELL	18568025	disease of cellular proliferation	DOID_14566
8698	SHAFFER_IRF4_TARGETS_IN_ACTIVATED_DENDRITIC_CELL	18568025	hematologic cancer	DOID_2531
8699	SHAFFER_IRF4_TARGETS_IN_ACTIVATED_DENDRITIC_CELL	18568025	immune system cancer	DOID_0060083
8700	SHAFFER_IRF4_TARGETS_IN_ACTIVATED_DENDRITIC_CELL	18568025	multiple myeloma	DOID_9538
8701	SHAFFER_IRF4_TARGETS_IN_ACTIVATED_DENDRITIC_CELL	18568025	myeloma	DOID_0070004
8702	SHAFFER_IRF4_TARGETS_IN_ACTIVATED_DENDRITIC_CELL	18568025	organ system cancer	DOID_0050686
8703	HSIAO_HOUSEKEEPING_GENES	11773596	NA	NA
8704	TAVAZOIE_METASTASIS	18185580	breast cancer	DOID_1612
8705	TAVAZOIE_METASTASIS	18185580	cancer	DOID_162
8706	TAVAZOIE_METASTASIS	18185580	disease of cellular proliferation	DOID_14566
8707	TAVAZOIE_METASTASIS	18185580	organ system cancer	DOID_0050686
8708	TAVAZOIE_METASTASIS	18185580	thoracic cancer	DOID_5093
8709	FERRANDO_HOX11_NEIGHBORS	12086890	cancer	DOID_162
8710	FERRANDO_HOX11_NEIGHBORS	12086890	disease of cellular proliferation	DOID_14566
8711	FERRANDO_HOX11_NEIGHBORS	12086890	hematologic cancer	DOID_2531
8712	FERRANDO_HOX11_NEIGHBORS	12086890	immune system cancer	DOID_0060083
8713	FERRANDO_HOX11_NEIGHBORS	12086890	leukemia	DOID_1240
8714	FERRANDO_HOX11_NEIGHBORS	12086890	lymphoblastic leukemia	DOID_1037
8715	FERRANDO_HOX11_NEIGHBORS	12086890	organ system cancer	DOID_0050686
8716	CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_HD_MTX_DN	12704389	cancer	DOID_162
8717	CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_HD_MTX_DN	12704389	disease of cellular proliferation	DOID_14566
8718	CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_HD_MTX_DN	12704389	hematologic cancer	DOID_2531
8719	CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_HD_MTX_DN	12704389	immune system cancer	DOID_0060083
8720	CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_HD_MTX_DN	12704389	leukemia	DOID_1240
8721	CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_HD_MTX_DN	12704389	lymphoblastic leukemia	DOID_1037
8722	CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_HD_MTX_DN	12704389	lymphoid leukemia	DOID_10747
8723	CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_HD_MTX_DN	12704389	organ system cancer	DOID_0050686
8724	ZHAN_EARLY_DIFFERENTIATION_GENES_DN	12393520	bone marrow cancer	DOID_4960
8725	ZHAN_EARLY_DIFFERENTIATION_GENES_DN	12393520	cancer	DOID_162
8726	ZHAN_EARLY_DIFFERENTIATION_GENES_DN	12393520	disease of cellular proliferation	DOID_14566
8727	ZHAN_EARLY_DIFFERENTIATION_GENES_DN	12393520	hematologic cancer	DOID_2531
8728	ZHAN_EARLY_DIFFERENTIATION_GENES_DN	12393520	immune system cancer	DOID_0060083
8729	ZHAN_EARLY_DIFFERENTIATION_GENES_DN	12393520	multiple myeloma	DOID_9538
8730	ZHAN_EARLY_DIFFERENTIATION_GENES_DN	12393520	myeloma	DOID_0070004
8731	ZHAN_EARLY_DIFFERENTIATION_GENES_DN	12393520	organ system cancer	DOID_0050686
8732	LIU_VAV3_PROSTATE_CARCINOGENESIS_UP	18676865	cancer	DOID_162
8733	LIU_VAV3_PROSTATE_CARCINOGENESIS_UP	18676865	disease of anatomical entity	DOID_7
8734	LIU_VAV3_PROSTATE_CARCINOGENESIS_UP	18676865	disease of cellular proliferation	DOID_14566
8735	LIU_VAV3_PROSTATE_CARCINOGENESIS_UP	18676865	male reproductive organ cancer	DOID_3856
8736	LIU_VAV3_PROSTATE_CARCINOGENESIS_UP	18676865	male reproductive system disease	DOID_48
8737	LIU_VAV3_PROSTATE_CARCINOGENESIS_UP	18676865	organ system cancer	DOID_0050686
8738	LIU_VAV3_PROSTATE_CARCINOGENESIS_UP	18676865	prostate cancer	DOID_10283
8739	LIU_VAV3_PROSTATE_CARCINOGENESIS_UP	18676865	prostate disease	DOID_47
8740	LIU_VAV3_PROSTATE_CARCINOGENESIS_UP	18676865	prostatitis	DOID_14654
8741	LIU_VAV3_PROSTATE_CARCINOGENESIS_UP	18676865	reproductive organ cancer	DOID_193
8742	LIU_VAV3_PROSTATE_CARCINOGENESIS_UP	18676865	reproductive system disease	DOID_15
8743	LIU_VAV3_PROSTATE_CARCINOGENESIS_DN	18676865	cancer	DOID_162
8744	LIU_VAV3_PROSTATE_CARCINOGENESIS_DN	18676865	disease of anatomical entity	DOID_7
8745	LIU_VAV3_PROSTATE_CARCINOGENESIS_DN	18676865	disease of cellular proliferation	DOID_14566
8746	LIU_VAV3_PROSTATE_CARCINOGENESIS_DN	18676865	male reproductive organ cancer	DOID_3856
8747	LIU_VAV3_PROSTATE_CARCINOGENESIS_DN	18676865	male reproductive system disease	DOID_48
8748	LIU_VAV3_PROSTATE_CARCINOGENESIS_DN	18676865	organ system cancer	DOID_0050686
8749	LIU_VAV3_PROSTATE_CARCINOGENESIS_DN	18676865	prostate cancer	DOID_10283
8750	LIU_VAV3_PROSTATE_CARCINOGENESIS_DN	18676865	prostate disease	DOID_47
8751	LIU_VAV3_PROSTATE_CARCINOGENESIS_DN	18676865	prostatitis	DOID_14654
8752	LIU_VAV3_PROSTATE_CARCINOGENESIS_DN	18676865	reproductive organ cancer	DOID_193
8753	LIU_VAV3_PROSTATE_CARCINOGENESIS_DN	18676865	reproductive system disease	DOID_15
8754	CROONQUIST_IL6_DEPRIVATION_UP	12791645	bone marrow cancer	DOID_4960
8755	CROONQUIST_IL6_DEPRIVATION_UP	12791645	cancer	DOID_162
8756	CROONQUIST_IL6_DEPRIVATION_UP	12791645	disease of cellular proliferation	DOID_14566
8757	CROONQUIST_IL6_DEPRIVATION_UP	12791645	hematologic cancer	DOID_2531
8758	CROONQUIST_IL6_DEPRIVATION_UP	12791645	immune system cancer	DOID_0060083
8759	CROONQUIST_IL6_DEPRIVATION_UP	12791645	multiple myeloma	DOID_9538
8760	CROONQUIST_IL6_DEPRIVATION_UP	12791645	myeloma	DOID_0070004
8761	CROONQUIST_IL6_DEPRIVATION_UP	12791645	organ system cancer	DOID_0050686
8762	CROONQUIST_IL6_DEPRIVATION_DN	12791645	bone marrow cancer	DOID_4960
8763	CROONQUIST_IL6_DEPRIVATION_DN	12791645	cancer	DOID_162
8764	CROONQUIST_IL6_DEPRIVATION_DN	12791645	disease of cellular proliferation	DOID_14566
8765	CROONQUIST_IL6_DEPRIVATION_DN	12791645	hematologic cancer	DOID_2531
8766	CROONQUIST_IL6_DEPRIVATION_DN	12791645	immune system cancer	DOID_0060083
8767	CROONQUIST_IL6_DEPRIVATION_DN	12791645	multiple myeloma	DOID_9538
8768	CROONQUIST_IL6_DEPRIVATION_DN	12791645	myeloma	DOID_0070004
8769	CROONQUIST_IL6_DEPRIVATION_DN	12791645	organ system cancer	DOID_0050686
8770	CROONQUIST_STROMAL_STIMULATION_UP	12791645	bone marrow cancer	DOID_4960
8771	CROONQUIST_STROMAL_STIMULATION_UP	12791645	cancer	DOID_162
8772	CROONQUIST_STROMAL_STIMULATION_UP	12791645	disease of cellular proliferation	DOID_14566
8773	CROONQUIST_STROMAL_STIMULATION_UP	12791645	hematologic cancer	DOID_2531
8774	CROONQUIST_STROMAL_STIMULATION_UP	12791645	immune system cancer	DOID_0060083
8775	CROONQUIST_STROMAL_STIMULATION_UP	12791645	multiple myeloma	DOID_9538
8776	CROONQUIST_STROMAL_STIMULATION_UP	12791645	myeloma	DOID_0070004
8777	CROONQUIST_STROMAL_STIMULATION_UP	12791645	organ system cancer	DOID_0050686
8778	CROONQUIST_NRAS_SIGNALING_UP	12791645	bone marrow cancer	DOID_4960
8779	CROONQUIST_NRAS_SIGNALING_UP	12791645	cancer	DOID_162
8780	CROONQUIST_NRAS_SIGNALING_UP	12791645	disease of cellular proliferation	DOID_14566
8781	CROONQUIST_NRAS_SIGNALING_UP	12791645	hematologic cancer	DOID_2531
8782	CROONQUIST_NRAS_SIGNALING_UP	12791645	immune system cancer	DOID_0060083
8783	CROONQUIST_NRAS_SIGNALING_UP	12791645	multiple myeloma	DOID_9538
8784	CROONQUIST_NRAS_SIGNALING_UP	12791645	myeloma	DOID_0070004
8785	CROONQUIST_NRAS_SIGNALING_UP	12791645	organ system cancer	DOID_0050686
8786	CROONQUIST_NRAS_SIGNALING_DN	12791645	bone marrow cancer	DOID_4960
8787	CROONQUIST_NRAS_SIGNALING_DN	12791645	cancer	DOID_162
8788	CROONQUIST_NRAS_SIGNALING_DN	12791645	disease of cellular proliferation	DOID_14566
8789	CROONQUIST_NRAS_SIGNALING_DN	12791645	hematologic cancer	DOID_2531
8790	CROONQUIST_NRAS_SIGNALING_DN	12791645	immune system cancer	DOID_0060083
8791	CROONQUIST_NRAS_SIGNALING_DN	12791645	multiple myeloma	DOID_9538
8792	CROONQUIST_NRAS_SIGNALING_DN	12791645	myeloma	DOID_0070004
8793	CROONQUIST_NRAS_SIGNALING_DN	12791645	organ system cancer	DOID_0050686
8794	CROONQUIST_NRAS_VS_STROMAL_STIMULATION_UP	12791645	bone marrow cancer	DOID_4960
8795	CROONQUIST_NRAS_VS_STROMAL_STIMULATION_UP	12791645	cancer	DOID_162
8796	CROONQUIST_NRAS_VS_STROMAL_STIMULATION_UP	12791645	disease of cellular proliferation	DOID_14566
8797	CROONQUIST_NRAS_VS_STROMAL_STIMULATION_UP	12791645	hematologic cancer	DOID_2531
8798	CROONQUIST_NRAS_VS_STROMAL_STIMULATION_UP	12791645	immune system cancer	DOID_0060083
8799	CROONQUIST_NRAS_VS_STROMAL_STIMULATION_UP	12791645	multiple myeloma	DOID_9538
8800	CROONQUIST_NRAS_VS_STROMAL_STIMULATION_UP	12791645	myeloma	DOID_0070004
8801	CROONQUIST_NRAS_VS_STROMAL_STIMULATION_UP	12791645	organ system cancer	DOID_0050686
8802	CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN	12791645	bone marrow cancer	DOID_4960
8803	CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN	12791645	cancer	DOID_162
8804	CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN	12791645	disease of cellular proliferation	DOID_14566
8805	CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN	12791645	hematologic cancer	DOID_2531
8806	CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN	12791645	immune system cancer	DOID_0060083
8807	CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN	12791645	multiple myeloma	DOID_9538
8808	CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN	12791645	myeloma	DOID_0070004
8809	CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN	12791645	organ system cancer	DOID_0050686
8810	ZHAN_LATE_DIFFERENTIATION_GENES_UP	12393520	bone marrow cancer	DOID_4960
8811	ZHAN_LATE_DIFFERENTIATION_GENES_UP	12393520	cancer	DOID_162
8812	ZHAN_LATE_DIFFERENTIATION_GENES_UP	12393520	disease of cellular proliferation	DOID_14566
8813	ZHAN_LATE_DIFFERENTIATION_GENES_UP	12393520	hematologic cancer	DOID_2531
8814	ZHAN_LATE_DIFFERENTIATION_GENES_UP	12393520	immune system cancer	DOID_0060083
8815	ZHAN_LATE_DIFFERENTIATION_GENES_UP	12393520	multiple myeloma	DOID_9538
8816	ZHAN_LATE_DIFFERENTIATION_GENES_UP	12393520	myeloma	DOID_0070004
8817	ZHAN_LATE_DIFFERENTIATION_GENES_UP	12393520	organ system cancer	DOID_0050686
8818	ZHAN_LATE_DIFFERENTIATION_GENES_DN	12393520	bone marrow cancer	DOID_4960
8819	ZHAN_LATE_DIFFERENTIATION_GENES_DN	12393520	cancer	DOID_162
8820	ZHAN_LATE_DIFFERENTIATION_GENES_DN	12393520	disease of cellular proliferation	DOID_14566
8821	ZHAN_LATE_DIFFERENTIATION_GENES_DN	12393520	hematologic cancer	DOID_2531
8822	ZHAN_LATE_DIFFERENTIATION_GENES_DN	12393520	immune system cancer	DOID_0060083
8823	ZHAN_LATE_DIFFERENTIATION_GENES_DN	12393520	multiple myeloma	DOID_9538
8824	ZHAN_LATE_DIFFERENTIATION_GENES_DN	12393520	myeloma	DOID_0070004
8825	ZHAN_LATE_DIFFERENTIATION_GENES_DN	12393520	organ system cancer	DOID_0050686
8826	ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_UP	12393520	bone marrow cancer	DOID_4960
8827	ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_UP	12393520	cancer	DOID_162
8828	ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_UP	12393520	disease of cellular proliferation	DOID_14566
8829	ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_UP	12393520	hematologic cancer	DOID_2531
8830	ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_UP	12393520	immune system cancer	DOID_0060083
8831	ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_UP	12393520	multiple myeloma	DOID_9538
8832	ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_UP	12393520	myeloma	DOID_0070004
8833	ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_UP	12393520	organ system cancer	DOID_0050686
8834	ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_DN	12393520	bone marrow cancer	DOID_4960
8835	ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_DN	12393520	cancer	DOID_162
8836	ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_DN	12393520	disease of cellular proliferation	DOID_14566
8837	ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_DN	12393520	hematologic cancer	DOID_2531
8838	ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_DN	12393520	immune system cancer	DOID_0060083
8839	ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_DN	12393520	multiple myeloma	DOID_9538
8840	ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_DN	12393520	myeloma	DOID_0070004
8841	ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_DN	12393520	organ system cancer	DOID_0050686
8842	ZHAN_V1_LATE_DIFFERENTIATION_GENES_UP	12393520	bone marrow cancer	DOID_4960
8843	ZHAN_V1_LATE_DIFFERENTIATION_GENES_UP	12393520	cancer	DOID_162
8844	ZHAN_V1_LATE_DIFFERENTIATION_GENES_UP	12393520	disease of cellular proliferation	DOID_14566
8845	ZHAN_V1_LATE_DIFFERENTIATION_GENES_UP	12393520	hematologic cancer	DOID_2531
8846	ZHAN_V1_LATE_DIFFERENTIATION_GENES_UP	12393520	immune system cancer	DOID_0060083
8847	ZHAN_V1_LATE_DIFFERENTIATION_GENES_UP	12393520	multiple myeloma	DOID_9538
8848	ZHAN_V1_LATE_DIFFERENTIATION_GENES_UP	12393520	myeloma	DOID_0070004
8849	ZHAN_V1_LATE_DIFFERENTIATION_GENES_UP	12393520	organ system cancer	DOID_0050686
8850	ZHAN_V1_LATE_DIFFERENTIATION_GENES_DN	12393520	bone marrow cancer	DOID_4960
8851	ZHAN_V1_LATE_DIFFERENTIATION_GENES_DN	12393520	cancer	DOID_162
8852	ZHAN_V1_LATE_DIFFERENTIATION_GENES_DN	12393520	disease of cellular proliferation	DOID_14566
8853	ZHAN_V1_LATE_DIFFERENTIATION_GENES_DN	12393520	hematologic cancer	DOID_2531
8854	ZHAN_V1_LATE_DIFFERENTIATION_GENES_DN	12393520	immune system cancer	DOID_0060083
8855	ZHAN_V1_LATE_DIFFERENTIATION_GENES_DN	12393520	multiple myeloma	DOID_9538
8856	ZHAN_V1_LATE_DIFFERENTIATION_GENES_DN	12393520	myeloma	DOID_0070004
8857	ZHAN_V1_LATE_DIFFERENTIATION_GENES_DN	12393520	organ system cancer	DOID_0050686
8858	ROME_INSULIN_TARGETS_IN_MUSCLE_UP	12621037	acquired metabolic disease	DOID_0060158
8859	ROME_INSULIN_TARGETS_IN_MUSCLE_UP	12621037	carbohydrate metabolism disease	DOID_0050013
8860	ROME_INSULIN_TARGETS_IN_MUSCLE_UP	12621037	diabetes mellitus	DOID_9351
8861	ROME_INSULIN_TARGETS_IN_MUSCLE_UP	12621037	disease of anatomical entity	DOID_7
8862	ROME_INSULIN_TARGETS_IN_MUSCLE_UP	12621037	disease of metabolism	DOID_0014667
8863	ROME_INSULIN_TARGETS_IN_MUSCLE_UP	12621037	endocrine pancreas disease	DOID_1428
8864	ROME_INSULIN_TARGETS_IN_MUSCLE_UP	12621037	endocrine system disease	DOID_28
8865	ROME_INSULIN_TARGETS_IN_MUSCLE_UP	12621037	glucose metabolism disease	DOID_4194
8866	ROME_INSULIN_TARGETS_IN_MUSCLE_UP	12621037	hyperinsulinism	DOID_2018
8867	ROME_INSULIN_TARGETS_IN_MUSCLE_UP	12621037	pancreas disease	DOID_26
8868	ROME_INSULIN_TARGETS_IN_MUSCLE_UP	12621037	type 2 diabetes mellitus	DOID_9352
8869	ROME_INSULIN_TARGETS_IN_MUSCLE_DN	12621037	acquired metabolic disease	DOID_0060158
8870	ROME_INSULIN_TARGETS_IN_MUSCLE_DN	12621037	carbohydrate metabolism disease	DOID_0050013
8871	ROME_INSULIN_TARGETS_IN_MUSCLE_DN	12621037	diabetes mellitus	DOID_9351
8872	ROME_INSULIN_TARGETS_IN_MUSCLE_DN	12621037	disease of anatomical entity	DOID_7
8873	ROME_INSULIN_TARGETS_IN_MUSCLE_DN	12621037	disease of metabolism	DOID_0014667
8874	ROME_INSULIN_TARGETS_IN_MUSCLE_DN	12621037	endocrine pancreas disease	DOID_1428
8875	ROME_INSULIN_TARGETS_IN_MUSCLE_DN	12621037	endocrine system disease	DOID_28
8876	ROME_INSULIN_TARGETS_IN_MUSCLE_DN	12621037	glucose metabolism disease	DOID_4194
8877	ROME_INSULIN_TARGETS_IN_MUSCLE_DN	12621037	hyperinsulinism	DOID_2018
8878	ROME_INSULIN_TARGETS_IN_MUSCLE_DN	12621037	pancreas disease	DOID_26
8879	ROME_INSULIN_TARGETS_IN_MUSCLE_DN	12621037	type 2 diabetes mellitus	DOID_9352
8880	VALK_AML_CLUSTER_1	15084694	acute myeloid leukemia	DOID_9119
8881	VALK_AML_CLUSTER_1	15084694	cancer	DOID_162
8882	VALK_AML_CLUSTER_1	15084694	disease of cellular proliferation	DOID_14566
8883	VALK_AML_CLUSTER_1	15084694	hematologic cancer	DOID_2531
8884	VALK_AML_CLUSTER_1	15084694	immune system cancer	DOID_0060083
8885	VALK_AML_CLUSTER_1	15084694	leukemia	DOID_1240
8886	VALK_AML_CLUSTER_1	15084694	myeloid leukemia	DOID_8692
8887	VALK_AML_CLUSTER_1	15084694	organ system cancer	DOID_0050686
8888	VALK_AML_CLUSTER_2	15084694	acute myeloid leukemia	DOID_9119
8889	VALK_AML_CLUSTER_2	15084694	cancer	DOID_162
8890	VALK_AML_CLUSTER_2	15084694	disease of cellular proliferation	DOID_14566
8891	VALK_AML_CLUSTER_2	15084694	hematologic cancer	DOID_2531
8892	VALK_AML_CLUSTER_2	15084694	immune system cancer	DOID_0060083
8893	VALK_AML_CLUSTER_2	15084694	leukemia	DOID_1240
8894	VALK_AML_CLUSTER_2	15084694	myeloid leukemia	DOID_8692
8895	VALK_AML_CLUSTER_2	15084694	organ system cancer	DOID_0050686
8896	VALK_AML_CLUSTER_3	15084694	acute myeloid leukemia	DOID_9119
8897	VALK_AML_CLUSTER_3	15084694	cancer	DOID_162
8898	VALK_AML_CLUSTER_3	15084694	disease of cellular proliferation	DOID_14566
8899	VALK_AML_CLUSTER_3	15084694	hematologic cancer	DOID_2531
8900	VALK_AML_CLUSTER_3	15084694	immune system cancer	DOID_0060083
8901	VALK_AML_CLUSTER_3	15084694	leukemia	DOID_1240
8902	VALK_AML_CLUSTER_3	15084694	myeloid leukemia	DOID_8692
8903	VALK_AML_CLUSTER_3	15084694	organ system cancer	DOID_0050686
8904	VALK_AML_CLUSTER_4	15084694	acute myeloid leukemia	DOID_9119
8905	VALK_AML_CLUSTER_4	15084694	cancer	DOID_162
8906	VALK_AML_CLUSTER_4	15084694	disease of cellular proliferation	DOID_14566
8907	VALK_AML_CLUSTER_4	15084694	hematologic cancer	DOID_2531
8908	VALK_AML_CLUSTER_4	15084694	immune system cancer	DOID_0060083
8909	VALK_AML_CLUSTER_4	15084694	leukemia	DOID_1240
8910	VALK_AML_CLUSTER_4	15084694	myeloid leukemia	DOID_8692
8911	VALK_AML_CLUSTER_4	15084694	organ system cancer	DOID_0050686
8912	VALK_AML_CLUSTER_5	15084694	acute myeloid leukemia	DOID_9119
8913	VALK_AML_CLUSTER_5	15084694	cancer	DOID_162
8914	VALK_AML_CLUSTER_5	15084694	disease of cellular proliferation	DOID_14566
8915	VALK_AML_CLUSTER_5	15084694	hematologic cancer	DOID_2531
8916	VALK_AML_CLUSTER_5	15084694	immune system cancer	DOID_0060083
8917	VALK_AML_CLUSTER_5	15084694	leukemia	DOID_1240
8918	VALK_AML_CLUSTER_5	15084694	myeloid leukemia	DOID_8692
8919	VALK_AML_CLUSTER_5	15084694	organ system cancer	DOID_0050686
8920	VALK_AML_CLUSTER_6	15084694	acute myeloid leukemia	DOID_9119
8921	VALK_AML_CLUSTER_6	15084694	cancer	DOID_162
8922	VALK_AML_CLUSTER_6	15084694	disease of cellular proliferation	DOID_14566
8923	VALK_AML_CLUSTER_6	15084694	hematologic cancer	DOID_2531
8924	VALK_AML_CLUSTER_6	15084694	immune system cancer	DOID_0060083
8925	VALK_AML_CLUSTER_6	15084694	leukemia	DOID_1240
8926	VALK_AML_CLUSTER_6	15084694	myeloid leukemia	DOID_8692
8927	VALK_AML_CLUSTER_6	15084694	organ system cancer	DOID_0050686
8928	VALK_AML_CLUSTER_7	15084694	acute myeloid leukemia	DOID_9119
8929	VALK_AML_CLUSTER_7	15084694	cancer	DOID_162
8930	VALK_AML_CLUSTER_7	15084694	disease of cellular proliferation	DOID_14566
8931	VALK_AML_CLUSTER_7	15084694	hematologic cancer	DOID_2531
8932	VALK_AML_CLUSTER_7	15084694	immune system cancer	DOID_0060083
8933	VALK_AML_CLUSTER_7	15084694	leukemia	DOID_1240
8934	VALK_AML_CLUSTER_7	15084694	myeloid leukemia	DOID_8692
8935	VALK_AML_CLUSTER_7	15084694	organ system cancer	DOID_0050686
8936	VALK_AML_CLUSTER_8	15084694	acute myeloid leukemia	DOID_9119
8937	VALK_AML_CLUSTER_8	15084694	cancer	DOID_162
8938	VALK_AML_CLUSTER_8	15084694	disease of cellular proliferation	DOID_14566
8939	VALK_AML_CLUSTER_8	15084694	hematologic cancer	DOID_2531
8940	VALK_AML_CLUSTER_8	15084694	immune system cancer	DOID_0060083
8941	VALK_AML_CLUSTER_8	15084694	leukemia	DOID_1240
8942	VALK_AML_CLUSTER_8	15084694	myeloid leukemia	DOID_8692
8943	VALK_AML_CLUSTER_8	15084694	organ system cancer	DOID_0050686
8944	VALK_AML_CLUSTER_9	15084694	acute myeloid leukemia	DOID_9119
8945	VALK_AML_CLUSTER_9	15084694	cancer	DOID_162
8946	VALK_AML_CLUSTER_9	15084694	disease of cellular proliferation	DOID_14566
8947	VALK_AML_CLUSTER_9	15084694	hematologic cancer	DOID_2531
8948	VALK_AML_CLUSTER_9	15084694	immune system cancer	DOID_0060083
8949	VALK_AML_CLUSTER_9	15084694	leukemia	DOID_1240
8950	VALK_AML_CLUSTER_9	15084694	myeloid leukemia	DOID_8692
8951	VALK_AML_CLUSTER_9	15084694	organ system cancer	DOID_0050686
8952	VALK_AML_CLUSTER_10	15084694	acute myeloid leukemia	DOID_9119
8953	VALK_AML_CLUSTER_10	15084694	cancer	DOID_162
8954	VALK_AML_CLUSTER_10	15084694	disease of cellular proliferation	DOID_14566
8955	VALK_AML_CLUSTER_10	15084694	hematologic cancer	DOID_2531
8956	VALK_AML_CLUSTER_10	15084694	immune system cancer	DOID_0060083
8957	VALK_AML_CLUSTER_10	15084694	leukemia	DOID_1240
8958	VALK_AML_CLUSTER_10	15084694	myeloid leukemia	DOID_8692
8959	VALK_AML_CLUSTER_10	15084694	organ system cancer	DOID_0050686
8960	VALK_AML_CLUSTER_11	15084694	acute myeloid leukemia	DOID_9119
8961	VALK_AML_CLUSTER_11	15084694	cancer	DOID_162
8962	VALK_AML_CLUSTER_11	15084694	disease of cellular proliferation	DOID_14566
8963	VALK_AML_CLUSTER_11	15084694	hematologic cancer	DOID_2531
8964	VALK_AML_CLUSTER_11	15084694	immune system cancer	DOID_0060083
8965	VALK_AML_CLUSTER_11	15084694	leukemia	DOID_1240
8966	VALK_AML_CLUSTER_11	15084694	myeloid leukemia	DOID_8692
8967	VALK_AML_CLUSTER_11	15084694	organ system cancer	DOID_0050686
8968	VALK_AML_CLUSTER_12	15084694	acute myeloid leukemia	DOID_9119
8969	VALK_AML_CLUSTER_12	15084694	cancer	DOID_162
8970	VALK_AML_CLUSTER_12	15084694	disease of cellular proliferation	DOID_14566
8971	VALK_AML_CLUSTER_12	15084694	hematologic cancer	DOID_2531
8972	VALK_AML_CLUSTER_12	15084694	immune system cancer	DOID_0060083
8973	VALK_AML_CLUSTER_12	15084694	leukemia	DOID_1240
8974	VALK_AML_CLUSTER_12	15084694	myeloid leukemia	DOID_8692
8975	VALK_AML_CLUSTER_12	15084694	organ system cancer	DOID_0050686
8976	VALK_AML_CLUSTER_13	15084694	acute myeloid leukemia	DOID_9119
8977	VALK_AML_CLUSTER_13	15084694	cancer	DOID_162
8978	VALK_AML_CLUSTER_13	15084694	disease of cellular proliferation	DOID_14566
8979	VALK_AML_CLUSTER_13	15084694	hematologic cancer	DOID_2531
8980	VALK_AML_CLUSTER_13	15084694	immune system cancer	DOID_0060083
8981	VALK_AML_CLUSTER_13	15084694	leukemia	DOID_1240
8982	VALK_AML_CLUSTER_13	15084694	myeloid leukemia	DOID_8692
8983	VALK_AML_CLUSTER_13	15084694	organ system cancer	DOID_0050686
8984	VALK_AML_CLUSTER_15	15084694	acute myeloid leukemia	DOID_9119
8985	VALK_AML_CLUSTER_15	15084694	cancer	DOID_162
8986	VALK_AML_CLUSTER_15	15084694	disease of cellular proliferation	DOID_14566
8987	VALK_AML_CLUSTER_15	15084694	hematologic cancer	DOID_2531
8988	VALK_AML_CLUSTER_15	15084694	immune system cancer	DOID_0060083
8989	VALK_AML_CLUSTER_15	15084694	leukemia	DOID_1240
8990	VALK_AML_CLUSTER_15	15084694	myeloid leukemia	DOID_8692
8991	VALK_AML_CLUSTER_15	15084694	organ system cancer	DOID_0050686
8992	VALK_AML_CLUSTER_16	15084694	acute myeloid leukemia	DOID_9119
8993	VALK_AML_CLUSTER_16	15084694	cancer	DOID_162
8994	VALK_AML_CLUSTER_16	15084694	disease of cellular proliferation	DOID_14566
8995	VALK_AML_CLUSTER_16	15084694	hematologic cancer	DOID_2531
8996	VALK_AML_CLUSTER_16	15084694	immune system cancer	DOID_0060083
8997	VALK_AML_CLUSTER_16	15084694	leukemia	DOID_1240
8998	VALK_AML_CLUSTER_16	15084694	myeloid leukemia	DOID_8692
8999	VALK_AML_CLUSTER_16	15084694	organ system cancer	DOID_0050686
9000	VALK_AML_WITH_11Q23_REARRANGED	15084694	acute myeloid leukemia	DOID_9119
9001	VALK_AML_WITH_11Q23_REARRANGED	15084694	cancer	DOID_162
9002	VALK_AML_WITH_11Q23_REARRANGED	15084694	disease of cellular proliferation	DOID_14566
9003	VALK_AML_WITH_11Q23_REARRANGED	15084694	hematologic cancer	DOID_2531
9004	VALK_AML_WITH_11Q23_REARRANGED	15084694	immune system cancer	DOID_0060083
9005	VALK_AML_WITH_11Q23_REARRANGED	15084694	leukemia	DOID_1240
9006	VALK_AML_WITH_11Q23_REARRANGED	15084694	myeloid leukemia	DOID_8692
9007	VALK_AML_WITH_11Q23_REARRANGED	15084694	organ system cancer	DOID_0050686
9008	VALK_AML_WITH_EVI1	15084694	acute myeloid leukemia	DOID_9119
9009	VALK_AML_WITH_EVI1	15084694	cancer	DOID_162
9010	VALK_AML_WITH_EVI1	15084694	disease of cellular proliferation	DOID_14566
9011	VALK_AML_WITH_EVI1	15084694	hematologic cancer	DOID_2531
9012	VALK_AML_WITH_EVI1	15084694	immune system cancer	DOID_0060083
9013	VALK_AML_WITH_EVI1	15084694	leukemia	DOID_1240
9014	VALK_AML_WITH_EVI1	15084694	myeloid leukemia	DOID_8692
9015	VALK_AML_WITH_EVI1	15084694	organ system cancer	DOID_0050686
9016	VALK_AML_WITH_CEBPA	15084694	acute myeloid leukemia	DOID_9119
9017	VALK_AML_WITH_CEBPA	15084694	cancer	DOID_162
9018	VALK_AML_WITH_CEBPA	15084694	disease of cellular proliferation	DOID_14566
9019	VALK_AML_WITH_CEBPA	15084694	hematologic cancer	DOID_2531
9020	VALK_AML_WITH_CEBPA	15084694	immune system cancer	DOID_0060083
9021	VALK_AML_WITH_CEBPA	15084694	leukemia	DOID_1240
9022	VALK_AML_WITH_CEBPA	15084694	myeloid leukemia	DOID_8692
9023	VALK_AML_WITH_CEBPA	15084694	organ system cancer	DOID_0050686
9024	VALK_AML_WITH_FLT3_ITD	15084694	acute myeloid leukemia	DOID_9119
9025	VALK_AML_WITH_FLT3_ITD	15084694	cancer	DOID_162
9026	VALK_AML_WITH_FLT3_ITD	15084694	disease of cellular proliferation	DOID_14566
9027	VALK_AML_WITH_FLT3_ITD	15084694	hematologic cancer	DOID_2531
9028	VALK_AML_WITH_FLT3_ITD	15084694	immune system cancer	DOID_0060083
9029	VALK_AML_WITH_FLT3_ITD	15084694	leukemia	DOID_1240
9030	VALK_AML_WITH_FLT3_ITD	15084694	myeloid leukemia	DOID_8692
9031	VALK_AML_WITH_FLT3_ITD	15084694	organ system cancer	DOID_0050686
9032	JISON_SICKLE_CELL_DISEASE_UP	15031206	anemia	DOID_2355
9033	JISON_SICKLE_CELL_DISEASE_UP	15031206	arterial occlusive disease	DOID_2868
9034	JISON_SICKLE_CELL_DISEASE_UP	15031206	arteriosclerosis	DOID_2349
9035	JISON_SICKLE_CELL_DISEASE_UP	15031206	arteriosclerotic cardiovascular disease	DOID_2348
9036	JISON_SICKLE_CELL_DISEASE_UP	15031206	atherosclerosis	DOID_1936
9037	JISON_SICKLE_CELL_DISEASE_UP	15031206	cardiovascular system disease	DOID_1287
9038	JISON_SICKLE_CELL_DISEASE_UP	15031206	disease of anatomical entity	DOID_7
9039	JISON_SICKLE_CELL_DISEASE_UP	15031206	hematopoietic system disease	DOID_74
9040	JISON_SICKLE_CELL_DISEASE_UP	15031206	immune system disease	DOID_2914
9041	JISON_SICKLE_CELL_DISEASE_UP	15031206	vascular disease	DOID_178
9042	JISON_SICKLE_CELL_DISEASE_DN	15031206	anemia	DOID_2355
9043	JISON_SICKLE_CELL_DISEASE_DN	15031206	arterial occlusive disease	DOID_2868
9044	JISON_SICKLE_CELL_DISEASE_DN	15031206	arteriosclerosis	DOID_2349
9045	JISON_SICKLE_CELL_DISEASE_DN	15031206	arteriosclerotic cardiovascular disease	DOID_2348
9046	JISON_SICKLE_CELL_DISEASE_DN	15031206	atherosclerosis	DOID_1936
9047	JISON_SICKLE_CELL_DISEASE_DN	15031206	cardiovascular system disease	DOID_1287
9048	JISON_SICKLE_CELL_DISEASE_DN	15031206	disease of anatomical entity	DOID_7
9049	JISON_SICKLE_CELL_DISEASE_DN	15031206	hematopoietic system disease	DOID_74
9050	JISON_SICKLE_CELL_DISEASE_DN	15031206	immune system disease	DOID_2914
9051	JISON_SICKLE_CELL_DISEASE_DN	15031206	vascular disease	DOID_178
9052	POOLA_INVASIVE_BREAST_CANCER_UP	15864312	breast cancer	DOID_1612
9053	POOLA_INVASIVE_BREAST_CANCER_UP	15864312	breast carcinoma in situ	DOID_8791
9054	POOLA_INVASIVE_BREAST_CANCER_UP	15864312	cancer	DOID_162
9055	POOLA_INVASIVE_BREAST_CANCER_UP	15864312	carcinoma	DOID_305
9056	POOLA_INVASIVE_BREAST_CANCER_UP	15864312	cell type cancer	DOID_0050687
9057	POOLA_INVASIVE_BREAST_CANCER_UP	15864312	disease of cellular proliferation	DOID_14566
9058	POOLA_INVASIVE_BREAST_CANCER_UP	15864312	ductal carcinoma	DOID_3007
9059	POOLA_INVASIVE_BREAST_CANCER_UP	15864312	ductal carcinoma in situ	DOID_0060074
9060	POOLA_INVASIVE_BREAST_CANCER_UP	15864312	in situ carcinoma	DOID_8719
9061	POOLA_INVASIVE_BREAST_CANCER_UP	15864312	organ system cancer	DOID_0050686
9062	POOLA_INVASIVE_BREAST_CANCER_UP	15864312	pre-malignant neoplasm	DOID_0060071
9063	POOLA_INVASIVE_BREAST_CANCER_UP	15864312	thoracic cancer	DOID_5093
9064	POOLA_INVASIVE_BREAST_CANCER_DN	15864312	breast cancer	DOID_1612
9065	POOLA_INVASIVE_BREAST_CANCER_DN	15864312	breast carcinoma in situ	DOID_8791
9066	POOLA_INVASIVE_BREAST_CANCER_DN	15864312	cancer	DOID_162
9067	POOLA_INVASIVE_BREAST_CANCER_DN	15864312	carcinoma	DOID_305
9068	POOLA_INVASIVE_BREAST_CANCER_DN	15864312	cell type cancer	DOID_0050687
9069	POOLA_INVASIVE_BREAST_CANCER_DN	15864312	disease of cellular proliferation	DOID_14566
9070	POOLA_INVASIVE_BREAST_CANCER_DN	15864312	ductal carcinoma	DOID_3007
9071	POOLA_INVASIVE_BREAST_CANCER_DN	15864312	ductal carcinoma in situ	DOID_0060074
9072	POOLA_INVASIVE_BREAST_CANCER_DN	15864312	in situ carcinoma	DOID_8719
9073	POOLA_INVASIVE_BREAST_CANCER_DN	15864312	organ system cancer	DOID_0050686
9074	POOLA_INVASIVE_BREAST_CANCER_DN	15864312	pre-malignant neoplasm	DOID_0060071
9075	POOLA_INVASIVE_BREAST_CANCER_DN	15864312	thoracic cancer	DOID_5093
9076	DING_LUNG_CANCER_BY_MUTATION_RATE	18948947	adenocarcinoma	DOID_299
9077	DING_LUNG_CANCER_BY_MUTATION_RATE	18948947	cancer	DOID_162
9078	DING_LUNG_CANCER_BY_MUTATION_RATE	18948947	carcinoma	DOID_305
9079	DING_LUNG_CANCER_BY_MUTATION_RATE	18948947	cell type cancer	DOID_0050687
9080	DING_LUNG_CANCER_BY_MUTATION_RATE	18948947	disease of cellular proliferation	DOID_14566
9081	DING_LUNG_CANCER_BY_MUTATION_RATE	18948947	lung adenocarcinoma	DOID_3910
9082	DING_LUNG_CANCER_BY_MUTATION_RATE	18948947	lung cancer	DOID_1324
9083	DING_LUNG_CANCER_BY_MUTATION_RATE	18948947	lung carcinoma	DOID_3905
9084	DING_LUNG_CANCER_BY_MUTATION_RATE	18948947	non-small cell lung carcinoma	DOID_3908
9085	DING_LUNG_CANCER_BY_MUTATION_RATE	18948947	organ system cancer	DOID_0050686
9086	DING_LUNG_CANCER_BY_MUTATION_RATE	18948947	respiratory system cancer	DOID_0050615
9087	BOYAULT_LIVER_CANCER_SUBCLASS_G1_UP	17187432	adenoma	DOID_657
9088	BOYAULT_LIVER_CANCER_SUBCLASS_G1_UP	17187432	benign neoplasm	DOID_0060072
9089	BOYAULT_LIVER_CANCER_SUBCLASS_G1_UP	17187432	cancer	DOID_162
9090	BOYAULT_LIVER_CANCER_SUBCLASS_G1_UP	17187432	carcinoma	DOID_305
9091	BOYAULT_LIVER_CANCER_SUBCLASS_G1_UP	17187432	cell type benign neoplasm	DOID_0060084
9092	BOYAULT_LIVER_CANCER_SUBCLASS_G1_UP	17187432	cell type cancer	DOID_0050687
9093	BOYAULT_LIVER_CANCER_SUBCLASS_G1_UP	17187432	disease of cellular proliferation	DOID_14566
9094	BOYAULT_LIVER_CANCER_SUBCLASS_G1_UP	17187432	gastrointestinal system cancer	DOID_3119
9095	BOYAULT_LIVER_CANCER_SUBCLASS_G1_UP	17187432	hepatocellular carcinoma	DOID_684
9096	BOYAULT_LIVER_CANCER_SUBCLASS_G1_UP	17187432	liver cancer	DOID_3571
9097	BOYAULT_LIVER_CANCER_SUBCLASS_G1_UP	17187432	liver carcinoma	DOID_686
9098	BOYAULT_LIVER_CANCER_SUBCLASS_G1_UP	17187432	organ system cancer	DOID_0050686
9099	BOYAULT_LIVER_CANCER_SUBCLASS_G1_DN	17187432	adenoma	DOID_657
9100	BOYAULT_LIVER_CANCER_SUBCLASS_G1_DN	17187432	benign neoplasm	DOID_0060072
9101	BOYAULT_LIVER_CANCER_SUBCLASS_G1_DN	17187432	cancer	DOID_162
9102	BOYAULT_LIVER_CANCER_SUBCLASS_G1_DN	17187432	carcinoma	DOID_305
9103	BOYAULT_LIVER_CANCER_SUBCLASS_G1_DN	17187432	cell type benign neoplasm	DOID_0060084
9104	BOYAULT_LIVER_CANCER_SUBCLASS_G1_DN	17187432	cell type cancer	DOID_0050687
9105	BOYAULT_LIVER_CANCER_SUBCLASS_G1_DN	17187432	disease of cellular proliferation	DOID_14566
9106	BOYAULT_LIVER_CANCER_SUBCLASS_G1_DN	17187432	gastrointestinal system cancer	DOID_3119
9107	BOYAULT_LIVER_CANCER_SUBCLASS_G1_DN	17187432	hepatocellular carcinoma	DOID_684
9108	BOYAULT_LIVER_CANCER_SUBCLASS_G1_DN	17187432	liver cancer	DOID_3571
9109	BOYAULT_LIVER_CANCER_SUBCLASS_G1_DN	17187432	liver carcinoma	DOID_686
9110	BOYAULT_LIVER_CANCER_SUBCLASS_G1_DN	17187432	organ system cancer	DOID_0050686
9111	BOYAULT_LIVER_CANCER_SUBCLASS_G2	17187432	adenoma	DOID_657
9112	BOYAULT_LIVER_CANCER_SUBCLASS_G2	17187432	benign neoplasm	DOID_0060072
9113	BOYAULT_LIVER_CANCER_SUBCLASS_G2	17187432	cancer	DOID_162
9114	BOYAULT_LIVER_CANCER_SUBCLASS_G2	17187432	carcinoma	DOID_305
9115	BOYAULT_LIVER_CANCER_SUBCLASS_G2	17187432	cell type benign neoplasm	DOID_0060084
9116	BOYAULT_LIVER_CANCER_SUBCLASS_G2	17187432	cell type cancer	DOID_0050687
9117	BOYAULT_LIVER_CANCER_SUBCLASS_G2	17187432	disease of cellular proliferation	DOID_14566
9118	BOYAULT_LIVER_CANCER_SUBCLASS_G2	17187432	gastrointestinal system cancer	DOID_3119
9119	BOYAULT_LIVER_CANCER_SUBCLASS_G2	17187432	hepatocellular carcinoma	DOID_684
9120	BOYAULT_LIVER_CANCER_SUBCLASS_G2	17187432	liver cancer	DOID_3571
9121	BOYAULT_LIVER_CANCER_SUBCLASS_G2	17187432	liver carcinoma	DOID_686
9122	BOYAULT_LIVER_CANCER_SUBCLASS_G2	17187432	organ system cancer	DOID_0050686
9123	BOYAULT_LIVER_CANCER_SUBCLASS_G3_UP	17187432	adenoma	DOID_657
9124	BOYAULT_LIVER_CANCER_SUBCLASS_G3_UP	17187432	benign neoplasm	DOID_0060072
9125	BOYAULT_LIVER_CANCER_SUBCLASS_G3_UP	17187432	cancer	DOID_162
9126	BOYAULT_LIVER_CANCER_SUBCLASS_G3_UP	17187432	carcinoma	DOID_305
9127	BOYAULT_LIVER_CANCER_SUBCLASS_G3_UP	17187432	cell type benign neoplasm	DOID_0060084
9128	BOYAULT_LIVER_CANCER_SUBCLASS_G3_UP	17187432	cell type cancer	DOID_0050687
9129	BOYAULT_LIVER_CANCER_SUBCLASS_G3_UP	17187432	disease of cellular proliferation	DOID_14566
9130	BOYAULT_LIVER_CANCER_SUBCLASS_G3_UP	17187432	gastrointestinal system cancer	DOID_3119
9131	BOYAULT_LIVER_CANCER_SUBCLASS_G3_UP	17187432	hepatocellular carcinoma	DOID_684
9132	BOYAULT_LIVER_CANCER_SUBCLASS_G3_UP	17187432	liver cancer	DOID_3571
9133	BOYAULT_LIVER_CANCER_SUBCLASS_G3_UP	17187432	liver carcinoma	DOID_686
9134	BOYAULT_LIVER_CANCER_SUBCLASS_G3_UP	17187432	organ system cancer	DOID_0050686
9135	BOYAULT_LIVER_CANCER_SUBCLASS_G3_DN	17187432	adenoma	DOID_657
9136	BOYAULT_LIVER_CANCER_SUBCLASS_G3_DN	17187432	benign neoplasm	DOID_0060072
9137	BOYAULT_LIVER_CANCER_SUBCLASS_G3_DN	17187432	cancer	DOID_162
9138	BOYAULT_LIVER_CANCER_SUBCLASS_G3_DN	17187432	carcinoma	DOID_305
9139	BOYAULT_LIVER_CANCER_SUBCLASS_G3_DN	17187432	cell type benign neoplasm	DOID_0060084
9140	BOYAULT_LIVER_CANCER_SUBCLASS_G3_DN	17187432	cell type cancer	DOID_0050687
9141	BOYAULT_LIVER_CANCER_SUBCLASS_G3_DN	17187432	disease of cellular proliferation	DOID_14566
9142	BOYAULT_LIVER_CANCER_SUBCLASS_G3_DN	17187432	gastrointestinal system cancer	DOID_3119
9143	BOYAULT_LIVER_CANCER_SUBCLASS_G3_DN	17187432	hepatocellular carcinoma	DOID_684
9144	BOYAULT_LIVER_CANCER_SUBCLASS_G3_DN	17187432	liver cancer	DOID_3571
9145	BOYAULT_LIVER_CANCER_SUBCLASS_G3_DN	17187432	liver carcinoma	DOID_686
9146	BOYAULT_LIVER_CANCER_SUBCLASS_G3_DN	17187432	organ system cancer	DOID_0050686
9147	BOYAULT_LIVER_CANCER_SUBCLASS_G5_DN	17187432	adenoma	DOID_657
9148	BOYAULT_LIVER_CANCER_SUBCLASS_G5_DN	17187432	benign neoplasm	DOID_0060072
9149	BOYAULT_LIVER_CANCER_SUBCLASS_G5_DN	17187432	cancer	DOID_162
9150	BOYAULT_LIVER_CANCER_SUBCLASS_G5_DN	17187432	carcinoma	DOID_305
9151	BOYAULT_LIVER_CANCER_SUBCLASS_G5_DN	17187432	cell type benign neoplasm	DOID_0060084
9152	BOYAULT_LIVER_CANCER_SUBCLASS_G5_DN	17187432	cell type cancer	DOID_0050687
9153	BOYAULT_LIVER_CANCER_SUBCLASS_G5_DN	17187432	disease of cellular proliferation	DOID_14566
9154	BOYAULT_LIVER_CANCER_SUBCLASS_G5_DN	17187432	gastrointestinal system cancer	DOID_3119
9155	BOYAULT_LIVER_CANCER_SUBCLASS_G5_DN	17187432	hepatocellular carcinoma	DOID_684
9156	BOYAULT_LIVER_CANCER_SUBCLASS_G5_DN	17187432	liver cancer	DOID_3571
9157	BOYAULT_LIVER_CANCER_SUBCLASS_G5_DN	17187432	liver carcinoma	DOID_686
9158	BOYAULT_LIVER_CANCER_SUBCLASS_G5_DN	17187432	organ system cancer	DOID_0050686
9159	BOYAULT_LIVER_CANCER_SUBCLASS_G6_UP	17187432	adenoma	DOID_657
9160	BOYAULT_LIVER_CANCER_SUBCLASS_G6_UP	17187432	benign neoplasm	DOID_0060072
9161	BOYAULT_LIVER_CANCER_SUBCLASS_G6_UP	17187432	cancer	DOID_162
9162	BOYAULT_LIVER_CANCER_SUBCLASS_G6_UP	17187432	carcinoma	DOID_305
9163	BOYAULT_LIVER_CANCER_SUBCLASS_G6_UP	17187432	cell type benign neoplasm	DOID_0060084
9164	BOYAULT_LIVER_CANCER_SUBCLASS_G6_UP	17187432	cell type cancer	DOID_0050687
9165	BOYAULT_LIVER_CANCER_SUBCLASS_G6_UP	17187432	disease of cellular proliferation	DOID_14566
9166	BOYAULT_LIVER_CANCER_SUBCLASS_G6_UP	17187432	gastrointestinal system cancer	DOID_3119
9167	BOYAULT_LIVER_CANCER_SUBCLASS_G6_UP	17187432	hepatocellular carcinoma	DOID_684
9168	BOYAULT_LIVER_CANCER_SUBCLASS_G6_UP	17187432	liver cancer	DOID_3571
9169	BOYAULT_LIVER_CANCER_SUBCLASS_G6_UP	17187432	liver carcinoma	DOID_686
9170	BOYAULT_LIVER_CANCER_SUBCLASS_G6_UP	17187432	organ system cancer	DOID_0050686
9171	BOYAULT_LIVER_CANCER_SUBCLASS_G6_DN	17187432	adenoma	DOID_657
9172	BOYAULT_LIVER_CANCER_SUBCLASS_G6_DN	17187432	benign neoplasm	DOID_0060072
9173	BOYAULT_LIVER_CANCER_SUBCLASS_G6_DN	17187432	cancer	DOID_162
9174	BOYAULT_LIVER_CANCER_SUBCLASS_G6_DN	17187432	carcinoma	DOID_305
9175	BOYAULT_LIVER_CANCER_SUBCLASS_G6_DN	17187432	cell type benign neoplasm	DOID_0060084
9176	BOYAULT_LIVER_CANCER_SUBCLASS_G6_DN	17187432	cell type cancer	DOID_0050687
9177	BOYAULT_LIVER_CANCER_SUBCLASS_G6_DN	17187432	disease of cellular proliferation	DOID_14566
9178	BOYAULT_LIVER_CANCER_SUBCLASS_G6_DN	17187432	gastrointestinal system cancer	DOID_3119
9179	BOYAULT_LIVER_CANCER_SUBCLASS_G6_DN	17187432	hepatocellular carcinoma	DOID_684
9180	BOYAULT_LIVER_CANCER_SUBCLASS_G6_DN	17187432	liver cancer	DOID_3571
9181	BOYAULT_LIVER_CANCER_SUBCLASS_G6_DN	17187432	liver carcinoma	DOID_686
9182	BOYAULT_LIVER_CANCER_SUBCLASS_G6_DN	17187432	organ system cancer	DOID_0050686
9183	BOYAULT_LIVER_CANCER_SUBCLASS_G12_UP	17187432	adenoma	DOID_657
9184	BOYAULT_LIVER_CANCER_SUBCLASS_G12_UP	17187432	benign neoplasm	DOID_0060072
9185	BOYAULT_LIVER_CANCER_SUBCLASS_G12_UP	17187432	cancer	DOID_162
9186	BOYAULT_LIVER_CANCER_SUBCLASS_G12_UP	17187432	carcinoma	DOID_305
9187	BOYAULT_LIVER_CANCER_SUBCLASS_G12_UP	17187432	cell type benign neoplasm	DOID_0060084
9188	BOYAULT_LIVER_CANCER_SUBCLASS_G12_UP	17187432	cell type cancer	DOID_0050687
9189	BOYAULT_LIVER_CANCER_SUBCLASS_G12_UP	17187432	disease of cellular proliferation	DOID_14566
9190	BOYAULT_LIVER_CANCER_SUBCLASS_G12_UP	17187432	gastrointestinal system cancer	DOID_3119
9191	BOYAULT_LIVER_CANCER_SUBCLASS_G12_UP	17187432	hepatocellular carcinoma	DOID_684
9192	BOYAULT_LIVER_CANCER_SUBCLASS_G12_UP	17187432	liver cancer	DOID_3571
9193	BOYAULT_LIVER_CANCER_SUBCLASS_G12_UP	17187432	liver carcinoma	DOID_686
9194	BOYAULT_LIVER_CANCER_SUBCLASS_G12_UP	17187432	organ system cancer	DOID_0050686
9195	BOYAULT_LIVER_CANCER_SUBCLASS_G12_DN	17187432	adenoma	DOID_657
9196	BOYAULT_LIVER_CANCER_SUBCLASS_G12_DN	17187432	benign neoplasm	DOID_0060072
9197	BOYAULT_LIVER_CANCER_SUBCLASS_G12_DN	17187432	cancer	DOID_162
9198	BOYAULT_LIVER_CANCER_SUBCLASS_G12_DN	17187432	carcinoma	DOID_305
9199	BOYAULT_LIVER_CANCER_SUBCLASS_G12_DN	17187432	cell type benign neoplasm	DOID_0060084
9200	BOYAULT_LIVER_CANCER_SUBCLASS_G12_DN	17187432	cell type cancer	DOID_0050687
9201	BOYAULT_LIVER_CANCER_SUBCLASS_G12_DN	17187432	disease of cellular proliferation	DOID_14566
9202	BOYAULT_LIVER_CANCER_SUBCLASS_G12_DN	17187432	gastrointestinal system cancer	DOID_3119
9203	BOYAULT_LIVER_CANCER_SUBCLASS_G12_DN	17187432	hepatocellular carcinoma	DOID_684
9204	BOYAULT_LIVER_CANCER_SUBCLASS_G12_DN	17187432	liver cancer	DOID_3571
9205	BOYAULT_LIVER_CANCER_SUBCLASS_G12_DN	17187432	liver carcinoma	DOID_686
9206	BOYAULT_LIVER_CANCER_SUBCLASS_G12_DN	17187432	organ system cancer	DOID_0050686
9207	BOYAULT_LIVER_CANCER_SUBCLASS_G23_UP	17187432	adenoma	DOID_657
9208	BOYAULT_LIVER_CANCER_SUBCLASS_G23_UP	17187432	benign neoplasm	DOID_0060072
9209	BOYAULT_LIVER_CANCER_SUBCLASS_G23_UP	17187432	cancer	DOID_162
9210	BOYAULT_LIVER_CANCER_SUBCLASS_G23_UP	17187432	carcinoma	DOID_305
9211	BOYAULT_LIVER_CANCER_SUBCLASS_G23_UP	17187432	cell type benign neoplasm	DOID_0060084
9212	BOYAULT_LIVER_CANCER_SUBCLASS_G23_UP	17187432	cell type cancer	DOID_0050687
9213	BOYAULT_LIVER_CANCER_SUBCLASS_G23_UP	17187432	disease of cellular proliferation	DOID_14566
9214	BOYAULT_LIVER_CANCER_SUBCLASS_G23_UP	17187432	gastrointestinal system cancer	DOID_3119
9215	BOYAULT_LIVER_CANCER_SUBCLASS_G23_UP	17187432	hepatocellular carcinoma	DOID_684
9216	BOYAULT_LIVER_CANCER_SUBCLASS_G23_UP	17187432	liver cancer	DOID_3571
9217	BOYAULT_LIVER_CANCER_SUBCLASS_G23_UP	17187432	liver carcinoma	DOID_686
9218	BOYAULT_LIVER_CANCER_SUBCLASS_G23_UP	17187432	organ system cancer	DOID_0050686
9219	BOYAULT_LIVER_CANCER_SUBCLASS_G56_UP	17187432	adenoma	DOID_657
9220	BOYAULT_LIVER_CANCER_SUBCLASS_G56_UP	17187432	benign neoplasm	DOID_0060072
9221	BOYAULT_LIVER_CANCER_SUBCLASS_G56_UP	17187432	cancer	DOID_162
9222	BOYAULT_LIVER_CANCER_SUBCLASS_G56_UP	17187432	carcinoma	DOID_305
9223	BOYAULT_LIVER_CANCER_SUBCLASS_G56_UP	17187432	cell type benign neoplasm	DOID_0060084
9224	BOYAULT_LIVER_CANCER_SUBCLASS_G56_UP	17187432	cell type cancer	DOID_0050687
9225	BOYAULT_LIVER_CANCER_SUBCLASS_G56_UP	17187432	disease of cellular proliferation	DOID_14566
9226	BOYAULT_LIVER_CANCER_SUBCLASS_G56_UP	17187432	gastrointestinal system cancer	DOID_3119
9227	BOYAULT_LIVER_CANCER_SUBCLASS_G56_UP	17187432	hepatocellular carcinoma	DOID_684
9228	BOYAULT_LIVER_CANCER_SUBCLASS_G56_UP	17187432	liver cancer	DOID_3571
9229	BOYAULT_LIVER_CANCER_SUBCLASS_G56_UP	17187432	liver carcinoma	DOID_686
9230	BOYAULT_LIVER_CANCER_SUBCLASS_G56_UP	17187432	organ system cancer	DOID_0050686
9231	BOYAULT_LIVER_CANCER_SUBCLASS_G56_DN	17187432	adenoma	DOID_657
9232	BOYAULT_LIVER_CANCER_SUBCLASS_G56_DN	17187432	benign neoplasm	DOID_0060072
9233	BOYAULT_LIVER_CANCER_SUBCLASS_G56_DN	17187432	cancer	DOID_162
9234	BOYAULT_LIVER_CANCER_SUBCLASS_G56_DN	17187432	carcinoma	DOID_305
9235	BOYAULT_LIVER_CANCER_SUBCLASS_G56_DN	17187432	cell type benign neoplasm	DOID_0060084
9236	BOYAULT_LIVER_CANCER_SUBCLASS_G56_DN	17187432	cell type cancer	DOID_0050687
9237	BOYAULT_LIVER_CANCER_SUBCLASS_G56_DN	17187432	disease of cellular proliferation	DOID_14566
9238	BOYAULT_LIVER_CANCER_SUBCLASS_G56_DN	17187432	gastrointestinal system cancer	DOID_3119
9239	BOYAULT_LIVER_CANCER_SUBCLASS_G56_DN	17187432	hepatocellular carcinoma	DOID_684
9240	BOYAULT_LIVER_CANCER_SUBCLASS_G56_DN	17187432	liver cancer	DOID_3571
9241	BOYAULT_LIVER_CANCER_SUBCLASS_G56_DN	17187432	liver carcinoma	DOID_686
9242	BOYAULT_LIVER_CANCER_SUBCLASS_G56_DN	17187432	organ system cancer	DOID_0050686
9243	BOYAULT_LIVER_CANCER_SUBCLASS_G123_UP	17187432	adenoma	DOID_657
9244	BOYAULT_LIVER_CANCER_SUBCLASS_G123_UP	17187432	benign neoplasm	DOID_0060072
9245	BOYAULT_LIVER_CANCER_SUBCLASS_G123_UP	17187432	cancer	DOID_162
9246	BOYAULT_LIVER_CANCER_SUBCLASS_G123_UP	17187432	carcinoma	DOID_305
9247	BOYAULT_LIVER_CANCER_SUBCLASS_G123_UP	17187432	cell type benign neoplasm	DOID_0060084
9248	BOYAULT_LIVER_CANCER_SUBCLASS_G123_UP	17187432	cell type cancer	DOID_0050687
9249	BOYAULT_LIVER_CANCER_SUBCLASS_G123_UP	17187432	disease of cellular proliferation	DOID_14566
9250	BOYAULT_LIVER_CANCER_SUBCLASS_G123_UP	17187432	gastrointestinal system cancer	DOID_3119
9251	BOYAULT_LIVER_CANCER_SUBCLASS_G123_UP	17187432	hepatocellular carcinoma	DOID_684
9252	BOYAULT_LIVER_CANCER_SUBCLASS_G123_UP	17187432	liver cancer	DOID_3571
9253	BOYAULT_LIVER_CANCER_SUBCLASS_G123_UP	17187432	liver carcinoma	DOID_686
9254	BOYAULT_LIVER_CANCER_SUBCLASS_G123_UP	17187432	organ system cancer	DOID_0050686
9255	BOYAULT_LIVER_CANCER_SUBCLASS_G123_DN	17187432	adenoma	DOID_657
9256	BOYAULT_LIVER_CANCER_SUBCLASS_G123_DN	17187432	benign neoplasm	DOID_0060072
9257	BOYAULT_LIVER_CANCER_SUBCLASS_G123_DN	17187432	cancer	DOID_162
9258	BOYAULT_LIVER_CANCER_SUBCLASS_G123_DN	17187432	carcinoma	DOID_305
9259	BOYAULT_LIVER_CANCER_SUBCLASS_G123_DN	17187432	cell type benign neoplasm	DOID_0060084
9260	BOYAULT_LIVER_CANCER_SUBCLASS_G123_DN	17187432	cell type cancer	DOID_0050687
9261	BOYAULT_LIVER_CANCER_SUBCLASS_G123_DN	17187432	disease of cellular proliferation	DOID_14566
9262	BOYAULT_LIVER_CANCER_SUBCLASS_G123_DN	17187432	gastrointestinal system cancer	DOID_3119
9263	BOYAULT_LIVER_CANCER_SUBCLASS_G123_DN	17187432	hepatocellular carcinoma	DOID_684
9264	BOYAULT_LIVER_CANCER_SUBCLASS_G123_DN	17187432	liver cancer	DOID_3571
9265	BOYAULT_LIVER_CANCER_SUBCLASS_G123_DN	17187432	liver carcinoma	DOID_686
9266	BOYAULT_LIVER_CANCER_SUBCLASS_G123_DN	17187432	organ system cancer	DOID_0050686
9267	CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_UP	18701503	adenocarcinoma	DOID_299
9268	CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_UP	18701503	cancer	DOID_162
9269	CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_UP	18701503	carcinoma	DOID_305
9270	CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_UP	18701503	cell type cancer	DOID_0050687
9271	CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_UP	18701503	disease by infectious agent	DOID_0050117
9272	CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_UP	18701503	disease of anatomical entity	DOID_7
9273	CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_UP	18701503	disease of cellular proliferation	DOID_14566
9274	CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_UP	18701503	gastrointestinal system cancer	DOID_3119
9275	CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_UP	18701503	gastrointestinal system disease	DOID_77
9276	CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_UP	18701503	hepatitis B	DOID_2043
9277	CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_UP	18701503	hepatitis C	DOID_1883
9278	CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_UP	18701503	hepatitis	DOID_2237
9279	CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_UP	18701503	hepatobiliary disease	DOID_3118
9280	CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_UP	18701503	hepatocellular carcinoma	DOID_684
9281	CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_UP	18701503	liver cancer	DOID_3571
9282	CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_UP	18701503	liver carcinoma	DOID_686
9283	CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_UP	18701503	liver disease	DOID_409
9284	CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_UP	18701503	organ system cancer	DOID_0050686
9285	CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_UP	18701503	viral infectious disease	DOID_934
9286	CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN	18701503	adenocarcinoma	DOID_299
9287	CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN	18701503	cancer	DOID_162
9288	CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN	18701503	carcinoma	DOID_305
9289	CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN	18701503	cell type cancer	DOID_0050687
9290	CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN	18701503	disease by infectious agent	DOID_0050117
9291	CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN	18701503	disease of anatomical entity	DOID_7
9292	CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN	18701503	disease of cellular proliferation	DOID_14566
9293	CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN	18701503	gastrointestinal system cancer	DOID_3119
9294	CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN	18701503	gastrointestinal system disease	DOID_77
9295	CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN	18701503	hepatitis B	DOID_2043
9296	CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN	18701503	hepatitis C	DOID_1883
9297	CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN	18701503	hepatitis	DOID_2237
9298	CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN	18701503	hepatobiliary disease	DOID_3118
9299	CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN	18701503	hepatocellular carcinoma	DOID_684
9300	CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN	18701503	liver cancer	DOID_3571
9301	CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN	18701503	liver carcinoma	DOID_686
9302	CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN	18701503	liver disease	DOID_409
9303	CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN	18701503	organ system cancer	DOID_0050686
9304	CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN	18701503	viral infectious disease	DOID_934
9305	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP	18701503	adenocarcinoma	DOID_299
9306	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP	18701503	cancer	DOID_162
9307	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP	18701503	carcinoma	DOID_305
9308	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP	18701503	cell type cancer	DOID_0050687
9309	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP	18701503	disease by infectious agent	DOID_0050117
9310	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP	18701503	disease of anatomical entity	DOID_7
9311	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP	18701503	disease of cellular proliferation	DOID_14566
9312	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP	18701503	gastrointestinal system cancer	DOID_3119
9313	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP	18701503	gastrointestinal system disease	DOID_77
9314	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP	18701503	hepatitis B	DOID_2043
9315	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP	18701503	hepatitis C	DOID_1883
9316	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP	18701503	hepatitis	DOID_2237
9317	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP	18701503	hepatobiliary disease	DOID_3118
9318	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP	18701503	hepatocellular carcinoma	DOID_684
9319	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP	18701503	liver cancer	DOID_3571
9320	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP	18701503	liver carcinoma	DOID_686
9321	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP	18701503	liver disease	DOID_409
9322	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP	18701503	organ system cancer	DOID_0050686
9323	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP	18701503	viral infectious disease	DOID_934
9324	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN	18701503	adenocarcinoma	DOID_299
9325	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN	18701503	cancer	DOID_162
9326	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN	18701503	carcinoma	DOID_305
9327	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN	18701503	cell type cancer	DOID_0050687
9328	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN	18701503	disease by infectious agent	DOID_0050117
9329	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN	18701503	disease of anatomical entity	DOID_7
9330	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN	18701503	disease of cellular proliferation	DOID_14566
9331	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN	18701503	gastrointestinal system cancer	DOID_3119
9332	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN	18701503	gastrointestinal system disease	DOID_77
9333	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN	18701503	hepatitis B	DOID_2043
9334	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN	18701503	hepatitis C	DOID_1883
9335	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN	18701503	hepatitis	DOID_2237
9336	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN	18701503	hepatobiliary disease	DOID_3118
9337	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN	18701503	hepatocellular carcinoma	DOID_684
9338	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN	18701503	liver cancer	DOID_3571
9339	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN	18701503	liver carcinoma	DOID_686
9340	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN	18701503	liver disease	DOID_409
9341	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN	18701503	organ system cancer	DOID_0050686
9342	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN	18701503	viral infectious disease	DOID_934
9343	CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_UP	18701503	adenocarcinoma	DOID_299
9344	CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_UP	18701503	cancer	DOID_162
9345	CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_UP	18701503	carcinoma	DOID_305
9346	CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_UP	18701503	cell type cancer	DOID_0050687
9347	CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_UP	18701503	disease by infectious agent	DOID_0050117
9348	CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_UP	18701503	disease of anatomical entity	DOID_7
9349	CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_UP	18701503	disease of cellular proliferation	DOID_14566
9350	CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_UP	18701503	gastrointestinal system cancer	DOID_3119
9351	CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_UP	18701503	gastrointestinal system disease	DOID_77
9352	CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_UP	18701503	hepatitis B	DOID_2043
9353	CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_UP	18701503	hepatitis C	DOID_1883
9354	CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_UP	18701503	hepatitis	DOID_2237
9355	CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_UP	18701503	hepatobiliary disease	DOID_3118
9356	CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_UP	18701503	hepatocellular carcinoma	DOID_684
9357	CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_UP	18701503	liver cancer	DOID_3571
9358	CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_UP	18701503	liver carcinoma	DOID_686
9359	CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_UP	18701503	liver disease	DOID_409
9360	CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_UP	18701503	organ system cancer	DOID_0050686
9361	CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_UP	18701503	viral infectious disease	DOID_934
9362	CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_DN	18701503	adenocarcinoma	DOID_299
9363	CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_DN	18701503	cancer	DOID_162
9364	CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_DN	18701503	carcinoma	DOID_305
9365	CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_DN	18701503	cell type cancer	DOID_0050687
9366	CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_DN	18701503	disease by infectious agent	DOID_0050117
9367	CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_DN	18701503	disease of anatomical entity	DOID_7
9368	CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_DN	18701503	disease of cellular proliferation	DOID_14566
9369	CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_DN	18701503	gastrointestinal system cancer	DOID_3119
9370	CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_DN	18701503	gastrointestinal system disease	DOID_77
9371	CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_DN	18701503	hepatitis B	DOID_2043
9372	CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_DN	18701503	hepatitis C	DOID_1883
9373	CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_DN	18701503	hepatitis	DOID_2237
9374	CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_DN	18701503	hepatobiliary disease	DOID_3118
9375	CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_DN	18701503	hepatocellular carcinoma	DOID_684
9376	CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_DN	18701503	liver cancer	DOID_3571
9377	CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_DN	18701503	liver carcinoma	DOID_686
9378	CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_DN	18701503	liver disease	DOID_409
9379	CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_DN	18701503	organ system cancer	DOID_0050686
9380	CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_DN	18701503	viral infectious disease	DOID_934
9381	CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_UP	18701503	adenocarcinoma	DOID_299
9382	CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_UP	18701503	cancer	DOID_162
9383	CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_UP	18701503	carcinoma	DOID_305
9384	CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_UP	18701503	cell type cancer	DOID_0050687
9385	CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_UP	18701503	disease by infectious agent	DOID_0050117
9386	CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_UP	18701503	disease of anatomical entity	DOID_7
9387	CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_UP	18701503	disease of cellular proliferation	DOID_14566
9388	CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_UP	18701503	gastrointestinal system cancer	DOID_3119
9389	CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_UP	18701503	gastrointestinal system disease	DOID_77
9390	CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_UP	18701503	hepatitis B	DOID_2043
9391	CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_UP	18701503	hepatitis C	DOID_1883
9392	CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_UP	18701503	hepatitis	DOID_2237
9393	CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_UP	18701503	hepatobiliary disease	DOID_3118
9394	CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_UP	18701503	hepatocellular carcinoma	DOID_684
9395	CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_UP	18701503	liver cancer	DOID_3571
9396	CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_UP	18701503	liver carcinoma	DOID_686
9397	CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_UP	18701503	liver disease	DOID_409
9398	CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_UP	18701503	organ system cancer	DOID_0050686
9399	CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_UP	18701503	viral infectious disease	DOID_934
9400	CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_DN	18701503	adenocarcinoma	DOID_299
9401	CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_DN	18701503	cancer	DOID_162
9402	CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_DN	18701503	carcinoma	DOID_305
9403	CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_DN	18701503	cell type cancer	DOID_0050687
9404	CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_DN	18701503	disease by infectious agent	DOID_0050117
9405	CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_DN	18701503	disease of anatomical entity	DOID_7
9406	CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_DN	18701503	disease of cellular proliferation	DOID_14566
9407	CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_DN	18701503	gastrointestinal system cancer	DOID_3119
9408	CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_DN	18701503	gastrointestinal system disease	DOID_77
9409	CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_DN	18701503	hepatitis B	DOID_2043
9410	CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_DN	18701503	hepatitis C	DOID_1883
9411	CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_DN	18701503	hepatitis	DOID_2237
9412	CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_DN	18701503	hepatobiliary disease	DOID_3118
9413	CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_DN	18701503	hepatocellular carcinoma	DOID_684
9414	CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_DN	18701503	liver cancer	DOID_3571
9415	CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_DN	18701503	liver carcinoma	DOID_686
9416	CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_DN	18701503	liver disease	DOID_409
9417	CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_DN	18701503	organ system cancer	DOID_0050686
9418	CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_DN	18701503	viral infectious disease	DOID_934
9419	CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_UP	18701503	adenocarcinoma	DOID_299
9420	CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_UP	18701503	cancer	DOID_162
9421	CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_UP	18701503	carcinoma	DOID_305
9422	CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_UP	18701503	cell type cancer	DOID_0050687
9423	CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_UP	18701503	disease by infectious agent	DOID_0050117
9424	CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_UP	18701503	disease of anatomical entity	DOID_7
9425	CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_UP	18701503	disease of cellular proliferation	DOID_14566
9426	CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_UP	18701503	gastrointestinal system cancer	DOID_3119
9427	CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_UP	18701503	gastrointestinal system disease	DOID_77
9428	CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_UP	18701503	hepatitis B	DOID_2043
9429	CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_UP	18701503	hepatitis C	DOID_1883
9430	CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_UP	18701503	hepatitis	DOID_2237
9431	CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_UP	18701503	hepatobiliary disease	DOID_3118
9432	CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_UP	18701503	hepatocellular carcinoma	DOID_684
9433	CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_UP	18701503	liver cancer	DOID_3571
9434	CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_UP	18701503	liver carcinoma	DOID_686
9435	CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_UP	18701503	liver disease	DOID_409
9436	CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_UP	18701503	organ system cancer	DOID_0050686
9437	CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_UP	18701503	viral infectious disease	DOID_934
9438	CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_DN	18701503	adenocarcinoma	DOID_299
9439	CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_DN	18701503	cancer	DOID_162
9440	CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_DN	18701503	carcinoma	DOID_305
9441	CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_DN	18701503	cell type cancer	DOID_0050687
9442	CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_DN	18701503	disease by infectious agent	DOID_0050117
9443	CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_DN	18701503	disease of anatomical entity	DOID_7
9444	CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_DN	18701503	disease of cellular proliferation	DOID_14566
9445	CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_DN	18701503	gastrointestinal system cancer	DOID_3119
9446	CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_DN	18701503	gastrointestinal system disease	DOID_77
9447	CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_DN	18701503	hepatitis B	DOID_2043
9448	CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_DN	18701503	hepatitis C	DOID_1883
9449	CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_DN	18701503	hepatitis	DOID_2237
9450	CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_DN	18701503	hepatobiliary disease	DOID_3118
9451	CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_DN	18701503	hepatocellular carcinoma	DOID_684
9452	CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_DN	18701503	liver cancer	DOID_3571
9453	CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_DN	18701503	liver carcinoma	DOID_686
9454	CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_DN	18701503	liver disease	DOID_409
9455	CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_DN	18701503	organ system cancer	DOID_0050686
9456	CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_DN	18701503	viral infectious disease	DOID_934
9457	COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP	18506891	adenocarcinoma	DOID_299
9458	COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP	18506891	cancer	DOID_162
9459	COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP	18506891	carcinoma	DOID_305
9460	COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP	18506891	cell type cancer	DOID_0050687
9461	COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP	18506891	disease of cellular proliferation	DOID_14566
9462	COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP	18506891	gastrointestinal system cancer	DOID_3119
9463	COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP	18506891	hepatocellular carcinoma	DOID_684
9464	COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP	18506891	liver cancer	DOID_3571
9465	COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP	18506891	liver carcinoma	DOID_686
9466	COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP	18506891	liver metastasis	DOID_12722
9467	COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP	18506891	organ system cancer	DOID_0050686
9468	COULOUARN_TEMPORAL_TGFB1_SIGNATURE_DN	18506891	adenocarcinoma	DOID_299
9469	COULOUARN_TEMPORAL_TGFB1_SIGNATURE_DN	18506891	cancer	DOID_162
9470	COULOUARN_TEMPORAL_TGFB1_SIGNATURE_DN	18506891	carcinoma	DOID_305
9471	COULOUARN_TEMPORAL_TGFB1_SIGNATURE_DN	18506891	cell type cancer	DOID_0050687
9472	COULOUARN_TEMPORAL_TGFB1_SIGNATURE_DN	18506891	disease of cellular proliferation	DOID_14566
9473	COULOUARN_TEMPORAL_TGFB1_SIGNATURE_DN	18506891	gastrointestinal system cancer	DOID_3119
9474	COULOUARN_TEMPORAL_TGFB1_SIGNATURE_DN	18506891	hepatocellular carcinoma	DOID_684
9475	COULOUARN_TEMPORAL_TGFB1_SIGNATURE_DN	18506891	liver cancer	DOID_3571
9476	COULOUARN_TEMPORAL_TGFB1_SIGNATURE_DN	18506891	liver carcinoma	DOID_686
9477	COULOUARN_TEMPORAL_TGFB1_SIGNATURE_DN	18506891	liver metastasis	DOID_12722
9478	COULOUARN_TEMPORAL_TGFB1_SIGNATURE_DN	18506891	organ system cancer	DOID_0050686
9479	HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_UP	18923165	cancer	DOID_162
9480	HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_UP	18923165	carcinoma	DOID_305
9481	HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_UP	18923165	cell type cancer	DOID_0050687
9482	HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_UP	18923165	disease of cellular proliferation	DOID_14566
9483	HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_UP	18923165	gastrointestinal system cancer	DOID_3119
9484	HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_UP	18923165	hepatocellular carcinoma	DOID_684
9485	HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_UP	18923165	liver cancer	DOID_3571
9486	HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_UP	18923165	liver carcinoma	DOID_686
9487	HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_UP	18923165	organ system cancer	DOID_0050686
9488	HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_DN	18923165	cancer	DOID_162
9489	HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_DN	18923165	carcinoma	DOID_305
9490	HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_DN	18923165	cell type cancer	DOID_0050687
9491	HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_DN	18923165	disease of cellular proliferation	DOID_14566
9492	HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_DN	18923165	gastrointestinal system cancer	DOID_3119
9493	HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_DN	18923165	hepatocellular carcinoma	DOID_684
9494	HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_DN	18923165	liver cancer	DOID_3571
9495	HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_DN	18923165	liver carcinoma	DOID_686
9496	HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_DN	18923165	organ system cancer	DOID_0050686
9497	HOSHIDA_LIVER_CANCER_SURVIVAL_UP	18923165	cancer	DOID_162
9498	HOSHIDA_LIVER_CANCER_SURVIVAL_UP	18923165	carcinoma	DOID_305
9499	HOSHIDA_LIVER_CANCER_SURVIVAL_UP	18923165	cell type cancer	DOID_0050687
9500	HOSHIDA_LIVER_CANCER_SURVIVAL_UP	18923165	disease of cellular proliferation	DOID_14566
9501	HOSHIDA_LIVER_CANCER_SURVIVAL_UP	18923165	gastrointestinal system cancer	DOID_3119
9502	HOSHIDA_LIVER_CANCER_SURVIVAL_UP	18923165	hepatocellular carcinoma	DOID_684
9503	HOSHIDA_LIVER_CANCER_SURVIVAL_UP	18923165	liver cancer	DOID_3571
9504	HOSHIDA_LIVER_CANCER_SURVIVAL_UP	18923165	liver carcinoma	DOID_686
9505	HOSHIDA_LIVER_CANCER_SURVIVAL_UP	18923165	organ system cancer	DOID_0050686
9506	HOSHIDA_LIVER_CANCER_SURVIVAL_DN	18923165	cancer	DOID_162
9507	HOSHIDA_LIVER_CANCER_SURVIVAL_DN	18923165	carcinoma	DOID_305
9508	HOSHIDA_LIVER_CANCER_SURVIVAL_DN	18923165	cell type cancer	DOID_0050687
9509	HOSHIDA_LIVER_CANCER_SURVIVAL_DN	18923165	disease of cellular proliferation	DOID_14566
9510	HOSHIDA_LIVER_CANCER_SURVIVAL_DN	18923165	gastrointestinal system cancer	DOID_3119
9511	HOSHIDA_LIVER_CANCER_SURVIVAL_DN	18923165	hepatocellular carcinoma	DOID_684
9512	HOSHIDA_LIVER_CANCER_SURVIVAL_DN	18923165	liver cancer	DOID_3571
9513	HOSHIDA_LIVER_CANCER_SURVIVAL_DN	18923165	liver carcinoma	DOID_686
9514	HOSHIDA_LIVER_CANCER_SURVIVAL_DN	18923165	organ system cancer	DOID_0050686
9515	KAPOSI_LIVER_CANCER_POOR_SURVIVAL_UP	16710476	cancer	DOID_162
9516	KAPOSI_LIVER_CANCER_POOR_SURVIVAL_UP	16710476	carcinoma	DOID_305
9517	KAPOSI_LIVER_CANCER_POOR_SURVIVAL_UP	16710476	cell type cancer	DOID_0050687
9518	KAPOSI_LIVER_CANCER_POOR_SURVIVAL_UP	16710476	disease of cellular proliferation	DOID_14566
9519	KAPOSI_LIVER_CANCER_POOR_SURVIVAL_UP	16710476	gastrointestinal system cancer	DOID_3119
9520	KAPOSI_LIVER_CANCER_POOR_SURVIVAL_UP	16710476	hepatocellular carcinoma	DOID_684
9521	KAPOSI_LIVER_CANCER_POOR_SURVIVAL_UP	16710476	liver cancer	DOID_3571
9522	KAPOSI_LIVER_CANCER_POOR_SURVIVAL_UP	16710476	liver carcinoma	DOID_686
9523	KAPOSI_LIVER_CANCER_POOR_SURVIVAL_UP	16710476	organ system cancer	DOID_0050686
9524	YAMASHITA_LIVER_CANCER_WITH_EPCAM_UP	18316609	cancer	DOID_162
9525	YAMASHITA_LIVER_CANCER_WITH_EPCAM_UP	18316609	carcinoma	DOID_305
9526	YAMASHITA_LIVER_CANCER_WITH_EPCAM_UP	18316609	cell type cancer	DOID_0050687
9527	YAMASHITA_LIVER_CANCER_WITH_EPCAM_UP	18316609	disease of cellular proliferation	DOID_14566
9528	YAMASHITA_LIVER_CANCER_WITH_EPCAM_UP	18316609	gastrointestinal system cancer	DOID_3119
9529	YAMASHITA_LIVER_CANCER_WITH_EPCAM_UP	18316609	hepatocellular carcinoma	DOID_684
9530	YAMASHITA_LIVER_CANCER_WITH_EPCAM_UP	18316609	liver cancer	DOID_3571
9531	YAMASHITA_LIVER_CANCER_WITH_EPCAM_UP	18316609	liver carcinoma	DOID_686
9532	YAMASHITA_LIVER_CANCER_WITH_EPCAM_UP	18316609	organ system cancer	DOID_0050686
9533	YAMASHITA_LIVER_CANCER_WITH_EPCAM_DN	18316609	cancer	DOID_162
9534	YAMASHITA_LIVER_CANCER_WITH_EPCAM_DN	18316609	carcinoma	DOID_305
9535	YAMASHITA_LIVER_CANCER_WITH_EPCAM_DN	18316609	cell type cancer	DOID_0050687
9536	YAMASHITA_LIVER_CANCER_WITH_EPCAM_DN	18316609	disease of cellular proliferation	DOID_14566
9537	YAMASHITA_LIVER_CANCER_WITH_EPCAM_DN	18316609	gastrointestinal system cancer	DOID_3119
9538	YAMASHITA_LIVER_CANCER_WITH_EPCAM_DN	18316609	hepatocellular carcinoma	DOID_684
9539	YAMASHITA_LIVER_CANCER_WITH_EPCAM_DN	18316609	liver cancer	DOID_3571
9540	YAMASHITA_LIVER_CANCER_WITH_EPCAM_DN	18316609	liver carcinoma	DOID_686
9541	YAMASHITA_LIVER_CANCER_WITH_EPCAM_DN	18316609	organ system cancer	DOID_0050686
9542	YAMASHITA_LIVER_CANCER_STEM_CELL_UP	19150350	cancer	DOID_162
9543	YAMASHITA_LIVER_CANCER_STEM_CELL_UP	19150350	carcinoma	DOID_305
9544	YAMASHITA_LIVER_CANCER_STEM_CELL_UP	19150350	cell type cancer	DOID_0050687
9545	YAMASHITA_LIVER_CANCER_STEM_CELL_UP	19150350	combined T cell and B cell immunodeficiency	DOID_628
9546	YAMASHITA_LIVER_CANCER_STEM_CELL_UP	19150350	disease of anatomical entity	DOID_7
9547	YAMASHITA_LIVER_CANCER_STEM_CELL_UP	19150350	disease of cellular proliferation	DOID_14566
9548	YAMASHITA_LIVER_CANCER_STEM_CELL_UP	19150350	gastrointestinal system cancer	DOID_3119
9549	YAMASHITA_LIVER_CANCER_STEM_CELL_UP	19150350	hepatocellular carcinoma	DOID_684
9550	YAMASHITA_LIVER_CANCER_STEM_CELL_UP	19150350	immune system disease	DOID_2914
9551	YAMASHITA_LIVER_CANCER_STEM_CELL_UP	19150350	liver cancer	DOID_3571
9552	YAMASHITA_LIVER_CANCER_STEM_CELL_UP	19150350	liver carcinoma	DOID_686
9553	YAMASHITA_LIVER_CANCER_STEM_CELL_UP	19150350	organ system cancer	DOID_0050686
9554	YAMASHITA_LIVER_CANCER_STEM_CELL_UP	19150350	primary immunodeficiency disease	DOID_612
9555	YAMASHITA_LIVER_CANCER_STEM_CELL_UP	19150350	severe combined immunodeficiency	DOID_627
9556	YAMASHITA_LIVER_CANCER_STEM_CELL_DN	19150350	cancer	DOID_162
9557	YAMASHITA_LIVER_CANCER_STEM_CELL_DN	19150350	carcinoma	DOID_305
9558	YAMASHITA_LIVER_CANCER_STEM_CELL_DN	19150350	cell type cancer	DOID_0050687
9559	YAMASHITA_LIVER_CANCER_STEM_CELL_DN	19150350	combined T cell and B cell immunodeficiency	DOID_628
9560	YAMASHITA_LIVER_CANCER_STEM_CELL_DN	19150350	disease of anatomical entity	DOID_7
9561	YAMASHITA_LIVER_CANCER_STEM_CELL_DN	19150350	disease of cellular proliferation	DOID_14566
9562	YAMASHITA_LIVER_CANCER_STEM_CELL_DN	19150350	gastrointestinal system cancer	DOID_3119
9563	YAMASHITA_LIVER_CANCER_STEM_CELL_DN	19150350	hepatocellular carcinoma	DOID_684
9564	YAMASHITA_LIVER_CANCER_STEM_CELL_DN	19150350	immune system disease	DOID_2914
9565	YAMASHITA_LIVER_CANCER_STEM_CELL_DN	19150350	liver cancer	DOID_3571
9566	YAMASHITA_LIVER_CANCER_STEM_CELL_DN	19150350	liver carcinoma	DOID_686
9567	YAMASHITA_LIVER_CANCER_STEM_CELL_DN	19150350	organ system cancer	DOID_0050686
9568	YAMASHITA_LIVER_CANCER_STEM_CELL_DN	19150350	primary immunodeficiency disease	DOID_612
9569	YAMASHITA_LIVER_CANCER_STEM_CELL_DN	19150350	severe combined immunodeficiency	DOID_627
9570	LEE_LIVER_CANCER_HEPATOBLAST	16532004	cancer	DOID_162
9571	LEE_LIVER_CANCER_HEPATOBLAST	16532004	carcinoma	DOID_305
9572	LEE_LIVER_CANCER_HEPATOBLAST	16532004	cell type cancer	DOID_0050687
9573	LEE_LIVER_CANCER_HEPATOBLAST	16532004	disease of cellular proliferation	DOID_14566
9574	LEE_LIVER_CANCER_HEPATOBLAST	16532004	gastrointestinal system cancer	DOID_3119
9575	LEE_LIVER_CANCER_HEPATOBLAST	16532004	hepatocellular carcinoma	DOID_684
9576	LEE_LIVER_CANCER_HEPATOBLAST	16532004	liver cancer	DOID_3571
9577	LEE_LIVER_CANCER_HEPATOBLAST	16532004	liver carcinoma	DOID_686
9578	LEE_LIVER_CANCER_HEPATOBLAST	16532004	organ system cancer	DOID_0050686
9579	WANG_RECURRENT_LIVER_CANCER_UP	17975138	cancer	DOID_162
9580	WANG_RECURRENT_LIVER_CANCER_UP	17975138	carcinoma	DOID_305
9581	WANG_RECURRENT_LIVER_CANCER_UP	17975138	cell type cancer	DOID_0050687
9582	WANG_RECURRENT_LIVER_CANCER_UP	17975138	disease of anatomical entity	DOID_7
9583	WANG_RECURRENT_LIVER_CANCER_UP	17975138	disease of cellular proliferation	DOID_14566
9584	WANG_RECURRENT_LIVER_CANCER_UP	17975138	gastrointestinal system cancer	DOID_3119
9585	WANG_RECURRENT_LIVER_CANCER_UP	17975138	gastrointestinal system disease	DOID_77
9586	WANG_RECURRENT_LIVER_CANCER_UP	17975138	hepatobiliary disease	DOID_3118
9587	WANG_RECURRENT_LIVER_CANCER_UP	17975138	hepatocellular carcinoma	DOID_684
9588	WANG_RECURRENT_LIVER_CANCER_UP	17975138	liver cancer	DOID_3571
9589	WANG_RECURRENT_LIVER_CANCER_UP	17975138	liver carcinoma	DOID_686
9590	WANG_RECURRENT_LIVER_CANCER_UP	17975138	liver cirrhosis	DOID_5082
9591	WANG_RECURRENT_LIVER_CANCER_UP	17975138	liver disease	DOID_409
9592	WANG_RECURRENT_LIVER_CANCER_UP	17975138	organ system cancer	DOID_0050686
9593	WANG_RECURRENT_LIVER_CANCER_DN	17975138	cancer	DOID_162
9594	WANG_RECURRENT_LIVER_CANCER_DN	17975138	carcinoma	DOID_305
9595	WANG_RECURRENT_LIVER_CANCER_DN	17975138	cell type cancer	DOID_0050687
9596	WANG_RECURRENT_LIVER_CANCER_DN	17975138	disease of anatomical entity	DOID_7
9597	WANG_RECURRENT_LIVER_CANCER_DN	17975138	disease of cellular proliferation	DOID_14566
9598	WANG_RECURRENT_LIVER_CANCER_DN	17975138	gastrointestinal system cancer	DOID_3119
9599	WANG_RECURRENT_LIVER_CANCER_DN	17975138	gastrointestinal system disease	DOID_77
9600	WANG_RECURRENT_LIVER_CANCER_DN	17975138	hepatobiliary disease	DOID_3118
9601	WANG_RECURRENT_LIVER_CANCER_DN	17975138	hepatocellular carcinoma	DOID_684
9602	WANG_RECURRENT_LIVER_CANCER_DN	17975138	liver cancer	DOID_3571
9603	WANG_RECURRENT_LIVER_CANCER_DN	17975138	liver carcinoma	DOID_686
9604	WANG_RECURRENT_LIVER_CANCER_DN	17975138	liver cirrhosis	DOID_5082
9605	WANG_RECURRENT_LIVER_CANCER_DN	17975138	liver disease	DOID_409
9606	WANG_RECURRENT_LIVER_CANCER_DN	17975138	organ system cancer	DOID_0050686
9607	WOO_LIVER_CANCER_RECURRENCE_UP	18381945	cancer	DOID_162
9608	WOO_LIVER_CANCER_RECURRENCE_UP	18381945	carcinoma	DOID_305
9609	WOO_LIVER_CANCER_RECURRENCE_UP	18381945	cell type cancer	DOID_0050687
9610	WOO_LIVER_CANCER_RECURRENCE_UP	18381945	disease by infectious agent	DOID_0050117
9611	WOO_LIVER_CANCER_RECURRENCE_UP	18381945	disease of anatomical entity	DOID_7
9612	WOO_LIVER_CANCER_RECURRENCE_UP	18381945	disease of cellular proliferation	DOID_14566
9613	WOO_LIVER_CANCER_RECURRENCE_UP	18381945	gastrointestinal system cancer	DOID_3119
9614	WOO_LIVER_CANCER_RECURRENCE_UP	18381945	gastrointestinal system disease	DOID_77
9615	WOO_LIVER_CANCER_RECURRENCE_UP	18381945	hepatitis B	DOID_2043
9616	WOO_LIVER_CANCER_RECURRENCE_UP	18381945	hepatitis	DOID_2237
9617	WOO_LIVER_CANCER_RECURRENCE_UP	18381945	hepatobiliary disease	DOID_3118
9618	WOO_LIVER_CANCER_RECURRENCE_UP	18381945	hepatocellular carcinoma	DOID_684
9619	WOO_LIVER_CANCER_RECURRENCE_UP	18381945	liver cancer	DOID_3571
9620	WOO_LIVER_CANCER_RECURRENCE_UP	18381945	liver carcinoma	DOID_686
9621	WOO_LIVER_CANCER_RECURRENCE_UP	18381945	liver disease	DOID_409
9622	WOO_LIVER_CANCER_RECURRENCE_UP	18381945	organ system cancer	DOID_0050686
9623	WOO_LIVER_CANCER_RECURRENCE_UP	18381945	viral infectious disease	DOID_934
9624	WOO_LIVER_CANCER_RECURRENCE_DN	18381945	cancer	DOID_162
9625	WOO_LIVER_CANCER_RECURRENCE_DN	18381945	carcinoma	DOID_305
9626	WOO_LIVER_CANCER_RECURRENCE_DN	18381945	cell type cancer	DOID_0050687
9627	WOO_LIVER_CANCER_RECURRENCE_DN	18381945	disease by infectious agent	DOID_0050117
9628	WOO_LIVER_CANCER_RECURRENCE_DN	18381945	disease of anatomical entity	DOID_7
9629	WOO_LIVER_CANCER_RECURRENCE_DN	18381945	disease of cellular proliferation	DOID_14566
9630	WOO_LIVER_CANCER_RECURRENCE_DN	18381945	gastrointestinal system cancer	DOID_3119
9631	WOO_LIVER_CANCER_RECURRENCE_DN	18381945	gastrointestinal system disease	DOID_77
9632	WOO_LIVER_CANCER_RECURRENCE_DN	18381945	hepatitis B	DOID_2043
9633	WOO_LIVER_CANCER_RECURRENCE_DN	18381945	hepatitis	DOID_2237
9634	WOO_LIVER_CANCER_RECURRENCE_DN	18381945	hepatobiliary disease	DOID_3118
9635	WOO_LIVER_CANCER_RECURRENCE_DN	18381945	hepatocellular carcinoma	DOID_684
9636	WOO_LIVER_CANCER_RECURRENCE_DN	18381945	liver cancer	DOID_3571
9637	WOO_LIVER_CANCER_RECURRENCE_DN	18381945	liver carcinoma	DOID_686
9638	WOO_LIVER_CANCER_RECURRENCE_DN	18381945	liver disease	DOID_409
9639	WOO_LIVER_CANCER_RECURRENCE_DN	18381945	organ system cancer	DOID_0050686
9640	WOO_LIVER_CANCER_RECURRENCE_DN	18381945	viral infectious disease	DOID_934
9641	YAGI_AML_WITH_T_8_21_TRANSLOCATION	12738660	acute myeloid leukemia	DOID_9119
9642	YAGI_AML_WITH_T_8_21_TRANSLOCATION	12738660	cancer	DOID_162
9643	YAGI_AML_WITH_T_8_21_TRANSLOCATION	12738660	disease of cellular proliferation	DOID_14566
9644	YAGI_AML_WITH_T_8_21_TRANSLOCATION	12738660	hematologic cancer	DOID_2531
9645	YAGI_AML_WITH_T_8_21_TRANSLOCATION	12738660	immune system cancer	DOID_0060083
9646	YAGI_AML_WITH_T_8_21_TRANSLOCATION	12738660	leukemia	DOID_1240
9647	YAGI_AML_WITH_T_8_21_TRANSLOCATION	12738660	myeloid leukemia	DOID_8692
9648	YAGI_AML_WITH_T_8_21_TRANSLOCATION	12738660	organ system cancer	DOID_0050686
9649	YAGI_AML_WITH_INV_16_TRANSLOCATION	12738660	acute myeloid leukemia	DOID_9119
9650	YAGI_AML_WITH_INV_16_TRANSLOCATION	12738660	cancer	DOID_162
9651	YAGI_AML_WITH_INV_16_TRANSLOCATION	12738660	disease of cellular proliferation	DOID_14566
9652	YAGI_AML_WITH_INV_16_TRANSLOCATION	12738660	hematologic cancer	DOID_2531
9653	YAGI_AML_WITH_INV_16_TRANSLOCATION	12738660	immune system cancer	DOID_0060083
9654	YAGI_AML_WITH_INV_16_TRANSLOCATION	12738660	leukemia	DOID_1240
9655	YAGI_AML_WITH_INV_16_TRANSLOCATION	12738660	myeloid leukemia	DOID_8692
9656	YAGI_AML_WITH_INV_16_TRANSLOCATION	12738660	organ system cancer	DOID_0050686
9657	YAGI_AML_WITH_T_9_11_TRANSLOCATION	12738660	acute myeloid leukemia	DOID_9119
9658	YAGI_AML_WITH_T_9_11_TRANSLOCATION	12738660	cancer	DOID_162
9659	YAGI_AML_WITH_T_9_11_TRANSLOCATION	12738660	disease of cellular proliferation	DOID_14566
9660	YAGI_AML_WITH_T_9_11_TRANSLOCATION	12738660	hematologic cancer	DOID_2531
9661	YAGI_AML_WITH_T_9_11_TRANSLOCATION	12738660	immune system cancer	DOID_0060083
9662	YAGI_AML_WITH_T_9_11_TRANSLOCATION	12738660	leukemia	DOID_1240
9663	YAGI_AML_WITH_T_9_11_TRANSLOCATION	12738660	myeloid leukemia	DOID_8692
9664	YAGI_AML_WITH_T_9_11_TRANSLOCATION	12738660	organ system cancer	DOID_0050686
9665	YAGI_AML_WITH_11Q23_REARRANGED	12738660	acute myeloid leukemia	DOID_9119
9666	YAGI_AML_WITH_11Q23_REARRANGED	12738660	cancer	DOID_162
9667	YAGI_AML_WITH_11Q23_REARRANGED	12738660	disease of cellular proliferation	DOID_14566
9668	YAGI_AML_WITH_11Q23_REARRANGED	12738660	hematologic cancer	DOID_2531
9669	YAGI_AML_WITH_11Q23_REARRANGED	12738660	immune system cancer	DOID_0060083
9670	YAGI_AML_WITH_11Q23_REARRANGED	12738660	leukemia	DOID_1240
9671	YAGI_AML_WITH_11Q23_REARRANGED	12738660	myeloid leukemia	DOID_8692
9672	YAGI_AML_WITH_11Q23_REARRANGED	12738660	organ system cancer	DOID_0050686
9673	YOSHIOKA_LIVER_CANCER_EARLY_RECURRENCE_UP	19167881	cancer	DOID_162
9674	YOSHIOKA_LIVER_CANCER_EARLY_RECURRENCE_UP	19167881	carcinoma	DOID_305
9675	YOSHIOKA_LIVER_CANCER_EARLY_RECURRENCE_UP	19167881	cell type cancer	DOID_0050687
9676	YOSHIOKA_LIVER_CANCER_EARLY_RECURRENCE_UP	19167881	disease of cellular proliferation	DOID_14566
9677	YOSHIOKA_LIVER_CANCER_EARLY_RECURRENCE_UP	19167881	gastrointestinal system cancer	DOID_3119
9678	YOSHIOKA_LIVER_CANCER_EARLY_RECURRENCE_UP	19167881	hepatocellular carcinoma	DOID_684
9679	YOSHIOKA_LIVER_CANCER_EARLY_RECURRENCE_UP	19167881	liver cancer	DOID_3571
9680	YOSHIOKA_LIVER_CANCER_EARLY_RECURRENCE_UP	19167881	liver carcinoma	DOID_686
9681	YOSHIOKA_LIVER_CANCER_EARLY_RECURRENCE_UP	19167881	organ system cancer	DOID_0050686
9682	YOSHIOKA_LIVER_CANCER_EARLY_RECURRENCE_DN	19167881	cancer	DOID_162
9683	YOSHIOKA_LIVER_CANCER_EARLY_RECURRENCE_DN	19167881	carcinoma	DOID_305
9684	YOSHIOKA_LIVER_CANCER_EARLY_RECURRENCE_DN	19167881	cell type cancer	DOID_0050687
9685	YOSHIOKA_LIVER_CANCER_EARLY_RECURRENCE_DN	19167881	disease of cellular proliferation	DOID_14566
9686	YOSHIOKA_LIVER_CANCER_EARLY_RECURRENCE_DN	19167881	gastrointestinal system cancer	DOID_3119
9687	YOSHIOKA_LIVER_CANCER_EARLY_RECURRENCE_DN	19167881	hepatocellular carcinoma	DOID_684
9688	YOSHIOKA_LIVER_CANCER_EARLY_RECURRENCE_DN	19167881	liver cancer	DOID_3571
9689	YOSHIOKA_LIVER_CANCER_EARLY_RECURRENCE_DN	19167881	liver carcinoma	DOID_686
9690	YOSHIOKA_LIVER_CANCER_EARLY_RECURRENCE_DN	19167881	organ system cancer	DOID_0050686
9691	KUROKAWA_LIVER_CANCER_EARLY_RECURRENCE_UP	15288478	cancer	DOID_162
9692	KUROKAWA_LIVER_CANCER_EARLY_RECURRENCE_UP	15288478	carcinoma	DOID_305
9693	KUROKAWA_LIVER_CANCER_EARLY_RECURRENCE_UP	15288478	cell type cancer	DOID_0050687
9694	KUROKAWA_LIVER_CANCER_EARLY_RECURRENCE_UP	15288478	disease of cellular proliferation	DOID_14566
9695	KUROKAWA_LIVER_CANCER_EARLY_RECURRENCE_UP	15288478	gastrointestinal system cancer	DOID_3119
9696	KUROKAWA_LIVER_CANCER_EARLY_RECURRENCE_UP	15288478	hepatocellular carcinoma	DOID_684
9697	KUROKAWA_LIVER_CANCER_EARLY_RECURRENCE_UP	15288478	liver cancer	DOID_3571
9698	KUROKAWA_LIVER_CANCER_EARLY_RECURRENCE_UP	15288478	liver carcinoma	DOID_686
9699	KUROKAWA_LIVER_CANCER_EARLY_RECURRENCE_UP	15288478	organ system cancer	DOID_0050686
9700	SETLUR_PROSTATE_CANCER_TMPRSS2_ERG_FUSION_UP	18505969	cancer	DOID_162
9701	SETLUR_PROSTATE_CANCER_TMPRSS2_ERG_FUSION_UP	18505969	disease of cellular proliferation	DOID_14566
9702	SETLUR_PROSTATE_CANCER_TMPRSS2_ERG_FUSION_UP	18505969	male reproductive organ cancer	DOID_3856
9703	SETLUR_PROSTATE_CANCER_TMPRSS2_ERG_FUSION_UP	18505969	organ system cancer	DOID_0050686
9704	SETLUR_PROSTATE_CANCER_TMPRSS2_ERG_FUSION_UP	18505969	prostate cancer	DOID_10283
9705	SETLUR_PROSTATE_CANCER_TMPRSS2_ERG_FUSION_UP	18505969	reproductive organ cancer	DOID_193
9706	SETLUR_PROSTATE_CANCER_TMPRSS2_ERG_FUSION_DN	18505969	cancer	DOID_162
9707	SETLUR_PROSTATE_CANCER_TMPRSS2_ERG_FUSION_DN	18505969	disease of cellular proliferation	DOID_14566
9708	SETLUR_PROSTATE_CANCER_TMPRSS2_ERG_FUSION_DN	18505969	male reproductive organ cancer	DOID_3856
9709	SETLUR_PROSTATE_CANCER_TMPRSS2_ERG_FUSION_DN	18505969	organ system cancer	DOID_0050686
9710	SETLUR_PROSTATE_CANCER_TMPRSS2_ERG_FUSION_DN	18505969	prostate cancer	DOID_10283
9711	SETLUR_PROSTATE_CANCER_TMPRSS2_ERG_FUSION_DN	18505969	reproductive organ cancer	DOID_193
9712	KESHELAVA_MULTIPLE_DRUG_RESISTANCE	17623797	autonomic nervous system neoplasm	DOID_2621
9713	KESHELAVA_MULTIPLE_DRUG_RESISTANCE	17623797	cancer	DOID_162
9714	KESHELAVA_MULTIPLE_DRUG_RESISTANCE	17623797	disease of cellular proliferation	DOID_14566
9715	KESHELAVA_MULTIPLE_DRUG_RESISTANCE	17623797	nervous system cancer	DOID_3093
9716	KESHELAVA_MULTIPLE_DRUG_RESISTANCE	17623797	neuroblastoma	DOID_769
9717	KESHELAVA_MULTIPLE_DRUG_RESISTANCE	17623797	organ system cancer	DOID_0050686
9718	KESHELAVA_MULTIPLE_DRUG_RESISTANCE	17623797	peripheral nervous system neoplasm	DOID_1192
9719	WINNEPENNINCKX_MELANOMA_METASTASIS_DN	16595783	cancer	DOID_162
9720	WINNEPENNINCKX_MELANOMA_METASTASIS_DN	16595783	cell type cancer	DOID_0050687
9721	WINNEPENNINCKX_MELANOMA_METASTASIS_DN	16595783	disease of cellular proliferation	DOID_14566
9722	WINNEPENNINCKX_MELANOMA_METASTASIS_DN	16595783	melanoma	DOID_1909
9723	TSAI_DNAJB4_TARGETS_UP	16788156	adenocarcinoma	DOID_299
9724	TSAI_DNAJB4_TARGETS_UP	16788156	cancer	DOID_162
9725	TSAI_DNAJB4_TARGETS_UP	16788156	carcinoma	DOID_305
9726	TSAI_DNAJB4_TARGETS_UP	16788156	cell type cancer	DOID_0050687
9727	TSAI_DNAJB4_TARGETS_UP	16788156	disease of cellular proliferation	DOID_14566
9728	TSAI_DNAJB4_TARGETS_UP	16788156	lung adenocarcinoma	DOID_3910
9729	TSAI_DNAJB4_TARGETS_UP	16788156	lung cancer	DOID_1324
9730	TSAI_DNAJB4_TARGETS_UP	16788156	lung carcinoma	DOID_3905
9731	TSAI_DNAJB4_TARGETS_UP	16788156	non-small cell lung carcinoma	DOID_3908
9732	TSAI_DNAJB4_TARGETS_UP	16788156	organ system cancer	DOID_0050686
9733	TSAI_DNAJB4_TARGETS_UP	16788156	respiratory system cancer	DOID_0050615
9734	ASGHARZADEH_NEUROBLASTOMA_POOR_SURVIVAL_DN	16954472	autonomic nervous system neoplasm	DOID_2621
9735	ASGHARZADEH_NEUROBLASTOMA_POOR_SURVIVAL_DN	16954472	cancer	DOID_162
9736	ASGHARZADEH_NEUROBLASTOMA_POOR_SURVIVAL_DN	16954472	disease of cellular proliferation	DOID_14566
9737	ASGHARZADEH_NEUROBLASTOMA_POOR_SURVIVAL_DN	16954472	nervous system cancer	DOID_3093
9738	ASGHARZADEH_NEUROBLASTOMA_POOR_SURVIVAL_DN	16954472	neuroblastoma	DOID_769
9739	ASGHARZADEH_NEUROBLASTOMA_POOR_SURVIVAL_DN	16954472	organ system cancer	DOID_0050686
9740	ASGHARZADEH_NEUROBLASTOMA_POOR_SURVIVAL_DN	16954472	peripheral nervous system neoplasm	DOID_1192
9741	LI_PROSTATE_CANCER_EPIGENETIC	15657340	cancer	DOID_162
9742	LI_PROSTATE_CANCER_EPIGENETIC	15657340	disease of cellular proliferation	DOID_14566
9743	LI_PROSTATE_CANCER_EPIGENETIC	15657340	male reproductive organ cancer	DOID_3856
9744	LI_PROSTATE_CANCER_EPIGENETIC	15657340	organ system cancer	DOID_0050686
9745	LI_PROSTATE_CANCER_EPIGENETIC	15657340	prostate cancer	DOID_10283
9746	LI_PROSTATE_CANCER_EPIGENETIC	15657340	reproductive organ cancer	DOID_193
9747	UROSEVIC_RESPONSE_TO_IMIQUIMOD	16077073	cancer	DOID_162
9748	UROSEVIC_RESPONSE_TO_IMIQUIMOD	16077073	carcinoma	DOID_305
9749	UROSEVIC_RESPONSE_TO_IMIQUIMOD	16077073	cell type cancer	DOID_0050687
9750	UROSEVIC_RESPONSE_TO_IMIQUIMOD	16077073	disease of cellular proliferation	DOID_14566
9751	UROSEVIC_RESPONSE_TO_IMIQUIMOD	16077073	hematologic cancer	DOID_2531
9752	UROSEVIC_RESPONSE_TO_IMIQUIMOD	16077073	immune system cancer	DOID_0060083
9753	UROSEVIC_RESPONSE_TO_IMIQUIMOD	16077073	integumentary system cancer	DOID_0060122
9754	UROSEVIC_RESPONSE_TO_IMIQUIMOD	16077073	lymphoma	DOID_0060058
9755	UROSEVIC_RESPONSE_TO_IMIQUIMOD	16077073	organ system cancer	DOID_0050686
9756	UROSEVIC_RESPONSE_TO_IMIQUIMOD	16077073	skin cancer	DOID_4159
9757	FONTAINE_FOLLICULAR_THYROID_ADENOMA_UP	17968324	adenoma	DOID_657
9758	FONTAINE_FOLLICULAR_THYROID_ADENOMA_UP	17968324	benign neoplasm	DOID_0060072
9759	FONTAINE_FOLLICULAR_THYROID_ADENOMA_UP	17968324	cancer	DOID_162
9760	FONTAINE_FOLLICULAR_THYROID_ADENOMA_UP	17968324	carcinoma	DOID_305
9761	FONTAINE_FOLLICULAR_THYROID_ADENOMA_UP	17968324	cell type benign neoplasm	DOID_0060084
9762	FONTAINE_FOLLICULAR_THYROID_ADENOMA_UP	17968324	cell type cancer	DOID_0050687
9763	FONTAINE_FOLLICULAR_THYROID_ADENOMA_UP	17968324	disease of cellular proliferation	DOID_14566
9764	FONTAINE_FOLLICULAR_THYROID_ADENOMA_UP	17968324	papillary carcinoma	DOID_3113
9765	FONTAINE_FOLLICULAR_THYROID_ADENOMA_UP	17968324	thyroid nodule	DOID_14313
9766	FONTAINE_FOLLICULAR_THYROID_ADENOMA_DN	17968324	adenoma	DOID_657
9767	FONTAINE_FOLLICULAR_THYROID_ADENOMA_DN	17968324	benign neoplasm	DOID_0060072
9768	FONTAINE_FOLLICULAR_THYROID_ADENOMA_DN	17968324	cancer	DOID_162
9769	FONTAINE_FOLLICULAR_THYROID_ADENOMA_DN	17968324	carcinoma	DOID_305
9770	FONTAINE_FOLLICULAR_THYROID_ADENOMA_DN	17968324	cell type benign neoplasm	DOID_0060084
9771	FONTAINE_FOLLICULAR_THYROID_ADENOMA_DN	17968324	cell type cancer	DOID_0050687
9772	FONTAINE_FOLLICULAR_THYROID_ADENOMA_DN	17968324	disease of cellular proliferation	DOID_14566
9773	FONTAINE_FOLLICULAR_THYROID_ADENOMA_DN	17968324	papillary carcinoma	DOID_3113
9774	FONTAINE_FOLLICULAR_THYROID_ADENOMA_DN	17968324	thyroid nodule	DOID_14313
9775	FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_UP	17968324	adenoma	DOID_657
9776	FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_UP	17968324	benign neoplasm	DOID_0060072
9777	FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_UP	17968324	cancer	DOID_162
9778	FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_UP	17968324	carcinoma	DOID_305
9779	FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_UP	17968324	cell type benign neoplasm	DOID_0060084
9780	FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_UP	17968324	cell type cancer	DOID_0050687
9781	FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_UP	17968324	disease of cellular proliferation	DOID_14566
9782	FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_UP	17968324	papillary carcinoma	DOID_3113
9783	FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_UP	17968324	thyroid nodule	DOID_14313
9784	FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_DN	17968324	adenoma	DOID_657
9785	FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_DN	17968324	benign neoplasm	DOID_0060072
9786	FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_DN	17968324	cancer	DOID_162
9787	FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_DN	17968324	carcinoma	DOID_305
9788	FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_DN	17968324	cell type benign neoplasm	DOID_0060084
9789	FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_DN	17968324	cell type cancer	DOID_0050687
9790	FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_DN	17968324	disease of cellular proliferation	DOID_14566
9791	FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_DN	17968324	papillary carcinoma	DOID_3113
9792	FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_DN	17968324	thyroid nodule	DOID_14313
9793	FONTAINE_PAPILLARY_THYROID_CARCINOMA_UP	17968324	adenoma	DOID_657
9794	FONTAINE_PAPILLARY_THYROID_CARCINOMA_UP	17968324	benign neoplasm	DOID_0060072
9795	FONTAINE_PAPILLARY_THYROID_CARCINOMA_UP	17968324	cancer	DOID_162
9796	FONTAINE_PAPILLARY_THYROID_CARCINOMA_UP	17968324	carcinoma	DOID_305
9797	FONTAINE_PAPILLARY_THYROID_CARCINOMA_UP	17968324	cell type benign neoplasm	DOID_0060084
9798	FONTAINE_PAPILLARY_THYROID_CARCINOMA_UP	17968324	cell type cancer	DOID_0050687
9799	FONTAINE_PAPILLARY_THYROID_CARCINOMA_UP	17968324	disease of cellular proliferation	DOID_14566
9800	FONTAINE_PAPILLARY_THYROID_CARCINOMA_UP	17968324	papillary carcinoma	DOID_3113
9801	FONTAINE_PAPILLARY_THYROID_CARCINOMA_UP	17968324	thyroid nodule	DOID_14313
9802	FONTAINE_PAPILLARY_THYROID_CARCINOMA_DN	17968324	adenoma	DOID_657
9803	FONTAINE_PAPILLARY_THYROID_CARCINOMA_DN	17968324	benign neoplasm	DOID_0060072
9804	FONTAINE_PAPILLARY_THYROID_CARCINOMA_DN	17968324	cancer	DOID_162
9805	FONTAINE_PAPILLARY_THYROID_CARCINOMA_DN	17968324	carcinoma	DOID_305
9806	FONTAINE_PAPILLARY_THYROID_CARCINOMA_DN	17968324	cell type benign neoplasm	DOID_0060084
9807	FONTAINE_PAPILLARY_THYROID_CARCINOMA_DN	17968324	cell type cancer	DOID_0050687
9808	FONTAINE_PAPILLARY_THYROID_CARCINOMA_DN	17968324	disease of cellular proliferation	DOID_14566
9809	FONTAINE_PAPILLARY_THYROID_CARCINOMA_DN	17968324	papillary carcinoma	DOID_3113
9810	FONTAINE_PAPILLARY_THYROID_CARCINOMA_DN	17968324	thyroid nodule	DOID_14313
9811	WEBER_METHYLATED_LCP_IN_FIBROBLAST_UP	17334365	NA	NA
9812	WEBER_METHYLATED_ICP_IN_FIBROBLAST	17334365	NA	NA
9813	WEBER_METHYLATED_LCP_IN_SPERM_UP	17334365	NA	NA
9814	PUJANA_BREAST_CANCER_WITH_BRCA1_MUTATED_UP	17922014	autosomal dominant disease	DOID_0050736
9815	PUJANA_BREAST_CANCER_WITH_BRCA1_MUTATED_UP	17922014	autosomal genetic disease	DOID_0050739
9816	PUJANA_BREAST_CANCER_WITH_BRCA1_MUTATED_UP	17922014	breast cancer	DOID_1612
9817	PUJANA_BREAST_CANCER_WITH_BRCA1_MUTATED_UP	17922014	cancer	DOID_162
9818	PUJANA_BREAST_CANCER_WITH_BRCA1_MUTATED_UP	17922014	disease of cellular proliferation	DOID_14566
9819	PUJANA_BREAST_CANCER_WITH_BRCA1_MUTATED_UP	17922014	genetic disease	DOID_630
9820	PUJANA_BREAST_CANCER_WITH_BRCA1_MUTATED_UP	17922014	hereditary breast ovarian cancer	DOID_5683
9821	PUJANA_BREAST_CANCER_WITH_BRCA1_MUTATED_UP	17922014	monogenic disease	DOID_0050177
9822	PUJANA_BREAST_CANCER_WITH_BRCA1_MUTATED_UP	17922014	organ system cancer	DOID_0050686
9823	PUJANA_BREAST_CANCER_WITH_BRCA1_MUTATED_UP	17922014	thoracic cancer	DOID_5093
9824	SYED_ESTRADIOL_RESPONSE	16116479	cancer	DOID_162
9825	SYED_ESTRADIOL_RESPONSE	16116479	disease of cellular proliferation	DOID_14566
9826	SYED_ESTRADIOL_RESPONSE	16116479	female reproductive organ cancer	DOID_120
9827	SYED_ESTRADIOL_RESPONSE	16116479	organ system cancer	DOID_0050686
9828	SYED_ESTRADIOL_RESPONSE	16116479	ovarian cancer	DOID_2394
9829	SYED_ESTRADIOL_RESPONSE	16116479	reproductive organ cancer	DOID_193
9830	STEIN_ESR1_TARGETS	18974123	breast cancer	DOID_1612
9831	STEIN_ESR1_TARGETS	18974123	breast carcinoma	DOID_3459
9832	STEIN_ESR1_TARGETS	18974123	cancer	DOID_162
9833	STEIN_ESR1_TARGETS	18974123	carcinoma	DOID_305
9834	STEIN_ESR1_TARGETS	18974123	cell type cancer	DOID_0050687
9835	STEIN_ESR1_TARGETS	18974123	disease of cellular proliferation	DOID_14566
9836	STEIN_ESR1_TARGETS	18974123	organ system cancer	DOID_0050686
9837	STEIN_ESR1_TARGETS	18974123	thoracic cancer	DOID_5093
9838	STEIN_ESRRA_TARGETS	18974123	breast cancer	DOID_1612
9839	STEIN_ESRRA_TARGETS	18974123	breast carcinoma	DOID_3459
9840	STEIN_ESRRA_TARGETS	18974123	cancer	DOID_162
9841	STEIN_ESRRA_TARGETS	18974123	carcinoma	DOID_305
9842	STEIN_ESRRA_TARGETS	18974123	cell type cancer	DOID_0050687
9843	STEIN_ESRRA_TARGETS	18974123	disease of cellular proliferation	DOID_14566
9844	STEIN_ESRRA_TARGETS	18974123	organ system cancer	DOID_0050686
9845	STEIN_ESRRA_TARGETS	18974123	thoracic cancer	DOID_5093
9846	STEIN_ESTROGEN_RESPONSE_NOT_VIA_ESRRA	18974123	breast cancer	DOID_1612
9847	STEIN_ESTROGEN_RESPONSE_NOT_VIA_ESRRA	18974123	breast carcinoma	DOID_3459
9848	STEIN_ESTROGEN_RESPONSE_NOT_VIA_ESRRA	18974123	cancer	DOID_162
9849	STEIN_ESTROGEN_RESPONSE_NOT_VIA_ESRRA	18974123	carcinoma	DOID_305
9850	STEIN_ESTROGEN_RESPONSE_NOT_VIA_ESRRA	18974123	cell type cancer	DOID_0050687
9851	STEIN_ESTROGEN_RESPONSE_NOT_VIA_ESRRA	18974123	disease of cellular proliferation	DOID_14566
9852	STEIN_ESTROGEN_RESPONSE_NOT_VIA_ESRRA	18974123	organ system cancer	DOID_0050686
9853	STEIN_ESTROGEN_RESPONSE_NOT_VIA_ESRRA	18974123	thoracic cancer	DOID_5093
9854	SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP	19074895	cancer	DOID_162
9855	SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP	19074895	carcinoma	DOID_305
9856	SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP	19074895	cell type cancer	DOID_0050687
9857	SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP	19074895	disease by infectious agent	DOID_0050117
9858	SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP	19074895	disease of anatomical entity	DOID_7
9859	SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP	19074895	disease of cellular proliferation	DOID_14566
9860	SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP	19074895	gastrointestinal system cancer	DOID_3119
9861	SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP	19074895	gastrointestinal system disease	DOID_77
9862	SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP	19074895	hepatitis C	DOID_1883
9863	SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP	19074895	hepatitis	DOID_2237
9864	SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP	19074895	hepatobiliary disease	DOID_3118
9865	SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP	19074895	hepatocellular carcinoma	DOID_684
9866	SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP	19074895	liver cancer	DOID_3571
9867	SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP	19074895	liver carcinoma	DOID_686
9868	SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP	19074895	liver cirrhosis	DOID_5082
9869	SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP	19074895	liver disease	DOID_409
9870	SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP	19074895	organ system cancer	DOID_0050686
9871	SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP	19074895	viral infectious disease	DOID_934
9872	LOPEZ_EPITHELIOID_MESOTHELIOMA	16540645	benign mesothelioma	DOID_2645
9873	LOPEZ_EPITHELIOID_MESOTHELIOMA	16540645	benign neoplasm	DOID_0060072
9874	LOPEZ_EPITHELIOID_MESOTHELIOMA	16540645	cell type benign neoplasm	DOID_0060084
9875	LOPEZ_EPITHELIOID_MESOTHELIOMA	16540645	disease of cellular proliferation	DOID_14566
9876	LOPEZ_MESOTHELIOMA_SURVIVAL_OVERALL_DN	16540645	benign mesothelioma	DOID_2645
9877	LOPEZ_MESOTHELIOMA_SURVIVAL_OVERALL_DN	16540645	benign neoplasm	DOID_0060072
9878	LOPEZ_MESOTHELIOMA_SURVIVAL_OVERALL_DN	16540645	cell type benign neoplasm	DOID_0060084
9879	LOPEZ_MESOTHELIOMA_SURVIVAL_OVERALL_DN	16540645	disease of cellular proliferation	DOID_14566
9880	LOPEZ_MESOTHELIOMA_SURVIVAL_UP	16540645	benign mesothelioma	DOID_2645
9881	LOPEZ_MESOTHELIOMA_SURVIVAL_UP	16540645	benign neoplasm	DOID_0060072
9882	LOPEZ_MESOTHELIOMA_SURVIVAL_UP	16540645	cell type benign neoplasm	DOID_0060084
9883	LOPEZ_MESOTHELIOMA_SURVIVAL_UP	16540645	disease of cellular proliferation	DOID_14566
9884	LOPEZ_MESOTHELIOMA_SURVIVAL_DN	16540645	benign mesothelioma	DOID_2645
9885	LOPEZ_MESOTHELIOMA_SURVIVAL_DN	16540645	benign neoplasm	DOID_0060072
9886	LOPEZ_MESOTHELIOMA_SURVIVAL_DN	16540645	cell type benign neoplasm	DOID_0060084
9887	LOPEZ_MESOTHELIOMA_SURVIVAL_DN	16540645	disease of cellular proliferation	DOID_14566
9888	KORKOLA_CORRELATED_WITH_POU5F1	16424014	cancer	DOID_162
9889	KORKOLA_CORRELATED_WITH_POU5F1	16424014	carcinoma	DOID_305
9890	KORKOLA_CORRELATED_WITH_POU5F1	16424014	cell type cancer	DOID_0050687
9891	KORKOLA_CORRELATED_WITH_POU5F1	16424014	disease of cellular proliferation	DOID_14566
9892	KORKOLA_CORRELATED_WITH_POU5F1	16424014	embryonal cancer	DOID_688
9893	KORKOLA_CORRELATED_WITH_POU5F1	16424014	embryonal carcinoma	DOID_3308
9894	KORKOLA_CORRELATED_WITH_POU5F1	16424014	germ cell cancer	DOID_2994
9895	KORKOLA_CORRELATED_WITH_POU5F1	16424014	germinoma	DOID_3304
9896	KORKOLA_CORRELATED_WITH_POU5F1	16424014	seminoma	DOID_4440
9897	KORKOLA_EMBRYONIC_CARCINOMA_VS_SEMINOMA_UP	16424014	cancer	DOID_162
9898	KORKOLA_EMBRYONIC_CARCINOMA_VS_SEMINOMA_UP	16424014	carcinoma	DOID_305
9899	KORKOLA_EMBRYONIC_CARCINOMA_VS_SEMINOMA_UP	16424014	cell type cancer	DOID_0050687
9900	KORKOLA_EMBRYONIC_CARCINOMA_VS_SEMINOMA_UP	16424014	disease of cellular proliferation	DOID_14566
9901	KORKOLA_EMBRYONIC_CARCINOMA_VS_SEMINOMA_UP	16424014	embryonal cancer	DOID_688
9902	KORKOLA_EMBRYONIC_CARCINOMA_VS_SEMINOMA_UP	16424014	embryonal carcinoma	DOID_3308
9903	KORKOLA_EMBRYONIC_CARCINOMA_VS_SEMINOMA_UP	16424014	germ cell cancer	DOID_2994
9904	KORKOLA_EMBRYONIC_CARCINOMA_VS_SEMINOMA_UP	16424014	germinoma	DOID_3304
9905	KORKOLA_EMBRYONIC_CARCINOMA_VS_SEMINOMA_UP	16424014	seminoma	DOID_4440
9906	KORKOLA_EMBRYONIC_CARCINOMA_VS_SEMINOMA_DN	16424014	cancer	DOID_162
9907	KORKOLA_EMBRYONIC_CARCINOMA_VS_SEMINOMA_DN	16424014	carcinoma	DOID_305
9908	KORKOLA_EMBRYONIC_CARCINOMA_VS_SEMINOMA_DN	16424014	cell type cancer	DOID_0050687
9909	KORKOLA_EMBRYONIC_CARCINOMA_VS_SEMINOMA_DN	16424014	disease of cellular proliferation	DOID_14566
9910	KORKOLA_EMBRYONIC_CARCINOMA_VS_SEMINOMA_DN	16424014	embryonal cancer	DOID_688
9911	KORKOLA_EMBRYONIC_CARCINOMA_VS_SEMINOMA_DN	16424014	embryonal carcinoma	DOID_3308
9912	KORKOLA_EMBRYONIC_CARCINOMA_VS_SEMINOMA_DN	16424014	germ cell cancer	DOID_2994
9913	KORKOLA_EMBRYONIC_CARCINOMA_VS_SEMINOMA_DN	16424014	germinoma	DOID_3304
9914	KORKOLA_EMBRYONIC_CARCINOMA_VS_SEMINOMA_DN	16424014	seminoma	DOID_4440
9915	KOBAYASHI_EGFR_SIGNALING_24HR_UP	17145885	cancer	DOID_162
9916	KOBAYASHI_EGFR_SIGNALING_24HR_UP	17145885	carcinoma	DOID_305
9917	KOBAYASHI_EGFR_SIGNALING_24HR_UP	17145885	cell type cancer	DOID_0050687
9918	KOBAYASHI_EGFR_SIGNALING_24HR_UP	17145885	disease of cellular proliferation	DOID_14566
9919	KOBAYASHI_EGFR_SIGNALING_24HR_UP	17145885	lung cancer	DOID_1324
9920	KOBAYASHI_EGFR_SIGNALING_24HR_UP	17145885	lung carcinoma	DOID_3905
9921	KOBAYASHI_EGFR_SIGNALING_24HR_UP	17145885	non-small cell lung carcinoma	DOID_3908
9922	KOBAYASHI_EGFR_SIGNALING_24HR_UP	17145885	organ system cancer	DOID_0050686
9923	KOBAYASHI_EGFR_SIGNALING_24HR_UP	17145885	respiratory system cancer	DOID_0050615
9924	KOBAYASHI_EGFR_SIGNALING_24HR_DN	17145885	cancer	DOID_162
9925	KOBAYASHI_EGFR_SIGNALING_24HR_DN	17145885	carcinoma	DOID_305
9926	KOBAYASHI_EGFR_SIGNALING_24HR_DN	17145885	cell type cancer	DOID_0050687
9927	KOBAYASHI_EGFR_SIGNALING_24HR_DN	17145885	disease of cellular proliferation	DOID_14566
9928	KOBAYASHI_EGFR_SIGNALING_24HR_DN	17145885	lung cancer	DOID_1324
9929	KOBAYASHI_EGFR_SIGNALING_24HR_DN	17145885	lung carcinoma	DOID_3905
9930	KOBAYASHI_EGFR_SIGNALING_24HR_DN	17145885	non-small cell lung carcinoma	DOID_3908
9931	KOBAYASHI_EGFR_SIGNALING_24HR_DN	17145885	organ system cancer	DOID_0050686
9932	KOBAYASHI_EGFR_SIGNALING_24HR_DN	17145885	respiratory system cancer	DOID_0050615
9933	FOURNIER_ACINAR_DEVELOPMENT_LATE_2	16849555	breast cancer	DOID_1612
9934	FOURNIER_ACINAR_DEVELOPMENT_LATE_2	16849555	cancer	DOID_162
9935	FOURNIER_ACINAR_DEVELOPMENT_LATE_2	16849555	disease of cellular proliferation	DOID_14566
9936	FOURNIER_ACINAR_DEVELOPMENT_LATE_2	16849555	organ system cancer	DOID_0050686
9937	FOURNIER_ACINAR_DEVELOPMENT_LATE_2	16849555	thoracic cancer	DOID_5093
9938	HOSHIDA_LIVER_CANCER_SUBCLASS_S1	19723656	cancer	DOID_162
9939	HOSHIDA_LIVER_CANCER_SUBCLASS_S1	19723656	carcinoma	DOID_305
9940	HOSHIDA_LIVER_CANCER_SUBCLASS_S1	19723656	cell type cancer	DOID_0050687
9941	HOSHIDA_LIVER_CANCER_SUBCLASS_S1	19723656	disease of cellular proliferation	DOID_14566
9942	HOSHIDA_LIVER_CANCER_SUBCLASS_S1	19723656	gastrointestinal system cancer	DOID_3119
9943	HOSHIDA_LIVER_CANCER_SUBCLASS_S1	19723656	hepatocellular carcinoma	DOID_684
9944	HOSHIDA_LIVER_CANCER_SUBCLASS_S1	19723656	liver cancer	DOID_3571
9945	HOSHIDA_LIVER_CANCER_SUBCLASS_S1	19723656	liver carcinoma	DOID_686
9946	HOSHIDA_LIVER_CANCER_SUBCLASS_S1	19723656	organ system cancer	DOID_0050686
9947	HOSHIDA_LIVER_CANCER_SUBCLASS_S2	19723656	cancer	DOID_162
9948	HOSHIDA_LIVER_CANCER_SUBCLASS_S2	19723656	carcinoma	DOID_305
9949	HOSHIDA_LIVER_CANCER_SUBCLASS_S2	19723656	cell type cancer	DOID_0050687
9950	HOSHIDA_LIVER_CANCER_SUBCLASS_S2	19723656	disease of cellular proliferation	DOID_14566
9951	HOSHIDA_LIVER_CANCER_SUBCLASS_S2	19723656	gastrointestinal system cancer	DOID_3119
9952	HOSHIDA_LIVER_CANCER_SUBCLASS_S2	19723656	hepatocellular carcinoma	DOID_684
9953	HOSHIDA_LIVER_CANCER_SUBCLASS_S2	19723656	liver cancer	DOID_3571
9954	HOSHIDA_LIVER_CANCER_SUBCLASS_S2	19723656	liver carcinoma	DOID_686
9955	HOSHIDA_LIVER_CANCER_SUBCLASS_S2	19723656	organ system cancer	DOID_0050686
9956	HOSHIDA_LIVER_CANCER_SUBCLASS_S3	19723656	cancer	DOID_162
9957	HOSHIDA_LIVER_CANCER_SUBCLASS_S3	19723656	carcinoma	DOID_305
9958	HOSHIDA_LIVER_CANCER_SUBCLASS_S3	19723656	cell type cancer	DOID_0050687
9959	HOSHIDA_LIVER_CANCER_SUBCLASS_S3	19723656	disease of cellular proliferation	DOID_14566
9960	HOSHIDA_LIVER_CANCER_SUBCLASS_S3	19723656	gastrointestinal system cancer	DOID_3119
9961	HOSHIDA_LIVER_CANCER_SUBCLASS_S3	19723656	hepatocellular carcinoma	DOID_684
9962	HOSHIDA_LIVER_CANCER_SUBCLASS_S3	19723656	liver cancer	DOID_3571
9963	HOSHIDA_LIVER_CANCER_SUBCLASS_S3	19723656	liver carcinoma	DOID_686
9964	HOSHIDA_LIVER_CANCER_SUBCLASS_S3	19723656	organ system cancer	DOID_0050686
9965	PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_UP	17510386	cancer	DOID_162
9966	PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_UP	17510386	disease of cellular proliferation	DOID_14566
9967	PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_DN	17510386	cancer	DOID_162
9968	PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_DN	17510386	disease of cellular proliferation	DOID_14566
9969	CAIRO_HEPATOBLASTOMA_UP	19061838	cancer	DOID_162
9970	CAIRO_HEPATOBLASTOMA_UP	19061838	disease of cellular proliferation	DOID_14566
9971	CAIRO_HEPATOBLASTOMA_UP	19061838	gastrointestinal system cancer	DOID_3119
9972	CAIRO_HEPATOBLASTOMA_UP	19061838	hepatoblastoma	DOID_687
9973	CAIRO_HEPATOBLASTOMA_UP	19061838	liver cancer	DOID_3571
9974	CAIRO_HEPATOBLASTOMA_UP	19061838	organ system cancer	DOID_0050686
9975	CAIRO_HEPATOBLASTOMA_DN	19061838	cancer	DOID_162
9976	CAIRO_HEPATOBLASTOMA_DN	19061838	disease of cellular proliferation	DOID_14566
9977	CAIRO_HEPATOBLASTOMA_DN	19061838	gastrointestinal system cancer	DOID_3119
9978	CAIRO_HEPATOBLASTOMA_DN	19061838	hepatoblastoma	DOID_687
9979	CAIRO_HEPATOBLASTOMA_DN	19061838	liver cancer	DOID_3571
9980	CAIRO_HEPATOBLASTOMA_DN	19061838	organ system cancer	DOID_0050686
9981	CAIRO_HEPATOBLASTOMA_CLASSES_UP	19061838	cancer	DOID_162
9982	CAIRO_HEPATOBLASTOMA_CLASSES_UP	19061838	disease of cellular proliferation	DOID_14566
9983	CAIRO_HEPATOBLASTOMA_CLASSES_UP	19061838	gastrointestinal system cancer	DOID_3119
9984	CAIRO_HEPATOBLASTOMA_CLASSES_UP	19061838	hepatoblastoma	DOID_687
9985	CAIRO_HEPATOBLASTOMA_CLASSES_UP	19061838	liver cancer	DOID_3571
9986	CAIRO_HEPATOBLASTOMA_CLASSES_UP	19061838	organ system cancer	DOID_0050686
9987	CAIRO_HEPATOBLASTOMA_CLASSES_DN	19061838	cancer	DOID_162
9988	CAIRO_HEPATOBLASTOMA_CLASSES_DN	19061838	disease of cellular proliferation	DOID_14566
9989	CAIRO_HEPATOBLASTOMA_CLASSES_DN	19061838	gastrointestinal system cancer	DOID_3119
9990	CAIRO_HEPATOBLASTOMA_CLASSES_DN	19061838	hepatoblastoma	DOID_687
9991	CAIRO_HEPATOBLASTOMA_CLASSES_DN	19061838	liver cancer	DOID_3571
9992	CAIRO_HEPATOBLASTOMA_CLASSES_DN	19061838	organ system cancer	DOID_0050686
9993	CAIRO_HEPATOBLASTOMA_POOR_SURVIVAL	19061838	cancer	DOID_162
9994	CAIRO_HEPATOBLASTOMA_POOR_SURVIVAL	19061838	disease of cellular proliferation	DOID_14566
9995	CAIRO_HEPATOBLASTOMA_POOR_SURVIVAL	19061838	gastrointestinal system cancer	DOID_3119
9996	CAIRO_HEPATOBLASTOMA_POOR_SURVIVAL	19061838	hepatoblastoma	DOID_687
9997	CAIRO_HEPATOBLASTOMA_POOR_SURVIVAL	19061838	liver cancer	DOID_3571
9998	CAIRO_HEPATOBLASTOMA_POOR_SURVIVAL	19061838	organ system cancer	DOID_0050686
9999	GUTIERREZ_CHRONIC_LYMPHOCYTIC_LEUKEMIA_UP	17252022	bone marrow cancer	DOID_4960
10000	GUTIERREZ_CHRONIC_LYMPHOCYTIC_LEUKEMIA_UP	17252022	cancer	DOID_162
10001	GUTIERREZ_CHRONIC_LYMPHOCYTIC_LEUKEMIA_UP	17252022	chronic leukemia	DOID_1036
10002	GUTIERREZ_CHRONIC_LYMPHOCYTIC_LEUKEMIA_UP	17252022	chronic lymphocytic leukemia	DOID_1040
10003	GUTIERREZ_CHRONIC_LYMPHOCYTIC_LEUKEMIA_UP	17252022	disease of cellular proliferation	DOID_14566
10004	GUTIERREZ_CHRONIC_LYMPHOCYTIC_LEUKEMIA_UP	17252022	disease of metabolism	DOID_0014667
10005	GUTIERREZ_CHRONIC_LYMPHOCYTIC_LEUKEMIA_UP	17252022	hematologic cancer	DOID_2531
10006	GUTIERREZ_CHRONIC_LYMPHOCYTIC_LEUKEMIA_UP	17252022	immune system cancer	DOID_0060083
10007	GUTIERREZ_CHRONIC_LYMPHOCYTIC_LEUKEMIA_UP	17252022	inherited metabolic disorder	DOID_655
10008	GUTIERREZ_CHRONIC_LYMPHOCYTIC_LEUKEMIA_UP	17252022	leukemia	DOID_1240
10009	GUTIERREZ_CHRONIC_LYMPHOCYTIC_LEUKEMIA_UP	17252022	lymphoblastic leukemia	DOID_1037
10010	GUTIERREZ_CHRONIC_LYMPHOCYTIC_LEUKEMIA_UP	17252022	macroglobulinemia	DOID_9080
10011	GUTIERREZ_CHRONIC_LYMPHOCYTIC_LEUKEMIA_UP	17252022	multiple myeloma	DOID_9538
10012	GUTIERREZ_CHRONIC_LYMPHOCYTIC_LEUKEMIA_UP	17252022	myeloma	DOID_0070004
10013	GUTIERREZ_CHRONIC_LYMPHOCYTIC_LEUKEMIA_UP	17252022	organ system cancer	DOID_0050686
10014	GUTIERREZ_CHRONIC_LYMPHOCYTIC_LEUKEMIA_UP	17252022	plasma protein metabolism disease	DOID_2345
10015	GUTIERREZ_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN	17252022	bone marrow cancer	DOID_4960
10016	GUTIERREZ_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN	17252022	cancer	DOID_162
10017	GUTIERREZ_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN	17252022	chronic leukemia	DOID_1036
10018	GUTIERREZ_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN	17252022	chronic lymphocytic leukemia	DOID_1040
10019	GUTIERREZ_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN	17252022	disease of cellular proliferation	DOID_14566
10020	GUTIERREZ_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN	17252022	disease of metabolism	DOID_0014667
10021	GUTIERREZ_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN	17252022	hematologic cancer	DOID_2531
10022	GUTIERREZ_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN	17252022	immune system cancer	DOID_0060083
10023	GUTIERREZ_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN	17252022	inherited metabolic disorder	DOID_655
10024	GUTIERREZ_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN	17252022	leukemia	DOID_1240
10025	GUTIERREZ_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN	17252022	lymphoblastic leukemia	DOID_1037
10026	GUTIERREZ_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN	17252022	macroglobulinemia	DOID_9080
10027	GUTIERREZ_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN	17252022	multiple myeloma	DOID_9538
10028	GUTIERREZ_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN	17252022	myeloma	DOID_0070004
10029	GUTIERREZ_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN	17252022	organ system cancer	DOID_0050686
10030	GUTIERREZ_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN	17252022	plasma protein metabolism disease	DOID_2345
10031	GUTIERREZ_MULTIPLE_MYELOMA_DN	17252022	bone marrow cancer	DOID_4960
10032	GUTIERREZ_MULTIPLE_MYELOMA_DN	17252022	cancer	DOID_162
10033	GUTIERREZ_MULTIPLE_MYELOMA_DN	17252022	chronic leukemia	DOID_1036
10034	GUTIERREZ_MULTIPLE_MYELOMA_DN	17252022	chronic lymphocytic leukemia	DOID_1040
10035	GUTIERREZ_MULTIPLE_MYELOMA_DN	17252022	disease of cellular proliferation	DOID_14566
10036	GUTIERREZ_MULTIPLE_MYELOMA_DN	17252022	disease of metabolism	DOID_0014667
10037	GUTIERREZ_MULTIPLE_MYELOMA_DN	17252022	hematologic cancer	DOID_2531
10038	GUTIERREZ_MULTIPLE_MYELOMA_DN	17252022	immune system cancer	DOID_0060083
10039	GUTIERREZ_MULTIPLE_MYELOMA_DN	17252022	inherited metabolic disorder	DOID_655
10040	GUTIERREZ_MULTIPLE_MYELOMA_DN	17252022	leukemia	DOID_1240
10041	GUTIERREZ_MULTIPLE_MYELOMA_DN	17252022	lymphoblastic leukemia	DOID_1037
10042	GUTIERREZ_MULTIPLE_MYELOMA_DN	17252022	macroglobulinemia	DOID_9080
10043	GUTIERREZ_MULTIPLE_MYELOMA_DN	17252022	multiple myeloma	DOID_9538
10044	GUTIERREZ_MULTIPLE_MYELOMA_DN	17252022	myeloma	DOID_0070004
10045	GUTIERREZ_MULTIPLE_MYELOMA_DN	17252022	organ system cancer	DOID_0050686
10046	GUTIERREZ_MULTIPLE_MYELOMA_DN	17252022	plasma protein metabolism disease	DOID_2345
10047	WINNEPENNINCKX_MELANOMA_METASTASIS_UP	16595783	cancer	DOID_162
10048	WINNEPENNINCKX_MELANOMA_METASTASIS_UP	16595783	cell type cancer	DOID_0050687
10049	WINNEPENNINCKX_MELANOMA_METASTASIS_UP	16595783	disease of cellular proliferation	DOID_14566
10050	WINNEPENNINCKX_MELANOMA_METASTASIS_UP	16595783	melanoma	DOID_1909
10051	HAHTOLA_CTCL_CUTANEOUS	16914566	cancer	DOID_162
10052	HAHTOLA_CTCL_CUTANEOUS	16914566	cutaneous T cell lymphoma	DOID_0060061
10053	HAHTOLA_CTCL_CUTANEOUS	16914566	disease by infectious agent	DOID_0050117
10054	HAHTOLA_CTCL_CUTANEOUS	16914566	disease of cellular proliferation	DOID_14566
10055	HAHTOLA_CTCL_CUTANEOUS	16914566	fungal infectious disease	DOID_1564
10056	HAHTOLA_CTCL_CUTANEOUS	16914566	hematologic cancer	DOID_2531
10057	HAHTOLA_CTCL_CUTANEOUS	16914566	immune system cancer	DOID_0060083
10058	HAHTOLA_CTCL_CUTANEOUS	16914566	lymphoma	DOID_0060058
10059	HAHTOLA_CTCL_CUTANEOUS	16914566	mature T-cell and NK-cell neoplasm	DOID_0050743
10060	HAHTOLA_CTCL_CUTANEOUS	16914566	mycosis fungoides	DOID_8691
10061	HAHTOLA_CTCL_CUTANEOUS	16914566	organ system cancer	DOID_0050686
10062	HAHTOLA_CTCL_CUTANEOUS	16914566	peripheral T-cell lymphoma	DOID_0050749
10063	HAHTOLA_CTCL_CUTANEOUS	16914566	Sezary's disease	DOID_8541
10064	HAHTOLA_CTCL_CUTANEOUS	16914566	syndrome	DOID_225
10065	HAHTOLA_CTCL_PATHOGENESIS	16914566	cancer	DOID_162
10066	HAHTOLA_CTCL_PATHOGENESIS	16914566	cutaneous T cell lymphoma	DOID_0060061
10067	HAHTOLA_CTCL_PATHOGENESIS	16914566	disease by infectious agent	DOID_0050117
10068	HAHTOLA_CTCL_PATHOGENESIS	16914566	disease of cellular proliferation	DOID_14566
10069	HAHTOLA_CTCL_PATHOGENESIS	16914566	fungal infectious disease	DOID_1564
10070	HAHTOLA_CTCL_PATHOGENESIS	16914566	hematologic cancer	DOID_2531
10071	HAHTOLA_CTCL_PATHOGENESIS	16914566	immune system cancer	DOID_0060083
10072	HAHTOLA_CTCL_PATHOGENESIS	16914566	lymphoma	DOID_0060058
10073	HAHTOLA_CTCL_PATHOGENESIS	16914566	mature T-cell and NK-cell neoplasm	DOID_0050743
10074	HAHTOLA_CTCL_PATHOGENESIS	16914566	mycosis fungoides	DOID_8691
10075	HAHTOLA_CTCL_PATHOGENESIS	16914566	organ system cancer	DOID_0050686
10076	HAHTOLA_CTCL_PATHOGENESIS	16914566	peripheral T-cell lymphoma	DOID_0050749
10077	HAHTOLA_CTCL_PATHOGENESIS	16914566	Sezary's disease	DOID_8541
10078	HAHTOLA_CTCL_PATHOGENESIS	16914566	syndrome	DOID_225
10079	UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN	16606835	chromosomal disease	DOID_0080014
10080	UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN	16606835	Down syndrome	DOID_14250
10081	UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN	16606835	genetic disease	DOID_630
10082	UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN	16606835	syndrome	DOID_225
10083	VANTVEER_BREAST_CANCER_POOR_PROGNOSIS	11823860	autosomal dominant disease	DOID_0050736
10084	VANTVEER_BREAST_CANCER_POOR_PROGNOSIS	11823860	autosomal genetic disease	DOID_0050739
10085	VANTVEER_BREAST_CANCER_POOR_PROGNOSIS	11823860	breast cancer	DOID_1612
10086	VANTVEER_BREAST_CANCER_POOR_PROGNOSIS	11823860	cancer	DOID_162
10087	VANTVEER_BREAST_CANCER_POOR_PROGNOSIS	11823860	disease of cellular proliferation	DOID_14566
10088	VANTVEER_BREAST_CANCER_POOR_PROGNOSIS	11823860	genetic disease	DOID_630
10089	VANTVEER_BREAST_CANCER_POOR_PROGNOSIS	11823860	hereditary breast ovarian cancer	DOID_5683
10090	VANTVEER_BREAST_CANCER_POOR_PROGNOSIS	11823860	monogenic disease	DOID_0050177
10091	VANTVEER_BREAST_CANCER_POOR_PROGNOSIS	11823860	organ system cancer	DOID_0050686
10092	VANTVEER_BREAST_CANCER_POOR_PROGNOSIS	11823860	thoracic cancer	DOID_5093
10093	CHIARETTI_T_ALL_REFRACTORY_TO_THERAPY	14684422	acute lymphocytic leukemia	DOID_9952
10094	CHIARETTI_T_ALL_REFRACTORY_TO_THERAPY	14684422	cancer	DOID_162
10095	CHIARETTI_T_ALL_REFRACTORY_TO_THERAPY	14684422	disease of cellular proliferation	DOID_14566
10096	CHIARETTI_T_ALL_REFRACTORY_TO_THERAPY	14684422	hematologic cancer	DOID_2531
10097	CHIARETTI_T_ALL_REFRACTORY_TO_THERAPY	14684422	immune system cancer	DOID_0060083
10098	CHIARETTI_T_ALL_REFRACTORY_TO_THERAPY	14684422	leukemia	DOID_1240
10099	CHIARETTI_T_ALL_REFRACTORY_TO_THERAPY	14684422	lymphoblastic leukemia	DOID_1037
10100	CHIARETTI_T_ALL_REFRACTORY_TO_THERAPY	14684422	organ system cancer	DOID_0050686
10101	CHIARETTI_T_ALL_RELAPSE_PROGNOSIS	14684422	acute lymphocytic leukemia	DOID_9952
10102	CHIARETTI_T_ALL_RELAPSE_PROGNOSIS	14684422	cancer	DOID_162
10103	CHIARETTI_T_ALL_RELAPSE_PROGNOSIS	14684422	disease of cellular proliferation	DOID_14566
10104	CHIARETTI_T_ALL_RELAPSE_PROGNOSIS	14684422	hematologic cancer	DOID_2531
10105	CHIARETTI_T_ALL_RELAPSE_PROGNOSIS	14684422	immune system cancer	DOID_0060083
10106	CHIARETTI_T_ALL_RELAPSE_PROGNOSIS	14684422	leukemia	DOID_1240
10107	CHIARETTI_T_ALL_RELAPSE_PROGNOSIS	14684422	lymphoblastic leukemia	DOID_1037
10108	CHIARETTI_T_ALL_RELAPSE_PROGNOSIS	14684422	organ system cancer	DOID_0050686
10109	ZHAN_MULTIPLE_MYELOMA_CD1_DN	16728703	bone disease	DOID_0080001
10110	ZHAN_MULTIPLE_MYELOMA_CD1_DN	16728703	bone marrow cancer	DOID_4960
10111	ZHAN_MULTIPLE_MYELOMA_CD1_DN	16728703	cancer	DOID_162
10112	ZHAN_MULTIPLE_MYELOMA_CD1_DN	16728703	disease of anatomical entity	DOID_7
10113	ZHAN_MULTIPLE_MYELOMA_CD1_DN	16728703	disease of cellular proliferation	DOID_14566
10114	ZHAN_MULTIPLE_MYELOMA_CD1_DN	16728703	hematologic cancer	DOID_2531
10115	ZHAN_MULTIPLE_MYELOMA_CD1_DN	16728703	immune system cancer	DOID_0060083
10116	ZHAN_MULTIPLE_MYELOMA_CD1_DN	16728703	multiple myeloma	DOID_9538
10117	ZHAN_MULTIPLE_MYELOMA_CD1_DN	16728703	musculoskeletal system disease	DOID_17
10118	ZHAN_MULTIPLE_MYELOMA_CD1_DN	16728703	myeloma	DOID_0070004
10119	ZHAN_MULTIPLE_MYELOMA_CD1_DN	16728703	organ system cancer	DOID_0050686
10120	ZHAN_MULTIPLE_MYELOMA_CD2_DN	16728703	bone disease	DOID_0080001
10121	ZHAN_MULTIPLE_MYELOMA_CD2_DN	16728703	bone marrow cancer	DOID_4960
10122	ZHAN_MULTIPLE_MYELOMA_CD2_DN	16728703	cancer	DOID_162
10123	ZHAN_MULTIPLE_MYELOMA_CD2_DN	16728703	disease of anatomical entity	DOID_7
10124	ZHAN_MULTIPLE_MYELOMA_CD2_DN	16728703	disease of cellular proliferation	DOID_14566
10125	ZHAN_MULTIPLE_MYELOMA_CD2_DN	16728703	hematologic cancer	DOID_2531
10126	ZHAN_MULTIPLE_MYELOMA_CD2_DN	16728703	immune system cancer	DOID_0060083
10127	ZHAN_MULTIPLE_MYELOMA_CD2_DN	16728703	multiple myeloma	DOID_9538
10128	ZHAN_MULTIPLE_MYELOMA_CD2_DN	16728703	musculoskeletal system disease	DOID_17
10129	ZHAN_MULTIPLE_MYELOMA_CD2_DN	16728703	myeloma	DOID_0070004
10130	ZHAN_MULTIPLE_MYELOMA_CD2_DN	16728703	organ system cancer	DOID_0050686
10131	ZHAN_MULTIPLE_MYELOMA_LB_DN	16728703	bone disease	DOID_0080001
10132	ZHAN_MULTIPLE_MYELOMA_LB_DN	16728703	bone marrow cancer	DOID_4960
10133	ZHAN_MULTIPLE_MYELOMA_LB_DN	16728703	cancer	DOID_162
10134	ZHAN_MULTIPLE_MYELOMA_LB_DN	16728703	disease of anatomical entity	DOID_7
10135	ZHAN_MULTIPLE_MYELOMA_LB_DN	16728703	disease of cellular proliferation	DOID_14566
10136	ZHAN_MULTIPLE_MYELOMA_LB_DN	16728703	hematologic cancer	DOID_2531
10137	ZHAN_MULTIPLE_MYELOMA_LB_DN	16728703	immune system cancer	DOID_0060083
10138	ZHAN_MULTIPLE_MYELOMA_LB_DN	16728703	multiple myeloma	DOID_9538
10139	ZHAN_MULTIPLE_MYELOMA_LB_DN	16728703	musculoskeletal system disease	DOID_17
10140	ZHAN_MULTIPLE_MYELOMA_LB_DN	16728703	myeloma	DOID_0070004
10141	ZHAN_MULTIPLE_MYELOMA_LB_DN	16728703	organ system cancer	DOID_0050686
10142	ZHAN_MULTIPLE_MYELOMA_HP_DN	16728703	bone disease	DOID_0080001
10143	ZHAN_MULTIPLE_MYELOMA_HP_DN	16728703	bone marrow cancer	DOID_4960
10144	ZHAN_MULTIPLE_MYELOMA_HP_DN	16728703	cancer	DOID_162
10145	ZHAN_MULTIPLE_MYELOMA_HP_DN	16728703	disease of anatomical entity	DOID_7
10146	ZHAN_MULTIPLE_MYELOMA_HP_DN	16728703	disease of cellular proliferation	DOID_14566
10147	ZHAN_MULTIPLE_MYELOMA_HP_DN	16728703	hematologic cancer	DOID_2531
10148	ZHAN_MULTIPLE_MYELOMA_HP_DN	16728703	immune system cancer	DOID_0060083
10149	ZHAN_MULTIPLE_MYELOMA_HP_DN	16728703	multiple myeloma	DOID_9538
10150	ZHAN_MULTIPLE_MYELOMA_HP_DN	16728703	musculoskeletal system disease	DOID_17
10151	ZHAN_MULTIPLE_MYELOMA_HP_DN	16728703	myeloma	DOID_0070004
10152	ZHAN_MULTIPLE_MYELOMA_HP_DN	16728703	organ system cancer	DOID_0050686
10153	ZHAN_MULTIPLE_MYELOMA_MF_DN	16728703	bone disease	DOID_0080001
10154	ZHAN_MULTIPLE_MYELOMA_MF_DN	16728703	bone marrow cancer	DOID_4960
10155	ZHAN_MULTIPLE_MYELOMA_MF_DN	16728703	cancer	DOID_162
10156	ZHAN_MULTIPLE_MYELOMA_MF_DN	16728703	disease of anatomical entity	DOID_7
10157	ZHAN_MULTIPLE_MYELOMA_MF_DN	16728703	disease of cellular proliferation	DOID_14566
10158	ZHAN_MULTIPLE_MYELOMA_MF_DN	16728703	hematologic cancer	DOID_2531
10159	ZHAN_MULTIPLE_MYELOMA_MF_DN	16728703	immune system cancer	DOID_0060083
10160	ZHAN_MULTIPLE_MYELOMA_MF_DN	16728703	multiple myeloma	DOID_9538
10161	ZHAN_MULTIPLE_MYELOMA_MF_DN	16728703	musculoskeletal system disease	DOID_17
10162	ZHAN_MULTIPLE_MYELOMA_MF_DN	16728703	myeloma	DOID_0070004
10163	ZHAN_MULTIPLE_MYELOMA_MF_DN	16728703	organ system cancer	DOID_0050686
10164	ZHAN_MULTIPLE_MYELOMA_MS_DN	16728703	bone disease	DOID_0080001
10165	ZHAN_MULTIPLE_MYELOMA_MS_DN	16728703	bone marrow cancer	DOID_4960
10166	ZHAN_MULTIPLE_MYELOMA_MS_DN	16728703	cancer	DOID_162
10167	ZHAN_MULTIPLE_MYELOMA_MS_DN	16728703	disease of anatomical entity	DOID_7
10168	ZHAN_MULTIPLE_MYELOMA_MS_DN	16728703	disease of cellular proliferation	DOID_14566
10169	ZHAN_MULTIPLE_MYELOMA_MS_DN	16728703	hematologic cancer	DOID_2531
10170	ZHAN_MULTIPLE_MYELOMA_MS_DN	16728703	immune system cancer	DOID_0060083
10171	ZHAN_MULTIPLE_MYELOMA_MS_DN	16728703	multiple myeloma	DOID_9538
10172	ZHAN_MULTIPLE_MYELOMA_MS_DN	16728703	musculoskeletal system disease	DOID_17
10173	ZHAN_MULTIPLE_MYELOMA_MS_DN	16728703	myeloma	DOID_0070004
10174	ZHAN_MULTIPLE_MYELOMA_MS_DN	16728703	organ system cancer	DOID_0050686
10175	ZHAN_MULTIPLE_MYELOMA_PR_DN	16728703	bone disease	DOID_0080001
10176	ZHAN_MULTIPLE_MYELOMA_PR_DN	16728703	bone marrow cancer	DOID_4960
10177	ZHAN_MULTIPLE_MYELOMA_PR_DN	16728703	cancer	DOID_162
10178	ZHAN_MULTIPLE_MYELOMA_PR_DN	16728703	disease of anatomical entity	DOID_7
10179	ZHAN_MULTIPLE_MYELOMA_PR_DN	16728703	disease of cellular proliferation	DOID_14566
10180	ZHAN_MULTIPLE_MYELOMA_PR_DN	16728703	hematologic cancer	DOID_2531
10181	ZHAN_MULTIPLE_MYELOMA_PR_DN	16728703	immune system cancer	DOID_0060083
10182	ZHAN_MULTIPLE_MYELOMA_PR_DN	16728703	multiple myeloma	DOID_9538
10183	ZHAN_MULTIPLE_MYELOMA_PR_DN	16728703	musculoskeletal system disease	DOID_17
10184	ZHAN_MULTIPLE_MYELOMA_PR_DN	16728703	myeloma	DOID_0070004
10185	ZHAN_MULTIPLE_MYELOMA_PR_DN	16728703	organ system cancer	DOID_0050686
10186	DANG_REGULATED_BY_MYC_UP	14519204	NA	NA
10187	DANG_REGULATED_BY_MYC_DN	14519204	NA	NA
10188	DANG_MYC_TARGETS_UP	14519204	NA	NA
10189	DANG_MYC_TARGETS_DN	14519204	NA	NA
10190	DORN_ADENOVIRUS_INFECTION_12HR_UP	15681441	NA	NA
10191	DORN_ADENOVIRUS_INFECTION_12HR_DN	15681441	NA	NA
10192	DORN_ADENOVIRUS_INFECTION_24HR_DN	15681441	NA	NA
10193	DORN_ADENOVIRUS_INFECTION_32HR_DN	15681441	NA	NA
10194	DORN_ADENOVIRUS_INFECTION_48HR_UP	15681441	NA	NA
10195	DORN_ADENOVIRUS_INFECTION_48HR_DN	15681441	NA	NA
10196	TIAN_TNF_SIGNALING_VIA_NFKB	15722553	combined T cell and B cell immunodeficiency	DOID_628
10197	TIAN_TNF_SIGNALING_VIA_NFKB	15722553	disease of anatomical entity	DOID_7
10198	TIAN_TNF_SIGNALING_VIA_NFKB	15722553	immune system disease	DOID_2914
10199	TIAN_TNF_SIGNALING_VIA_NFKB	15722553	interleukin-7 receptor alpha deficiency	DOID_0060015
10200	TIAN_TNF_SIGNALING_VIA_NFKB	15722553	primary immunodeficiency disease	DOID_612
10201	TIAN_TNF_SIGNALING_VIA_NFKB	15722553	severe combined immunodeficiency	DOID_627
10202	TIAN_TNF_SIGNALING_NOT_VIA_NFKB	15722553	combined T cell and B cell immunodeficiency	DOID_628
10203	TIAN_TNF_SIGNALING_NOT_VIA_NFKB	15722553	disease of anatomical entity	DOID_7
10204	TIAN_TNF_SIGNALING_NOT_VIA_NFKB	15722553	immune system disease	DOID_2914
10205	TIAN_TNF_SIGNALING_NOT_VIA_NFKB	15722553	interleukin-7 receptor alpha deficiency	DOID_0060015
10206	TIAN_TNF_SIGNALING_NOT_VIA_NFKB	15722553	primary immunodeficiency disease	DOID_612
10207	TIAN_TNF_SIGNALING_NOT_VIA_NFKB	15722553	severe combined immunodeficiency	DOID_627
10208	WONG_EMBRYONIC_STEM_CELL_CORE	18397753	cancer	DOID_162
10209	WONG_EMBRYONIC_STEM_CELL_CORE	18397753	combined T cell and B cell immunodeficiency	DOID_628
10210	WONG_EMBRYONIC_STEM_CELL_CORE	18397753	disease of anatomical entity	DOID_7
10211	WONG_EMBRYONIC_STEM_CELL_CORE	18397753	disease of cellular proliferation	DOID_14566
10212	WONG_EMBRYONIC_STEM_CELL_CORE	18397753	immune system disease	DOID_2914
10213	WONG_EMBRYONIC_STEM_CELL_CORE	18397753	primary immunodeficiency disease	DOID_612
10214	WONG_EMBRYONIC_STEM_CELL_CORE	18397753	severe combined immunodeficiency	DOID_627
10215	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP	17464315	cancer	DOID_162
10216	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP	17464315	cell type cancer	DOID_0050687
10217	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP	17464315	connective tissue cancer	DOID_201
10218	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP	17464315	disease of cellular proliferation	DOID_14566
10219	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP	17464315	fibrosarcoma	DOID_3355
10220	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP	17464315	fibrous histiocytoma	DOID_4415
10221	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP	17464315	histiocytoma	DOID_4231
10222	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP	17464315	leiomyosarcoma	DOID_1967
10223	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP	17464315	lipomatous cancer	DOID_3939
10224	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP	17464315	liposarcoma	DOID_3382
10225	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP	17464315	malignant fibroxanthoma	DOID_1907
10226	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP	17464315	malignant peripheral nerve sheath tumor	DOID_5940
10227	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP	17464315	muscle cancer	DOID_4045
10228	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP	17464315	musculoskeletal system cancer	DOID_0060100
10229	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP	17464315	nervous system cancer	DOID_3093
10230	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP	17464315	organ system cancer	DOID_0050686
10231	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP	17464315	peripheral nerve sheath neoplasm	DOID_3193
10232	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP	17464315	peripheral nervous system neoplasm	DOID_1192
10233	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP	17464315	sarcoma	DOID_1115
10234	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP	17464315	smooth muscle cancer	DOID_4230
10235	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_DN	17464315	cancer	DOID_162
10236	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_DN	17464315	cell type cancer	DOID_0050687
10237	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_DN	17464315	connective tissue cancer	DOID_201
10238	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_DN	17464315	disease of cellular proliferation	DOID_14566
10239	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_DN	17464315	fibrosarcoma	DOID_3355
10240	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_DN	17464315	fibrous histiocytoma	DOID_4415
10241	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_DN	17464315	histiocytoma	DOID_4231
10242	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_DN	17464315	leiomyosarcoma	DOID_1967
10243	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_DN	17464315	lipomatous cancer	DOID_3939
10244	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_DN	17464315	liposarcoma	DOID_3382
10245	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_DN	17464315	malignant fibroxanthoma	DOID_1907
10246	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_DN	17464315	malignant peripheral nerve sheath tumor	DOID_5940
10247	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_DN	17464315	muscle cancer	DOID_4045
10248	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_DN	17464315	musculoskeletal system cancer	DOID_0060100
10249	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_DN	17464315	nervous system cancer	DOID_3093
10250	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_DN	17464315	organ system cancer	DOID_0050686
10251	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_DN	17464315	peripheral nerve sheath neoplasm	DOID_3193
10252	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_DN	17464315	peripheral nervous system neoplasm	DOID_1192
10253	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_DN	17464315	sarcoma	DOID_1115
10254	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_DN	17464315	smooth muscle cancer	DOID_4230
10255	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP	17464315	cancer	DOID_162
10256	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP	17464315	cell type cancer	DOID_0050687
10257	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP	17464315	connective tissue cancer	DOID_201
10258	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP	17464315	disease of cellular proliferation	DOID_14566
10259	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP	17464315	fibrosarcoma	DOID_3355
10260	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP	17464315	fibrous histiocytoma	DOID_4415
10261	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP	17464315	histiocytoma	DOID_4231
10262	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP	17464315	leiomyosarcoma	DOID_1967
10263	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP	17464315	lipomatous cancer	DOID_3939
10264	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP	17464315	liposarcoma	DOID_3382
10265	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP	17464315	malignant fibroxanthoma	DOID_1907
10266	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP	17464315	malignant peripheral nerve sheath tumor	DOID_5940
10267	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP	17464315	muscle cancer	DOID_4045
10268	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP	17464315	musculoskeletal system cancer	DOID_0060100
10269	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP	17464315	nervous system cancer	DOID_3093
10270	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP	17464315	organ system cancer	DOID_0050686
10271	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP	17464315	peripheral nerve sheath neoplasm	DOID_3193
10272	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP	17464315	peripheral nervous system neoplasm	DOID_1192
10273	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP	17464315	sarcoma	DOID_1115
10274	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP	17464315	smooth muscle cancer	DOID_4230
10275	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN	17464315	cancer	DOID_162
10276	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN	17464315	cell type cancer	DOID_0050687
10277	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN	17464315	connective tissue cancer	DOID_201
10278	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN	17464315	disease of cellular proliferation	DOID_14566
10279	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN	17464315	fibrosarcoma	DOID_3355
10280	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN	17464315	fibrous histiocytoma	DOID_4415
10281	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN	17464315	histiocytoma	DOID_4231
10282	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN	17464315	leiomyosarcoma	DOID_1967
10283	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN	17464315	lipomatous cancer	DOID_3939
10284	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN	17464315	liposarcoma	DOID_3382
10285	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN	17464315	malignant fibroxanthoma	DOID_1907
10286	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN	17464315	malignant peripheral nerve sheath tumor	DOID_5940
10287	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN	17464315	muscle cancer	DOID_4045
10288	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN	17464315	musculoskeletal system cancer	DOID_0060100
10289	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN	17464315	nervous system cancer	DOID_3093
10290	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN	17464315	organ system cancer	DOID_0050686
10291	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN	17464315	peripheral nerve sheath neoplasm	DOID_3193
10292	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN	17464315	peripheral nervous system neoplasm	DOID_1192
10293	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN	17464315	sarcoma	DOID_1115
10294	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN	17464315	smooth muscle cancer	DOID_4230
10295	CHANDRAN_METASTASIS_UP	17430594	cancer	DOID_162
10296	CHANDRAN_METASTASIS_UP	17430594	disease of cellular proliferation	DOID_14566
10297	CHANDRAN_METASTASIS_UP	17430594	male reproductive organ cancer	DOID_3856
10298	CHANDRAN_METASTASIS_UP	17430594	organ system cancer	DOID_0050686
10299	CHANDRAN_METASTASIS_UP	17430594	prostate cancer	DOID_10283
10300	CHANDRAN_METASTASIS_UP	17430594	reproductive organ cancer	DOID_193
10301	CHANDRAN_METASTASIS_DN	17430594	cancer	DOID_162
10302	CHANDRAN_METASTASIS_DN	17430594	disease of cellular proliferation	DOID_14566
10303	CHANDRAN_METASTASIS_DN	17430594	male reproductive organ cancer	DOID_3856
10304	CHANDRAN_METASTASIS_DN	17430594	organ system cancer	DOID_0050686
10305	CHANDRAN_METASTASIS_DN	17430594	prostate cancer	DOID_10283
10306	CHANDRAN_METASTASIS_DN	17430594	reproductive organ cancer	DOID_193
10307	SENGUPTA_EBNA1_ANTICORRELATED	16912175	cancer	DOID_162
10308	SENGUPTA_EBNA1_ANTICORRELATED	16912175	carcinoma	DOID_305
10309	SENGUPTA_EBNA1_ANTICORRELATED	16912175	cell type cancer	DOID_0050687
10310	SENGUPTA_EBNA1_ANTICORRELATED	16912175	disease of cellular proliferation	DOID_14566
10311	SENGUPTA_EBNA1_ANTICORRELATED	16912175	nasopharynx carcinoma	DOID_9261
10312	SENGUPTA_EBNA1_ANTICORRELATED	16912175	organ system cancer	DOID_0050686
10313	SENGUPTA_EBNA1_ANTICORRELATED	16912175	respiratory system cancer	DOID_0050615
10314	MOOTHA_FFA_OXYDATION	12808457	acquired metabolic disease	DOID_0060158
10315	MOOTHA_FFA_OXYDATION	12808457	carbohydrate metabolism disease	DOID_0050013
10316	MOOTHA_FFA_OXYDATION	12808457	diabetes mellitus	DOID_9351
10317	MOOTHA_FFA_OXYDATION	12808457	disease of metabolism	DOID_0014667
10318	MOOTHA_FFA_OXYDATION	12808457	glucose metabolism disease	DOID_4194
10319	MOOTHA_GLUCONEOGENESIS	12808457	acquired metabolic disease	DOID_0060158
10320	MOOTHA_GLUCONEOGENESIS	12808457	carbohydrate metabolism disease	DOID_0050013
10321	MOOTHA_GLUCONEOGENESIS	12808457	diabetes mellitus	DOID_9351
10322	MOOTHA_GLUCONEOGENESIS	12808457	disease of metabolism	DOID_0014667
10323	MOOTHA_GLUCONEOGENESIS	12808457	glucose metabolism disease	DOID_4194
10324	MOOTHA_GLYCOGEN_METABOLISM	12808457	acquired metabolic disease	DOID_0060158
10325	MOOTHA_GLYCOGEN_METABOLISM	12808457	carbohydrate metabolism disease	DOID_0050013
10326	MOOTHA_GLYCOGEN_METABOLISM	12808457	diabetes mellitus	DOID_9351
10327	MOOTHA_GLYCOGEN_METABOLISM	12808457	disease of metabolism	DOID_0014667
10328	MOOTHA_GLYCOGEN_METABOLISM	12808457	glucose metabolism disease	DOID_4194
10329	MOOTHA_GLYCOLYSIS	12808457	acquired metabolic disease	DOID_0060158
10330	MOOTHA_GLYCOLYSIS	12808457	carbohydrate metabolism disease	DOID_0050013
10331	MOOTHA_GLYCOLYSIS	12808457	diabetes mellitus	DOID_9351
10332	MOOTHA_GLYCOLYSIS	12808457	disease of metabolism	DOID_0014667
10333	MOOTHA_GLYCOLYSIS	12808457	glucose metabolism disease	DOID_4194
10334	HO_LIVER_CANCER_VASCULAR_INVASION	17009164	cancer	DOID_162
10335	HO_LIVER_CANCER_VASCULAR_INVASION	17009164	carcinoma	DOID_305
10336	HO_LIVER_CANCER_VASCULAR_INVASION	17009164	cell type cancer	DOID_0050687
10337	HO_LIVER_CANCER_VASCULAR_INVASION	17009164	disease of cellular proliferation	DOID_14566
10338	HO_LIVER_CANCER_VASCULAR_INVASION	17009164	gastrointestinal system cancer	DOID_3119
10339	HO_LIVER_CANCER_VASCULAR_INVASION	17009164	hepatocellular carcinoma	DOID_684
10340	HO_LIVER_CANCER_VASCULAR_INVASION	17009164	liver cancer	DOID_3571
10341	HO_LIVER_CANCER_VASCULAR_INVASION	17009164	liver carcinoma	DOID_686
10342	HO_LIVER_CANCER_VASCULAR_INVASION	17009164	organ system cancer	DOID_0050686
10343	MURAKAMI_UV_RESPONSE_1HR_UP	11532376	NA	NA
10344	DAZARD_UV_RESPONSE_CLUSTER_G24	12771951	cancer	DOID_162
10345	DAZARD_UV_RESPONSE_CLUSTER_G24	12771951	carcinoma	DOID_305
10346	DAZARD_UV_RESPONSE_CLUSTER_G24	12771951	cell type cancer	DOID_0050687
10347	DAZARD_UV_RESPONSE_CLUSTER_G24	12771951	disease of cellular proliferation	DOID_14566
10348	DAZARD_UV_RESPONSE_CLUSTER_G24	12771951	squamous cell carcinoma	DOID_1749
10349	NIELSEN_GIST	11965276	cancer	DOID_162
10350	NIELSEN_GIST	11965276	cell type cancer	DOID_0050687
10351	NIELSEN_GIST	11965276	connective tissue cancer	DOID_201
10352	NIELSEN_GIST	11965276	disease of cellular proliferation	DOID_14566
10353	NIELSEN_GIST	11965276	fibrous histiocytoma	DOID_4415
10354	NIELSEN_GIST	11965276	histiocytoma	DOID_4231
10355	NIELSEN_GIST	11965276	leiomyosarcoma	DOID_1967
10356	NIELSEN_GIST	11965276	lipomatous cancer	DOID_3939
10357	NIELSEN_GIST	11965276	liposarcoma	DOID_3382
10358	NIELSEN_GIST	11965276	muscle cancer	DOID_4045
10359	NIELSEN_GIST	11965276	musculoskeletal system cancer	DOID_0060100
10360	NIELSEN_GIST	11965276	organ system cancer	DOID_0050686
10361	NIELSEN_GIST	11965276	sarcoma	DOID_1115
10362	NIELSEN_GIST	11965276	smooth muscle cancer	DOID_4230
10363	DASU_IL6_SIGNALING_UP	15095275	NA	NA
10364	JIANG_HYPOXIA_VIA_VHL	12692265	cancer	DOID_162
10365	JIANG_HYPOXIA_VIA_VHL	12692265	carcinoma	DOID_305
10366	JIANG_HYPOXIA_VIA_VHL	12692265	cell type cancer	DOID_0050687
10367	JIANG_HYPOXIA_VIA_VHL	12692265	disease of cellular proliferation	DOID_14566
10368	JIANG_HYPOXIA_VIA_VHL	12692265	kidney cancer	DOID_263
10369	JIANG_HYPOXIA_VIA_VHL	12692265	organ system cancer	DOID_0050686
10370	JIANG_HYPOXIA_VIA_VHL	12692265	renal carcinoma	DOID_4451
10371	JIANG_HYPOXIA_VIA_VHL	12692265	renal cell carcinoma	DOID_4450
10372	JIANG_HYPOXIA_VIA_VHL	12692265	urinary system cancer	DOID_3996
10373	WU_APOPTOSIS_BY_CDKN1A_VIA_TP53	12138103	cancer	DOID_162
10374	WU_APOPTOSIS_BY_CDKN1A_VIA_TP53	12138103	disease of cellular proliferation	DOID_14566
10375	WU_APOPTOSIS_BY_CDKN1A_VIA_TP53	12138103	female reproductive organ cancer	DOID_120
10376	WU_APOPTOSIS_BY_CDKN1A_VIA_TP53	12138103	organ system cancer	DOID_0050686
10377	WU_APOPTOSIS_BY_CDKN1A_VIA_TP53	12138103	ovarian cancer	DOID_2394
10378	WU_APOPTOSIS_BY_CDKN1A_VIA_TP53	12138103	reproductive organ cancer	DOID_193
10379	WU_APOPTOSIS_BY_CDKN1A_NOT_VIA_TP53	12138103	cancer	DOID_162
10380	WU_APOPTOSIS_BY_CDKN1A_NOT_VIA_TP53	12138103	disease of cellular proliferation	DOID_14566
10381	WU_APOPTOSIS_BY_CDKN1A_NOT_VIA_TP53	12138103	female reproductive organ cancer	DOID_120
10382	WU_APOPTOSIS_BY_CDKN1A_NOT_VIA_TP53	12138103	organ system cancer	DOID_0050686
10383	WU_APOPTOSIS_BY_CDKN1A_NOT_VIA_TP53	12138103	ovarian cancer	DOID_2394
10384	WU_APOPTOSIS_BY_CDKN1A_NOT_VIA_TP53	12138103	reproductive organ cancer	DOID_193
10385	SASSON_RESPONSE_TO_GONADOTROPHINS_UP	15026540	NA	NA
10386	SASSON_RESPONSE_TO_GONADOTROPHINS_DN	15026540	NA	NA
10387	SASSON_RESPONSE_TO_FORSKOLIN_UP	15026540	NA	NA
10388	SASSON_RESPONSE_TO_FORSKOLIN_DN	15026540	NA	NA
10389	BROWNE_HCMV_INFECTION_30MIN_UP	11711622	NA	NA
10390	BROWNE_HCMV_INFECTION_30MIN_DN	11711622	NA	NA
10391	BROWNE_HCMV_INFECTION_1HR_UP	11711622	NA	NA
10392	BROWNE_HCMV_INFECTION_1HR_DN	11711622	NA	NA
10393	BROWNE_HCMV_INFECTION_2HR_UP	11711622	NA	NA
10394	BROWNE_HCMV_INFECTION_2HR_DN	11711622	NA	NA
10395	BROWNE_HCMV_INFECTION_4HR_UP	11711622	NA	NA
10396	BROWNE_HCMV_INFECTION_4HR_DN	11711622	NA	NA
10397	RAGHAVACHARI_PLATELET_SPECIFIC_GENES	17353439	anemia	DOID_2355
10398	RAGHAVACHARI_PLATELET_SPECIFIC_GENES	17353439	disease of anatomical entity	DOID_7
10399	RAGHAVACHARI_PLATELET_SPECIFIC_GENES	17353439	hematopoietic system disease	DOID_74
10400	RAGHAVACHARI_PLATELET_SPECIFIC_GENES	17353439	immune system disease	DOID_2914
10401	ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_DN	16728703	bone disease	DOID_0080001
10402	ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_DN	16728703	bone marrow cancer	DOID_4960
10403	ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_DN	16728703	cancer	DOID_162
10404	ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_DN	16728703	disease of anatomical entity	DOID_7
10405	ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_DN	16728703	disease of cellular proliferation	DOID_14566
10406	ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_DN	16728703	hematologic cancer	DOID_2531
10407	ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_DN	16728703	immune system cancer	DOID_0060083
10408	ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_DN	16728703	multiple myeloma	DOID_9538
10409	ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_DN	16728703	musculoskeletal system disease	DOID_17
10410	ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_DN	16728703	myeloma	DOID_0070004
10411	ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_DN	16728703	organ system cancer	DOID_0050686
10412	ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_UP	16728703	bone disease	DOID_0080001
10413	ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_UP	16728703	bone marrow cancer	DOID_4960
10414	ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_UP	16728703	cancer	DOID_162
10415	ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_UP	16728703	disease of anatomical entity	DOID_7
10416	ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_UP	16728703	disease of cellular proliferation	DOID_14566
10417	ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_UP	16728703	hematologic cancer	DOID_2531
10418	ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_UP	16728703	immune system cancer	DOID_0060083
10419	ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_UP	16728703	multiple myeloma	DOID_9538
10420	ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_UP	16728703	musculoskeletal system disease	DOID_17
10421	ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_UP	16728703	myeloma	DOID_0070004
10422	ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_UP	16728703	organ system cancer	DOID_0050686
10423	ZHAN_MULTIPLE_MYELOMA_PR_UP	16728703	bone disease	DOID_0080001
10424	ZHAN_MULTIPLE_MYELOMA_PR_UP	16728703	bone marrow cancer	DOID_4960
10425	ZHAN_MULTIPLE_MYELOMA_PR_UP	16728703	cancer	DOID_162
10426	ZHAN_MULTIPLE_MYELOMA_PR_UP	16728703	disease of anatomical entity	DOID_7
10427	ZHAN_MULTIPLE_MYELOMA_PR_UP	16728703	disease of cellular proliferation	DOID_14566
10428	ZHAN_MULTIPLE_MYELOMA_PR_UP	16728703	hematologic cancer	DOID_2531
10429	ZHAN_MULTIPLE_MYELOMA_PR_UP	16728703	immune system cancer	DOID_0060083
10430	ZHAN_MULTIPLE_MYELOMA_PR_UP	16728703	multiple myeloma	DOID_9538
10431	ZHAN_MULTIPLE_MYELOMA_PR_UP	16728703	musculoskeletal system disease	DOID_17
10432	ZHAN_MULTIPLE_MYELOMA_PR_UP	16728703	myeloma	DOID_0070004
10433	ZHAN_MULTIPLE_MYELOMA_PR_UP	16728703	organ system cancer	DOID_0050686
10434	ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_UP	16728703	bone disease	DOID_0080001
10435	ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_UP	16728703	bone marrow cancer	DOID_4960
10436	ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_UP	16728703	cancer	DOID_162
10437	ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_UP	16728703	disease of anatomical entity	DOID_7
10438	ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_UP	16728703	disease of cellular proliferation	DOID_14566
10439	ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_UP	16728703	hematologic cancer	DOID_2531
10440	ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_UP	16728703	immune system cancer	DOID_0060083
10441	ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_UP	16728703	multiple myeloma	DOID_9538
10442	ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_UP	16728703	musculoskeletal system disease	DOID_17
10443	ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_UP	16728703	myeloma	DOID_0070004
10444	ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_UP	16728703	organ system cancer	DOID_0050686
10445	ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_DN	16728703	bone disease	DOID_0080001
10446	ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_DN	16728703	bone marrow cancer	DOID_4960
10447	ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_DN	16728703	cancer	DOID_162
10448	ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_DN	16728703	disease of anatomical entity	DOID_7
10449	ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_DN	16728703	disease of cellular proliferation	DOID_14566
10450	ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_DN	16728703	hematologic cancer	DOID_2531
10451	ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_DN	16728703	immune system cancer	DOID_0060083
10452	ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_DN	16728703	multiple myeloma	DOID_9538
10453	ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_DN	16728703	musculoskeletal system disease	DOID_17
10454	ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_DN	16728703	myeloma	DOID_0070004
10455	ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_DN	16728703	organ system cancer	DOID_0050686
10456	ZHAN_MULTIPLE_MYELOMA_LB_UP	16728703	bone disease	DOID_0080001
10457	ZHAN_MULTIPLE_MYELOMA_LB_UP	16728703	bone marrow cancer	DOID_4960
10458	ZHAN_MULTIPLE_MYELOMA_LB_UP	16728703	cancer	DOID_162
10459	ZHAN_MULTIPLE_MYELOMA_LB_UP	16728703	disease of anatomical entity	DOID_7
10460	ZHAN_MULTIPLE_MYELOMA_LB_UP	16728703	disease of cellular proliferation	DOID_14566
10461	ZHAN_MULTIPLE_MYELOMA_LB_UP	16728703	hematologic cancer	DOID_2531
10462	ZHAN_MULTIPLE_MYELOMA_LB_UP	16728703	immune system cancer	DOID_0060083
10463	ZHAN_MULTIPLE_MYELOMA_LB_UP	16728703	multiple myeloma	DOID_9538
10464	ZHAN_MULTIPLE_MYELOMA_LB_UP	16728703	musculoskeletal system disease	DOID_17
10465	ZHAN_MULTIPLE_MYELOMA_LB_UP	16728703	myeloma	DOID_0070004
10466	ZHAN_MULTIPLE_MYELOMA_LB_UP	16728703	organ system cancer	DOID_0050686
10467	ZHAN_MULTIPLE_MYELOMA_MS_UP	16728703	bone disease	DOID_0080001
10468	ZHAN_MULTIPLE_MYELOMA_MS_UP	16728703	bone marrow cancer	DOID_4960
10469	ZHAN_MULTIPLE_MYELOMA_MS_UP	16728703	cancer	DOID_162
10470	ZHAN_MULTIPLE_MYELOMA_MS_UP	16728703	disease of anatomical entity	DOID_7
10471	ZHAN_MULTIPLE_MYELOMA_MS_UP	16728703	disease of cellular proliferation	DOID_14566
10472	ZHAN_MULTIPLE_MYELOMA_MS_UP	16728703	hematologic cancer	DOID_2531
10473	ZHAN_MULTIPLE_MYELOMA_MS_UP	16728703	immune system cancer	DOID_0060083
10474	ZHAN_MULTIPLE_MYELOMA_MS_UP	16728703	multiple myeloma	DOID_9538
10475	ZHAN_MULTIPLE_MYELOMA_MS_UP	16728703	musculoskeletal system disease	DOID_17
10476	ZHAN_MULTIPLE_MYELOMA_MS_UP	16728703	myeloma	DOID_0070004
10477	ZHAN_MULTIPLE_MYELOMA_MS_UP	16728703	organ system cancer	DOID_0050686
10478	ZHAN_MULTIPLE_MYELOMA_HP_UP	16728703	bone disease	DOID_0080001
10479	ZHAN_MULTIPLE_MYELOMA_HP_UP	16728703	bone marrow cancer	DOID_4960
10480	ZHAN_MULTIPLE_MYELOMA_HP_UP	16728703	cancer	DOID_162
10481	ZHAN_MULTIPLE_MYELOMA_HP_UP	16728703	disease of anatomical entity	DOID_7
10482	ZHAN_MULTIPLE_MYELOMA_HP_UP	16728703	disease of cellular proliferation	DOID_14566
10483	ZHAN_MULTIPLE_MYELOMA_HP_UP	16728703	hematologic cancer	DOID_2531
10484	ZHAN_MULTIPLE_MYELOMA_HP_UP	16728703	immune system cancer	DOID_0060083
10485	ZHAN_MULTIPLE_MYELOMA_HP_UP	16728703	multiple myeloma	DOID_9538
10486	ZHAN_MULTIPLE_MYELOMA_HP_UP	16728703	musculoskeletal system disease	DOID_17
10487	ZHAN_MULTIPLE_MYELOMA_HP_UP	16728703	myeloma	DOID_0070004
10488	ZHAN_MULTIPLE_MYELOMA_HP_UP	16728703	organ system cancer	DOID_0050686
10489	ZHAN_MULTIPLE_MYELOMA_CD1_UP	16728703	bone disease	DOID_0080001
10490	ZHAN_MULTIPLE_MYELOMA_CD1_UP	16728703	bone marrow cancer	DOID_4960
10491	ZHAN_MULTIPLE_MYELOMA_CD1_UP	16728703	cancer	DOID_162
10492	ZHAN_MULTIPLE_MYELOMA_CD1_UP	16728703	disease of anatomical entity	DOID_7
10493	ZHAN_MULTIPLE_MYELOMA_CD1_UP	16728703	disease of cellular proliferation	DOID_14566
10494	ZHAN_MULTIPLE_MYELOMA_CD1_UP	16728703	hematologic cancer	DOID_2531
10495	ZHAN_MULTIPLE_MYELOMA_CD1_UP	16728703	immune system cancer	DOID_0060083
10496	ZHAN_MULTIPLE_MYELOMA_CD1_UP	16728703	multiple myeloma	DOID_9538
10497	ZHAN_MULTIPLE_MYELOMA_CD1_UP	16728703	musculoskeletal system disease	DOID_17
10498	ZHAN_MULTIPLE_MYELOMA_CD1_UP	16728703	myeloma	DOID_0070004
10499	ZHAN_MULTIPLE_MYELOMA_CD1_UP	16728703	organ system cancer	DOID_0050686
10500	ZHAN_MULTIPLE_MYELOMA_CD2_UP	16728703	bone disease	DOID_0080001
10501	ZHAN_MULTIPLE_MYELOMA_CD2_UP	16728703	bone marrow cancer	DOID_4960
10502	ZHAN_MULTIPLE_MYELOMA_CD2_UP	16728703	cancer	DOID_162
10503	ZHAN_MULTIPLE_MYELOMA_CD2_UP	16728703	disease of anatomical entity	DOID_7
10504	ZHAN_MULTIPLE_MYELOMA_CD2_UP	16728703	disease of cellular proliferation	DOID_14566
10505	ZHAN_MULTIPLE_MYELOMA_CD2_UP	16728703	hematologic cancer	DOID_2531
10506	ZHAN_MULTIPLE_MYELOMA_CD2_UP	16728703	immune system cancer	DOID_0060083
10507	ZHAN_MULTIPLE_MYELOMA_CD2_UP	16728703	multiple myeloma	DOID_9538
10508	ZHAN_MULTIPLE_MYELOMA_CD2_UP	16728703	musculoskeletal system disease	DOID_17
10509	ZHAN_MULTIPLE_MYELOMA_CD2_UP	16728703	myeloma	DOID_0070004
10510	ZHAN_MULTIPLE_MYELOMA_CD2_UP	16728703	organ system cancer	DOID_0050686
10511	ZHAN_MULTIPLE_MYELOMA_MF_UP	16728703	bone disease	DOID_0080001
10512	ZHAN_MULTIPLE_MYELOMA_MF_UP	16728703	bone marrow cancer	DOID_4960
10513	ZHAN_MULTIPLE_MYELOMA_MF_UP	16728703	cancer	DOID_162
10514	ZHAN_MULTIPLE_MYELOMA_MF_UP	16728703	disease of anatomical entity	DOID_7
10515	ZHAN_MULTIPLE_MYELOMA_MF_UP	16728703	disease of cellular proliferation	DOID_14566
10516	ZHAN_MULTIPLE_MYELOMA_MF_UP	16728703	hematologic cancer	DOID_2531
10517	ZHAN_MULTIPLE_MYELOMA_MF_UP	16728703	immune system cancer	DOID_0060083
10518	ZHAN_MULTIPLE_MYELOMA_MF_UP	16728703	multiple myeloma	DOID_9538
10519	ZHAN_MULTIPLE_MYELOMA_MF_UP	16728703	musculoskeletal system disease	DOID_17
10520	ZHAN_MULTIPLE_MYELOMA_MF_UP	16728703	myeloma	DOID_0070004
10521	ZHAN_MULTIPLE_MYELOMA_MF_UP	16728703	organ system cancer	DOID_0050686
10522	URS_ADIPOCYTE_DIFFERENTIATION_DN	15051823	acquired metabolic disease	DOID_0060158
10523	URS_ADIPOCYTE_DIFFERENTIATION_DN	15051823	disease of metabolism	DOID_0014667
10524	URS_ADIPOCYTE_DIFFERENTIATION_DN	15051823	nutrition disease	DOID_374
10525	URS_ADIPOCYTE_DIFFERENTIATION_DN	15051823	obesity	DOID_9970
10526	URS_ADIPOCYTE_DIFFERENTIATION_DN	15051823	overnutrition	DOID_654
10527	URS_ADIPOCYTE_DIFFERENTIATION_UP	15051823	acquired metabolic disease	DOID_0060158
10528	URS_ADIPOCYTE_DIFFERENTIATION_UP	15051823	disease of metabolism	DOID_0014667
10529	URS_ADIPOCYTE_DIFFERENTIATION_UP	15051823	nutrition disease	DOID_374
10530	URS_ADIPOCYTE_DIFFERENTIATION_UP	15051823	obesity	DOID_9970
10531	URS_ADIPOCYTE_DIFFERENTIATION_UP	15051823	overnutrition	DOID_654
10532	KAYO_AGING_MUSCLE_DN	11309484	NA	NA
10533	KAYO_AGING_MUSCLE_UP	11309484	NA	NA
10534	LU_AGING_BRAIN_DN	15190254	Alzheimer's disease	DOID_10652
10535	LU_AGING_BRAIN_DN	15190254	central nervous system disease	DOID_331
10536	LU_AGING_BRAIN_DN	15190254	cognitive disorder	DOID_1561
10537	LU_AGING_BRAIN_DN	15190254	dementia	DOID_1307
10538	LU_AGING_BRAIN_DN	15190254	disease of anatomical entity	DOID_7
10539	LU_AGING_BRAIN_DN	15190254	disease of mental health	DOID_150
10540	LU_AGING_BRAIN_DN	15190254	nervous system disease	DOID_863
10541	LU_AGING_BRAIN_DN	15190254	neurodegenerative disease	DOID_1289
10542	LU_AGING_BRAIN_DN	15190254	tauopathy	DOID_680
10543	LU_AGING_BRAIN_UP	15190254	Alzheimer's disease	DOID_10652
10544	LU_AGING_BRAIN_UP	15190254	central nervous system disease	DOID_331
10545	LU_AGING_BRAIN_UP	15190254	cognitive disorder	DOID_1561
10546	LU_AGING_BRAIN_UP	15190254	dementia	DOID_1307
10547	LU_AGING_BRAIN_UP	15190254	disease of anatomical entity	DOID_7
10548	LU_AGING_BRAIN_UP	15190254	disease of mental health	DOID_150
10549	LU_AGING_BRAIN_UP	15190254	nervous system disease	DOID_863
10550	LU_AGING_BRAIN_UP	15190254	neurodegenerative disease	DOID_1289
10551	LU_AGING_BRAIN_UP	15190254	tauopathy	DOID_680
10552	RODWELL_AGING_KIDNEY_DN	15562319	NA	NA
10553	RODWELL_AGING_KIDNEY_NO_BLOOD_DN	15562319	NA	NA
10554	RODWELL_AGING_KIDNEY_NO_BLOOD_UP	15562319	NA	NA
10555	RODWELL_AGING_KIDNEY_UP	15562319	NA	NA
10556	BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_DN	14769913	Alzheimer's disease	DOID_10652
10557	BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_DN	14769913	central nervous system disease	DOID_331
10558	BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_DN	14769913	cognitive disorder	DOID_1561
10559	BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_DN	14769913	dementia	DOID_1307
10560	BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_DN	14769913	disease of anatomical entity	DOID_7
10561	BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_DN	14769913	disease of mental health	DOID_150
10562	BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_DN	14769913	nervous system disease	DOID_863
10563	BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_DN	14769913	neurodegenerative disease	DOID_1289
10564	BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_DN	14769913	tauopathy	DOID_680
10565	BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP	14769913	Alzheimer's disease	DOID_10652
10566	BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP	14769913	central nervous system disease	DOID_331
10567	BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP	14769913	cognitive disorder	DOID_1561
10568	BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP	14769913	dementia	DOID_1307
10569	BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP	14769913	disease of anatomical entity	DOID_7
10570	BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP	14769913	disease of mental health	DOID_150
10571	BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP	14769913	nervous system disease	DOID_863
10572	BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP	14769913	neurodegenerative disease	DOID_1289
10573	BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP	14769913	tauopathy	DOID_680
10574	KAAB_HEART_ATRIUM_VS_VENTRICLE_UP	15103417	cardiomyopathy	DOID_0050700
10575	KAAB_HEART_ATRIUM_VS_VENTRICLE_UP	15103417	cardiovascular system disease	DOID_1287
10576	KAAB_HEART_ATRIUM_VS_VENTRICLE_UP	15103417	dilated cardiomyopathy	DOID_12930
10577	KAAB_HEART_ATRIUM_VS_VENTRICLE_UP	15103417	disease of anatomical entity	DOID_7
10578	KAAB_HEART_ATRIUM_VS_VENTRICLE_UP	15103417	extrinsic cardiomyopathy	DOID_3978
10579	KAAB_HEART_ATRIUM_VS_VENTRICLE_UP	15103417	heart disease	DOID_114
10580	KAAB_HEART_ATRIUM_VS_VENTRICLE_UP	15103417	intrinsic cardiomyopathy	DOID_0060036
10581	KAAB_HEART_ATRIUM_VS_VENTRICLE_UP	15103417	ischemia	DOID_326
10582	KAAB_HEART_ATRIUM_VS_VENTRICLE_UP	15103417	ischemic heart disease	DOID_3394
10583	KAAB_HEART_ATRIUM_VS_VENTRICLE_UP	15103417	vascular disease	DOID_178
10584	WANG_SMARCE1_TARGETS_DN	16135788	breast cancer	DOID_1612
10585	WANG_SMARCE1_TARGETS_DN	16135788	breast carcinoma	DOID_3459
10586	WANG_SMARCE1_TARGETS_DN	16135788	cancer	DOID_162
10587	WANG_SMARCE1_TARGETS_DN	16135788	carcinoma	DOID_305
10588	WANG_SMARCE1_TARGETS_DN	16135788	cell type cancer	DOID_0050687
10589	WANG_SMARCE1_TARGETS_DN	16135788	disease of cellular proliferation	DOID_14566
10590	WANG_SMARCE1_TARGETS_DN	16135788	organ system cancer	DOID_0050686
10591	WANG_SMARCE1_TARGETS_DN	16135788	thoracic cancer	DOID_5093
10592	WANG_SMARCE1_TARGETS_UP	16135788	breast cancer	DOID_1612
10593	WANG_SMARCE1_TARGETS_UP	16135788	breast carcinoma	DOID_3459
10594	WANG_SMARCE1_TARGETS_UP	16135788	cancer	DOID_162
10595	WANG_SMARCE1_TARGETS_UP	16135788	carcinoma	DOID_305
10596	WANG_SMARCE1_TARGETS_UP	16135788	cell type cancer	DOID_0050687
10597	WANG_SMARCE1_TARGETS_UP	16135788	disease of cellular proliferation	DOID_14566
10598	WANG_SMARCE1_TARGETS_UP	16135788	organ system cancer	DOID_0050686
10599	WANG_SMARCE1_TARGETS_UP	16135788	thoracic cancer	DOID_5093
10600	BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_24HR_DN	15980968	cancer	DOID_162
10601	BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_24HR_DN	15980968	cell type cancer	DOID_0050687
10602	BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_24HR_DN	15980968	disease of cellular proliferation	DOID_14566
10603	BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_24HR_DN	15980968	malignant glioma	DOID_3070
10604	BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_DN	15980968	cancer	DOID_162
10605	BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_DN	15980968	cell type cancer	DOID_0050687
10606	BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_DN	15980968	disease of cellular proliferation	DOID_14566
10607	BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_DN	15980968	malignant glioma	DOID_3070
10608	BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_UP	15980968	cancer	DOID_162
10609	BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_UP	15980968	cell type cancer	DOID_0050687
10610	BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_UP	15980968	disease of cellular proliferation	DOID_14566
10611	BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_UP	15980968	malignant glioma	DOID_3070
10612	BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_24HR_UP	15980968	cancer	DOID_162
10613	BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_24HR_UP	15980968	cell type cancer	DOID_0050687
10614	BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_24HR_UP	15980968	disease of cellular proliferation	DOID_14566
10615	BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_24HR_UP	15980968	malignant glioma	DOID_3070
10616	BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_48HR_DN	15980968	cancer	DOID_162
10617	BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_48HR_DN	15980968	cell type cancer	DOID_0050687
10618	BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_48HR_DN	15980968	disease of cellular proliferation	DOID_14566
10619	BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_48HR_DN	15980968	malignant glioma	DOID_3070
10620	BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_48HR_UP	15980968	cancer	DOID_162
10621	BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_48HR_UP	15980968	cell type cancer	DOID_0050687
10622	BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_48HR_UP	15980968	disease of cellular proliferation	DOID_14566
10623	BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_48HR_UP	15980968	malignant glioma	DOID_3070
10624	HEDENFALK_BREAST_CANCER_BRACX_DN	12610208	autosomal dominant disease	DOID_0050736
10625	HEDENFALK_BREAST_CANCER_BRACX_DN	12610208	autosomal genetic disease	DOID_0050739
10626	HEDENFALK_BREAST_CANCER_BRACX_DN	12610208	breast cancer	DOID_1612
10627	HEDENFALK_BREAST_CANCER_BRACX_DN	12610208	cancer	DOID_162
10628	HEDENFALK_BREAST_CANCER_BRACX_DN	12610208	disease of cellular proliferation	DOID_14566
10629	HEDENFALK_BREAST_CANCER_BRACX_DN	12610208	female reproductive organ cancer	DOID_120
10630	HEDENFALK_BREAST_CANCER_BRACX_DN	12610208	genetic disease	DOID_630
10631	HEDENFALK_BREAST_CANCER_BRACX_DN	12610208	hereditary breast ovarian cancer	DOID_5683
10632	HEDENFALK_BREAST_CANCER_BRACX_DN	12610208	monogenic disease	DOID_0050177
10633	HEDENFALK_BREAST_CANCER_BRACX_DN	12610208	organ system cancer	DOID_0050686
10634	HEDENFALK_BREAST_CANCER_BRACX_DN	12610208	ovarian cancer	DOID_2394
10635	HEDENFALK_BREAST_CANCER_BRACX_DN	12610208	reproductive organ cancer	DOID_193
10636	HEDENFALK_BREAST_CANCER_BRACX_DN	12610208	thoracic cancer	DOID_5093
10637	HEDENFALK_BREAST_CANCER_BRACX_UP	12610208	autosomal dominant disease	DOID_0050736
10638	HEDENFALK_BREAST_CANCER_BRACX_UP	12610208	autosomal genetic disease	DOID_0050739
10639	HEDENFALK_BREAST_CANCER_BRACX_UP	12610208	breast cancer	DOID_1612
10640	HEDENFALK_BREAST_CANCER_BRACX_UP	12610208	cancer	DOID_162
10641	HEDENFALK_BREAST_CANCER_BRACX_UP	12610208	disease of cellular proliferation	DOID_14566
10642	HEDENFALK_BREAST_CANCER_BRACX_UP	12610208	female reproductive organ cancer	DOID_120
10643	HEDENFALK_BREAST_CANCER_BRACX_UP	12610208	genetic disease	DOID_630
10644	HEDENFALK_BREAST_CANCER_BRACX_UP	12610208	hereditary breast ovarian cancer	DOID_5683
10645	HEDENFALK_BREAST_CANCER_BRACX_UP	12610208	monogenic disease	DOID_0050177
10646	HEDENFALK_BREAST_CANCER_BRACX_UP	12610208	organ system cancer	DOID_0050686
10647	HEDENFALK_BREAST_CANCER_BRACX_UP	12610208	ovarian cancer	DOID_2394
10648	HEDENFALK_BREAST_CANCER_BRACX_UP	12610208	reproductive organ cancer	DOID_193
10649	HEDENFALK_BREAST_CANCER_BRACX_UP	12610208	thoracic cancer	DOID_5093
10650	MACLACHLAN_BRCA1_TARGETS_DN	10644742	autosomal dominant disease	DOID_0050736
10651	MACLACHLAN_BRCA1_TARGETS_DN	10644742	autosomal genetic disease	DOID_0050739
10652	MACLACHLAN_BRCA1_TARGETS_DN	10644742	breast cancer	DOID_1612
10653	MACLACHLAN_BRCA1_TARGETS_DN	10644742	cancer	DOID_162
10654	MACLACHLAN_BRCA1_TARGETS_DN	10644742	disease of anatomical entity	DOID_7
10655	MACLACHLAN_BRCA1_TARGETS_DN	10644742	disease of cellular proliferation	DOID_14566
10656	MACLACHLAN_BRCA1_TARGETS_DN	10644742	eye and adnexa disease	DOID_1492
10657	MACLACHLAN_BRCA1_TARGETS_DN	10644742	eye disease	DOID_5614
10658	MACLACHLAN_BRCA1_TARGETS_DN	10644742	female reproductive organ cancer	DOID_120
10659	MACLACHLAN_BRCA1_TARGETS_DN	10644742	genetic disease	DOID_630
10660	MACLACHLAN_BRCA1_TARGETS_DN	10644742	globe disease	DOID_1242
10661	MACLACHLAN_BRCA1_TARGETS_DN	10644742	hereditary breast ovarian cancer	DOID_5683
10662	MACLACHLAN_BRCA1_TARGETS_DN	10644742	monogenic disease	DOID_0050177
10663	MACLACHLAN_BRCA1_TARGETS_DN	10644742	nervous system cancer	DOID_3093
10664	MACLACHLAN_BRCA1_TARGETS_DN	10644742	nervous system disease	DOID_863
10665	MACLACHLAN_BRCA1_TARGETS_DN	10644742	ocular cancer	DOID_2174
10666	MACLACHLAN_BRCA1_TARGETS_DN	10644742	organ system cancer	DOID_0050686
10667	MACLACHLAN_BRCA1_TARGETS_DN	10644742	ovarian cancer	DOID_2394
10668	MACLACHLAN_BRCA1_TARGETS_DN	10644742	reproductive organ cancer	DOID_193
10669	MACLACHLAN_BRCA1_TARGETS_DN	10644742	retinal cancer	DOID_4645
10670	MACLACHLAN_BRCA1_TARGETS_DN	10644742	retinal cell cancer	DOID_771
10671	MACLACHLAN_BRCA1_TARGETS_DN	10644742	retinal disease	DOID_5679
10672	MACLACHLAN_BRCA1_TARGETS_DN	10644742	retinoblastoma	DOID_768
10673	MACLACHLAN_BRCA1_TARGETS_DN	10644742	sensory system cancer	DOID_0060116
10674	MACLACHLAN_BRCA1_TARGETS_DN	10644742	sensory system disease	DOID_0050155
10675	MACLACHLAN_BRCA1_TARGETS_DN	10644742	thoracic cancer	DOID_5093
10676	MACLACHLAN_BRCA1_TARGETS_UP	10644742	autosomal dominant disease	DOID_0050736
10677	MACLACHLAN_BRCA1_TARGETS_UP	10644742	autosomal genetic disease	DOID_0050739
10678	MACLACHLAN_BRCA1_TARGETS_UP	10644742	breast cancer	DOID_1612
10679	MACLACHLAN_BRCA1_TARGETS_UP	10644742	cancer	DOID_162
10680	MACLACHLAN_BRCA1_TARGETS_UP	10644742	disease of anatomical entity	DOID_7
10681	MACLACHLAN_BRCA1_TARGETS_UP	10644742	disease of cellular proliferation	DOID_14566
10682	MACLACHLAN_BRCA1_TARGETS_UP	10644742	eye and adnexa disease	DOID_1492
10683	MACLACHLAN_BRCA1_TARGETS_UP	10644742	eye disease	DOID_5614
10684	MACLACHLAN_BRCA1_TARGETS_UP	10644742	female reproductive organ cancer	DOID_120
10685	MACLACHLAN_BRCA1_TARGETS_UP	10644742	genetic disease	DOID_630
10686	MACLACHLAN_BRCA1_TARGETS_UP	10644742	globe disease	DOID_1242
10687	MACLACHLAN_BRCA1_TARGETS_UP	10644742	hereditary breast ovarian cancer	DOID_5683
10688	MACLACHLAN_BRCA1_TARGETS_UP	10644742	monogenic disease	DOID_0050177
10689	MACLACHLAN_BRCA1_TARGETS_UP	10644742	nervous system cancer	DOID_3093
10690	MACLACHLAN_BRCA1_TARGETS_UP	10644742	nervous system disease	DOID_863
10691	MACLACHLAN_BRCA1_TARGETS_UP	10644742	ocular cancer	DOID_2174
10692	MACLACHLAN_BRCA1_TARGETS_UP	10644742	organ system cancer	DOID_0050686
10693	MACLACHLAN_BRCA1_TARGETS_UP	10644742	ovarian cancer	DOID_2394
10694	MACLACHLAN_BRCA1_TARGETS_UP	10644742	reproductive organ cancer	DOID_193
10695	MACLACHLAN_BRCA1_TARGETS_UP	10644742	retinal cancer	DOID_4645
10696	MACLACHLAN_BRCA1_TARGETS_UP	10644742	retinal cell cancer	DOID_771
10697	MACLACHLAN_BRCA1_TARGETS_UP	10644742	retinal disease	DOID_5679
10698	MACLACHLAN_BRCA1_TARGETS_UP	10644742	retinoblastoma	DOID_768
10699	MACLACHLAN_BRCA1_TARGETS_UP	10644742	sensory system cancer	DOID_0060116
10700	MACLACHLAN_BRCA1_TARGETS_UP	10644742	sensory system disease	DOID_0050155
10701	MACLACHLAN_BRCA1_TARGETS_UP	10644742	thoracic cancer	DOID_5093
10702	JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_DN	12096084	adenocarcinoma	DOID_299
10703	JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_DN	12096084	autosomal dominant disease	DOID_0050736
10704	JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_DN	12096084	autosomal genetic disease	DOID_0050739
10705	JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_DN	12096084	cancer	DOID_162
10706	JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_DN	12096084	carcinoma	DOID_305
10707	JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_DN	12096084	cell type cancer	DOID_0050687
10708	JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_DN	12096084	clear cell adenocarcinoma	DOID_4468
10709	JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_DN	12096084	cystadenocarcinoma	DOID_3111
10710	JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_DN	12096084	disease of cellular proliferation	DOID_14566
10711	JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_DN	12096084	female reproductive organ cancer	DOID_120
10712	JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_DN	12096084	genetic disease	DOID_630
10713	JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_DN	12096084	hereditary breast ovarian cancer	DOID_5683
10714	JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_DN	12096084	malignant ovarian surface epithelial-stromal neoplasm	DOID_2151
10715	JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_DN	12096084	monogenic disease	DOID_0050177
10716	JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_DN	12096084	organ system cancer	DOID_0050686
10717	JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_DN	12096084	ovarian cancer	DOID_2394
10718	JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_DN	12096084	ovarian carcinoma	DOID_4001
10719	JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_DN	12096084	ovary adenocarcinoma	DOID_3713
10720	JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_DN	12096084	ovary epithelial cancer	DOID_2152
10721	JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_DN	12096084	reproductive organ cancer	DOID_193
10722	JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP	12096084	adenocarcinoma	DOID_299
10723	JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP	12096084	autosomal dominant disease	DOID_0050736
10724	JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP	12096084	autosomal genetic disease	DOID_0050739
10725	JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP	12096084	cancer	DOID_162
10726	JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP	12096084	carcinoma	DOID_305
10727	JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP	12096084	cell type cancer	DOID_0050687
10728	JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP	12096084	clear cell adenocarcinoma	DOID_4468
10729	JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP	12096084	cystadenocarcinoma	DOID_3111
10730	JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP	12096084	disease of cellular proliferation	DOID_14566
10731	JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP	12096084	female reproductive organ cancer	DOID_120
10732	JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP	12096084	genetic disease	DOID_630
10733	JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP	12096084	hereditary breast ovarian cancer	DOID_5683
10734	JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP	12096084	malignant ovarian surface epithelial-stromal neoplasm	DOID_2151
10735	JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP	12096084	monogenic disease	DOID_0050177
10736	JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP	12096084	organ system cancer	DOID_0050686
10737	JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP	12096084	ovarian cancer	DOID_2394
10738	JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP	12096084	ovarian carcinoma	DOID_4001
10739	JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP	12096084	ovary adenocarcinoma	DOID_3713
10740	JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP	12096084	ovary epithelial cancer	DOID_2152
10741	JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP	12096084	reproductive organ cancer	DOID_193
10742	HEDENFALK_BREAST_CANCER_HEREDITARY_VS_SPORADIC	11207349	autosomal dominant disease	DOID_0050736
10743	HEDENFALK_BREAST_CANCER_HEREDITARY_VS_SPORADIC	11207349	autosomal genetic disease	DOID_0050739
10744	HEDENFALK_BREAST_CANCER_HEREDITARY_VS_SPORADIC	11207349	breast cancer	DOID_1612
10745	HEDENFALK_BREAST_CANCER_HEREDITARY_VS_SPORADIC	11207349	cancer	DOID_162
10746	HEDENFALK_BREAST_CANCER_HEREDITARY_VS_SPORADIC	11207349	disease of cellular proliferation	DOID_14566
10747	HEDENFALK_BREAST_CANCER_HEREDITARY_VS_SPORADIC	11207349	genetic disease	DOID_630
10748	HEDENFALK_BREAST_CANCER_HEREDITARY_VS_SPORADIC	11207349	hereditary breast ovarian cancer	DOID_5683
10749	HEDENFALK_BREAST_CANCER_HEREDITARY_VS_SPORADIC	11207349	monogenic disease	DOID_0050177
10750	HEDENFALK_BREAST_CANCER_HEREDITARY_VS_SPORADIC	11207349	organ system cancer	DOID_0050686
10751	HEDENFALK_BREAST_CANCER_HEREDITARY_VS_SPORADIC	11207349	thoracic cancer	DOID_5093
10752	HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2	11207349	autosomal dominant disease	DOID_0050736
10753	HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2	11207349	autosomal genetic disease	DOID_0050739
10754	HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2	11207349	breast cancer	DOID_1612
10755	HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2	11207349	cancer	DOID_162
10756	HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2	11207349	disease of cellular proliferation	DOID_14566
10757	HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2	11207349	genetic disease	DOID_630
10758	HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2	11207349	hereditary breast ovarian cancer	DOID_5683
10759	HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2	11207349	monogenic disease	DOID_0050177
10760	HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2	11207349	organ system cancer	DOID_0050686
10761	HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2	11207349	thoracic cancer	DOID_5093
10762	HENDRICKS_SMARCA4_TARGETS_DN	14673169	breast cancer	DOID_1612
10763	HENDRICKS_SMARCA4_TARGETS_DN	14673169	cancer	DOID_162
10764	HENDRICKS_SMARCA4_TARGETS_DN	14673169	disease of cellular proliferation	DOID_14566
10765	HENDRICKS_SMARCA4_TARGETS_DN	14673169	organ system cancer	DOID_0050686
10766	HENDRICKS_SMARCA4_TARGETS_DN	14673169	thoracic cancer	DOID_5093
10767	HENDRICKS_SMARCA4_TARGETS_UP	14673169	breast cancer	DOID_1612
10768	HENDRICKS_SMARCA4_TARGETS_UP	14673169	cancer	DOID_162
10769	HENDRICKS_SMARCA4_TARGETS_UP	14673169	disease of cellular proliferation	DOID_14566
10770	HENDRICKS_SMARCA4_TARGETS_UP	14673169	organ system cancer	DOID_0050686
10771	HENDRICKS_SMARCA4_TARGETS_UP	14673169	thoracic cancer	DOID_5093
10772	DELLA_RESPONSE_TO_TSA_AND_BUTYRATE	11423116	cancer	DOID_162
10773	DELLA_RESPONSE_TO_TSA_AND_BUTYRATE	11423116	colon cancer	DOID_219
10774	DELLA_RESPONSE_TO_TSA_AND_BUTYRATE	11423116	colorectal cancer	DOID_9256
10775	DELLA_RESPONSE_TO_TSA_AND_BUTYRATE	11423116	disease of cellular proliferation	DOID_14566
10776	DELLA_RESPONSE_TO_TSA_AND_BUTYRATE	11423116	gastrointestinal system cancer	DOID_3119
10777	DELLA_RESPONSE_TO_TSA_AND_BUTYRATE	11423116	intestinal cancer	DOID_10155
10778	DELLA_RESPONSE_TO_TSA_AND_BUTYRATE	11423116	large intestine cancer	DOID_5672
10779	DELLA_RESPONSE_TO_TSA_AND_BUTYRATE	11423116	organ system cancer	DOID_0050686
10780	KAYO_CALORIE_RESTRICTION_MUSCLE_DN	11309484	NA	NA
10781	KAYO_CALORIE_RESTRICTION_MUSCLE_UP	11309484	NA	NA
10782	RHODES_CANCER_META_SIGNATURE	15184677	cancer	DOID_162
10783	RHODES_CANCER_META_SIGNATURE	15184677	disease of cellular proliferation	DOID_14566
10784	RHODES_UNDIFFERENTIATED_CANCER	15184677	cancer	DOID_162
10785	RHODES_UNDIFFERENTIATED_CANCER	15184677	disease of cellular proliferation	DOID_14566
10786	ZHANG_RESPONSE_TO_CANTHARIDIN_DN	14639605	cancer	DOID_162
10787	ZHANG_RESPONSE_TO_CANTHARIDIN_DN	14639605	disease of cellular proliferation	DOID_14566
10788	ZHANG_RESPONSE_TO_CANTHARIDIN_DN	14639605	hematologic cancer	DOID_2531
10789	ZHANG_RESPONSE_TO_CANTHARIDIN_DN	14639605	immune system cancer	DOID_0060083
10790	ZHANG_RESPONSE_TO_CANTHARIDIN_DN	14639605	leukemia	DOID_1240
10791	ZHANG_RESPONSE_TO_CANTHARIDIN_DN	14639605	organ system cancer	DOID_0050686
10792	ZHANG_RESPONSE_TO_CANTHARIDIN_UP	14639605	cancer	DOID_162
10793	ZHANG_RESPONSE_TO_CANTHARIDIN_UP	14639605	disease of cellular proliferation	DOID_14566
10794	ZHANG_RESPONSE_TO_CANTHARIDIN_UP	14639605	hematologic cancer	DOID_2531
10795	ZHANG_RESPONSE_TO_CANTHARIDIN_UP	14639605	immune system cancer	DOID_0060083
10796	ZHANG_RESPONSE_TO_CANTHARIDIN_UP	14639605	leukemia	DOID_1240
10797	ZHANG_RESPONSE_TO_CANTHARIDIN_UP	14639605	organ system cancer	DOID_0050686
10798	MCLACHLAN_DENTAL_CARIES_DN	15869869	dental caries	DOID_216
10799	MCLACHLAN_DENTAL_CARIES_DN	15869869	disease of anatomical entity	DOID_7
10800	MCLACHLAN_DENTAL_CARIES_DN	15869869	gastrointestinal system disease	DOID_77
10801	MCLACHLAN_DENTAL_CARIES_DN	15869869	mouth disease	DOID_403
10802	MCLACHLAN_DENTAL_CARIES_DN	15869869	soft tissue disease	DOID_872
10803	MCLACHLAN_DENTAL_CARIES_DN	15869869	teeth hard tissue disease	DOID_214
10804	MCLACHLAN_DENTAL_CARIES_DN	15869869	tooth disease	DOID_1091
10805	MCLACHLAN_DENTAL_CARIES_UP	15869869	dental caries	DOID_216
10806	MCLACHLAN_DENTAL_CARIES_UP	15869869	disease of anatomical entity	DOID_7
10807	MCLACHLAN_DENTAL_CARIES_UP	15869869	gastrointestinal system disease	DOID_77
10808	MCLACHLAN_DENTAL_CARIES_UP	15869869	mouth disease	DOID_403
10809	MCLACHLAN_DENTAL_CARIES_UP	15869869	soft tissue disease	DOID_872
10810	MCLACHLAN_DENTAL_CARIES_UP	15869869	teeth hard tissue disease	DOID_214
10811	MCLACHLAN_DENTAL_CARIES_UP	15869869	tooth disease	DOID_1091
10812	WHITESIDE_CISPLATIN_RESISTANCE_DN	14737109	cancer	DOID_162
10813	WHITESIDE_CISPLATIN_RESISTANCE_DN	14737109	disease of cellular proliferation	DOID_14566
10814	WHITESIDE_CISPLATIN_RESISTANCE_DN	14737109	lung cancer	DOID_1324
10815	WHITESIDE_CISPLATIN_RESISTANCE_DN	14737109	organ system cancer	DOID_0050686
10816	WHITESIDE_CISPLATIN_RESISTANCE_DN	14737109	respiratory system cancer	DOID_0050615
10817	WHITESIDE_CISPLATIN_RESISTANCE_UP	14737109	cancer	DOID_162
10818	WHITESIDE_CISPLATIN_RESISTANCE_UP	14737109	disease of cellular proliferation	DOID_14566
10819	WHITESIDE_CISPLATIN_RESISTANCE_UP	14737109	lung cancer	DOID_1324
10820	WHITESIDE_CISPLATIN_RESISTANCE_UP	14737109	organ system cancer	DOID_0050686
10821	WHITESIDE_CISPLATIN_RESISTANCE_UP	14737109	respiratory system cancer	DOID_0050615
10822	WANG_CISPLATIN_RESPONSE_AND_XPC_DN	15107491	autosomal genetic disease	DOID_0050739
10823	WANG_CISPLATIN_RESPONSE_AND_XPC_DN	15107491	autosomal recessive disease	DOID_0050737
10824	WANG_CISPLATIN_RESPONSE_AND_XPC_DN	15107491	cancer	DOID_162
10825	WANG_CISPLATIN_RESPONSE_AND_XPC_DN	15107491	disease of cellular proliferation	DOID_14566
10826	WANG_CISPLATIN_RESPONSE_AND_XPC_DN	15107491	genetic disease	DOID_630
10827	WANG_CISPLATIN_RESPONSE_AND_XPC_DN	15107491	monogenic disease	DOID_0050177
10828	WANG_CISPLATIN_RESPONSE_AND_XPC_DN	15107491	xeroderma pigmentosum	DOID_0050427
10829	WANG_CISPLATIN_RESPONSE_AND_XPC_UP	15107491	autosomal genetic disease	DOID_0050739
10830	WANG_CISPLATIN_RESPONSE_AND_XPC_UP	15107491	autosomal recessive disease	DOID_0050737
10831	WANG_CISPLATIN_RESPONSE_AND_XPC_UP	15107491	cancer	DOID_162
10832	WANG_CISPLATIN_RESPONSE_AND_XPC_UP	15107491	disease of cellular proliferation	DOID_14566
10833	WANG_CISPLATIN_RESPONSE_AND_XPC_UP	15107491	genetic disease	DOID_630
10834	WANG_CISPLATIN_RESPONSE_AND_XPC_UP	15107491	monogenic disease	DOID_0050177
10835	WANG_CISPLATIN_RESPONSE_AND_XPC_UP	15107491	xeroderma pigmentosum	DOID_0050427
10836	ZHU_CMV_24_HR_DN	9826724	NA	NA
10837	ZHU_CMV_24_HR_UP	9826724	NA	NA
10838	ZHU_CMV_8_HR_DN	9826724	NA	NA
10839	ZHU_CMV_8_HR_UP	9826724	NA	NA
10840	ZHU_CMV_ALL_DN	9826724	NA	NA
10841	ZHU_CMV_ALL_UP	9826724	NA	NA
10842	BROWNE_HCMV_INFECTION_6HR_DN	11711622	NA	NA
10843	BROWNE_HCMV_INFECTION_6HR_UP	11711622	NA	NA
10844	BROWNE_HCMV_INFECTION_10HR_DN	11711622	NA	NA
10845	BROWNE_HCMV_INFECTION_10HR_UP	11711622	NA	NA
10846	BROWNE_HCMV_INFECTION_12HR_DN	11711622	NA	NA
10847	BROWNE_HCMV_INFECTION_12HR_UP	11711622	NA	NA
10848	BROWNE_HCMV_INFECTION_14HR_DN	11711622	NA	NA
10849	BROWNE_HCMV_INFECTION_14HR_UP	11711622	NA	NA
10850	BROWNE_HCMV_INFECTION_16HR_DN	11711622	NA	NA
10851	BROWNE_HCMV_INFECTION_16HR_UP	11711622	NA	NA
10852	BROWNE_HCMV_INFECTION_18HR_DN	11711622	NA	NA
10853	BROWNE_HCMV_INFECTION_18HR_UP	11711622	NA	NA
10854	BROWNE_HCMV_INFECTION_20HR_DN	11711622	NA	NA
10855	BROWNE_HCMV_INFECTION_20HR_UP	11711622	NA	NA
10856	BROWNE_HCMV_INFECTION_24HR_DN	11711622	NA	NA
10857	BROWNE_HCMV_INFECTION_24HR_UP	11711622	NA	NA
10858	BROWNE_HCMV_INFECTION_48HR_DN	11711622	NA	NA
10859	BROWNE_HCMV_INFECTION_48HR_UP	11711622	NA	NA
10860	BROWNE_HCMV_INFECTION_8HR_DN	11711622	NA	NA
10861	BROWNE_HCMV_INFECTION_8HR_UP	11711622	NA	NA
10862	SONG_TARGETS_OF_IE86_CMV_PROTEIN	11867723	NA	NA
10863	LIANG_SILENCED_BY_METHYLATION_2	11861364	cancer	DOID_162
10864	LIANG_SILENCED_BY_METHYLATION_2	11861364	carcinoma	DOID_305
10865	LIANG_SILENCED_BY_METHYLATION_2	11861364	cell type cancer	DOID_0050687
10866	LIANG_SILENCED_BY_METHYLATION_2	11861364	disease of cellular proliferation	DOID_14566
10867	LIANG_SILENCED_BY_METHYLATION_2	11861364	organ system cancer	DOID_0050686
10868	LIANG_SILENCED_BY_METHYLATION_2	11861364	urinary bladder cancer	DOID_11054
10869	LIANG_SILENCED_BY_METHYLATION_2	11861364	urinary system cancer	DOID_3996
10870	LIANG_SILENCED_BY_METHYLATION_DN	11861364	cancer	DOID_162
10871	LIANG_SILENCED_BY_METHYLATION_DN	11861364	carcinoma	DOID_305
10872	LIANG_SILENCED_BY_METHYLATION_DN	11861364	cell type cancer	DOID_0050687
10873	LIANG_SILENCED_BY_METHYLATION_DN	11861364	disease of cellular proliferation	DOID_14566
10874	LIANG_SILENCED_BY_METHYLATION_DN	11861364	organ system cancer	DOID_0050686
10875	LIANG_SILENCED_BY_METHYLATION_DN	11861364	urinary bladder cancer	DOID_11054
10876	LIANG_SILENCED_BY_METHYLATION_DN	11861364	urinary system cancer	DOID_3996
10877	LIANG_SILENCED_BY_METHYLATION_UP	11861364	cancer	DOID_162
10878	LIANG_SILENCED_BY_METHYLATION_UP	11861364	carcinoma	DOID_305
10879	LIANG_SILENCED_BY_METHYLATION_UP	11861364	cell type cancer	DOID_0050687
10880	LIANG_SILENCED_BY_METHYLATION_UP	11861364	disease of cellular proliferation	DOID_14566
10881	LIANG_SILENCED_BY_METHYLATION_UP	11861364	organ system cancer	DOID_0050686
10882	LIANG_SILENCED_BY_METHYLATION_UP	11861364	urinary bladder cancer	DOID_11054
10883	LIANG_SILENCED_BY_METHYLATION_UP	11861364	urinary system cancer	DOID_3996
10884	SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2	12839967	cancer	DOID_162
10885	SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2	12839967	carcinoma	DOID_305
10886	SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2	12839967	cell type cancer	DOID_0050687
10887	SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2	12839967	disease of cellular proliferation	DOID_14566
10888	SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2	12839967	endocrine gland cancer	DOID_170
10889	SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2	12839967	organ system cancer	DOID_0050686
10890	SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2	12839967	pancreatic cancer	DOID_1793
10891	SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2	12839967	pancreatic carcinoma	DOID_4905
10892	SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1	12839967	cancer	DOID_162
10893	SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1	12839967	carcinoma	DOID_305
10894	SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1	12839967	cell type cancer	DOID_0050687
10895	SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1	12839967	disease of cellular proliferation	DOID_14566
10896	SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1	12839967	endocrine gland cancer	DOID_170
10897	SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1	12839967	organ system cancer	DOID_0050686
10898	SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1	12839967	pancreatic cancer	DOID_1793
10899	SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1	12839967	pancreatic carcinoma	DOID_4905
10900	BAELDE_DIABETIC_NEPHROPATHY_DN	15042541	acquired metabolic disease	DOID_0060158
10901	BAELDE_DIABETIC_NEPHROPATHY_DN	15042541	carbohydrate metabolism disease	DOID_0050013
10902	BAELDE_DIABETIC_NEPHROPATHY_DN	15042541	diabetes mellitus	DOID_9351
10903	BAELDE_DIABETIC_NEPHROPATHY_DN	15042541	diabetic nephropathy	DOID_2370
10904	BAELDE_DIABETIC_NEPHROPATHY_DN	15042541	disease of anatomical entity	DOID_7
10905	BAELDE_DIABETIC_NEPHROPATHY_DN	15042541	disease of metabolism	DOID_0014667
10906	BAELDE_DIABETIC_NEPHROPATHY_DN	15042541	glucose metabolism disease	DOID_4194
10907	BAELDE_DIABETIC_NEPHROPATHY_DN	15042541	kidney disease	DOID_557
10908	BAELDE_DIABETIC_NEPHROPATHY_DN	15042541	proteinuria	DOID_576
10909	BAELDE_DIABETIC_NEPHROPATHY_DN	15042541	urinary system disease	DOID_18
10910	BAELDE_DIABETIC_NEPHROPATHY_UP	15042541	acquired metabolic disease	DOID_0060158
10911	BAELDE_DIABETIC_NEPHROPATHY_UP	15042541	carbohydrate metabolism disease	DOID_0050013
10912	BAELDE_DIABETIC_NEPHROPATHY_UP	15042541	diabetes mellitus	DOID_9351
10913	BAELDE_DIABETIC_NEPHROPATHY_UP	15042541	diabetic nephropathy	DOID_2370
10914	BAELDE_DIABETIC_NEPHROPATHY_UP	15042541	disease of anatomical entity	DOID_7
10915	BAELDE_DIABETIC_NEPHROPATHY_UP	15042541	disease of metabolism	DOID_0014667
10916	BAELDE_DIABETIC_NEPHROPATHY_UP	15042541	glucose metabolism disease	DOID_4194
10917	BAELDE_DIABETIC_NEPHROPATHY_UP	15042541	kidney disease	DOID_557
10918	BAELDE_DIABETIC_NEPHROPATHY_UP	15042541	proteinuria	DOID_576
10919	BAELDE_DIABETIC_NEPHROPATHY_UP	15042541	urinary system disease	DOID_18
10920	MARTINEZ_RESPONSE_TO_TRABECTEDIN	11755394	cancer	DOID_162
10921	MARTINEZ_RESPONSE_TO_TRABECTEDIN	11755394	disease of cellular proliferation	DOID_14566
10922	GAJATE_RESPONSE_TO_TRABECTEDIN_DN	12198119	cancer	DOID_162
10923	GAJATE_RESPONSE_TO_TRABECTEDIN_DN	12198119	disease of cellular proliferation	DOID_14566
10924	GAJATE_RESPONSE_TO_TRABECTEDIN_UP	12198119	cancer	DOID_162
10925	GAJATE_RESPONSE_TO_TRABECTEDIN_UP	12198119	disease of cellular proliferation	DOID_14566
10926	MARCHINI_TRABECTEDIN_RESISTANCE_DN	15661559	cancer	DOID_162
10927	MARCHINI_TRABECTEDIN_RESISTANCE_DN	15661559	chondrosarcoma	DOID_3371
10928	MARCHINI_TRABECTEDIN_RESISTANCE_DN	15661559	connective tissue cancer	DOID_201
10929	MARCHINI_TRABECTEDIN_RESISTANCE_DN	15661559	disease of cellular proliferation	DOID_14566
10930	MARCHINI_TRABECTEDIN_RESISTANCE_DN	15661559	female reproductive organ cancer	DOID_120
10931	MARCHINI_TRABECTEDIN_RESISTANCE_DN	15661559	musculoskeletal system cancer	DOID_0060100
10932	MARCHINI_TRABECTEDIN_RESISTANCE_DN	15661559	organ system cancer	DOID_0050686
10933	MARCHINI_TRABECTEDIN_RESISTANCE_DN	15661559	ovarian cancer	DOID_2394
10934	MARCHINI_TRABECTEDIN_RESISTANCE_DN	15661559	reproductive organ cancer	DOID_193
10935	MARCHINI_TRABECTEDIN_RESISTANCE_UP	15661559	cancer	DOID_162
10936	MARCHINI_TRABECTEDIN_RESISTANCE_UP	15661559	chondrosarcoma	DOID_3371
10937	MARCHINI_TRABECTEDIN_RESISTANCE_UP	15661559	connective tissue cancer	DOID_201
10938	MARCHINI_TRABECTEDIN_RESISTANCE_UP	15661559	disease of cellular proliferation	DOID_14566
10939	MARCHINI_TRABECTEDIN_RESISTANCE_UP	15661559	female reproductive organ cancer	DOID_120
10940	MARCHINI_TRABECTEDIN_RESISTANCE_UP	15661559	musculoskeletal system cancer	DOID_0060100
10941	MARCHINI_TRABECTEDIN_RESISTANCE_UP	15661559	organ system cancer	DOID_0050686
10942	MARCHINI_TRABECTEDIN_RESISTANCE_UP	15661559	ovarian cancer	DOID_2394
10943	MARCHINI_TRABECTEDIN_RESISTANCE_UP	15661559	reproductive organ cancer	DOID_193
10944	MARTINEZ_RESPONSE_TO_TRABECTEDIN_DN	15897246	autosomal dominant disease	DOID_0050736
10945	MARTINEZ_RESPONSE_TO_TRABECTEDIN_DN	15897246	autosomal genetic disease	DOID_0050739
10946	MARTINEZ_RESPONSE_TO_TRABECTEDIN_DN	15897246	cancer	DOID_162
10947	MARTINEZ_RESPONSE_TO_TRABECTEDIN_DN	15897246	cell type cancer	DOID_0050687
10948	MARTINEZ_RESPONSE_TO_TRABECTEDIN_DN	15897246	disease of cellular proliferation	DOID_14566
10949	MARTINEZ_RESPONSE_TO_TRABECTEDIN_DN	15897246	genetic disease	DOID_630
10950	MARTINEZ_RESPONSE_TO_TRABECTEDIN_DN	15897246	hereditary breast ovarian cancer	DOID_5683
10951	MARTINEZ_RESPONSE_TO_TRABECTEDIN_DN	15897246	monogenic disease	DOID_0050177
10952	MARTINEZ_RESPONSE_TO_TRABECTEDIN_DN	15897246	sarcoma	DOID_1115
10953	MARTINEZ_RESPONSE_TO_TRABECTEDIN_UP	15897246	autosomal dominant disease	DOID_0050736
10954	MARTINEZ_RESPONSE_TO_TRABECTEDIN_UP	15897246	autosomal genetic disease	DOID_0050739
10955	MARTINEZ_RESPONSE_TO_TRABECTEDIN_UP	15897246	cancer	DOID_162
10956	MARTINEZ_RESPONSE_TO_TRABECTEDIN_UP	15897246	cell type cancer	DOID_0050687
10957	MARTINEZ_RESPONSE_TO_TRABECTEDIN_UP	15897246	disease of cellular proliferation	DOID_14566
10958	MARTINEZ_RESPONSE_TO_TRABECTEDIN_UP	15897246	genetic disease	DOID_630
10959	MARTINEZ_RESPONSE_TO_TRABECTEDIN_UP	15897246	hereditary breast ovarian cancer	DOID_5683
10960	MARTINEZ_RESPONSE_TO_TRABECTEDIN_UP	15897246	monogenic disease	DOID_0050177
10961	MARTINEZ_RESPONSE_TO_TRABECTEDIN_UP	15897246	sarcoma	DOID_1115
10962	JI_RESPONSE_TO_FSH_DN	15386376	autosomal dominant disease	DOID_0050736
10963	JI_RESPONSE_TO_FSH_DN	15386376	autosomal genetic disease	DOID_0050739
10964	JI_RESPONSE_TO_FSH_DN	15386376	cancer	DOID_162
10965	JI_RESPONSE_TO_FSH_DN	15386376	disease of cellular proliferation	DOID_14566
10966	JI_RESPONSE_TO_FSH_DN	15386376	female reproductive organ cancer	DOID_120
10967	JI_RESPONSE_TO_FSH_DN	15386376	genetic disease	DOID_630
10968	JI_RESPONSE_TO_FSH_DN	15386376	hereditary breast ovarian cancer	DOID_5683
10969	JI_RESPONSE_TO_FSH_DN	15386376	monogenic disease	DOID_0050177
10970	JI_RESPONSE_TO_FSH_DN	15386376	organ system cancer	DOID_0050686
10971	JI_RESPONSE_TO_FSH_DN	15386376	ovarian cancer	DOID_2394
10972	JI_RESPONSE_TO_FSH_DN	15386376	reproductive organ cancer	DOID_193
10973	JI_RESPONSE_TO_FSH_UP	15386376	autosomal dominant disease	DOID_0050736
10974	JI_RESPONSE_TO_FSH_UP	15386376	autosomal genetic disease	DOID_0050739
10975	JI_RESPONSE_TO_FSH_UP	15386376	cancer	DOID_162
10976	JI_RESPONSE_TO_FSH_UP	15386376	disease of cellular proliferation	DOID_14566
10977	JI_RESPONSE_TO_FSH_UP	15386376	female reproductive organ cancer	DOID_120
10978	JI_RESPONSE_TO_FSH_UP	15386376	genetic disease	DOID_630
10979	JI_RESPONSE_TO_FSH_UP	15386376	hereditary breast ovarian cancer	DOID_5683
10980	JI_RESPONSE_TO_FSH_UP	15386376	monogenic disease	DOID_0050177
10981	JI_RESPONSE_TO_FSH_UP	15386376	organ system cancer	DOID_0050686
10982	JI_RESPONSE_TO_FSH_UP	15386376	ovarian cancer	DOID_2394
10983	JI_RESPONSE_TO_FSH_UP	15386376	reproductive organ cancer	DOID_193
10984	XU_GH1_AUTOCRINE_TARGETS_DN	15845533	breast cancer	DOID_1612
10985	XU_GH1_AUTOCRINE_TARGETS_DN	15845533	breast carcinoma	DOID_3459
10986	XU_GH1_AUTOCRINE_TARGETS_DN	15845533	cancer	DOID_162
10987	XU_GH1_AUTOCRINE_TARGETS_DN	15845533	carcinoma	DOID_305
10988	XU_GH1_AUTOCRINE_TARGETS_DN	15845533	cell type cancer	DOID_0050687
10989	XU_GH1_AUTOCRINE_TARGETS_DN	15845533	disease of cellular proliferation	DOID_14566
10990	XU_GH1_AUTOCRINE_TARGETS_DN	15845533	organ system cancer	DOID_0050686
10991	XU_GH1_AUTOCRINE_TARGETS_DN	15845533	thoracic cancer	DOID_5093
10992	XU_GH1_AUTOCRINE_TARGETS_UP	15845533	breast cancer	DOID_1612
10993	XU_GH1_AUTOCRINE_TARGETS_UP	15845533	breast carcinoma	DOID_3459
10994	XU_GH1_AUTOCRINE_TARGETS_UP	15845533	cancer	DOID_162
10995	XU_GH1_AUTOCRINE_TARGETS_UP	15845533	carcinoma	DOID_305
10996	XU_GH1_AUTOCRINE_TARGETS_UP	15845533	cell type cancer	DOID_0050687
10997	XU_GH1_AUTOCRINE_TARGETS_UP	15845533	disease of cellular proliferation	DOID_14566
10998	XU_GH1_AUTOCRINE_TARGETS_UP	15845533	organ system cancer	DOID_0050686
10999	XU_GH1_AUTOCRINE_TARGETS_UP	15845533	thoracic cancer	DOID_5093
11000	XU_GH1_EXOGENOUS_TARGETS_DN	15845533	breast cancer	DOID_1612
11001	XU_GH1_EXOGENOUS_TARGETS_DN	15845533	breast carcinoma	DOID_3459
11002	XU_GH1_EXOGENOUS_TARGETS_DN	15845533	cancer	DOID_162
11003	XU_GH1_EXOGENOUS_TARGETS_DN	15845533	carcinoma	DOID_305
11004	XU_GH1_EXOGENOUS_TARGETS_DN	15845533	cell type cancer	DOID_0050687
11005	XU_GH1_EXOGENOUS_TARGETS_DN	15845533	disease of cellular proliferation	DOID_14566
11006	XU_GH1_EXOGENOUS_TARGETS_DN	15845533	organ system cancer	DOID_0050686
11007	XU_GH1_EXOGENOUS_TARGETS_DN	15845533	thoracic cancer	DOID_5093
11008	XU_GH1_EXOGENOUS_TARGETS_UP	15845533	breast cancer	DOID_1612
11009	XU_GH1_EXOGENOUS_TARGETS_UP	15845533	breast carcinoma	DOID_3459
11010	XU_GH1_EXOGENOUS_TARGETS_UP	15845533	cancer	DOID_162
11011	XU_GH1_EXOGENOUS_TARGETS_UP	15845533	carcinoma	DOID_305
11012	XU_GH1_EXOGENOUS_TARGETS_UP	15845533	cell type cancer	DOID_0050687
11013	XU_GH1_EXOGENOUS_TARGETS_UP	15845533	disease of cellular proliferation	DOID_14566
11014	XU_GH1_EXOGENOUS_TARGETS_UP	15845533	organ system cancer	DOID_0050686
11015	XU_GH1_EXOGENOUS_TARGETS_UP	15845533	thoracic cancer	DOID_5093
11016	WU_HBX_TARGETS_1_DN	11439330	cancer	DOID_162
11017	WU_HBX_TARGETS_1_DN	11439330	carcinoma	DOID_305
11018	WU_HBX_TARGETS_1_DN	11439330	cell type cancer	DOID_0050687
11019	WU_HBX_TARGETS_1_DN	11439330	disease by infectious agent	DOID_0050117
11020	WU_HBX_TARGETS_1_DN	11439330	disease of anatomical entity	DOID_7
11021	WU_HBX_TARGETS_1_DN	11439330	disease of cellular proliferation	DOID_14566
11022	WU_HBX_TARGETS_1_DN	11439330	gastrointestinal system cancer	DOID_3119
11023	WU_HBX_TARGETS_1_DN	11439330	gastrointestinal system disease	DOID_77
11024	WU_HBX_TARGETS_1_DN	11439330	hepatitis B	DOID_2043
11025	WU_HBX_TARGETS_1_DN	11439330	hepatitis	DOID_2237
11026	WU_HBX_TARGETS_1_DN	11439330	hepatobiliary disease	DOID_3118
11027	WU_HBX_TARGETS_1_DN	11439330	hepatocellular carcinoma	DOID_684
11028	WU_HBX_TARGETS_1_DN	11439330	liver cancer	DOID_3571
11029	WU_HBX_TARGETS_1_DN	11439330	liver carcinoma	DOID_686
11030	WU_HBX_TARGETS_1_DN	11439330	liver disease	DOID_409
11031	WU_HBX_TARGETS_1_DN	11439330	organ system cancer	DOID_0050686
11032	WU_HBX_TARGETS_1_DN	11439330	viral infectious disease	DOID_934
11033	WU_HBX_TARGETS_1_UP	11439330	cancer	DOID_162
11034	WU_HBX_TARGETS_1_UP	11439330	carcinoma	DOID_305
11035	WU_HBX_TARGETS_1_UP	11439330	cell type cancer	DOID_0050687
11036	WU_HBX_TARGETS_1_UP	11439330	disease by infectious agent	DOID_0050117
11037	WU_HBX_TARGETS_1_UP	11439330	disease of anatomical entity	DOID_7
11038	WU_HBX_TARGETS_1_UP	11439330	disease of cellular proliferation	DOID_14566
11039	WU_HBX_TARGETS_1_UP	11439330	gastrointestinal system cancer	DOID_3119
11040	WU_HBX_TARGETS_1_UP	11439330	gastrointestinal system disease	DOID_77
11041	WU_HBX_TARGETS_1_UP	11439330	hepatitis B	DOID_2043
11042	WU_HBX_TARGETS_1_UP	11439330	hepatitis	DOID_2237
11043	WU_HBX_TARGETS_1_UP	11439330	hepatobiliary disease	DOID_3118
11044	WU_HBX_TARGETS_1_UP	11439330	hepatocellular carcinoma	DOID_684
11045	WU_HBX_TARGETS_1_UP	11439330	liver cancer	DOID_3571
11046	WU_HBX_TARGETS_1_UP	11439330	liver carcinoma	DOID_686
11047	WU_HBX_TARGETS_1_UP	11439330	liver disease	DOID_409
11048	WU_HBX_TARGETS_1_UP	11439330	organ system cancer	DOID_0050686
11049	WU_HBX_TARGETS_1_UP	11439330	viral infectious disease	DOID_934
11050	WU_HBX_TARGETS_3_DN	11439330	cancer	DOID_162
11051	WU_HBX_TARGETS_3_DN	11439330	carcinoma	DOID_305
11052	WU_HBX_TARGETS_3_DN	11439330	cell type cancer	DOID_0050687
11053	WU_HBX_TARGETS_3_DN	11439330	disease by infectious agent	DOID_0050117
11054	WU_HBX_TARGETS_3_DN	11439330	disease of anatomical entity	DOID_7
11055	WU_HBX_TARGETS_3_DN	11439330	disease of cellular proliferation	DOID_14566
11056	WU_HBX_TARGETS_3_DN	11439330	gastrointestinal system cancer	DOID_3119
11057	WU_HBX_TARGETS_3_DN	11439330	gastrointestinal system disease	DOID_77
11058	WU_HBX_TARGETS_3_DN	11439330	hepatitis B	DOID_2043
11059	WU_HBX_TARGETS_3_DN	11439330	hepatitis	DOID_2237
11060	WU_HBX_TARGETS_3_DN	11439330	hepatobiliary disease	DOID_3118
11061	WU_HBX_TARGETS_3_DN	11439330	hepatocellular carcinoma	DOID_684
11062	WU_HBX_TARGETS_3_DN	11439330	liver cancer	DOID_3571
11063	WU_HBX_TARGETS_3_DN	11439330	liver carcinoma	DOID_686
11064	WU_HBX_TARGETS_3_DN	11439330	liver disease	DOID_409
11065	WU_HBX_TARGETS_3_DN	11439330	organ system cancer	DOID_0050686
11066	WU_HBX_TARGETS_3_DN	11439330	viral infectious disease	DOID_934
11067	WU_HBX_TARGETS_3_UP	11439330	cancer	DOID_162
11068	WU_HBX_TARGETS_3_UP	11439330	carcinoma	DOID_305
11069	WU_HBX_TARGETS_3_UP	11439330	cell type cancer	DOID_0050687
11070	WU_HBX_TARGETS_3_UP	11439330	disease by infectious agent	DOID_0050117
11071	WU_HBX_TARGETS_3_UP	11439330	disease of anatomical entity	DOID_7
11072	WU_HBX_TARGETS_3_UP	11439330	disease of cellular proliferation	DOID_14566
11073	WU_HBX_TARGETS_3_UP	11439330	gastrointestinal system cancer	DOID_3119
11074	WU_HBX_TARGETS_3_UP	11439330	gastrointestinal system disease	DOID_77
11075	WU_HBX_TARGETS_3_UP	11439330	hepatitis B	DOID_2043
11076	WU_HBX_TARGETS_3_UP	11439330	hepatitis	DOID_2237
11077	WU_HBX_TARGETS_3_UP	11439330	hepatobiliary disease	DOID_3118
11078	WU_HBX_TARGETS_3_UP	11439330	hepatocellular carcinoma	DOID_684
11079	WU_HBX_TARGETS_3_UP	11439330	liver cancer	DOID_3571
11080	WU_HBX_TARGETS_3_UP	11439330	liver carcinoma	DOID_686
11081	WU_HBX_TARGETS_3_UP	11439330	liver disease	DOID_409
11082	WU_HBX_TARGETS_3_UP	11439330	organ system cancer	DOID_0050686
11083	WU_HBX_TARGETS_3_UP	11439330	viral infectious disease	DOID_934
11084	WU_HBX_TARGETS_2_DN	11439330	cancer	DOID_162
11085	WU_HBX_TARGETS_2_DN	11439330	carcinoma	DOID_305
11086	WU_HBX_TARGETS_2_DN	11439330	cell type cancer	DOID_0050687
11087	WU_HBX_TARGETS_2_DN	11439330	disease by infectious agent	DOID_0050117
11088	WU_HBX_TARGETS_2_DN	11439330	disease of anatomical entity	DOID_7
11089	WU_HBX_TARGETS_2_DN	11439330	disease of cellular proliferation	DOID_14566
11090	WU_HBX_TARGETS_2_DN	11439330	gastrointestinal system cancer	DOID_3119
11091	WU_HBX_TARGETS_2_DN	11439330	gastrointestinal system disease	DOID_77
11092	WU_HBX_TARGETS_2_DN	11439330	hepatitis B	DOID_2043
11093	WU_HBX_TARGETS_2_DN	11439330	hepatitis	DOID_2237
11094	WU_HBX_TARGETS_2_DN	11439330	hepatobiliary disease	DOID_3118
11095	WU_HBX_TARGETS_2_DN	11439330	hepatocellular carcinoma	DOID_684
11096	WU_HBX_TARGETS_2_DN	11439330	liver cancer	DOID_3571
11097	WU_HBX_TARGETS_2_DN	11439330	liver carcinoma	DOID_686
11098	WU_HBX_TARGETS_2_DN	11439330	liver disease	DOID_409
11099	WU_HBX_TARGETS_2_DN	11439330	organ system cancer	DOID_0050686
11100	WU_HBX_TARGETS_2_DN	11439330	viral infectious disease	DOID_934
11101	WU_HBX_TARGETS_2_UP	11439330	cancer	DOID_162
11102	WU_HBX_TARGETS_2_UP	11439330	carcinoma	DOID_305
11103	WU_HBX_TARGETS_2_UP	11439330	cell type cancer	DOID_0050687
11104	WU_HBX_TARGETS_2_UP	11439330	disease by infectious agent	DOID_0050117
11105	WU_HBX_TARGETS_2_UP	11439330	disease of anatomical entity	DOID_7
11106	WU_HBX_TARGETS_2_UP	11439330	disease of cellular proliferation	DOID_14566
11107	WU_HBX_TARGETS_2_UP	11439330	gastrointestinal system cancer	DOID_3119
11108	WU_HBX_TARGETS_2_UP	11439330	gastrointestinal system disease	DOID_77
11109	WU_HBX_TARGETS_2_UP	11439330	hepatitis B	DOID_2043
11110	WU_HBX_TARGETS_2_UP	11439330	hepatitis	DOID_2237
11111	WU_HBX_TARGETS_2_UP	11439330	hepatobiliary disease	DOID_3118
11112	WU_HBX_TARGETS_2_UP	11439330	hepatocellular carcinoma	DOID_684
11113	WU_HBX_TARGETS_2_UP	11439330	liver cancer	DOID_3571
11114	WU_HBX_TARGETS_2_UP	11439330	liver carcinoma	DOID_686
11115	WU_HBX_TARGETS_2_UP	11439330	liver disease	DOID_409
11116	WU_HBX_TARGETS_2_UP	11439330	organ system cancer	DOID_0050686
11117	WU_HBX_TARGETS_2_UP	11439330	viral infectious disease	DOID_934
11118	MARIADASON_RESPONSE_TO_CURCUMIN_SULINDAC_5	10969808	cancer	DOID_162
11119	MARIADASON_RESPONSE_TO_CURCUMIN_SULINDAC_5	10969808	colon cancer	DOID_219
11120	MARIADASON_RESPONSE_TO_CURCUMIN_SULINDAC_5	10969808	colorectal cancer	DOID_9256
11121	MARIADASON_RESPONSE_TO_CURCUMIN_SULINDAC_5	10969808	disease of cellular proliferation	DOID_14566
11122	MARIADASON_RESPONSE_TO_CURCUMIN_SULINDAC_5	10969808	gastrointestinal system cancer	DOID_3119
11123	MARIADASON_RESPONSE_TO_CURCUMIN_SULINDAC_5	10969808	intestinal cancer	DOID_10155
11124	MARIADASON_RESPONSE_TO_CURCUMIN_SULINDAC_5	10969808	large intestine cancer	DOID_5672
11125	MARIADASON_RESPONSE_TO_CURCUMIN_SULINDAC_5	10969808	organ system cancer	DOID_0050686
11126	KAAB_FAILED_HEART_ATRIUM_DN	15103417	cardiomyopathy	DOID_0050700
11127	KAAB_FAILED_HEART_ATRIUM_DN	15103417	cardiovascular system disease	DOID_1287
11128	KAAB_FAILED_HEART_ATRIUM_DN	15103417	dilated cardiomyopathy	DOID_12930
11129	KAAB_FAILED_HEART_ATRIUM_DN	15103417	disease of anatomical entity	DOID_7
11130	KAAB_FAILED_HEART_ATRIUM_DN	15103417	extrinsic cardiomyopathy	DOID_3978
11131	KAAB_FAILED_HEART_ATRIUM_DN	15103417	heart disease	DOID_114
11132	KAAB_FAILED_HEART_ATRIUM_DN	15103417	intrinsic cardiomyopathy	DOID_0060036
11133	KAAB_FAILED_HEART_ATRIUM_DN	15103417	ischemia	DOID_326
11134	KAAB_FAILED_HEART_ATRIUM_DN	15103417	ischemic heart disease	DOID_3394
11135	KAAB_FAILED_HEART_ATRIUM_DN	15103417	vascular disease	DOID_178
11136	KAAB_FAILED_HEART_ATRIUM_UP	15103417	cardiomyopathy	DOID_0050700
11137	KAAB_FAILED_HEART_ATRIUM_UP	15103417	cardiovascular system disease	DOID_1287
11138	KAAB_FAILED_HEART_ATRIUM_UP	15103417	dilated cardiomyopathy	DOID_12930
11139	KAAB_FAILED_HEART_ATRIUM_UP	15103417	disease of anatomical entity	DOID_7
11140	KAAB_FAILED_HEART_ATRIUM_UP	15103417	extrinsic cardiomyopathy	DOID_3978
11141	KAAB_FAILED_HEART_ATRIUM_UP	15103417	heart disease	DOID_114
11142	KAAB_FAILED_HEART_ATRIUM_UP	15103417	intrinsic cardiomyopathy	DOID_0060036
11143	KAAB_FAILED_HEART_ATRIUM_UP	15103417	ischemia	DOID_326
11144	KAAB_FAILED_HEART_ATRIUM_UP	15103417	ischemic heart disease	DOID_3394
11145	KAAB_FAILED_HEART_ATRIUM_UP	15103417	vascular disease	DOID_178
11146	KAAB_FAILED_HEART_VENTRICLE_DN	15103417	cardiomyopathy	DOID_0050700
11147	KAAB_FAILED_HEART_VENTRICLE_DN	15103417	cardiovascular system disease	DOID_1287
11148	KAAB_FAILED_HEART_VENTRICLE_DN	15103417	dilated cardiomyopathy	DOID_12930
11149	KAAB_FAILED_HEART_VENTRICLE_DN	15103417	disease of anatomical entity	DOID_7
11150	KAAB_FAILED_HEART_VENTRICLE_DN	15103417	extrinsic cardiomyopathy	DOID_3978
11151	KAAB_FAILED_HEART_VENTRICLE_DN	15103417	heart disease	DOID_114
11152	KAAB_FAILED_HEART_VENTRICLE_DN	15103417	intrinsic cardiomyopathy	DOID_0060036
11153	KAAB_FAILED_HEART_VENTRICLE_DN	15103417	ischemia	DOID_326
11154	KAAB_FAILED_HEART_VENTRICLE_DN	15103417	ischemic heart disease	DOID_3394
11155	KAAB_FAILED_HEART_VENTRICLE_DN	15103417	vascular disease	DOID_178
11156	GEORGANTAS_HSC_MARKERS	15231652	cancer	DOID_162
11157	GEORGANTAS_HSC_MARKERS	15231652	disease of cellular proliferation	DOID_14566
11158	LY_AGING_PREMATURE_DN	10741968	autosomal genetic disease	DOID_0050739
11159	LY_AGING_PREMATURE_DN	10741968	autosomal recessive disease	DOID_0050737
11160	LY_AGING_PREMATURE_DN	10741968	genetic disease	DOID_630
11161	LY_AGING_PREMATURE_DN	10741968	genetic disorder	DOID_0050325
11162	LY_AGING_PREMATURE_DN	10741968	medical disorder	DOID_0060035
11163	LY_AGING_PREMATURE_DN	10741968	monogenic disease	DOID_0050177
11164	LY_AGING_PREMATURE_DN	10741968	progeria	DOID_3911
11165	SEMENZA_HIF1_TARGETS	11516994	brain ischemia	DOID_2316
11166	SEMENZA_HIF1_TARGETS	11516994	cancer	DOID_162
11167	SEMENZA_HIF1_TARGETS	11516994	cardiovascular system disease	DOID_1287
11168	SEMENZA_HIF1_TARGETS	11516994	disease of anatomical entity	DOID_7
11169	SEMENZA_HIF1_TARGETS	11516994	disease of cellular proliferation	DOID_14566
11170	SEMENZA_HIF1_TARGETS	11516994	hypertension	DOID_10763
11171	SEMENZA_HIF1_TARGETS	11516994	ischemia	DOID_326
11172	SEMENZA_HIF1_TARGETS	11516994	pulmonary hypertension	DOID_6432
11173	SEMENZA_HIF1_TARGETS	11516994	vascular disease	DOID_178
11174	CHANG_IMMORTALIZED_BY_HPV31_DN	10756030	NA	NA
11175	CHANG_IMMORTALIZED_BY_HPV31_UP	10756030	NA	NA
11176	SU_KIDNEY	11904358	NA	NA
11177	SU_LIVER	11904358	NA	NA
11178	SU_PANCREAS	11904358	NA	NA
11179	SU_PLACENTA	11904358	NA	NA
11180	SU_SALIVARY_GLAND	11904358	NA	NA
11181	SU_TESTIS	11904358	NA	NA
11182	SU_THYMUS	11904358	NA	NA
11183	WEBER_METHYLATED_IN_COLON_CANCER	16007088	cancer	DOID_162
11184	WEBER_METHYLATED_IN_COLON_CANCER	16007088	disease of cellular proliferation	DOID_14566
11185	JIANG_HYPOXIA_NORMAL	12692265	cancer	DOID_162
11186	JIANG_HYPOXIA_NORMAL	12692265	carcinoma	DOID_305
11187	JIANG_HYPOXIA_NORMAL	12692265	cell type cancer	DOID_0050687
11188	JIANG_HYPOXIA_NORMAL	12692265	disease of cellular proliferation	DOID_14566
11189	JIANG_HYPOXIA_NORMAL	12692265	kidney cancer	DOID_263
11190	JIANG_HYPOXIA_NORMAL	12692265	organ system cancer	DOID_0050686
11191	JIANG_HYPOXIA_NORMAL	12692265	renal carcinoma	DOID_4451
11192	JIANG_HYPOXIA_NORMAL	12692265	renal cell carcinoma	DOID_4450
11193	JIANG_HYPOXIA_NORMAL	12692265	urinary system cancer	DOID_3996
11194	JIANG_HYPOXIA_CANCER	12692265	cancer	DOID_162
11195	JIANG_HYPOXIA_CANCER	12692265	carcinoma	DOID_305
11196	JIANG_HYPOXIA_CANCER	12692265	cell type cancer	DOID_0050687
11197	JIANG_HYPOXIA_CANCER	12692265	disease of cellular proliferation	DOID_14566
11198	JIANG_HYPOXIA_CANCER	12692265	kidney cancer	DOID_263
11199	JIANG_HYPOXIA_CANCER	12692265	organ system cancer	DOID_0050686
11200	JIANG_HYPOXIA_CANCER	12692265	renal carcinoma	DOID_4451
11201	JIANG_HYPOXIA_CANCER	12692265	renal cell carcinoma	DOID_4450
11202	JIANG_HYPOXIA_CANCER	12692265	urinary system cancer	DOID_3996
11203	LEONARD_HYPOXIA	12885785	disease of anatomical entity	DOID_7
11204	LEONARD_HYPOXIA	12885785	kidney disease	DOID_557
11205	LEONARD_HYPOXIA	12885785	kidney failure	DOID_1074
11206	LEONARD_HYPOXIA	12885785	urinary system disease	DOID_18
11207	HARRIS_HYPOXIA	11902584	cancer	DOID_162
11208	HARRIS_HYPOXIA	11902584	disease of cellular proliferation	DOID_14566
11209	EHRLICH_ICF_SYNDROM_DN	11741835	syndrome	DOID_225
11210	TRACEY_RESISTANCE_TO_IFNA2_DN	12414529	cancer	DOID_162
11211	TRACEY_RESISTANCE_TO_IFNA2_DN	12414529	cutaneous T cell lymphoma	DOID_0060061
11212	TRACEY_RESISTANCE_TO_IFNA2_DN	12414529	disease by infectious agent	DOID_0050117
11213	TRACEY_RESISTANCE_TO_IFNA2_DN	12414529	disease of cellular proliferation	DOID_14566
11214	TRACEY_RESISTANCE_TO_IFNA2_DN	12414529	fungal infectious disease	DOID_1564
11215	TRACEY_RESISTANCE_TO_IFNA2_DN	12414529	hematologic cancer	DOID_2531
11216	TRACEY_RESISTANCE_TO_IFNA2_DN	12414529	immune system cancer	DOID_0060083
11217	TRACEY_RESISTANCE_TO_IFNA2_DN	12414529	lymphoma	DOID_0060058
11218	TRACEY_RESISTANCE_TO_IFNA2_DN	12414529	mature T-cell and NK-cell neoplasm	DOID_0050743
11219	TRACEY_RESISTANCE_TO_IFNA2_DN	12414529	mycosis fungoides	DOID_8691
11220	TRACEY_RESISTANCE_TO_IFNA2_DN	12414529	organ system cancer	DOID_0050686
11221	TRACEY_RESISTANCE_TO_IFNA2_DN	12414529	peripheral T-cell lymphoma	DOID_0050749
11222	BROWNE_INTERFERON_RESPONSIVE_GENES	11711622	NA	NA
11223	NATSUME_RESPONSE_TO_INTERFERON_BETA_DN	16140920	cancer	DOID_162
11224	NATSUME_RESPONSE_TO_INTERFERON_BETA_DN	16140920	cell type cancer	DOID_0050687
11225	NATSUME_RESPONSE_TO_INTERFERON_BETA_DN	16140920	disease of cellular proliferation	DOID_14566
11226	NATSUME_RESPONSE_TO_INTERFERON_BETA_DN	16140920	malignant glioma	DOID_3070
11227	NATSUME_RESPONSE_TO_INTERFERON_BETA_UP	16140920	cancer	DOID_162
11228	NATSUME_RESPONSE_TO_INTERFERON_BETA_UP	16140920	cell type cancer	DOID_0050687
11229	NATSUME_RESPONSE_TO_INTERFERON_BETA_UP	16140920	disease of cellular proliferation	DOID_14566
11230	NATSUME_RESPONSE_TO_INTERFERON_BETA_UP	16140920	malignant glioma	DOID_3070
11231	MAHAJAN_RESPONSE_TO_IL1A_DN	12091409	NA	NA
11232	MAHAJAN_RESPONSE_TO_IL1A_UP	12091409	NA	NA
11233	DASU_IL6_SIGNALING_SCAR_DN	15095275	NA	NA
11234	DASU_IL6_SIGNALING_SCAR_UP	15095275	NA	NA
11235	ABE_INNER_EAR	12471561	auditory system disease	DOID_2742
11236	ABE_INNER_EAR	12471561	disease of anatomical entity	DOID_7
11237	ABE_INNER_EAR	12471561	nervous system disease	DOID_863
11238	ABE_INNER_EAR	12471561	nonsyndromic deafness	DOID_0050563
11239	ABE_INNER_EAR	12471561	sensory system disease	DOID_0050155
11240	CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN	12824457	cardiomyopathy	DOID_0050700
11241	CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN	12824457	cardiovascular system disease	DOID_1287
11242	CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN	12824457	dilated cardiomyopathy	DOID_12930
11243	CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN	12824457	disease of anatomical entity	DOID_7
11244	CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN	12824457	heart disease	DOID_114
11245	CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN	12824457	intrinsic cardiomyopathy	DOID_0060036
11246	CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP	12824457	cardiomyopathy	DOID_0050700
11247	CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP	12824457	cardiovascular system disease	DOID_1287
11248	CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP	12824457	dilated cardiomyopathy	DOID_12930
11249	CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP	12824457	disease of anatomical entity	DOID_7
11250	CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP	12824457	heart disease	DOID_114
11251	CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP	12824457	intrinsic cardiomyopathy	DOID_0060036
11252	RAMASWAMY_METASTASIS_DN	12469122	adenocarcinoma	DOID_299
11253	RAMASWAMY_METASTASIS_DN	12469122	cancer	DOID_162
11254	RAMASWAMY_METASTASIS_DN	12469122	carcinoma	DOID_305
11255	RAMASWAMY_METASTASIS_DN	12469122	cell type cancer	DOID_0050687
11256	RAMASWAMY_METASTASIS_DN	12469122	disease of cellular proliferation	DOID_14566
11257	RAMASWAMY_METASTASIS_UP	12469122	adenocarcinoma	DOID_299
11258	RAMASWAMY_METASTASIS_UP	12469122	cancer	DOID_162
11259	RAMASWAMY_METASTASIS_UP	12469122	carcinoma	DOID_305
11260	RAMASWAMY_METASTASIS_UP	12469122	cell type cancer	DOID_0050687
11261	RAMASWAMY_METASTASIS_UP	12469122	disease of cellular proliferation	DOID_14566
11262	LY_AGING_MIDDLE_DN	10741968	autosomal genetic disease	DOID_0050739
11263	LY_AGING_MIDDLE_DN	10741968	autosomal recessive disease	DOID_0050737
11264	LY_AGING_MIDDLE_DN	10741968	genetic disease	DOID_630
11265	LY_AGING_MIDDLE_DN	10741968	genetic disorder	DOID_0050325
11266	LY_AGING_MIDDLE_DN	10741968	medical disorder	DOID_0060035
11267	LY_AGING_MIDDLE_DN	10741968	monogenic disease	DOID_0050177
11268	LY_AGING_MIDDLE_DN	10741968	progeria	DOID_3911
11269	LY_AGING_MIDDLE_UP	10741968	autosomal genetic disease	DOID_0050739
11270	LY_AGING_MIDDLE_UP	10741968	autosomal recessive disease	DOID_0050737
11271	LY_AGING_MIDDLE_UP	10741968	genetic disease	DOID_630
11272	LY_AGING_MIDDLE_UP	10741968	genetic disorder	DOID_0050325
11273	LY_AGING_MIDDLE_UP	10741968	medical disorder	DOID_0060035
11274	LY_AGING_MIDDLE_UP	10741968	monogenic disease	DOID_0050177
11275	LY_AGING_MIDDLE_UP	10741968	progeria	DOID_3911
11276	KRASNOSELSKAYA_ILF3_TARGETS_DN	12036489	disease by infectious agent	DOID_0050117
11277	KRASNOSELSKAYA_ILF3_TARGETS_DN	12036489	viral infectious disease	DOID_934
11278	KRASNOSELSKAYA_ILF3_TARGETS_UP	12036489	disease by infectious agent	DOID_0050117
11279	KRASNOSELSKAYA_ILF3_TARGETS_UP	12036489	viral infectious disease	DOID_934
11280	CHENG_RESPONSE_TO_NICKEL_ACETATE	12915101	cancer	DOID_162
11281	CHENG_RESPONSE_TO_NICKEL_ACETATE	12915101	disease of cellular proliferation	DOID_14566
11282	CHENG_RESPONSE_TO_NICKEL_ACETATE	12915101	lung cancer	DOID_1324
11283	CHENG_RESPONSE_TO_NICKEL_ACETATE	12915101	organ system cancer	DOID_0050686
11284	CHENG_RESPONSE_TO_NICKEL_ACETATE	12915101	respiratory system cancer	DOID_0050615
11285	BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_DN	12479369	cancer	DOID_162
11286	BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_DN	12479369	cell type cancer	DOID_0050687
11287	BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_DN	12479369	disease of cellular proliferation	DOID_14566
11288	BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_DN	12479369	germ cell and embryonal cancer	DOID_3095
11289	BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_DN	12479369	germ cell cancer	DOID_2994
11290	BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_DN	12479369	medulloblastoma	DOID_3858
11291	BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_DN	12479369	muscle cancer	DOID_4045
11292	BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_DN	12479369	musculoskeletal system cancer	DOID_0060100
11293	BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_DN	12479369	neuroectodermal tumor	DOID_171
11294	BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_DN	12479369	organ system cancer	DOID_0050686
11295	BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_DN	12479369	primitive neuroectodermal tumor	DOID_168
11296	BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_DN	12479369	rhabdomyosarcoma	DOID_3247
11297	BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_DN	12479369	skeletal muscle cancer	DOID_4043
11298	BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_UP	12479369	cancer	DOID_162
11299	BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_UP	12479369	cell type cancer	DOID_0050687
11300	BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_UP	12479369	disease of cellular proliferation	DOID_14566
11301	BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_UP	12479369	germ cell and embryonal cancer	DOID_3095
11302	BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_UP	12479369	germ cell cancer	DOID_2994
11303	BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_UP	12479369	medulloblastoma	DOID_3858
11304	BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_UP	12479369	muscle cancer	DOID_4045
11305	BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_UP	12479369	musculoskeletal system cancer	DOID_0060100
11306	BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_UP	12479369	neuroectodermal tumor	DOID_171
11307	BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_UP	12479369	organ system cancer	DOID_0050686
11308	BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_UP	12479369	primitive neuroectodermal tumor	DOID_168
11309	BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_UP	12479369	rhabdomyosarcoma	DOID_3247
11310	BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_UP	12479369	skeletal muscle cancer	DOID_4043
11311	LY_AGING_OLD_DN	10741968	autosomal genetic disease	DOID_0050739
11312	LY_AGING_OLD_DN	10741968	autosomal recessive disease	DOID_0050737
11313	LY_AGING_OLD_DN	10741968	genetic disease	DOID_630
11314	LY_AGING_OLD_DN	10741968	genetic disorder	DOID_0050325
11315	LY_AGING_OLD_DN	10741968	medical disorder	DOID_0060035
11316	LY_AGING_OLD_DN	10741968	monogenic disease	DOID_0050177
11317	LY_AGING_OLD_DN	10741968	progeria	DOID_3911
11318	CHUANG_OXIDATIVE_STRESS_RESPONSE_UP	12414654	breast cancer	DOID_1612
11319	CHUANG_OXIDATIVE_STRESS_RESPONSE_UP	12414654	cancer	DOID_162
11320	CHUANG_OXIDATIVE_STRESS_RESPONSE_UP	12414654	disease of cellular proliferation	DOID_14566
11321	CHUANG_OXIDATIVE_STRESS_RESPONSE_UP	12414654	organ system cancer	DOID_0050686
11322	CHUANG_OXIDATIVE_STRESS_RESPONSE_UP	12414654	thoracic cancer	DOID_5093
11323	WEIGEL_OXIDATIVE_STRESS_RESPONSE	12419474	age related macular degeneration	DOID_10871
11324	WEIGEL_OXIDATIVE_STRESS_RESPONSE	12419474	degeneration of macula and posterior pole	DOID_2007
11325	WEIGEL_OXIDATIVE_STRESS_RESPONSE	12419474	disease of anatomical entity	DOID_7
11326	WEIGEL_OXIDATIVE_STRESS_RESPONSE	12419474	eye and adnexa disease	DOID_1492
11327	WEIGEL_OXIDATIVE_STRESS_RESPONSE	12419474	eye disease	DOID_5614
11328	WEIGEL_OXIDATIVE_STRESS_RESPONSE	12419474	globe disease	DOID_1242
11329	WEIGEL_OXIDATIVE_STRESS_RESPONSE	12419474	macular degeneration	DOID_4448
11330	WEIGEL_OXIDATIVE_STRESS_RESPONSE	12419474	nervous system disease	DOID_863
11331	WEIGEL_OXIDATIVE_STRESS_RESPONSE	12419474	retinal degeneration	DOID_8466
11332	WEIGEL_OXIDATIVE_STRESS_RESPONSE	12419474	retinal disease	DOID_5679
11333	WEIGEL_OXIDATIVE_STRESS_RESPONSE	12419474	sensory system disease	DOID_0050155
11334	WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2	12419474	age related macular degeneration	DOID_10871
11335	WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2	12419474	degeneration of macula and posterior pole	DOID_2007
11336	WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2	12419474	disease of anatomical entity	DOID_7
11337	WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2	12419474	eye and adnexa disease	DOID_1492
11338	WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2	12419474	eye disease	DOID_5614
11339	WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2	12419474	globe disease	DOID_1242
11340	WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2	12419474	macular degeneration	DOID_4448
11341	WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2	12419474	nervous system disease	DOID_863
11342	WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2	12419474	retinal degeneration	DOID_8466
11343	WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2	12419474	retinal disease	DOID_5679
11344	WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2	12419474	sensory system disease	DOID_0050155
11345	WEIGEL_OXIDATIVE_STRESS_BY_TBH_AND_H2O2	12419474	age related macular degeneration	DOID_10871
11346	WEIGEL_OXIDATIVE_STRESS_BY_TBH_AND_H2O2	12419474	degeneration of macula and posterior pole	DOID_2007
11347	WEIGEL_OXIDATIVE_STRESS_BY_TBH_AND_H2O2	12419474	disease of anatomical entity	DOID_7
11348	WEIGEL_OXIDATIVE_STRESS_BY_TBH_AND_H2O2	12419474	eye and adnexa disease	DOID_1492
11349	WEIGEL_OXIDATIVE_STRESS_BY_TBH_AND_H2O2	12419474	eye disease	DOID_5614
11350	WEIGEL_OXIDATIVE_STRESS_BY_TBH_AND_H2O2	12419474	globe disease	DOID_1242
11351	WEIGEL_OXIDATIVE_STRESS_BY_TBH_AND_H2O2	12419474	macular degeneration	DOID_4448
11352	WEIGEL_OXIDATIVE_STRESS_BY_TBH_AND_H2O2	12419474	nervous system disease	DOID_863
11353	WEIGEL_OXIDATIVE_STRESS_BY_TBH_AND_H2O2	12419474	retinal degeneration	DOID_8466
11354	WEIGEL_OXIDATIVE_STRESS_BY_TBH_AND_H2O2	12419474	retinal disease	DOID_5679
11355	WEIGEL_OXIDATIVE_STRESS_BY_TBH_AND_H2O2	12419474	sensory system disease	DOID_0050155
11356	WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_TBH	12419474	age related macular degeneration	DOID_10871
11357	WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_TBH	12419474	degeneration of macula and posterior pole	DOID_2007
11358	WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_TBH	12419474	disease of anatomical entity	DOID_7
11359	WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_TBH	12419474	eye and adnexa disease	DOID_1492
11360	WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_TBH	12419474	eye disease	DOID_5614
11361	WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_TBH	12419474	globe disease	DOID_1242
11362	WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_TBH	12419474	macular degeneration	DOID_4448
11363	WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_TBH	12419474	nervous system disease	DOID_863
11364	WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_TBH	12419474	retinal degeneration	DOID_8466
11365	WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_TBH	12419474	retinal disease	DOID_5679
11366	WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_TBH	12419474	sensory system disease	DOID_0050155
11367	INGA_TP53_TARGETS	12446780	breast cancer	DOID_1612
11368	INGA_TP53_TARGETS	12446780	cancer	DOID_162
11369	INGA_TP53_TARGETS	12446780	disease of cellular proliferation	DOID_14566
11370	INGA_TP53_TARGETS	12446780	organ system cancer	DOID_0050686
11371	INGA_TP53_TARGETS	12446780	thoracic cancer	DOID_5093
11372	KIM_GASTRIC_CANCER_CHEMOSENSITIVITY	15033468	cancer	DOID_162
11373	KIM_GASTRIC_CANCER_CHEMOSENSITIVITY	15033468	disease of cellular proliferation	DOID_14566
11374	DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN	12885910	NA	NA
11375	DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP	12885910	NA	NA
11376	ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN	12719586	disease by infectious agent	DOID_0050117
11377	ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN	12719586	viral infectious disease	DOID_934
11378	ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_UP	12719586	disease by infectious agent	DOID_0050117
11379	ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_UP	12719586	viral infectious disease	DOID_934
11380	VERRECCHIA_RESPONSE_TO_TGFB1_C1	11279127	NA	NA
11381	VERRECCHIA_RESPONSE_TO_TGFB1_C2	11279127	NA	NA
11382	VERRECCHIA_RESPONSE_TO_TGFB1_C3	11279127	NA	NA
11383	VERRECCHIA_RESPONSE_TO_TGFB1_C4	11279127	NA	NA
11384	VERRECCHIA_RESPONSE_TO_TGFB1_C5	11279127	NA	NA
11385	VERRECCHIA_EARLY_RESPONSE_TO_TGFB1	11279127	NA	NA
11386	VERRECCHIA_DELAYED_RESPONSE_TO_TGFB1	11279127	NA	NA
11387	SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER	12839967	cancer	DOID_162
11388	SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER	12839967	carcinoma	DOID_305
11389	SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER	12839967	cell type cancer	DOID_0050687
11390	SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER	12839967	disease of cellular proliferation	DOID_14566
11391	SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER	12839967	endocrine gland cancer	DOID_170
11392	SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER	12839967	organ system cancer	DOID_0050686
11393	SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER	12839967	pancreatic cancer	DOID_1793
11394	SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER	12839967	pancreatic carcinoma	DOID_4905
11395	MOREIRA_RESPONSE_TO_TSA_DN	14606959	NA	NA
11396	MOREIRA_RESPONSE_TO_TSA_UP	14606959	NA	NA
11397	CHIBA_RESPONSE_TO_TSA_DN	15452378	cancer	DOID_162
11398	CHIBA_RESPONSE_TO_TSA_DN	15452378	carcinoma	DOID_305
11399	CHIBA_RESPONSE_TO_TSA_DN	15452378	cell type cancer	DOID_0050687
11400	CHIBA_RESPONSE_TO_TSA_DN	15452378	disease of cellular proliferation	DOID_14566
11401	CHIBA_RESPONSE_TO_TSA_DN	15452378	gastrointestinal system cancer	DOID_3119
11402	CHIBA_RESPONSE_TO_TSA_DN	15452378	hepatocellular carcinoma	DOID_684
11403	CHIBA_RESPONSE_TO_TSA_DN	15452378	liver cancer	DOID_3571
11404	CHIBA_RESPONSE_TO_TSA_DN	15452378	liver carcinoma	DOID_686
11405	CHIBA_RESPONSE_TO_TSA_DN	15452378	organ system cancer	DOID_0050686
11406	CHIBA_RESPONSE_TO_TSA_UP	15452378	cancer	DOID_162
11407	CHIBA_RESPONSE_TO_TSA_UP	15452378	carcinoma	DOID_305
11408	CHIBA_RESPONSE_TO_TSA_UP	15452378	cell type cancer	DOID_0050687
11409	CHIBA_RESPONSE_TO_TSA_UP	15452378	disease of cellular proliferation	DOID_14566
11410	CHIBA_RESPONSE_TO_TSA_UP	15452378	gastrointestinal system cancer	DOID_3119
11411	CHIBA_RESPONSE_TO_TSA_UP	15452378	hepatocellular carcinoma	DOID_684
11412	CHIBA_RESPONSE_TO_TSA_UP	15452378	liver cancer	DOID_3571
11413	CHIBA_RESPONSE_TO_TSA_UP	15452378	liver carcinoma	DOID_686
11414	CHIBA_RESPONSE_TO_TSA_UP	15452378	organ system cancer	DOID_0050686
11415	CHIBA_RESPONSE_TO_TSA	15336447	cancer	DOID_162
11416	CHIBA_RESPONSE_TO_TSA	15336447	carcinoma	DOID_305
11417	CHIBA_RESPONSE_TO_TSA	15336447	cell type cancer	DOID_0050687
11418	CHIBA_RESPONSE_TO_TSA	15336447	disease of cellular proliferation	DOID_14566
11419	CHIBA_RESPONSE_TO_TSA	15336447	gastrointestinal system cancer	DOID_3119
11420	CHIBA_RESPONSE_TO_TSA	15336447	hepatocellular carcinoma	DOID_684
11421	CHIBA_RESPONSE_TO_TSA	15336447	liver cancer	DOID_3571
11422	CHIBA_RESPONSE_TO_TSA	15336447	liver carcinoma	DOID_686
11423	CHIBA_RESPONSE_TO_TSA	15336447	organ system cancer	DOID_0050686
11424	SATO_SILENCED_BY_DEACETYLATION_IN_PANCREATIC_CANCER	12839967	cancer	DOID_162
11425	SATO_SILENCED_BY_DEACETYLATION_IN_PANCREATIC_CANCER	12839967	carcinoma	DOID_305
11426	SATO_SILENCED_BY_DEACETYLATION_IN_PANCREATIC_CANCER	12839967	cell type cancer	DOID_0050687
11427	SATO_SILENCED_BY_DEACETYLATION_IN_PANCREATIC_CANCER	12839967	disease of cellular proliferation	DOID_14566
11428	SATO_SILENCED_BY_DEACETYLATION_IN_PANCREATIC_CANCER	12839967	endocrine gland cancer	DOID_170
11429	SATO_SILENCED_BY_DEACETYLATION_IN_PANCREATIC_CANCER	12839967	organ system cancer	DOID_0050686
11430	SATO_SILENCED_BY_DEACETYLATION_IN_PANCREATIC_CANCER	12839967	pancreatic cancer	DOID_1793
11431	SATO_SILENCED_BY_DEACETYLATION_IN_PANCREATIC_CANCER	12839967	pancreatic carcinoma	DOID_4905
11432	DAZARD_UV_RESPONSE_CLUSTER_G1	12771951	cancer	DOID_162
11433	DAZARD_UV_RESPONSE_CLUSTER_G1	12771951	carcinoma	DOID_305
11434	DAZARD_UV_RESPONSE_CLUSTER_G1	12771951	cell type cancer	DOID_0050687
11435	DAZARD_UV_RESPONSE_CLUSTER_G1	12771951	disease of cellular proliferation	DOID_14566
11436	DAZARD_UV_RESPONSE_CLUSTER_G1	12771951	squamous cell carcinoma	DOID_1749
11437	DAZARD_UV_RESPONSE_CLUSTER_G2	12771951	cancer	DOID_162
11438	DAZARD_UV_RESPONSE_CLUSTER_G2	12771951	carcinoma	DOID_305
11439	DAZARD_UV_RESPONSE_CLUSTER_G2	12771951	cell type cancer	DOID_0050687
11440	DAZARD_UV_RESPONSE_CLUSTER_G2	12771951	disease of cellular proliferation	DOID_14566
11441	DAZARD_UV_RESPONSE_CLUSTER_G2	12771951	squamous cell carcinoma	DOID_1749
11442	DAZARD_UV_RESPONSE_CLUSTER_G3	12771951	cancer	DOID_162
11443	DAZARD_UV_RESPONSE_CLUSTER_G3	12771951	carcinoma	DOID_305
11444	DAZARD_UV_RESPONSE_CLUSTER_G3	12771951	cell type cancer	DOID_0050687
11445	DAZARD_UV_RESPONSE_CLUSTER_G3	12771951	disease of cellular proliferation	DOID_14566
11446	DAZARD_UV_RESPONSE_CLUSTER_G3	12771951	squamous cell carcinoma	DOID_1749
11447	DAZARD_UV_RESPONSE_CLUSTER_G4	12771951	cancer	DOID_162
11448	DAZARD_UV_RESPONSE_CLUSTER_G4	12771951	carcinoma	DOID_305
11449	DAZARD_UV_RESPONSE_CLUSTER_G4	12771951	cell type cancer	DOID_0050687
11450	DAZARD_UV_RESPONSE_CLUSTER_G4	12771951	disease of cellular proliferation	DOID_14566
11451	DAZARD_UV_RESPONSE_CLUSTER_G4	12771951	squamous cell carcinoma	DOID_1749
11452	DAZARD_UV_RESPONSE_CLUSTER_G6	12771951	cancer	DOID_162
11453	DAZARD_UV_RESPONSE_CLUSTER_G6	12771951	carcinoma	DOID_305
11454	DAZARD_UV_RESPONSE_CLUSTER_G6	12771951	cell type cancer	DOID_0050687
11455	DAZARD_UV_RESPONSE_CLUSTER_G6	12771951	disease of cellular proliferation	DOID_14566
11456	DAZARD_UV_RESPONSE_CLUSTER_G6	12771951	squamous cell carcinoma	DOID_1749
11457	DAZARD_RESPONSE_TO_UV_NHEK_DN	12771951	cancer	DOID_162
11458	DAZARD_RESPONSE_TO_UV_NHEK_DN	12771951	carcinoma	DOID_305
11459	DAZARD_RESPONSE_TO_UV_NHEK_DN	12771951	cell type cancer	DOID_0050687
11460	DAZARD_RESPONSE_TO_UV_NHEK_DN	12771951	disease of cellular proliferation	DOID_14566
11461	DAZARD_RESPONSE_TO_UV_NHEK_DN	12771951	squamous cell carcinoma	DOID_1749
11462	DAZARD_RESPONSE_TO_UV_NHEK_UP	12771951	cancer	DOID_162
11463	DAZARD_RESPONSE_TO_UV_NHEK_UP	12771951	carcinoma	DOID_305
11464	DAZARD_RESPONSE_TO_UV_NHEK_UP	12771951	cell type cancer	DOID_0050687
11465	DAZARD_RESPONSE_TO_UV_NHEK_UP	12771951	disease of cellular proliferation	DOID_14566
11466	DAZARD_RESPONSE_TO_UV_NHEK_UP	12771951	squamous cell carcinoma	DOID_1749
11467	TAKAO_RESPONSE_TO_UVB_RADIATION_DN	11982916	NA	NA
11468	TAKAO_RESPONSE_TO_UVB_RADIATION_UP	11982916	NA	NA
11469	SESTO_RESPONSE_TO_UV_C0	11867738	cancer	DOID_162
11470	SESTO_RESPONSE_TO_UV_C0	11867738	disease of cellular proliferation	DOID_14566
11471	SESTO_RESPONSE_TO_UV_C1	11867738	cancer	DOID_162
11472	SESTO_RESPONSE_TO_UV_C1	11867738	disease of cellular proliferation	DOID_14566
11473	SESTO_RESPONSE_TO_UV_C2	11867738	cancer	DOID_162
11474	SESTO_RESPONSE_TO_UV_C2	11867738	disease of cellular proliferation	DOID_14566
11475	SESTO_RESPONSE_TO_UV_C3	11867738	cancer	DOID_162
11476	SESTO_RESPONSE_TO_UV_C3	11867738	disease of cellular proliferation	DOID_14566
11477	SESTO_RESPONSE_TO_UV_C4	11867738	cancer	DOID_162
11478	SESTO_RESPONSE_TO_UV_C4	11867738	disease of cellular proliferation	DOID_14566
11479	SESTO_RESPONSE_TO_UV_C5	11867738	cancer	DOID_162
11480	SESTO_RESPONSE_TO_UV_C5	11867738	disease of cellular proliferation	DOID_14566
11481	SESTO_RESPONSE_TO_UV_C6	11867738	cancer	DOID_162
11482	SESTO_RESPONSE_TO_UV_C6	11867738	disease of cellular proliferation	DOID_14566
11483	SESTO_RESPONSE_TO_UV_C7	11867738	cancer	DOID_162
11484	SESTO_RESPONSE_TO_UV_C7	11867738	disease of cellular proliferation	DOID_14566
11485	SESTO_RESPONSE_TO_UV_C8	11867738	cancer	DOID_162
11486	SESTO_RESPONSE_TO_UV_C8	11867738	disease of cellular proliferation	DOID_14566
11487	MURAKAMI_UV_RESPONSE_24HR	11532376	NA	NA
11488	MURAKAMI_UV_RESPONSE_6HR_DN	11532376	NA	NA
11489	MURAKAMI_UV_RESPONSE_6HR_UP	11532376	NA	NA
11490	DAZARD_RESPONSE_TO_UV_SCC_DN	12771951	cancer	DOID_162
11491	DAZARD_RESPONSE_TO_UV_SCC_DN	12771951	carcinoma	DOID_305
11492	DAZARD_RESPONSE_TO_UV_SCC_DN	12771951	cell type cancer	DOID_0050687
11493	DAZARD_RESPONSE_TO_UV_SCC_DN	12771951	disease of cellular proliferation	DOID_14566
11494	DAZARD_RESPONSE_TO_UV_SCC_DN	12771951	squamous cell carcinoma	DOID_1749
11495	DAZARD_RESPONSE_TO_UV_SCC_UP	12771951	cancer	DOID_162
11496	DAZARD_RESPONSE_TO_UV_SCC_UP	12771951	carcinoma	DOID_305
11497	DAZARD_RESPONSE_TO_UV_SCC_UP	12771951	cell type cancer	DOID_0050687
11498	DAZARD_RESPONSE_TO_UV_SCC_UP	12771951	disease of cellular proliferation	DOID_14566
11499	DAZARD_RESPONSE_TO_UV_SCC_UP	12771951	squamous cell carcinoma	DOID_1749
11500	GENTILE_UV_HIGH_DOSE_DN	12907719	NA	NA
11501	GENTILE_UV_HIGH_DOSE_UP	12907719	NA	NA
11502	GENTILE_UV_RESPONSE_CLUSTER_D1	12907719	NA	NA
11503	GENTILE_UV_RESPONSE_CLUSTER_D2	12907719	NA	NA
11504	GENTILE_RESPONSE_CLUSTER_D3	12907719	NA	NA
11505	GENTILE_UV_RESPONSE_CLUSTER_D4	12907719	NA	NA
11506	GENTILE_UV_RESPONSE_CLUSTER_D5	12907719	NA	NA
11507	GENTILE_UV_RESPONSE_CLUSTER_D6	12907719	NA	NA
11508	GENTILE_UV_RESPONSE_CLUSTER_D7	12907719	NA	NA
11509	GENTILE_UV_RESPONSE_CLUSTER_D8	12907719	NA	NA
11510	GENTILE_UV_RESPONSE_CLUSTER_D9	12907719	NA	NA
11511	GENTILE_UV_LOW_DOSE_DN	12907719	NA	NA
11512	GENTILE_UV_LOW_DOSE_UP	12907719	NA	NA
11513	ABE_VEGFA_TARGETS_2HR	12197474	chromosomal disease	DOID_0080014
11514	ABE_VEGFA_TARGETS_2HR	12197474	Down syndrome	DOID_14250
11515	ABE_VEGFA_TARGETS_2HR	12197474	genetic disease	DOID_630
11516	ABE_VEGFA_TARGETS_2HR	12197474	syndrome	DOID_225
11517	ABE_VEGFA_TARGETS_30MIN	12197474	chromosomal disease	DOID_0080014
11518	ABE_VEGFA_TARGETS_30MIN	12197474	Down syndrome	DOID_14250
11519	ABE_VEGFA_TARGETS_30MIN	12197474	genetic disease	DOID_630
11520	ABE_VEGFA_TARGETS_30MIN	12197474	syndrome	DOID_225
11521	ABE_VEGFA_TARGETS	12197474	chromosomal disease	DOID_0080014
11522	ABE_VEGFA_TARGETS	12197474	Down syndrome	DOID_14250
11523	ABE_VEGFA_TARGETS	12197474	genetic disease	DOID_630
11524	ABE_VEGFA_TARGETS	12197474	syndrome	DOID_225
11525	KAAB_HEART_ATRIUM_VS_VENTRICLE_DN	15103417	cardiomyopathy	DOID_0050700
11526	KAAB_HEART_ATRIUM_VS_VENTRICLE_DN	15103417	cardiovascular system disease	DOID_1287
11527	KAAB_HEART_ATRIUM_VS_VENTRICLE_DN	15103417	dilated cardiomyopathy	DOID_12930
11528	KAAB_HEART_ATRIUM_VS_VENTRICLE_DN	15103417	disease of anatomical entity	DOID_7
11529	KAAB_HEART_ATRIUM_VS_VENTRICLE_DN	15103417	extrinsic cardiomyopathy	DOID_3978
11530	KAAB_HEART_ATRIUM_VS_VENTRICLE_DN	15103417	heart disease	DOID_114
11531	KAAB_HEART_ATRIUM_VS_VENTRICLE_DN	15103417	intrinsic cardiomyopathy	DOID_0060036
11532	KAAB_HEART_ATRIUM_VS_VENTRICLE_DN	15103417	ischemia	DOID_326
11533	KAAB_HEART_ATRIUM_VS_VENTRICLE_DN	15103417	ischemic heart disease	DOID_3394
11534	KAAB_HEART_ATRIUM_VS_VENTRICLE_DN	15103417	vascular disease	DOID_178
11535	JIANG_VHL_TARGETS	12692265	cancer	DOID_162
11536	JIANG_VHL_TARGETS	12692265	carcinoma	DOID_305
11537	JIANG_VHL_TARGETS	12692265	cell type cancer	DOID_0050687
11538	JIANG_VHL_TARGETS	12692265	disease of cellular proliferation	DOID_14566
11539	JIANG_VHL_TARGETS	12692265	kidney cancer	DOID_263
11540	JIANG_VHL_TARGETS	12692265	organ system cancer	DOID_0050686
11541	JIANG_VHL_TARGETS	12692265	renal carcinoma	DOID_4451
11542	JIANG_VHL_TARGETS	12692265	renal cell carcinoma	DOID_4450
11543	JIANG_VHL_TARGETS	12692265	urinary system cancer	DOID_3996
11544	MOOTHA_HUMAN_MITODB_6_2002	12808457	acquired metabolic disease	DOID_0060158
11545	MOOTHA_HUMAN_MITODB_6_2002	12808457	carbohydrate metabolism disease	DOID_0050013
11546	MOOTHA_HUMAN_MITODB_6_2002	12808457	diabetes mellitus	DOID_9351
11547	MOOTHA_HUMAN_MITODB_6_2002	12808457	disease of metabolism	DOID_0014667
11548	MOOTHA_HUMAN_MITODB_6_2002	12808457	glucose metabolism disease	DOID_4194
11549	MOOTHA_MITOCHONDRIA	12808457	acquired metabolic disease	DOID_0060158
11550	MOOTHA_MITOCHONDRIA	12808457	carbohydrate metabolism disease	DOID_0050013
11551	MOOTHA_MITOCHONDRIA	12808457	diabetes mellitus	DOID_9351
11552	MOOTHA_MITOCHONDRIA	12808457	disease of metabolism	DOID_0014667
11553	MOOTHA_MITOCHONDRIA	12808457	glucose metabolism disease	DOID_4194
11554	MOOTHA_PGC	12808457	acquired metabolic disease	DOID_0060158
11555	MOOTHA_PGC	12808457	carbohydrate metabolism disease	DOID_0050013
11556	MOOTHA_PGC	12808457	diabetes mellitus	DOID_9351
11557	MOOTHA_PGC	12808457	disease of metabolism	DOID_0014667
11558	MOOTHA_PGC	12808457	glucose metabolism disease	DOID_4194
11559	MOOTHA_TCA	12808457	acquired metabolic disease	DOID_0060158
11560	MOOTHA_TCA	12808457	carbohydrate metabolism disease	DOID_0050013
11561	MOOTHA_TCA	12808457	diabetes mellitus	DOID_9351
11562	MOOTHA_TCA	12808457	disease of metabolism	DOID_0014667
11563	MOOTHA_TCA	12808457	glucose metabolism disease	DOID_4194
11564	NING_CHRONIC_OBSTRUCTIVE_PULMONARY_DISEASE_DN	15469929	chronic obstructive pulmonary disease	DOID_3083
11565	NING_CHRONIC_OBSTRUCTIVE_PULMONARY_DISEASE_DN	15469929	disease of anatomical entity	DOID_7
11566	NING_CHRONIC_OBSTRUCTIVE_PULMONARY_DISEASE_DN	15469929	lower respiratory tract disease	DOID_0050161
11567	NING_CHRONIC_OBSTRUCTIVE_PULMONARY_DISEASE_DN	15469929	lung disease	DOID_850
11568	NING_CHRONIC_OBSTRUCTIVE_PULMONARY_DISEASE_DN	15469929	obstructive lung disease	DOID_2320
11569	NING_CHRONIC_OBSTRUCTIVE_PULMONARY_DISEASE_DN	15469929	respiratory system disease	DOID_1579
11570	NING_CHRONIC_OBSTRUCTIVE_PULMONARY_DISEASE_UP	15469929	chronic obstructive pulmonary disease	DOID_3083
11571	NING_CHRONIC_OBSTRUCTIVE_PULMONARY_DISEASE_UP	15469929	disease of anatomical entity	DOID_7
11572	NING_CHRONIC_OBSTRUCTIVE_PULMONARY_DISEASE_UP	15469929	lower respiratory tract disease	DOID_0050161
11573	NING_CHRONIC_OBSTRUCTIVE_PULMONARY_DISEASE_UP	15469929	lung disease	DOID_850
11574	NING_CHRONIC_OBSTRUCTIVE_PULMONARY_DISEASE_UP	15469929	obstructive lung disease	DOID_2320
11575	NING_CHRONIC_OBSTRUCTIVE_PULMONARY_DISEASE_UP	15469929	respiratory system disease	DOID_1579
11576	ZUCCHI_METASTASIS_DN	15608061	breast cancer	DOID_1612
11577	ZUCCHI_METASTASIS_DN	15608061	breast carcinoma	DOID_3459
11578	ZUCCHI_METASTASIS_DN	15608061	cancer	DOID_162
11579	ZUCCHI_METASTASIS_DN	15608061	carcinoma	DOID_305
11580	ZUCCHI_METASTASIS_DN	15608061	cell type cancer	DOID_0050687
11581	ZUCCHI_METASTASIS_DN	15608061	disease of cellular proliferation	DOID_14566
11582	ZUCCHI_METASTASIS_DN	15608061	ductal carcinoma	DOID_3007
11583	ZUCCHI_METASTASIS_DN	15608061	invasive ductal carcinoma	DOID_3008
11584	ZUCCHI_METASTASIS_DN	15608061	organ system cancer	DOID_0050686
11585	ZUCCHI_METASTASIS_DN	15608061	thoracic cancer	DOID_5093
11586	ZUCCHI_METASTASIS_UP	15608061	breast cancer	DOID_1612
11587	ZUCCHI_METASTASIS_UP	15608061	breast carcinoma	DOID_3459
11588	ZUCCHI_METASTASIS_UP	15608061	cancer	DOID_162
11589	ZUCCHI_METASTASIS_UP	15608061	carcinoma	DOID_305
11590	ZUCCHI_METASTASIS_UP	15608061	cell type cancer	DOID_0050687
11591	ZUCCHI_METASTASIS_UP	15608061	disease of cellular proliferation	DOID_14566
11592	ZUCCHI_METASTASIS_UP	15608061	ductal carcinoma	DOID_3007
11593	ZUCCHI_METASTASIS_UP	15608061	invasive ductal carcinoma	DOID_3008
11594	ZUCCHI_METASTASIS_UP	15608061	organ system cancer	DOID_0050686
11595	ZUCCHI_METASTASIS_UP	15608061	thoracic cancer	DOID_5093
11596	LEE_LIVER_CANCER_SURVIVAL_DN	15349906	cancer	DOID_162
11597	LEE_LIVER_CANCER_SURVIVAL_DN	15349906	carcinoma	DOID_305
11598	LEE_LIVER_CANCER_SURVIVAL_DN	15349906	cell type cancer	DOID_0050687
11599	LEE_LIVER_CANCER_SURVIVAL_DN	15349906	disease of cellular proliferation	DOID_14566
11600	LEE_LIVER_CANCER_SURVIVAL_DN	15349906	gastrointestinal system cancer	DOID_3119
11601	LEE_LIVER_CANCER_SURVIVAL_DN	15349906	hepatocellular carcinoma	DOID_684
11602	LEE_LIVER_CANCER_SURVIVAL_DN	15349906	liver cancer	DOID_3571
11603	LEE_LIVER_CANCER_SURVIVAL_DN	15349906	liver carcinoma	DOID_686
11604	LEE_LIVER_CANCER_SURVIVAL_DN	15349906	organ system cancer	DOID_0050686
11605	LEE_LIVER_CANCER_SURVIVAL_UP	15349906	cancer	DOID_162
11606	LEE_LIVER_CANCER_SURVIVAL_UP	15349906	carcinoma	DOID_305
11607	LEE_LIVER_CANCER_SURVIVAL_UP	15349906	cell type cancer	DOID_0050687
11608	LEE_LIVER_CANCER_SURVIVAL_UP	15349906	disease of cellular proliferation	DOID_14566
11609	LEE_LIVER_CANCER_SURVIVAL_UP	15349906	gastrointestinal system cancer	DOID_3119
11610	LEE_LIVER_CANCER_SURVIVAL_UP	15349906	hepatocellular carcinoma	DOID_684
11611	LEE_LIVER_CANCER_SURVIVAL_UP	15349906	liver cancer	DOID_3571
11612	LEE_LIVER_CANCER_SURVIVAL_UP	15349906	liver carcinoma	DOID_686
11613	LEE_LIVER_CANCER_SURVIVAL_UP	15349906	organ system cancer	DOID_0050686
11614	ZHANG_TARGETS_OF_EWSR1_FLI1_FUSION	15930281	cancer	DOID_162
11615	ZHANG_TARGETS_OF_EWSR1_FLI1_FUSION	15930281	cell type cancer	DOID_0050687
11616	ZHANG_TARGETS_OF_EWSR1_FLI1_FUSION	15930281	combined T cell and B cell immunodeficiency	DOID_628
11617	ZHANG_TARGETS_OF_EWSR1_FLI1_FUSION	15930281	disease of anatomical entity	DOID_7
11618	ZHANG_TARGETS_OF_EWSR1_FLI1_FUSION	15930281	disease of cellular proliferation	DOID_14566
11619	ZHANG_TARGETS_OF_EWSR1_FLI1_FUSION	15930281	immune system disease	DOID_2914
11620	ZHANG_TARGETS_OF_EWSR1_FLI1_FUSION	15930281	muscle cancer	DOID_4045
11621	ZHANG_TARGETS_OF_EWSR1_FLI1_FUSION	15930281	musculoskeletal system cancer	DOID_0060100
11622	ZHANG_TARGETS_OF_EWSR1_FLI1_FUSION	15930281	organ system cancer	DOID_0050686
11623	ZHANG_TARGETS_OF_EWSR1_FLI1_FUSION	15930281	primary immunodeficiency disease	DOID_612
11624	ZHANG_TARGETS_OF_EWSR1_FLI1_FUSION	15930281	rhabdomyosarcoma	DOID_3247
11625	ZHANG_TARGETS_OF_EWSR1_FLI1_FUSION	15930281	sarcoma	DOID_1115
11626	ZHANG_TARGETS_OF_EWSR1_FLI1_FUSION	15930281	severe combined immunodeficiency	DOID_627
11627	ZHANG_TARGETS_OF_EWSR1_FLI1_FUSION	15930281	skeletal muscle cancer	DOID_4043